data_1nfa_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1nfa _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.467 ' O ' ' HA3' ' A' ' 52' ' ' GLY . 34.7 Cg_endo . . . . . 0 C--O 1.213 -0.753 0 N-CA-C 110.238 -0.716 . . . . 1.0 110.238 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.577 ' CE2' ' O ' ' A' ' 162' ' ' THR . 2.8 m-85 -69.31 135.19 50.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 1.0 109.568 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 51' ' ' HIS . 3.3 pt-20 -172.31 126.8 0.54 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.964 -1.085 . . . . 1.0 109.838 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.509 ' O ' ' CG ' ' A' ' 15' ' ' LEU . 1.3 pp -108.55 87.81 2.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.333 -0.854 . . . . 1.0 109.264 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -101.63 148.31 25.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.187 -0.945 . . . . 1.0 109.768 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 47' ' ' ILE . 1.2 mp -69.55 141.74 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.378 -0.826 . . . . 1.0 108.824 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.495 ' OE2' ' CZ ' ' A' ' 115' ' ' ARG . 4.9 tt0 -76.6 -32.93 58.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.296 -0.878 . . . . 1.0 109.816 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.457 ' HB ' HG12 ' A' ' 47' ' ' ILE . 98.2 t -142.29 134.54 26.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.186 -0.946 . . . . 1.0 109.631 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.79 99.92 41.18 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.357 -0.84 . . . . 1.0 109.287 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 46' ' ' PRO . 34.9 Cg_endo -76.53 -179.21 5.1 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.396 2.064 . . . . 1.0 110.576 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -43.18 162.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 1.0 109.476 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.483 ' CB ' ' HG2' ' A' ' 171' ' ' PRO . 8.4 t -119.48 50.02 1.29 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -0.886 . . . . 1.0 109.988 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.29 167.07 17.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.115 -0.991 . . . . 1.0 109.283 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.582 ' CE1' HG23 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -170.4 118.6 0.55 Allowed 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 120.154 -0.618 . . . . 1.0 109.63 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.23 76.59 7.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.317 -0.864 . . . . 1.0 109.259 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.422 0 O-C-N 121.328 -0.858 . . . . 1.0 109.929 -179.719 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 122.684 1.231 . . . . 1.0 110.832 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.582 HG23 ' CE1' ' A' ' 25' ' ' HIS . 3.9 p -133.74 121.28 39.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 107.131 -1.433 . . . . 1.0 107.131 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 121' ' ' ALA . 24.8 mmtt -155.32 116.16 3.9 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.297 -0.877 . . . . 1.0 109.56 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.24 -152.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.6 -0.688 . . . . 1.0 110.081 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 42' ' ' ALA . 1.8 m -51.56 158.39 0.92 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.23 -0.919 . . . . 1.0 109.963 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.449 ' O ' ' O ' ' A' ' 45' ' ' HIS . . . 43.0 47.04 4.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.434 -0.791 . . . . 1.0 109.425 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.521 ' HA3' ' CA ' ' A' ' 119' ' ' ASP . . . 44.46 51.66 7.7 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.386 -1.485 . . . . 1.0 109.386 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.451 ' HA3' ' HD2' ' A' ' 39' ' ' LYS . . . 63.89 -87.58 0.07 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.686 -1.365 . . . . 1.0 109.686 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.527 ' CB ' HG23 ' A' ' 118' ' ' ILE . 2.1 m-70 -50.96 144.93 12.85 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.213 -1.169 . . . . 1.0 109.852 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.452 ' HB2' HG22 ' A' ' 17' ' ' ILE . 36.2 Cg_endo -79.43 -167.93 0.57 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.763 2.309 . . . . 1.0 110.522 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.524 HG22 ' CG1' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -93.23 158.57 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.521 HG22 ' CZ ' ' A' ' 151' ' ' PHE . 3.4 t -136.76 132.84 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 120.925 -1.109 . . . . 1.0 110.359 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.485 ' O ' ' CG ' ' A' ' 49' ' ' GLN . 2.6 pt20 -145.36 120.22 9.94 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.913 -0.773 . . . . 1.0 108.913 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.442 ' HG ' ' HB3' ' A' ' 15' ' ' LEU . 0.3 OUTLIER -86.22 124.11 32.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.149 -0.97 . . . . 1.0 109.893 -179.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 14' ' ' GLU . 18.0 p80 -141.23 132.59 26.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.28 -0.887 . . . . 1.0 108.802 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 137.0 -2.79 3.32 Favored Glycine 0 N--CA 1.483 1.798 0 C-N-CA 119.262 -1.447 . . . . 1.0 110.578 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.563 ' CE2' ' HB2' ' A' ' 163' ' ' LEU . 0.5 OUTLIER -129.32 117.8 21.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.062 -1.257 . . . . 1.0 109.492 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.516 ' CD1' ' O ' ' A' ' 54' ' ' LEU . 1.3 pp -99.96 35.61 2.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.156 -0.965 . . . . 1.0 109.567 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.561 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 3.9 tp10 -80.0 144.22 33.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 1.0 109.583 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.411 ' ND2' ' C ' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -87.72 34.6 0.71 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.232 -0.917 . . . . 1.0 109.957 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.485 ' O ' ' CG ' ' A' ' 110' ' ' PRO . 11.7 pt-20 -133.96 143.92 49.45 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.266 -0.897 . . . . 1.0 109.276 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.406 ' C ' HD22 ' A' ' 59' ' ' LEU . 35.6 Cg_endo -78.57 134.15 12.16 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.307 2.005 . . . . 1.0 110.63 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.406 HD22 ' C ' ' A' ' 58' ' ' PRO . 12.8 mt -115.59 165.07 13.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.199 -0.938 . . . . 1.0 108.683 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.444 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 40.7 mtt -106.13 112.99 26.25 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.147 -0.971 . . . . 1.0 109.993 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.528 ' CD2' ' HB2' ' A' ' 63' ' ' LEU . 1.9 tt -70.18 142.08 52.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.578 -0.701 . . . . 1.0 109.349 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.468 ' OE1' ' NH2' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -99.03 96.57 7.9 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.219 -0.926 . . . . 1.0 108.858 179.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.631 ' CD1' ' CE1' ' A' ' 151' ' ' PHE . 20.8 tp -119.15 132.07 55.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.296 -0.878 . . . . 1.0 109.911 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.48 ' CB ' HG11 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -164.96 165.83 19.9 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.717 -0.845 . . . . 1.0 108.717 179.304 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.492 ' CD1' ' C ' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -105.13 120.94 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.937 -1.102 . . . . 1.0 109.242 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.411 ' N ' HD12 ' A' ' 65' ' ' ILE . . . -132.2 149.1 19.35 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.696 -1.361 . . . . 1.0 109.696 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.556 HG23 ' CD2' ' A' ' 76' ' ' HIS . 16.2 p -83.66 154.45 23.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.371 -1.076 . . . . 1.0 109.319 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.517 ' CB ' ' HD2' ' A' ' 148' ' ' ARG . . . -159.82 118.1 2.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 1.0 109.773 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.447 ' CG ' ' NH2' ' A' ' 146' ' ' ARG . 0.4 OUTLIER -102.23 -13.52 17.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.908 . . . . 1.0 109.164 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -142.5 -55.26 0.43 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.363 -0.836 . . . . 1.0 109.412 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.66 -34.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.955 . . . . 1.0 109.697 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.3 mt -66.34 86.8 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.914 . . . . 1.0 109.587 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.522 ' O ' ' CD1' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -50.03 154.77 1.05 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.265 -0.897 . . . . 1.0 109.686 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.473 ' HB3' ' HD2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -144.37 162.24 40.59 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.317 -0.864 . . . . 1.0 108.748 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 74' ' ' ARG . 33.1 Cg_endo -76.32 121.18 5.95 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.213 1.942 . . . . 1.0 110.051 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.577 ' CG ' ' HB2' ' A' ' 79' ' ' TYR . 1.6 t-80 -57.89 163.4 2.7 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.361 -0.837 . . . . 1.0 110.016 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.12 -76.29 0.08 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 1.0 109.548 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -125.41 21.86 7.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 1.0 109.706 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.577 ' HB2' ' CG ' ' A' ' 76' ' ' HIS . 3.9 m-30 -79.91 75.99 6.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.213 -0.93 . . . . 1.0 109.077 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.529 ' CB ' ' HB3' ' A' ' 102' ' ' LYS . 4.2 pt20 -139.0 4.41 2.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.945 -1.097 . . . . 1.0 110.307 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 122' ' ' GLY . 15.0 m -78.65 144.77 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.958 -1.089 . . . . 1.0 109.182 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.588 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 3.1 p80 -175.93 59.38 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 118.998 -1.081 . . . . 1.0 110.194 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 120' ' ' CYS . 2.9 mmt85 -81.44 140.15 34.82 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.112 -0.993 . . . . 1.0 109.325 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.496 ' CG1' ' HB2' ' A' ' 120' ' ' CYS . 3.5 mp -106.32 135.58 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.205 -0.934 . . . . 1.0 109.764 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 49.9 p . . . . . 0 C--N 1.303 -1.453 0 O-C-N 121.406 -0.808 . . . . 1.0 109.106 179.915 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.449 HG11 HG21 ' A' ' 91' ' ' THR . 6.6 p . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.3 m -86.78 16.02 5.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 1.0 109.524 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.449 HG21 HG11 ' A' ' 89' ' ' VAL . 7.4 t -69.89 125.95 28.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -0.952 . . . . 1.0 109.575 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.52 ' O ' ' CG2' ' A' ' 106' ' ' ILE . 18.3 m -93.88 91.21 6.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.92 . . . . 1.0 109.235 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.458 ' HA ' HG12 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -103.3 173.28 6.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -0.974 . . . . 1.0 109.951 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -145.76 161.66 39.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.477 -0.765 . . . . 1.0 109.167 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.519 ' CG ' ' NE2' ' A' ' 82' ' ' HIS . 43.5 mt-10 -128.51 120.54 26.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 1.0 109.872 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 102' ' ' LYS . . . -114.18 124.56 52.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 1.0 108.94 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.52 ' HB ' ' CD ' ' A' ' 102' ' ' LYS . 0.1 OUTLIER -124.73 126.39 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.09 -1.006 . . . . 1.0 109.876 -179.421 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.527 ' O ' ' CB ' ' A' ' 99' ' ' SER . 0.6 OUTLIER -126.22 59.77 1.32 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.938 . . . . 1.0 109.448 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER 77.03 103.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 1.0 109.612 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' A' ' 99' ' ' SER . 3.2 p-10 42.88 43.31 3.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.694 -0.629 . . . . 1.0 110.18 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 99' ' ' SER . 0.3 OUTLIER -159.58 87.96 0.84 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.993 -1.067 . . . . 1.0 109.776 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.529 ' HB3' ' CB ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -97.32 152.67 18.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.343 -0.848 . . . . 1.0 109.159 179.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.48 HG11 ' CB ' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -146.36 169.97 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.217 -0.927 . . . . 1.0 109.06 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.521 ' CD1' ' HG ' ' A' ' 63' ' ' LEU . 3.3 mt -120.31 128.56 53.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.933 . . . . 1.0 109.615 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -123.94 106.73 10.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.269 -0.894 . . . . 1.0 108.835 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.52 ' CG2' ' O ' ' A' ' 92' ' ' THR . 4.5 mt -119.38 115.95 33.88 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 1.0 109.832 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.453 ' HD2' ' O ' ' A' ' 92' ' ' THR . 33.7 Cg_endo -75.87 119.0 5.23 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 121.96 1.773 . . . . 1.0 109.448 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.45 ' HA ' ' HG2' ' A' ' 114' ' ' MET . 6.1 mt -115.52 165.18 13.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.193 -0.942 . . . . 1.0 110.494 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.484 ' CD2' ' CG ' ' A' ' 112' ' ' ASN . 1.0 OUTLIER -97.3 126.69 40.92 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.485 ' CG ' ' O ' ' A' ' 57' ' ' GLU . 36.5 Cg_endo -79.96 -30.65 2.14 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 122.345 2.03 . . . . 1.0 112.03 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 54' ' ' LEU . 2.1 tt0 -139.35 66.99 1.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.773 -1.204 . . . . 1.0 110.526 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -165.39 -67.52 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 1.0 109.505 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.4 OUTLIER 164.63 108.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.05 -1.032 . . . . 1.0 109.343 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.45 ' HG2' ' HA ' ' A' ' 108' ' ' LEU . 5.9 tpt -154.67 49.83 0.6 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.911 . . . . 1.0 110.129 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.495 ' CZ ' ' OE2' ' A' ' 18' ' ' GLU . 10.0 ttt-85 -74.69 134.33 41.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.966 . . . . 1.0 108.633 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -138.37 153.12 48.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.902 -1.124 . . . . 1.0 110.294 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.524 ' CG1' HG22 ' A' ' 47' ' ' ILE . 4.5 m -126.14 126.46 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.527 HG23 ' CB ' ' A' ' 45' ' ' HIS . 32.4 mt -99.17 104.3 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 1.0 109.604 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.521 ' CA ' ' HA3' ' A' ' 43' ' ' GLY . 14.6 p-10 -149.5 39.48 0.81 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 1.0 109.353 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.496 ' HB2' ' CG1' ' A' ' 84' ' ' ILE . 60.7 m -145.05 59.03 1.3 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 1.0 109.51 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.522 ' O ' ' CG ' ' A' ' 39' ' ' LYS . . . -143.47 -176.38 4.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.417 -0.802 . . . . 1.0 109.119 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.506 ' O ' ' CG2' ' A' ' 81' ' ' VAL . . . -154.6 168.66 32.77 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.575 -1.41 . . . . 1.0 109.575 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.547 HG23 ' CE2' ' A' ' 79' ' ' TYR . 0.3 OUTLIER -114.55 154.63 15.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.236 -1.155 . . . . 1.0 108.836 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.62 109.58 16.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.129 -0.982 . . . . 1.0 109.506 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.509 ' CD ' ' O ' ' A' ' 125' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.303 -0.873 . . . . 1.0 109.434 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.31 0.576 . . . . 1.0 109.467 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.453 ' HD2' ' O ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -89.58 164.78 14.62 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.27 -0.894 . . . . 1.0 109.594 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.524 ' CG2' ' HB ' ' A' ' 172' ' ' ILE . 31.6 m -140.84 163.49 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.472 -0.768 . . . . 1.0 109.254 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.517 ' HD2' ' CB ' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -155.58 113.31 3.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.958 . . . . 1.0 109.706 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.56 HD23 ' CE2' ' A' ' 151' ' ' PHE . 1.7 tt -79.76 121.56 25.51 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.208 -0.932 . . . . 1.0 109.217 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 36.0 t -96.42 123.55 48.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.232 -0.917 . . . . 1.0 109.574 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.631 ' CE1' ' CD1' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -120.5 92.33 3.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 1.0 108.954 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.525 ' CB ' ' HA ' ' A' ' 166' ' ' GLN . 24.4 ptt85 -139.28 137.59 36.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.139 -0.976 . . . . 1.0 110.219 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 164' ' ' SER . 9.8 p -115.42 128.28 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.264 -0.897 . . . . 1.0 108.669 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.432 ' CD2' ' NH1' ' A' ' 152' ' ' ARG . 64.3 m-70 -126.69 116.63 21.26 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.11 -0.994 . . . . 1.0 109.542 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.535 ' CG1' ' HB3' ' A' ' 163' ' ' LEU . 9.8 p -99.16 141.35 22.7 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.206 -0.934 . . . . 1.0 109.169 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.524 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 35.4 Cg_endo -77.32 119.03 4.82 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.422 2.081 . . . . 1.0 110.634 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.448 ' OE1' ' HD2' ' A' ' 158' ' ' PRO . 0.1 OUTLIER -160.19 173.03 5.22 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.266 -0.896 . . . . 1.0 109.44 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.448 ' HD2' ' OE1' ' A' ' 157' ' ' GLN . 35.1 Cg_endo -77.87 -67.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.327 2.018 . . . . 1.0 110.44 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 36.6 m -64.15 109.38 1.83 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.905 . . . . 1.0 109.345 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.28 -30.27 11.14 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.542 -1.423 . . . . 1.0 109.542 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.7 mtp85 -79.59 79.06 6.1 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.257 -1.016 . . . . 1.0 108.257 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.577 ' O ' ' CE2' ' A' ' 13' ' ' TYR . 1.3 m -136.39 -79.77 0.4 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.001 -0.74 . . . . 1.0 109.001 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.563 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 0.1 OUTLIER -149.26 106.31 3.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.984 -1.072 . . . . 1.0 108.189 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -163.83 106.34 0.95 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.608 -1.307 . . . . 1.0 109.466 -179.284 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 152' ' ' ARG . 0.2 OUTLIER -134.19 151.36 51.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.081 -1.012 . . . . 1.0 109.696 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.525 ' HA ' ' CB ' ' A' ' 152' ' ' ARG . 15.4 mt-30 -123.69 139.44 53.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 1.0 109.374 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.467 ' O ' ' CG1' ' A' ' 167' ' ' VAL . 46.7 t -142.54 71.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.214 -0.929 . . . . 1.0 109.674 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.6 108.89 20.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 1.0 109.212 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 2.7 m -148.6 137.83 21.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.945 . . . . 1.0 109.674 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 169' ' ' SER . 0.6 OUTLIER 171.74 92.49 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.359 -0.838 . . . . 1.0 109.52 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.483 ' HG2' ' CB ' ' A' ' 23' ' ' SER . 34.8 Cg_endo -77.42 72.02 6.16 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.373 2.049 . . . . 1.0 110.694 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.524 ' HB ' ' CG2' ' A' ' 147' ' ' VAL . 13.8 mm -115.21 78.74 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 1.0 109.233 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 1.0 109.746 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo . . . . . 0 C--O 1.216 -0.603 0 N-CA-C 110.395 -0.656 . . . . 1.0 110.395 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.453 ' HA ' ' HA3' ' A' ' 52' ' ' GLY . 13.0 m-30 -80.06 123.32 27.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 1.0 109.469 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -152.2 130.07 11.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.942 . . . . 1.0 109.616 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.427 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 53.8 tp -107.41 83.47 1.82 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.237 -0.914 . . . . 1.0 109.198 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.61 157.48 23.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 1.0 109.805 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.478 HG22 ' NE2' ' A' ' 20' ' ' GLN . 1.1 mp -79.86 144.35 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.412 ' OE1' ' CD ' ' A' ' 49' ' ' GLN . 27.6 tp10 -80.7 -63.88 1.31 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 1.0 109.094 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.499 HG22 ' CG1' ' A' ' 47' ' ' ILE . 2.0 t -92.69 126.21 45.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.339 -0.851 . . . . 1.0 109.134 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.478 ' NE2' HG22 ' A' ' 17' ' ' ILE . 5.5 tp-100 -130.67 63.65 70.58 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.938 . . . . 1.0 109.66 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 20' ' ' GLN . 36.0 Cg_endo -78.09 -177.96 4.26 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.513 2.142 . . . . 1.0 110.449 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.414 ' HE2' ' CD2' ' A' ' 24' ' ' HIS . 2.1 ttpt -50.36 161.01 0.33 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.229 -0.919 . . . . 1.0 109.383 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.411 ' O ' ' CG1' ' A' ' 172' ' ' ILE . 2.1 t -154.62 58.72 0.69 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.263 -0.898 . . . . 1.0 109.871 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.414 ' CD2' ' HE2' ' A' ' 22' ' ' LYS . 1.9 p80 -103.5 166.22 10.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 1.0 109.411 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.572 ' CE1' ' HA ' ' A' ' 38' ' ' VAL . 3.7 t60 -163.86 113.12 1.23 Allowed 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.405 -0.81 . . . . 1.0 109.827 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.439 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 5.1 ttp180 -89.57 75.95 7.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.406 -0.808 . . . . 1.0 109.103 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.354 -0.841 . . . . 1.0 109.767 -179.774 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.541 ' C ' ' CE1' ' A' ' 25' ' ' HIS . . . . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.572 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 2.5 p -54.84 106.08 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.329 -0.857 . . . . 1.0 109.468 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.4 98.92 4.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 1.0 109.583 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.449 ' O ' ' O ' ' A' ' 41' ' ' SER . . . -158.23 95.92 1.4 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.896 . . . . 1.0 109.548 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 43' ' ' GLY . 1.9 t 60.87 144.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 1.0 109.465 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 51.45 -90.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.888 . . . . 1.0 109.423 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 41' ' ' SER . . . -167.92 34.88 0.21 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.442 -1.463 . . . . 1.0 109.442 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.522 ' HA3' ' CG2' ' A' ' 38' ' ' VAL . . . 109.69 -84.83 0.38 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.563 -1.415 . . . . 1.0 109.563 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.458 ' HB3' ' HD2' ' A' ' 46' ' ' PRO . 74.0 m-70 -77.14 159.88 77.18 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.358 -1.084 . . . . 1.0 109.504 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.464 ' HG3' ' OE1' ' A' ' 20' ' ' GLN . 35.1 Cg_endo -77.47 -176.79 3.4 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 122.598 2.199 . . . . 1.0 110.679 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.499 ' CG1' HG22 ' A' ' 19' ' ' VAL . 3.8 mm -94.04 159.51 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.496 -0.753 . . . . 1.0 109.142 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.49 HG23 ' CZ ' ' A' ' 151' ' ' PHE . 2.9 t -132.78 135.68 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.154 -0.966 . . . . 1.0 109.895 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.445 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 2.6 pt20 -150.23 143.43 24.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.827 . . . . 1.0 109.111 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.425 HD13 HG13 ' A' ' 153' ' ' VAL . 3.0 tt -113.48 140.12 48.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.17 -0.957 . . . . 1.0 109.772 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 51' ' ' HIS . 14.6 p80 -140.08 81.59 1.82 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 1.0 109.093 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . -156.65 -97.92 0.14 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.049 -1.22 . . . . 1.0 110.049 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.467 ' HB3' ' CG ' ' A' ' 111' ' ' GLU . 0.4 OUTLIER -39.56 129.51 1.9 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.835 -0.803 . . . . 1.0 110.145 -179.519 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.5 mt -101.54 3.66 40.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.321 -0.862 . . . . 1.0 109.561 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 111' ' ' GLU . 2.7 tm-20 -79.71 138.5 37.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.179 -0.95 . . . . 1.0 109.362 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.452 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 4.6 p30 -85.96 56.74 4.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.913 . . . . 1.0 109.599 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.483 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 5.0 mt-10 -105.64 143.2 26.35 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 1.0 109.245 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.455 ' O ' HD21 ' A' ' 59' ' ' LEU . 36.2 Cg_endo -78.62 120.19 4.7 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.394 2.063 . . . . 1.0 110.451 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 107' ' ' PRO . 20.6 mt -119.94 164.51 15.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 1.0 109.138 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.454 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -111.26 132.83 54.06 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.172 -0.955 . . . . 1.0 109.61 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.508 ' CD2' ' HB3' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -86.54 121.79 29.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.39 -0.819 . . . . 1.0 109.265 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 152' ' ' ARG . 9.4 mm-40 -92.48 75.68 5.14 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.203 -0.936 . . . . 1.0 108.872 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.508 ' HB3' ' CD2' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -116.06 155.61 27.82 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.372 -0.83 . . . . 1.0 109.672 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.524 ' HA ' ' CD1' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -165.6 -178.91 5.12 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.381 -0.824 . . . . 1.0 108.909 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.513 ' O ' ' CG2' ' A' ' 65' ' ' ILE . 0.8 OUTLIER -112.77 100.58 11.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.068 -1.02 . . . . 1.0 109.091 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 74' ' ' ARG . . . -118.99 149.94 18.06 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.942 -1.263 . . . . 1.0 109.942 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.632 ' CG2' ' CD2' ' A' ' 76' ' ' HIS . 20.4 p -78.4 146.78 34.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.421 -1.046 . . . . 1.0 109.151 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.433 ' HB2' ' HD2' ' A' ' 148' ' ' ARG . . . -152.49 116.16 4.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.148 -0.97 . . . . 1.0 109.535 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.501 ' HA ' ' NE ' ' A' ' 146' ' ' ARG . 1.6 p30 -85.0 -25.86 27.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.37 -0.832 . . . . 1.0 109.334 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -133.0 -49.49 0.87 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.192 -0.942 . . . . 1.0 109.322 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -175.06 -38.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 1.0 109.565 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.438 ' HA ' ' NH1' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -55.89 89.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.907 . . . . 1.0 109.601 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -51.9 171.79 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.178 -0.951 . . . . 1.0 109.613 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.517 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 2.1 mtm180 -168.99 163.17 7.72 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.354 -0.841 . . . . 1.0 109.284 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 76' ' ' HIS . 35.3 Cg_endo -77.64 108.33 2.54 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.352 2.035 . . . . 1.0 110.437 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.632 ' CD2' ' CG2' ' A' ' 67' ' ' THR . 19.1 t-80 -42.07 161.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.423 -0.798 . . . . 1.0 110.01 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -48.83 -74.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.303 -0.873 . . . . 1.0 109.369 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -135.32 22.79 3.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -0.929 . . . . 1.0 109.39 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.574 ' CE2' HG23 ' A' ' 123' ' ' ILE . 4.7 m-30 -80.21 118.45 21.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.262 -0.899 . . . . 1.0 109.354 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.521 ' HB2' ' CG ' ' A' ' 102' ' ' LYS . 0.1 OUTLIER -163.32 23.69 0.08 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.973 . . . . 1.0 109.804 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.516 ' CG2' ' O ' ' A' ' 122' ' ' GLY . 15.1 m -86.14 150.93 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.098 -1.001 . . . . 1.0 109.307 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.563 ' CE1' ' HB1' ' A' ' 121' ' ' ALA . 12.5 t60 -175.38 75.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.286 -0.884 . . . . 1.0 109.414 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 120' ' ' CYS . 15.2 mmm180 -109.7 130.24 55.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.295 -0.878 . . . . 1.0 109.64 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.524 HG21 ' CB ' ' A' ' 120' ' ' CYS . 4.6 mp -104.22 136.18 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 1.0 109.455 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.448 HG21 ' O ' ' A' ' 84' ' ' ILE . 69.4 p . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.393 -0.817 . . . . 1.0 109.288 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.8 p . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.26 0.552 . . . . 1.0 109.537 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.36 12.78 7.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -0.94 . . . . 1.0 109.589 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.477 ' CG2' HD23 ' A' ' 108' ' ' LEU . 16.0 m -103.14 104.88 15.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 1.0 109.472 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.51 ' O ' ' CG2' ' A' ' 106' ' ' ILE . 10.0 t -54.22 158.56 2.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.16 -0.962 . . . . 1.0 109.338 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.24 172.79 12.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 1.0 109.7 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -155.07 151.78 28.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.361 -0.837 . . . . 1.0 109.534 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -125.7 132.84 52.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 1.0 109.313 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -125.27 120.65 31.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.13 -0.981 . . . . 1.0 109.699 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.452 HD11 ' HA ' ' A' ' 102' ' ' LYS . 9.9 tp -125.0 133.7 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 1.0 109.293 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.518 ' O ' ' CB ' ' A' ' 99' ' ' SER . 1.0 OUTLIER -133.34 50.86 2.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.222 -0.924 . . . . 1.0 109.53 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER 76.66 114.16 0.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.309 -0.87 . . . . 1.0 109.742 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.43 ' CG ' ' O ' ' A' ' 99' ' ' SER . 3.9 p-10 43.49 35.03 0.86 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.665 -0.647 . . . . 1.0 110.476 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.512 ' HB ' ' CD2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -156.15 102.63 2.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.927 -1.108 . . . . 1.0 109.743 179.642 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.521 ' CG ' ' HB2' ' A' ' 80' ' ' GLN . 4.5 tptt -112.29 153.68 26.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 1.0 109.386 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.513 HG11 ' CB ' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -158.54 168.66 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.271 -0.893 . . . . 1.0 109.113 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.524 ' CD1' ' HA ' ' A' ' 64' ' ' PHE . 1.1 mt -116.79 134.85 54.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 1.0 109.734 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -127.08 112.32 15.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.368 -0.833 . . . . 1.0 109.273 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.51 ' CG2' ' O ' ' A' ' 92' ' ' THR . 3.4 mt -121.69 107.0 36.59 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.907 . . . . 1.0 109.606 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 33.8 Cg_endo -75.46 104.39 1.9 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 122.09 1.86 . . . . 1.0 110.133 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.477 HD23 ' CG2' ' A' ' 91' ' ' THR . 3.0 mt -129.02 163.67 24.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.399 -0.813 . . . . 1.0 109.695 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -129.86 69.23 81.55 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.386 -0.821 . . . . 1.0 109.238 179.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.504 ' HA ' ' CG ' ' A' ' 114' ' ' MET . 36.8 Cg_endo -81.02 45.47 2.01 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 122.703 2.269 . . . . 1.0 110.908 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 55' ' ' GLU . 53.6 mp0 -97.85 -11.48 23.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.99 -1.069 . . . . 1.0 109.684 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 113' ' ' SER . 0.3 OUTLIER -107.85 -55.6 2.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.18 -0.95 . . . . 1.0 109.429 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.1 OUTLIER 169.8 102.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 1.0 109.501 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.504 ' CG ' ' HA ' ' A' ' 110' ' ' PRO . 1.0 OUTLIER -164.79 122.31 1.62 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 1.0 109.574 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.413 ' HD3' ' CG2' ' A' ' 47' ' ' ILE . 7.5 ttm180 -102.01 136.08 42.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.883 . . . . 1.0 109.477 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.06 139.67 53.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 1.0 109.349 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.452 ' HA ' HG21 ' A' ' 47' ' ' ILE . 4.3 m -114.99 127.03 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 1.0 109.547 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 45' ' ' HIS . 16.1 mt -113.06 100.96 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 1.0 109.387 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.479 ' HB2' ' CA ' ' A' ' 43' ' ' GLY . 4.9 p-10 -153.71 50.72 0.68 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 1.0 109.486 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.524 ' CB ' HG21 ' A' ' 84' ' ' ILE . 96.0 m -137.77 42.85 2.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.221 -0.925 . . . . 1.0 109.589 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.563 ' HB1' ' CE1' ' A' ' 82' ' ' HIS . . . -129.59 172.21 11.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.867 . . . . 1.0 108.95 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.516 ' O ' ' CG2' ' A' ' 81' ' ' VAL . . . -145.36 -165.5 11.3 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.794 -1.322 . . . . 1.0 109.794 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.574 HG23 ' CE2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -125.42 157.18 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.32 -1.106 . . . . 1.0 108.93 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.6 tp -140.05 147.05 39.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.098 -1.001 . . . . 1.0 109.725 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.6 tttm . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 1.0 109.232 179.801 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.495 -0.558 . . . . 1.0 109.495 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.501 ' NE ' ' HA ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -98.45 175.13 6.14 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.219 -0.925 . . . . 1.0 109.439 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 17.3 m -138.83 167.19 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.357 -0.84 . . . . 1.0 109.567 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.467 ' HA ' ' HB3' ' A' ' 170' ' ' ASN . 0.0 OUTLIER -155.44 111.7 3.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.854 . . . . 1.0 109.534 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.456 HD13 ' O ' ' A' ' 64' ' ' PHE . 11.2 tp -81.44 113.25 19.38 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.213 -0.929 . . . . 1.0 108.947 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 10.6 t -93.46 143.5 11.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.399 -0.813 . . . . 1.0 110.237 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.49 ' CZ ' HG23 ' A' ' 48' ' ' VAL . 10.4 m-85 -133.49 113.36 12.4 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.517 ' CB ' ' O ' ' A' ' 165' ' ' LEU . 10.2 ptt85 -145.45 106.76 4.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.933 -1.105 . . . . 1.0 110.529 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 164' ' ' SER . 9.8 p -92.55 128.83 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.256 -1.016 . . . . 1.0 108.256 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.506 ' ND1' ' HB2' ' A' ' 164' ' ' SER . 48.7 m-70 -121.39 117.4 26.83 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.034 -1.041 . . . . 1.0 110.43 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.529 ' CG1' ' HB3' ' A' ' 163' ' ' LEU . 8.1 p -99.61 141.13 22.25 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.779 -0.823 . . . . 1.0 108.779 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.524 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 33.4 Cg_endo -75.29 115.04 4.13 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.16 1.907 . . . . 1.0 110.501 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.491 ' NE2' ' HD2' ' A' ' 158' ' ' PRO . 0.9 OUTLIER -136.3 169.13 14.28 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.532 -0.73 . . . . 1.0 109.058 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.491 ' HD2' ' NE2' ' A' ' 157' ' ' GLN . 34.3 Cg_endo -76.69 -65.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.316 2.01 . . . . 1.0 110.284 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.28 -84.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 1.0 109.25 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 152.42 -43.7 0.65 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.565 -1.414 . . . . 1.0 109.565 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -79.01 80.25 5.36 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.987 -1.116 . . . . 1.0 107.987 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' A' ' 163' ' ' LEU . 1.3 m -133.55 -89.56 0.39 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.56 -0.712 . . . . 1.0 109.374 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.547 ' N ' ' CG2' ' A' ' 162' ' ' THR . 8.9 tp -125.91 96.91 4.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.83 -1.169 . . . . 1.0 108.737 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.506 ' HB2' ' ND1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -163.25 119.26 1.76 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.016 -1.052 . . . . 1.0 109.229 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.517 ' O ' ' CB ' ' A' ' 152' ' ' ARG . 22.3 mt -142.63 175.07 10.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.976 -1.078 . . . . 1.0 110.428 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.466 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 2.6 mt-30 -142.27 70.84 1.34 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.607 -0.683 . . . . 1.0 109.201 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 37.9 t -87.79 106.04 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 1.0 110.066 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.454 ' HB3' HG21 ' A' ' 150' ' ' VAL . . . -112.03 112.75 24.61 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.543 -0.91 . . . . 1.0 108.543 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 0.0 OUTLIER -136.8 140.99 42.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.989 -1.07 . . . . 1.0 110.261 -179.153 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.467 ' HB3' ' HA ' ' A' ' 148' ' ' ARG . 22.7 t-20 175.93 97.73 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.41 74.38 4.73 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.284 1.99 . . . . 1.0 110.588 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.497 HG22 HD11 ' A' ' 172' ' ' ILE . 27.6 mt -138.96 126.37 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.331 -0.856 . . . . 1.0 109.287 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 1.0 109.532 -179.874 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 C--O 1.215 -0.654 0 N-CA-C 110.255 -0.71 . . . . 1.0 110.255 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.569 ' CE2' ' O ' ' A' ' 162' ' ' THR . 6.6 m-85 -102.61 169.72 8.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -0.934 . . . . 1.0 109.758 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -160.86 130.82 5.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 1.0 109.456 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 23.3 tp -126.83 84.4 2.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.362 -0.836 . . . . 1.0 109.327 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -127.35 154.53 44.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.285 -0.884 . . . . 1.0 109.715 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.468 HG22 ' HB2' ' A' ' 46' ' ' PRO . 0.7 OUTLIER -67.01 148.33 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.336 -0.853 . . . . 1.0 108.774 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.479 ' O ' ' CG2' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -70.97 -34.61 71.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.381 -0.824 . . . . 1.0 109.535 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.479 ' CG2' ' O ' ' A' ' 18' ' ' GLU . 72.3 t -157.78 135.6 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 121.206 -0.934 . . . . 1.0 109.435 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.09 80.45 7.04 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 1.0 109.522 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.463 ' HD3' HG13 ' A' ' 19' ' ' VAL . 36.2 Cg_endo -78.52 179.23 6.69 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.519 2.146 . . . . 1.0 110.21 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 21' ' ' PRO . 9.7 mttt -44.56 108.6 0.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.087 -1.008 . . . . 1.0 109.185 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.1 p -130.72 39.41 3.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.126 -0.984 . . . . 1.0 109.945 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.458 ' HA ' HG12 ' A' ' 172' ' ' ILE . 2.0 p-80 -99.69 166.39 11.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.082 -1.011 . . . . 1.0 109.395 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.57 ' CE1' ' HA ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -135.45 105.26 6.15 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.671 -0.812 . . . . 1.0 109.843 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.4 ttm-85 -92.4 70.98 5.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.429 -0.795 . . . . 1.0 109.053 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.432 0 O-C-N 121.465 -0.772 . . . . 1.0 109.469 -179.883 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.402 0.62 . . . . 1.0 109.593 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.57 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 2.2 p -54.99 113.77 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.4 -0.813 . . . . 1.0 109.451 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -137.3 99.48 3.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.347 -0.846 . . . . 1.0 109.598 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.66 -154.34 0.6 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.377 -0.827 . . . . 1.0 109.458 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.5 t -69.84 -72.48 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 1.0 109.636 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.36 69.03 2.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 1.0 109.405 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.92 -82.12 0.87 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.31 -1.516 . . . . 1.0 109.31 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -165.97 -37.2 0.02 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.64 -1.384 . . . . 1.0 109.64 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -100.69 160.21 27.47 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.267 -1.137 . . . . 1.0 109.72 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.468 ' HB2' HG22 ' A' ' 17' ' ' ILE . 35.8 Cg_endo -78.59 -176.64 3.38 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.539 2.159 . . . . 1.0 110.482 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.518 HG22 ' CG1' ' A' ' 117' ' ' VAL . 1.0 OUTLIER -94.14 158.07 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.463 HG22 ' CZ ' ' A' ' 151' ' ' PHE . 2.9 t -134.54 135.94 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.983 -1.073 . . . . 1.0 110.399 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.57 ' HG2' ' CE1' ' A' ' 51' ' ' HIS . 5.0 tt0 -151.41 144.28 24.47 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.914 -0.773 . . . . 1.0 108.914 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.9 tt -113.23 138.51 49.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.085 -1.009 . . . . 1.0 109.994 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.57 ' CE1' ' HG2' ' A' ' 49' ' ' GLN . 7.5 m-70 -140.33 77.9 1.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.401 -0.812 . . . . 1.0 109.25 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . -177.03 84.69 0.07 OUTLIER Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.687 -1.244 . . . . 1.0 110.049 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.569 ' CD2' ' OE2' ' A' ' 111' ' ' GLU . 3.5 t80 177.16 132.09 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -1.196 . . . . 1.0 109.619 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.2 -10.84 17.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 1.0 109.437 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -89.75 145.25 25.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 1.0 109.502 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -103.73 57.13 0.73 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.309 -0.87 . . . . 1.0 109.35 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -110.1 156.46 40.05 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 1.0 109.454 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 109' ' ' LEU . 35.8 Cg_endo -78.31 131.07 10.45 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.5 2.133 . . . . 1.0 110.49 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.521 HD11 ' CD2' ' A' ' 163' ' ' LEU . 6.5 mt -128.88 162.79 26.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 1.0 109.225 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.468 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 2.1 mpp? -105.78 131.63 52.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.275 -0.891 . . . . 1.0 109.355 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.519 HD22 ' CB ' ' A' ' 63' ' ' LEU . 1.1 tt -90.26 141.27 28.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.376 -0.828 . . . . 1.0 109.388 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 62' ' ' GLN . 0.9 OUTLIER -104.64 78.12 1.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.184 -0.948 . . . . 1.0 109.681 -179.764 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.627 ' CD1' ' CE1' ' A' ' 151' ' ' PHE . 23.4 tp -100.87 135.18 42.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 1.0 109.086 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.51 ' CD2' HG11 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -165.45 159.67 17.16 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.542 -0.911 . . . . 1.0 108.542 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.423 ' O ' ' CG2' ' A' ' 65' ' ' ILE . 1.2 tp -110.84 125.49 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 1.0 109.057 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' A' ' 74' ' ' ARG . . . -145.08 142.38 10.77 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.619 -1.392 . . . . 1.0 109.619 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.503 HG21 ' CD2' ' A' ' 76' ' ' HIS . 72.4 p -66.64 178.85 1.17 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.496 -1.003 . . . . 1.0 109.945 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -170.23 125.37 0.76 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.465 -0.772 . . . . 1.0 109.072 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.83 -38.03 20.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 1.0 108.962 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -140.45 -56.43 0.53 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.167 -0.958 . . . . 1.0 109.699 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.492 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -152.14 -47.57 0.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.875 . . . . 1.0 109.524 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mt -52.47 89.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.353 -0.842 . . . . 1.0 109.684 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.527 HD23 ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -48.11 171.93 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.105 -0.997 . . . . 1.0 110.362 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -168.91 167.22 5.97 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.384 -0.823 . . . . 1.0 108.867 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 74' ' ' ARG . 32.7 Cg_endo -74.06 142.69 31.39 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.072 1.848 . . . . 1.0 109.96 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.577 ' NE2' ' CG1' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -50.72 146.84 5.31 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.252 -0.905 . . . . 1.0 109.763 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.19 -59.54 4.9 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.363 -0.836 . . . . 1.0 109.294 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -136.34 4.04 2.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -0.908 . . . . 1.0 109.912 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.566 ' HB2' ' CG ' ' A' ' 76' ' ' HIS . 6.7 m-30 -99.02 103.19 15.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.984 -1.072 . . . . 1.0 109.25 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.52 ' HB2' ' CG ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -138.88 7.64 2.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.064 -1.023 . . . . 1.0 109.643 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.52 ' CG1' ' HB2' ' A' ' 124' ' ' LEU . 35.6 m -64.39 157.89 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.182 -0.949 . . . . 1.0 109.464 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.489 ' CE1' HD12 ' A' ' 84' ' ' ILE . 35.0 t-80 -175.83 90.53 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.478 -0.763 . . . . 1.0 109.296 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -122.53 144.71 48.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.117 -0.99 . . . . 1.0 109.742 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.531 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 3.3 mp -110.45 125.09 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.29 -0.881 . . . . 1.0 109.51 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 1.0 109.701 -179.97 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.474 ' O ' ' CG1' ' A' ' 89' ' ' VAL . 5.4 p . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.57 31.89 0.9 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.11 -0.994 . . . . 1.0 109.627 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.424 ' C ' ' OG1' ' A' ' 92' ' ' THR . 19.6 m -91.94 -91.09 0.16 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.316 -0.865 . . . . 1.0 109.14 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.516 ' O ' ' CG2' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -174.54 82.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 1.0 109.383 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.51 160.99 13.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.937 . . . . 1.0 110.048 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.51 ' CB ' ' HG3' ' A' ' 105' ' ' GLU . 0.2 OUTLIER -155.53 160.91 40.91 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.007 -0.738 . . . . 1.0 109.007 179.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' A' ' 94' ' ' HIS . 0.7 OUTLIER -132.82 150.66 52.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.988 -1.07 . . . . 1.0 109.813 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -153.84 124.17 7.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.845 . . . . 1.0 109.225 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.521 ' HB ' ' CD ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -119.52 131.61 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 1.0 109.606 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.521 ' O ' ' CB ' ' A' ' 99' ' ' SER . 0.8 OUTLIER -126.05 68.7 1.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 1.0 109.207 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 1.4 m 76.35 93.82 0.07 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -0.843 . . . . 1.0 109.333 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 99' ' ' SER . 1.1 p-10 42.85 55.12 4.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.492 -0.755 . . . . 1.0 109.721 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.467 ' HB ' ' HG ' ' A' ' 98' ' ' LEU . 6.1 m -160.05 80.43 0.7 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.124 -0.985 . . . . 1.0 109.551 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.521 ' CD ' ' HB ' ' A' ' 97' ' ' ILE . 2.1 mmmp? -85.38 131.21 34.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 1.0 109.374 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.51 HG11 ' CD2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -129.49 165.82 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.22 -0.925 . . . . 1.0 109.154 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.15 141.66 49.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 1.0 109.595 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.51 ' HG3' ' CB ' ' A' ' 94' ' ' HIS . 2.1 pt-20 -137.46 117.07 12.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.332 -0.855 . . . . 1.0 109.147 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.526 ' CG2' ' CD2' ' A' ' 108' ' ' LEU . 12.4 mt -118.11 98.84 51.76 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.853 . . . . 1.0 109.849 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 60' ' ' MET . 35.3 Cg_endo -76.73 97.61 1.15 Allowed 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.379 2.052 . . . . 1.0 110.302 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.526 ' CD2' ' CG2' ' A' ' 106' ' ' ILE . 0.6 OUTLIER -145.12 165.26 28.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 1.0 109.657 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -115.37 81.52 8.59 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.303 -0.873 . . . . 1.0 109.698 -179.841 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 108' ' ' LEU . 37.1 Cg_endo -81.0 42.54 1.36 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.634 2.223 . . . . 1.0 110.706 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.569 ' OE2' ' CD2' ' A' ' 53' ' ' TYR . 0.9 OUTLIER -100.33 28.79 4.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.124 -0.985 . . . . 1.0 109.597 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 113' ' ' SER . 0.0 OUTLIER -138.01 -70.31 0.44 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.198 -0.939 . . . . 1.0 109.142 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 112' ' ' ASN . 3.5 t 178.19 101.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 1.0 109.237 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 4.5 ptm -164.04 131.11 3.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 1.0 109.562 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.458 ' HB2' ' OE1' ' A' ' 49' ' ' GLN . 35.7 ttp180 -106.68 131.65 53.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 1.0 109.373 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -116.07 101.96 9.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 1.0 109.377 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.518 ' CG1' HG22 ' A' ' 47' ' ' ILE . 4.6 m -81.06 127.01 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.334 -0.854 . . . . 1.0 109.445 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.574 ' CD1' ' CD2' ' A' ' 63' ' ' LEU . 10.6 mt -107.55 115.01 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.295 -0.878 . . . . 1.0 109.4 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 118' ' ' ILE . 0.6 OUTLIER -156.8 53.41 0.52 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 1.0 109.03 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 83' ' ' ARG . 1.8 p -141.95 57.07 1.48 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.259 -0.9 . . . . 1.0 109.59 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.12 167.25 22.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 1.0 109.131 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.513 ' O ' ' CG2' ' A' ' 81' ' ' VAL . . . -137.63 -176.07 14.23 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.833 -1.307 . . . . 1.0 109.833 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.562 HD12 ' CD2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -116.41 171.72 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.354 -1.086 . . . . 1.0 109.083 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.52 ' HB2' ' CG1' ' A' ' 81' ' ' VAL . 13.5 tp -128.86 157.72 40.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 1.0 109.811 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.452 ' O ' ' CD ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.358 -0.839 . . . . 1.0 109.157 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 121.4 0.619 . . . . 1.0 109.751 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.519 ' N ' ' HD2' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -154.86 154.77 33.22 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.419 -0.801 . . . . 1.0 109.433 179.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.577 ' CG1' ' NE2' ' A' ' 76' ' ' HIS . 32.6 m -139.25 162.44 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.908 . . . . 1.0 109.226 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 8.0 ttt180 -141.61 112.47 7.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -0.95 . . . . 1.0 109.655 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.54 HD22 ' CE2' ' A' ' 151' ' ' PHE . 44.0 tp -79.12 123.84 27.75 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.317 -0.865 . . . . 1.0 109.051 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 37.2 t -95.0 146.0 7.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.233 -0.917 . . . . 1.0 109.773 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.627 ' CE1' ' CD1' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -148.1 99.43 3.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 1.0 109.021 -179.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.514 ' CB ' ' HA ' ' A' ' 166' ' ' GLN . 14.1 ptt180 -150.33 136.4 18.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.98 -1.075 . . . . 1.0 110.255 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 164' ' ' SER . 9.8 p -115.42 129.02 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.568 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 33.2 m-70 -126.88 118.46 24.64 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.129 -0.982 . . . . 1.0 110.119 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.525 ' CG1' ' HB3' ' A' ' 163' ' ' LEU . 13.0 p -99.04 140.98 22.11 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.363 -0.836 . . . . 1.0 108.769 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.523 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 33.2 Cg_endo -75.25 115.29 4.21 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.161 1.907 . . . . 1.0 110.245 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.459 ' HG3' HG22 ' A' ' 162' ' ' THR . 9.8 mm-40 -136.51 167.28 22.16 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.541 -0.724 . . . . 1.0 109.292 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 157' ' ' GLN . 34.6 Cg_endo -77.32 -63.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.299 1.999 . . . . 1.0 110.21 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.6 t -55.74 -75.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.385 -0.822 . . . . 1.0 109.346 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 142.09 -43.27 1.08 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.482 -1.447 . . . . 1.0 109.482 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.86 80.48 5.2 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.879 -1.156 . . . . 1.0 107.879 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.569 ' O ' ' CE2' ' A' ' 13' ' ' TYR . 1.3 m -136.2 -78.23 0.42 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.462 -0.774 . . . . 1.0 109.432 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.525 ' HB3' ' CG1' ' A' ' 155' ' ' VAL . 8.3 tp -141.06 100.93 3.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.074 -1.016 . . . . 1.0 108.962 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.568 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -162.21 98.27 1.04 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.025 -1.047 . . . . 1.0 109.534 179.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 152' ' ' ARG . 0.2 OUTLIER -126.73 151.88 47.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.331 -0.856 . . . . 1.0 109.625 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.514 ' HA ' ' CB ' ' A' ' 152' ' ' ARG . 5.6 mt-30 -118.51 145.53 45.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.902 . . . . 1.0 109.535 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 151' ' ' PHE . 47.0 t -152.39 93.26 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.124 -0.985 . . . . 1.0 109.78 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 149' ' ' LEU . . . -112.44 110.46 20.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.198 -0.939 . . . . 1.0 109.362 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 0.1 OUTLIER -159.51 136.63 9.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.158 -0.964 . . . . 1.0 109.872 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 169' ' ' SER . 0.2 OUTLIER 176.67 99.14 0.11 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.385 -0.822 . . . . 1.0 109.07 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.46 95.3 1.04 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.311 2.008 . . . . 1.0 110.964 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.529 ' HB ' ' CG2' ' A' ' 147' ' ' VAL . 14.9 mt -150.36 161.36 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.432 -0.793 . . . . 1.0 109.137 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.456 ' N ' ' CG2' ' A' ' 172' ' ' ILE . 3.3 mt-10 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.247 -0.908 . . . . 1.0 109.803 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo . . . . . 0 C--O 1.216 -0.601 0 N-CA-C 110.374 -0.664 . . . . 1.0 110.374 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 52' ' ' GLY . 3.1 m-85 -56.72 145.74 28.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.2 -0.937 . . . . 1.0 109.326 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -157.13 124.14 5.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.903 -1.123 . . . . 1.0 110.089 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.512 ' CD2' ' HB ' ' A' ' 153' ' ' VAL . 17.5 tp -107.8 81.72 1.55 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.395 -0.815 . . . . 1.0 108.867 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -116.34 157.1 25.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.87 . . . . 1.0 109.903 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.51 HG21 ' N ' ' A' ' 18' ' ' GLU . 1.4 mp -62.96 149.81 9.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.296 -0.878 . . . . 1.0 108.664 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.553 ' CG ' ' NE2' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -64.65 -42.71 95.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.923 . . . . 1.0 109.11 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.461 ' HB ' HD13 ' A' ' 47' ' ' ILE . 71.3 t -151.81 126.76 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.277 -0.89 . . . . 1.0 109.092 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.466 ' HG2' ' CG2' ' A' ' 17' ' ' ILE . 9.0 mm-40 -115.28 79.14 6.48 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.905 . . . . 1.0 109.484 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.43 ' HD3' ' C ' ' A' ' 19' ' ' VAL . 36.2 Cg_endo -77.8 -179.35 5.36 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.352 2.035 . . . . 1.0 110.453 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.68 113.97 5.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 1.0 109.062 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.527 ' HA ' ' CB ' ' A' ' 40' ' ' ALA . 3.0 t -139.29 72.46 1.4 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.226 -0.921 . . . . 1.0 109.855 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -99.69 166.89 10.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.244 -0.91 . . . . 1.0 109.256 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.568 ' CE1' ' HA ' ' A' ' 38' ' ' VAL . 9.3 t60 -135.78 104.19 5.67 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 119.852 -0.739 . . . . 1.0 109.339 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -79.08 77.83 5.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.426 -0.796 . . . . 1.0 109.212 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.394 -0.816 . . . . 1.0 109.648 -179.696 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.248 0.547 . . . . 1.0 109.607 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.568 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 2.2 p -57.48 122.79 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.365 -0.835 . . . . 1.0 109.43 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.32 109.93 3.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 1.0 109.439 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.527 ' CB ' ' HA ' ' A' ' 23' ' ' SER . . . -136.34 -91.63 0.27 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 1.0 109.77 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.8 m -102.61 135.26 44.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.222 -0.924 . . . . 1.0 109.662 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.562 ' HB2' ' CE1' ' A' ' 45' ' ' HIS . . . 67.45 10.1 7.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.928 . . . . 1.0 109.38 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.8 10.8 42.3 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.413 -1.475 . . . . 1.0 109.413 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 45' ' ' HIS . . . 77.06 83.4 0.52 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.644 -1.383 . . . . 1.0 109.644 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.573 ' CG ' ' HB3' ' A' ' 119' ' ' ASP . 23.4 p-80 -179.81 123.0 0.23 Allowed Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.168 -1.195 . . . . 1.0 109.962 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.24 146.61 19.97 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 122.0 1.8 . . . . 1.0 109.416 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.531 ' CG2' ' CG1' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -97.31 135.1 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.909 -1.119 . . . . 1.0 109.142 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.41 HG22 HD13 ' A' ' 118' ' ' ILE . 3.0 t -118.63 130.79 72.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.017 -1.052 . . . . 1.0 109.814 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.553 ' NE2' ' CG ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -161.4 117.74 2.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.338 -0.852 . . . . 1.0 109.465 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 tt -77.07 136.37 38.65 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.126 -0.984 . . . . 1.0 109.154 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.0 87.47 2.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.182 -0.949 . . . . 1.0 109.262 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.48 ' O ' ' CD1' ' A' ' 13' ' ' TYR . . . 163.92 64.48 0.02 OUTLIER Glycine 0 N--CA 1.483 1.807 0 C-N-CA 119.56 -1.305 . . . . 1.0 110.166 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.56 ' CE1' ' HB2' ' A' ' 55' ' ' GLU . 0.2 OUTLIER 175.62 121.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.109 -1.23 . . . . 1.0 109.687 179.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.7 mt -104.0 22.6 14.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.323 -0.861 . . . . 1.0 109.31 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.56 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -87.35 145.22 26.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.179 -0.951 . . . . 1.0 109.685 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.83 46.43 1.33 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.2 -0.938 . . . . 1.0 109.712 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 17.1 pt-20 -122.98 127.75 25.59 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.255 -0.903 . . . . 1.0 109.185 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.459 ' O ' HD21 ' A' ' 59' ' ' LEU . 36.4 Cg_endo -79.44 151.18 22.61 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 122.147 1.898 . . . . 1.0 110.624 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.522 ' CD2' HG22 ' A' ' 155' ' ' VAL . 18.6 mt -128.48 142.7 51.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.309 -0.869 . . . . 1.0 108.91 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.467 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -79.95 102.05 8.98 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.074 -1.016 . . . . 1.0 109.423 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.514 HD22 ' N ' ' A' ' 63' ' ' LEU . 3.0 tt -59.59 135.11 57.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.405 -0.809 . . . . 1.0 109.612 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -102.45 97.06 7.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.359 -0.838 . . . . 1.0 108.998 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.564 HD12 ' CZ ' ' A' ' 151' ' ' PHE . 26.8 tp -123.35 139.21 54.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.179 -0.951 . . . . 1.0 109.634 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.475 ' CG ' ' N ' ' A' ' 65' ' ' ILE . 2.3 p90 -159.96 -163.9 1.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.325 -0.86 . . . . 1.0 108.928 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.496 ' O ' ' CG2' ' A' ' 65' ' ' ILE . 2.8 tp -125.36 115.62 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.827 . . . . 1.0 108.828 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.434 ' CA ' ' O ' ' A' ' 74' ' ' ARG . . . -135.09 148.07 19.43 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.677 -1.249 . . . . 1.0 109.996 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.636 ' CG2' ' CD2' ' A' ' 76' ' ' HIS . 17.4 p -83.97 156.34 22.35 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.519 -0.989 . . . . 1.0 109.225 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.522 ' CB ' ' HG3' ' A' ' 148' ' ' ARG . . . -159.42 120.39 3.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.067 -1.021 . . . . 1.0 109.724 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.93 -10.91 56.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 1.0 109.374 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -166.65 -44.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.887 . . . . 1.0 109.38 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.487 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -168.33 -36.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 1.0 109.619 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.98 89.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -0.886 . . . . 1.0 109.548 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -54.21 169.21 0.19 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.243 -0.911 . . . . 1.0 109.6 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.434 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -175.19 155.17 1.75 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 1.0 109.486 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.404 ' HD2' ' HG2' ' A' ' 74' ' ' ARG . 36.0 Cg_endo -77.67 116.93 4.14 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.483 2.122 . . . . 1.0 110.342 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.636 ' CD2' ' CG2' ' A' ' 67' ' ' THR . 1.7 t-80 -54.07 154.48 4.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.186 -0.947 . . . . 1.0 109.699 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.95 -72.2 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 1.0 109.796 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.442 ' O ' HD22 ' A' ' 124' ' ' LEU . 1.1 p90 -130.97 12.83 5.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.091 -1.006 . . . . 1.0 109.858 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.575 ' HB2' ' CG ' ' A' ' 76' ' ' HIS . 5.8 m-85 -79.98 117.18 20.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.061 -1.024 . . . . 1.0 108.943 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.526 ' CB ' ' HB3' ' A' ' 102' ' ' LYS . 1.5 pp0? -174.55 33.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.148 -0.97 . . . . 1.0 109.984 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 122' ' ' GLY . 5.6 m -91.94 140.91 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 1.0 109.641 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.576 ' CD2' ' HB3' ' A' ' 121' ' ' ALA . 13.4 t-80 -175.58 111.26 0.11 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.401 -0.812 . . . . 1.0 108.94 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.4 OUTLIER -145.08 135.18 23.88 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.09 -1.006 . . . . 1.0 110.116 -179.685 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.464 HG13 ' HB3' ' A' ' 120' ' ' CYS . 4.0 mp -99.75 128.45 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.596 -0.69 . . . . 1.0 109.379 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.7 p . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 1.0 109.356 -179.976 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.6 p -102.94 -13.8 16.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.22 -0.925 . . . . 1.0 109.452 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 91' ' ' THR . 11.4 t -65.05 115.55 5.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.263 -0.898 . . . . 1.0 109.618 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.518 ' O ' ' CG2' ' A' ' 106' ' ' ILE . 14.5 t -78.62 148.78 33.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.947 . . . . 1.0 109.142 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.46 ' HB3' HG12 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -137.18 174.39 10.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.129 -0.982 . . . . 1.0 110.043 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.46 ' O ' HD22 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -152.76 159.56 43.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.495 -0.753 . . . . 1.0 109.139 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.454 ' HB3' ' CE ' ' A' ' 102' ' ' LYS . 27.8 mm-40 -127.14 147.79 50.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.979 . . . . 1.0 109.819 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -151.76 121.55 7.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 1.0 109.427 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.462 ' HB ' ' HD2' ' A' ' 102' ' ' LYS . 2.6 tp -110.27 142.32 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 1.0 109.648 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.472 ' HG ' ' HB ' ' A' ' 101' ' ' THR . 0.5 OUTLIER -130.81 49.62 2.3 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.329 -0.857 . . . . 1.0 109.367 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 98' ' ' LEU . 2.0 p 73.92 112.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.864 . . . . 1.0 110.213 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.429 ' CG ' ' O ' ' A' ' 99' ' ' SER . 2.2 p-10 42.71 32.65 0.4 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.603 -0.686 . . . . 1.0 110.502 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.472 ' HB ' ' HG ' ' A' ' 98' ' ' LEU . 43.7 m -160.24 88.66 0.82 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.883 -1.135 . . . . 1.0 109.971 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.526 ' HB3' ' CB ' ' A' ' 80' ' ' GLN . 3.8 tptt -91.88 147.5 22.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 1.0 109.239 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.519 ' N ' ' HG3' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -136.8 167.43 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.205 -0.934 . . . . 1.0 109.104 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.493 ' CB ' ' O ' ' A' ' 63' ' ' LEU . 1.0 OUTLIER -121.59 124.43 44.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 1.0 109.65 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.85 120.36 39.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.28 -0.887 . . . . 1.0 109.152 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.518 ' CG2' ' O ' ' A' ' 92' ' ' THR . 71.3 mt -133.24 108.61 12.45 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.107 -0.996 . . . . 1.0 109.684 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 60' ' ' MET . 33.9 Cg_endo -75.17 115.6 4.31 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 122.079 1.853 . . . . 1.0 109.844 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.451 HD22 ' O ' ' A' ' 107' ' ' PRO . 21.1 mt -123.45 165.45 17.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.261 -0.899 . . . . 1.0 110.787 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.522 ' N ' ' HD3' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -139.21 59.7 15.5 Favored Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 108.788 -0.819 . . . . 1.0 108.788 179.199 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.522 ' HD3' ' N ' ' A' ' 109' ' ' LEU . 35.6 Cg_endo -76.95 -3.88 14.28 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.373 2.049 . . . . 1.0 110.622 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 55' ' ' GLU . 3.2 mt-10 -43.63 -36.01 1.99 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.502 -0.749 . . . . 1.0 109.115 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 113' ' ' SER . 3.4 p30 -94.77 -44.33 7.82 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.476 -0.765 . . . . 1.0 109.202 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 1.4 p 164.72 107.54 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 1.0 109.261 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.435 ' HB3' ' HA ' ' A' ' 110' ' ' PRO . 0.9 OUTLIER -154.69 94.08 1.64 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.32 -0.863 . . . . 1.0 109.358 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.54 129.77 42.6 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 1.0 109.233 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -136.09 134.7 38.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.895 . . . . 1.0 109.636 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.531 ' CG1' ' CG2' ' A' ' 47' ' ' ILE . 3.3 m -106.35 145.78 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.279 -0.888 . . . . 1.0 109.238 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 45' ' ' HIS . 14.3 mt -112.76 93.93 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.176 -0.952 . . . . 1.0 109.509 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.573 ' HB3' ' CG ' ' A' ' 45' ' ' HIS . 9.4 p-10 -127.66 26.44 5.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.591 -0.693 . . . . 1.0 109.257 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.464 ' HB3' HG13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -122.42 44.65 2.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.245 -0.909 . . . . 1.0 110.003 -179.406 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.576 ' HB3' ' CD2' ' A' ' 82' ' ' HIS . . . -129.56 177.01 7.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.967 . . . . 1.0 109.102 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.515 ' O ' ' CG2' ' A' ' 81' ' ' VAL . . . -155.95 -169.84 20.63 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.548 -1.421 . . . . 1.0 109.548 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.498 ' CG2' ' CD2' ' A' ' 79' ' ' TYR . 1.8 mt -125.68 173.41 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -1.129 . . . . 1.0 109.437 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.494 HD21 ' CG1' ' A' ' 81' ' ' VAL . 1.4 pp -140.12 158.14 44.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -0.826 . . . . 1.0 109.396 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 1.0 109.552 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 121.15 0.5 . . . . 1.0 109.828 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.47 ' HD2' ' O ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -101.98 158.85 15.84 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.103 -0.998 . . . . 1.0 109.374 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.449 ' O ' ' HG2' ' A' ' 148' ' ' ARG . 2.2 m -141.49 165.33 18.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.437 -0.79 . . . . 1.0 109.147 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.522 ' HG3' ' CB ' ' A' ' 68' ' ' ALA . 20.7 mmm-85 -150.31 119.0 6.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.074 -1.017 . . . . 1.0 109.865 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.459 HD13 HD12 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -79.82 120.25 23.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.292 -0.88 . . . . 1.0 109.278 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 47.4 t -96.74 126.15 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.263 -0.898 . . . . 1.0 109.535 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.564 ' CZ ' HD12 ' A' ' 63' ' ' LEU . 3.1 m-85 -127.71 118.3 23.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.849 . . . . 1.0 109.062 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 1.9 ptm180 -150.33 141.17 22.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.131 -0.98 . . . . 1.0 109.977 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.512 ' HB ' ' CD2' ' A' ' 15' ' ' LEU . 8.8 p -117.32 128.46 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.683 -0.858 . . . . 1.0 108.683 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.452 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 55.1 m-70 -121.69 115.13 22.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.139 -0.975 . . . . 1.0 110.329 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.525 ' CG2' ' HD2' ' A' ' 156' ' ' PRO . 13.9 p -99.66 141.93 23.69 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.901 -0.778 . . . . 1.0 108.901 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.525 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 32.8 Cg_endo -75.16 114.52 4.03 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.065 1.843 . . . . 1.0 110.357 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.456 ' HB3' ' HD2' ' A' ' 158' ' ' PRO . 3.9 mm-40 -133.41 168.33 18.45 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.553 -0.717 . . . . 1.0 109.069 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 157' ' ' GLN . 34.4 Cg_endo -77.0 -64.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.259 1.973 . . . . 1.0 110.249 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.4 m -62.1 -58.05 9.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.935 . . . . 1.0 109.245 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 124.55 -36.19 2.96 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.738 -1.345 . . . . 1.0 109.738 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -79.14 80.04 5.51 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.498 -1.001 . . . . 1.0 108.312 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.469 HG23 HG12 ' A' ' 155' ' ' VAL . 1.3 m -140.54 -74.18 0.34 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.958 -0.756 . . . . 1.0 108.958 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.52 HD22 ' CD1' ' A' ' 59' ' ' LEU . 7.8 tp -142.25 97.62 3.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.09 -1.006 . . . . 1.0 108.644 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.452 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.2 OUTLIER -163.11 87.14 0.55 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.071 -1.018 . . . . 1.0 109.245 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.486 ' CD2' ' N ' ' A' ' 165' ' ' LEU . 1.8 pt? -132.31 170.78 14.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -0.956 . . . . 1.0 109.805 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.455 ' NE2' ' HD2' ' A' ' 152' ' ' ARG . 2.5 tt0 -117.44 157.44 26.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.327 -0.858 . . . . 1.0 109.498 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 151' ' ' PHE . 48.3 t -149.32 81.87 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 1.0 109.653 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.451 ' HB2' ' NH2' ' A' ' 148' ' ' ARG . . . -90.8 103.46 16.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.198 -0.939 . . . . 1.0 109.354 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 170' ' ' ASN . 0.0 OUTLIER -120.07 136.5 54.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -0.967 . . . . 1.0 109.657 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 169' ' ' SER . 1.8 m-20 163.27 85.5 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 1.0 109.383 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.91 72.24 6.24 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.461 2.107 . . . . 1.0 110.574 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' ' 146' ' ' ARG . 12.3 mt -126.71 134.44 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 1.0 109.284 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 1.0 109.631 -179.922 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo . . . . . 0 C--O 1.215 -0.638 0 N-CA-C 110.381 -0.661 . . . . 1.0 110.381 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.66 ' CE2' ' CD1' ' A' ' 53' ' ' TYR . 3.6 m-30 -58.36 145.06 39.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.167 -0.958 . . . . 1.0 109.215 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.517 ' HA ' ' CD1' ' A' ' 165' ' ' LEU . 53.1 tt0 179.48 142.96 0.14 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.148 -0.97 . . . . 1.0 109.271 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.463 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -98.79 116.8 31.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.339 -0.851 . . . . 1.0 109.213 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -110.76 132.84 53.85 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.338 -0.851 . . . . 1.0 109.916 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.453 HG22 ' HB2' ' A' ' 46' ' ' PRO . 1.1 mp -60.83 143.36 14.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.358 -0.979 . . . . 1.0 108.358 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -71.96 -54.23 10.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 1.0 109.676 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.435 HG13 ' HD3' ' A' ' 21' ' ' PRO . 30.5 t -120.33 133.61 66.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.239 -0.913 . . . . 1.0 109.61 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -127.0 76.24 76.1 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.214 -0.929 . . . . 1.0 109.429 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.435 ' HD3' HG13 ' A' ' 19' ' ' VAL . 35.5 Cg_endo -77.69 -175.71 2.83 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.511 2.141 . . . . 1.0 110.51 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -43.46 131.08 5.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.451 -0.781 . . . . 1.0 109.406 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.459 ' OG ' ' OD1' ' A' ' 170' ' ' ASN . 7.9 t -112.86 40.07 2.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.189 -0.944 . . . . 1.0 109.841 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.469 ' HA ' ' CG2' ' A' ' 172' ' ' ILE . 1.9 p80 -103.04 166.16 10.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.05 -1.031 . . . . 1.0 109.505 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.571 ' CD2' HD12 ' A' ' 123' ' ' ILE . 1.0 OUTLIER -154.49 89.83 1.29 Allowed 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.901 -0.72 . . . . 1.0 109.674 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.42 72.63 10.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.307 -0.871 . . . . 1.0 109.138 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.424 0 O-C-N 121.471 -0.768 . . . . 1.0 109.811 -179.684 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.452 0.644 . . . . 1.0 109.751 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.57 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 2.4 p -89.67 119.23 36.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.539 -0.725 . . . . 1.0 109.269 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -155.18 105.37 2.51 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -0.936 . . . . 1.0 109.577 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.51 -88.29 0.54 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 1.0 109.449 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 p -114.97 -92.2 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 1.0 109.652 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.27 -69.45 0.12 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 1.0 109.457 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -167.25 26.68 0.15 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.522 -1.431 . . . . 1.0 109.522 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.474 ' HA3' ' CG2' ' A' ' 38' ' ' VAL . . . 112.34 -59.5 0.37 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.463 ' HB3' ' HD2' ' A' ' 46' ' ' PRO . 13.1 m-70 -104.64 161.03 24.06 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.307 -1.113 . . . . 1.0 109.472 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 45' ' ' HIS . 35.4 Cg_endo -78.0 -179.59 5.59 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.505 2.136 . . . . 1.0 110.512 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.515 ' CG2' HG11 ' A' ' 117' ' ' VAL . 2.5 mm -94.11 156.64 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.374 -0.829 . . . . 1.0 109.075 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.507 HG22 ' CZ ' ' A' ' 151' ' ' PHE . 10.8 t -129.31 141.76 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.112 -0.992 . . . . 1.0 110.117 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.463 ' HB2' ' HG3' ' A' ' 115' ' ' ARG . 7.1 tt0 -160.4 147.06 15.65 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.422 HD12 ' OE2' ' A' ' 111' ' ' GLU . 0.6 OUTLIER -78.5 148.13 33.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.886 -1.134 . . . . 1.0 109.617 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -140.14 77.65 1.62 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.445 -0.785 . . . . 1.0 109.37 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 163.87 -109.97 0.4 Allowed Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.455 -1.355 . . . . 1.0 110.476 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.66 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 1.5 t80 -39.18 141.22 0.34 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.826 -0.808 . . . . 1.0 110.178 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 111' ' ' GLU . 0.7 OUTLIER -136.62 46.67 2.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.331 -0.856 . . . . 1.0 109.492 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.575 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 1.2 tt0 -87.25 145.41 26.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 1.0 109.331 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.62 49.98 1.87 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.202 -0.936 . . . . 1.0 109.853 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -122.36 153.54 62.06 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 1.0 109.432 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.489 ' C ' ' CD2' ' A' ' 59' ' ' LEU . 35.3 Cg_endo -78.11 131.03 10.62 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.521 2.148 . . . . 1.0 110.462 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.489 ' CD2' ' C ' ' A' ' 58' ' ' PRO . 4.3 mt -128.14 163.02 25.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 1.0 109.16 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.455 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 4.4 ptt? -110.48 138.72 46.5 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.238 -0.914 . . . . 1.0 109.771 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -91.71 147.44 22.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.413 -0.804 . . . . 1.0 109.391 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.436 ' O ' ' HG2' ' A' ' 152' ' ' ARG . 0.9 OUTLIER -124.48 77.6 1.59 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.307 -0.871 . . . . 1.0 109.041 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.57 HD23 ' CZ ' ' A' ' 151' ' ' PHE . 0.5 OUTLIER -125.64 156.89 38.52 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.205 -0.934 . . . . 1.0 109.842 -179.569 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.512 ' CB ' HG11 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -166.16 -164.93 0.73 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.38 -0.97 . . . . 1.0 108.38 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.519 ' O ' ' CG2' ' A' ' 65' ' ' ILE . 0.5 OUTLIER -117.56 112.51 39.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.889 -1.132 . . . . 1.0 108.53 178.656 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.8 147.31 16.8 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.829 -1.308 . . . . 1.0 109.829 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.634 ' CG2' ' CD2' ' A' ' 76' ' ' HIS . 4.7 p -83.26 134.02 34.96 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.476 -1.014 . . . . 1.0 109.404 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.14 121.28 3.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.218 -0.926 . . . . 1.0 109.371 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -84.84 -26.52 27.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.9 . . . . 1.0 109.503 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.96 -38.75 0.34 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 1.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' LEU . 2.7 ttm180 -168.96 -35.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.121 -0.987 . . . . 1.0 109.674 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.462 ' O ' ' CD ' ' A' ' 74' ' ' ARG . 0.1 OUTLIER -44.06 94.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 1.0 109.701 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -80.17 136.36 36.48 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.222 -0.924 . . . . 1.0 109.623 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -157.83 166.48 16.47 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.285 -0.884 . . . . 1.0 109.136 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.46 ' HB3' HG22 ' A' ' 101' ' ' THR . 33.4 Cg_endo -75.47 137.26 20.49 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.147 1.898 . . . . 1.0 110.223 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.634 ' CD2' ' CG2' ' A' ' 67' ' ' THR . 0.3 OUTLIER -65.27 157.53 28.74 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.29 -0.882 . . . . 1.0 109.848 -179.529 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.3 -58.88 2.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.299 -0.876 . . . . 1.0 109.467 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -128.31 2.86 5.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.203 -0.936 . . . . 1.0 109.794 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.575 ' HB2' ' CD2' ' A' ' 76' ' ' HIS . 5.7 m-85 -100.72 76.15 1.78 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.13 -0.981 . . . . 1.0 109.414 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.502 ' HB2' ' CB ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -141.97 8.68 1.89 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 1.0 110.002 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 122' ' ' GLY . 10.2 m -67.64 143.69 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.034 -1.041 . . . . 1.0 109.52 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.479 ' CD2' ' HB1' ' A' ' 121' ' ' ALA . 10.2 t-160 -175.48 107.23 0.09 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.47 -0.769 . . . . 1.0 109.438 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.462 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -144.8 142.84 30.3 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.165 -0.96 . . . . 1.0 109.711 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.481 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 4.1 mp -101.01 158.98 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.349 -0.844 . . . . 1.0 109.196 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.475 ' N ' HG21 ' A' ' 84' ' ' ILE . 23.8 p . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.149 -0.969 . . . . 1.0 109.275 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.5 t -86.85 -30.16 21.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 1.0 109.561 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.452 HG23 HG23 ' A' ' 106' ' ' ILE . 11.5 m -108.57 105.06 14.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.328 -0.857 . . . . 1.0 109.505 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.495 ' O ' ' CG2' ' A' ' 106' ' ' ILE . 6.9 m -52.63 157.46 1.56 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 1.0 109.338 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.463 ' HA ' HD11 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -140.69 174.99 9.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 1.0 109.917 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -152.41 160.77 43.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.479 -0.763 . . . . 1.0 109.505 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.16 148.69 52.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.139 -0.976 . . . . 1.0 109.668 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -158.66 121.14 3.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 1.0 109.571 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.425 HD11 ' C ' ' A' ' 101' ' ' THR . 2.7 tp -107.44 141.06 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 1.0 109.412 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.516 ' O ' ' CB ' ' A' ' 99' ' ' SER . 0.5 OUTLIER -132.9 50.33 2.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 1.0 109.511 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 1.6 m 77.75 108.03 0.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.454 -0.779 . . . . 1.0 109.748 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 99' ' ' SER . 9.1 p30 44.25 41.28 4.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.493 -0.754 . . . . 1.0 110.364 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.485 ' HB ' ' CD2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -158.91 79.32 0.77 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.971 -1.08 . . . . 1.0 109.77 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.502 ' CB ' ' HB2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -82.09 119.14 23.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.944 . . . . 1.0 109.131 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.512 HG11 ' CB ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -122.41 161.18 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.214 -0.929 . . . . 1.0 109.528 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.484 ' CD1' HD13 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -129.67 121.9 27.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.463 -0.773 . . . . 1.0 109.388 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.459 ' O ' HD11 ' A' ' 106' ' ' ILE . 0.7 OUTLIER -99.59 139.47 35.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 1.0 109.28 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.495 ' CG2' ' O ' ' A' ' 92' ' ' THR . 2.9 mm -133.12 96.71 17.27 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 1.0 109.956 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.522 ' O ' ' CD2' ' A' ' 108' ' ' LEU . 34.7 Cg_endo -76.25 108.19 2.62 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.349 2.033 . . . . 1.0 109.738 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.522 ' CD2' ' O ' ' A' ' 107' ' ' PRO . 0.4 OUTLIER -144.56 165.48 27.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 1.0 110.247 -179.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.452 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 0.8 OUTLIER -131.6 66.71 78.82 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.489 -0.757 . . . . 1.0 109.205 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.508 ' HB3' ' CG ' ' A' ' 114' ' ' MET . 36.7 Cg_endo -81.06 42.33 1.32 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.652 2.235 . . . . 1.0 110.635 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.516 ' CB ' ' O ' ' A' ' 55' ' ' GLU . 1.5 mp0 -93.83 -0.35 55.83 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.023 -1.048 . . . . 1.0 109.665 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.502 ' O ' ' CB ' ' A' ' 113' ' ' SER . 0.6 OUTLIER -108.24 -51.82 2.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.107 -0.996 . . . . 1.0 109.278 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.3 OUTLIER 164.79 97.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 1.0 109.237 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.508 ' CG ' ' HB3' ' A' ' 110' ' ' PRO . 5.4 ptm -162.39 133.46 5.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.146 -0.972 . . . . 1.0 109.972 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.463 ' HG3' ' HB2' ' A' ' 49' ' ' GLN . 14.2 ttp180 -112.25 131.85 55.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.205 -0.935 . . . . 1.0 109.21 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -120.54 117.28 27.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 1.0 109.512 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.515 HG11 ' CG2' ' A' ' 47' ' ' ILE . 5.1 m -92.83 135.8 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.296 -0.878 . . . . 1.0 109.371 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' ' 45' ' ' HIS . 7.8 mt -112.75 116.52 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.216 -0.927 . . . . 1.0 109.549 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 17.3 p30 -156.88 52.35 0.5 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 1.0 109.477 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.458 ' HB3' ' HA ' ' A' ' 84' ' ' ILE . 0.8 OUTLIER -135.54 53.5 1.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -0.872 . . . . 1.0 109.5 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.479 ' HB1' ' CD2' ' A' ' 82' ' ' HIS . . . -139.84 175.95 9.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.842 . . . . 1.0 109.338 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.525 ' O ' ' CG2' ' A' ' 81' ' ' VAL . . . -143.69 -178.04 19.12 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.376 -1.49 . . . . 1.0 109.376 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.571 HD12 ' CD2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -117.75 158.73 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.177 -1.19 . . . . 1.0 109.131 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.57 147.69 47.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 1.0 109.425 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.7 ttpm? . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.238 -0.914 . . . . 1.0 109.425 -179.967 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 74.8 p . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 121.273 0.559 . . . . 1.0 110.354 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.522 ' CD ' ' O ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -157.13 124.39 5.23 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.381 -0.824 . . . . 1.0 110.204 179.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.58 ' CG1' ' NE2' ' A' ' 76' ' ' HIS . 13.9 m -137.48 165.55 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.248 -0.907 . . . . 1.0 108.803 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 170' ' ' ASN . 0.0 OUTLIER -155.46 139.14 16.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.054 -1.029 . . . . 1.0 110.14 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.491 ' CD2' HD11 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -99.75 101.01 12.04 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.385 -0.822 . . . . 1.0 108.875 179.405 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 21.5 t -77.16 140.88 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.933 . . . . 1.0 109.692 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.57 ' CZ ' HD23 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -136.66 111.16 8.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.277 -0.89 . . . . 1.0 109.484 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.487 ' HD3' ' NE2' ' A' ' 166' ' ' GLN . 12.6 ptt180 -144.22 133.16 22.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.884 -1.135 . . . . 1.0 109.922 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.3 p -109.53 127.89 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.53 -0.915 . . . . 1.0 108.53 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.498 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 51.0 m-70 -123.17 114.1 19.84 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.199 -0.938 . . . . 1.0 110.132 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.529 ' CG1' HG23 ' A' ' 162' ' ' THR . 11.4 p -99.4 141.12 22.27 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.242 -0.911 . . . . 1.0 108.938 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.513 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 33.9 Cg_endo -75.93 117.0 4.56 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.294 1.996 . . . . 1.0 110.561 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.507 ' NE2' ' HD2' ' A' ' 158' ' ' PRO . 4.1 mm100 -154.83 168.92 11.07 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.312 -0.867 . . . . 1.0 109.116 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.507 ' HD2' ' NE2' ' A' ' 157' ' ' GLN . 34.4 Cg_endo -77.2 -65.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.326 2.017 . . . . 1.0 110.25 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.4 104.54 0.79 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.193 -0.942 . . . . 1.0 109.191 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -46.45 -28.1 3.22 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.465 -1.454 . . . . 1.0 109.465 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.4 mtt-85 -79.22 79.64 5.63 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.37 -1.076 . . . . 1.0 108.259 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.558 ' CG2' ' N ' ' A' ' 163' ' ' LEU . 1.3 m -140.04 -90.04 0.18 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.441 -0.787 . . . . 1.0 109.15 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.558 ' N ' ' CG2' ' A' ' 162' ' ' THR . 8.9 tp -140.34 97.9 3.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.958 -1.089 . . . . 1.0 108.986 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.498 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -163.3 94.81 0.82 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.084 -1.01 . . . . 1.0 109.408 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.519 ' CD2' ' N ' ' A' ' 165' ' ' LEU . 1.8 pt? -138.37 175.32 9.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 1.0 109.984 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.487 ' NE2' ' HD3' ' A' ' 152' ' ' ARG . 0.7 OUTLIER -119.22 161.84 19.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.434 -0.791 . . . . 1.0 109.843 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 151' ' ' PHE . 41.5 t -151.74 74.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.448 -0.782 . . . . 1.0 109.036 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.48 102.86 15.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.093 -1.004 . . . . 1.0 109.104 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 t -143.41 88.68 2.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.917 . . . . 1.0 110.057 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.513 ' N ' ' HD3' ' A' ' 171' ' ' PRO . 1.1 m-20 -179.69 60.6 0.11 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 1.0 109.341 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' A' ' 170' ' ' ASN . 36.4 Cg_endo -78.67 96.91 1.1 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.383 2.056 . . . . 1.0 111.011 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.53 ' HB ' ' CG2' ' A' ' 147' ' ' VAL . 1.6 mt -101.53 147.05 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.166 -0.959 . . . . 1.0 108.679 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.46 0 O-C-N 121.088 -1.007 . . . . 1.0 110.132 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo . . . . . 0 C--O 1.215 -0.625 0 N-CA-C 110.613 -0.572 . . . . 1.0 110.613 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.576 ' CZ ' ' O ' ' A' ' 162' ' ' THR . 5.8 m-85 -67.82 152.11 46.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.872 . . . . 1.0 109.277 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.28 129.72 13.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.918 -1.114 . . . . 1.0 109.855 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.453 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 58.4 tp -121.04 75.02 1.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.42 155.27 33.82 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.44 -0.787 . . . . 1.0 109.982 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.498 HG22 ' NE2' ' A' ' 20' ' ' GLN . 0.6 OUTLIER -66.81 145.8 13.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.532 -0.914 . . . . 1.0 108.532 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.505 ' HB2' ' NE2' ' A' ' 49' ' ' GLN . 3.8 tp10 -72.51 -53.52 11.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 1.0 109.749 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.4 HG21 ' HG3' ' A' ' 18' ' ' GLU . 21.7 t -127.99 142.04 44.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.262 -0.899 . . . . 1.0 109.618 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.498 ' NE2' HG22 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -120.58 82.49 33.36 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 1.0 109.354 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 22' ' ' LYS . 35.0 Cg_endo -77.72 -177.53 3.92 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.436 2.09 . . . . 1.0 110.376 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 21' ' ' PRO . 12.7 mttt -43.86 112.69 0.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.37 -0.831 . . . . 1.0 109.227 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.53 ' HB3' ' CG ' ' A' ' 171' ' ' PRO . 2.1 t -110.24 29.64 7.48 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.198 -0.939 . . . . 1.0 109.89 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -103.21 165.9 10.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 1.0 109.476 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.578 ' CE1' ' HA ' ' A' ' 38' ' ' VAL . 76.6 t60 -157.21 118.07 3.6 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.516 -0.74 . . . . 1.0 109.894 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.451 ' HD2' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -90.98 89.17 7.32 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.408 -0.807 . . . . 1.0 108.881 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.472 0 O-C-N 121.172 -0.955 . . . . 1.0 109.395 -179.676 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.466 ' HB3' ' CA ' ' A' ' 122' ' ' GLY . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.43 0.633 . . . . 1.0 109.665 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.578 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 1.7 p -73.33 121.49 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.418 -0.801 . . . . 1.0 109.372 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -153.23 110.58 3.51 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.307 -0.871 . . . . 1.0 109.506 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 44' ' ' GLY . . . -165.17 150.31 9.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.373 -0.829 . . . . 1.0 109.563 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 40' ' ' ALA . 80.6 p 43.78 -118.08 0.55 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 1.0 109.39 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.6 57.47 4.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.304 -1.498 . . . . 1.0 109.524 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' A' ' 119' ' ' ASP . . . 88.25 -19.14 36.96 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.568 -1.413 . . . . 1.0 109.568 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 40' ' ' ALA . . . 116.41 -71.03 0.27 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.582 -1.407 . . . . 1.0 109.582 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.429 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 21.9 m80 -60.11 154.25 51.88 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.249 -1.148 . . . . 1.0 109.578 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.45 ' HB2' HG22 ' A' ' 17' ' ' ILE . 35.5 Cg_endo -78.09 178.7 7.27 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.492 2.128 . . . . 1.0 110.472 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.514 ' CG2' HG11 ' A' ' 117' ' ' VAL . 2.3 mm -94.53 160.87 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 1.0 109.266 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.8 t -135.81 127.3 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.234 -0.916 . . . . 1.0 109.732 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.521 ' HG3' ' CE1' ' A' ' 51' ' ' HIS . 14.2 pt20 -151.17 142.14 23.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.339 -0.851 . . . . 1.0 109.348 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 110' ' ' PRO . 1.3 tt -98.62 138.99 35.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 1.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.521 ' CE1' ' HG3' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -140.78 76.23 1.54 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.169 -0.957 . . . . 1.0 109.331 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 53' ' ' TYR . . . 171.05 96.03 0.1 Allowed Glycine 0 N--CA 1.486 2.01 0 N-CA-C 110.038 -1.225 . . . . 1.0 110.038 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.634 ' CE2' ' CB ' ' A' ' 55' ' ' GLU . 6.2 t80 178.02 129.01 0.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -1.14 . . . . 1.0 109.425 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.92 13.74 32.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 1.0 109.394 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.634 ' CB ' ' CE2' ' A' ' 53' ' ' TYR . 0.7 OUTLIER -116.8 144.49 44.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 1.0 109.432 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.421 ' O ' ' OD1' ' A' ' 56' ' ' ASN . 5.9 p30 -101.83 50.85 0.84 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 1.0 109.472 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.488 ' C ' ' CD1' ' A' ' 109' ' ' LEU . 1.9 mp0 -108.89 146.0 32.88 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 1.0 109.458 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.524 ' O ' ' CD2' ' A' ' 59' ' ' LEU . 35.5 Cg_endo -77.96 145.99 22.8 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.441 2.094 . . . . 1.0 110.363 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.589 ' CD1' ' CD2' ' A' ' 163' ' ' LEU . 7.4 mt -139.27 162.76 34.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.262 -0.898 . . . . 1.0 109.51 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.458 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -98.34 110.42 23.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.315 -0.866 . . . . 1.0 109.534 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.526 ' CD2' ' HB2' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -60.77 143.45 54.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.257 -0.902 . . . . 1.0 109.312 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.489 ' N ' ' HG ' ' A' ' 61' ' ' LEU . 6.3 mm-40 -105.21 80.38 1.59 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.189 -0.945 . . . . 1.0 109.718 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.54 HD11 ' CE1' ' A' ' 151' ' ' PHE . 18.2 tp -99.94 121.43 41.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.303 -0.873 . . . . 1.0 109.129 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.485 ' C ' ' CD1' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -143.43 146.84 33.79 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 -179.434 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.517 ' O ' ' CG2' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -109.23 115.63 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 1.0 108.779 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.525 ' CA ' ' O ' ' A' ' 74' ' ' ARG . . . -132.8 144.26 16.11 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.548 -1.311 . . . . 1.0 110.204 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.633 ' CG2' ' CD2' ' A' ' 76' ' ' HIS . 14.8 p -71.2 161.44 31.09 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.525 -0.985 . . . . 1.0 108.959 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.521 ' CB ' ' HG3' ' A' ' 148' ' ' ARG . . . -172.52 124.72 0.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.129 -0.982 . . . . 1.0 109.77 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.6 -13.42 24.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -0.881 . . . . 1.0 109.16 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -156.08 -67.34 0.11 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.352 -0.843 . . . . 1.0 109.357 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.553 ' CD ' ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -144.82 -39.18 0.26 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 1.0 109.67 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.553 ' N ' ' CD ' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -51.84 88.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.41 -0.806 . . . . 1.0 109.848 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 71' ' ' ARG . 2.3 pp -66.63 143.9 56.72 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.26 -0.9 . . . . 1.0 109.59 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.525 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -152.87 165.44 17.59 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.158 -0.964 . . . . 1.0 109.452 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.51 146.03 24.03 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.414 2.076 . . . . 1.0 110.211 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.633 ' CD2' ' CG2' ' A' ' 67' ' ' THR . 0.7 OUTLIER -76.87 160.54 29.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 1.0 109.656 -179.743 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.81 -67.09 0.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -0.866 . . . . 1.0 109.786 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -130.83 23.56 4.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.163 -0.96 . . . . 1.0 109.934 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.571 ' HB2' ' CG ' ' A' ' 76' ' ' HIS . 4.8 m-85 -101.46 74.26 1.52 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.054 -1.029 . . . . 1.0 109.418 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.493 ' CB ' ' HB3' ' A' ' 102' ' ' LYS . 11.0 pt20 -139.49 7.46 2.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.163 -0.96 . . . . 1.0 109.669 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 122' ' ' GLY . 1.3 m -60.91 140.58 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.092 -1.005 . . . . 1.0 109.067 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.57 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 1.0 OUTLIER -176.3 114.05 0.11 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.092 -1.043 . . . . 1.0 109.791 -179.612 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.2 OUTLIER -136.74 126.32 25.29 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.215 -0.928 . . . . 1.0 109.557 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.462 ' HA ' ' HB3' ' A' ' 120' ' ' CYS . 4.4 mp -99.68 137.43 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.256 -0.903 . . . . 1.0 109.628 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 N--CA 1.488 1.47 0 O-C-N 121.403 -0.811 . . . . 1.0 109.137 179.785 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.412 ' O ' ' OG ' ' A' ' 90' ' ' SER . 1.7 t . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 89' ' ' VAL . 3.5 m -165.53 31.64 0.05 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.499 -0.881 . . . . 1.0 109.668 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.488 HG21 ' N ' ' A' ' 92' ' ' THR . 9.8 t -64.96 -36.48 84.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.206 -0.934 . . . . 1.0 109.558 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.488 ' N ' HG21 ' A' ' 91' ' ' THR . 58.4 m -163.17 135.91 5.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.199 -0.938 . . . . 1.0 109.587 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -168.39 169.13 10.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -0.882 . . . . 1.0 109.56 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -155.22 145.63 22.01 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.844 . . . . 1.0 109.51 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.515 ' OE1' ' NE2' ' A' ' 82' ' ' HIS . 8.0 tt0 -114.58 146.11 41.17 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.305 -0.872 . . . . 1.0 109.428 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -142.82 122.36 13.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 1.0 109.367 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.489 HD12 ' N ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -135.55 134.95 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.239 -0.913 . . . . 1.0 109.475 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.521 ' O ' ' CG ' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -138.49 64.82 1.48 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.064 -1.023 . . . . 1.0 109.675 -179.628 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.462 ' O ' ' OD1' ' A' ' 100' ' ' ASN . 1.7 p 62.29 117.44 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.894 . . . . 1.0 109.586 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 99' ' ' SER . 3.7 p-10 44.46 37.03 1.87 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.622 -0.674 . . . . 1.0 110.715 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.469 ' HB ' ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -159.32 85.16 0.79 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.972 -1.08 . . . . 1.0 109.401 179.248 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.493 ' HB3' ' CB ' ' A' ' 80' ' ' GLN . 6.0 tptm -105.91 95.02 5.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.892 . . . . 1.0 109.727 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.49 171.4 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.326 -0.859 . . . . 1.0 108.963 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.518 HD23 ' N ' ' A' ' 105' ' ' GLU . 0.5 OUTLIER -139.91 122.81 16.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 1.0 109.351 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.518 ' N ' HD23 ' A' ' 104' ' ' LEU . 7.1 mm-40 -123.1 140.14 53.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.303 -0.873 . . . . 1.0 109.292 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.443 ' CG2' ' O ' ' A' ' 92' ' ' THR . 28.1 mt -129.03 107.31 18.02 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 1.0 109.528 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 60' ' ' MET . 34.6 Cg_endo -76.64 107.81 2.53 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.218 1.945 . . . . 1.0 110.35 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.405 ' HB2' ' HE3' ' A' ' 114' ' ' MET . 0.6 OUTLIER -146.0 165.18 29.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.876 . . . . 1.0 109.752 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.517 ' CD2' ' O ' ' A' ' 109' ' ' LEU . 3.5 tt -117.07 85.84 19.06 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.408 -0.807 . . . . 1.0 109.451 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.441 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 37.1 Cg_endo -81.84 30.53 0.52 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.711 2.274 . . . . 1.0 111.199 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.523 ' OE1' ' CB ' ' A' ' 53' ' ' TYR . 9.7 mm-40 -102.96 49.95 0.82 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.842 -1.161 . . . . 1.0 109.512 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 113' ' ' SER . 0.6 OUTLIER -161.78 -61.63 0.05 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.216 -0.928 . . . . 1.0 109.478 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 6.1 p 167.8 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.324 -0.86 . . . . 1.0 109.19 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.405 ' HE3' ' HB2' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -155.14 125.23 6.66 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.235 -0.915 . . . . 1.0 109.616 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -94.61 129.78 41.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 1.0 109.191 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.36 99.71 8.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.318 -0.864 . . . . 1.0 109.518 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.514 HG11 ' CG2' ' A' ' 47' ' ' ILE . 4.4 m -86.85 143.28 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 1.0 109.425 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 45' ' ' HIS . 2.7 mt -133.29 123.86 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.891 . . . . 1.0 109.552 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.449 ' HB2' ' HA3' ' A' ' 43' ' ' GLY . 8.3 p-10 -175.28 46.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 1.0 109.566 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 83' ' ' ARG . 9.9 m -132.95 43.45 2.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 1.0 109.565 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.511 ' HB3' ' CB ' ' A' ' 82' ' ' HIS . . . -134.42 128.29 33.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.253 -0.905 . . . . 1.0 109.13 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.518 ' O ' ' CG2' ' A' ' 81' ' ' VAL . . . -93.51 -172.08 39.6 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.395 -1.482 . . . . 1.0 109.395 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.44 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 0.6 OUTLIER -125.48 166.92 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.363 -1.081 . . . . 1.0 108.818 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.413 HD11 ' O ' ' A' ' 123' ' ' ILE . 0.8 OUTLIER -140.94 164.45 30.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.905 . . . . 1.0 109.622 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 41.6 mttt . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.383 -0.823 . . . . 1.0 109.096 179.769 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -105.04 157.38 17.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.886 . . . . 1.0 109.254 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.506 HG11 ' NE2' ' A' ' 76' ' ' HIS . 1.6 m -140.49 168.25 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.382 -0.823 . . . . 1.0 109.406 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.525 ' HG2' ' CB ' ' A' ' 170' ' ' ASN . 5.2 mmt180 -148.82 99.32 2.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 1.0 109.563 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.526 HD11 ' CD2' ' A' ' 151' ' ' PHE . 0.7 OUTLIER -79.77 115.93 19.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.104 -0.997 . . . . 1.0 108.889 179.635 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 4.3 t -87.09 114.43 26.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.204 -0.935 . . . . 1.0 109.87 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.54 ' CE1' HD11 ' A' ' 63' ' ' LEU . 1.6 m-85 -108.39 113.33 26.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 1.0 109.228 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 5.4 ptt180 -150.6 159.41 44.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.899 -1.126 . . . . 1.0 109.95 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.4 p -143.41 128.51 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.281 -0.887 . . . . 1.0 108.659 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.504 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 20.9 m-70 -132.46 113.63 13.35 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.073 -1.017 . . . . 1.0 110.372 -179.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.534 ' CG1' ' HB3' ' A' ' 163' ' ' LEU . 12.6 p -99.04 141.85 23.6 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 108.556 -0.905 . . . . 1.0 108.556 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.533 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 32.0 Cg_endo -73.64 115.88 4.49 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.093 1.862 . . . . 1.0 110.881 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.456 ' HB2' ' HD2' ' A' ' 158' ' ' PRO . 1.6 pm0 -133.14 160.94 66.66 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 157' ' ' GLN . 34.9 Cg_endo -77.56 -66.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.305 2.003 . . . . 1.0 110.675 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.5 t -59.38 -93.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 1.0 109.621 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 171.38 -33.91 0.15 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.412 -1.475 . . . . 1.0 109.412 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -79.08 80.3 5.44 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.92 -1.141 . . . . 1.0 107.92 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.576 ' O ' ' CZ ' ' A' ' 13' ' ' TYR . 1.3 m -138.9 -90.17 0.2 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.509 -0.744 . . . . 1.0 109.486 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.589 ' CD2' ' CD1' ' A' ' 59' ' ' LEU . 7.4 tp -146.96 109.19 4.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.58 -1.325 . . . . 1.0 109.615 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.504 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.0 OUTLIER -162.94 91.49 0.73 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.035 -1.041 . . . . 1.0 109.38 178.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -120.64 155.46 33.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.345 -0.847 . . . . 1.0 109.495 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.464 ' HA ' ' CB ' ' A' ' 152' ' ' ARG . 3.5 tt0 -134.16 142.34 47.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.163 -0.96 . . . . 1.0 109.568 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 168' ' ' ALA . 46.3 t -146.07 161.28 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 1.0 109.398 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.467 ' N ' ' CG1' ' A' ' 167' ' ' VAL . . . -151.29 92.71 1.82 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.389 -0.82 . . . . 1.0 108.847 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.437 ' HB2' HD13 ' A' ' 149' ' ' LEU . 20.4 m -82.93 160.43 22.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.954 . . . . 1.0 109.632 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.525 ' CB ' ' HG2' ' A' ' 148' ' ' ARG . 0.7 OUTLIER -174.51 63.04 0.25 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.162 -0.961 . . . . 1.0 110.059 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.53 ' CG ' ' HB3' ' A' ' 23' ' ' SER . 37.5 Cg_endo -83.23 52.04 3.81 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.477 2.118 . . . . 1.0 110.296 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 13.0 mt -151.06 128.02 2.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.456 -0.778 . . . . 1.0 109.534 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 1.0 109.362 179.873 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo . . . . . 0 C--O 1.214 -0.69 0 N-CA-C 110.293 -0.695 . . . . 1.0 110.293 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.473 ' HA ' ' HA3' ' A' ' 52' ' ' GLY . 3.6 m-85 -105.5 137.95 42.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.152 -0.967 . . . . 1.0 109.63 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.453 ' CG ' ' O ' ' A' ' 13' ' ' TYR . 1.6 mt-10 179.72 139.16 0.12 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 1.0 109.764 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.489 ' O ' ' CG ' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -99.87 98.82 9.57 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.291 -0.881 . . . . 1.0 109.055 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -99.96 155.14 17.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.191 -0.943 . . . . 1.0 109.768 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.491 ' CG2' ' NE2' ' A' ' 20' ' ' GLN . 12.7 mm -72.95 134.44 29.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.398 -0.813 . . . . 1.0 109.266 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.426 ' HB2' ' CD ' ' A' ' 49' ' ' GLN . 44.2 tt0 -68.89 -55.1 12.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.137 -0.977 . . . . 1.0 108.967 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.455 HG21 ' HD3' ' A' ' 21' ' ' PRO . 9.8 p -118.58 130.22 73.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.376 -0.827 . . . . 1.0 108.871 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.491 ' NE2' ' CG2' ' A' ' 17' ' ' ILE . 9.2 tp-100 -129.94 63.97 70.51 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.08 -1.012 . . . . 1.0 110.023 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 23' ' ' SER . 35.8 Cg_endo -78.44 -175.34 2.67 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.406 2.07 . . . . 1.0 109.88 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -48.45 94.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.917 . . . . 1.0 108.78 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 21' ' ' PRO . 1.4 p -94.02 40.24 1.08 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.25 -0.906 . . . . 1.0 110.252 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.46 ' HA ' HG12 ' A' ' 172' ' ' ILE . 0.0 OUTLIER -99.49 167.25 10.73 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.969 -1.082 . . . . 1.0 108.284 179.205 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.635 ' CD2' ' CD1' ' A' ' 123' ' ' ILE . 16.0 t60 -133.7 134.03 42.57 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 119.341 -0.944 . . . . 1.0 110.068 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.457 ' HD2' ' O ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -106.1 75.73 1.12 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 179.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.47 -0.769 . . . . 1.0 109.79 -179.064 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.497 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 1.8 p -57.03 135.4 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 1.0 109.34 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.06 115.26 4.1 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.417 -0.802 . . . . 1.0 109.698 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 42' ' ' ALA . . . -156.5 114.84 3.33 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.509 -0.745 . . . . 1.0 109.548 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 50.91 -88.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.473 -0.767 . . . . 1.0 110.085 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 40' ' ' ALA . . . -85.03 46.25 1.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.099 -1.0 . . . . 1.0 109.832 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.39 9.32 42.62 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.887 -1.285 . . . . 1.0 109.887 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.71 -80.06 0.31 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.643 -1.383 . . . . 1.0 109.643 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -88.36 157.53 50.15 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.317 -1.108 . . . . 1.0 109.672 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.453 ' HG3' ' OE1' ' A' ' 20' ' ' GLN . 35.8 Cg_endo -78.41 178.74 7.21 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.601 2.201 . . . . 1.0 110.528 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.521 HG22 ' CG1' ' A' ' 117' ' ' VAL . 5.0 mt -94.45 157.05 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.481 -0.762 . . . . 1.0 109.199 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.57 HG22 ' CZ ' ' A' ' 151' ' ' PHE . 2.1 t -131.66 128.1 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.207 -0.933 . . . . 1.0 109.829 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.426 ' CD ' ' HB2' ' A' ' 18' ' ' GLU . 7.1 pt20 -140.95 138.17 33.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 1.0 109.353 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.466 ' HG ' ' HB3' ' A' ' 15' ' ' LEU . 2.7 tt -98.2 136.68 38.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 1.0 109.75 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -140.52 97.98 3.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.333 -0.854 . . . . 1.0 109.16 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . -178.89 -86.5 0.07 OUTLIER Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.631 -1.271 . . . . 1.0 110.133 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.514 ' OH ' ' NE2' ' A' ' 157' ' ' GLN . 0.8 OUTLIER -38.37 121.86 1.03 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 122.1 -0.647 . . . . 1.0 110.345 -179.414 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.85 1.72 37.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.361 -0.837 . . . . 1.0 109.538 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -79.82 145.66 32.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.148 -0.97 . . . . 1.0 109.423 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.431 ' C ' ' ND2' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -84.61 44.68 1.07 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 1.0 109.824 -179.683 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.461 ' O ' HD21 ' A' ' 109' ' ' LEU . 5.1 mm-40 -99.23 150.59 36.86 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 1.0 109.304 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.447 ' HA ' HD22 ' A' ' 109' ' ' LEU . 36.0 Cg_endo -77.68 139.48 17.95 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.306 2.004 . . . . 1.0 110.385 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.442 HD13 ' OE2' ' A' ' 111' ' ' GLU . 5.8 mt -128.26 159.04 36.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 1.0 109.452 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.432 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.3 OUTLIER -121.31 107.84 13.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.133 -0.979 . . . . 1.0 109.519 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.497 ' CD2' ' HB3' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -61.92 116.59 5.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.903 . . . . 1.0 109.543 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.42 ' O ' ' HG2' ' A' ' 152' ' ' ARG . 73.4 mm-40 -94.99 78.18 3.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.12 -0.988 . . . . 1.0 109.067 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.571 HD23 ' CE1' ' A' ' 151' ' ' PHE . 0.6 OUTLIER -112.85 157.84 20.9 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.377 -0.827 . . . . 1.0 109.714 -179.598 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.522 ' O ' ' CD2' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -165.74 176.95 7.58 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 179.354 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.639 ' CD1' ' CE1' ' A' ' 76' ' ' HIS . 0.2 OUTLIER -114.75 118.6 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.109 -0.994 . . . . 1.0 108.862 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.44 150.28 19.64 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.611 -1.28 . . . . 1.0 110.06 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.621 ' CG2' ' CD2' ' A' ' 76' ' ' HIS . 0.6 OUTLIER -89.2 151.23 22.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.456 -1.026 . . . . 1.0 109.269 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.443 ' HB1' ' HD3' ' A' ' 148' ' ' ARG . . . -145.92 113.08 6.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.17 -0.956 . . . . 1.0 109.538 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.2 -27.89 25.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.351 -0.843 . . . . 1.0 109.245 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -136.43 -52.48 0.71 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.302 -0.874 . . . . 1.0 109.311 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.5 OUTLIER -175.17 -34.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.9 . . . . 1.0 109.627 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 mt -55.9 91.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 1.0 109.74 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -47.39 166.64 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.224 -0.922 . . . . 1.0 109.474 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.466 ' HB2' ' HD2' ' A' ' 75' ' ' PRO . 5.1 ptm180 -175.15 162.03 2.3 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.901 . . . . 1.0 109.086 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 74' ' ' ARG . 34.3 Cg_endo -76.97 137.64 17.68 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.229 1.953 . . . . 1.0 110.334 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.639 ' CE1' ' CD1' ' A' ' 65' ' ' ILE . 0.1 OUTLIER -64.16 156.5 28.33 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.246 -0.909 . . . . 1.0 109.625 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.11 -78.72 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.323 -0.86 . . . . 1.0 109.663 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -107.99 19.54 19.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 1.0 109.503 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.572 ' HB2' ' CD2' ' A' ' 76' ' ' HIS . 88.8 m-85 -111.57 112.25 23.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.903 . . . . 1.0 109.463 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.496 ' NE2' ' HD3' ' A' ' 102' ' ' LYS . 8.1 pt20 -167.32 30.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -0.845 . . . . 1.0 108.843 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 122' ' ' GLY . 31.3 m -52.94 158.6 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 121.62 0.724 . . . . 1.0 110.139 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.577 ' CD2' ' HG3' ' A' ' 95' ' ' GLU . 14.3 t60 -176.06 66.73 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.464 -0.773 . . . . 1.0 108.961 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.0 OUTLIER -113.38 157.99 21.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.873 . . . . 1.0 109.855 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.0 mp -130.34 156.75 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.413 -0.804 . . . . 1.0 108.991 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 40.9 p . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.083 -1.011 . . . . 1.0 109.755 -179.799 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' A' ' 89' ' ' VAL . 13.2 p . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.304 0.573 . . . . 1.0 109.575 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.4 m -90.39 32.07 0.98 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 1.0 109.395 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.4 m -66.06 137.32 56.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 1.0 109.437 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.6 m -52.55 106.11 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 1.0 109.542 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.65 170.1 9.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -0.87 . . . . 1.0 109.603 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -155.26 161.03 41.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.342 -0.849 . . . . 1.0 109.392 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.577 ' HG3' ' CD2' ' A' ' 82' ' ' HIS . 0.5 OUTLIER -141.24 148.65 40.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 1.0 109.334 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -152.51 127.96 9.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 1.0 109.731 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.439 ' HB ' ' HD2' ' A' ' 102' ' ' LYS . 2.7 tp -106.29 142.55 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 1.0 109.346 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.522 ' O ' ' CB ' ' A' ' 99' ' ' SER . 0.6 OUTLIER -132.99 53.0 2.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.912 . . . . 1.0 109.787 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 1.6 m 77.08 104.17 0.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.327 -0.858 . . . . 1.0 110.021 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 99' ' ' SER . 9.0 p30 44.32 43.14 5.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.532 -0.73 . . . . 1.0 110.334 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.51 ' HB ' ' CD2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -159.3 77.64 0.72 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.987 -1.071 . . . . 1.0 109.774 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.496 ' HD3' ' NE2' ' A' ' 80' ' ' GLN . 4.2 tptm -81.96 129.75 34.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.861 . . . . 1.0 109.003 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.445 ' HA ' ' HB2' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -128.1 169.58 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.157 -0.965 . . . . 1.0 109.861 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.57 HD12 ' CE1' ' A' ' 82' ' ' HIS . 0.2 OUTLIER -131.21 130.59 43.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.462 -0.774 . . . . 1.0 109.236 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -128.21 132.33 48.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -0.913 . . . . 1.0 109.683 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.564 ' CG2' ' CD2' ' A' ' 108' ' ' LEU . 5.3 mt -129.67 102.69 17.9 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 1.0 109.279 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 60' ' ' MET . 34.1 Cg_endo -75.43 98.4 1.17 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.196 1.93 . . . . 1.0 110.539 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.564 ' CD2' ' CG2' ' A' ' 106' ' ' ILE . 0.4 OUTLIER -145.23 165.33 28.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.376 -0.827 . . . . 1.0 109.41 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.461 HD21 ' O ' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -114.41 80.65 6.13 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 1.0 109.697 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.467 ' HA ' ' HB3' ' A' ' 114' ' ' MET . 36.3 Cg_endo -78.7 75.74 4.84 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.501 2.134 . . . . 1.0 110.268 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.459 ' HB3' ' O ' ' A' ' 53' ' ' TYR . 3.4 mt-10 -138.6 -49.3 0.53 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.267 -0.896 . . . . 1.0 109.603 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -79.89 -49.82 11.37 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.331 -0.855 . . . . 1.0 109.495 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.6 t -175.53 98.69 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.347 -0.846 . . . . 1.0 109.319 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.467 ' HB3' ' HA ' ' A' ' 110' ' ' PRO . 5.0 tpp -165.8 108.46 0.78 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 1.0 109.343 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -99.98 139.23 35.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.346 -0.846 . . . . 1.0 109.092 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.36 92.46 3.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -0.971 . . . . 1.0 109.547 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.521 ' CG1' HG22 ' A' ' 47' ' ' ILE . 3.5 m -91.78 128.34 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.225 -0.922 . . . . 1.0 109.322 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 99.1 mt -118.57 111.81 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.178 -0.951 . . . . 1.0 109.656 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -163.12 28.57 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 1.0 109.449 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 83' ' ' ARG . 4.2 p -116.38 42.89 2.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 1.0 109.347 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.75 164.43 28.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 1.0 109.478 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.523 ' O ' ' CG2' ' A' ' 81' ' ' VAL . . . -125.39 -173.77 13.76 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.904 -1.678 . . . . 1.0 108.904 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.635 ' CD1' ' CD2' ' A' ' 25' ' ' HIS . 0.9 OUTLIER -116.27 170.75 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.978 -1.307 . . . . 1.0 109.231 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.39 146.26 41.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 1.0 109.517 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 1.0 109.405 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.43 -0.581 . . . . 1.0 109.43 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -93.91 154.83 17.49 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.121 -0.987 . . . . 1.0 109.685 -179.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.572 ' CG1' ' NE2' ' A' ' 76' ' ' HIS . 14.1 m -140.26 145.12 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.465 ' HA ' ' HB3' ' A' ' 170' ' ' ASN . 2.5 ptt180 -149.73 135.43 18.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.016 -1.052 . . . . 1.0 110.106 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.522 ' CD2' ' O ' ' A' ' 64' ' ' PHE . 1.6 mt -87.49 121.33 29.79 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.462 -0.774 . . . . 1.0 109.51 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.18 132.9 35.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.194 -0.941 . . . . 1.0 109.29 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.571 ' CE1' HD23 ' A' ' 63' ' ' LEU . 5.8 m-85 -125.69 114.48 18.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.14 -0.975 . . . . 1.0 109.414 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 19.5 ptt180 -150.59 127.41 11.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.944 . . . . 1.0 109.6 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.436 HG13 HD12 ' A' ' 50' ' ' LEU . 3.1 p -106.9 129.34 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.039 -1.038 . . . . 1.0 109.37 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -111.57 107.78 17.06 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.272 -0.892 . . . . 1.0 108.736 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.586 ' CG2' ' CD2' ' A' ' 163' ' ' LEU . 40.1 t -99.09 136.1 20.63 Favored Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.245 -0.909 . . . . 1.0 109.034 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.447 ' HD2' HG11 ' A' ' 155' ' ' VAL . 35.7 Cg_endo -77.72 141.65 19.65 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 122.534 2.156 . . . . 1.0 111.323 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.529 ' CG ' ' HD2' ' A' ' 158' ' ' PRO . 0.9 OUTLIER -160.35 179.12 1.42 Allowed Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.529 ' HD2' ' CG ' ' A' ' 157' ' ' GLN . 33.8 Cg_endo -78.27 -53.32 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.393 2.062 . . . . 1.0 110.094 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 158' ' ' PRO . 17.3 m -59.22 -148.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.662 -0.649 . . . . 1.0 109.583 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -125.05 -80.74 0.43 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.105 -1.198 . . . . 1.0 110.105 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 40.7 mtt-85 -78.14 80.96 4.55 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.482 -1.01 . . . . 1.0 108.809 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.563 ' CG2' ' N ' ' A' ' 163' ' ' LEU . 0.7 OUTLIER -102.76 -52.69 3.02 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.583 -0.698 . . . . 1.0 109.338 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.586 ' CD2' ' CG2' ' A' ' 155' ' ' VAL . 9.9 tp -155.49 96.17 1.76 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.399 -0.963 . . . . 1.0 108.399 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.86 101.71 1.01 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.069 -1.02 . . . . 1.0 109.165 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.506 ' CD2' ' N ' ' A' ' 165' ' ' LEU . 2.2 pt? -137.1 170.04 16.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 1.0 109.777 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.454 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 2.8 mt-30 -113.61 155.03 26.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.361 -0.837 . . . . 1.0 109.781 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 151' ' ' PHE . 45.6 t -149.74 80.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.883 . . . . 1.0 109.63 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.71 105.59 17.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 1.0 109.162 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 170' ' ' ASN . 79.7 p -120.18 117.86 29.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.939 . . . . 1.0 109.772 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 169' ' ' SER . 0.7 OUTLIER 163.03 73.72 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.366 -0.834 . . . . 1.0 109.418 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.68 85.8 1.74 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.419 2.079 . . . . 1.0 110.399 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.525 ' O ' ' CG ' ' A' ' 146' ' ' ARG . 4.3 mt -123.07 164.95 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -0.929 . . . . 1.0 108.996 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 172' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 O-C-N 121.168 -0.958 . . . . 1.0 109.692 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.443 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 35.8 Cg_endo . . . . . 0 C--O 1.214 -0.691 0 N-CA-C 110.49 -0.619 . . . . 1.0 110.49 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 162' ' ' THR . 7.5 m-85 -73.12 131.58 42.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 1.0 109.446 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -145.7 124.57 12.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.997 -1.064 . . . . 1.0 109.806 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.499 HD21 ' CG1' ' A' ' 153' ' ' VAL . 20.1 tp -120.07 82.74 1.94 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.363 -0.835 . . . . 1.0 109.038 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.62 159.43 26.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.31 -0.869 . . . . 1.0 109.863 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.466 ' CG2' ' O ' ' A' ' 47' ' ' ILE . 1.3 mp -75.98 142.18 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.338 -0.851 . . . . 1.0 108.774 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.46 ' O ' HG21 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -65.27 -42.75 92.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.339 -0.851 . . . . 1.0 109.618 -179.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 18' ' ' GLU . 20.2 t -141.49 133.07 27.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.294 -0.879 . . . . 1.0 109.463 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -119.05 77.16 15.76 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.153 -0.967 . . . . 1.0 109.561 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 23' ' ' SER . 35.9 Cg_endo -78.36 -176.91 3.51 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.513 2.142 . . . . 1.0 110.221 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 21' ' ' PRO . 2.4 mptt -44.35 99.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.317 -0.864 . . . . 1.0 109.008 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 21' ' ' PRO . 2.1 t -96.63 40.92 1.12 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 1.0 109.956 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -99.9 166.96 10.81 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.089 -1.007 . . . . 1.0 109.318 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.57 ' CE1' ' HA ' ' A' ' 38' ' ' VAL . 3.2 t60 -143.23 133.7 24.85 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.723 -0.791 . . . . 1.0 109.64 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.463 ' HD3' ' O ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -105.68 74.31 1.06 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.345 -0.847 . . . . 1.0 109.047 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 1.0 109.54 -179.766 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.528 0.68 . . . . 1.0 109.619 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.57 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 2.4 p -54.5 119.63 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.367 -0.833 . . . . 1.0 109.535 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -142.65 99.3 3.45 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.27 -0.894 . . . . 1.0 109.852 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.41 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -93.85 -147.21 0.25 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.322 -0.861 . . . . 1.0 109.142 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.94 171.55 10.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.046 -1.034 . . . . 1.0 109.471 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 54.64 64.33 1.85 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 1.0 109.393 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.12 -68.68 3.48 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.345 -1.502 . . . . 1.0 109.345 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.518 ' CA ' ' HB2' ' A' ' 119' ' ' ASP . . . 173.11 36.16 0.03 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.578 -1.409 . . . . 1.0 109.578 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.563 ' CG ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER 165.42 177.67 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.195 -1.18 . . . . 1.0 109.294 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.563 ' HD2' ' CG ' ' A' ' 45' ' ' HIS . 35.0 Cg_endo -77.34 172.05 16.64 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.426 2.084 . . . . 1.0 110.506 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.499 ' CG2' ' HD3' ' A' ' 115' ' ' ARG . 4.2 mm -105.33 161.71 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 1.0 109.659 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.3 t -139.9 125.5 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.393 -0.817 . . . . 1.0 109.245 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -146.64 157.18 43.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.927 . . . . 1.0 109.547 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 110' ' ' PRO . 5.4 tt -114.63 134.67 54.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 1.0 109.419 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -140.59 79.04 1.68 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 1.0 109.308 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 53' ' ' TYR . . . 177.45 64.31 0.06 OUTLIER Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.806 -1.318 . . . . 1.0 109.806 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.525 ' CE1' ' HB2' ' A' ' 55' ' ' GLU . 0.4 OUTLIER 177.0 118.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.158 -1.201 . . . . 1.0 109.594 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.434 ' HA ' ' OE1' ' A' ' 111' ' ' GLU . 0.7 OUTLIER -106.98 25.46 11.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.241 -0.912 . . . . 1.0 109.299 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.525 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 38.8 tp10 -89.98 145.15 25.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.236 -0.915 . . . . 1.0 109.482 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -89.0 35.92 0.8 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.221 -0.924 . . . . 1.0 109.532 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.489 ' HG2' ' CG ' ' A' ' 55' ' ' GLU . 26.2 pt-20 -112.76 147.67 37.66 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 1.0 109.422 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.417 ' C ' HD22 ' A' ' 59' ' ' LEU . 35.3 Cg_endo -78.11 141.06 18.29 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.374 2.049 . . . . 1.0 110.527 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.461 HD22 ' HG3' ' A' ' 57' ' ' GLU . 7.5 mt -120.09 163.77 17.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.898 . . . . 1.0 109.19 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.448 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -116.22 100.18 7.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.208 -0.933 . . . . 1.0 109.981 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.528 ' CD2' ' HB2' ' A' ' 63' ' ' LEU . 1.6 tt -65.72 127.94 33.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.879 . . . . 1.0 108.923 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 152' ' ' ARG . 90.4 mt-30 -91.34 92.22 8.5 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.217 -0.927 . . . . 1.0 109.208 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.528 ' HB2' ' CD2' ' A' ' 61' ' ' LEU . 15.0 tp -99.6 139.84 34.67 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.316 -0.865 . . . . 1.0 109.022 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.498 ' CG ' ' N ' ' A' ' 65' ' ' ILE . 0.2 OUTLIER -163.86 168.36 19.61 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.159 -0.963 . . . . 1.0 108.79 -179.314 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.555 HD13 ' CE1' ' A' ' 76' ' ' HIS . 0.0 OUTLIER -132.47 116.8 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.814 . . . . 1.0 108.869 179.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -130.98 152.6 20.0 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.843 -1.303 . . . . 1.0 109.843 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.563 HG22 ' CD2' ' A' ' 76' ' ' HIS . 40.7 p -74.03 157.39 36.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.389 -1.065 . . . . 1.0 109.433 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -169.06 113.58 0.56 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.262 -0.899 . . . . 1.0 109.632 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.39 9.54 37.91 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.273 -0.892 . . . . 1.0 109.346 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -168.67 -54.39 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.31 -0.868 . . . . 1.0 109.192 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 73' ' ' LEU . 3.0 tpt180 -175.23 -33.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.87 . . . . 1.0 109.698 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.464 HD11 ' O ' ' A' ' 72' ' ' LEU . 0.9 OUTLIER -54.12 92.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.295 -0.878 . . . . 1.0 109.774 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.5 OUTLIER -56.62 164.88 1.3 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.236 -0.915 . . . . 1.0 109.733 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.519 ' CD ' ' HD2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -175.15 170.86 1.34 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 1.0 109.22 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.519 ' HD2' ' CD ' ' A' ' 74' ' ' ARG . 35.2 Cg_endo -77.23 136.67 16.3 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.338 2.026 . . . . 1.0 110.414 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.577 ' NE2' ' CG1' ' A' ' 147' ' ' VAL . 0.2 OUTLIER -59.2 147.3 35.96 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.278 -0.889 . . . . 1.0 109.719 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 76' ' ' HIS . . . -46.02 -77.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 125' ' ' LYS . 79.3 m-85 -140.66 23.71 2.27 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.95 -0.759 . . . . 1.0 108.95 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.577 ' CD2' ' HB3' ' A' ' 125' ' ' LYS . 63.0 m-85 -78.32 106.97 10.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 1.0 109.31 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 80' ' ' GLN . 11.2 tt0 -119.48 85.27 2.34 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 122' ' ' GLY . 3.8 m -69.75 138.15 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.322 -0.861 . . . . 1.0 110.037 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -175.96 85.45 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.467 -0.771 . . . . 1.0 109.096 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.21 81.04 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.05 -1.031 . . . . 1.0 110.309 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.7 mp -109.34 147.85 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 1.0 108.724 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 67.6 p . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.145 -0.972 . . . . 1.0 109.819 -179.6 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.506 ' CG1' HG21 ' A' ' 91' ' ' THR . 5.9 p . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.9 t -74.41 -42.03 59.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.065 -1.022 . . . . 1.0 109.389 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.506 HG21 ' CG1' ' A' ' 89' ' ' VAL . 6.4 t -72.86 -168.96 0.52 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.921 . . . . 1.0 109.385 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.46 ' O ' HG21 ' A' ' 106' ' ' ILE . 4.4 m -103.48 158.32 16.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 1.0 109.461 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.39 157.35 46.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 1.0 109.786 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -155.86 119.03 4.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.404 -0.81 . . . . 1.0 109.449 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.96 141.9 32.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.127 -0.983 . . . . 1.0 109.473 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.409 ' O ' HG22 ' A' ' 103' ' ' VAL . . . -130.67 120.67 24.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.92 . . . . 1.0 109.574 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.516 ' CD1' ' O ' ' A' ' 101' ' ' THR . 5.1 tp -117.2 144.98 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.36 -0.838 . . . . 1.0 109.323 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.471 ' O ' ' CG ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -135.89 49.42 2.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.115 -0.991 . . . . 1.0 109.676 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER 74.34 114.85 0.06 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.199 -0.938 . . . . 1.0 109.666 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 99' ' ' SER . 3.7 p-10 43.91 35.52 1.14 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.584 -0.698 . . . . 1.0 110.623 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.516 ' O ' ' CD1' ' A' ' 97' ' ' ILE . 0.2 OUTLIER -149.85 105.19 3.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.841 -1.162 . . . . 1.0 109.952 179.543 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -90.33 106.23 18.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 1.0 109.13 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -109.8 172.03 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.289 -0.882 . . . . 1.0 109.229 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 1.9 mp -128.22 137.67 52.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.816 . . . . 1.0 109.518 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -133.58 112.81 11.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 1.0 109.264 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.46 HG21 ' O ' ' A' ' 92' ' ' THR . 51.9 mt -123.2 107.87 32.4 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 1.0 109.741 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.523 ' O ' ' CD2' ' A' ' 108' ' ' LEU . 34.7 Cg_endo -76.98 125.32 7.92 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.097 1.865 . . . . 1.0 110.231 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 107' ' ' PRO . 3.4 mt -134.12 151.63 51.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 1.0 110.006 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.456 HD11 ' O ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -123.38 91.29 49.9 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.416 -0.802 . . . . 1.0 108.93 179.505 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.455 ' HB3' ' HB3' ' A' ' 50' ' ' LEU . 35.9 Cg_endo -78.07 70.49 7.07 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.515 2.143 . . . . 1.0 110.631 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.494 ' O ' ' CG ' ' A' ' 111' ' ' GLU . 19.8 tp10 -118.56 0.71 11.61 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.284 -0.885 . . . . 1.0 109.639 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.498 ' O ' ' CB ' ' A' ' 113' ' ' SER . 0.0 OUTLIER -143.55 -65.11 0.38 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.105 -0.997 . . . . 1.0 109.496 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.4 OUTLIER 164.61 109.95 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.147 -0.971 . . . . 1.0 109.157 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.451 ' SD ' HD13 ' A' ' 109' ' ' LEU . 9.4 ptm -154.09 117.43 4.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.2 -0.938 . . . . 1.0 109.915 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.499 ' HD3' ' CG2' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -88.29 136.45 32.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.435 -0.79 . . . . 1.0 109.415 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.03 108.99 16.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 1.0 109.365 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.404 HG11 ' CD ' ' A' ' 115' ' ' ARG . 4.3 m -95.25 159.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -0.934 . . . . 1.0 109.667 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.486 ' O ' ' CB ' ' A' ' 45' ' ' HIS . 8.3 mt -146.95 102.6 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 1.0 109.228 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.518 ' HB2' ' CA ' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -147.56 47.39 1.11 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 1.0 109.71 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 63.8 m -145.04 54.2 1.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.881 . . . . 1.0 109.355 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 122' ' ' GLY . . . -145.26 87.24 1.8 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.917 . . . . 1.0 109.845 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.52 ' O ' ' CG1' ' A' ' 81' ' ' VAL . . . -56.44 -166.36 0.06 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 108.389 -1.884 . . . . 1.0 108.389 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.433 HG23 ' CD2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -114.29 151.77 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.707 -1.466 . . . . 1.0 109.178 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -143.44 82.57 1.74 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.438 -0.789 . . . . 1.0 109.702 -179.642 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.577 ' HB3' ' CD2' ' A' ' 79' ' ' TYR . 4.3 ptmt . . . . . 0 N--CA 1.494 1.74 0 O-C-N 120.822 -1.174 . . . . 1.0 110.207 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.1 p . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 121.482 0.658 . . . . 1.0 109.68 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.12 128.02 7.41 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.388 -0.82 . . . . 1.0 109.187 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.577 ' CG1' ' NE2' ' A' ' 76' ' ' HIS . 6.8 m -136.2 161.28 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.964 . . . . 1.0 109.517 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -145.24 126.41 14.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.189 -0.945 . . . . 1.0 109.667 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.454 HD21 HG12 ' A' ' 65' ' ' ILE . 2.0 mm? -79.86 114.52 18.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.335 -0.853 . . . . 1.0 108.997 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 45.6 t -85.93 122.74 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.235 -0.916 . . . . 1.0 109.497 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.457 ' O ' ' HB ' ' A' ' 167' ' ' VAL . 8.0 m-85 -119.76 95.75 4.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.33 -0.856 . . . . 1.0 109.125 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 19.5 ptt180 -135.63 129.93 33.59 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.141 -0.974 . . . . 1.0 109.566 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.499 ' CG1' HD21 ' A' ' 15' ' ' LEU . 11.9 p -108.19 128.6 63.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.306 -0.871 . . . . 1.0 108.763 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.567 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 41.0 m-70 -124.34 108.54 12.31 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.197 -0.94 . . . . 1.0 109.76 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.528 ' CG1' ' HB3' ' A' ' 163' ' ' LEU . 7.7 p -99.22 141.24 22.51 Favored Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 121.314 -0.866 . . . . 1.0 109.172 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.513 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 34.5 Cg_endo -77.19 115.34 3.95 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.174 1.916 . . . . 1.0 109.994 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.457 ' OE1' ' HD2' ' A' ' 158' ' ' PRO . 72.2 mm-40 -143.23 163.58 36.52 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.424 -0.797 . . . . 1.0 109.52 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.457 ' HD2' ' OE1' ' A' ' 157' ' ' GLN . 35.0 Cg_endo -77.92 -55.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.402 2.068 . . . . 1.0 109.777 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 158' ' ' PRO . 0.2 OUTLIER -45.71 171.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.628 -0.67 . . . . 1.0 109.466 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -93.86 -66.37 1.04 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.173 -1.171 . . . . 1.0 110.173 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.6 mtm-85 -78.98 79.21 5.39 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.399 -1.334 . . . . 1.0 107.399 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.535 ' O ' ' CD2' ' A' ' 13' ' ' TYR . 2.7 t -102.03 -108.34 0.24 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.673 -0.642 . . . . 1.0 110.518 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.528 ' HB3' ' CG1' ' A' ' 155' ' ' VAL . 8.6 tp -129.1 96.46 4.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.295 -1.503 . . . . 1.0 108.299 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.567 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -162.85 100.34 1.0 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.874 -1.141 . . . . 1.0 109.699 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.581 ' CD2' ' N ' ' A' ' 165' ' ' LEU . 1.0 OUTLIER -134.61 170.04 16.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.178 -0.952 . . . . 1.0 109.64 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.434 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 3.1 mm-40 -121.73 147.31 46.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 1.0 109.557 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.496 ' O ' ' CG1' ' A' ' 167' ' ' VAL . 41.8 t -145.47 70.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.871 . . . . 1.0 109.407 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.77 107.72 19.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.222 -0.924 . . . . 1.0 109.192 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 0.3 OUTLIER -156.33 123.49 5.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 1.0 109.7 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 169' ' ' SER . 1.8 t30 172.2 94.94 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.37 -0.831 . . . . 1.0 109.287 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.65 107.9 2.46 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.414 2.076 . . . . 1.0 110.48 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.542 HG22 HD11 ' A' ' 172' ' ' ILE . 24.6 mt -137.43 159.47 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.874 . . . . 1.0 108.99 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 145' ' ' THR . 2.9 mt-10 . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.127 -0.983 . . . . 1.0 109.854 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.425 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 36.3 Cg_endo . . . . . 0 C--O 1.216 -0.602 0 N-CA-C 110.596 -0.578 . . . . 1.0 110.596 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.575 ' CE2' ' O ' ' A' ' 162' ' ' THR . 8.3 m-85 -56.09 155.75 6.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 1.0 109.063 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 12' ' ' PRO . 20.7 mt-10 -152.21 103.01 2.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.885 -1.134 . . . . 1.0 110.25 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.3 tp -112.24 76.78 1.0 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.436 -0.95 . . . . 1.0 108.436 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.45 ' O ' ' OE1' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -114.87 176.25 5.14 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.322 -0.861 . . . . 1.0 110.188 -179.022 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.511 ' CG2' ' HG2' ' A' ' 20' ' ' GLN . 0.8 OUTLIER -86.75 146.48 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 108.705 -0.85 . . . . 1.0 108.705 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.51 ' HB2' ' NE2' ' A' ' 49' ' ' GLN . 0.8 OUTLIER -77.06 -61.13 2.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 1.0 109.261 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 19' ' ' VAL . 9.7 p -109.67 136.02 46.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.385 -0.822 . . . . 1.0 109.307 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.511 ' HG2' ' CG2' ' A' ' 17' ' ' ILE . 9.4 mm-40 -129.06 66.02 75.34 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.143 -0.973 . . . . 1.0 109.599 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.522 ' HG2' ' CB ' ' A' ' 41' ' ' SER . 35.4 Cg_endo -77.62 -177.03 3.54 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.464 2.109 . . . . 1.0 110.575 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -61.85 151.7 33.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.366 -0.834 . . . . 1.0 109.129 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.448 ' HB3' ' HG2' ' A' ' 171' ' ' PRO . 2.2 t -163.76 61.58 0.16 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.14 -0.975 . . . . 1.0 110.038 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . 0.433 ' HA ' HG12 ' A' ' 172' ' ' ILE . 1.9 p80 -99.52 165.52 11.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.084 -1.01 . . . . 1.0 108.881 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.577 ' CE1' ' HA ' ' A' ' 38' ' ' VAL . 1.1 m-70 -139.54 110.41 6.8 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.703 -0.799 . . . . 1.0 109.894 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -87.12 64.98 8.68 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.424 -0.954 . . . . 1.0 108.424 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.504 0 CA-C-O 121.367 0.603 . . . . 1.0 109.88 -179.226 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.427 ' HB2' ' HE3' ' A' ' 39' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.598 0.713 . . . . 1.0 109.762 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.577 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 2.4 p -100.27 102.3 13.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.939 -0.704 . . . . 1.0 109.732 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 12.5 ptpt -153.9 110.43 3.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.898 . . . . 1.0 109.614 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.66 -45.25 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.14 -0.975 . . . . 1.0 109.517 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.522 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 0.3 OUTLIER -100.68 102.1 13.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 1.0 109.621 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 41' ' ' SER . . . 61.52 42.32 11.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 1.0 109.521 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 92.09 -21.39 37.42 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.653 -1.379 . . . . 1.0 109.653 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.516 ' N ' ' OD2' ' A' ' 119' ' ' ASP . . . 155.22 106.79 0.27 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.473 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.3 OUTLIER 73.92 146.18 0.11 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.254 -1.145 . . . . 1.0 109.758 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.401 ' HA ' ' OG ' ' A' ' 41' ' ' SER . 35.2 Cg_endo -78.12 -178.81 4.9 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.651 2.234 . . . . 1.0 110.577 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.511 HG22 ' CG1' ' A' ' 117' ' ' VAL . 5.2 mt -94.32 158.34 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.513 -0.742 . . . . 1.0 109.278 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.536 HG23 ' CZ ' ' A' ' 151' ' ' PHE . 11.1 t -140.35 88.1 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.159 -0.963 . . . . 1.0 110.108 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.62 ' CG ' ' CE1' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -98.8 175.74 5.86 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 1.0 108.903 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 tt -134.81 136.73 42.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.933 -1.104 . . . . 1.0 110.036 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.62 ' CE1' ' CG ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -140.55 79.08 1.68 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.353 -0.842 . . . . 1.0 108.844 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 53' ' ' TYR . . . -174.33 88.22 0.08 OUTLIER Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.544 -1.312 . . . . 1.0 110.234 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.566 ' CE2' HD13 ' A' ' 59' ' ' LEU . 2.0 t80 176.8 131.83 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -1.109 . . . . 1.0 109.654 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.9 mt -108.89 4.42 23.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 1.0 109.539 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.453 ' HB3' ' HG2' ' A' ' 57' ' ' GLU . 2.7 mt-10 -95.24 143.39 26.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 1.0 109.507 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -90.73 35.12 0.89 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.918 . . . . 1.0 109.337 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.461 ' HG3' HD22 ' A' ' 59' ' ' LEU . 17.3 pt-20 -110.83 151.97 43.25 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 1.0 109.357 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.31 134.2 12.55 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.436 2.091 . . . . 1.0 110.534 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.584 ' CD1' ' CD2' ' A' ' 163' ' ' LEU . 16.1 mt -118.63 165.44 13.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.238 -0.914 . . . . 1.0 109.077 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' MET . . . . . 0.463 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -105.13 136.03 45.38 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.174 -0.954 . . . . 1.0 109.583 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.519 ' CD2' ' HB2' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -89.41 136.15 33.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.36 -0.838 . . . . 1.0 109.224 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -97.2 85.96 3.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.204 -0.935 . . . . 1.0 109.536 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.588 ' CD1' ' CE1' ' A' ' 151' ' ' PHE . 18.8 tp -99.36 130.95 45.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 1.0 108.822 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.499 ' HB2' ' CG1' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -155.44 143.54 20.05 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -0.968 . . . . 1.0 109.113 -179.326 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.573 ' CD1' ' CE1' ' A' ' 76' ' ' HIS . 0.1 OUTLIER -103.99 124.54 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.446 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.515 ' N ' HD12 ' A' ' 65' ' ' ILE . . . -136.8 149.17 20.1 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.915 -1.274 . . . . 1.0 109.915 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.513 ' OG1' ' NE ' ' A' ' 74' ' ' ARG . 73.5 p -83.14 156.51 23.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.28 -1.13 . . . . 1.0 109.362 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.45 ' HB2' ' HG3' ' A' ' 148' ' ' ARG . . . -160.56 116.99 2.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 1.0 109.694 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -85.45 -25.13 27.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.169 -0.957 . . . . 1.0 109.14 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.12 -42.02 0.21 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.382 -0.824 . . . . 1.0 109.425 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' LEU . 13.0 ttm180 -175.35 -34.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 1.0 109.569 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.4 ' CD1' ' O ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -48.67 91.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 1.0 109.865 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.7 OUTLIER -58.21 155.73 10.93 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.163 -0.961 . . . . 1.0 109.656 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.513 ' NE ' ' OG1' ' A' ' 67' ' ' THR . 10.8 ptt180 -175.27 172.19 1.14 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.88 . . . . 1.0 108.7 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 74' ' ' ARG . 33.7 Cg_endo -77.18 161.73 32.06 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.141 1.894 . . . . 1.0 110.312 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.685 ' CD2' ' CD1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -64.35 156.03 30.47 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.227 -0.921 . . . . 1.0 109.708 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.28 -48.92 4.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 1.0 109.84 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -120.39 26.83 8.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.18 -0.95 . . . . 1.0 109.899 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.685 ' CD1' ' CD2' ' A' ' 76' ' ' HIS . 0.2 OUTLIER -140.86 148.68 40.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.148 -0.97 . . . . 1.0 109.127 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.452 ' HG3' ' HB2' ' A' ' 102' ' ' LYS . 20.5 tt0 -165.05 -36.41 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.122 -0.986 . . . . 1.0 109.589 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 122' ' ' GLY . 12.8 m -50.78 143.22 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.052 -1.03 . . . . 1.0 109.633 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.402 ' O ' ' OE2' ' A' ' 95' ' ' GLU . 3.9 t-80 -175.93 67.98 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.532 -0.73 . . . . 1.0 109.319 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.0 OUTLIER -134.41 153.97 51.62 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.236 -0.915 . . . . 1.0 109.815 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.491 ' CG1' ' HB2' ' A' ' 120' ' ' CYS . 3.8 mp -100.01 143.63 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.447 -0.783 . . . . 1.0 109.486 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.4 p . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 1.0 109.404 -179.986 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.5 m -78.71 3.78 15.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 1.0 109.606 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.521 ' CG2' HG23 ' A' ' 106' ' ' ILE . 16.3 m -104.82 101.36 10.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.213 -0.93 . . . . 1.0 109.539 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.526 ' O ' ' CG2' ' A' ' 106' ' ' ILE . 22.7 m -46.08 115.71 1.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -0.935 . . . . 1.0 109.652 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.456 ' HA ' HG22 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -114.21 173.68 6.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 1.0 109.654 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.1 162.67 40.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.375 -0.828 . . . . 1.0 109.519 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.402 ' OE2' ' O ' ' A' ' 82' ' ' HIS . 1.2 tt0 -124.31 133.59 53.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.864 . . . . 1.0 109.492 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.461 ' O ' HG21 ' A' ' 103' ' ' VAL . . . -124.66 121.53 34.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 1.0 109.55 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.422 HD13 ' C ' ' A' ' 101' ' ' THR . 6.1 tp -111.79 140.12 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 1.0 109.444 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.51 ' O ' ' CB ' ' A' ' 99' ' ' SER . 0.5 OUTLIER -132.32 49.41 2.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.138 -0.976 . . . . 1.0 109.691 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 3.1 t 76.8 112.34 0.07 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.897 . . . . 1.0 110.279 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.432 ' CG ' ' O ' ' A' ' 99' ' ' SER . 3.5 p-10 43.64 31.96 0.51 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.689 -0.632 . . . . 1.0 111.032 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.441 ' HB ' ' HG ' ' A' ' 98' ' ' LEU . 2.5 m -160.2 96.29 1.19 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.737 -1.227 . . . . 1.0 110.226 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.452 ' HB2' ' HG3' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -88.87 153.71 20.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.229 -0.919 . . . . 1.0 108.943 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.499 ' CG1' ' HB2' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -144.18 173.57 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.071 -1.018 . . . . 1.0 109.211 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.52 ' CD2' HD13 ' A' ' 106' ' ' ILE . 0.2 OUTLIER -123.92 130.81 53.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.924 . . . . 1.0 109.954 -179.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -133.1 122.64 24.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.358 -0.839 . . . . 1.0 108.864 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 92' ' ' THR . 26.8 mt -133.94 112.73 12.48 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.035 -1.04 . . . . 1.0 110.119 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.492 ' C ' ' CD2' ' A' ' 108' ' ' LEU . 34.0 Cg_endo -76.56 121.24 5.89 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 122.091 1.861 . . . . 1.0 109.712 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.512 HD23 ' CG2' ' A' ' 91' ' ' THR . 2.5 mt -126.36 165.55 18.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 1.0 110.667 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.59 ' CB ' ' CD ' ' A' ' 110' ' ' PRO . 0.6 OUTLIER -72.26 -170.82 0.17 Allowed Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 108.081 -1.081 . . . . 1.0 108.081 179.259 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.59 ' CD ' ' CB ' ' A' ' 109' ' ' LEU . 33.4 Cg_endo -77.64 -76.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 121.532 1.488 . . . . 1.0 110.848 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.44 ' HG3' ' HA ' ' A' ' 51' ' ' HIS . 1.8 tt0 -170.46 52.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.897 -1.127 . . . . 1.0 110.131 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.474 ' O ' ' CB ' ' A' ' 113' ' ' SER . 13.2 p30 -79.73 -40.65 28.37 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.086 -1.009 . . . . 1.0 109.166 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.5 OUTLIER 164.68 87.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.361 -0.837 . . . . 1.0 109.157 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.508 ' HE3' ' N ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -162.51 139.71 8.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.155 -0.966 . . . . 1.0 110.19 -179.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -119.6 137.75 53.66 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.386 -0.821 . . . . 1.0 108.937 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -112.49 97.91 6.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.158 -0.964 . . . . 1.0 109.749 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.511 ' CG1' HG22 ' A' ' 47' ' ' ILE . 5.4 m -96.42 127.22 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 1.0 109.349 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.459 ' O ' ' HB3' ' A' ' 45' ' ' HIS . 65.9 mt -102.56 111.26 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 1.0 109.358 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.516 ' OD2' ' N ' ' A' ' 44' ' ' GLY . 3.9 t0 -147.12 41.83 1.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.943 . . . . 1.0 109.619 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.491 ' HB2' ' CG1' ' A' ' 84' ' ' ILE . 63.8 m -145.22 57.77 1.26 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -0.956 . . . . 1.0 109.824 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.516 ' O ' ' CG1' ' A' ' 38' ' ' VAL . . . -128.33 152.94 47.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 1.0 108.881 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.456 ' O ' HG22 ' A' ' 81' ' ' VAL . . . -114.21 -174.35 18.53 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.838 -1.305 . . . . 1.0 109.838 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.501 HG22 HD11 ' A' ' 123' ' ' ILE . 1.2 mt -125.23 171.79 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -1.104 . . . . 1.0 109.055 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.424 HD13 HG12 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -140.31 161.36 37.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 1.0 109.569 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.303 -0.873 . . . . 1.0 109.377 179.883 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.459 ' CG2' ' OH ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.158 0.504 . . . . 1.0 109.654 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.545 ' NH2' ' ND2' ' A' ' 170' ' ' ASN . 6.4 ptm180 -86.73 176.59 7.66 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.233 -0.917 . . . . 1.0 109.288 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.508 ' O ' ' ND2' ' A' ' 170' ' ' ASN . 27.7 m -134.7 -174.68 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.403 -0.811 . . . . 1.0 109.877 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.451 ' CB ' ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -149.29 95.97 2.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.33 -0.856 . . . . 1.0 109.319 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.514 ' CD2' HG12 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -78.0 124.51 28.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.986 -1.071 . . . . 1.0 109.035 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.6 t -110.04 114.41 46.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.233 -0.917 . . . . 1.0 109.776 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.588 ' CE1' ' CD1' ' A' ' 63' ' ' LEU . 21.6 m-85 -110.43 113.29 25.83 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.769 -0.826 . . . . 1.0 108.769 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 10.0 ptt180 -149.46 138.73 21.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.171 -0.955 . . . . 1.0 109.781 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 164' ' ' SER . 8.7 p -112.66 128.52 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.471 -0.937 . . . . 1.0 108.471 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.567 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 41.7 m-70 -128.89 118.45 22.71 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.16 -0.962 . . . . 1.0 110.002 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.534 ' CG1' ' HB3' ' A' ' 163' ' ' LEU . 14.7 p -98.52 141.2 22.53 Favored Pre-proline 0 N--CA 1.487 1.406 0 O-C-N 121.279 -0.888 . . . . 1.0 108.788 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 33.0 Cg_endo -74.73 114.05 3.94 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.197 1.931 . . . . 1.0 110.615 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.451 ' HB3' ' HD2' ' A' ' 158' ' ' PRO . 0.6 OUTLIER -135.71 166.05 31.42 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.506 -0.746 . . . . 1.0 109.006 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 157' ' ' GLN . 34.4 Cg_endo -76.34 -64.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.261 1.974 . . . . 1.0 110.373 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.0 m -53.77 -78.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.195 -0.94 . . . . 1.0 109.349 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 144.44 -42.07 1.06 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.458 -1.457 . . . . 1.0 109.458 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.01 79.96 5.37 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.022 -1.103 . . . . 1.0 108.022 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.575 ' O ' ' CE2' ' A' ' 13' ' ' TYR . 1.3 m -135.05 -88.38 0.36 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.533 -0.73 . . . . 1.0 109.367 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.584 ' CD2' ' CD1' ' A' ' 59' ' ' LEU . 7.6 tp -131.15 102.89 6.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.021 -1.049 . . . . 1.0 109.08 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.567 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -162.11 114.31 1.71 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.08 -1.012 . . . . 1.0 109.593 179.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 152' ' ' ARG . 1.0 OUTLIER -122.81 175.36 6.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.335 -0.853 . . . . 1.0 109.753 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.449 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 0.7 OUTLIER -147.87 105.66 3.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.425 -0.797 . . . . 1.0 109.426 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 43.8 t -118.28 154.01 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 1.0 109.332 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 149' ' ' LEU . . . -151.41 102.83 2.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 1.0 109.214 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 170' ' ' ASN . 0.4 OUTLIER -130.71 161.78 30.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.957 . . . . 1.0 109.693 -179.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.545 ' ND2' ' NH2' ' A' ' 146' ' ' ARG . 1.6 p-10 164.93 97.77 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.343 -0.848 . . . . 1.0 109.567 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.448 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 36.1 Cg_endo -79.45 67.81 8.48 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.419 2.08 . . . . 1.0 110.48 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.446 HD11 HG23 ' A' ' 147' ' ' VAL . 16.1 mt -136.6 124.45 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.104 -0.997 . . . . 1.0 109.443 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 1.0 109.363 179.891 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo . . . . . 0 C--O 1.215 -0.638 0 N-CA-C 110.486 -0.621 . . . . 1.0 110.486 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.565 ' CD1' ' O ' ' A' ' 162' ' ' THR . 1.8 m-85 -95.65 162.9 13.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 1.0 109.459 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -152.42 142.69 22.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.138 -0.976 . . . . 1.0 109.918 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.414 ' HG ' HG22 ' A' ' 167' ' ' VAL . 22.8 tp -136.31 98.05 3.74 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.784 -0.821 . . . . 1.0 108.784 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.47 164.23 29.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 1.0 110.227 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.454 ' CG1' ' O ' ' A' ' 47' ' ' ILE . 0.8 OUTLIER -92.36 145.29 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.547 -0.909 . . . . 1.0 108.547 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.412 ' O ' ' CG2' ' A' ' 19' ' ' VAL . 1.3 tp10 -75.4 -35.83 60.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.936 . . . . 1.0 110.3 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.463 ' HB ' HG13 ' A' ' 47' ' ' ILE . 80.0 t -154.48 98.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 O-C-N 120.814 -1.179 . . . . 1.0 110.157 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.456 ' HG3' ' HD2' ' A' ' 21' ' ' PRO . 0.6 OUTLIER -51.63 160.34 1.06 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.442 -0.786 . . . . 1.0 109.037 179.422 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.468 ' HB3' ' O ' ' A' ' 44' ' ' GLY . 36.2 Cg_endo -78.38 154.92 28.36 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.458 2.106 . . . . 1.0 110.415 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.6 mmtm -46.09 165.12 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.266 -0.896 . . . . 1.0 109.453 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 23' ' ' SER . 5.2 t -94.19 24.39 4.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 1.0 110.142 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.04 166.38 23.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.94 -1.1 . . . . 1.0 110.003 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.58 ' CE1' ' HB ' ' A' ' 38' ' ' VAL . 0.8 OUTLIER -162.48 106.76 1.15 Allowed 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.303 -0.629 . . . . 1.0 109.303 179.428 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.1 ttp85 -75.17 91.74 2.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.255 -0.903 . . . . 1.0 109.36 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.312 0 O-C-N 121.315 -0.866 . . . . 1.0 109.523 179.906 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.442 0.639 . . . . 1.0 109.517 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.58 ' HB ' ' CE1' ' A' ' 25' ' ' HIS . 2.4 p -68.33 142.06 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.403 -0.81 . . . . 1.0 109.445 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.483 ' N ' HG21 ' A' ' 38' ' ' VAL . 4.2 mttt -143.8 105.41 4.3 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.278 -0.889 . . . . 1.0 109.766 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 41' ' ' SER . . . -161.16 105.8 1.34 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.411 -0.806 . . . . 1.0 108.905 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 40' ' ' ALA . 19.2 p 44.17 -105.56 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 1.0 108.903 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.517 ' HB1' ' CD2' ' A' ' 45' ' ' HIS . . . -88.57 48.0 1.58 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.582 -1.324 . . . . 1.0 108.232 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.82 -111.11 3.82 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.039 -2.024 . . . . 1.0 108.039 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 45' ' ' HIS . . . -89.61 -22.15 37.87 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.219 -1.952 . . . . 1.0 108.219 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.606 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 2.3 t-80 79.43 27.96 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.355 0 N-CA-C 113.315 0.857 . . . . 1.0 113.315 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 45' ' ' HIS . 37.3 Cg_endo -79.34 114.25 3.27 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 N-CA-C 108.935 -1.217 . . . . 1.0 108.935 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.571 ' CG2' ' NH2' ' A' ' 115' ' ' ARG . 0.0 OUTLIER -102.32 144.95 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.967 -1.083 . . . . 1.0 108.802 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.576 HG22 ' CZ ' ' A' ' 151' ' ' PHE . 5.2 t -137.27 124.49 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.033 -1.042 . . . . 1.0 110.369 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.565 ' NE2' ' NH1' ' A' ' 115' ' ' ARG . 4.8 tt0 -140.06 142.51 36.16 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.524 -0.917 . . . . 1.0 108.524 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.04 141.05 48.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.939 -1.1 . . . . 1.0 109.897 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -140.66 84.98 1.97 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.349 -0.844 . . . . 1.0 109.449 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 53' ' ' TYR . . . 170.01 105.22 0.18 Allowed Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.304 -1.427 . . . . 1.0 110.648 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 111' ' ' GLU . 3.5 t80 175.9 156.95 0.22 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.426 -1.044 . . . . 1.0 109.965 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.488 ' CD1' ' C ' ' A' ' 54' ' ' LEU . 3.3 pp -140.71 11.02 2.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.421 -0.799 . . . . 1.0 109.255 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.449 ' O ' ' CE2' ' A' ' 53' ' ' TYR . 1.6 tm-20 -120.77 145.67 47.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.303 -0.873 . . . . 1.0 109.658 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.402 ' C ' ' ND2' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -90.25 35.81 0.87 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 1.0 109.96 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.487 ' C ' ' CD1' ' A' ' 109' ' ' LEU . 15.1 pt-20 -100.62 137.84 19.97 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.146 -0.971 . . . . 1.0 109.424 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.512 ' O ' ' CD2' ' A' ' 59' ' ' LEU . 36.7 Cg_endo -79.92 154.23 22.78 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.511 2.141 . . . . 1.0 110.501 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.512 ' CD2' ' O ' ' A' ' 58' ' ' PRO . 2.3 mt -141.27 156.29 45.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 1.0 109.172 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -87.26 135.55 33.27 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.223 -0.923 . . . . 1.0 109.104 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.52 ' CD2' ' HB2' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -87.94 131.15 34.71 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.275 -0.89 . . . . 1.0 109.499 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -98.52 82.66 2.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -0.911 . . . . 1.0 109.572 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.573 HD11 ' CZ ' ' A' ' 151' ' ' PHE . 58.9 tp -99.64 135.98 40.25 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.247 -0.908 . . . . 1.0 108.81 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.573 ' CE2' ' HA3' ' A' ' 66' ' ' GLY . 1.7 t80 -148.4 164.05 35.28 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.226 -0.921 . . . . 1.0 109.042 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.523 ' CG2' ' O ' ' A' ' 65' ' ' ILE . 8.1 tp -129.38 102.85 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.573 ' HA3' ' CE2' ' A' ' 64' ' ' PHE . . . -124.65 153.69 17.83 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 110.067 -1.213 . . . . 1.0 110.067 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.582 ' CG2' ' CD2' ' A' ' 76' ' ' HIS . 1.1 p -77.22 149.56 35.47 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.464 -1.021 . . . . 1.0 109.23 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.72 115.74 4.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 1.0 109.752 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.25 -7.95 58.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 1.0 109.522 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -159.91 -44.34 0.05 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -0.929 . . . . 1.0 109.452 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -175.08 -34.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.262 -0.899 . . . . 1.0 109.625 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.08 89.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.9 . . . . 1.0 109.739 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 71' ' ' ARG . 2.2 pp -65.35 129.72 40.76 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.283 -0.885 . . . . 1.0 109.666 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.482 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 13.5 mmt180 -145.13 160.31 46.49 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 1.0 109.247 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -75.99 142.67 25.21 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.342 2.028 . . . . 1.0 110.202 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.582 ' CD2' ' CG2' ' A' ' 67' ' ' THR . 0.3 OUTLIER -67.44 160.97 26.36 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.221 -0.924 . . . . 1.0 109.569 -179.642 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.513 ' HB2' ' CD1' ' A' ' 78' ' ' PHE . . . -73.87 -65.21 0.86 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.307 -0.871 . . . . 1.0 110.308 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.683 ' CE2' ' CE1' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -111.91 -4.34 14.59 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.033 -1.042 . . . . 1.0 110.219 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.683 ' CE1' ' CE2' ' A' ' 78' ' ' PHE . 52.3 m-85 -83.89 105.94 15.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.98 -1.075 . . . . 1.0 108.963 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.525 ' HB2' ' CG ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -143.66 10.11 1.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.073 -1.017 . . . . 1.0 110.081 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 122' ' ' GLY . 11.9 m -75.68 146.91 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.983 -1.073 . . . . 1.0 109.497 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.615 ' CE1' ' CD1' ' A' ' 104' ' ' LEU . 5.7 t-80 -175.49 67.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.476 -0.765 . . . . 1.0 109.237 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.6 OUTLIER -122.66 139.9 53.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.235 -0.916 . . . . 1.0 109.746 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . 0.587 ' CG2' ' CB ' ' A' ' 120' ' ' CYS . 4.5 mp -100.11 133.52 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.343 -0.848 . . . . 1.0 109.675 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.275 -0.891 . . . . 1.0 109.302 179.802 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.452 HG23 ' HB ' ' A' ' 91' ' ' THR . 8.7 p . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.3 m -74.65 -0.43 17.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 1.0 109.806 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.452 ' HB ' HG23 ' A' ' 89' ' ' VAL . 16.4 m -80.75 -83.01 0.11 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.069 -1.019 . . . . 1.0 109.387 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER 179.33 162.46 0.85 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.302 -0.874 . . . . 1.0 109.459 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.518 ' HA ' ' CG1' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -165.19 156.98 15.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.263 -0.898 . . . . 1.0 110.014 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.465 ' HB2' ' O ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -155.61 150.08 26.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.467 -0.77 . . . . 1.0 109.064 179.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -120.45 148.48 43.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.136 -0.978 . . . . 1.0 109.837 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.29 121.22 9.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.303 -0.873 . . . . 1.0 109.557 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.495 ' HB ' ' CE ' ' A' ' 102' ' ' LYS . 2.1 tp -110.75 106.12 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.342 -0.849 . . . . 1.0 109.606 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.469 HD22 ' HB ' ' A' ' 101' ' ' THR . 2.1 pt? -110.15 130.28 55.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.205 -0.934 . . . . 1.0 109.48 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.535 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 16.6 m 35.07 83.98 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.077 -0.39 . . . . 1.0 111.379 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 99' ' ' SER . 0.7 OUTLIER 42.72 29.42 0.17 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.684 -0.635 . . . . 1.0 112.482 178.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.469 ' HB ' HD22 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -132.34 109.4 9.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.247 -1.533 . . . . 1.0 109.969 179.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . 0.525 ' CG ' ' HB2' ' A' ' 80' ' ' GLN . 9.9 mmtp -85.96 137.93 32.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.1 -1.0 . . . . 1.0 109.358 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.455 HG11 ' HB2' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -143.98 172.68 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.331 -0.855 . . . . 1.0 109.089 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.615 ' CD1' ' CE1' ' A' ' 82' ' ' HIS . 0.5 OUTLIER -124.31 135.55 53.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.27 -0.894 . . . . 1.0 110.147 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.502 ' N ' HD21 ' A' ' 104' ' ' LEU . 0.4 OUTLIER -139.99 125.03 18.58 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.601 -0.889 . . . . 1.0 108.601 179.405 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.518 ' CG1' ' HA ' ' A' ' 93' ' ' SER . 4.1 mp -128.94 115.81 19.03 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.976 -1.077 . . . . 1.0 110.115 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.41 97.3 1.12 Allowed 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 121.946 1.764 . . . . 1.0 109.64 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.494 HD13 ' CD ' ' A' ' 110' ' ' PRO . 0.7 OUTLIER -145.75 167.59 22.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 1.0 109.485 -179.205 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.521 ' CD2' ' OD1' ' A' ' 112' ' ' ASN . 3.9 tt -115.03 78.56 5.6 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.921 . . . . 1.0 110.346 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.494 ' CD ' HD13 ' A' ' 108' ' ' LEU . 38.1 Cg_endo -83.25 40.13 0.9 Allowed 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.589 2.192 . . . . 1.0 110.082 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.576 ' HB2' ' CD2' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -120.81 22.39 11.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.047 -1.033 . . . . 1.0 110.056 -178.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 0.2 OUTLIER -122.32 -52.9 1.93 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.114 -0.991 . . . . 1.0 109.119 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 1.4 p 164.59 86.01 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.371 -0.831 . . . . 1.0 108.989 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' MET . . . . . 0.446 ' SD ' ' HA ' ' A' ' 110' ' ' PRO . 0.5 OUTLIER -154.7 144.55 21.66 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.14 -0.975 . . . . 1.0 109.829 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.571 ' NH2' ' CG2' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -101.44 142.73 32.39 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.541 -0.911 . . . . 1.0 108.541 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.516 ' N ' ' HD3' ' A' ' 115' ' ' ARG . . . -134.78 96.55 3.56 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.994 -1.066 . . . . 1.0 109.87 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 117' ' ' VAL . 3.9 m -86.45 131.37 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.346 -0.846 . . . . 1.0 109.145 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.466 ' O ' ' HG2' ' A' ' 46' ' ' PRO . 2.2 mt -117.27 130.1 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.217 -0.927 . . . . 1.0 109.153 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 42' ' ' ALA . 0.7 OUTLIER -171.66 57.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.863 . . . . 1.0 109.695 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.587 ' CB ' ' CG2' ' A' ' 84' ' ' ILE . 60.7 m -145.19 43.73 1.32 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.137 -0.977 . . . . 1.0 109.845 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.449 ' O ' HG13 ' A' ' 38' ' ' VAL . . . -126.64 165.95 18.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 1.0 108.833 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . 0.511 ' O ' ' CG2' ' A' ' 81' ' ' VAL . . . -139.76 -179.48 17.76 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.697 -1.361 . . . . 1.0 109.697 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.573 HD13 ' CD2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -119.43 158.54 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.357 -1.084 . . . . 1.0 109.072 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.571 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -99.9 126.24 46.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 1.0 109.459 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.0 mttt . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.191 -0.943 . . . . 1.0 109.495 -179.85 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.465 ' O ' ' HB ' ' A' ' 67' ' ' THR . 11.2 mtt180 -85.1 166.62 16.49 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.267 -0.896 . . . . 1.0 109.417 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 172' ' ' ILE . 2.9 m -140.57 151.7 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -0.841 . . . . 1.0 109.422 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.496 ' HA ' ' CB ' ' A' ' 170' ' ' ASN . 42.6 mtt180 -154.52 125.72 7.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.132 -0.98 . . . . 1.0 109.448 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.494 HD22 ' ND2' ' A' ' 170' ' ' ASN . 0.4 OUTLIER -81.26 109.48 15.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.161 -0.962 . . . . 1.0 109.717 -179.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . 0.52 ' CG1' ' OE1' ' A' ' 166' ' ' GLN . 44.0 t -81.47 123.85 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.377 -0.827 . . . . 1.0 109.846 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.576 ' CZ ' HG22 ' A' ' 48' ' ' VAL . 1.9 m-85 -110.4 121.51 45.46 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.656 -0.868 . . . . 1.0 108.656 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . 0.517 ' CG ' ' HA ' ' A' ' 166' ' ' GLN . 1.8 mtt180 -145.03 123.12 12.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.92 -1.112 . . . . 1.0 110.184 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.516 HG11 ' CD1' ' A' ' 163' ' ' LEU . 7.1 p -114.85 129.71 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.476 -0.935 . . . . 1.0 108.476 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' HIS . . . . . 0.555 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 49.8 m-70 -130.35 113.43 14.35 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.116 -0.99 . . . . 1.0 109.718 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.531 ' CG2' ' HD2' ' A' ' 156' ' ' PRO . 5.2 p -98.74 140.94 22.12 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.306 -0.871 . . . . 1.0 109.019 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 33.6 Cg_endo -75.04 116.17 4.5 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.319 2.012 . . . . 1.0 110.791 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLN . . . . . 0.465 ' HB2' ' HD2' ' A' ' 158' ' ' PRO . 0.8 OUTLIER -132.71 165.24 37.95 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.506 -0.746 . . . . 1.0 109.247 -179.556 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 157' ' ' GLN . 33.8 Cg_endo -76.4 -63.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.194 1.93 . . . . 1.0 109.985 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.6 t -64.91 -90.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -0.862 . . . . 1.0 109.184 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . 0.431 ' HA2' ' CD ' ' A' ' 157' ' ' GLN . . . 164.06 -28.21 0.22 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.641 -1.383 . . . . 1.0 109.641 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -79.28 79.62 5.7 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.363 -1.081 . . . . 1.0 108.556 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.565 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 1.3 m -134.97 -82.21 0.43 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.839 -0.8 . . . . 1.0 108.839 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LEU . . . . . 0.539 ' O ' ' CG ' ' A' ' 163' ' ' LEU . 2.1 pp -159.69 106.96 1.69 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.957 -1.09 . . . . 1.0 109.728 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.555 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -164.95 85.02 0.4 Allowed 'General case' 0 C--N 1.294 -1.833 0 O-C-N 120.803 -1.186 . . . . 1.0 109.141 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.503 HD21 ' N ' ' A' ' 165' ' ' LEU . 1.5 pt? -131.38 168.82 16.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.034 -1.042 . . . . 1.0 110.026 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.52 ' OE1' ' CG1' ' A' ' 150' ' ' VAL . 7.0 tp-100 -101.97 149.74 23.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.452 -0.78 . . . . 1.0 109.548 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . 0.49 ' O ' ' CG1' ' A' ' 167' ' ' VAL . 39.0 t -144.18 71.51 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 1.0 109.521 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.44 136.19 42.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.089 -1.007 . . . . 1.0 109.5 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 7.3 t -175.3 133.96 0.31 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 1.0 109.613 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.496 ' CB ' ' HA ' ' A' ' 148' ' ' ARG . 1.9 t30 170.03 97.72 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.356 -0.84 . . . . 1.0 109.436 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PRO . . . . . 0.436 ' HG2' ' HB2' ' A' ' 23' ' ' SER . 35.3 Cg_endo -77.57 72.18 6.15 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.404 2.069 . . . . 1.0 110.615 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ILE . . . . . 0.588 ' CG2' ' CG2' ' A' ' 147' ' ' VAL . 13.9 mm -107.79 126.92 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.202 -0.937 . . . . 1.0 109.251 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.453 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 9.9 pt-20 . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 1.0 109.575 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.337 0.589 . . . . 1.0 109.424 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.44 -153.77 0.47 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.2 -0.938 . . . . 1.0 109.395 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.51 57.82 1.24 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 1.0 109.583 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.596 ' CD1' ' N ' ' A' ' 5' ' ' GLN . 31.1 p90 -68.3 -38.97 82.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.227 -0.921 . . . . 1.0 109.495 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.596 ' N ' ' CD1' ' A' ' 4' ' ' TRP . 10.4 tt0 174.42 77.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.257 -0.902 . . . . 1.0 109.368 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.509 HD23 ' NE1' ' A' ' 4' ' ' TRP . 3.1 mm? -118.03 85.0 22.71 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.289 -0.882 . . . . 1.0 109.5 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.1 79.82 3.16 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.324 2.016 . . . . 1.0 110.586 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.68 41.35 0.4 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.444 -0.785 . . . . 1.0 109.283 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.406 ' O ' ' OG ' ' A' ' 10' ' ' SER . 25.3 m80 -140.22 172.15 13.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.863 . . . . 1.0 109.592 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 9' ' ' HIS . 69.5 m -166.23 55.1 0.1 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.356 -0.84 . . . . 1.0 109.357 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.13 97.02 0.19 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.563 -1.415 . . . . 1.0 109.563 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.467 ' O ' ' HA3' ' A' ' 52' ' ' GLY . 34.7 Cg_endo -77.18 -163.03 0.19 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.367 2.044 . . . . 1.0 110.238 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.577 ' CE2' ' O ' ' A' ' 162' ' ' THR . 2.8 m-85 -69.31 135.19 50.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 1.0 109.568 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 51' ' ' HIS . 3.3 pt-20 -172.31 126.8 0.54 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.964 -1.085 . . . . 1.0 109.838 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.509 ' O ' ' CG ' ' A' ' 15' ' ' LEU . 1.3 pp -108.55 87.81 2.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.333 -0.854 . . . . 1.0 109.264 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -101.63 148.31 25.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.187 -0.945 . . . . 1.0 109.768 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 47' ' ' ILE . 1.2 mp -69.55 141.74 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.378 -0.826 . . . . 1.0 108.824 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.495 ' OE2' ' CZ ' ' A' ' 115' ' ' ARG . 4.9 tt0 -76.6 -32.93 58.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.296 -0.878 . . . . 1.0 109.816 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.457 ' HB ' HG12 ' A' ' 47' ' ' ILE . 98.2 t -142.29 134.54 26.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.186 -0.946 . . . . 1.0 109.631 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.79 99.92 41.18 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.357 -0.84 . . . . 1.0 109.287 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 46' ' ' PRO . 34.9 Cg_endo -76.53 -179.21 5.1 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.396 2.064 . . . . 1.0 110.576 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -43.18 162.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 1.0 109.476 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.483 ' CB ' ' HG2' ' A' ' 171' ' ' PRO . 8.4 t -119.48 50.02 1.29 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -0.886 . . . . 1.0 109.988 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.29 167.07 17.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.115 -0.991 . . . . 1.0 109.283 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.582 ' CE1' HG23 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -170.4 118.6 0.55 Allowed 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 120.154 -0.618 . . . . 1.0 109.63 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.542 ' HA ' ' CE1' ' A' ' 28' ' ' HIS . 0.0 OUTLIER -80.23 76.59 7.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.317 -0.864 . . . . 1.0 109.259 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -83.26 68.45 9.64 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.328 -0.858 . . . . 1.0 109.929 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.542 ' CE1' ' HA ' ' A' ' 26' ' ' ARG . 1.8 p-80 -162.75 55.93 0.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.957 . . . . 1.0 109.635 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.574 ' O ' ' CG ' ' A' ' 29' ' ' TYR . 9.7 p90 -179.93 115.03 0.05 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 120.066 -0.653 . . . . 1.0 109.614 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 1.3 pt-20 173.42 74.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.142 -0.974 . . . . 1.0 109.604 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.442 ' O ' ' CG2' ' A' ' 31' ' ' THR . 86.4 m -145.69 32.64 1.05 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.913 . . . . 1.0 108.954 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.72 -72.62 0.69 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.484 -0.76 . . . . 1.0 109.469 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.45 -91.95 0.03 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.488 -1.445 . . . . 1.0 109.488 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.75 -38.99 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -1.117 . . . . 1.0 109.423 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 36' ' ' GLY . 19.6 mtt180 -161.57 42.5 0.15 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 1.0 109.573 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 35' ' ' ARG . . . -50.35 -179.66 0.03 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.359 -1.496 . . . . 1.0 109.359 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.28 176.83 7.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.074 -1.251 . . . . 1.0 110.832 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.582 HG23 ' CE1' ' A' ' 25' ' ' HIS . 3.9 p -133.74 121.28 39.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 107.131 -1.433 . . . . 1.0 107.131 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 121' ' ' ALA . 24.8 mmtt -155.32 116.16 3.9 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.297 -0.877 . . . . 1.0 109.56 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.24 -152.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.6 -0.688 . . . . 1.0 110.081 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 42' ' ' ALA . 1.8 m -51.56 158.39 0.92 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.23 -0.919 . . . . 1.0 109.963 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.449 ' O ' ' O ' ' A' ' 45' ' ' HIS . . . 43.0 47.04 4.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.434 -0.791 . . . . 1.0 109.425 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.521 ' HA3' ' CA ' ' A' ' 119' ' ' ASP . . . 44.46 51.66 7.7 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.386 -1.485 . . . . 1.0 109.386 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.451 ' HA3' ' HD2' ' A' ' 39' ' ' LYS . . . 63.89 -87.58 0.07 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.686 -1.365 . . . . 1.0 109.686 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.527 ' CB ' HG23 ' A' ' 118' ' ' ILE . 2.1 m-70 -50.96 144.93 12.85 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.213 -1.169 . . . . 1.0 109.852 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.452 ' HB2' HG22 ' A' ' 17' ' ' ILE . 36.2 Cg_endo -79.43 -167.93 0.57 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.763 2.309 . . . . 1.0 110.522 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.524 HG22 ' CG1' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -93.23 158.57 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.521 HG22 ' CZ ' ' A' ' 151' ' ' PHE . 3.4 t -136.76 132.84 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 120.925 -1.109 . . . . 1.0 110.359 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.485 ' O ' ' CG ' ' A' ' 49' ' ' GLN . 2.6 pt20 -145.36 120.22 9.94 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.913 -0.773 . . . . 1.0 108.913 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.442 ' HG ' ' HB3' ' A' ' 15' ' ' LEU . 0.3 OUTLIER -86.22 124.11 32.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.149 -0.97 . . . . 1.0 109.893 -179.545 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 14' ' ' GLU . 18.0 p80 -141.23 132.59 26.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.28 -0.887 . . . . 1.0 108.802 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 137.0 -2.79 3.32 Favored Glycine 0 N--CA 1.483 1.798 0 C-N-CA 119.262 -1.447 . . . . 1.0 110.578 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.563 ' CE2' ' HB2' ' A' ' 163' ' ' LEU . 0.5 OUTLIER -129.32 117.8 21.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.062 -1.257 . . . . 1.0 109.492 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.516 ' CD1' ' O ' ' A' ' 54' ' ' LEU . 1.3 pp -99.96 35.61 2.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.156 -0.965 . . . . 1.0 109.567 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.561 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 3.9 tp10 -80.0 144.22 33.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 1.0 109.583 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.411 ' ND2' ' C ' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -87.72 34.6 0.71 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.232 -0.917 . . . . 1.0 109.957 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.485 ' O ' ' CG ' ' A' ' 110' ' ' PRO . 11.7 pt-20 -133.96 143.92 49.45 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.266 -0.897 . . . . 1.0 109.276 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.406 ' C ' HD22 ' A' ' 59' ' ' LEU . 35.6 Cg_endo -78.57 134.15 12.16 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.307 2.005 . . . . 1.0 110.63 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.406 HD22 ' C ' ' A' ' 58' ' ' PRO . 12.8 mt -115.59 165.07 13.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.199 -0.938 . . . . 1.0 108.683 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.444 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 40.7 mtt -106.13 112.99 26.25 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.147 -0.971 . . . . 1.0 109.993 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.528 ' CD2' ' HB2' ' A' ' 63' ' ' LEU . 1.9 tt -70.18 142.08 52.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.578 -0.701 . . . . 1.0 109.349 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.468 ' OE1' ' NH2' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -99.03 96.57 7.9 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.219 -0.926 . . . . 1.0 108.858 179.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.631 ' CD1' ' CE1' ' A' ' 151' ' ' PHE . 20.8 tp -119.15 132.07 55.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.296 -0.878 . . . . 1.0 109.911 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.48 ' CB ' HG11 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -164.96 165.83 19.9 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.717 -0.845 . . . . 1.0 108.717 179.304 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.492 ' CD1' ' C ' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -105.13 120.94 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.937 -1.102 . . . . 1.0 109.242 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.411 ' N ' HD12 ' A' ' 65' ' ' ILE . . . -132.2 149.1 19.35 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.696 -1.361 . . . . 1.0 109.696 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.556 HG23 ' CD2' ' A' ' 76' ' ' HIS . 16.2 p -83.66 154.45 23.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.371 -1.076 . . . . 1.0 109.319 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.517 ' CB ' ' HD2' ' A' ' 148' ' ' ARG . . . -159.82 118.1 2.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 1.0 109.773 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.447 ' CG ' ' NH2' ' A' ' 146' ' ' ARG . 0.4 OUTLIER -102.23 -13.52 17.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.908 . . . . 1.0 109.164 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -142.5 -55.26 0.43 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.363 -0.836 . . . . 1.0 109.412 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.66 -34.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.955 . . . . 1.0 109.697 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 70.3 mt -66.34 86.8 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.914 . . . . 1.0 109.587 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.522 ' O ' ' CD1' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -50.03 154.77 1.05 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.265 -0.897 . . . . 1.0 109.686 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.473 ' HB3' ' HD2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -144.37 162.24 40.59 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.317 -0.864 . . . . 1.0 108.748 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 74' ' ' ARG . 33.1 Cg_endo -76.32 121.18 5.95 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.213 1.942 . . . . 1.0 110.051 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.577 ' CG ' ' HB2' ' A' ' 79' ' ' TYR . 1.6 t-80 -57.89 163.4 2.7 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.361 -0.837 . . . . 1.0 110.016 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.12 -76.29 0.08 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 1.0 109.548 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.542 ' CE1' HD13 ' A' ' 131' ' ' ILE . 8.3 m-85 -125.41 21.86 7.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 1.0 109.706 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.577 ' HB2' ' CG ' ' A' ' 76' ' ' HIS . 3.9 m-30 -79.91 75.99 6.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.213 -0.93 . . . . 1.0 109.077 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.529 ' CB ' ' HB3' ' A' ' 102' ' ' LYS . 4.2 pt20 -139.0 4.41 2.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.945 -1.097 . . . . 1.0 110.307 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 122' ' ' GLY . 15.0 m -78.65 144.77 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.958 -1.089 . . . . 1.0 109.182 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.588 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 3.1 p80 -175.93 59.38 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 118.998 -1.081 . . . . 1.0 110.194 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 120' ' ' CYS . 2.9 mmt85 -81.44 140.15 34.82 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.112 -0.993 . . . . 1.0 109.325 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.496 ' CG1' ' HB2' ' A' ' 120' ' ' CYS . 3.5 mp -106.32 135.58 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.205 -0.934 . . . . 1.0 109.764 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 87' ' ' LYS . 49.9 p -145.52 -147.39 0.21 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.406 -0.808 . . . . 1.0 109.106 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 85' ' ' THR . . . 41.42 -94.15 0.01 OUTLIER Glycine 0 N--CA 1.482 1.755 0 N-CA-C 110.37 -1.092 . . . . 1.0 110.37 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.0 OUTLIER -74.51 148.17 41.19 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.237 -1.155 . . . . 1.0 109.608 -179.67 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.06 118.41 36.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 1.0 109.604 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.449 HG11 HG21 ' A' ' 91' ' ' THR . 6.6 p -108.9 139.43 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 1.0 109.318 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.3 m -86.78 16.02 5.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 1.0 109.524 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.449 HG21 HG11 ' A' ' 89' ' ' VAL . 7.4 t -69.89 125.95 28.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -0.952 . . . . 1.0 109.575 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.52 ' O ' ' CG2' ' A' ' 106' ' ' ILE . 18.3 m -93.88 91.21 6.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.92 . . . . 1.0 109.235 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.458 ' HA ' HG12 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -103.3 173.28 6.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -0.974 . . . . 1.0 109.951 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -145.76 161.66 39.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.477 -0.765 . . . . 1.0 109.167 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.519 ' CG ' ' NE2' ' A' ' 82' ' ' HIS . 43.5 mt-10 -128.51 120.54 26.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 1.0 109.872 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 102' ' ' LYS . . . -114.18 124.56 52.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 1.0 108.94 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.52 ' HB ' ' CD ' ' A' ' 102' ' ' LYS . 0.1 OUTLIER -124.73 126.39 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.09 -1.006 . . . . 1.0 109.876 -179.421 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.527 ' O ' ' CB ' ' A' ' 99' ' ' SER . 0.6 OUTLIER -126.22 59.77 1.32 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.938 . . . . 1.0 109.448 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER 77.03 103.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 1.0 109.612 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' A' ' 99' ' ' SER . 3.2 p-10 42.88 43.31 3.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.694 -0.629 . . . . 1.0 110.18 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.454 ' OG1' ' O ' ' A' ' 99' ' ' SER . 0.3 OUTLIER -159.58 87.96 0.84 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.993 -1.067 . . . . 1.0 109.776 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.529 ' HB3' ' CB ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -97.32 152.67 18.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.343 -0.848 . . . . 1.0 109.159 179.549 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.48 HG11 ' CB ' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -146.36 169.97 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.217 -0.927 . . . . 1.0 109.06 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.521 ' CD1' ' HG ' ' A' ' 63' ' ' LEU . 3.3 mt -120.31 128.56 53.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.933 . . . . 1.0 109.615 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -123.94 106.73 10.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.269 -0.894 . . . . 1.0 108.835 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.52 ' CG2' ' O ' ' A' ' 92' ' ' THR . 4.5 mt -119.38 115.95 33.88 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 1.0 109.832 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.453 ' HD2' ' O ' ' A' ' 92' ' ' THR . 33.7 Cg_endo -75.87 119.0 5.23 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 121.96 1.773 . . . . 1.0 109.448 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.45 ' HA ' ' HG2' ' A' ' 114' ' ' MET . 6.1 mt -115.52 165.18 13.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.193 -0.942 . . . . 1.0 110.494 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.484 ' CD2' ' CG ' ' A' ' 112' ' ' ASN . 1.0 OUTLIER -97.3 126.69 40.92 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.485 ' CG ' ' O ' ' A' ' 57' ' ' GLU . 36.5 Cg_endo -79.96 -30.65 2.14 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 122.345 2.03 . . . . 1.0 112.03 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.453 ' HB2' ' HA ' ' A' ' 54' ' ' LEU . 2.1 tt0 -139.35 66.99 1.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.773 -1.204 . . . . 1.0 110.526 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.506 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -165.39 -67.52 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 1.0 109.505 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.4 OUTLIER 164.63 108.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.05 -1.032 . . . . 1.0 109.343 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.45 ' HG2' ' HA ' ' A' ' 108' ' ' LEU . 5.9 tpt -154.67 49.83 0.6 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.911 . . . . 1.0 110.129 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.495 ' CZ ' ' OE2' ' A' ' 18' ' ' GLU . 10.0 ttt-85 -74.69 134.33 41.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.966 . . . . 1.0 108.633 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -138.37 153.12 48.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.902 -1.124 . . . . 1.0 110.294 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.524 ' CG1' HG22 ' A' ' 47' ' ' ILE . 4.5 m -126.14 126.46 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.527 HG23 ' CB ' ' A' ' 45' ' ' HIS . 32.4 mt -99.17 104.3 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 1.0 109.604 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.521 ' CA ' ' HA3' ' A' ' 43' ' ' GLY . 14.6 p-10 -149.5 39.48 0.81 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 1.0 109.353 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.496 ' HB2' ' CG1' ' A' ' 84' ' ' ILE . 60.7 m -145.05 59.03 1.3 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 1.0 109.51 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.522 ' O ' ' CG ' ' A' ' 39' ' ' LYS . . . -143.47 -176.38 4.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.417 -0.802 . . . . 1.0 109.119 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.506 ' O ' ' CG2' ' A' ' 81' ' ' VAL . . . -154.6 168.66 32.77 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.575 -1.41 . . . . 1.0 109.575 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.547 HG23 ' CE2' ' A' ' 79' ' ' TYR . 0.3 OUTLIER -114.55 154.63 15.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.236 -1.155 . . . . 1.0 108.836 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.62 109.58 16.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.129 -0.982 . . . . 1.0 109.506 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.509 ' CD ' ' O ' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -99.67 110.3 22.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.303 -0.873 . . . . 1.0 109.434 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.77 24.13 2.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.319 -0.863 . . . . 1.0 109.355 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -53.06 163.89 0.47 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.44 -0.787 . . . . 1.0 109.569 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -168.66 27.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.286 -0.884 . . . . 1.0 109.397 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.512 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 0.1 OUTLIER 54.7 36.79 27.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -0.88 . . . . 1.0 109.469 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 129' ' ' SER . 0.6 OUTLIER 163.93 68.23 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 1.0 109.418 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.542 HD13 ' CE1' ' A' ' 78' ' ' PHE . 1.2 tt -66.19 116.77 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.257 -0.902 . . . . 1.0 109.501 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.4 ' HB3' ' HD3' ' A' ' 134' ' ' ARG . 0.3 OUTLIER -148.3 162.31 39.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -0.919 . . . . 1.0 109.562 -179.908 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.419 ' C ' ' HG2' ' A' ' 134' ' ' ARG . 13.5 mt -73.28 83.02 1.38 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.344 -0.847 . . . . 1.0 109.528 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -167.06 -61.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 1.0 109.545 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 134' ' ' ARG . 0.1 OUTLIER 164.73 142.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.17 -0.956 . . . . 1.0 109.464 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.38 97.05 1.07 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.49 -1.444 . . . . 1.0 109.49 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.411 ' O ' HG21 ' A' ' 138' ' ' THR . 2.9 pt-20 -127.03 117.92 23.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -1.151 . . . . 1.0 109.469 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.492 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 46.5 p -152.16 -49.06 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.892 . . . . 1.0 109.478 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 138' ' ' THR . 0.5 OUTLIER 166.13 -70.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.925 . . . . 1.0 109.387 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.47 ' CG1' ' N ' ' A' ' 141' ' ' GLY . 11.6 pt -145.22 -42.3 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 1.0 109.467 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.47 ' N ' ' CG1' ' A' ' 140' ' ' ILE . . . 140.99 152.65 5.79 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.635 -1.386 . . . . 1.0 109.635 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.401 ' HG3' ' C ' ' A' ' 141' ' ' GLY . 17.6 mtt180 -140.95 52.2 1.6 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -1.15 . . . . 1.0 109.412 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -157.63 154.14 27.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 1.0 109.441 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.541 ' ND2' ' NH1' ' A' ' 146' ' ' ARG . 0.8 OUTLIER -47.11 164.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.936 . . . . 1.0 109.436 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.432 ' HB ' ' SG ' ' A' ' 174' ' ' CYS . 0.1 OUTLIER -154.43 51.48 0.64 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.346 -0.846 . . . . 1.0 109.467 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.541 ' NH1' ' ND2' ' A' ' 144' ' ' ASN . 0.0 OUTLIER -89.58 164.78 14.62 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.27 -0.894 . . . . 1.0 109.594 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.524 ' CG2' ' HB ' ' A' ' 172' ' ' ILE . 31.6 m -140.84 163.49 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.472 -0.768 . . . . 1.0 109.254 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.517 ' HD2' ' CB ' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -155.58 113.31 3.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.958 . . . . 1.0 109.706 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.56 HD23 ' CE2' ' A' ' 151' ' ' PHE . 1.7 tt -79.76 121.56 25.51 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.208 -0.932 . . . . 1.0 109.217 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 36.0 t -96.42 123.55 48.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.232 -0.917 . . . . 1.0 109.574 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.631 ' CE1' ' CD1' ' A' ' 63' ' ' LEU . 0.7 OUTLIER -120.5 92.33 3.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 1.0 108.954 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.525 ' CB ' ' HA ' ' A' ' 166' ' ' GLN . 24.4 ptt85 -139.28 137.59 36.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.139 -0.976 . . . . 1.0 110.219 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 164' ' ' SER . 9.8 p -115.42 128.28 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.264 -0.897 . . . . 1.0 108.669 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.432 ' CD2' ' NH1' ' A' ' 152' ' ' ARG . 64.3 m-70 -126.69 116.63 21.26 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.11 -0.994 . . . . 1.0 109.542 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.535 ' CG1' ' HB3' ' A' ' 163' ' ' LEU . 9.8 p -99.16 141.35 22.7 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.206 -0.934 . . . . 1.0 109.169 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.524 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 35.4 Cg_endo -77.32 119.03 4.82 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.422 2.081 . . . . 1.0 110.634 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.448 ' OE1' ' HD2' ' A' ' 158' ' ' PRO . 0.1 OUTLIER -160.19 173.03 5.22 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.266 -0.896 . . . . 1.0 109.44 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.448 ' HD2' ' OE1' ' A' ' 157' ' ' GLN . 35.1 Cg_endo -77.87 -67.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.327 2.018 . . . . 1.0 110.44 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 36.6 m -64.15 109.38 1.83 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.905 . . . . 1.0 109.345 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.28 -30.27 11.14 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.542 -1.423 . . . . 1.0 109.542 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.7 mtp85 -79.59 79.06 6.1 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.257 -1.016 . . . . 1.0 108.257 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.577 ' O ' ' CE2' ' A' ' 13' ' ' TYR . 1.3 m -136.39 -79.77 0.4 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.001 -0.74 . . . . 1.0 109.001 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.563 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 0.1 OUTLIER -149.26 106.31 3.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.984 -1.072 . . . . 1.0 108.189 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 153' ' ' VAL . 0.0 OUTLIER -163.83 106.34 0.95 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.608 -1.307 . . . . 1.0 109.466 -179.284 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 152' ' ' ARG . 0.2 OUTLIER -134.19 151.36 51.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.081 -1.012 . . . . 1.0 109.696 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.525 ' HA ' ' CB ' ' A' ' 152' ' ' ARG . 15.4 mt-30 -123.69 139.44 53.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 1.0 109.374 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.467 ' O ' ' CG1' ' A' ' 167' ' ' VAL . 46.7 t -142.54 71.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.214 -0.929 . . . . 1.0 109.674 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.6 108.89 20.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 1.0 109.212 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 2.7 m -148.6 137.83 21.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.945 . . . . 1.0 109.674 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 169' ' ' SER . 0.6 OUTLIER 171.74 92.49 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.359 -0.838 . . . . 1.0 109.52 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.483 ' HG2' ' CB ' ' A' ' 23' ' ' SER . 34.8 Cg_endo -77.42 72.02 6.16 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.373 2.049 . . . . 1.0 110.694 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.524 ' HB ' ' CG2' ' A' ' 147' ' ' VAL . 13.8 mm -115.21 78.74 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 1.0 109.233 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.54 135.92 33.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 1.0 109.746 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.432 ' SG ' ' HB ' ' A' ' 145' ' ' THR . 1.4 m -104.7 -177.02 3.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.371 -0.83 . . . . 1.0 109.299 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.2 p -167.76 -178.46 3.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.144 -0.972 . . . . 1.0 109.605 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.525 ' O ' ' CG ' ' A' ' 177' ' ' ARG . 3.2 pm0 -57.58 146.55 29.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 1.0 109.513 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 176' ' ' GLN . 2.0 ptp180 41.91 35.53 0.54 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.492 -0.755 . . . . 1.0 109.694 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.028 -0.987 . . . . 1.0 109.46 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mtm . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.265 0.555 . . . . 1.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.494 ' CG ' ' O ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -132.45 63.83 1.62 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.242 -0.911 . . . . 1.0 109.53 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.83 76.83 2.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.293 -0.879 . . . . 1.0 109.448 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.488 ' CD1' ' N ' ' A' ' 5' ' ' GLN . 13.8 p90 -66.44 -31.97 73.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 1.0 109.494 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.488 ' N ' ' CD1' ' A' ' 4' ' ' TRP . 0.2 OUTLIER 170.47 79.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.905 . . . . 1.0 109.515 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 tp -146.61 66.7 11.03 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 1.0 109.488 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.9 96.32 1.09 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.45 2.1 . . . . 1.0 110.378 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 p -119.89 41.58 3.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.204 -0.935 . . . . 1.0 109.324 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.462 ' O ' ' HB2' ' A' ' 10' ' ' SER . 5.8 p-80 -139.68 105.3 5.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.869 . . . . 1.0 109.403 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 9' ' ' HIS . 19.1 m 64.82 -175.05 0.17 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 1.0 109.436 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 160.68 -91.77 0.11 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.587 -1.405 . . . . 1.0 109.587 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.2 173.72 13.48 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.527 2.151 . . . . 1.0 110.395 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.453 ' HA ' ' HA3' ' A' ' 52' ' ' GLY . 13.0 m-30 -80.06 123.32 27.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 1.0 109.469 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -152.2 130.07 11.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.942 . . . . 1.0 109.616 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.427 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 53.8 tp -107.41 83.47 1.82 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.237 -0.914 . . . . 1.0 109.198 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.61 157.48 23.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 1.0 109.805 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.478 HG22 ' NE2' ' A' ' 20' ' ' GLN . 1.1 mp -79.86 144.35 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.412 ' OE1' ' CD ' ' A' ' 49' ' ' GLN . 27.6 tp10 -80.7 -63.88 1.31 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 1.0 109.094 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.499 HG22 ' CG1' ' A' ' 47' ' ' ILE . 2.0 t -92.69 126.21 45.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.339 -0.851 . . . . 1.0 109.134 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.478 ' NE2' HG22 ' A' ' 17' ' ' ILE . 5.5 tp-100 -130.67 63.65 70.58 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.938 . . . . 1.0 109.66 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 20' ' ' GLN . 36.0 Cg_endo -78.09 -177.96 4.26 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.513 2.142 . . . . 1.0 110.449 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.414 ' HE2' ' CD2' ' A' ' 24' ' ' HIS . 2.1 ttpt -50.36 161.01 0.33 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.229 -0.919 . . . . 1.0 109.383 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.411 ' O ' ' CG1' ' A' ' 172' ' ' ILE . 2.1 t -154.62 58.72 0.69 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.263 -0.898 . . . . 1.0 109.871 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.414 ' CD2' ' HE2' ' A' ' 22' ' ' LYS . 1.9 p80 -103.5 166.22 10.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 1.0 109.411 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.572 ' CE1' ' HA ' ' A' ' 38' ' ' VAL . 3.7 t60 -163.86 113.12 1.23 Allowed 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.405 -0.81 . . . . 1.0 109.827 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.439 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 5.1 ttp180 -89.57 75.95 7.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.406 -0.808 . . . . 1.0 109.103 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.79 165.44 0.9 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.354 -0.841 . . . . 1.0 109.767 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.413 ' ND1' ' O ' ' A' ' 28' ' ' HIS . 10.5 p80 -94.99 111.69 23.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.877 . . . . 1.0 109.417 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -81.68 -14.66 56.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 1.0 109.663 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -114.49 -148.41 0.43 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.91 . . . . 1.0 109.516 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.2 p -120.62 38.27 4.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 1.0 109.281 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.433 ' O ' ' HG3' ' A' ' 32' ' ' GLU . 4.8 pt-20 -135.27 51.75 2.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.862 . . . . 1.0 109.501 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 34' ' ' SER . . . -115.36 -13.35 9.01 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.537 -1.425 . . . . 1.0 109.537 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 16.6 t 61.18 -90.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -1.162 . . . . 1.0 109.484 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -141.85 96.86 3.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.174 -0.954 . . . . 1.0 109.563 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -131.38 82.13 0.32 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.572 -1.411 . . . . 1.0 109.572 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.541 ' C ' ' CE1' ' A' ' 25' ' ' HIS . . . -91.49 165.69 13.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -1.167 . . . . 1.0 109.449 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.572 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 2.5 p -54.84 106.08 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.329 -0.857 . . . . 1.0 109.468 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.4 98.92 4.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 1.0 109.583 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.449 ' O ' ' O ' ' A' ' 41' ' ' SER . . . -158.23 95.92 1.4 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.896 . . . . 1.0 109.548 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 43' ' ' GLY . 1.9 t 60.87 144.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 1.0 109.465 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 51.45 -90.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.888 . . . . 1.0 109.423 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 41' ' ' SER . . . -167.92 34.88 0.21 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.442 -1.463 . . . . 1.0 109.442 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.522 ' HA3' ' CG2' ' A' ' 38' ' ' VAL . . . 109.69 -84.83 0.38 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.563 -1.415 . . . . 1.0 109.563 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.458 ' HB3' ' HD2' ' A' ' 46' ' ' PRO . 74.0 m-70 -77.14 159.88 77.18 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.358 -1.084 . . . . 1.0 109.504 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.464 ' HG3' ' OE1' ' A' ' 20' ' ' GLN . 35.1 Cg_endo -77.47 -176.79 3.4 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 122.598 2.199 . . . . 1.0 110.679 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.499 ' CG1' HG22 ' A' ' 19' ' ' VAL . 3.8 mm -94.04 159.51 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.496 -0.753 . . . . 1.0 109.142 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.49 HG23 ' CZ ' ' A' ' 151' ' ' PHE . 2.9 t -132.78 135.68 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.154 -0.966 . . . . 1.0 109.895 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.445 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 2.6 pt20 -150.23 143.43 24.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.827 . . . . 1.0 109.111 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.425 HD13 HG13 ' A' ' 153' ' ' VAL . 3.0 tt -113.48 140.12 48.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.17 -0.957 . . . . 1.0 109.772 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 51' ' ' HIS . 14.6 p80 -140.08 81.59 1.82 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 1.0 109.093 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.453 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . -156.65 -97.92 0.14 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.049 -1.22 . . . . 1.0 110.049 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.467 ' HB3' ' CG ' ' A' ' 111' ' ' GLU . 0.4 OUTLIER -39.56 129.51 1.9 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.835 -0.803 . . . . 1.0 110.145 -179.519 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.5 mt -101.54 3.66 40.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.321 -0.862 . . . . 1.0 109.561 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 111' ' ' GLU . 2.7 tm-20 -79.71 138.5 37.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.179 -0.95 . . . . 1.0 109.362 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.452 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 4.6 p30 -85.96 56.74 4.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.913 . . . . 1.0 109.599 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.483 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 5.0 mt-10 -105.64 143.2 26.35 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 1.0 109.245 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.455 ' O ' HD21 ' A' ' 59' ' ' LEU . 36.2 Cg_endo -78.62 120.19 4.7 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.394 2.063 . . . . 1.0 110.451 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 107' ' ' PRO . 20.6 mt -119.94 164.51 15.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 1.0 109.138 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.454 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -111.26 132.83 54.06 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.172 -0.955 . . . . 1.0 109.61 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.508 ' CD2' ' HB3' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -86.54 121.79 29.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.39 -0.819 . . . . 1.0 109.265 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 152' ' ' ARG . 9.4 mm-40 -92.48 75.68 5.14 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.203 -0.936 . . . . 1.0 108.872 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.508 ' HB3' ' CD2' ' A' ' 61' ' ' LEU . 0.4 OUTLIER -116.06 155.61 27.82 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.372 -0.83 . . . . 1.0 109.672 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.524 ' HA ' ' CD1' ' A' ' 104' ' ' LEU . 0.3 OUTLIER -165.6 -178.91 5.12 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.381 -0.824 . . . . 1.0 108.909 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.513 ' O ' ' CG2' ' A' ' 65' ' ' ILE . 0.8 OUTLIER -112.77 100.58 11.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.068 -1.02 . . . . 1.0 109.091 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 74' ' ' ARG . . . -118.99 149.94 18.06 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.942 -1.263 . . . . 1.0 109.942 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.632 ' CG2' ' CD2' ' A' ' 76' ' ' HIS . 20.4 p -78.4 146.78 34.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.421 -1.046 . . . . 1.0 109.151 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.433 ' HB2' ' HD2' ' A' ' 148' ' ' ARG . . . -152.49 116.16 4.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.148 -0.97 . . . . 1.0 109.535 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.501 ' HA ' ' NE ' ' A' ' 146' ' ' ARG . 1.6 p30 -85.0 -25.86 27.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.37 -0.832 . . . . 1.0 109.334 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -133.0 -49.49 0.87 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.192 -0.942 . . . . 1.0 109.322 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -175.06 -38.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 1.0 109.565 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.438 ' HA ' ' NH1' ' A' ' 71' ' ' ARG . 0.1 OUTLIER -55.89 89.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.907 . . . . 1.0 109.601 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -51.9 171.79 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.178 -0.951 . . . . 1.0 109.613 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.517 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 2.1 mtm180 -168.99 163.17 7.72 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.354 -0.841 . . . . 1.0 109.284 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 76' ' ' HIS . 35.3 Cg_endo -77.64 108.33 2.54 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.352 2.035 . . . . 1.0 110.437 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.632 ' CD2' ' CG2' ' A' ' 67' ' ' THR . 19.1 t-80 -42.07 161.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.423 -0.798 . . . . 1.0 110.01 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.438 ' HB3' HD12 ' A' ' 131' ' ' ILE . . . -48.83 -74.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.303 -0.873 . . . . 1.0 109.369 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.57 ' CD2' HD11 ' A' ' 126' ' ' LEU . 54.5 m-85 -135.32 22.79 3.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -0.929 . . . . 1.0 109.39 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.574 ' CE2' HG23 ' A' ' 123' ' ' ILE . 4.7 m-30 -80.21 118.45 21.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.262 -0.899 . . . . 1.0 109.354 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.521 ' HB2' ' CG ' ' A' ' 102' ' ' LYS . 0.1 OUTLIER -163.32 23.69 0.08 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.973 . . . . 1.0 109.804 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.516 ' CG2' ' O ' ' A' ' 122' ' ' GLY . 15.1 m -86.14 150.93 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.098 -1.001 . . . . 1.0 109.307 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.563 ' CE1' ' HB1' ' A' ' 121' ' ' ALA . 12.5 t60 -175.38 75.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.286 -0.884 . . . . 1.0 109.414 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 120' ' ' CYS . 15.2 mmm180 -109.7 130.24 55.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.295 -0.878 . . . . 1.0 109.64 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.524 HG21 ' CB ' ' A' ' 120' ' ' CYS . 4.6 mp -104.22 136.18 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 1.0 109.455 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 87' ' ' LYS . 69.4 p -141.28 -162.71 1.42 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.393 -0.817 . . . . 1.0 109.288 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 85' ' ' THR . . . 41.3 -96.48 0.01 OUTLIER Glycine 0 N--CA 1.482 1.741 0 N-CA-C 110.259 -1.137 . . . . 1.0 110.259 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.4 OUTLIER -74.62 111.44 9.82 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.24 -1.153 . . . . 1.0 109.626 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.07 143.54 26.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.275 -0.89 . . . . 1.0 109.357 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.8 p -105.07 154.04 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.186 -0.946 . . . . 1.0 109.537 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.36 12.78 7.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -0.94 . . . . 1.0 109.589 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.477 ' CG2' HD23 ' A' ' 108' ' ' LEU . 16.0 m -103.14 104.88 15.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 1.0 109.472 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.51 ' O ' ' CG2' ' A' ' 106' ' ' ILE . 10.0 t -54.22 158.56 2.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.16 -0.962 . . . . 1.0 109.338 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.24 172.79 12.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 1.0 109.7 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -155.07 151.78 28.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.361 -0.837 . . . . 1.0 109.534 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -125.7 132.84 52.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 1.0 109.313 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -125.27 120.65 31.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.13 -0.981 . . . . 1.0 109.699 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.452 HD11 ' HA ' ' A' ' 102' ' ' LYS . 9.9 tp -125.0 133.7 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 1.0 109.293 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.518 ' O ' ' CB ' ' A' ' 99' ' ' SER . 1.0 OUTLIER -133.34 50.86 2.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.222 -0.924 . . . . 1.0 109.53 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER 76.66 114.16 0.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.309 -0.87 . . . . 1.0 109.742 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.43 ' CG ' ' O ' ' A' ' 99' ' ' SER . 3.9 p-10 43.49 35.03 0.86 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.665 -0.647 . . . . 1.0 110.476 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.512 ' HB ' ' CD2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -156.15 102.63 2.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.927 -1.108 . . . . 1.0 109.743 179.642 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.521 ' CG ' ' HB2' ' A' ' 80' ' ' GLN . 4.5 tptt -112.29 153.68 26.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 1.0 109.386 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.513 HG11 ' CB ' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -158.54 168.66 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.271 -0.893 . . . . 1.0 109.113 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.524 ' CD1' ' HA ' ' A' ' 64' ' ' PHE . 1.1 mt -116.79 134.85 54.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 1.0 109.734 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -127.08 112.32 15.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.368 -0.833 . . . . 1.0 109.273 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.51 ' CG2' ' O ' ' A' ' 92' ' ' THR . 3.4 mt -121.69 107.0 36.59 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.907 . . . . 1.0 109.606 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 33.8 Cg_endo -75.46 104.39 1.9 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 122.09 1.86 . . . . 1.0 110.133 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.477 HD23 ' CG2' ' A' ' 91' ' ' THR . 3.0 mt -129.02 163.67 24.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.399 -0.813 . . . . 1.0 109.695 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -129.86 69.23 81.55 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.386 -0.821 . . . . 1.0 109.238 179.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.504 ' HA ' ' CG ' ' A' ' 114' ' ' MET . 36.8 Cg_endo -81.02 45.47 2.01 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 122.703 2.269 . . . . 1.0 110.908 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 55' ' ' GLU . 53.6 mp0 -97.85 -11.48 23.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.99 -1.069 . . . . 1.0 109.684 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 113' ' ' SER . 0.3 OUTLIER -107.85 -55.6 2.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.18 -0.95 . . . . 1.0 109.429 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.1 OUTLIER 169.8 102.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 1.0 109.501 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.504 ' CG ' ' HA ' ' A' ' 110' ' ' PRO . 1.0 OUTLIER -164.79 122.31 1.62 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 1.0 109.574 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.413 ' HD3' ' CG2' ' A' ' 47' ' ' ILE . 7.5 ttm180 -102.01 136.08 42.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.883 . . . . 1.0 109.477 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.06 139.67 53.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 1.0 109.349 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.452 ' HA ' HG21 ' A' ' 47' ' ' ILE . 4.3 m -114.99 127.03 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 1.0 109.547 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.454 ' O ' ' HB2' ' A' ' 45' ' ' HIS . 16.1 mt -113.06 100.96 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 1.0 109.387 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.479 ' HB2' ' CA ' ' A' ' 43' ' ' GLY . 4.9 p-10 -153.71 50.72 0.68 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 1.0 109.486 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.524 ' CB ' HG21 ' A' ' 84' ' ' ILE . 96.0 m -137.77 42.85 2.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.221 -0.925 . . . . 1.0 109.589 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.563 ' HB1' ' CE1' ' A' ' 82' ' ' HIS . . . -129.59 172.21 11.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.867 . . . . 1.0 108.95 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.516 ' O ' ' CG2' ' A' ' 81' ' ' VAL . . . -145.36 -165.5 11.3 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.794 -1.322 . . . . 1.0 109.794 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.574 HG23 ' CE2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -125.42 157.18 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.32 -1.106 . . . . 1.0 108.93 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 7.6 tp -140.05 147.05 39.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.098 -1.001 . . . . 1.0 109.725 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -112.1 115.83 29.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 1.0 109.232 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.57 HD11 ' CD2' ' A' ' 78' ' ' PHE . 2.3 pt? -79.81 -16.05 56.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 1.0 109.748 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.455 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER 63.09 -87.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.352 -0.842 . . . . 1.0 109.61 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.449 ' ND2' ' O ' ' A' ' 128' ' ' ASN . 3.7 p-10 -42.06 107.75 0.08 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.461 -0.774 . . . . 1.0 109.789 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 38.1 p 175.96 -39.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 1.0 109.053 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 129' ' ' SER . 4.4 m-20 83.3 54.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.3 0.571 . . . . 1.0 109.936 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.495 ' CG2' ' O ' ' A' ' 131' ' ' ILE . 2.8 tt -135.19 59.94 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.367 -0.833 . . . . 1.0 109.335 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 131' ' ' ILE . 3.0 tt0 177.02 98.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.588 -0.695 . . . . 1.0 109.349 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 53.4 tp -154.28 131.68 11.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.193 -0.942 . . . . 1.0 109.567 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -109.8 -19.29 13.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -0.936 . . . . 1.0 109.497 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 136' ' ' GLY . 16.9 mttm -84.65 77.67 10.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 1.0 109.449 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 137' ' ' GLU . . . -61.17 -115.97 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.657 -1.377 . . . . 1.0 109.657 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.536 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 1.9 tt0 83.0 -43.47 0.11 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.904 -0.762 . . . . 1.0 109.887 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 138' ' ' THR . 0.0 OUTLIER -134.97 57.66 1.8 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.022 -1.049 . . . . 1.0 109.418 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 139' ' ' ASP . 24.1 p-10 178.94 -175.1 0.2 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 1.0 109.468 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.4 ' O ' HG13 ' A' ' 140' ' ' ILE . 3.4 tp -86.8 -14.92 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 1.0 109.447 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.77 131.78 0.03 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.69 -1.364 . . . . 1.0 109.69 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -147.05 116.79 7.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -1.147 . . . . 1.0 109.503 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -123.71 104.42 8.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 1.0 109.392 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -168.62 136.68 2.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 1.0 109.5 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.514 ' CB ' ' HB2' ' A' ' 174' ' ' CYS . 0.0 OUTLIER -159.99 53.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 1.0 109.495 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.501 ' NE ' ' HA ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -98.45 175.13 6.14 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.219 -0.925 . . . . 1.0 109.439 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 17.3 m -138.83 167.19 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.357 -0.84 . . . . 1.0 109.567 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.467 ' HA ' ' HB3' ' A' ' 170' ' ' ASN . 0.0 OUTLIER -155.44 111.7 3.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.854 . . . . 1.0 109.534 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.456 HD13 ' O ' ' A' ' 64' ' ' PHE . 11.2 tp -81.44 113.25 19.38 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.213 -0.929 . . . . 1.0 108.947 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 10.6 t -93.46 143.5 11.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.399 -0.813 . . . . 1.0 110.237 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.49 ' CZ ' HG23 ' A' ' 48' ' ' VAL . 10.4 m-85 -133.49 113.36 12.4 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.517 ' CB ' ' O ' ' A' ' 165' ' ' LEU . 10.2 ptt85 -145.45 106.76 4.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.933 -1.105 . . . . 1.0 110.529 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.454 ' O ' ' HA ' ' A' ' 164' ' ' SER . 9.8 p -92.55 128.83 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.256 -1.016 . . . . 1.0 108.256 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.506 ' ND1' ' HB2' ' A' ' 164' ' ' SER . 48.7 m-70 -121.39 117.4 26.83 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.034 -1.041 . . . . 1.0 110.43 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.529 ' CG1' ' HB3' ' A' ' 163' ' ' LEU . 8.1 p -99.61 141.13 22.25 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.779 -0.823 . . . . 1.0 108.779 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.524 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 33.4 Cg_endo -75.29 115.04 4.13 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.16 1.907 . . . . 1.0 110.501 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.491 ' NE2' ' HD2' ' A' ' 158' ' ' PRO . 0.9 OUTLIER -136.3 169.13 14.28 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.532 -0.73 . . . . 1.0 109.058 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.491 ' HD2' ' NE2' ' A' ' 157' ' ' GLN . 34.3 Cg_endo -76.69 -65.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.316 2.01 . . . . 1.0 110.284 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.28 -84.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 1.0 109.25 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 152.42 -43.7 0.65 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.565 -1.414 . . . . 1.0 109.565 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -79.01 80.25 5.36 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.987 -1.116 . . . . 1.0 107.987 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.547 ' CG2' ' N ' ' A' ' 163' ' ' LEU . 1.3 m -133.55 -89.56 0.39 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.56 -0.712 . . . . 1.0 109.374 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.547 ' N ' ' CG2' ' A' ' 162' ' ' THR . 8.9 tp -125.91 96.91 4.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.83 -1.169 . . . . 1.0 108.737 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.506 ' HB2' ' ND1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -163.25 119.26 1.76 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.016 -1.052 . . . . 1.0 109.229 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.517 ' O ' ' CB ' ' A' ' 152' ' ' ARG . 22.3 mt -142.63 175.07 10.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.976 -1.078 . . . . 1.0 110.428 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.466 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 2.6 mt-30 -142.27 70.84 1.34 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.607 -0.683 . . . . 1.0 109.201 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 37.9 t -87.79 106.04 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 1.0 110.066 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.454 ' HB3' HG21 ' A' ' 150' ' ' VAL . . . -112.03 112.75 24.61 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.543 -0.91 . . . . 1.0 108.543 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 0.0 OUTLIER -136.8 140.99 42.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.989 -1.07 . . . . 1.0 110.261 -179.153 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.467 ' HB3' ' HA ' ' A' ' 148' ' ' ARG . 22.7 t-20 175.93 97.73 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.41 74.38 4.73 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.284 1.99 . . . . 1.0 110.588 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.497 HG22 HD11 ' A' ' 172' ' ' ILE . 27.6 mt -138.96 126.37 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.331 -0.856 . . . . 1.0 109.287 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -141.46 144.57 34.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 1.0 109.532 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.514 ' HB2' ' CB ' ' A' ' 145' ' ' THR . 35.8 m -114.67 -171.71 1.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 1.0 109.452 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 174' ' ' CYS . 5.8 p 178.52 34.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -0.883 . . . . 1.0 109.365 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.419 ' O ' ' O ' ' A' ' 175' ' ' SER . 0.8 OUTLIER 56.33 166.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 1.0 109.446 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 178' ' ' SER . 0.4 OUTLIER -154.61 -39.11 0.09 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.198 -0.938 . . . . 1.0 109.526 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 177' ' ' ARG . 10.4 t . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.0 -1.0 . . . . 1.0 109.442 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.7 pttp -112.51 129.05 56.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.225 -0.922 . . . . 1.0 109.424 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -56.81 -179.85 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 1.0 109.521 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.413 ' CG ' ' N ' ' A' ' 5' ' ' GLN . 31.6 p-90 -67.37 -37.22 82.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.222 -0.924 . . . . 1.0 109.544 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.413 ' N ' ' CG ' ' A' ' 4' ' ' TRP . 0.0 OUTLIER -178.22 79.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 1.0 109.463 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 tp -151.29 121.44 3.64 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.32 -0.862 . . . . 1.0 109.227 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.26 94.45 1.07 Allowed 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 122.058 1.839 . . . . 1.0 110.5 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 p -143.52 40.59 1.44 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 1.0 109.419 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.426 ' O ' ' HB2' ' A' ' 10' ' ' SER . 3.2 p80 -140.33 145.94 37.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.316 -0.865 . . . . 1.0 109.502 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 9' ' ' HIS . 4.4 m 68.59 123.92 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 1.0 109.682 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.472 ' N ' ' HD3' ' A' ' 12' ' ' PRO . . . 46.59 62.74 3.46 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.681 -1.367 . . . . 1.0 109.681 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 11' ' ' GLY . 35.9 Cg_endo -78.15 117.29 4.09 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.523 2.149 . . . . 1.0 110.255 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.569 ' CE2' ' O ' ' A' ' 162' ' ' THR . 6.6 m-85 -102.61 169.72 8.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -0.934 . . . . 1.0 109.758 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -160.86 130.82 5.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 1.0 109.456 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 23.3 tp -126.83 84.4 2.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.362 -0.836 . . . . 1.0 109.327 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -127.35 154.53 44.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.285 -0.884 . . . . 1.0 109.715 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.468 HG22 ' HB2' ' A' ' 46' ' ' PRO . 0.7 OUTLIER -67.01 148.33 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.336 -0.853 . . . . 1.0 108.774 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.479 ' O ' ' CG2' ' A' ' 19' ' ' VAL . 1.0 OUTLIER -70.97 -34.61 71.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.381 -0.824 . . . . 1.0 109.535 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.479 ' CG2' ' O ' ' A' ' 18' ' ' GLU . 72.3 t -157.78 135.6 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 121.206 -0.934 . . . . 1.0 109.435 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.09 80.45 7.04 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 1.0 109.522 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.463 ' HD3' HG13 ' A' ' 19' ' ' VAL . 36.2 Cg_endo -78.52 179.23 6.69 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.519 2.146 . . . . 1.0 110.21 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 21' ' ' PRO . 9.7 mttt -44.56 108.6 0.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.087 -1.008 . . . . 1.0 109.185 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.1 p -130.72 39.41 3.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.126 -0.984 . . . . 1.0 109.945 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.458 ' HA ' HG12 ' A' ' 172' ' ' ILE . 2.0 p-80 -99.69 166.39 11.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.082 -1.011 . . . . 1.0 109.395 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.57 ' CE1' ' HA ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -135.45 105.26 6.15 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.671 -0.812 . . . . 1.0 109.843 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.4 ttm-85 -92.4 70.98 5.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.429 -0.795 . . . . 1.0 109.053 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.554 ' O ' ' CE1' ' A' ' 29' ' ' TYR . . . -68.31 123.51 20.94 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.465 -0.772 . . . . 1.0 109.469 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -50.19 172.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.346 -0.846 . . . . 1.0 109.375 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.554 ' CE1' ' O ' ' A' ' 27' ' ' ALA . 9.6 m-85 -136.97 -53.69 0.7 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 1.0 109.482 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -104.31 -87.93 0.43 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 1.0 109.487 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.3 t -144.85 68.27 1.25 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.283 -0.886 . . . . 1.0 109.432 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -137.25 54.43 1.85 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 1.0 109.588 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.86 178.03 28.76 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.583 -1.407 . . . . 1.0 109.583 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -138.16 117.1 12.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -1.124 . . . . 1.0 109.426 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.48 ' CG ' ' C ' ' A' ' 34' ' ' SER . 0.0 OUTLIER 40.55 -94.0 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.639 -0.663 . . . . 1.0 109.85 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 34' ' ' SER . . . 61.06 68.25 1.76 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.509 -1.437 . . . . 1.0 109.509 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 36' ' ' GLY . . . -46.41 172.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.237 -1.155 . . . . 1.0 109.593 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.57 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 2.2 p -54.99 113.77 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.4 -0.813 . . . . 1.0 109.451 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -137.3 99.48 3.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.347 -0.846 . . . . 1.0 109.598 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.66 -154.34 0.6 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.377 -0.827 . . . . 1.0 109.458 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.5 t -69.84 -72.48 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 1.0 109.636 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.36 69.03 2.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 1.0 109.405 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.92 -82.12 0.87 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.31 -1.516 . . . . 1.0 109.31 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -165.97 -37.2 0.02 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.64 -1.384 . . . . 1.0 109.64 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -100.69 160.21 27.47 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.267 -1.137 . . . . 1.0 109.72 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.468 ' HB2' HG22 ' A' ' 17' ' ' ILE . 35.8 Cg_endo -78.59 -176.64 3.38 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.539 2.159 . . . . 1.0 110.482 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.518 HG22 ' CG1' ' A' ' 117' ' ' VAL . 1.0 OUTLIER -94.14 158.07 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.463 HG22 ' CZ ' ' A' ' 151' ' ' PHE . 2.9 t -134.54 135.94 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.983 -1.073 . . . . 1.0 110.399 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.57 ' HG2' ' CE1' ' A' ' 51' ' ' HIS . 5.0 tt0 -151.41 144.28 24.47 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.914 -0.773 . . . . 1.0 108.914 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.9 tt -113.23 138.51 49.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.085 -1.009 . . . . 1.0 109.994 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.57 ' CE1' ' HG2' ' A' ' 49' ' ' GLN . 7.5 m-70 -140.33 77.9 1.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.401 -0.812 . . . . 1.0 109.25 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.458 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . -177.03 84.69 0.07 OUTLIER Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.687 -1.244 . . . . 1.0 110.049 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.569 ' CD2' ' OE2' ' A' ' 111' ' ' GLU . 3.5 t80 177.16 132.09 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -1.196 . . . . 1.0 109.619 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.2 -10.84 17.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 1.0 109.437 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -89.75 145.25 25.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 1.0 109.502 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -103.73 57.13 0.73 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.309 -0.87 . . . . 1.0 109.35 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -110.1 156.46 40.05 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 1.0 109.454 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.448 ' HA ' ' HB3' ' A' ' 109' ' ' LEU . 35.8 Cg_endo -78.31 131.07 10.45 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.5 2.133 . . . . 1.0 110.49 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.521 HD11 ' CD2' ' A' ' 163' ' ' LEU . 6.5 mt -128.88 162.79 26.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 1.0 109.225 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.468 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 2.1 mpp? -105.78 131.63 52.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.275 -0.891 . . . . 1.0 109.355 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.519 HD22 ' CB ' ' A' ' 63' ' ' LEU . 1.1 tt -90.26 141.27 28.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.376 -0.828 . . . . 1.0 109.388 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 62' ' ' GLN . 0.9 OUTLIER -104.64 78.12 1.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.184 -0.948 . . . . 1.0 109.681 -179.764 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.627 ' CD1' ' CE1' ' A' ' 151' ' ' PHE . 23.4 tp -100.87 135.18 42.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 1.0 109.086 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.51 ' CD2' HG11 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -165.45 159.67 17.16 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.542 -0.911 . . . . 1.0 108.542 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.423 ' O ' ' CG2' ' A' ' 65' ' ' ILE . 1.2 tp -110.84 125.49 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 1.0 109.057 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' A' ' 74' ' ' ARG . . . -145.08 142.38 10.77 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.619 -1.392 . . . . 1.0 109.619 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.503 HG21 ' CD2' ' A' ' 76' ' ' HIS . 72.4 p -66.64 178.85 1.17 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.496 -1.003 . . . . 1.0 109.945 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -170.23 125.37 0.76 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.465 -0.772 . . . . 1.0 109.072 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.83 -38.03 20.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 1.0 108.962 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -140.45 -56.43 0.53 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.167 -0.958 . . . . 1.0 109.699 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.492 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -152.14 -47.57 0.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.875 . . . . 1.0 109.524 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mt -52.47 89.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.353 -0.842 . . . . 1.0 109.684 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.527 HD23 ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -48.11 171.93 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.105 -0.997 . . . . 1.0 110.362 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -168.91 167.22 5.97 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.384 -0.823 . . . . 1.0 108.867 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 74' ' ' ARG . 32.7 Cg_endo -74.06 142.69 31.39 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.072 1.848 . . . . 1.0 109.96 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.577 ' NE2' ' CG1' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -50.72 146.84 5.31 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.252 -0.905 . . . . 1.0 109.763 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.19 -59.54 4.9 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.363 -0.836 . . . . 1.0 109.294 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.569 ' CD2' HD21 ' A' ' 126' ' ' LEU . 74.9 m-85 -136.34 4.04 2.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -0.908 . . . . 1.0 109.912 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.566 ' HB2' ' CG ' ' A' ' 76' ' ' HIS . 6.7 m-30 -99.02 103.19 15.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.984 -1.072 . . . . 1.0 109.25 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.52 ' HB2' ' CG ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -138.88 7.64 2.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.064 -1.023 . . . . 1.0 109.643 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.52 ' CG1' ' HB2' ' A' ' 124' ' ' LEU . 35.6 m -64.39 157.89 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.182 -0.949 . . . . 1.0 109.464 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.489 ' CE1' HD12 ' A' ' 84' ' ' ILE . 35.0 t-80 -175.83 90.53 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.478 -0.763 . . . . 1.0 109.296 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -122.53 144.71 48.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.117 -0.99 . . . . 1.0 109.742 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.531 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 3.3 mp -110.45 125.09 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.29 -0.881 . . . . 1.0 109.51 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 86' ' ' GLY . 10.2 p -136.49 -95.75 0.23 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 1.0 109.701 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 85' ' ' THR . . . -41.15 -68.67 0.61 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 110.091 -1.204 . . . . 1.0 110.091 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 120' ' ' CYS . 0.0 OUTLIER -74.74 120.32 20.13 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.22 -1.165 . . . . 1.0 109.072 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.27 136.27 53.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -0.906 . . . . 1.0 109.642 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.474 ' O ' ' CG1' ' A' ' 89' ' ' VAL . 5.4 p -111.0 120.87 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 1.0 109.054 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.57 31.89 0.9 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.11 -0.994 . . . . 1.0 109.627 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.424 ' C ' ' OG1' ' A' ' 92' ' ' THR . 19.6 m -91.94 -91.09 0.16 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.316 -0.865 . . . . 1.0 109.14 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.516 ' O ' ' CG2' ' A' ' 106' ' ' ILE . 0.2 OUTLIER -174.54 82.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 1.0 109.383 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.51 160.99 13.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.937 . . . . 1.0 110.048 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.51 ' CB ' ' HG3' ' A' ' 105' ' ' GLU . 0.2 OUTLIER -155.53 160.91 40.91 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.007 -0.738 . . . . 1.0 109.007 179.786 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' A' ' 94' ' ' HIS . 0.7 OUTLIER -132.82 150.66 52.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.988 -1.07 . . . . 1.0 109.813 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -153.84 124.17 7.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.845 . . . . 1.0 109.225 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.521 ' HB ' ' CD ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -119.52 131.61 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 1.0 109.606 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.521 ' O ' ' CB ' ' A' ' 99' ' ' SER . 0.8 OUTLIER -126.05 68.7 1.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 1.0 109.207 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 1.4 m 76.35 93.82 0.07 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -0.843 . . . . 1.0 109.333 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 99' ' ' SER . 1.1 p-10 42.85 55.12 4.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.492 -0.755 . . . . 1.0 109.721 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.467 ' HB ' ' HG ' ' A' ' 98' ' ' LEU . 6.1 m -160.05 80.43 0.7 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.124 -0.985 . . . . 1.0 109.551 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.521 ' CD ' ' HB ' ' A' ' 97' ' ' ILE . 2.1 mmmp? -85.38 131.21 34.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 1.0 109.374 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.51 HG11 ' CD2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -129.49 165.82 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.22 -0.925 . . . . 1.0 109.154 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.15 141.66 49.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 1.0 109.595 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.51 ' HG3' ' CB ' ' A' ' 94' ' ' HIS . 2.1 pt-20 -137.46 117.07 12.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.332 -0.855 . . . . 1.0 109.147 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.526 ' CG2' ' CD2' ' A' ' 108' ' ' LEU . 12.4 mt -118.11 98.84 51.76 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.853 . . . . 1.0 109.849 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 60' ' ' MET . 35.3 Cg_endo -76.73 97.61 1.15 Allowed 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.379 2.052 . . . . 1.0 110.302 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.526 ' CD2' ' CG2' ' A' ' 106' ' ' ILE . 0.6 OUTLIER -145.12 165.26 28.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 1.0 109.657 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -115.37 81.52 8.59 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.303 -0.873 . . . . 1.0 109.698 -179.841 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 108' ' ' LEU . 37.1 Cg_endo -81.0 42.54 1.36 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.634 2.223 . . . . 1.0 110.706 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.569 ' OE2' ' CD2' ' A' ' 53' ' ' TYR . 0.9 OUTLIER -100.33 28.79 4.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.124 -0.985 . . . . 1.0 109.597 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 113' ' ' SER . 0.0 OUTLIER -138.01 -70.31 0.44 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.198 -0.939 . . . . 1.0 109.142 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 112' ' ' ASN . 3.5 t 178.19 101.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 1.0 109.237 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 4.5 ptm -164.04 131.11 3.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 1.0 109.562 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.458 ' HB2' ' OE1' ' A' ' 49' ' ' GLN . 35.7 ttp180 -106.68 131.65 53.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 1.0 109.373 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -116.07 101.96 9.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 1.0 109.377 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.518 ' CG1' HG22 ' A' ' 47' ' ' ILE . 4.6 m -81.06 127.01 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.334 -0.854 . . . . 1.0 109.445 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.574 ' CD1' ' CD2' ' A' ' 63' ' ' LEU . 10.6 mt -107.55 115.01 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.295 -0.878 . . . . 1.0 109.4 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 118' ' ' ILE . 0.6 OUTLIER -156.8 53.41 0.52 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 1.0 109.03 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.462 ' O ' ' O ' ' A' ' 83' ' ' ARG . 1.8 p -141.95 57.07 1.48 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.259 -0.9 . . . . 1.0 109.59 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.12 167.25 22.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 1.0 109.131 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.513 ' O ' ' CG2' ' A' ' 81' ' ' VAL . . . -137.63 -176.07 14.23 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.833 -1.307 . . . . 1.0 109.833 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.562 HD12 ' CD2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -116.41 171.72 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.354 -1.086 . . . . 1.0 109.083 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.52 ' HB2' ' CG1' ' A' ' 81' ' ' VAL . 13.5 tp -128.86 157.72 40.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 1.0 109.811 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.452 ' O ' ' CD ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -113.23 155.58 24.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.358 -0.839 . . . . 1.0 109.157 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.569 HD21 ' CD2' ' A' ' 78' ' ' PHE . 51.2 tp -117.62 -93.4 0.51 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.104 -0.997 . . . . 1.0 109.54 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.516 ' N ' ' HG ' ' A' ' 126' ' ' LEU . 0.2 OUTLIER 170.03 -78.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 1.0 109.063 180.0 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -123.48 113.24 18.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.248 -0.907 . . . . 1.0 109.326 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.6 p -81.31 126.22 31.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.208 -0.932 . . . . 1.0 109.579 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -165.07 56.84 0.12 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.209 -0.932 . . . . 1.0 109.517 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.488 ' CG2' ' O ' ' A' ' 131' ' ' ILE . 2.9 tt -121.05 70.4 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.428 -0.795 . . . . 1.0 109.51 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.83 119.08 29.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.907 . . . . 1.0 109.643 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.25 -47.05 37.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.888 . . . . 1.0 109.431 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 34.4 ptt85 176.15 144.91 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 1.0 109.542 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.46 124.93 4.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -0.939 . . . . 1.0 109.489 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -92.34 -3.25 67.34 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.692 -1.363 . . . . 1.0 109.692 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.401 ' N ' ' CD ' ' A' ' 137' ' ' GLU . 2.1 pm0 -177.49 156.53 1.19 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -1.177 . . . . 1.0 109.391 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.439 ' O ' ' HB2' ' A' ' 139' ' ' ASP . 0.9 OUTLIER -154.29 -44.49 0.09 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 1.0 109.579 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.457 ' O ' HG22 ' A' ' 140' ' ' ILE . 11.4 m-20 65.51 10.33 6.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.907 . . . . 1.0 109.529 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.457 HG22 ' O ' ' A' ' 139' ' ' ASP . 0.2 OUTLIER -160.01 -72.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 1.0 109.294 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 142' ' ' ARG . . . 100.25 -70.78 0.47 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.649 -1.38 . . . . 1.0 109.649 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 141' ' ' GLY . 28.0 mmm180 65.25 170.38 0.21 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.193 -1.181 . . . . 1.0 109.39 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 144' ' ' ASN . 0.3 OUTLIER -125.94 56.89 1.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.905 . . . . 1.0 109.495 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 143' ' ' LYS . 3.4 p30 40.64 93.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.679 -0.638 . . . . 1.0 109.904 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 174' ' ' CYS . 0.0 OUTLIER -143.47 46.7 1.5 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.214 -0.929 . . . . 1.0 109.751 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.519 ' N ' ' HD2' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -154.86 154.77 33.22 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.419 -0.801 . . . . 1.0 109.433 179.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.577 ' CG1' ' NE2' ' A' ' 76' ' ' HIS . 32.6 m -139.25 162.44 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.908 . . . . 1.0 109.226 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 8.0 ttt180 -141.61 112.47 7.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -0.95 . . . . 1.0 109.655 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.54 HD22 ' CE2' ' A' ' 151' ' ' PHE . 44.0 tp -79.12 123.84 27.75 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.317 -0.865 . . . . 1.0 109.051 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 37.2 t -95.0 146.0 7.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.233 -0.917 . . . . 1.0 109.773 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.627 ' CE1' ' CD1' ' A' ' 63' ' ' LEU . 0.2 OUTLIER -148.1 99.43 3.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 1.0 109.021 -179.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.514 ' CB ' ' HA ' ' A' ' 166' ' ' GLN . 14.1 ptt180 -150.33 136.4 18.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.98 -1.075 . . . . 1.0 110.255 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 164' ' ' SER . 9.8 p -115.42 129.02 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.568 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 33.2 m-70 -126.88 118.46 24.64 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.129 -0.982 . . . . 1.0 110.119 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.525 ' CG1' ' HB3' ' A' ' 163' ' ' LEU . 13.0 p -99.04 140.98 22.11 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.363 -0.836 . . . . 1.0 108.769 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.523 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 33.2 Cg_endo -75.25 115.29 4.21 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.161 1.907 . . . . 1.0 110.245 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.459 ' HG3' HG22 ' A' ' 162' ' ' THR . 9.8 mm-40 -136.51 167.28 22.16 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.541 -0.724 . . . . 1.0 109.292 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 157' ' ' GLN . 34.6 Cg_endo -77.32 -63.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.299 1.999 . . . . 1.0 110.21 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.6 t -55.74 -75.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.385 -0.822 . . . . 1.0 109.346 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 142.09 -43.27 1.08 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.482 -1.447 . . . . 1.0 109.482 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.86 80.48 5.2 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.879 -1.156 . . . . 1.0 107.879 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.569 ' O ' ' CE2' ' A' ' 13' ' ' TYR . 1.3 m -136.2 -78.23 0.42 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.462 -0.774 . . . . 1.0 109.432 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.525 ' HB3' ' CG1' ' A' ' 155' ' ' VAL . 8.3 tp -141.06 100.93 3.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.074 -1.016 . . . . 1.0 108.962 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.568 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -162.21 98.27 1.04 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.025 -1.047 . . . . 1.0 109.534 179.576 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 152' ' ' ARG . 0.2 OUTLIER -126.73 151.88 47.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.331 -0.856 . . . . 1.0 109.625 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.514 ' HA ' ' CB ' ' A' ' 152' ' ' ARG . 5.6 mt-30 -118.51 145.53 45.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.902 . . . . 1.0 109.535 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.462 ' O ' ' HB2' ' A' ' 151' ' ' PHE . 47.0 t -152.39 93.26 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.124 -0.985 . . . . 1.0 109.78 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 149' ' ' LEU . . . -112.44 110.46 20.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.198 -0.939 . . . . 1.0 109.362 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 0.1 OUTLIER -159.51 136.63 9.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.158 -0.964 . . . . 1.0 109.872 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 169' ' ' SER . 0.2 OUTLIER 176.67 99.14 0.11 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.385 -0.822 . . . . 1.0 109.07 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.46 95.3 1.04 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.311 2.008 . . . . 1.0 110.964 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.529 ' HB ' ' CG2' ' A' ' 147' ' ' VAL . 14.9 mt -150.36 161.36 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.432 -0.793 . . . . 1.0 109.137 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.456 ' N ' ' CG2' ' A' ' 172' ' ' ILE . 3.3 mt-10 -118.32 172.6 7.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.247 -0.908 . . . . 1.0 109.803 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.533 ' HB3' ' CE2' ' A' ' 79' ' ' TYR . 6.0 m -114.71 153.29 30.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 1.0 109.315 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.435 ' O ' ' OH ' ' A' ' 79' ' ' TYR . 1.3 p -164.96 166.65 19.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.293 -0.879 . . . . 1.0 109.541 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.97 -176.23 3.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.203 -0.935 . . . . 1.0 109.384 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.31 -83.58 0.48 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.147 -0.971 . . . . 1.0 109.411 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.036 -0.983 . . . . 1.0 109.471 -179.979 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.41 ' O ' ' HB2' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -152.66 135.51 15.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.228 -0.92 . . . . 1.0 109.476 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 2' ' ' LYS . 0.3 OUTLIER 174.49 -67.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.235 -0.916 . . . . 1.0 109.434 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.555 ' CG ' ' N ' ' A' ' 5' ' ' GLN . 23.5 p-90 -78.62 -46.0 20.29 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.304 -0.873 . . . . 1.0 109.54 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.555 ' N ' ' CG ' ' A' ' 4' ' ' TRP . 2.2 tt0 -179.75 81.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.138 -0.976 . . . . 1.0 109.371 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.469 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 0.2 OUTLIER -166.52 62.68 0.73 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.254 -0.904 . . . . 1.0 109.557 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.469 ' HD3' ' N ' ' A' ' 6' ' ' LEU . 35.4 Cg_endo -77.91 94.62 1.07 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.404 2.069 . . . . 1.0 110.357 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.9 p -155.04 46.4 0.52 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.839 . . . . 1.0 109.508 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.07 114.24 27.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 1.0 109.482 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.8 m -154.76 52.06 0.63 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.173 -0.955 . . . . 1.0 109.549 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.81 73.56 0.54 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.594 -1.402 . . . . 1.0 109.594 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.04 -162.46 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.532 2.155 . . . . 1.0 110.374 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 52' ' ' GLY . 3.1 m-85 -56.72 145.74 28.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.2 -0.937 . . . . 1.0 109.326 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -157.13 124.14 5.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.903 -1.123 . . . . 1.0 110.089 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.512 ' CD2' ' HB ' ' A' ' 153' ' ' VAL . 17.5 tp -107.8 81.72 1.55 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.395 -0.815 . . . . 1.0 108.867 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -116.34 157.1 25.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.87 . . . . 1.0 109.903 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.51 HG21 ' N ' ' A' ' 18' ' ' GLU . 1.4 mp -62.96 149.81 9.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.296 -0.878 . . . . 1.0 108.664 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.553 ' CG ' ' NE2' ' A' ' 49' ' ' GLN . 0.7 OUTLIER -64.65 -42.71 95.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.923 . . . . 1.0 109.11 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.461 ' HB ' HD13 ' A' ' 47' ' ' ILE . 71.3 t -151.81 126.76 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.277 -0.89 . . . . 1.0 109.092 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.466 ' HG2' ' CG2' ' A' ' 17' ' ' ILE . 9.0 mm-40 -115.28 79.14 6.48 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.905 . . . . 1.0 109.484 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.43 ' HD3' ' C ' ' A' ' 19' ' ' VAL . 36.2 Cg_endo -77.8 -179.35 5.36 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.352 2.035 . . . . 1.0 110.453 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.68 113.97 5.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 1.0 109.062 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.527 ' HA ' ' CB ' ' A' ' 40' ' ' ALA . 3.0 t -139.29 72.46 1.4 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.226 -0.921 . . . . 1.0 109.855 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -99.69 166.89 10.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.244 -0.91 . . . . 1.0 109.256 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.568 ' CE1' ' HA ' ' A' ' 38' ' ' VAL . 9.3 t60 -135.78 104.19 5.67 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 119.852 -0.739 . . . . 1.0 109.339 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -79.08 77.83 5.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.426 -0.796 . . . . 1.0 109.212 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 28' ' ' HIS . . . -60.03 93.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.394 -0.816 . . . . 1.0 109.648 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.463 ' HB2' ' O ' ' A' ' 27' ' ' ALA . 2.4 t-160 176.58 33.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.847 . . . . 1.0 109.32 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -95.44 -168.89 1.86 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.292 -0.88 . . . . 1.0 109.551 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -70.16 145.76 51.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.314 -0.866 . . . . 1.0 109.59 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.3 t -145.05 38.23 1.17 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.358 -0.839 . . . . 1.0 109.521 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.4 20.89 13.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -0.931 . . . . 1.0 109.525 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -177.24 -50.24 0.07 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.583 -1.407 . . . . 1.0 109.583 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.13 150.46 22.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -1.151 . . . . 1.0 109.497 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 -88.83 -89.74 0.14 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 1.0 109.509 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.89 175.97 21.0 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.567 -1.413 . . . . 1.0 109.567 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -175.17 170.09 3.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -1.138 . . . . 1.0 109.607 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.568 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 2.2 p -57.48 122.79 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.365 -0.835 . . . . 1.0 109.43 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.32 109.93 3.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 1.0 109.439 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.527 ' CB ' ' HA ' ' A' ' 23' ' ' SER . . . -136.34 -91.63 0.27 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 1.0 109.77 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.8 m -102.61 135.26 44.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.222 -0.924 . . . . 1.0 109.662 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.562 ' HB2' ' CE1' ' A' ' 45' ' ' HIS . . . 67.45 10.1 7.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.928 . . . . 1.0 109.38 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.8 10.8 42.3 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.413 -1.475 . . . . 1.0 109.413 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 45' ' ' HIS . . . 77.06 83.4 0.52 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.644 -1.383 . . . . 1.0 109.644 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.573 ' CG ' ' HB3' ' A' ' 119' ' ' ASP . 23.4 p-80 -179.81 123.0 0.23 Allowed Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.168 -1.195 . . . . 1.0 109.962 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.24 146.61 19.97 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 122.0 1.8 . . . . 1.0 109.416 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.531 ' CG2' ' CG1' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -97.31 135.1 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.909 -1.119 . . . . 1.0 109.142 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.41 HG22 HD13 ' A' ' 118' ' ' ILE . 3.0 t -118.63 130.79 72.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.017 -1.052 . . . . 1.0 109.814 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.553 ' NE2' ' CG ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -161.4 117.74 2.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.338 -0.852 . . . . 1.0 109.465 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.0 tt -77.07 136.37 38.65 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.126 -0.984 . . . . 1.0 109.154 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.0 87.47 2.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.182 -0.949 . . . . 1.0 109.262 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.48 ' O ' ' CD1' ' A' ' 13' ' ' TYR . . . 163.92 64.48 0.02 OUTLIER Glycine 0 N--CA 1.483 1.807 0 C-N-CA 119.56 -1.305 . . . . 1.0 110.166 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.56 ' CE1' ' HB2' ' A' ' 55' ' ' GLU . 0.2 OUTLIER 175.62 121.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.109 -1.23 . . . . 1.0 109.687 179.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.7 mt -104.0 22.6 14.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.323 -0.861 . . . . 1.0 109.31 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.56 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -87.35 145.22 26.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.179 -0.951 . . . . 1.0 109.685 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.83 46.43 1.33 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.2 -0.938 . . . . 1.0 109.712 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 17.1 pt-20 -122.98 127.75 25.59 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.255 -0.903 . . . . 1.0 109.185 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.459 ' O ' HD21 ' A' ' 59' ' ' LEU . 36.4 Cg_endo -79.44 151.18 22.61 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 122.147 1.898 . . . . 1.0 110.624 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.522 ' CD2' HG22 ' A' ' 155' ' ' VAL . 18.6 mt -128.48 142.7 51.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.309 -0.869 . . . . 1.0 108.91 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.467 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -79.95 102.05 8.98 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.074 -1.016 . . . . 1.0 109.423 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.514 HD22 ' N ' ' A' ' 63' ' ' LEU . 3.0 tt -59.59 135.11 57.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.405 -0.809 . . . . 1.0 109.612 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -102.45 97.06 7.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.359 -0.838 . . . . 1.0 108.998 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.564 HD12 ' CZ ' ' A' ' 151' ' ' PHE . 26.8 tp -123.35 139.21 54.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.179 -0.951 . . . . 1.0 109.634 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.475 ' CG ' ' N ' ' A' ' 65' ' ' ILE . 2.3 p90 -159.96 -163.9 1.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.325 -0.86 . . . . 1.0 108.928 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.496 ' O ' ' CG2' ' A' ' 65' ' ' ILE . 2.8 tp -125.36 115.62 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.827 . . . . 1.0 108.828 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.434 ' CA ' ' O ' ' A' ' 74' ' ' ARG . . . -135.09 148.07 19.43 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.677 -1.249 . . . . 1.0 109.996 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.636 ' CG2' ' CD2' ' A' ' 76' ' ' HIS . 17.4 p -83.97 156.34 22.35 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.519 -0.989 . . . . 1.0 109.225 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.522 ' CB ' ' HG3' ' A' ' 148' ' ' ARG . . . -159.42 120.39 3.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.067 -1.021 . . . . 1.0 109.724 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.93 -10.91 56.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 1.0 109.374 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -166.65 -44.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.887 . . . . 1.0 109.38 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.487 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -168.33 -36.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 1.0 109.619 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.98 89.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -0.886 . . . . 1.0 109.548 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -54.21 169.21 0.19 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.243 -0.911 . . . . 1.0 109.6 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.434 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -175.19 155.17 1.75 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 1.0 109.486 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.404 ' HD2' ' HG2' ' A' ' 74' ' ' ARG . 36.0 Cg_endo -77.67 116.93 4.14 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.483 2.122 . . . . 1.0 110.342 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.636 ' CD2' ' CG2' ' A' ' 67' ' ' THR . 1.7 t-80 -54.07 154.48 4.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.186 -0.947 . . . . 1.0 109.699 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.95 -72.2 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 1.0 109.796 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.56 ' CG ' HD13 ' A' ' 126' ' ' LEU . 1.1 p90 -130.97 12.83 5.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.091 -1.006 . . . . 1.0 109.858 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.575 ' HB2' ' CG ' ' A' ' 76' ' ' HIS . 5.8 m-85 -79.98 117.18 20.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.061 -1.024 . . . . 1.0 108.943 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.526 ' CB ' ' HB3' ' A' ' 102' ' ' LYS . 1.5 pp0? -174.55 33.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.148 -0.97 . . . . 1.0 109.984 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 122' ' ' GLY . 5.6 m -91.94 140.91 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 1.0 109.641 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.576 ' CD2' ' HB3' ' A' ' 121' ' ' ALA . 13.4 t-80 -175.58 111.26 0.11 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.401 -0.812 . . . . 1.0 108.94 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.4 OUTLIER -145.08 135.18 23.88 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.09 -1.006 . . . . 1.0 110.116 -179.685 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.464 HG13 ' HB3' ' A' ' 120' ' ' CYS . 4.0 mp -99.75 128.45 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.596 -0.69 . . . . 1.0 109.379 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 86' ' ' GLY . 38.7 p -99.98 -154.37 0.47 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 1.0 109.356 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 85' ' ' THR . . . 41.07 -152.12 0.12 Allowed Glycine 0 N--CA 1.484 1.881 0 N-CA-C 110.071 -1.212 . . . . 1.0 110.071 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -155.2 69.56 0.72 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.265 -1.138 . . . . 1.0 109.576 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.54 40.01 3.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.203 -0.936 . . . . 1.0 109.67 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -148.16 135.97 14.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.178 -0.951 . . . . 1.0 108.982 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.6 p -102.94 -13.8 16.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.22 -0.925 . . . . 1.0 109.452 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 91' ' ' THR . 11.4 t -65.05 115.55 5.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.263 -0.898 . . . . 1.0 109.618 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.518 ' O ' ' CG2' ' A' ' 106' ' ' ILE . 14.5 t -78.62 148.78 33.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.947 . . . . 1.0 109.142 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.46 ' HB3' HG12 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -137.18 174.39 10.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.129 -0.982 . . . . 1.0 110.043 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.46 ' O ' HD22 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -152.76 159.56 43.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.495 -0.753 . . . . 1.0 109.139 179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.454 ' HB3' ' CE ' ' A' ' 102' ' ' LYS . 27.8 mm-40 -127.14 147.79 50.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.979 . . . . 1.0 109.819 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -151.76 121.55 7.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 1.0 109.427 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.462 ' HB ' ' HD2' ' A' ' 102' ' ' LYS . 2.6 tp -110.27 142.32 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 1.0 109.648 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.472 ' HG ' ' HB ' ' A' ' 101' ' ' THR . 0.5 OUTLIER -130.81 49.62 2.3 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.329 -0.857 . . . . 1.0 109.367 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 98' ' ' LEU . 2.0 p 73.92 112.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.864 . . . . 1.0 110.213 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.429 ' CG ' ' O ' ' A' ' 99' ' ' SER . 2.2 p-10 42.71 32.65 0.4 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.603 -0.686 . . . . 1.0 110.502 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.472 ' HB ' ' HG ' ' A' ' 98' ' ' LEU . 43.7 m -160.24 88.66 0.82 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.883 -1.135 . . . . 1.0 109.971 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.526 ' HB3' ' CB ' ' A' ' 80' ' ' GLN . 3.8 tptt -91.88 147.5 22.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 1.0 109.239 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.519 ' N ' ' HG3' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -136.8 167.43 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.205 -0.934 . . . . 1.0 109.104 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.493 ' CB ' ' O ' ' A' ' 63' ' ' LEU . 1.0 OUTLIER -121.59 124.43 44.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 1.0 109.65 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.85 120.36 39.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.28 -0.887 . . . . 1.0 109.152 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.518 ' CG2' ' O ' ' A' ' 92' ' ' THR . 71.3 mt -133.24 108.61 12.45 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.107 -0.996 . . . . 1.0 109.684 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 60' ' ' MET . 33.9 Cg_endo -75.17 115.6 4.31 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 122.079 1.853 . . . . 1.0 109.844 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.451 HD22 ' O ' ' A' ' 107' ' ' PRO . 21.1 mt -123.45 165.45 17.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.261 -0.899 . . . . 1.0 110.787 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.522 ' N ' ' HD3' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -139.21 59.7 15.5 Favored Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 108.788 -0.819 . . . . 1.0 108.788 179.199 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.522 ' HD3' ' N ' ' A' ' 109' ' ' LEU . 35.6 Cg_endo -76.95 -3.88 14.28 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.373 2.049 . . . . 1.0 110.622 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 55' ' ' GLU . 3.2 mt-10 -43.63 -36.01 1.99 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.502 -0.749 . . . . 1.0 109.115 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 113' ' ' SER . 3.4 p30 -94.77 -44.33 7.82 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.476 -0.765 . . . . 1.0 109.202 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 1.4 p 164.72 107.54 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 1.0 109.261 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.435 ' HB3' ' HA ' ' A' ' 110' ' ' PRO . 0.9 OUTLIER -154.69 94.08 1.64 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.32 -0.863 . . . . 1.0 109.358 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.54 129.77 42.6 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 1.0 109.233 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -136.09 134.7 38.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.895 . . . . 1.0 109.636 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.531 ' CG1' ' CG2' ' A' ' 47' ' ' ILE . 3.3 m -106.35 145.78 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.279 -0.888 . . . . 1.0 109.238 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 45' ' ' HIS . 14.3 mt -112.76 93.93 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.176 -0.952 . . . . 1.0 109.509 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.573 ' HB3' ' CG ' ' A' ' 45' ' ' HIS . 9.4 p-10 -127.66 26.44 5.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.591 -0.693 . . . . 1.0 109.257 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.464 ' HB3' HG13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -122.42 44.65 2.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.245 -0.909 . . . . 1.0 110.003 -179.406 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.576 ' HB3' ' CD2' ' A' ' 82' ' ' HIS . . . -129.56 177.01 7.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.967 . . . . 1.0 109.102 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.515 ' O ' ' CG2' ' A' ' 81' ' ' VAL . . . -155.95 -169.84 20.63 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.548 -1.421 . . . . 1.0 109.548 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.498 ' CG2' ' CD2' ' A' ' 79' ' ' TYR . 1.8 mt -125.68 173.41 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -1.129 . . . . 1.0 109.437 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.494 HD21 ' CG1' ' A' ' 81' ' ' VAL . 1.4 pp -140.12 158.14 44.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -0.826 . . . . 1.0 109.396 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.9 139.23 50.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 1.0 109.552 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.56 HD13 ' CG ' ' A' ' 78' ' ' PHE . 10.5 mt -116.06 -170.7 1.85 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 1.0 109.394 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.35 -58.64 1.85 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 1.0 109.523 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -163.15 118.84 1.75 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.282 -0.886 . . . . 1.0 109.448 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.537 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 52.2 p -100.79 -27.3 13.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.884 . . . . 1.0 109.476 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 129' ' ' SER . 16.6 t0 83.39 59.42 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.264 0.554 . . . . 1.0 109.517 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.441 ' O ' HG21 ' A' ' 131' ' ' ILE . 3.3 tp -103.98 134.46 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.208 -0.932 . . . . 1.0 109.456 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -84.04 111.92 19.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 1.0 109.518 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.451 ' C ' ' CD1' ' A' ' 133' ' ' LEU . 0.5 OUTLIER -170.98 -57.64 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.216 -0.927 . . . . 1.0 109.463 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.03 -35.86 67.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 1.0 109.322 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.32 155.42 28.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 1.0 109.488 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 179.19 -86.17 0.07 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.517 -1.433 . . . . 1.0 109.517 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -122.54 -64.45 1.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -1.119 . . . . 1.0 109.42 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.89 149.2 52.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 1.0 109.429 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 139' ' ' ASP . 24.6 p-10 -59.84 155.28 16.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.953 . . . . 1.0 109.448 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -119.18 -69.2 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.199 -0.938 . . . . 1.0 108.856 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -115.09 -147.99 9.36 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.588 -1.405 . . . . 1.0 109.588 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.97 -85.62 0.56 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -1.135 . . . . 1.0 109.506 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.401 ' O ' ' CG ' ' A' ' 143' ' ' LYS . 0.0 OUTLIER -87.85 73.09 9.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.278 -0.889 . . . . 1.0 109.525 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -59.94 128.51 37.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 1.0 109.348 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.11 53.42 0.34 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.092 -1.005 . . . . 1.0 109.828 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.47 ' HD2' ' O ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -101.98 158.85 15.84 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.103 -0.998 . . . . 1.0 109.374 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.449 ' O ' ' HG2' ' A' ' 148' ' ' ARG . 2.2 m -141.49 165.33 18.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.437 -0.79 . . . . 1.0 109.147 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.522 ' HG3' ' CB ' ' A' ' 68' ' ' ALA . 20.7 mmm-85 -150.31 119.0 6.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.074 -1.017 . . . . 1.0 109.865 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.459 HD13 HD12 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -79.82 120.25 23.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.292 -0.88 . . . . 1.0 109.278 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 47.4 t -96.74 126.15 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.263 -0.898 . . . . 1.0 109.535 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.564 ' CZ ' HD12 ' A' ' 63' ' ' LEU . 3.1 m-85 -127.71 118.3 23.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.849 . . . . 1.0 109.062 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 1.9 ptm180 -150.33 141.17 22.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.131 -0.98 . . . . 1.0 109.977 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.512 ' HB ' ' CD2' ' A' ' 15' ' ' LEU . 8.8 p -117.32 128.46 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.683 -0.858 . . . . 1.0 108.683 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.452 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 55.1 m-70 -121.69 115.13 22.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.139 -0.975 . . . . 1.0 110.329 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.525 ' CG2' ' HD2' ' A' ' 156' ' ' PRO . 13.9 p -99.66 141.93 23.69 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.901 -0.778 . . . . 1.0 108.901 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.525 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 32.8 Cg_endo -75.16 114.52 4.03 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.065 1.843 . . . . 1.0 110.357 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.456 ' HB3' ' HD2' ' A' ' 158' ' ' PRO . 3.9 mm-40 -133.41 168.33 18.45 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.553 -0.717 . . . . 1.0 109.069 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 157' ' ' GLN . 34.4 Cg_endo -77.0 -64.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.259 1.973 . . . . 1.0 110.249 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.4 m -62.1 -58.05 9.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.935 . . . . 1.0 109.245 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 124.55 -36.19 2.96 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.738 -1.345 . . . . 1.0 109.738 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -79.14 80.04 5.51 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.498 -1.001 . . . . 1.0 108.312 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.469 HG23 HG12 ' A' ' 155' ' ' VAL . 1.3 m -140.54 -74.18 0.34 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.958 -0.756 . . . . 1.0 108.958 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.52 HD22 ' CD1' ' A' ' 59' ' ' LEU . 7.8 tp -142.25 97.62 3.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.09 -1.006 . . . . 1.0 108.644 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.452 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.2 OUTLIER -163.11 87.14 0.55 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.071 -1.018 . . . . 1.0 109.245 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.486 ' CD2' ' N ' ' A' ' 165' ' ' LEU . 1.8 pt? -132.31 170.78 14.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -0.956 . . . . 1.0 109.805 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.455 ' NE2' ' HD2' ' A' ' 152' ' ' ARG . 2.5 tt0 -117.44 157.44 26.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.327 -0.858 . . . . 1.0 109.498 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 151' ' ' PHE . 48.3 t -149.32 81.87 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 1.0 109.653 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.451 ' HB2' ' NH2' ' A' ' 148' ' ' ARG . . . -90.8 103.46 16.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.198 -0.939 . . . . 1.0 109.354 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 170' ' ' ASN . 0.0 OUTLIER -120.07 136.5 54.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -0.967 . . . . 1.0 109.657 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 169' ' ' SER . 1.8 m-20 163.27 85.5 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 1.0 109.383 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.91 72.24 6.24 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.461 2.107 . . . . 1.0 110.574 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' ' 146' ' ' ARG . 12.3 mt -126.71 134.44 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 1.0 109.284 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -156.0 125.1 6.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 1.0 109.631 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.452 ' O ' ' OG ' ' A' ' 175' ' ' SER . 1.3 m -95.37 -173.8 3.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 1.0 109.491 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 174' ' ' CYS . 4.9 p 63.28 159.11 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 1.0 109.659 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 177' ' ' ARG . 0.3 OUTLIER 61.06 45.57 9.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 1.0 109.627 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 176' ' ' GLN . 0.0 OUTLIER 48.18 -176.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -0.9 . . . . 1.0 109.483 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.973 -1.013 . . . . 1.0 109.457 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.459 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -160.66 151.08 18.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.186 -0.946 . . . . 1.0 109.428 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 2' ' ' LYS . 0.3 OUTLIER 74.13 -162.62 0.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.29 -0.882 . . . . 1.0 109.525 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.44 ' CG ' ' N ' ' A' ' 5' ' ' GLN . 52.4 p-90 -103.73 -46.2 4.58 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.309 -0.869 . . . . 1.0 109.538 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.44 ' N ' ' CG ' ' A' ' 4' ' ' TRP . 0.3 OUTLIER 172.94 85.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 1.0 109.483 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.5 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 1.2 mt -133.05 60.82 52.06 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.326 -0.858 . . . . 1.0 109.411 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.5 ' HD3' ' N ' ' A' ' 6' ' ' LEU . 35.6 Cg_endo -78.18 106.81 2.21 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.399 2.066 . . . . 1.0 110.46 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.6 p -139.16 41.1 2.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.241 -0.912 . . . . 1.0 109.47 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -140.2 132.55 28.36 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.33 -0.856 . . . . 1.0 109.511 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.4 t -120.44 128.72 53.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 1.0 109.507 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.25 146.15 7.38 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.48 -1.448 . . . . 1.0 109.48 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.3 -91.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.389 2.059 . . . . 1.0 110.381 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.66 ' CE2' ' CD1' ' A' ' 53' ' ' TYR . 3.6 m-30 -58.36 145.06 39.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.167 -0.958 . . . . 1.0 109.215 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.517 ' HA ' ' CD1' ' A' ' 165' ' ' LEU . 53.1 tt0 179.48 142.96 0.14 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.148 -0.97 . . . . 1.0 109.271 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -98.79 116.8 31.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.339 -0.851 . . . . 1.0 109.213 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -110.76 132.84 53.85 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.338 -0.851 . . . . 1.0 109.916 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.453 HG22 ' HB2' ' A' ' 46' ' ' PRO . 1.1 mp -60.83 143.36 14.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.358 -0.979 . . . . 1.0 108.358 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -71.96 -54.23 10.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 1.0 109.676 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.435 HG13 ' HD3' ' A' ' 21' ' ' PRO . 30.5 t -120.33 133.61 66.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.239 -0.913 . . . . 1.0 109.61 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -127.0 76.24 76.1 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.214 -0.929 . . . . 1.0 109.429 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.435 ' HD3' HG13 ' A' ' 19' ' ' VAL . 35.5 Cg_endo -77.69 -175.71 2.83 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.511 2.141 . . . . 1.0 110.51 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -43.46 131.08 5.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.451 -0.781 . . . . 1.0 109.406 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.459 ' OG ' ' OD1' ' A' ' 170' ' ' ASN . 7.9 t -112.86 40.07 2.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.189 -0.944 . . . . 1.0 109.841 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.469 ' HA ' ' CG2' ' A' ' 172' ' ' ILE . 1.9 p80 -103.04 166.16 10.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.05 -1.031 . . . . 1.0 109.505 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.571 ' CD2' HD12 ' A' ' 123' ' ' ILE . 1.0 OUTLIER -154.49 89.83 1.29 Allowed 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.901 -0.72 . . . . 1.0 109.674 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.42 72.63 10.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.307 -0.871 . . . . 1.0 109.138 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -70.66 148.95 47.5 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.471 -0.768 . . . . 1.0 109.811 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -69.76 146.54 51.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.289 -0.882 . . . . 1.0 109.341 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.462 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 78.6 m-85 -132.35 86.57 2.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 1.0 109.504 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER 169.62 -157.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -0.924 . . . . 1.0 109.459 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.7 t -122.32 34.69 5.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 1.0 109.496 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.475 ' HG3' ' N ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -122.83 -27.2 4.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.348 -0.845 . . . . 1.0 109.601 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.475 ' N ' ' HG3' ' A' ' 32' ' ' GLU . . . -68.92 133.59 26.98 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.624 -1.391 . . . . 1.0 109.624 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.08 -67.58 0.85 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -1.122 . . . . 1.0 109.447 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.0 mmt85 -76.62 88.11 3.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 1.0 109.342 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -110.7 121.95 6.05 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.637 -1.385 . . . . 1.0 109.637 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -173.25 175.13 3.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -1.186 . . . . 1.0 109.751 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.57 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 2.4 p -89.67 119.23 36.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.539 -0.725 . . . . 1.0 109.269 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -155.18 105.37 2.51 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -0.936 . . . . 1.0 109.577 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.51 -88.29 0.54 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 1.0 109.449 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 p -114.97 -92.2 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 1.0 109.652 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.27 -69.45 0.12 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 1.0 109.457 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -167.25 26.68 0.15 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.522 -1.431 . . . . 1.0 109.522 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.474 ' HA3' ' CG2' ' A' ' 38' ' ' VAL . . . 112.34 -59.5 0.37 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.463 ' HB3' ' HD2' ' A' ' 46' ' ' PRO . 13.1 m-70 -104.64 161.03 24.06 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.307 -1.113 . . . . 1.0 109.472 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 45' ' ' HIS . 35.4 Cg_endo -78.0 -179.59 5.59 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.505 2.136 . . . . 1.0 110.512 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.515 ' CG2' HG11 ' A' ' 117' ' ' VAL . 2.5 mm -94.11 156.64 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.374 -0.829 . . . . 1.0 109.075 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.507 HG22 ' CZ ' ' A' ' 151' ' ' PHE . 10.8 t -129.31 141.76 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.112 -0.992 . . . . 1.0 110.117 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.463 ' HB2' ' HG3' ' A' ' 115' ' ' ARG . 7.1 tt0 -160.4 147.06 15.65 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.422 HD12 ' OE2' ' A' ' 111' ' ' GLU . 0.6 OUTLIER -78.5 148.13 33.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.886 -1.134 . . . . 1.0 109.617 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -140.14 77.65 1.62 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.445 -0.785 . . . . 1.0 109.37 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 163.87 -109.97 0.4 Allowed Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.455 -1.355 . . . . 1.0 110.476 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.66 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 1.5 t80 -39.18 141.22 0.34 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.826 -0.808 . . . . 1.0 110.178 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 111' ' ' GLU . 0.7 OUTLIER -136.62 46.67 2.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.331 -0.856 . . . . 1.0 109.492 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.575 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 1.2 tt0 -87.25 145.41 26.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 1.0 109.331 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.62 49.98 1.87 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.202 -0.936 . . . . 1.0 109.853 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -122.36 153.54 62.06 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 1.0 109.432 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.489 ' C ' ' CD2' ' A' ' 59' ' ' LEU . 35.3 Cg_endo -78.11 131.03 10.62 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.521 2.148 . . . . 1.0 110.462 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.489 ' CD2' ' C ' ' A' ' 58' ' ' PRO . 4.3 mt -128.14 163.02 25.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 1.0 109.16 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.455 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 4.4 ptt? -110.48 138.72 46.5 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.238 -0.914 . . . . 1.0 109.771 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 106' ' ' ILE . 0.1 OUTLIER -91.71 147.44 22.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.413 -0.804 . . . . 1.0 109.391 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.436 ' O ' ' HG2' ' A' ' 152' ' ' ARG . 0.9 OUTLIER -124.48 77.6 1.59 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.307 -0.871 . . . . 1.0 109.041 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.57 HD23 ' CZ ' ' A' ' 151' ' ' PHE . 0.5 OUTLIER -125.64 156.89 38.52 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.205 -0.934 . . . . 1.0 109.842 -179.569 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.512 ' CB ' HG11 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -166.16 -164.93 0.73 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.38 -0.97 . . . . 1.0 108.38 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.519 ' CG2' ' O ' ' A' ' 65' ' ' ILE . 0.5 OUTLIER -117.56 112.51 39.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.889 -1.132 . . . . 1.0 108.53 178.656 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.8 147.31 16.8 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.829 -1.308 . . . . 1.0 109.829 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.634 ' CG2' ' CD2' ' A' ' 76' ' ' HIS . 4.7 p -83.26 134.02 34.96 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.476 -1.014 . . . . 1.0 109.404 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.14 121.28 3.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.218 -0.926 . . . . 1.0 109.371 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -84.84 -26.52 27.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.9 . . . . 1.0 109.503 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.96 -38.75 0.34 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 1.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' LEU . 2.7 ttm180 -168.96 -35.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.121 -0.987 . . . . 1.0 109.674 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.462 ' O ' ' CD ' ' A' ' 74' ' ' ARG . 0.1 OUTLIER -44.06 94.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 1.0 109.701 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -80.17 136.36 36.48 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.222 -0.924 . . . . 1.0 109.623 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -157.83 166.48 16.47 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.285 -0.884 . . . . 1.0 109.136 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.46 ' HB3' HG22 ' A' ' 101' ' ' THR . 33.4 Cg_endo -75.47 137.26 20.49 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.147 1.898 . . . . 1.0 110.223 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.634 ' CD2' ' CG2' ' A' ' 67' ' ' THR . 0.3 OUTLIER -65.27 157.53 28.74 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.29 -0.882 . . . . 1.0 109.848 -179.529 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.3 -58.88 2.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.299 -0.876 . . . . 1.0 109.467 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.58 ' CG ' HD22 ' A' ' 126' ' ' LEU . 2.3 m-85 -128.31 2.86 5.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.203 -0.936 . . . . 1.0 109.794 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.575 ' HB2' ' CD2' ' A' ' 76' ' ' HIS . 5.7 m-85 -100.72 76.15 1.78 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.13 -0.981 . . . . 1.0 109.414 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.502 ' HB2' ' CB ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -141.97 8.68 1.89 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 1.0 110.002 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 122' ' ' GLY . 10.2 m -67.64 143.69 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.034 -1.041 . . . . 1.0 109.52 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.479 ' CD2' ' HB1' ' A' ' 121' ' ' ALA . 10.2 t-160 -175.48 107.23 0.09 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.47 -0.769 . . . . 1.0 109.438 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.462 ' HG2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -144.8 142.84 30.3 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.165 -0.96 . . . . 1.0 109.711 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.481 ' N ' ' CD1' ' A' ' 84' ' ' ILE . 4.1 mp -101.01 158.98 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.349 -0.844 . . . . 1.0 109.196 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.475 ' N ' HG21 ' A' ' 84' ' ' ILE . 23.8 p -99.93 -105.17 0.22 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.149 -0.969 . . . . 1.0 109.275 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 85' ' ' THR . . . -44.51 109.14 0.24 Allowed Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.716 -1.353 . . . . 1.0 109.716 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.1 tptt -74.58 82.34 2.01 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.104 -1.233 . . . . 1.0 109.417 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.55 44.85 0.46 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.302 -0.874 . . . . 1.0 109.579 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.7 p -86.98 171.93 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.255 -0.903 . . . . 1.0 109.402 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.5 t -86.85 -30.16 21.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 1.0 109.561 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.452 HG23 HG23 ' A' ' 106' ' ' ILE . 11.5 m -108.57 105.06 14.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.328 -0.857 . . . . 1.0 109.505 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.495 ' O ' ' CG2' ' A' ' 106' ' ' ILE . 6.9 m -52.63 157.46 1.56 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 1.0 109.338 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.463 ' HA ' HD11 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -140.69 174.99 9.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 1.0 109.917 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -152.41 160.77 43.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.479 -0.763 . . . . 1.0 109.505 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.16 148.69 52.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.139 -0.976 . . . . 1.0 109.668 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -158.66 121.14 3.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 1.0 109.571 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.425 HD11 ' C ' ' A' ' 101' ' ' THR . 2.7 tp -107.44 141.06 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 1.0 109.412 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.516 ' O ' ' CB ' ' A' ' 99' ' ' SER . 0.5 OUTLIER -132.9 50.33 2.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 1.0 109.511 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 1.6 m 77.75 108.03 0.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.454 -0.779 . . . . 1.0 109.748 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 99' ' ' SER . 9.1 p30 44.25 41.28 4.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.493 -0.754 . . . . 1.0 110.364 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.485 ' HB ' ' CD2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -158.91 79.32 0.77 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.971 -1.08 . . . . 1.0 109.77 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.502 ' CB ' ' HB2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -82.09 119.14 23.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.944 . . . . 1.0 109.131 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.512 HG11 ' CB ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -122.41 161.18 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.214 -0.929 . . . . 1.0 109.528 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.484 ' CD1' HD13 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -129.67 121.9 27.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.463 -0.773 . . . . 1.0 109.388 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.459 ' O ' HD11 ' A' ' 106' ' ' ILE . 0.7 OUTLIER -99.59 139.47 35.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 1.0 109.28 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.495 ' CG2' ' O ' ' A' ' 92' ' ' THR . 2.9 mm -133.12 96.71 17.27 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 1.0 109.956 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.522 ' O ' ' CD2' ' A' ' 108' ' ' LEU . 34.7 Cg_endo -76.25 108.19 2.62 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.349 2.033 . . . . 1.0 109.738 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.522 ' CD2' ' O ' ' A' ' 107' ' ' PRO . 0.4 OUTLIER -144.56 165.48 27.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 1.0 110.247 -179.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.452 ' HB3' ' HA ' ' A' ' 58' ' ' PRO . 0.8 OUTLIER -131.6 66.71 78.82 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.489 -0.757 . . . . 1.0 109.205 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.508 ' HB3' ' CG ' ' A' ' 114' ' ' MET . 36.7 Cg_endo -81.06 42.33 1.32 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.652 2.235 . . . . 1.0 110.635 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.516 ' CB ' ' O ' ' A' ' 55' ' ' GLU . 1.5 mp0 -93.83 -0.35 55.83 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.023 -1.048 . . . . 1.0 109.665 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.502 ' O ' ' CB ' ' A' ' 113' ' ' SER . 0.6 OUTLIER -108.24 -51.82 2.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.107 -0.996 . . . . 1.0 109.278 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.3 OUTLIER 164.79 97.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 1.0 109.237 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.508 ' CG ' ' HB3' ' A' ' 110' ' ' PRO . 5.4 ptm -162.39 133.46 5.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.146 -0.972 . . . . 1.0 109.972 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.463 ' HG3' ' HB2' ' A' ' 49' ' ' GLN . 14.2 ttp180 -112.25 131.85 55.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.205 -0.935 . . . . 1.0 109.21 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -120.54 117.28 27.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 1.0 109.512 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.515 HG11 ' CG2' ' A' ' 47' ' ' ILE . 5.1 m -92.83 135.8 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.296 -0.878 . . . . 1.0 109.371 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.453 ' O ' ' HB2' ' A' ' 45' ' ' HIS . 7.8 mt -112.75 116.52 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.216 -0.927 . . . . 1.0 109.549 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 17.3 p30 -156.88 52.35 0.5 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 1.0 109.477 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.458 ' HB3' ' HA ' ' A' ' 84' ' ' ILE . 0.8 OUTLIER -135.54 53.5 1.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -0.872 . . . . 1.0 109.5 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.479 ' HB1' ' CD2' ' A' ' 82' ' ' HIS . . . -139.84 175.95 9.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.842 . . . . 1.0 109.338 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.525 ' O ' ' CG2' ' A' ' 81' ' ' VAL . . . -143.69 -178.04 19.12 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.376 -1.49 . . . . 1.0 109.376 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.571 HD12 ' CD2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -117.75 158.73 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.177 -1.19 . . . . 1.0 109.131 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.57 147.69 47.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 1.0 109.425 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.475 ' HG2' ' N ' ' A' ' 126' ' ' LEU . 1.7 ttpm? -116.83 154.88 29.96 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.238 -0.914 . . . . 1.0 109.425 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.58 HD22 ' CG ' ' A' ' 78' ' ' PHE . 14.8 mt -79.85 125.58 29.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -0.882 . . . . 1.0 109.354 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.72 -41.06 79.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 1.0 109.599 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.493 ' O ' ' CB ' ' A' ' 129' ' ' SER . 14.0 p30 -179.95 -165.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 1.0 109.547 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 128' ' ' ASN . 1.5 p 74.55 -152.87 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 1.0 109.518 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.49 ' N ' ' OG ' ' A' ' 129' ' ' SER . 2.3 t70 -179.7 66.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 1.0 109.405 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.518 HG12 ' CD2' ' A' ' 133' ' ' LEU . 1.5 tt -67.08 151.32 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.311 -0.868 . . . . 1.0 109.504 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -122.85 92.45 3.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.888 . . . . 1.0 109.393 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.518 ' CD2' HG12 ' A' ' 131' ' ' ILE . 1.6 mm? -87.86 16.98 5.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.369 -0.832 . . . . 1.0 109.558 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.467 ' HB2' ' NH2' ' A' ' 134' ' ' ARG . 0.0 OUTLIER 174.94 88.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.202 -0.936 . . . . 1.0 109.477 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -170.79 104.4 0.25 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.261 -0.899 . . . . 1.0 109.533 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.93 -65.62 2.24 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.487 -1.445 . . . . 1.0 109.487 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 137' ' ' GLU . 11.8 pt-20 -110.88 120.02 41.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -1.13 . . . . 1.0 109.48 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -85.28 127.41 34.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 1.0 109.512 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.42 -76.84 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.279 -0.888 . . . . 1.0 109.448 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 7.2 pt -153.34 20.62 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.166 -0.958 . . . . 1.0 109.585 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 158.46 -167.4 34.55 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.666 -1.374 . . . . 1.0 109.666 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -154.96 151.68 28.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.354 -1.086 . . . . 1.0 109.308 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -148.25 139.89 23.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.183 -0.948 . . . . 1.0 109.822 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 174' ' ' CYS . 73.7 m-80 -109.72 107.5 17.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.33 -0.856 . . . . 1.0 109.192 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 174' ' ' CYS . 74.8 p -148.19 43.85 1.05 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.292 -0.963 . . . . 1.0 110.354 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.522 ' O ' ' CD ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -157.13 124.39 5.23 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.381 -0.824 . . . . 1.0 110.204 179.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.58 ' CG1' ' NE2' ' A' ' 76' ' ' HIS . 13.9 m -137.48 165.55 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.248 -0.907 . . . . 1.0 108.803 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 170' ' ' ASN . 0.0 OUTLIER -155.46 139.14 16.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.054 -1.029 . . . . 1.0 110.14 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.491 ' CD2' HD11 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -99.75 101.01 12.04 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.385 -0.822 . . . . 1.0 108.875 179.405 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.454 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 21.5 t -77.16 140.88 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.933 . . . . 1.0 109.692 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.57 ' CZ ' HD23 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -136.66 111.16 8.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.277 -0.89 . . . . 1.0 109.484 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.487 ' HD3' ' NE2' ' A' ' 166' ' ' GLN . 12.6 ptt180 -144.22 133.16 22.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.884 -1.135 . . . . 1.0 109.922 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.3 p -109.53 127.89 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.53 -0.915 . . . . 1.0 108.53 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.498 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 51.0 m-70 -123.17 114.1 19.84 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.199 -0.938 . . . . 1.0 110.132 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.529 ' CG1' HG23 ' A' ' 162' ' ' THR . 11.4 p -99.4 141.12 22.27 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.242 -0.911 . . . . 1.0 108.938 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.513 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 33.9 Cg_endo -75.93 117.0 4.56 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.294 1.996 . . . . 1.0 110.561 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.507 ' NE2' ' HD2' ' A' ' 158' ' ' PRO . 4.1 mm100 -154.83 168.92 11.07 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.312 -0.867 . . . . 1.0 109.116 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.507 ' HD2' ' NE2' ' A' ' 157' ' ' GLN . 34.4 Cg_endo -77.2 -65.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.326 2.017 . . . . 1.0 110.25 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.4 104.54 0.79 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.193 -0.942 . . . . 1.0 109.191 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -46.45 -28.1 3.22 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.465 -1.454 . . . . 1.0 109.465 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.4 mtt-85 -79.22 79.64 5.63 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.37 -1.076 . . . . 1.0 108.259 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.558 ' CG2' ' N ' ' A' ' 163' ' ' LEU . 1.3 m -140.04 -90.04 0.18 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.441 -0.787 . . . . 1.0 109.15 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.558 ' N ' ' CG2' ' A' ' 162' ' ' THR . 8.9 tp -140.34 97.9 3.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.958 -1.089 . . . . 1.0 108.986 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.498 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -163.3 94.81 0.82 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.084 -1.01 . . . . 1.0 109.408 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.519 ' N ' ' CD2' ' A' ' 165' ' ' LEU . 1.8 pt? -138.37 175.32 9.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 1.0 109.984 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.487 ' NE2' ' HD3' ' A' ' 152' ' ' ARG . 0.7 OUTLIER -119.22 161.84 19.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.434 -0.791 . . . . 1.0 109.843 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.48 ' N ' ' O ' ' A' ' 151' ' ' PHE . 41.5 t -151.74 74.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.448 -0.782 . . . . 1.0 109.036 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.48 102.86 15.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.093 -1.004 . . . . 1.0 109.104 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 t -143.41 88.68 2.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.917 . . . . 1.0 110.057 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.513 ' N ' ' HD3' ' A' ' 171' ' ' PRO . 1.1 m-20 -179.69 60.6 0.11 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 1.0 109.341 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' A' ' 170' ' ' ASN . 36.4 Cg_endo -78.67 96.91 1.1 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.383 2.056 . . . . 1.0 111.011 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.53 ' HB ' ' CG2' ' A' ' 147' ' ' VAL . 1.6 mt -101.53 147.05 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.166 -0.959 . . . . 1.0 108.679 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.56 119.6 37.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.088 -1.007 . . . . 1.0 110.132 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.53 ' O ' ' CB ' ' A' ' 175' ' ' SER . 2.8 m -95.06 -167.71 1.68 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.9 -1.148 . . . . 1.0 107.9 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.53 ' CB ' ' O ' ' A' ' 174' ' ' CYS . 3.3 p 165.18 -94.78 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.215 -0.928 . . . . 1.0 109.837 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.506 ' CG ' ' O ' ' A' ' 175' ' ' SER . 31.5 mt-30 -157.74 -150.63 0.27 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.961 -1.087 . . . . 1.0 109.491 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.415 ' CG ' ' O ' ' A' ' 176' ' ' GLN . 0.8 OUTLIER -177.3 83.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.327 -0.858 . . . . 1.0 109.512 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.995 -1.002 . . . . 1.0 109.409 -179.955 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.248 0.547 . . . . 1.0 109.555 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.457 ' HB2' HD13 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -79.75 -179.72 7.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.18 -0.95 . . . . 1.0 109.426 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -133.35 -91.7 0.36 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 1.0 109.349 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.611 ' CD1' ' N ' ' A' ' 5' ' ' GLN . 40.1 p90 -87.06 -45.68 10.51 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.248 -0.908 . . . . 1.0 109.569 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.611 ' N ' ' CD1' ' A' ' 4' ' ' TRP . 0.6 OUTLIER -178.95 77.35 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.234 -0.916 . . . . 1.0 109.515 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.499 ' C ' ' CD2' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -64.48 160.63 49.95 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.27 -0.894 . . . . 1.0 109.96 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 6' ' ' LEU . 35.7 Cg_endo -78.92 124.55 6.2 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.303 2.002 . . . . 1.0 110.366 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.0 p -129.33 45.81 2.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 1.0 109.501 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.507 ' O ' ' CB ' ' A' ' 10' ' ' SER . 2.9 p-80 -99.92 157.88 16.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.926 . . . . 1.0 109.328 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 9' ' ' HIS . 4.3 t 75.36 83.94 0.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 1.0 109.354 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.31 -87.2 0.06 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.76 -1.336 . . . . 1.0 109.76 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.29 172.04 16.01 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.501 2.134 . . . . 1.0 110.613 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.576 ' CZ ' ' O ' ' A' ' 162' ' ' THR . 5.8 m-85 -67.82 152.11 46.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.872 . . . . 1.0 109.277 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.28 129.72 13.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.918 -1.114 . . . . 1.0 109.855 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 15' ' ' LEU . 58.4 tp -121.04 75.02 1.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.42 155.27 33.82 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.44 -0.787 . . . . 1.0 109.982 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.498 HG22 ' NE2' ' A' ' 20' ' ' GLN . 0.6 OUTLIER -66.81 145.8 13.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.532 -0.914 . . . . 1.0 108.532 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.505 ' HB2' ' NE2' ' A' ' 49' ' ' GLN . 3.8 tp10 -72.51 -53.52 11.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 1.0 109.749 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.4 HG21 ' HG3' ' A' ' 18' ' ' GLU . 21.7 t -127.99 142.04 44.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.262 -0.899 . . . . 1.0 109.618 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.498 ' NE2' HG22 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -120.58 82.49 33.36 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 1.0 109.354 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 22' ' ' LYS . 35.0 Cg_endo -77.72 -177.53 3.92 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.436 2.09 . . . . 1.0 110.376 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 21' ' ' PRO . 12.7 mttt -43.86 112.69 0.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.37 -0.831 . . . . 1.0 109.227 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.53 ' HB3' ' CG ' ' A' ' 171' ' ' PRO . 2.1 t -110.24 29.64 7.48 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.198 -0.939 . . . . 1.0 109.89 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -103.21 165.9 10.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 1.0 109.476 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.578 ' CE1' ' HA ' ' A' ' 38' ' ' VAL . 76.6 t60 -157.21 118.07 3.6 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.516 -0.74 . . . . 1.0 109.894 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.451 ' O ' ' HD2' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -90.98 89.17 7.32 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.408 -0.807 . . . . 1.0 108.881 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' A' ' 28' ' ' HIS . . . -54.49 118.5 4.21 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.172 -0.955 . . . . 1.0 109.395 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.412 ' C ' ' O ' ' A' ' 27' ' ' ALA . 17.1 m170 -42.21 156.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.421 -0.799 . . . . 1.0 109.946 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.427 ' O ' ' C ' ' A' ' 30' ' ' GLU . 76.8 m-85 -132.65 -92.77 0.37 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.373 -0.83 . . . . 1.0 109.219 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 29' ' ' TYR . 1.1 mt-10 42.89 -154.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.271 -0.893 . . . . 1.0 109.757 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.6 p -144.09 35.47 1.23 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.36 -0.837 . . . . 1.0 109.316 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.12 72.9 1.52 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.341 -0.85 . . . . 1.0 109.473 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.07 120.97 0.03 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.55 -1.42 . . . . 1.0 109.55 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.4 m -69.85 -87.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -1.166 . . . . 1.0 109.463 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.29 -168.61 0.16 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.949 . . . . 1.0 109.465 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.43 147.09 17.42 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.496 -1.441 . . . . 1.0 109.496 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.466 ' HB3' ' CA ' ' A' ' 122' ' ' GLY . . . -139.49 171.4 14.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -1.195 . . . . 1.0 109.665 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.578 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 1.7 p -73.33 121.49 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.418 -0.801 . . . . 1.0 109.372 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -153.23 110.58 3.51 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.307 -0.871 . . . . 1.0 109.506 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 44' ' ' GLY . . . -165.17 150.31 9.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.373 -0.829 . . . . 1.0 109.563 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 40' ' ' ALA . 80.6 p 43.78 -118.08 0.55 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 1.0 109.39 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.6 57.47 4.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.304 -1.498 . . . . 1.0 109.524 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' A' ' 119' ' ' ASP . . . 88.25 -19.14 36.96 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.568 -1.413 . . . . 1.0 109.568 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 40' ' ' ALA . . . 116.41 -71.03 0.27 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.582 -1.407 . . . . 1.0 109.582 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.429 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 21.9 m80 -60.11 154.25 51.88 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.249 -1.148 . . . . 1.0 109.578 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.45 ' HB2' HG22 ' A' ' 17' ' ' ILE . 35.5 Cg_endo -78.09 178.7 7.27 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.492 2.128 . . . . 1.0 110.472 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.514 ' CG2' HG11 ' A' ' 117' ' ' VAL . 2.3 mm -94.53 160.87 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 1.0 109.266 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.8 t -135.81 127.3 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.234 -0.916 . . . . 1.0 109.732 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.521 ' HG3' ' CE1' ' A' ' 51' ' ' HIS . 14.2 pt20 -151.17 142.14 23.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.339 -0.851 . . . . 1.0 109.348 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 110' ' ' PRO . 1.3 tt -98.62 138.99 35.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 1.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.521 ' CE1' ' HG3' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -140.78 76.23 1.54 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.169 -0.957 . . . . 1.0 109.331 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 53' ' ' TYR . . . 171.05 96.03 0.1 Allowed Glycine 0 N--CA 1.486 2.01 0 N-CA-C 110.038 -1.225 . . . . 1.0 110.038 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.634 ' CE2' ' CB ' ' A' ' 55' ' ' GLU . 6.2 t80 178.02 129.01 0.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -1.14 . . . . 1.0 109.425 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.92 13.74 32.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 1.0 109.394 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.634 ' CB ' ' CE2' ' A' ' 53' ' ' TYR . 0.7 OUTLIER -116.8 144.49 44.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 1.0 109.432 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.421 ' OD1' ' O ' ' A' ' 56' ' ' ASN . 5.9 p30 -101.83 50.85 0.84 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 1.0 109.472 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.488 ' C ' ' CD1' ' A' ' 109' ' ' LEU . 1.9 mp0 -108.89 146.0 32.88 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 1.0 109.458 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.524 ' O ' ' CD2' ' A' ' 59' ' ' LEU . 35.5 Cg_endo -77.96 145.99 22.8 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.441 2.094 . . . . 1.0 110.363 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.589 ' CD1' ' CD2' ' A' ' 163' ' ' LEU . 7.4 mt -139.27 162.76 34.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.262 -0.898 . . . . 1.0 109.51 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.458 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -98.34 110.42 23.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.315 -0.866 . . . . 1.0 109.534 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.526 ' CD2' ' HB2' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -60.77 143.45 54.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.257 -0.902 . . . . 1.0 109.312 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.489 ' N ' ' HG ' ' A' ' 61' ' ' LEU . 6.3 mm-40 -105.21 80.38 1.59 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.189 -0.945 . . . . 1.0 109.718 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.54 HD11 ' CE1' ' A' ' 151' ' ' PHE . 18.2 tp -99.94 121.43 41.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.303 -0.873 . . . . 1.0 109.129 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.485 ' CD1' ' C ' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -143.43 146.84 33.79 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 -179.434 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.517 ' CG2' ' O ' ' A' ' 65' ' ' ILE . 0.0 OUTLIER -109.23 115.63 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 1.0 108.779 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.525 ' CA ' ' O ' ' A' ' 74' ' ' ARG . . . -132.8 144.26 16.11 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.548 -1.311 . . . . 1.0 110.204 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.633 ' CG2' ' CD2' ' A' ' 76' ' ' HIS . 14.8 p -71.2 161.44 31.09 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.525 -0.985 . . . . 1.0 108.959 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.521 ' CB ' ' HG3' ' A' ' 148' ' ' ARG . . . -172.52 124.72 0.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.129 -0.982 . . . . 1.0 109.77 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.6 -13.42 24.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -0.881 . . . . 1.0 109.16 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -156.08 -67.34 0.11 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.352 -0.843 . . . . 1.0 109.357 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.553 ' CD ' ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -144.82 -39.18 0.26 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 1.0 109.67 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.553 ' N ' ' CD ' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -51.84 88.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.41 -0.806 . . . . 1.0 109.848 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 71' ' ' ARG . 2.3 pp -66.63 143.9 56.72 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.26 -0.9 . . . . 1.0 109.59 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.525 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -152.87 165.44 17.59 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.158 -0.964 . . . . 1.0 109.452 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.51 146.03 24.03 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.414 2.076 . . . . 1.0 110.211 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.633 ' CD2' ' CG2' ' A' ' 67' ' ' THR . 0.7 OUTLIER -76.87 160.54 29.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 1.0 109.656 -179.743 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.81 -67.09 0.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -0.866 . . . . 1.0 109.786 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -130.83 23.56 4.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.163 -0.96 . . . . 1.0 109.934 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.571 ' HB2' ' CG ' ' A' ' 76' ' ' HIS . 4.8 m-85 -101.46 74.26 1.52 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.054 -1.029 . . . . 1.0 109.418 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.493 ' CB ' ' HB3' ' A' ' 102' ' ' LYS . 11.0 pt20 -139.49 7.46 2.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.163 -0.96 . . . . 1.0 109.669 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.518 ' CG2' ' O ' ' A' ' 122' ' ' GLY . 1.3 m -60.91 140.58 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.092 -1.005 . . . . 1.0 109.067 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.57 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 1.0 OUTLIER -176.3 114.05 0.11 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.092 -1.043 . . . . 1.0 109.791 -179.612 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.2 OUTLIER -136.74 126.32 25.29 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.215 -0.928 . . . . 1.0 109.557 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.462 ' HA ' ' HB3' ' A' ' 120' ' ' CYS . 4.4 mp -99.68 137.43 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.256 -0.903 . . . . 1.0 109.628 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 86' ' ' GLY . 39.9 p -145.05 -149.27 0.27 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.403 -0.811 . . . . 1.0 109.137 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 85' ' ' THR . . . 42.1 -165.46 0.02 OUTLIER Glycine 0 N--CA 1.483 1.787 0 N-CA-C 110.083 -1.207 . . . . 1.0 110.083 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.61 68.54 3.42 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.239 -1.154 . . . . 1.0 109.541 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.8 -164.99 0.95 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 1.0 109.299 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.412 ' O ' ' OG ' ' A' ' 90' ' ' SER . 1.7 t -66.08 123.54 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.207 -0.933 . . . . 1.0 109.035 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 89' ' ' VAL . 3.5 m -165.53 31.64 0.05 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.499 -0.881 . . . . 1.0 109.668 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.488 HG21 ' N ' ' A' ' 92' ' ' THR . 9.8 t -64.96 -36.48 84.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.206 -0.934 . . . . 1.0 109.558 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.488 ' N ' HG21 ' A' ' 91' ' ' THR . 58.4 m -163.17 135.91 5.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.199 -0.938 . . . . 1.0 109.587 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -168.39 169.13 10.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -0.882 . . . . 1.0 109.56 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -155.22 145.63 22.01 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.844 . . . . 1.0 109.51 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.515 ' OE1' ' NE2' ' A' ' 82' ' ' HIS . 8.0 tt0 -114.58 146.11 41.17 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.305 -0.872 . . . . 1.0 109.428 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -142.82 122.36 13.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 1.0 109.367 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.489 HD12 ' N ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -135.55 134.95 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.239 -0.913 . . . . 1.0 109.475 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.521 ' CG ' ' O ' ' A' ' 98' ' ' LEU . 0.7 OUTLIER -138.49 64.82 1.48 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.064 -1.023 . . . . 1.0 109.675 -179.628 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.462 ' O ' ' OD1' ' A' ' 100' ' ' ASN . 1.7 p 62.29 117.44 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.894 . . . . 1.0 109.586 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 99' ' ' SER . 3.7 p-10 44.46 37.03 1.87 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.622 -0.674 . . . . 1.0 110.715 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.469 ' HB ' ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -159.32 85.16 0.79 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.972 -1.08 . . . . 1.0 109.401 179.248 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.493 ' HB3' ' CB ' ' A' ' 80' ' ' GLN . 6.0 tptm -105.91 95.02 5.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.892 . . . . 1.0 109.727 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.49 171.4 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.326 -0.859 . . . . 1.0 108.963 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.518 HD23 ' N ' ' A' ' 105' ' ' GLU . 0.5 OUTLIER -139.91 122.81 16.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 1.0 109.351 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.518 ' N ' HD23 ' A' ' 104' ' ' LEU . 7.1 mm-40 -123.1 140.14 53.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.303 -0.873 . . . . 1.0 109.292 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.443 ' CG2' ' O ' ' A' ' 92' ' ' THR . 28.1 mt -129.03 107.31 18.02 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 1.0 109.528 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.458 ' HA ' ' HA ' ' A' ' 60' ' ' MET . 34.6 Cg_endo -76.64 107.81 2.53 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.218 1.945 . . . . 1.0 110.35 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.405 ' HB2' ' HE3' ' A' ' 114' ' ' MET . 0.6 OUTLIER -146.0 165.18 29.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.876 . . . . 1.0 109.752 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.517 ' CD2' ' O ' ' A' ' 109' ' ' LEU . 3.5 tt -117.07 85.84 19.06 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.408 -0.807 . . . . 1.0 109.451 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.441 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 37.1 Cg_endo -81.84 30.53 0.52 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.711 2.274 . . . . 1.0 111.199 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.523 ' OE1' ' CB ' ' A' ' 53' ' ' TYR . 9.7 mm-40 -102.96 49.95 0.82 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.842 -1.161 . . . . 1.0 109.512 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 113' ' ' SER . 0.6 OUTLIER -161.78 -61.63 0.05 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.216 -0.928 . . . . 1.0 109.478 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 6.1 p 167.8 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.324 -0.86 . . . . 1.0 109.19 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.405 ' HE3' ' HB2' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -155.14 125.23 6.66 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.235 -0.915 . . . . 1.0 109.616 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 -94.61 129.78 41.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 1.0 109.191 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.36 99.71 8.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.318 -0.864 . . . . 1.0 109.518 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.514 HG11 ' CG2' ' A' ' 47' ' ' ILE . 4.4 m -86.85 143.28 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 1.0 109.425 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.429 ' O ' ' HB2' ' A' ' 45' ' ' HIS . 2.7 mt -133.29 123.86 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.891 . . . . 1.0 109.552 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.449 ' HB2' ' HA3' ' A' ' 43' ' ' GLY . 8.3 p-10 -175.28 46.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 1.0 109.566 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.462 ' HB3' ' HA ' ' A' ' 84' ' ' ILE . 9.9 m -132.95 43.45 2.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 1.0 109.565 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.511 ' HB3' ' CB ' ' A' ' 82' ' ' HIS . . . -134.42 128.29 33.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.253 -0.905 . . . . 1.0 109.13 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.518 ' O ' ' CG2' ' A' ' 81' ' ' VAL . . . -93.51 -172.08 39.6 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.395 -1.482 . . . . 1.0 109.395 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.44 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 0.6 OUTLIER -125.48 166.92 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.363 -1.081 . . . . 1.0 108.818 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.413 HD11 ' O ' ' A' ' 123' ' ' ILE . 0.8 OUTLIER -140.94 164.45 30.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.905 . . . . 1.0 109.622 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 41.6 mttt -147.49 97.04 2.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.383 -0.823 . . . . 1.0 109.096 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.576 ' N ' ' CD2' ' A' ' 126' ' ' LEU . 0.5 OUTLIER -104.99 -165.67 1.15 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 1.0 109.753 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.513 ' HG3' ' N ' ' A' ' 128' ' ' ASN . 6.9 ptt180 -166.14 -147.69 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.407 -0.808 . . . . 1.0 109.172 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.513 ' N ' ' HG3' ' A' ' 127' ' ' ARG . 0.5 OUTLIER 64.3 57.1 1.24 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.127 -0.983 . . . . 1.0 109.578 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 66.4 p 178.95 -167.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 1.0 109.426 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.19 60.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 1.0 109.426 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.449 ' O ' ' CG1' ' A' ' 131' ' ' ILE . 0.3 OUTLIER -93.88 69.99 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.313 -0.867 . . . . 1.0 109.504 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.427 ' OE1' ' O ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -154.67 161.58 41.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.219 -0.925 . . . . 1.0 109.479 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.406 ' O ' ' HG2' ' A' ' 135' ' ' LYS . 0.4 OUTLIER -64.94 110.42 2.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -0.945 . . . . 1.0 109.481 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.93 119.3 8.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.28 -0.887 . . . . 1.0 109.48 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.406 ' HG2' ' O ' ' A' ' 133' ' ' LEU . 0.9 OUTLIER 173.99 174.77 0.16 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 1.0 109.437 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.58 125.34 28.49 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.601 -1.4 . . . . 1.0 109.601 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -111.53 16.53 20.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.252 -1.146 . . . . 1.0 109.445 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 20.3 p -100.17 139.63 35.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 1.0 109.445 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.421 ' C ' HG21 ' A' ' 140' ' ' ILE . 1.7 m-20 -153.81 -39.33 0.1 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.923 . . . . 1.0 109.402 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.52 ' N ' ' CD1' ' A' ' 140' ' ' ILE . 0.2 OUTLIER -142.83 30.06 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.315 -0.865 . . . . 1.0 109.424 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 166.83 -132.07 2.52 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.563 -1.415 . . . . 1.0 109.563 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.9 ttm-85 -150.93 -41.71 0.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -1.161 . . . . 1.0 109.468 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -104.0 134.9 46.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 1.0 109.43 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -113.9 141.81 46.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 1.0 109.492 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.526 ' CB ' ' HB2' ' A' ' 174' ' ' CYS . 0.2 OUTLIER -157.59 53.02 0.47 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.245 -0.909 . . . . 1.0 109.394 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.463 ' HD2' ' O ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -105.04 157.38 17.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.886 . . . . 1.0 109.254 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.506 HG11 ' NE2' ' A' ' 76' ' ' HIS . 1.6 m -140.49 168.25 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.382 -0.823 . . . . 1.0 109.406 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.525 ' HG2' ' CB ' ' A' ' 170' ' ' ASN . 5.2 mmt180 -148.82 99.32 2.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 1.0 109.563 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.526 HD11 ' CD2' ' A' ' 151' ' ' PHE . 0.7 OUTLIER -79.77 115.93 19.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.104 -0.997 . . . . 1.0 108.889 179.635 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 4.3 t -87.09 114.43 26.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.204 -0.935 . . . . 1.0 109.87 -179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.54 ' CE1' HD11 ' A' ' 63' ' ' LEU . 1.6 m-85 -108.39 113.33 26.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 1.0 109.228 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 5.4 ptt180 -150.6 159.41 44.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.899 -1.126 . . . . 1.0 109.95 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 10.4 p -143.41 128.51 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.281 -0.887 . . . . 1.0 108.659 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.504 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 20.9 m-70 -132.46 113.63 13.35 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.073 -1.017 . . . . 1.0 110.372 -179.077 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.534 ' CG1' ' HB3' ' A' ' 163' ' ' LEU . 12.6 p -99.04 141.85 23.6 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 108.556 -0.905 . . . . 1.0 108.556 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.533 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 32.0 Cg_endo -73.64 115.88 4.49 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.093 1.862 . . . . 1.0 110.881 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.456 ' HB2' ' HD2' ' A' ' 158' ' ' PRO . 1.6 pm0 -133.14 160.94 66.66 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.456 ' HD2' ' HB2' ' A' ' 157' ' ' GLN . 34.9 Cg_endo -77.56 -66.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.305 2.003 . . . . 1.0 110.675 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.5 t -59.38 -93.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 1.0 109.621 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 171.38 -33.91 0.15 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.412 -1.475 . . . . 1.0 109.412 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -79.08 80.3 5.44 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.92 -1.141 . . . . 1.0 107.92 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.576 ' O ' ' CZ ' ' A' ' 13' ' ' TYR . 1.3 m -138.9 -90.17 0.2 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.509 -0.744 . . . . 1.0 109.486 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.589 ' CD2' ' CD1' ' A' ' 59' ' ' LEU . 7.4 tp -146.96 109.19 4.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.58 -1.325 . . . . 1.0 109.615 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.504 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.0 OUTLIER -162.94 91.49 0.73 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.035 -1.041 . . . . 1.0 109.38 178.793 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 165' ' ' LEU . 0.2 OUTLIER -120.64 155.46 33.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.345 -0.847 . . . . 1.0 109.495 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.464 ' HA ' ' CB ' ' A' ' 152' ' ' ARG . 3.5 tt0 -134.16 142.34 47.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.163 -0.96 . . . . 1.0 109.568 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 168' ' ' ALA . 46.3 t -146.07 161.28 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 1.0 109.398 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.467 ' N ' ' CG1' ' A' ' 167' ' ' VAL . . . -151.29 92.71 1.82 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.389 -0.82 . . . . 1.0 108.847 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.437 ' HB2' HD13 ' A' ' 149' ' ' LEU . 20.4 m -82.93 160.43 22.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.954 . . . . 1.0 109.632 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.525 ' CB ' ' HG2' ' A' ' 148' ' ' ARG . 0.7 OUTLIER -174.51 63.04 0.25 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.162 -0.961 . . . . 1.0 110.059 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.53 ' CG ' ' HB3' ' A' ' 23' ' ' SER . 37.5 Cg_endo -83.23 52.04 3.81 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.477 2.118 . . . . 1.0 110.296 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 13.0 mt -151.06 128.02 2.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.456 -0.778 . . . . 1.0 109.534 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -155.86 102.29 2.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 1.0 109.362 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.526 ' HB2' ' CB ' ' A' ' 145' ' ' THR . 61.0 m -89.94 174.47 7.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 1.0 109.579 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.424 ' HB3' ' O ' ' A' ' 174' ' ' CYS . 5.9 p 178.89 -149.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 1.0 109.356 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -50.53 -22.58 2.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 1.0 109.506 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 23.7 ttt-85 -50.68 -76.06 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -0.872 . . . . 1.0 109.475 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.021 -0.99 . . . . 1.0 109.412 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.454 ' O ' ' O ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.226 0.536 . . . . 1.0 109.594 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' A' ' 1' ' ' MET . 0.1 OUTLIER 46.14 -170.16 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.175 -0.953 . . . . 1.0 109.241 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.461 ' HB2' HD13 ' A' ' 6' ' ' LEU . 90.1 m-20 -135.45 -95.36 0.26 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.112 -0.992 . . . . 1.0 109.603 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.556 ' CE3' ' HB3' ' A' ' 5' ' ' GLN . 44.4 p-90 -115.27 -49.31 2.77 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.009 -1.057 . . . . 1.0 109.704 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.556 ' HB3' ' CE3' ' A' ' 4' ' ' TRP . 4.8 tt0 -179.22 75.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.122 -0.986 . . . . 1.0 109.634 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.582 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -164.37 160.28 16.09 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 1.0 109.692 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 6' ' ' LEU . 36.0 Cg_endo -79.49 102.66 1.51 Allowed 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.438 2.092 . . . . 1.0 110.323 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.436 ' HB3' ' CD2' ' A' ' 6' ' ' LEU . 38.4 p -125.74 43.5 3.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 1.0 109.517 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -127.99 164.6 21.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 1.0 109.434 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 m -179.43 118.95 0.07 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.318 -0.864 . . . . 1.0 109.522 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.9 -144.87 1.07 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.425 -1.47 . . . . 1.0 109.425 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.52 -175.3 2.61 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.395 2.063 . . . . 1.0 110.293 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.473 ' HA ' ' HA3' ' A' ' 52' ' ' GLY . 3.6 m-85 -105.5 137.95 42.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.152 -0.967 . . . . 1.0 109.63 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.453 ' CG ' ' O ' ' A' ' 13' ' ' TYR . 1.6 mt-10 179.72 139.16 0.12 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 1.0 109.764 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.489 ' O ' ' CG ' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -99.87 98.82 9.57 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.291 -0.881 . . . . 1.0 109.055 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -99.96 155.14 17.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.191 -0.943 . . . . 1.0 109.768 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.491 ' CG2' ' NE2' ' A' ' 20' ' ' GLN . 12.7 mm -72.95 134.44 29.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.398 -0.813 . . . . 1.0 109.266 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.426 ' HB2' ' CD ' ' A' ' 49' ' ' GLN . 44.2 tt0 -68.89 -55.1 12.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.137 -0.977 . . . . 1.0 108.967 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.455 HG21 ' HD3' ' A' ' 21' ' ' PRO . 9.8 p -118.58 130.22 73.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.376 -0.827 . . . . 1.0 108.871 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.491 ' NE2' ' CG2' ' A' ' 17' ' ' ILE . 9.2 tp-100 -129.94 63.97 70.51 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.08 -1.012 . . . . 1.0 110.023 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.506 ' O ' ' N ' ' A' ' 23' ' ' SER . 35.8 Cg_endo -78.44 -175.34 2.67 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.406 2.07 . . . . 1.0 109.88 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -48.45 94.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.917 . . . . 1.0 108.78 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 21' ' ' PRO . 1.4 p -94.02 40.24 1.08 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.25 -0.906 . . . . 1.0 110.252 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.46 ' HA ' HG12 ' A' ' 172' ' ' ILE . 0.0 OUTLIER -99.49 167.25 10.73 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.969 -1.082 . . . . 1.0 108.284 179.205 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.635 ' CD2' ' CD1' ' A' ' 123' ' ' ILE . 16.0 t60 -133.7 134.03 42.57 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 119.341 -0.944 . . . . 1.0 110.068 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.459 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -106.1 75.73 1.12 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 179.356 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.57 ' O ' ' CE2' ' A' ' 29' ' ' TYR . . . -54.2 165.05 0.56 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.47 -0.769 . . . . 1.0 109.79 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -60.99 149.73 35.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.385 -0.822 . . . . 1.0 110.289 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.576 ' CD1' HG23 ' A' ' 31' ' ' THR . 0.1 OUTLIER -166.51 69.32 0.11 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER 78.37 28.1 0.49 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.553 -0.717 . . . . 1.0 109.397 -179.621 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.576 HG23 ' CD1' ' A' ' 29' ' ' TYR . 15.4 t -145.49 59.77 1.27 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 1.0 109.272 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.9 156.13 17.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 1.0 109.738 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.58 -35.73 0.03 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.516 -1.434 . . . . 1.0 109.516 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.09 149.28 34.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -1.123 . . . . 1.0 109.446 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 mmm-85 -75.07 121.85 22.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -0.893 . . . . 1.0 109.475 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.408 ' O ' ' HB1' ' A' ' 37' ' ' ALA . . . -139.54 -134.97 3.2 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.571 -1.412 . . . . 1.0 109.571 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 36' ' ' GLY . . . -179.04 171.85 1.33 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -1.155 . . . . 1.0 109.434 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.497 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 1.8 p -57.03 135.4 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 1.0 109.34 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.06 115.26 4.1 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.417 -0.802 . . . . 1.0 109.698 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 42' ' ' ALA . . . -156.5 114.84 3.33 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.509 -0.745 . . . . 1.0 109.548 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 50.91 -88.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.473 -0.767 . . . . 1.0 110.085 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.517 ' N ' ' O ' ' A' ' 40' ' ' ALA . . . -85.03 46.25 1.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.099 -1.0 . . . . 1.0 109.832 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.39 9.32 42.62 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.887 -1.285 . . . . 1.0 109.887 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 135.71 -80.06 0.31 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.643 -1.383 . . . . 1.0 109.643 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -88.36 157.53 50.15 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.317 -1.108 . . . . 1.0 109.672 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.453 ' HG3' ' OE1' ' A' ' 20' ' ' GLN . 35.8 Cg_endo -78.41 178.74 7.21 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.601 2.201 . . . . 1.0 110.528 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.521 HG22 ' CG1' ' A' ' 117' ' ' VAL . 5.0 mt -94.45 157.05 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.481 -0.762 . . . . 1.0 109.199 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.57 HG22 ' CZ ' ' A' ' 151' ' ' PHE . 2.1 t -131.66 128.1 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.207 -0.933 . . . . 1.0 109.829 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.426 ' CD ' ' HB2' ' A' ' 18' ' ' GLU . 7.1 pt20 -140.95 138.17 33.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 1.0 109.353 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.466 ' HG ' ' HB3' ' A' ' 15' ' ' LEU . 2.7 tt -98.2 136.68 38.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 1.0 109.75 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -140.52 97.98 3.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.333 -0.854 . . . . 1.0 109.16 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.473 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . -178.89 -86.5 0.07 OUTLIER Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.631 -1.271 . . . . 1.0 110.133 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.514 ' OH ' ' NE2' ' A' ' 157' ' ' GLN . 0.8 OUTLIER -38.37 121.86 1.03 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 122.1 -0.647 . . . . 1.0 110.345 -179.414 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.85 1.72 37.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.361 -0.837 . . . . 1.0 109.538 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -79.82 145.66 32.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.148 -0.97 . . . . 1.0 109.423 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.431 ' ND2' ' C ' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -84.61 44.68 1.07 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 1.0 109.824 -179.683 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.461 ' O ' HD21 ' A' ' 109' ' ' LEU . 5.1 mm-40 -99.23 150.59 36.86 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 1.0 109.304 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.447 ' HA ' HD22 ' A' ' 109' ' ' LEU . 36.0 Cg_endo -77.68 139.48 17.95 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.306 2.004 . . . . 1.0 110.385 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.442 HD13 ' OE2' ' A' ' 111' ' ' GLU . 5.8 mt -128.26 159.04 36.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 1.0 109.452 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.432 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.3 OUTLIER -121.31 107.84 13.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.133 -0.979 . . . . 1.0 109.519 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.497 ' CD2' ' HB3' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -61.92 116.59 5.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.903 . . . . 1.0 109.543 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.42 ' O ' ' HG2' ' A' ' 152' ' ' ARG . 73.4 mm-40 -94.99 78.18 3.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.12 -0.988 . . . . 1.0 109.067 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.571 HD23 ' CE1' ' A' ' 151' ' ' PHE . 0.6 OUTLIER -112.85 157.84 20.9 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.377 -0.827 . . . . 1.0 109.714 -179.598 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.522 ' O ' ' CD2' ' A' ' 149' ' ' LEU . 0.2 OUTLIER -165.74 176.95 7.58 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 179.354 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.639 ' CD1' ' CE1' ' A' ' 76' ' ' HIS . 0.2 OUTLIER -114.75 118.6 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.109 -0.994 . . . . 1.0 108.862 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.44 150.28 19.64 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.611 -1.28 . . . . 1.0 110.06 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.621 ' CG2' ' CD2' ' A' ' 76' ' ' HIS . 0.6 OUTLIER -89.2 151.23 22.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.456 -1.026 . . . . 1.0 109.269 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.443 ' HB1' ' HD3' ' A' ' 148' ' ' ARG . . . -145.92 113.08 6.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.17 -0.956 . . . . 1.0 109.538 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.448 ' OD2' ' HB2' ' A' ' 144' ' ' ASN . 0.2 OUTLIER -85.2 -27.89 25.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.351 -0.843 . . . . 1.0 109.245 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -136.43 -52.48 0.71 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.302 -0.874 . . . . 1.0 109.311 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.5 OUTLIER -175.17 -34.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.9 . . . . 1.0 109.627 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 mt -55.9 91.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 1.0 109.74 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -47.39 166.64 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.224 -0.922 . . . . 1.0 109.474 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.466 ' HB2' ' HD2' ' A' ' 75' ' ' PRO . 5.1 ptm180 -175.15 162.03 2.3 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.901 . . . . 1.0 109.086 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 74' ' ' ARG . 34.3 Cg_endo -76.97 137.64 17.68 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.229 1.953 . . . . 1.0 110.334 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.639 ' CE1' ' CD1' ' A' ' 65' ' ' ILE . 0.1 OUTLIER -64.16 156.5 28.33 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.246 -0.909 . . . . 1.0 109.625 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.11 -78.72 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.323 -0.86 . . . . 1.0 109.663 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.445 ' CB ' HD13 ' A' ' 126' ' ' LEU . 80.2 m-85 -107.99 19.54 19.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 1.0 109.503 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.572 ' HB2' ' CD2' ' A' ' 76' ' ' HIS . 88.8 m-85 -111.57 112.25 23.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.903 . . . . 1.0 109.463 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.496 ' NE2' ' HD3' ' A' ' 102' ' ' LYS . 8.1 pt20 -167.32 30.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -0.845 . . . . 1.0 108.843 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 122' ' ' GLY . 31.3 m -52.94 158.6 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 121.62 0.724 . . . . 1.0 110.139 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.577 ' CD2' ' HG3' ' A' ' 95' ' ' GLU . 14.3 t60 -176.06 66.73 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.464 -0.773 . . . . 1.0 108.961 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.0 OUTLIER -113.38 157.99 21.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.873 . . . . 1.0 109.855 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.0 mp -130.34 156.75 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.413 -0.804 . . . . 1.0 108.991 179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.457 ' O ' ' OG1' ' A' ' 88' ' ' THR . 40.9 p -99.93 167.84 10.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.083 -1.011 . . . . 1.0 109.755 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -50.13 -75.98 0.18 Allowed Glycine 0 N--CA 1.478 1.437 0 N-CA-C 109.808 -1.317 . . . . 1.0 109.808 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 100.71 8.72 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.319 -1.107 . . . . 1.0 109.961 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 85' ' ' THR . 0.0 OUTLIER -165.32 -165.03 0.81 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.241 -0.912 . . . . 1.0 109.435 179.637 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' A' ' 89' ' ' VAL . 13.2 p -64.94 104.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.231 -0.918 . . . . 1.0 109.575 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.4 m -90.39 32.07 0.98 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 1.0 109.395 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 22.4 m -66.06 137.32 56.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 1.0 109.437 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.6 m -52.55 106.11 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 1.0 109.542 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.65 170.1 9.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -0.87 . . . . 1.0 109.603 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -155.26 161.03 41.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.342 -0.849 . . . . 1.0 109.392 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.577 ' HG3' ' CD2' ' A' ' 82' ' ' HIS . 0.5 OUTLIER -141.24 148.65 40.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 1.0 109.334 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -152.51 127.96 9.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 1.0 109.731 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.439 ' HB ' ' HD2' ' A' ' 102' ' ' LYS . 2.7 tp -106.29 142.55 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 1.0 109.346 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.522 ' O ' ' CB ' ' A' ' 99' ' ' SER . 0.6 OUTLIER -132.99 53.0 2.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.912 . . . . 1.0 109.787 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 1.6 m 77.08 104.17 0.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.327 -0.858 . . . . 1.0 110.021 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 99' ' ' SER . 9.0 p30 44.32 43.14 5.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.532 -0.73 . . . . 1.0 110.334 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.51 ' HB ' ' CD2' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -159.3 77.64 0.72 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.987 -1.071 . . . . 1.0 109.774 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.496 ' HD3' ' NE2' ' A' ' 80' ' ' GLN . 4.2 tptm -81.96 129.75 34.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.861 . . . . 1.0 109.003 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.445 ' HA ' ' HB2' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -128.1 169.58 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.157 -0.965 . . . . 1.0 109.861 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.57 HD12 ' CE1' ' A' ' 82' ' ' HIS . 0.2 OUTLIER -131.21 130.59 43.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.462 -0.774 . . . . 1.0 109.236 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -128.21 132.33 48.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -0.913 . . . . 1.0 109.683 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.564 ' CG2' ' CD2' ' A' ' 108' ' ' LEU . 5.3 mt -129.67 102.69 17.9 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 1.0 109.279 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 34.1 Cg_endo -75.43 98.4 1.17 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.196 1.93 . . . . 1.0 110.539 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.564 ' CD2' ' CG2' ' A' ' 106' ' ' ILE . 0.4 OUTLIER -145.23 165.33 28.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.376 -0.827 . . . . 1.0 109.41 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.461 HD21 ' O ' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -114.41 80.65 6.13 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 1.0 109.697 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.467 ' HA ' ' HB3' ' A' ' 114' ' ' MET . 36.3 Cg_endo -78.7 75.74 4.84 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.501 2.134 . . . . 1.0 110.268 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.459 ' HB3' ' O ' ' A' ' 53' ' ' TYR . 3.4 mt-10 -138.6 -49.3 0.53 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.267 -0.896 . . . . 1.0 109.603 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -79.89 -49.82 11.37 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.331 -0.855 . . . . 1.0 109.495 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.6 t -175.53 98.69 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.347 -0.846 . . . . 1.0 109.319 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.467 ' HB3' ' HA ' ' A' ' 110' ' ' PRO . 5.0 tpp -165.8 108.46 0.78 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 1.0 109.343 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -99.98 139.23 35.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.346 -0.846 . . . . 1.0 109.092 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.36 92.46 3.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -0.971 . . . . 1.0 109.547 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.521 ' CG1' HG22 ' A' ' 47' ' ' ILE . 3.5 m -91.78 128.34 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.225 -0.922 . . . . 1.0 109.322 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 99.1 mt -118.57 111.81 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.178 -0.951 . . . . 1.0 109.656 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -163.12 28.57 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 1.0 109.449 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 83' ' ' ARG . 4.2 p -116.38 42.89 2.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 1.0 109.347 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.75 164.43 28.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 1.0 109.478 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.523 ' O ' ' CG2' ' A' ' 81' ' ' VAL . . . -125.39 -173.77 13.76 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.904 -1.678 . . . . 1.0 108.904 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.635 ' CD1' ' CD2' ' A' ' 25' ' ' HIS . 0.9 OUTLIER -116.27 170.75 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.978 -1.307 . . . . 1.0 109.231 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -115.39 146.26 41.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 1.0 109.517 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.76 124.31 51.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 1.0 109.405 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.593 ' CD1' ' N ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -120.74 64.36 0.85 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.214 -0.929 . . . . 1.0 109.794 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 126' ' ' LEU . 1.5 mtt85 44.46 -93.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.852 . . . . 1.0 109.633 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -153.68 60.22 0.74 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.096 -1.003 . . . . 1.0 109.502 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 29.9 t -109.01 160.85 15.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.894 . . . . 1.0 109.537 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.92 64.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 1.0 109.48 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.506 ' O ' ' CG2' ' A' ' 131' ' ' ILE . 6.8 tt -68.0 117.65 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.905 . . . . 1.0 109.402 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -131.5 145.86 51.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -0.896 . . . . 1.0 109.515 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.94 125.68 51.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.319 -0.863 . . . . 1.0 109.508 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.49 ' O ' ' N ' ' A' ' 136' ' ' GLY . 0.0 OUTLIER -135.11 169.58 17.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 1.0 109.439 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.22 91.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.91 . . . . 1.0 109.42 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 134' ' ' ARG . . . 126.92 164.72 11.78 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.591 -1.403 . . . . 1.0 109.591 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -142.75 66.4 1.33 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.203 -1.175 . . . . 1.0 109.474 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 139' ' ' ASP . 72.9 p -127.52 21.6 6.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 1.0 109.472 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 138' ' ' THR . 6.5 m-20 61.7 132.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 1.0 109.443 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -110.7 -38.7 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.305 -0.872 . . . . 1.0 109.426 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 144.34 -148.05 19.61 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.494 -1.443 . . . . 1.0 109.494 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.2 32.06 1.23 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.197 -1.178 . . . . 1.0 109.509 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 144' ' ' ASN . 36.7 mmtm -89.82 -174.71 4.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.894 . . . . 1.0 109.372 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 143' ' ' LYS . 0.2 OUTLIER 58.12 133.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.514 0.673 . . . . 1.0 110.343 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.482 ' CB ' ' HB2' ' A' ' 174' ' ' CYS . 0.0 OUTLIER -160.23 53.86 0.33 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 1.0 109.43 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -93.91 154.83 17.49 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.121 -0.987 . . . . 1.0 109.685 -179.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.572 ' CG1' ' NE2' ' A' ' 76' ' ' HIS . 14.1 m -140.26 145.12 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.465 ' HA ' ' HB3' ' A' ' 170' ' ' ASN . 2.5 ptt180 -149.73 135.43 18.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.016 -1.052 . . . . 1.0 110.106 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.522 ' CD2' ' O ' ' A' ' 64' ' ' PHE . 1.6 mt -87.49 121.33 29.79 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.462 -0.774 . . . . 1.0 109.51 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 21.6 t -92.18 132.9 35.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.194 -0.941 . . . . 1.0 109.29 179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.571 ' CE1' HD23 ' A' ' 63' ' ' LEU . 5.8 m-85 -125.69 114.48 18.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.14 -0.975 . . . . 1.0 109.414 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 19.5 ptt180 -150.59 127.41 11.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.944 . . . . 1.0 109.6 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.436 HG13 HD12 ' A' ' 50' ' ' LEU . 3.1 p -106.9 129.34 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.039 -1.038 . . . . 1.0 109.37 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -111.57 107.78 17.06 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.272 -0.892 . . . . 1.0 108.736 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.586 ' CG2' ' CD2' ' A' ' 163' ' ' LEU . 40.1 t -99.09 136.1 20.63 Favored Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.245 -0.909 . . . . 1.0 109.034 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.447 ' HD2' HG11 ' A' ' 155' ' ' VAL . 35.7 Cg_endo -77.72 141.65 19.65 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 122.534 2.156 . . . . 1.0 111.323 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.529 ' CG ' ' HD2' ' A' ' 158' ' ' PRO . 0.9 OUTLIER -160.35 179.12 1.42 Allowed Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.529 ' HD2' ' CG ' ' A' ' 157' ' ' GLN . 33.8 Cg_endo -78.27 -53.32 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.393 2.062 . . . . 1.0 110.094 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 158' ' ' PRO . 17.3 m -59.22 -148.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.662 -0.649 . . . . 1.0 109.583 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -125.05 -80.74 0.43 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.105 -1.198 . . . . 1.0 110.105 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 40.7 mtt-85 -78.14 80.96 4.55 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.482 -1.01 . . . . 1.0 108.809 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.563 ' CG2' ' N ' ' A' ' 163' ' ' LEU . 0.7 OUTLIER -102.76 -52.69 3.02 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.583 -0.698 . . . . 1.0 109.338 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.586 ' CD2' ' CG2' ' A' ' 155' ' ' VAL . 9.9 tp -155.49 96.17 1.76 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.399 -0.963 . . . . 1.0 108.399 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.86 101.71 1.01 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.069 -1.02 . . . . 1.0 109.165 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.506 ' N ' ' CD2' ' A' ' 165' ' ' LEU . 2.2 pt? -137.1 170.04 16.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 1.0 109.777 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.454 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 2.8 mt-30 -113.61 155.03 26.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.361 -0.837 . . . . 1.0 109.781 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' A' ' 151' ' ' PHE . 45.6 t -149.74 80.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.883 . . . . 1.0 109.63 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.71 105.59 17.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 1.0 109.162 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 170' ' ' ASN . 79.7 p -120.18 117.86 29.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.939 . . . . 1.0 109.772 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 169' ' ' SER . 0.7 OUTLIER 163.03 73.72 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.366 -0.834 . . . . 1.0 109.418 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.68 85.8 1.74 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.419 2.079 . . . . 1.0 110.399 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.525 ' O ' ' CG ' ' A' ' 146' ' ' ARG . 4.3 mt -123.07 164.95 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -0.929 . . . . 1.0 108.996 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 172' ' ' ILE . 0.4 OUTLIER -155.73 139.35 16.01 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.168 -0.958 . . . . 1.0 109.692 -179.79 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.482 ' HB2' ' CB ' ' A' ' 145' ' ' THR . 9.9 m -119.59 -168.55 1.61 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.334 -0.854 . . . . 1.0 109.228 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 176' ' ' GLN . 4.3 p -164.76 30.7 0.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.164 -0.96 . . . . 1.0 109.542 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.51 ' O ' ' CB ' ' A' ' 177' ' ' ARG . 0.6 OUTLIER 44.14 27.97 0.24 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 1.0 109.481 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.51 ' CB ' ' O ' ' A' ' 176' ' ' GLN . 0.3 OUTLIER 76.18 98.8 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.332 -0.855 . . . . 1.0 109.503 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.072 -0.966 . . . . 1.0 109.538 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.0 -45.55 34.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 1.0 109.624 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.05 117.75 0.09 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 1.0 109.545 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.51 ' CE3' ' HB2' ' A' ' 5' ' ' GLN . 33.0 p-90 -86.19 -32.44 21.22 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.332 -0.855 . . . . 1.0 109.476 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.51 ' HB2' ' CE3' ' A' ' 4' ' ' TRP . 0.1 OUTLIER -178.03 82.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 1.0 109.479 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.454 HD11 ' O ' ' A' ' 5' ' ' GLN . 4.8 tp -163.19 97.03 1.05 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 1.0 109.426 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.45 144.7 23.02 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.416 2.077 . . . . 1.0 110.474 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.4 p -154.01 58.64 0.72 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.293 -0.879 . . . . 1.0 109.387 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 36.5 t60 -99.99 130.68 46.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 1.0 109.469 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.6 p -177.82 54.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.903 . . . . 1.0 109.625 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.23 -161.93 12.38 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.514 -1.434 . . . . 1.0 109.514 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.443 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 35.8 Cg_endo -77.93 -9.21 16.83 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.433 2.089 . . . . 1.0 110.49 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.535 ' CD2' ' O ' ' A' ' 162' ' ' THR . 7.5 m-85 -73.12 131.58 42.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 1.0 109.446 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -145.7 124.57 12.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.997 -1.064 . . . . 1.0 109.806 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.499 HD21 ' CG1' ' A' ' 153' ' ' VAL . 20.1 tp -120.07 82.74 1.94 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.363 -0.835 . . . . 1.0 109.038 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.62 159.43 26.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.31 -0.869 . . . . 1.0 109.863 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.466 ' CG2' ' O ' ' A' ' 47' ' ' ILE . 1.3 mp -75.98 142.18 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.338 -0.851 . . . . 1.0 108.774 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.46 ' O ' HG21 ' A' ' 19' ' ' VAL . 0.6 OUTLIER -65.27 -42.75 92.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.339 -0.851 . . . . 1.0 109.618 -179.814 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 18' ' ' GLU . 20.2 t -141.49 133.07 27.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.294 -0.879 . . . . 1.0 109.463 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -119.05 77.16 15.76 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.153 -0.967 . . . . 1.0 109.561 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 23' ' ' SER . 35.9 Cg_endo -78.36 -176.91 3.51 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.513 2.142 . . . . 1.0 110.221 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 21' ' ' PRO . 2.4 mptt -44.35 99.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.317 -0.864 . . . . 1.0 109.008 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 21' ' ' PRO . 2.1 t -96.63 40.92 1.12 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 1.0 109.956 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -99.9 166.96 10.81 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.089 -1.007 . . . . 1.0 109.318 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.57 ' CE1' ' HA ' ' A' ' 38' ' ' VAL . 3.2 t60 -143.23 133.7 24.85 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.723 -0.791 . . . . 1.0 109.64 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.463 ' HD3' ' O ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -105.68 74.31 1.06 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.345 -0.847 . . . . 1.0 109.047 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.81 161.45 2.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 1.0 109.54 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.516 ' NE2' ' O ' ' A' ' 34' ' ' SER . 1.7 m-70 -61.88 156.77 19.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 1.0 109.703 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 30' ' ' GLU . 69.7 m-85 -120.94 -145.04 0.36 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.304 -0.873 . . . . 1.0 109.195 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 29' ' ' TYR . 9.3 mt-10 -43.88 -84.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.086 -1.009 . . . . 1.0 109.442 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.87 48.06 1.62 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 1.0 109.364 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -139.01 84.43 2.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.269 -0.894 . . . . 1.0 109.531 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.3 152.89 23.56 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.615 -1.394 . . . . 1.0 109.615 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.516 ' O ' ' NE2' ' A' ' 28' ' ' HIS . 0.8 OUTLIER -84.2 -147.93 0.1 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -1.147 . . . . 1.0 109.415 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.455 ' HD3' ' O ' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -132.26 56.53 1.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 1.0 109.39 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.85 129.48 6.17 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.553 -1.419 . . . . 1.0 109.553 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.95 173.02 1.16 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -1.16 . . . . 1.0 109.619 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.57 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 2.4 p -54.5 119.63 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.367 -0.833 . . . . 1.0 109.535 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -142.65 99.3 3.45 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.27 -0.894 . . . . 1.0 109.852 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.41 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -93.85 -147.21 0.25 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.322 -0.861 . . . . 1.0 109.142 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.94 171.55 10.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.046 -1.034 . . . . 1.0 109.471 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 54.64 64.33 1.85 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 1.0 109.393 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.12 -68.68 3.48 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.345 -1.502 . . . . 1.0 109.345 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.518 ' CA ' ' HB2' ' A' ' 119' ' ' ASP . . . 173.11 36.16 0.03 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.578 -1.409 . . . . 1.0 109.578 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.563 ' CG ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER 165.42 177.67 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.195 -1.18 . . . . 1.0 109.294 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.563 ' HD2' ' CG ' ' A' ' 45' ' ' HIS . 35.0 Cg_endo -77.34 172.05 16.64 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.426 2.084 . . . . 1.0 110.506 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.499 ' CG2' ' HD3' ' A' ' 115' ' ' ARG . 4.2 mm -105.33 161.71 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 1.0 109.659 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.3 t -139.9 125.5 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.393 -0.817 . . . . 1.0 109.245 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -146.64 157.18 43.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.927 . . . . 1.0 109.547 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 110' ' ' PRO . 5.4 tt -114.63 134.67 54.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 1.0 109.419 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -140.59 79.04 1.68 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 1.0 109.308 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 53' ' ' TYR . . . 177.45 64.31 0.06 OUTLIER Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.806 -1.318 . . . . 1.0 109.806 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.525 ' CE1' ' HB2' ' A' ' 55' ' ' GLU . 0.4 OUTLIER 177.0 118.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.158 -1.201 . . . . 1.0 109.594 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.434 ' HA ' ' OE1' ' A' ' 111' ' ' GLU . 0.7 OUTLIER -106.98 25.46 11.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.241 -0.912 . . . . 1.0 109.299 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.525 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 38.8 tp10 -89.98 145.15 25.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.236 -0.915 . . . . 1.0 109.482 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -89.0 35.92 0.8 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.221 -0.924 . . . . 1.0 109.532 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.489 ' HG2' ' CG ' ' A' ' 55' ' ' GLU . 26.2 pt-20 -112.76 147.67 37.66 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 1.0 109.422 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.417 ' C ' HD22 ' A' ' 59' ' ' LEU . 35.3 Cg_endo -78.11 141.06 18.29 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.374 2.049 . . . . 1.0 110.527 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.461 HD22 ' HG3' ' A' ' 57' ' ' GLU . 7.5 mt -120.09 163.77 17.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.898 . . . . 1.0 109.19 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.448 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -116.22 100.18 7.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.208 -0.933 . . . . 1.0 109.981 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.528 ' CD2' ' HB2' ' A' ' 63' ' ' LEU . 1.6 tt -65.72 127.94 33.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.879 . . . . 1.0 108.923 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 152' ' ' ARG . 90.4 mt-30 -91.34 92.22 8.5 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.217 -0.927 . . . . 1.0 109.208 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.528 ' HB2' ' CD2' ' A' ' 61' ' ' LEU . 15.0 tp -99.6 139.84 34.67 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.316 -0.865 . . . . 1.0 109.022 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.498 ' CG ' ' N ' ' A' ' 65' ' ' ILE . 0.2 OUTLIER -163.86 168.36 19.61 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.159 -0.963 . . . . 1.0 108.79 -179.314 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.555 HD13 ' CE1' ' A' ' 76' ' ' HIS . 0.0 OUTLIER -132.47 116.8 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.814 . . . . 1.0 108.869 179.735 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -130.98 152.6 20.0 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.843 -1.303 . . . . 1.0 109.843 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.563 HG22 ' CD2' ' A' ' 76' ' ' HIS . 40.7 p -74.03 157.39 36.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.389 -1.065 . . . . 1.0 109.433 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -169.06 113.58 0.56 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.262 -0.899 . . . . 1.0 109.632 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.39 9.54 37.91 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.273 -0.892 . . . . 1.0 109.346 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -168.67 -54.39 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.31 -0.868 . . . . 1.0 109.192 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 73' ' ' LEU . 3.0 tpt180 -175.23 -33.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.87 . . . . 1.0 109.698 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.464 HD11 ' O ' ' A' ' 72' ' ' LEU . 0.9 OUTLIER -54.12 92.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.295 -0.878 . . . . 1.0 109.774 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.5 OUTLIER -56.62 164.88 1.3 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.236 -0.915 . . . . 1.0 109.733 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.519 ' CD ' ' HD2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -175.15 170.86 1.34 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 1.0 109.22 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.519 ' HD2' ' CD ' ' A' ' 74' ' ' ARG . 35.2 Cg_endo -77.23 136.67 16.3 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.338 2.026 . . . . 1.0 110.414 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.577 ' NE2' ' CG1' ' A' ' 147' ' ' VAL . 0.2 OUTLIER -59.2 147.3 35.96 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.278 -0.889 . . . . 1.0 109.719 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 76' ' ' HIS . . . -46.02 -77.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.463 ' O ' ' HA ' ' A' ' 125' ' ' LYS . 79.3 m-85 -140.66 23.71 2.27 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.95 -0.759 . . . . 1.0 108.95 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.577 ' CD2' ' HB3' ' A' ' 125' ' ' LYS . 63.0 m-85 -78.32 106.97 10.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 1.0 109.31 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 80' ' ' GLN . 11.2 tt0 -119.48 85.27 2.34 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.52 ' CG1' ' O ' ' A' ' 122' ' ' GLY . 3.8 m -69.75 138.15 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.322 -0.861 . . . . 1.0 110.037 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -175.96 85.45 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.467 -0.771 . . . . 1.0 109.096 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.21 81.04 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.05 -1.031 . . . . 1.0 110.309 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.448 HG23 HG21 ' A' ' 88' ' ' THR . 2.7 mp -109.34 147.85 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 1.0 108.724 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 86' ' ' GLY . 67.6 p -99.8 170.18 8.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.145 -0.972 . . . . 1.0 109.819 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 85' ' ' THR . . . -41.29 -46.21 4.3 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 109.857 -1.297 . . . . 1.0 109.857 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -74.62 84.92 2.08 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.301 -1.117 . . . . 1.0 109.133 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.448 HG21 HG23 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -74.61 -172.17 1.45 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.342 -0.849 . . . . 1.0 109.538 -179.643 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.506 ' CG1' HG21 ' A' ' 91' ' ' THR . 5.9 p -74.44 176.36 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.296 -0.877 . . . . 1.0 109.107 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.9 t -74.41 -42.03 59.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.065 -1.022 . . . . 1.0 109.389 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.506 HG21 ' CG1' ' A' ' 89' ' ' VAL . 6.4 t -72.86 -168.96 0.52 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.921 . . . . 1.0 109.385 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.46 ' O ' HG21 ' A' ' 106' ' ' ILE . 4.4 m -103.48 158.32 16.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 1.0 109.461 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.39 157.35 46.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 1.0 109.786 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -155.86 119.03 4.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.404 -0.81 . . . . 1.0 109.449 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.96 141.9 32.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.127 -0.983 . . . . 1.0 109.473 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.409 ' O ' HG22 ' A' ' 103' ' ' VAL . . . -130.67 120.67 24.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.92 . . . . 1.0 109.574 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.516 ' CD1' ' O ' ' A' ' 101' ' ' THR . 5.1 tp -117.2 144.98 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.36 -0.838 . . . . 1.0 109.323 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.471 ' O ' ' CG ' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -135.89 49.42 2.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.115 -0.991 . . . . 1.0 109.676 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER 74.34 114.85 0.06 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.199 -0.938 . . . . 1.0 109.666 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 3.7 p-10 43.91 35.52 1.14 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.584 -0.698 . . . . 1.0 110.623 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.516 ' O ' ' CD1' ' A' ' 97' ' ' ILE . 0.2 OUTLIER -149.85 105.19 3.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.841 -1.162 . . . . 1.0 109.952 179.543 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -90.33 106.23 18.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 1.0 109.13 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 96' ' ' ALA . 0.2 OUTLIER -109.8 172.03 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.289 -0.882 . . . . 1.0 109.229 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 1.9 mp -128.22 137.67 52.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.816 . . . . 1.0 109.518 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -133.58 112.81 11.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 1.0 109.264 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.46 HG21 ' O ' ' A' ' 92' ' ' THR . 51.9 mt -123.2 107.87 32.4 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 1.0 109.741 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.523 ' O ' ' CD2' ' A' ' 108' ' ' LEU . 34.7 Cg_endo -76.98 125.32 7.92 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.097 1.865 . . . . 1.0 110.231 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 107' ' ' PRO . 3.4 mt -134.12 151.63 51.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 1.0 110.006 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.456 HD11 ' O ' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -123.38 91.29 49.9 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.416 -0.802 . . . . 1.0 108.93 179.505 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.455 ' HB3' ' HB3' ' A' ' 50' ' ' LEU . 35.9 Cg_endo -78.07 70.49 7.07 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.515 2.143 . . . . 1.0 110.631 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.494 ' O ' ' CG ' ' A' ' 111' ' ' GLU . 19.8 tp10 -118.56 0.71 11.61 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.284 -0.885 . . . . 1.0 109.639 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.498 ' O ' ' CB ' ' A' ' 113' ' ' SER . 0.0 OUTLIER -143.55 -65.11 0.38 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.105 -0.997 . . . . 1.0 109.496 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.4 OUTLIER 164.61 109.95 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.147 -0.971 . . . . 1.0 109.157 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.451 ' SD ' HD13 ' A' ' 109' ' ' LEU . 9.4 ptm -154.09 117.43 4.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.2 -0.938 . . . . 1.0 109.915 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.499 ' HD3' ' CG2' ' A' ' 47' ' ' ILE . 0.1 OUTLIER -88.29 136.45 32.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.435 -0.79 . . . . 1.0 109.415 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.03 108.99 16.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 1.0 109.365 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.404 HG11 ' CD ' ' A' ' 115' ' ' ARG . 4.3 m -95.25 159.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -0.934 . . . . 1.0 109.667 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.486 ' O ' ' CB ' ' A' ' 45' ' ' HIS . 8.3 mt -146.95 102.6 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 1.0 109.228 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.518 ' HB2' ' CA ' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -147.56 47.39 1.11 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 1.0 109.71 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 63.8 m -145.04 54.2 1.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.881 . . . . 1.0 109.355 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.461 ' O ' ' O ' ' A' ' 122' ' ' GLY . . . -145.26 87.24 1.8 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.917 . . . . 1.0 109.845 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.52 ' O ' ' CG1' ' A' ' 81' ' ' VAL . . . -56.44 -166.36 0.06 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 108.389 -1.884 . . . . 1.0 108.389 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.433 HG23 ' CD2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -114.29 151.77 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.707 -1.466 . . . . 1.0 109.178 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -143.44 82.57 1.74 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.438 -0.789 . . . . 1.0 109.702 -179.642 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.577 ' HB3' ' CD2' ' A' ' 79' ' ' TYR . 4.3 ptmt -108.74 65.68 0.63 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.822 -1.174 . . . . 1.0 110.207 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.469 HD23 ' O ' ' A' ' 125' ' ' LYS . 2.4 mm? -146.31 75.59 1.41 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.466 -0.771 . . . . 1.0 109.104 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -141.91 -155.9 0.63 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.886 . . . . 1.0 109.454 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.507 ' O ' ' N ' ' A' ' 130' ' ' ASP . 1.2 p30 -153.19 -50.82 0.1 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 1.0 109.424 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 130' ' ' ASP . 7.9 m 44.31 -94.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 1.0 109.493 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 128' ' ' ASN . 6.1 p-10 177.17 59.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.125 -0.985 . . . . 1.0 109.582 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.521 HG22 HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -74.37 117.64 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.224 -0.923 . . . . 1.0 109.443 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.518 ' O ' ' CD1' ' A' ' 131' ' ' ILE . 47.7 tt0 -64.81 140.53 58.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 1.0 109.549 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.64 153.66 43.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 1.0 109.419 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -174.37 -38.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.166 -0.959 . . . . 1.0 109.624 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.02 139.01 43.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.947 . . . . 1.0 109.559 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -144.14 152.81 24.59 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.433 -1.467 . . . . 1.0 109.433 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.91 145.96 42.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -1.147 . . . . 1.0 109.509 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 138' ' ' THR . 0.0 OUTLIER -148.96 57.73 1.03 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.34 -0.85 . . . . 1.0 109.459 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -72.93 -32.52 65.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.343 -0.848 . . . . 1.0 109.452 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.576 ' N ' ' CD1' ' A' ' 140' ' ' ILE . 0.2 OUTLIER -147.73 34.87 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.924 . . . . 1.0 109.459 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 108.19 -172.14 16.74 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.435 -1.466 . . . . 1.0 109.435 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.29 156.62 37.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -1.13 . . . . 1.0 109.521 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.1 26.3 9.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 1.0 109.425 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -91.58 70.81 5.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 1.0 109.513 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.1 p -160.47 47.5 0.24 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.449 -0.782 . . . . 1.0 109.68 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.12 128.02 7.41 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.388 -0.82 . . . . 1.0 109.187 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.577 ' CG1' ' NE2' ' A' ' 76' ' ' HIS . 6.8 m -136.2 161.28 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.964 . . . . 1.0 109.517 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 10.7 mtt-85 -145.24 126.41 14.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.189 -0.945 . . . . 1.0 109.667 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.454 HD21 HG12 ' A' ' 65' ' ' ILE . 2.0 mm? -79.86 114.52 18.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.335 -0.853 . . . . 1.0 108.997 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 45.6 t -85.93 122.74 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.235 -0.916 . . . . 1.0 109.497 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.457 ' O ' ' HB ' ' A' ' 167' ' ' VAL . 8.0 m-85 -119.76 95.75 4.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.33 -0.856 . . . . 1.0 109.125 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 62' ' ' GLN . 19.5 ptt180 -135.63 129.93 33.59 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.141 -0.974 . . . . 1.0 109.566 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.499 ' CG1' HD21 ' A' ' 15' ' ' LEU . 11.9 p -108.19 128.6 63.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.306 -0.871 . . . . 1.0 108.763 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.567 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 41.0 m-70 -124.34 108.54 12.31 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.197 -0.94 . . . . 1.0 109.76 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.528 ' CG1' ' HB3' ' A' ' 163' ' ' LEU . 7.7 p -99.22 141.24 22.51 Favored Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 121.314 -0.866 . . . . 1.0 109.172 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.513 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 34.5 Cg_endo -77.19 115.34 3.95 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.174 1.916 . . . . 1.0 109.994 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.457 ' OE1' ' HD2' ' A' ' 158' ' ' PRO . 72.2 mm-40 -143.23 163.58 36.52 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.424 -0.797 . . . . 1.0 109.52 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.457 ' HD2' ' OE1' ' A' ' 157' ' ' GLN . 35.0 Cg_endo -77.92 -55.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.402 2.068 . . . . 1.0 109.777 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 158' ' ' PRO . 0.2 OUTLIER -45.71 171.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.628 -0.67 . . . . 1.0 109.466 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -93.86 -66.37 1.04 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.173 -1.171 . . . . 1.0 110.173 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.6 mtm-85 -78.98 79.21 5.39 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.399 -1.334 . . . . 1.0 107.399 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.535 ' O ' ' CD2' ' A' ' 13' ' ' TYR . 2.7 t -102.03 -108.34 0.24 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.673 -0.642 . . . . 1.0 110.518 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.528 ' HB3' ' CG1' ' A' ' 155' ' ' VAL . 8.6 tp -129.1 96.46 4.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.295 -1.503 . . . . 1.0 108.299 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.567 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -162.85 100.34 1.0 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.874 -1.141 . . . . 1.0 109.699 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.581 ' CD2' ' N ' ' A' ' 165' ' ' LEU . 1.0 OUTLIER -134.61 170.04 16.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.178 -0.952 . . . . 1.0 109.64 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.434 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 3.1 mm-40 -121.73 147.31 46.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 1.0 109.557 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.496 ' O ' ' CG1' ' A' ' 167' ' ' VAL . 41.8 t -145.47 70.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.871 . . . . 1.0 109.407 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.77 107.72 19.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.222 -0.924 . . . . 1.0 109.192 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 0.3 OUTLIER -156.33 123.49 5.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 1.0 109.7 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 169' ' ' SER . 1.8 t30 172.2 94.94 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.37 -0.831 . . . . 1.0 109.287 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.65 107.9 2.46 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.414 2.076 . . . . 1.0 110.48 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.542 HG22 HD11 ' A' ' 172' ' ' ILE . 24.6 mt -137.43 159.47 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.874 . . . . 1.0 108.99 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.467 ' HA ' ' O ' ' A' ' 145' ' ' THR . 2.9 mt-10 -130.34 123.12 29.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.127 -0.983 . . . . 1.0 109.854 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.46 ' O ' ' HB3' ' A' ' 175' ' ' SER . 3.3 m -84.7 -169.28 2.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -0.872 . . . . 1.0 109.047 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 177' ' ' ARG . 1.2 p 176.47 -33.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.171 -0.955 . . . . 1.0 109.665 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.463 ' HB3' ' HD3' ' A' ' 125' ' ' LYS . 6.3 tp60 -44.38 95.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.989 . . . . 1.0 109.46 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 175' ' ' SER . 0.0 OUTLIER -168.51 154.76 7.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.273 -0.892 . . . . 1.0 109.424 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.941 -1.028 . . . . 1.0 109.507 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.9 ttp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.8 40.42 0.65 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -0.893 . . . . 1.0 109.45 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -174.95 -156.46 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 1.0 109.249 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.566 ' CE2' HD11 ' A' ' 6' ' ' LEU . 53.9 p-90 -97.48 -49.09 5.03 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.253 -0.905 . . . . 1.0 109.611 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' A' ' 4' ' ' TRP . 0.5 OUTLIER 163.04 90.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.366 -0.834 . . . . 1.0 109.481 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.59 ' N ' ' CD1' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -130.61 154.53 81.74 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.197 -0.939 . . . . 1.0 109.577 179.497 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.75 95.55 1.03 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.479 2.12 . . . . 1.0 110.296 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.61 43.97 1.61 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.166 -0.959 . . . . 1.0 109.495 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 18.8 m170 -116.0 87.04 2.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.298 -0.876 . . . . 1.0 109.461 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.94 99.74 3.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 1.0 109.573 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -158.31 142.67 8.64 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.387 -1.485 . . . . 1.0 109.387 179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.425 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 36.3 Cg_endo -78.92 110.27 2.74 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.441 2.094 . . . . 1.0 110.596 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.575 ' CE2' ' O ' ' A' ' 162' ' ' THR . 8.3 m-85 -56.09 155.75 6.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 1.0 109.063 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.425 ' HG3' ' O ' ' A' ' 12' ' ' PRO . 20.7 mt-10 -152.21 103.01 2.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.885 -1.134 . . . . 1.0 110.25 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.3 tp -112.24 76.78 1.0 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.436 -0.95 . . . . 1.0 108.436 179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.45 ' O ' ' OE1' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -114.87 176.25 5.14 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.322 -0.861 . . . . 1.0 110.188 -179.022 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.511 ' CG2' ' HG2' ' A' ' 20' ' ' GLN . 0.8 OUTLIER -86.75 146.48 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 108.705 -0.85 . . . . 1.0 108.705 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.51 ' HB2' ' NE2' ' A' ' 49' ' ' GLN . 0.8 OUTLIER -77.06 -61.13 2.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 1.0 109.261 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.454 HG11 ' O ' ' A' ' 19' ' ' VAL . 9.7 p -109.67 136.02 46.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.385 -0.822 . . . . 1.0 109.307 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.511 ' HG2' ' CG2' ' A' ' 17' ' ' ILE . 9.4 mm-40 -129.06 66.02 75.34 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.143 -0.973 . . . . 1.0 109.599 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.522 ' HG2' ' CB ' ' A' ' 41' ' ' SER . 35.4 Cg_endo -77.62 -177.03 3.54 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.464 2.109 . . . . 1.0 110.575 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -61.85 151.7 33.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.366 -0.834 . . . . 1.0 109.129 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.448 ' HB3' ' HG2' ' A' ' 171' ' ' PRO . 2.2 t -163.76 61.58 0.16 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.14 -0.975 . . . . 1.0 110.038 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . 0.433 ' HA ' HG12 ' A' ' 172' ' ' ILE . 1.9 p80 -99.52 165.52 11.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.084 -1.01 . . . . 1.0 108.881 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.577 ' CE1' ' HA ' ' A' ' 38' ' ' VAL . 1.1 m-70 -139.54 110.41 6.8 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.703 -0.799 . . . . 1.0 109.894 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.507 ' O ' ' CE2' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -87.12 64.98 8.68 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.424 -0.954 . . . . 1.0 108.424 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.3 82.8 3.77 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.367 0.603 . . . . 1.0 109.88 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.54 ' C ' ' CG ' ' A' ' 29' ' ' TYR . 5.6 p-80 174.63 113.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.322 -0.861 . . . . 1.0 109.295 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.573 ' N ' ' CD1' ' A' ' 29' ' ' TYR . 0.1 OUTLIER 169.55 171.97 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.553 -0.717 . . . . 1.0 109.305 -179.481 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -161.4 31.35 0.13 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.916 . . . . 1.0 109.544 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 13.3 m -144.63 43.45 1.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 1.0 109.489 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.404 ' OE1' ' CD2' ' A' ' 29' ' ' TYR . 5.2 pt-20 -133.7 -41.31 0.85 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 1.0 109.481 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.08 -131.29 5.77 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.607 -1.397 . . . . 1.0 109.607 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 35' ' ' ARG . 1.2 t -128.08 117.49 21.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.162 -1.199 . . . . 1.0 109.581 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.437 ' HD3' ' O ' ' A' ' 35' ' ' ARG . 0.0 OUTLIER 172.48 70.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.302 -0.874 . . . . 1.0 109.517 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -120.29 92.57 0.52 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.695 -1.362 . . . . 1.0 109.695 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.427 ' HB2' ' HE3' ' A' ' 39' ' ' LYS . . . -128.57 175.23 8.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.201 -1.176 . . . . 1.0 109.762 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.577 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 2.4 p -100.27 102.3 13.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.939 -0.704 . . . . 1.0 109.732 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 12.5 ptpt -153.9 110.43 3.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.898 . . . . 1.0 109.614 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.66 -45.25 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.14 -0.975 . . . . 1.0 109.517 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.522 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 0.3 OUTLIER -100.68 102.1 13.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 1.0 109.621 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 41' ' ' SER . . . 61.52 42.32 11.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 1.0 109.521 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 92.09 -21.39 37.42 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.653 -1.379 . . . . 1.0 109.653 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.516 ' N ' ' OD2' ' A' ' 119' ' ' ASP . . . 155.22 106.79 0.27 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.473 ' CB ' ' O ' ' A' ' 44' ' ' GLY . 0.3 OUTLIER 73.92 146.18 0.11 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.254 -1.145 . . . . 1.0 109.758 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.401 ' HA ' ' OG ' ' A' ' 41' ' ' SER . 35.2 Cg_endo -78.12 -178.81 4.9 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.651 2.234 . . . . 1.0 110.577 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.511 HG22 ' CG1' ' A' ' 117' ' ' VAL . 5.2 mt -94.32 158.34 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.513 -0.742 . . . . 1.0 109.278 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.536 HG23 ' CZ ' ' A' ' 151' ' ' PHE . 11.1 t -140.35 88.1 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.159 -0.963 . . . . 1.0 110.108 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.62 ' CG ' ' CE1' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -98.8 175.74 5.86 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 1.0 108.903 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 8.2 tt -134.81 136.73 42.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.933 -1.104 . . . . 1.0 110.036 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.62 ' CE1' ' CG ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -140.55 79.08 1.68 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.353 -0.842 . . . . 1.0 108.844 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 53' ' ' TYR . . . -174.33 88.22 0.08 OUTLIER Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.544 -1.312 . . . . 1.0 110.234 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.566 ' CE2' HD13 ' A' ' 59' ' ' LEU . 2.0 t80 176.8 131.83 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -1.109 . . . . 1.0 109.654 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.9 mt -108.89 4.42 23.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 1.0 109.539 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.453 ' HB3' ' HG2' ' A' ' 57' ' ' GLU . 2.7 mt-10 -95.24 143.39 26.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 1.0 109.507 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -90.73 35.12 0.89 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.918 . . . . 1.0 109.337 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.461 ' HG3' HD22 ' A' ' 59' ' ' LEU . 17.3 pt-20 -110.83 151.97 43.25 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 1.0 109.357 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.31 134.2 12.55 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.436 2.091 . . . . 1.0 110.534 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.584 ' CD1' ' CD2' ' A' ' 163' ' ' LEU . 16.1 mt -118.63 165.44 13.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.238 -0.914 . . . . 1.0 109.077 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.463 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -105.13 136.03 45.38 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.174 -0.954 . . . . 1.0 109.583 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.519 ' CD2' ' HB2' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -89.41 136.15 33.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.36 -0.838 . . . . 1.0 109.224 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.449 ' HB2' ' O ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -97.2 85.96 3.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.204 -0.935 . . . . 1.0 109.536 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.588 ' CD1' ' CE1' ' A' ' 151' ' ' PHE . 18.8 tp -99.36 130.95 45.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 1.0 108.822 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.499 ' HB2' ' CG1' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -155.44 143.54 20.05 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -0.968 . . . . 1.0 109.113 -179.326 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.573 ' CD1' ' CE1' ' A' ' 76' ' ' HIS . 0.1 OUTLIER -103.99 124.54 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.446 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.515 ' N ' HD12 ' A' ' 65' ' ' ILE . . . -136.8 149.17 20.1 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.915 -1.274 . . . . 1.0 109.915 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.513 ' OG1' ' NE ' ' A' ' 74' ' ' ARG . 73.5 p -83.14 156.51 23.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.28 -1.13 . . . . 1.0 109.362 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.45 ' HB2' ' HG3' ' A' ' 148' ' ' ARG . . . -160.56 116.99 2.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 1.0 109.694 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -85.45 -25.13 27.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.169 -0.957 . . . . 1.0 109.14 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.12 -42.02 0.21 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.382 -0.824 . . . . 1.0 109.425 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' LEU . 13.0 ttm180 -175.35 -34.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 1.0 109.569 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.4 ' CD1' ' O ' ' A' ' 72' ' ' LEU . 0.7 OUTLIER -48.67 91.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 1.0 109.865 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.7 OUTLIER -58.21 155.73 10.93 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.163 -0.961 . . . . 1.0 109.656 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.513 ' NE ' ' OG1' ' A' ' 67' ' ' THR . 10.8 ptt180 -175.27 172.19 1.14 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.88 . . . . 1.0 108.7 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 74' ' ' ARG . 33.7 Cg_endo -77.18 161.73 32.06 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.141 1.894 . . . . 1.0 110.312 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.685 ' CD2' ' CD1' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -64.35 156.03 30.47 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.227 -0.921 . . . . 1.0 109.708 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.28 -48.92 4.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 1.0 109.84 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.479 ' CD1' ' HB2' ' A' ' 126' ' ' LEU . 18.6 m-85 -120.39 26.83 8.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.18 -0.95 . . . . 1.0 109.899 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.685 ' CD1' ' CD2' ' A' ' 76' ' ' HIS . 0.2 OUTLIER -140.86 148.68 40.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.148 -0.97 . . . . 1.0 109.127 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.452 ' HG3' ' HB2' ' A' ' 102' ' ' LYS . 20.5 tt0 -165.05 -36.41 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.122 -0.986 . . . . 1.0 109.589 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 122' ' ' GLY . 12.8 m -50.78 143.22 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.052 -1.03 . . . . 1.0 109.633 -179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.402 ' O ' ' OE2' ' A' ' 95' ' ' GLU . 3.9 t-80 -175.93 67.98 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.532 -0.73 . . . . 1.0 109.319 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.0 OUTLIER -134.41 153.97 51.62 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.236 -0.915 . . . . 1.0 109.815 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.491 ' CG1' ' HB2' ' A' ' 120' ' ' CYS . 3.8 mp -100.01 143.63 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.447 -0.783 . . . . 1.0 109.486 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 86' ' ' GLY . 34.4 p -135.41 -166.35 1.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 1.0 109.404 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 85' ' ' THR . . . 41.47 -107.99 0.11 Allowed Glycine 0 N--CA 1.484 1.84 0 N-CA-C 110.046 -1.222 . . . . 1.0 110.046 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.84 118.9 18.33 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.244 -1.15 . . . . 1.0 109.601 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.19 169.64 12.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 1.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.0 p -103.8 160.23 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.332 -0.855 . . . . 1.0 109.418 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 2.5 m -78.71 3.78 15.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 1.0 109.606 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.521 ' CG2' HG23 ' A' ' 106' ' ' ILE . 16.3 m -104.82 101.36 10.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.213 -0.93 . . . . 1.0 109.539 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.526 ' O ' ' CG2' ' A' ' 106' ' ' ILE . 22.7 m -46.08 115.71 1.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -0.935 . . . . 1.0 109.652 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.456 ' HA ' HG22 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -114.21 173.68 6.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 1.0 109.654 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.1 162.67 40.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.375 -0.828 . . . . 1.0 109.519 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.402 ' OE2' ' O ' ' A' ' 82' ' ' HIS . 1.2 tt0 -124.31 133.59 53.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.864 . . . . 1.0 109.492 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.461 ' O ' HG21 ' A' ' 103' ' ' VAL . . . -124.66 121.53 34.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 1.0 109.55 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.422 HD13 ' C ' ' A' ' 101' ' ' THR . 6.1 tp -111.79 140.12 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 1.0 109.444 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.51 ' O ' ' CB ' ' A' ' 99' ' ' SER . 0.5 OUTLIER -132.32 49.41 2.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.138 -0.976 . . . . 1.0 109.691 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 3.1 t 76.8 112.34 0.07 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.897 . . . . 1.0 110.279 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.432 ' CG ' ' O ' ' A' ' 99' ' ' SER . 3.5 p-10 43.64 31.96 0.51 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.689 -0.632 . . . . 1.0 111.032 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.441 ' HB ' ' HG ' ' A' ' 98' ' ' LEU . 2.5 m -160.2 96.29 1.19 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.737 -1.227 . . . . 1.0 110.226 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.452 ' HB2' ' HG3' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -88.87 153.71 20.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.229 -0.919 . . . . 1.0 108.943 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.499 ' CG1' ' HB2' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -144.18 173.57 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.071 -1.018 . . . . 1.0 109.211 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.52 ' CD2' HD13 ' A' ' 106' ' ' ILE . 0.2 OUTLIER -123.92 130.81 53.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.924 . . . . 1.0 109.954 -179.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -133.1 122.64 24.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.358 -0.839 . . . . 1.0 108.864 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 92' ' ' THR . 26.8 mt -133.94 112.73 12.48 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.035 -1.04 . . . . 1.0 110.119 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.492 ' C ' ' CD2' ' A' ' 108' ' ' LEU . 34.0 Cg_endo -76.56 121.24 5.89 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 122.091 1.861 . . . . 1.0 109.712 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.512 HD23 ' CG2' ' A' ' 91' ' ' THR . 2.5 mt -126.36 165.55 18.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 1.0 110.667 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.59 ' CB ' ' CD ' ' A' ' 110' ' ' PRO . 0.6 OUTLIER -72.26 -170.82 0.17 Allowed Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 108.081 -1.081 . . . . 1.0 108.081 179.259 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.59 ' CD ' ' CB ' ' A' ' 109' ' ' LEU . 33.4 Cg_endo -77.64 -76.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 121.532 1.488 . . . . 1.0 110.848 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.44 ' HG3' ' HA ' ' A' ' 51' ' ' HIS . 1.8 tt0 -170.46 52.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.897 -1.127 . . . . 1.0 110.131 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.474 ' O ' ' CB ' ' A' ' 113' ' ' SER . 13.2 p30 -79.73 -40.65 28.37 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.086 -1.009 . . . . 1.0 109.166 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.5 OUTLIER 164.68 87.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.361 -0.837 . . . . 1.0 109.157 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.508 ' HE3' ' N ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -162.51 139.71 8.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.155 -0.966 . . . . 1.0 110.19 -179.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -119.6 137.75 53.66 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.386 -0.821 . . . . 1.0 108.937 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -112.49 97.91 6.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.158 -0.964 . . . . 1.0 109.749 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.511 ' CG1' HG22 ' A' ' 47' ' ' ILE . 5.4 m -96.42 127.22 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 1.0 109.349 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.459 ' O ' ' HB3' ' A' ' 45' ' ' HIS . 65.9 mt -102.56 111.26 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 1.0 109.358 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.516 ' OD2' ' N ' ' A' ' 44' ' ' GLY . 3.9 t0 -147.12 41.83 1.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.943 . . . . 1.0 109.619 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.491 ' HB2' ' CG1' ' A' ' 84' ' ' ILE . 63.8 m -145.22 57.77 1.26 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -0.956 . . . . 1.0 109.824 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.516 ' O ' ' CG1' ' A' ' 38' ' ' VAL . . . -128.33 152.94 47.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 1.0 108.881 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.456 ' O ' HG22 ' A' ' 81' ' ' VAL . . . -114.21 -174.35 18.53 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.838 -1.305 . . . . 1.0 109.838 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.501 HG22 HD11 ' A' ' 123' ' ' ILE . 1.2 mt -125.23 171.79 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -1.104 . . . . 1.0 109.055 179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.424 HD13 HG12 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -140.31 161.36 37.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 1.0 109.569 179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -136.51 124.68 23.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -0.873 . . . . 1.0 109.377 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.479 ' HB2' ' CD1' ' A' ' 78' ' ' PHE . 1.4 mp -89.77 166.15 13.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 1.0 109.487 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -160.7 28.53 0.15 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.253 -0.905 . . . . 1.0 109.413 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -133.46 12.53 4.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 1.0 109.496 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -137.11 -85.43 0.32 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.181 -0.949 . . . . 1.0 109.53 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 129' ' ' SER . 9.1 t0 83.45 59.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.313 0.578 . . . . 1.0 109.468 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 12.1 tt -99.34 121.96 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.232 -0.918 . . . . 1.0 109.489 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -169.57 111.18 0.46 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 1.0 109.509 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.405 ' O ' ' HB3' ' A' ' 134' ' ' ARG . 3.9 pp -127.9 133.81 49.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 1.0 109.415 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' A' ' 133' ' ' LEU . 33.5 ptt85 -178.55 -168.4 0.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 1.0 109.524 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -94.56 147.77 22.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 1.0 109.492 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 110.7 174.66 20.34 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.544 -1.422 . . . . 1.0 109.544 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -146.47 147.49 31.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -1.135 . . . . 1.0 109.428 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.429 HG22 ' HA ' ' A' ' 143' ' ' LYS . 72.2 p -125.31 -166.32 1.53 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 1.0 109.527 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -76.74 -85.97 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.912 . . . . 1.0 109.386 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 20.2 pt -135.18 16.19 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 1.0 109.445 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 142' ' ' ARG . . . 169.22 -149.05 12.82 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.548 -1.421 . . . . 1.0 109.548 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.526 ' CG ' ' O ' ' A' ' 141' ' ' GLY . 9.1 ptt180 40.53 57.39 2.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.693 -0.887 . . . . 1.0 110.097 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.429 ' HA ' HG22 ' A' ' 138' ' ' THR . 0.0 OUTLIER -97.61 78.13 2.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.314 -0.866 . . . . 1.0 109.304 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.455 ' HA ' ' HB3' ' A' ' 175' ' ' SER . 0.1 OUTLIER 66.2 137.91 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 1.0 109.272 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.462 ' OG1' ' HB2' ' A' ' 174' ' ' CYS . 0.1 OUTLIER -159.38 53.02 0.38 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.188 -0.945 . . . . 1.0 109.654 -179.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.545 ' NH2' ' ND2' ' A' ' 170' ' ' ASN . 6.4 ptm180 -86.73 176.59 7.66 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.233 -0.917 . . . . 1.0 109.288 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.508 ' O ' ' ND2' ' A' ' 170' ' ' ASN . 27.7 m -134.7 -174.68 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.403 -0.811 . . . . 1.0 109.877 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.451 ' CB ' ' O ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -149.29 95.97 2.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.33 -0.856 . . . . 1.0 109.319 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.514 ' CD2' HG12 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -78.0 124.51 28.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.986 -1.071 . . . . 1.0 109.035 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.6 t -110.04 114.41 46.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.233 -0.917 . . . . 1.0 109.776 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.588 ' CE1' ' CD1' ' A' ' 63' ' ' LEU . 21.6 m-85 -110.43 113.29 25.83 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.769 -0.826 . . . . 1.0 108.769 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 10.0 ptt180 -149.46 138.73 21.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.171 -0.955 . . . . 1.0 109.781 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 164' ' ' SER . 8.7 p -112.66 128.52 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.471 -0.937 . . . . 1.0 108.471 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.567 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 41.7 m-70 -128.89 118.45 22.71 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.16 -0.962 . . . . 1.0 110.002 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.534 ' CG1' ' HB3' ' A' ' 163' ' ' LEU . 14.7 p -98.52 141.2 22.53 Favored Pre-proline 0 N--CA 1.487 1.406 0 O-C-N 121.279 -0.888 . . . . 1.0 108.788 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 33.0 Cg_endo -74.73 114.05 3.94 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.197 1.931 . . . . 1.0 110.615 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.451 ' HB3' ' HD2' ' A' ' 158' ' ' PRO . 0.6 OUTLIER -135.71 166.05 31.42 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.506 -0.746 . . . . 1.0 109.006 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.451 ' HD2' ' HB3' ' A' ' 157' ' ' GLN . 34.4 Cg_endo -76.34 -64.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.261 1.974 . . . . 1.0 110.373 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.0 m -53.77 -78.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.195 -0.94 . . . . 1.0 109.349 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 144.44 -42.07 1.06 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.458 -1.457 . . . . 1.0 109.458 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.01 79.96 5.37 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.022 -1.103 . . . . 1.0 108.022 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.575 ' O ' ' CE2' ' A' ' 13' ' ' TYR . 1.3 m -135.05 -88.38 0.36 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.533 -0.73 . . . . 1.0 109.367 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.584 ' CD2' ' CD1' ' A' ' 59' ' ' LEU . 7.6 tp -131.15 102.89 6.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.021 -1.049 . . . . 1.0 109.08 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.567 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -162.11 114.31 1.71 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.08 -1.012 . . . . 1.0 109.593 179.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 152' ' ' ARG . 1.0 OUTLIER -122.81 175.36 6.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.335 -0.853 . . . . 1.0 109.753 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.449 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 0.7 OUTLIER -147.87 105.66 3.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.425 -0.797 . . . . 1.0 109.426 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 43.8 t -118.28 154.01 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 1.0 109.332 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 149' ' ' LEU . . . -151.41 102.83 2.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 1.0 109.214 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 170' ' ' ASN . 0.4 OUTLIER -130.71 161.78 30.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.957 . . . . 1.0 109.693 -179.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.545 ' ND2' ' NH2' ' A' ' 146' ' ' ARG . 1.6 p-10 164.93 97.77 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.343 -0.848 . . . . 1.0 109.567 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.448 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 36.1 Cg_endo -79.45 67.81 8.48 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.419 2.08 . . . . 1.0 110.48 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.446 HD11 HG23 ' A' ' 147' ' ' VAL . 16.1 mt -136.6 124.45 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.104 -0.997 . . . . 1.0 109.443 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -147.17 108.0 4.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 1.0 109.363 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 175' ' ' SER . 63.9 m -85.17 175.95 8.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.206 -0.933 . . . . 1.0 109.462 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 174' ' ' CYS . 1.0 OUTLIER 82.57 -42.78 0.12 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.783 -0.573 . . . . 1.0 110.053 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.42 ' CB ' ' O ' ' A' ' 175' ' ' SER . 27.0 tt0 70.32 78.68 0.19 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.981 -1.074 . . . . 1.0 109.597 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.93 -44.91 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.946 . . . . 1.0 109.474 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.426 ' OXT' ' OG ' ' A' ' 178' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.988 -1.006 . . . . 1.0 109.471 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.417 ' O ' ' OD2' ' A' ' 3' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 3' ' ' ASP . 9.0 tttt -69.91 -32.58 70.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.858 . . . . 1.0 109.408 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.548 ' CB ' ' CD2' ' A' ' 6' ' ' LEU . 11.5 m-20 62.02 169.44 0.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 1.0 109.493 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.569 ' CG ' ' N ' ' A' ' 5' ' ' GLN . 21.9 p-90 -77.41 -46.73 21.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.192 -0.943 . . . . 1.0 109.874 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.569 ' N ' ' CG ' ' A' ' 4' ' ' TRP . 1.1 tt0 176.56 83.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 1.0 109.625 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.548 ' CD2' ' CB ' ' A' ' 3' ' ' ASP . 0.4 OUTLIER -96.38 161.17 27.81 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.305 -0.872 . . . . 1.0 109.253 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 6' ' ' LEU . 34.5 Cg_endo -76.41 160.51 35.43 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.312 2.008 . . . . 1.0 110.274 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.7 p -130.62 46.95 2.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 1.0 109.663 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.559 ' CG ' ' N ' ' A' ' 10' ' ' SER . 73.9 t60 -99.77 165.73 11.44 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.178 -0.951 . . . . 1.0 109.343 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.559 ' N ' ' CG ' ' A' ' 9' ' ' HIS . 1.5 p 73.35 146.69 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.126 -0.984 . . . . 1.0 109.417 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.7 -145.26 6.43 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.604 -1.399 . . . . 1.0 109.604 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.5 -158.79 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.425 2.083 . . . . 1.0 110.486 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.565 ' CD1' ' O ' ' A' ' 162' ' ' THR . 1.8 m-85 -95.65 162.9 13.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 1.0 109.459 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -152.42 142.69 22.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.138 -0.976 . . . . 1.0 109.918 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.414 ' HG ' HG22 ' A' ' 167' ' ' VAL . 22.8 tp -136.31 98.05 3.74 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.784 -0.821 . . . . 1.0 108.784 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.47 164.23 29.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 1.0 110.227 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.454 ' CG1' ' O ' ' A' ' 47' ' ' ILE . 0.8 OUTLIER -92.36 145.29 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.547 -0.909 . . . . 1.0 108.547 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.412 ' O ' ' CG2' ' A' ' 19' ' ' VAL . 1.3 tp10 -75.4 -35.83 60.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.936 . . . . 1.0 110.3 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.463 ' HB ' HG13 ' A' ' 47' ' ' ILE . 80.0 t -154.48 98.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 O-C-N 120.814 -1.179 . . . . 1.0 110.157 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.456 ' HG3' ' HD2' ' A' ' 21' ' ' PRO . 0.6 OUTLIER -51.63 160.34 1.06 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.442 -0.786 . . . . 1.0 109.037 179.422 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.468 ' HB3' ' O ' ' A' ' 44' ' ' GLY . 36.2 Cg_endo -78.38 154.92 28.36 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.458 2.106 . . . . 1.0 110.415 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.6 mmtm -46.09 165.12 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.266 -0.896 . . . . 1.0 109.453 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 23' ' ' SER . 5.2 t -94.19 24.39 4.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 1.0 110.142 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.04 166.38 23.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.94 -1.1 . . . . 1.0 110.003 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.58 ' CE1' ' HB ' ' A' ' 38' ' ' VAL . 0.8 OUTLIER -162.48 106.76 1.15 Allowed 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.303 -0.629 . . . . 1.0 109.303 179.428 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.56 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . 24.1 ttp85 -75.17 91.74 2.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.255 -0.903 . . . . 1.0 109.36 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.554 ' O ' ' CD2' ' A' ' 28' ' ' HIS . . . -143.22 88.94 2.06 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.315 -0.866 . . . . 1.0 109.523 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.554 ' CD2' ' O ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER 169.97 38.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.92 . . . . 1.0 109.503 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.56 ' CE1' ' HG3' ' A' ' 26' ' ' ARG . 32.2 m-85 -129.54 -70.32 0.65 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.239 -0.913 . . . . 1.0 109.542 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.454 ' O ' ' HG3' ' A' ' 30' ' ' GLU . 6.8 pt-20 -86.16 118.8 25.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.272 -0.893 . . . . 1.0 109.548 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.412 ' C ' ' HG3' ' A' ' 32' ' ' GLU . 1.9 t -145.1 36.32 1.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 1.0 109.435 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.412 ' HG3' ' C ' ' A' ' 31' ' ' THR . 1.0 OUTLIER -140.05 52.32 1.68 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.179 -0.951 . . . . 1.0 109.475 -179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.2 149.45 6.3 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.774 -1.331 . . . . 1.0 109.774 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 36' ' ' GLY . 8.2 t 65.88 9.75 6.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.328 -1.101 . . . . 1.0 109.516 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 52.01 -90.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.88 . . . . 1.0 109.434 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 34' ' ' SER . . . 117.12 112.33 2.65 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.643 -1.383 . . . . 1.0 109.643 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -119.77 174.19 6.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -1.112 . . . . 1.0 109.517 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.58 ' HB ' ' CE1' ' A' ' 25' ' ' HIS . 2.4 p -68.33 142.06 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.403 -0.81 . . . . 1.0 109.445 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.483 ' N ' HG21 ' A' ' 38' ' ' VAL . 4.2 mttt -143.8 105.41 4.3 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.278 -0.889 . . . . 1.0 109.766 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 41' ' ' SER . . . -161.16 105.8 1.34 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.411 -0.806 . . . . 1.0 108.905 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 40' ' ' ALA . 19.2 p 44.17 -105.56 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 1.0 108.903 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.517 ' HB1' ' CD2' ' A' ' 45' ' ' HIS . . . -88.57 48.0 1.58 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.582 -1.324 . . . . 1.0 108.232 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 67.82 -111.11 3.82 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.039 -2.024 . . . . 1.0 108.039 -178.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 45' ' ' HIS . . . -89.61 -22.15 37.87 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.219 -1.952 . . . . 1.0 108.219 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.606 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 2.3 t-80 79.43 27.96 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.355 0 N-CA-C 113.315 0.857 . . . . 1.0 113.315 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 45' ' ' HIS . 37.3 Cg_endo -79.34 114.25 3.27 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 N-CA-C 108.935 -1.217 . . . . 1.0 108.935 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.571 ' CG2' ' NH2' ' A' ' 115' ' ' ARG . 0.0 OUTLIER -102.32 144.95 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.967 -1.083 . . . . 1.0 108.802 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.576 HG22 ' CZ ' ' A' ' 151' ' ' PHE . 5.2 t -137.27 124.49 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.033 -1.042 . . . . 1.0 110.369 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.565 ' NE2' ' NH1' ' A' ' 115' ' ' ARG . 4.8 tt0 -140.06 142.51 36.16 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.524 -0.917 . . . . 1.0 108.524 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.04 141.05 48.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.939 -1.1 . . . . 1.0 109.897 -179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -140.66 84.98 1.97 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.349 -0.844 . . . . 1.0 109.449 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 53' ' ' TYR . . . 170.01 105.22 0.18 Allowed Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.304 -1.427 . . . . 1.0 110.648 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 111' ' ' GLU . 3.5 t80 175.9 156.95 0.22 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.426 -1.044 . . . . 1.0 109.965 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.488 ' CD1' ' C ' ' A' ' 54' ' ' LEU . 3.3 pp -140.71 11.02 2.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.421 -0.799 . . . . 1.0 109.255 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.449 ' O ' ' CE2' ' A' ' 53' ' ' TYR . 1.6 tm-20 -120.77 145.67 47.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.303 -0.873 . . . . 1.0 109.658 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.402 ' C ' ' ND2' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -90.25 35.81 0.87 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 1.0 109.96 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.487 ' C ' ' CD1' ' A' ' 109' ' ' LEU . 15.1 pt-20 -100.62 137.84 19.97 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.146 -0.971 . . . . 1.0 109.424 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.512 ' O ' ' CD2' ' A' ' 59' ' ' LEU . 36.7 Cg_endo -79.92 154.23 22.78 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.511 2.141 . . . . 1.0 110.501 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.512 ' CD2' ' O ' ' A' ' 58' ' ' PRO . 2.3 mt -141.27 156.29 45.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 1.0 109.172 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -87.26 135.55 33.27 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.223 -0.923 . . . . 1.0 109.104 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.52 ' CD2' ' HB2' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -87.94 131.15 34.71 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.275 -0.89 . . . . 1.0 109.499 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -98.52 82.66 2.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -0.911 . . . . 1.0 109.572 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.573 HD11 ' CZ ' ' A' ' 151' ' ' PHE . 58.9 tp -99.64 135.98 40.25 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.247 -0.908 . . . . 1.0 108.81 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.573 ' CE2' ' HA3' ' A' ' 66' ' ' GLY . 1.7 t80 -148.4 164.05 35.28 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.226 -0.921 . . . . 1.0 109.042 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.523 ' CG2' ' O ' ' A' ' 65' ' ' ILE . 8.1 tp -129.38 102.85 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.573 ' HA3' ' CE2' ' A' ' 64' ' ' PHE . . . -124.65 153.69 17.83 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 110.067 -1.213 . . . . 1.0 110.067 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.582 ' CG2' ' CD2' ' A' ' 76' ' ' HIS . 1.1 p -77.22 149.56 35.47 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.464 -1.021 . . . . 1.0 109.23 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -153.72 115.74 4.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 1.0 109.752 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.25 -7.95 58.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 1.0 109.522 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -159.91 -44.34 0.05 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -0.929 . . . . 1.0 109.452 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -175.08 -34.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.262 -0.899 . . . . 1.0 109.625 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.08 89.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.9 . . . . 1.0 109.739 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 71' ' ' ARG . 2.2 pp -65.35 129.72 40.76 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.283 -0.885 . . . . 1.0 109.666 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.482 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 13.5 mmt180 -145.13 160.31 46.49 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 1.0 109.247 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -75.99 142.67 25.21 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.342 2.028 . . . . 1.0 110.202 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.582 ' CD2' ' CG2' ' A' ' 67' ' ' THR . 0.3 OUTLIER -67.44 160.97 26.36 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.221 -0.924 . . . . 1.0 109.569 -179.642 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.513 ' HB2' ' CD1' ' A' ' 78' ' ' PHE . . . -73.87 -65.21 0.86 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.307 -0.871 . . . . 1.0 110.308 -179.38 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.683 ' CE2' ' CE1' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -111.91 -4.34 14.59 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.033 -1.042 . . . . 1.0 110.219 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.683 ' CE1' ' CE2' ' A' ' 78' ' ' PHE . 52.3 m-85 -83.89 105.94 15.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.98 -1.075 . . . . 1.0 108.963 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.525 ' HB2' ' CG ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -143.66 10.11 1.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.073 -1.017 . . . . 1.0 110.081 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 122' ' ' GLY . 11.9 m -75.68 146.91 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.983 -1.073 . . . . 1.0 109.497 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.615 ' CE1' ' CD1' ' A' ' 104' ' ' LEU . 5.7 t-80 -175.49 67.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.476 -0.765 . . . . 1.0 109.237 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.6 OUTLIER -122.66 139.9 53.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.235 -0.916 . . . . 1.0 109.746 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . 0.587 ' CG2' ' CB ' ' A' ' 120' ' ' CYS . 4.5 mp -100.11 133.52 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.343 -0.848 . . . . 1.0 109.675 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 86' ' ' GLY . 2.0 p -126.41 -163.88 1.27 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.275 -0.891 . . . . 1.0 109.302 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 85' ' ' THR . . . 41.66 -124.21 3.2 Favored Glycine 0 N--CA 1.483 1.829 0 N-CA-C 110.039 -1.224 . . . . 1.0 110.039 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.93 108.5 7.7 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.234 -1.156 . . . . 1.0 109.513 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.528 ' CG2' HG23 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -94.64 -177.17 4.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.363 -0.836 . . . . 1.0 109.409 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.452 HG23 ' HB ' ' A' ' 91' ' ' THR . 8.7 p -88.49 132.61 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.321 -0.862 . . . . 1.0 109.306 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.3 m -74.65 -0.43 17.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 1.0 109.806 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.452 ' HB ' HG23 ' A' ' 89' ' ' VAL . 16.4 m -80.75 -83.01 0.11 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.069 -1.019 . . . . 1.0 109.387 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.451 HG22 ' O ' ' A' ' 91' ' ' THR . 0.0 OUTLIER 179.33 162.46 0.85 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.302 -0.874 . . . . 1.0 109.459 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.518 ' HA ' ' CG1' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -165.19 156.98 15.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.263 -0.898 . . . . 1.0 110.014 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.465 ' HB2' ' O ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -155.61 150.08 26.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.467 -0.77 . . . . 1.0 109.064 179.78 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -120.45 148.48 43.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.136 -0.978 . . . . 1.0 109.837 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.29 121.22 9.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.303 -0.873 . . . . 1.0 109.557 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.495 ' HB ' ' CE ' ' A' ' 102' ' ' LYS . 2.1 tp -110.75 106.12 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.342 -0.849 . . . . 1.0 109.606 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.469 HD22 ' HB ' ' A' ' 101' ' ' THR . 2.1 pt? -110.15 130.28 55.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.205 -0.934 . . . . 1.0 109.48 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.535 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 16.6 m 35.07 83.98 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.077 -0.39 . . . . 1.0 111.379 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 99' ' ' SER . 0.7 OUTLIER 42.72 29.42 0.17 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.684 -0.635 . . . . 1.0 112.482 178.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.469 ' HB ' HD22 ' A' ' 98' ' ' LEU . 0.2 OUTLIER -132.34 109.4 9.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.247 -1.533 . . . . 1.0 109.969 179.141 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.525 ' CG ' ' HB2' ' A' ' 80' ' ' GLN . 9.9 mmtp -85.96 137.93 32.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.1 -1.0 . . . . 1.0 109.358 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.455 HG11 ' HB2' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -143.98 172.68 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.331 -0.855 . . . . 1.0 109.089 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.615 ' CD1' ' CE1' ' A' ' 82' ' ' HIS . 0.5 OUTLIER -124.31 135.55 53.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.27 -0.894 . . . . 1.0 110.147 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.502 ' N ' HD21 ' A' ' 104' ' ' LEU . 0.4 OUTLIER -139.99 125.03 18.58 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.601 -0.889 . . . . 1.0 108.601 179.405 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.518 ' CG1' ' HA ' ' A' ' 93' ' ' SER . 4.1 mp -128.94 115.81 19.03 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.976 -1.077 . . . . 1.0 110.115 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.41 97.3 1.12 Allowed 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 121.946 1.764 . . . . 1.0 109.64 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.494 HD13 ' CD ' ' A' ' 110' ' ' PRO . 0.7 OUTLIER -145.75 167.59 22.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 1.0 109.485 -179.205 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.521 ' CD2' ' OD1' ' A' ' 112' ' ' ASN . 3.9 tt -115.03 78.56 5.6 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.921 . . . . 1.0 110.346 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.494 ' CD ' HD13 ' A' ' 108' ' ' LEU . 38.1 Cg_endo -83.25 40.13 0.9 Allowed 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.589 2.192 . . . . 1.0 110.082 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.576 ' HB2' ' CD2' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -120.81 22.39 11.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.047 -1.033 . . . . 1.0 110.056 -178.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.523 ' OD1' ' N ' ' A' ' 112' ' ' ASN . 0.2 OUTLIER -122.32 -52.9 1.93 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.114 -0.991 . . . . 1.0 109.119 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 1.4 p 164.59 86.01 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.371 -0.831 . . . . 1.0 108.989 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' MET . . . . . 0.446 ' SD ' ' HA ' ' A' ' 110' ' ' PRO . 0.5 OUTLIER -154.7 144.55 21.66 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.14 -0.975 . . . . 1.0 109.829 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.571 ' NH2' ' CG2' ' A' ' 47' ' ' ILE . 0.0 OUTLIER -101.44 142.73 32.39 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.541 -0.911 . . . . 1.0 108.541 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.516 ' N ' ' HD3' ' A' ' 115' ' ' ARG . . . -134.78 96.55 3.56 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.994 -1.066 . . . . 1.0 109.87 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 117' ' ' VAL . 3.9 m -86.45 131.37 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.346 -0.846 . . . . 1.0 109.145 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.466 ' O ' ' HG2' ' A' ' 46' ' ' PRO . 2.2 mt -117.27 130.1 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.217 -0.927 . . . . 1.0 109.153 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 42' ' ' ALA . 0.7 OUTLIER -171.66 57.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.863 . . . . 1.0 109.695 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.587 ' CB ' ' CG2' ' A' ' 84' ' ' ILE . 60.7 m -145.19 43.73 1.32 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.137 -0.977 . . . . 1.0 109.845 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.449 ' O ' HG13 ' A' ' 38' ' ' VAL . . . -126.64 165.95 18.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 1.0 108.833 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . 0.511 ' O ' ' CG2' ' A' ' 81' ' ' VAL . . . -139.76 -179.48 17.76 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.697 -1.361 . . . . 1.0 109.697 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.573 HD13 ' CD2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -119.43 158.54 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.357 -1.084 . . . . 1.0 109.072 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.571 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -99.9 126.24 46.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 1.0 109.459 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -99.76 88.76 3.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.191 -0.943 . . . . 1.0 109.495 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.49 ' O ' ' CD2' ' A' ' 126' ' ' LEU . 1.7 tt -113.25 -3.6 13.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 1.0 109.648 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 63.69 160.18 0.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.141 -0.974 . . . . 1.0 109.505 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 40.8 p30 -115.83 47.81 1.31 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -0.91 . . . . 1.0 109.477 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 4.4 t -66.43 -28.48 68.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 1.0 109.482 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 129' ' ' SER . 0.3 OUTLIER 167.32 63.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.196 -0.94 . . . . 1.0 109.508 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.521 ' O ' ' CG2' ' A' ' 131' ' ' ILE . 0.6 OUTLIER -72.64 106.04 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.253 -0.904 . . . . 1.0 109.448 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.3 88.43 6.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 1.0 109.578 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.523 HD23 ' N ' ' A' ' 133' ' ' LEU . 0.0 OUTLIER -74.31 159.88 31.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.293 -0.88 . . . . 1.0 109.96 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.462 ' O ' HD21 ' A' ' 133' ' ' LEU . 4.2 ptp85 -65.99 -168.29 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 1.0 109.526 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 134' ' ' ARG . 5.6 mmtm -44.03 106.78 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.928 . . . . 1.0 109.466 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -106.37 -146.9 14.1 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.604 -1.398 . . . . 1.0 109.604 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -177.3 -34.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -1.082 . . . . 1.0 109.367 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 139' ' ' ASP . 12.7 t -144.89 177.03 9.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.273 -0.892 . . . . 1.0 109.332 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 138' ' ' THR . 1.8 m-20 66.54 99.79 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -0.932 . . . . 1.0 109.458 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.1 tp -177.84 42.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 1.0 109.422 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.46 ' O ' ' HG2' ' A' ' 142' ' ' ARG . . . -98.78 -8.66 54.06 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.747 -1.341 . . . . 1.0 109.747 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . 0.46 ' HG2' ' O ' ' A' ' 141' ' ' GLY . 0.0 OUTLIER 38.52 37.19 0.16 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.788 -0.831 . . . . 1.0 110.305 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 144' ' ' ASN . 1.5 mtpt -127.13 138.96 53.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 1.0 109.458 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 143' ' ' LYS . 1.2 m-20 67.38 163.28 0.19 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 1.0 109.516 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.495 ' HB ' ' CB ' ' A' ' 174' ' ' CYS . 0.0 OUTLIER -156.73 52.45 0.51 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.348 -0.845 . . . . 1.0 109.386 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.465 ' O ' ' HB ' ' A' ' 67' ' ' THR . 11.2 mtt180 -85.1 166.62 16.49 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.267 -0.896 . . . . 1.0 109.417 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.588 ' CG2' ' CG2' ' A' ' 172' ' ' ILE . 2.9 m -140.57 151.7 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -0.841 . . . . 1.0 109.422 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.496 ' HA ' ' CB ' ' A' ' 170' ' ' ASN . 42.6 mtt180 -154.52 125.72 7.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.132 -0.98 . . . . 1.0 109.448 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.494 HD22 ' ND2' ' A' ' 170' ' ' ASN . 0.4 OUTLIER -81.26 109.48 15.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.161 -0.962 . . . . 1.0 109.717 -179.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . 0.52 ' CG1' ' OE1' ' A' ' 166' ' ' GLN . 44.0 t -81.47 123.85 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.377 -0.827 . . . . 1.0 109.846 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.576 ' CZ ' HG22 ' A' ' 48' ' ' VAL . 1.9 m-85 -110.4 121.51 45.46 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.656 -0.868 . . . . 1.0 108.656 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . 0.517 ' CG ' ' HA ' ' A' ' 166' ' ' GLN . 1.8 mtt180 -145.03 123.12 12.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.92 -1.112 . . . . 1.0 110.184 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.516 HG11 ' CD1' ' A' ' 163' ' ' LEU . 7.1 p -114.85 129.71 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.476 -0.935 . . . . 1.0 108.476 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' HIS . . . . . 0.555 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 49.8 m-70 -130.35 113.43 14.35 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.116 -0.99 . . . . 1.0 109.718 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.531 ' CG2' ' HD2' ' A' ' 156' ' ' PRO . 5.2 p -98.74 140.94 22.12 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.306 -0.871 . . . . 1.0 109.019 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 33.6 Cg_endo -75.04 116.17 4.5 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.319 2.012 . . . . 1.0 110.791 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLN . . . . . 0.465 ' HB2' ' HD2' ' A' ' 158' ' ' PRO . 0.8 OUTLIER -132.71 165.24 37.95 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.506 -0.746 . . . . 1.0 109.247 -179.556 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 157' ' ' GLN . 33.8 Cg_endo -76.4 -63.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.194 1.93 . . . . 1.0 109.985 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.6 t -64.91 -90.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -0.862 . . . . 1.0 109.184 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . 0.431 ' HA2' ' CD ' ' A' ' 157' ' ' GLN . . . 164.06 -28.21 0.22 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.641 -1.383 . . . . 1.0 109.641 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -79.28 79.62 5.7 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.363 -1.081 . . . . 1.0 108.556 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.565 ' O ' ' CD1' ' A' ' 13' ' ' TYR . 1.3 m -134.97 -82.21 0.43 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.839 -0.8 . . . . 1.0 108.839 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LEU . . . . . 0.539 ' O ' ' CG ' ' A' ' 163' ' ' LEU . 2.1 pp -159.69 106.96 1.69 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.957 -1.09 . . . . 1.0 109.728 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.555 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -164.95 85.02 0.4 Allowed 'General case' 0 C--N 1.294 -1.833 0 O-C-N 120.803 -1.186 . . . . 1.0 109.141 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.503 HD21 ' N ' ' A' ' 165' ' ' LEU . 1.5 pt? -131.38 168.82 16.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.034 -1.042 . . . . 1.0 110.026 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.52 ' OE1' ' CG1' ' A' ' 150' ' ' VAL . 7.0 tp-100 -101.97 149.74 23.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.452 -0.78 . . . . 1.0 109.548 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . 0.49 ' O ' ' CG1' ' A' ' 167' ' ' VAL . 39.0 t -144.18 71.51 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 1.0 109.521 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.44 136.19 42.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.089 -1.007 . . . . 1.0 109.5 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 7.3 t -175.3 133.96 0.31 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 1.0 109.613 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.496 ' CB ' ' HA ' ' A' ' 148' ' ' ARG . 1.9 t30 170.03 97.72 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.356 -0.84 . . . . 1.0 109.436 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PRO . . . . . 0.436 ' HG2' ' HB2' ' A' ' 23' ' ' SER . 35.3 Cg_endo -77.57 72.18 6.15 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.404 2.069 . . . . 1.0 110.615 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ILE . . . . . 0.588 ' CG2' ' CG2' ' A' ' 147' ' ' VAL . 13.9 mm -107.79 126.92 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.202 -0.937 . . . . 1.0 109.251 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.453 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 9.9 pt-20 -116.0 145.94 42.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 1.0 109.575 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' CYS . . . . . 0.495 ' CB ' ' HB ' ' A' ' 145' ' ' THR . 4.4 m -114.31 -170.35 1.71 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 1.0 109.414 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.409 ' C ' ' HG2' ' A' ' 176' ' ' GLN . 1.2 p 65.64 113.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 1.0 109.479 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLN . . . . . 0.409 ' HG2' ' C ' ' A' ' 175' ' ' SER . 0.0 OUTLIER -131.53 -153.29 0.55 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.875 . . . . 1.0 109.404 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.429 ' O ' ' OG ' ' A' ' 178' ' ' SER . 2.4 mpt_? -67.55 160.65 27.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 1.0 109.501 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 177' ' ' ARG . 25.2 p . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.968 -1.015 . . . . 1.0 109.45 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.504 ' O ' ' HA3' ' A' ' 52' ' ' GLY . 34.7 Cg_endo . . . . . 0 C--O 1.213 -0.753 0 N-CA-C 110.238 -0.716 . . . . 1.0 110.238 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.577 ' CE2' ' O ' ' A' ' 162' ' ' THR . 2.8 m-85 -69.31 135.19 50.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 1.0 109.568 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 51' ' ' HIS . 3.3 pt-20 -172.31 126.8 0.54 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.964 -1.085 . . . . 1.0 109.838 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.686 ' O ' HD12 ' A' ' 15' ' ' LEU . 1.3 pp -108.55 87.81 2.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.333 -0.854 . . . . 1.0 109.264 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -101.63 148.31 25.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.187 -0.945 . . . . 1.0 109.768 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.539 HG23 ' O ' ' A' ' 47' ' ' ILE . 1.2 mp -69.55 141.74 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.378 -0.826 . . . . 1.0 108.824 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.495 ' OE2' ' CZ ' ' A' ' 115' ' ' ARG . 4.9 tt0 -76.6 -32.93 58.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.296 -0.878 . . . . 1.0 109.816 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.488 ' HB ' HG12 ' A' ' 47' ' ' ILE . 98.2 t -142.29 134.54 26.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.186 -0.946 . . . . 1.0 109.631 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.402 ' HG2' ' CG2' ' A' ' 17' ' ' ILE . 0.7 OUTLIER -122.79 99.92 41.18 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.357 -0.84 . . . . 1.0 109.287 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.489 ' HG3' ' HB3' ' A' ' 42' ' ' ALA . 34.9 Cg_endo -76.53 -179.21 5.1 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.396 2.064 . . . . 1.0 110.576 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -43.18 162.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 1.0 109.476 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.488 ' CB ' ' HG2' ' A' ' 171' ' ' PRO . 8.4 t -119.48 50.02 1.29 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -0.886 . . . . 1.0 109.988 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.29 167.07 17.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.115 -0.991 . . . . 1.0 109.283 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 1.042 ' CE1' HG22 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -170.4 118.6 0.55 Allowed 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 120.154 -0.618 . . . . 1.0 109.63 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.23 76.59 7.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.317 -0.864 . . . . 1.0 109.259 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.428 ' HB2' ' CD1' ' A' ' 123' ' ' ILE . . . . . . . . 0 N--CA 1.487 1.422 0 O-C-N 121.328 -0.858 . . . . 1.0 109.929 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 122.684 1.231 . . . . 1.0 110.832 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 1.042 HG22 ' CE1' ' A' ' 25' ' ' HIS . 3.9 p -133.74 121.28 39.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 107.131 -1.433 . . . . 1.0 107.131 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 121' ' ' ALA . 24.8 mmtt -155.32 116.16 3.9 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.297 -0.877 . . . . 1.0 109.56 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.24 -152.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.6 -0.688 . . . . 1.0 110.081 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 42' ' ' ALA . 1.8 m -51.56 158.39 0.92 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.23 -0.919 . . . . 1.0 109.963 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.489 ' HB3' ' HG3' ' A' ' 21' ' ' PRO . . . 43.0 47.04 4.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.434 -0.791 . . . . 1.0 109.425 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.515 ' HA3' ' CA ' ' A' ' 119' ' ' ASP . . . 44.46 51.66 7.7 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.386 -1.485 . . . . 1.0 109.386 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.466 ' HA3' ' HD2' ' A' ' 39' ' ' LYS . . . 63.89 -87.58 0.07 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.686 -1.365 . . . . 1.0 109.686 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.46 ' NE2' HD12 ' A' ' 149' ' ' LEU . 36.7 m170 -50.96 144.93 12.85 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.213 -1.169 . . . . 1.0 109.852 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . 36.2 Cg_endo -79.43 -167.93 0.57 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.763 2.309 . . . . 1.0 110.522 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.989 ' CG2' HG12 ' A' ' 117' ' ' VAL . 0.9 OUTLIER -93.23 158.57 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.557 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 3.4 t -136.76 132.84 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 120.925 -1.109 . . . . 1.0 110.359 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.485 ' O ' ' CG ' ' A' ' 49' ' ' GLN . 2.6 pt20 -145.36 120.22 9.94 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.913 -0.773 . . . . 1.0 108.913 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.475 ' HG ' ' HB3' ' A' ' 15' ' ' LEU . 0.3 OUTLIER -86.22 124.11 32.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.149 -0.97 . . . . 1.0 109.893 -179.545 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.484 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 51.4 p-80 -141.23 132.59 26.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.28 -0.887 . . . . 1.0 108.802 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 12' ' ' PRO . . . 137.0 -2.79 3.32 Favored Glycine 0 N--CA 1.483 1.798 0 C-N-CA 119.262 -1.447 . . . . 1.0 110.578 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.583 ' CE2' ' HB2' ' A' ' 163' ' ' LEU . 0.5 OUTLIER -129.32 117.8 21.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.062 -1.257 . . . . 1.0 109.492 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.844 HD12 ' O ' ' A' ' 54' ' ' LEU . 1.3 pp -99.96 35.61 2.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.156 -0.965 . . . . 1.0 109.567 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.56 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 3.9 tp10 -80.0 144.22 33.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 1.0 109.583 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -87.72 34.6 0.71 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.232 -0.917 . . . . 1.0 109.957 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.655 ' HG3' HD21 ' A' ' 59' ' ' LEU . 11.7 pt-20 -133.96 143.92 49.45 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.266 -0.897 . . . . 1.0 109.276 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.576 ' O ' HD23 ' A' ' 59' ' ' LEU . 35.6 Cg_endo -78.57 134.15 12.16 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.307 2.005 . . . . 1.0 110.63 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.655 HD21 ' HG3' ' A' ' 57' ' ' GLU . 12.8 mt -115.59 165.07 13.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.199 -0.938 . . . . 1.0 108.683 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.426 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 40.7 mtt -106.13 112.99 26.25 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.147 -0.971 . . . . 1.0 109.993 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.896 HD21 ' HB2' ' A' ' 63' ' ' LEU . 1.9 tt -70.18 142.08 52.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.578 -0.701 . . . . 1.0 109.349 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.468 ' OE1' ' NH2' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -99.03 96.57 7.9 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.219 -0.926 . . . . 1.0 108.858 179.588 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.137 HD13 ' CE1' ' A' ' 151' ' ' PHE . 20.8 tp -119.15 132.07 55.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.296 -0.878 . . . . 1.0 109.911 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.59 ' HB3' HG12 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -164.96 165.83 19.9 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.717 -0.845 . . . . 1.0 108.717 179.304 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.759 HD13 ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -105.13 120.94 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.937 -1.102 . . . . 1.0 109.242 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.759 ' N ' HD13 ' A' ' 65' ' ' ILE . . . -132.2 149.1 19.35 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.696 -1.361 . . . . 1.0 109.696 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.746 HG22 ' CD2' ' A' ' 76' ' ' HIS . 16.2 p -83.66 154.45 23.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.371 -1.076 . . . . 1.0 109.319 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.555 ' HB3' ' HD2' ' A' ' 148' ' ' ARG . . . -159.82 118.1 2.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 1.0 109.773 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.447 ' CG ' ' NH2' ' A' ' 146' ' ' ARG . 0.4 OUTLIER -102.23 -13.52 17.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.908 . . . . 1.0 109.164 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -142.5 -55.26 0.43 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.363 -0.836 . . . . 1.0 109.412 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.66 -34.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.955 . . . . 1.0 109.697 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 72' ' ' LEU . 70.3 mt -66.34 86.8 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.914 . . . . 1.0 109.587 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.662 ' O ' HD12 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -50.03 154.77 1.05 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.265 -0.897 . . . . 1.0 109.686 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.497 ' HB3' ' HD2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -144.37 162.24 40.59 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.317 -0.864 . . . . 1.0 108.748 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 74' ' ' ARG . 33.1 Cg_endo -76.32 121.18 5.95 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.213 1.942 . . . . 1.0 110.051 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.915 ' NE2' HG12 ' A' ' 147' ' ' VAL . 1.6 t-80 -57.89 163.4 2.7 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.361 -0.837 . . . . 1.0 110.016 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.12 -76.29 0.08 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 1.0 109.548 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -125.41 21.86 7.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 1.0 109.706 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.586 ' HB2' ' CG ' ' A' ' 76' ' ' HIS . 3.9 m-30 -79.91 75.99 6.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.213 -0.93 . . . . 1.0 109.077 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.553 ' CB ' ' HB3' ' A' ' 102' ' ' LYS . 1.1 pt20 -139.0 4.41 2.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.945 -1.097 . . . . 1.0 110.307 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.91 HG23 ' O ' ' A' ' 122' ' ' GLY . 15.0 m -78.65 144.77 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.958 -1.089 . . . . 1.0 109.182 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.588 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 3.1 p80 -175.93 59.38 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 118.998 -1.081 . . . . 1.0 110.194 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 120' ' ' CYS . 2.9 mmt85 -81.44 140.15 34.82 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.112 -0.993 . . . . 1.0 109.325 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.516 ' CG1' ' HB2' ' A' ' 120' ' ' CYS . 3.5 mp -106.32 135.58 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.205 -0.934 . . . . 1.0 109.764 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 49.9 p . . . . . 0 C--N 1.303 -1.453 0 O-C-N 121.406 -0.808 . . . . 1.0 109.106 179.915 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.863 HG13 HG22 ' A' ' 91' ' ' THR . 6.6 p . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.3 m -86.78 16.02 5.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 1.0 109.524 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.863 HG22 HG13 ' A' ' 89' ' ' VAL . 7.4 t -69.89 125.95 28.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -0.952 . . . . 1.0 109.575 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.829 ' O ' HG23 ' A' ' 106' ' ' ILE . 18.3 m -93.88 91.21 6.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.92 . . . . 1.0 109.235 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.55 ' HA ' HG23 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -103.3 173.28 6.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -0.974 . . . . 1.0 109.951 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -145.76 161.66 39.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.477 -0.765 . . . . 1.0 109.167 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.523 ' HG2' ' NE2' ' A' ' 82' ' ' HIS . 43.5 mt-10 -128.51 120.54 26.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 1.0 109.872 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 102' ' ' LYS . . . -114.18 124.56 52.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 1.0 108.94 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.688 HD13 ' N ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -124.73 126.39 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.09 -1.006 . . . . 1.0 109.876 -179.421 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.688 ' N ' HD13 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -126.22 59.77 1.32 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.938 . . . . 1.0 109.448 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER 77.03 103.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 1.0 109.612 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' A' ' 99' ' ' SER . 3.2 p-10 42.88 43.31 3.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.694 -0.629 . . . . 1.0 110.18 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.463 ' HB ' ' HG ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -159.58 87.96 0.84 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.993 -1.067 . . . . 1.0 109.776 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.553 ' HB3' ' CB ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -97.32 152.67 18.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.343 -0.848 . . . . 1.0 109.159 179.549 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.59 HG12 ' HB3' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -146.36 169.97 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.217 -0.927 . . . . 1.0 109.06 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.019 HD12 ' HG ' ' A' ' 63' ' ' LEU . 3.3 mt -120.31 128.56 53.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.933 . . . . 1.0 109.615 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -123.94 106.73 10.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.269 -0.894 . . . . 1.0 108.835 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.829 HG23 ' O ' ' A' ' 92' ' ' THR . 4.5 mt -119.38 115.95 33.88 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 1.0 109.832 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.742 ' C ' HD23 ' A' ' 108' ' ' LEU . 33.7 Cg_endo -75.87 119.0 5.23 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 121.96 1.773 . . . . 1.0 109.448 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.742 HD23 ' C ' ' A' ' 107' ' ' PRO . 6.1 mt -115.52 165.18 13.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.193 -0.942 . . . . 1.0 110.494 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.862 HD23 ' HB2' ' A' ' 112' ' ' ASN . 1.0 OUTLIER -97.3 126.69 40.92 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.485 ' CG ' ' O ' ' A' ' 57' ' ' GLU . 36.5 Cg_endo -79.96 -30.65 2.14 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 122.345 2.03 . . . . 1.0 112.03 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 54' ' ' LEU . 2.1 tt0 -139.35 66.99 1.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.773 -1.204 . . . . 1.0 110.526 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.862 ' HB2' HD23 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -165.39 -67.52 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 1.0 109.505 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.4 OUTLIER 164.63 108.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.05 -1.032 . . . . 1.0 109.343 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.45 ' O ' ' HG3' ' A' ' 114' ' ' MET . 5.9 tpt -154.67 49.83 0.6 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.911 . . . . 1.0 110.129 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.495 ' CZ ' ' OE2' ' A' ' 18' ' ' GLU . 10.0 ttt-85 -74.69 134.33 41.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.966 . . . . 1.0 108.633 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -138.37 153.12 48.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.902 -1.124 . . . . 1.0 110.294 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.989 HG12 ' CG2' ' A' ' 47' ' ' ILE . 4.5 m -126.14 126.46 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.476 ' CD1' HD21 ' A' ' 63' ' ' LEU . 32.4 mt -99.17 104.3 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 1.0 109.604 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.515 ' CA ' ' HA3' ' A' ' 43' ' ' GLY . 14.6 p-10 -149.5 39.48 0.81 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 1.0 109.353 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.516 ' HB2' ' CG1' ' A' ' 84' ' ' ILE . 60.7 m -145.05 59.03 1.3 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 1.0 109.51 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.522 ' O ' ' CG ' ' A' ' 39' ' ' LYS . . . -143.47 -176.38 4.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.417 -0.802 . . . . 1.0 109.119 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.91 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -154.6 168.66 32.77 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.575 -1.41 . . . . 1.0 109.575 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -114.55 154.63 15.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.236 -1.155 . . . . 1.0 108.836 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.517 HD23 HG21 ' A' ' 81' ' ' VAL . 0.5 OUTLIER -118.62 109.58 16.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.129 -0.982 . . . . 1.0 109.506 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.509 ' CD ' ' O ' ' A' ' 125' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.303 -0.873 . . . . 1.0 109.434 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.31 0.576 . . . . 1.0 109.467 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -89.58 164.78 14.62 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.27 -0.894 . . . . 1.0 109.594 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.915 HG12 ' NE2' ' A' ' 76' ' ' HIS . 31.6 m -140.84 163.49 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.472 -0.768 . . . . 1.0 109.254 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.555 ' HD2' ' HB3' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -155.58 113.31 3.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.958 . . . . 1.0 109.706 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.911 HD21 ' CD1' ' A' ' 63' ' ' LEU . 1.7 tt -79.76 121.56 25.51 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.208 -0.932 . . . . 1.0 109.217 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 36.0 t -96.42 123.55 48.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.232 -0.917 . . . . 1.0 109.574 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 1.137 ' CE1' HD13 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -120.5 92.33 3.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 1.0 108.954 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.537 ' CB ' ' HA ' ' A' ' 166' ' ' GLN . 24.4 ptt85 -139.28 137.59 36.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.139 -0.976 . . . . 1.0 110.219 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.701 ' CG1' HD21 ' A' ' 163' ' ' LEU . 9.8 p -115.42 128.28 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.264 -0.897 . . . . 1.0 108.669 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.582 ' CD2' ' HB2' ' A' ' 164' ' ' SER . 46.6 m80 -126.69 116.63 21.26 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.11 -0.994 . . . . 1.0 109.542 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 1.04 ' HB ' HD12 ' A' ' 163' ' ' LEU . 9.8 p -99.16 141.35 22.7 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.206 -0.934 . . . . 1.0 109.169 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 35.4 Cg_endo -77.32 119.03 4.82 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.422 2.081 . . . . 1.0 110.634 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.461 ' OE1' ' HD2' ' A' ' 158' ' ' PRO . 0.1 OUTLIER -160.19 173.03 5.22 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.266 -0.896 . . . . 1.0 109.44 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.461 ' HD2' ' OE1' ' A' ' 157' ' ' GLN . 35.1 Cg_endo -77.87 -67.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.327 2.018 . . . . 1.0 110.44 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 36.6 m -64.15 109.38 1.83 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.905 . . . . 1.0 109.345 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.28 -30.27 11.14 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.542 -1.423 . . . . 1.0 109.542 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.7 mtp85 -79.59 79.06 6.1 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.257 -1.016 . . . . 1.0 108.257 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.647 HG22 ' N ' ' A' ' 163' ' ' LEU . 1.3 m -136.39 -79.77 0.4 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.001 -0.74 . . . . 1.0 109.001 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 1.04 HD12 ' HB ' ' A' ' 155' ' ' VAL . 0.1 OUTLIER -149.26 106.31 3.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.984 -1.072 . . . . 1.0 108.189 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.666 ' N ' HD22 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -163.83 106.34 0.95 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.608 -1.307 . . . . 1.0 109.466 -179.284 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.691 HD13 ' H ' ' A' ' 166' ' ' GLN . 0.2 OUTLIER -134.19 151.36 51.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.081 -1.012 . . . . 1.0 109.696 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.691 ' H ' HD13 ' A' ' 165' ' ' LEU . 27.9 mt-30 -123.69 139.44 53.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 1.0 109.374 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 167' ' ' VAL . 46.7 t -142.54 71.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.214 -0.929 . . . . 1.0 109.674 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.6 108.89 20.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 1.0 109.212 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 2.7 m -148.6 137.83 21.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.945 . . . . 1.0 109.674 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 169' ' ' SER . 0.6 OUTLIER 171.74 92.49 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.359 -0.838 . . . . 1.0 109.52 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.488 ' HG2' ' CB ' ' A' ' 23' ' ' SER . 34.8 Cg_endo -77.42 72.02 6.16 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.373 2.049 . . . . 1.0 110.694 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 172' ' ' ILE . 13.8 mm -115.21 78.74 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 1.0 109.233 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 1.0 109.746 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo . . . . . 0 C--O 1.216 -0.603 0 N-CA-C 110.395 -0.656 . . . . 1.0 110.395 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.498 ' HA ' ' HA3' ' A' ' 52' ' ' GLY . 13.0 m-30 -80.06 123.32 27.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 1.0 109.469 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -152.2 130.07 11.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.942 . . . . 1.0 109.616 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.689 HD13 HD12 ' A' ' 50' ' ' LEU . 53.8 tp -107.41 83.47 1.82 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.237 -0.914 . . . . 1.0 109.198 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.61 157.48 23.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 1.0 109.805 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.674 HG21 ' NE2' ' A' ' 20' ' ' GLN . 1.1 mp -79.86 144.35 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.412 ' OE1' ' CD ' ' A' ' 49' ' ' GLN . 27.6 tp10 -80.7 -63.88 1.31 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 1.0 109.094 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.561 HG12 ' HD3' ' A' ' 21' ' ' PRO . 2.0 t -92.69 126.21 45.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.339 -0.851 . . . . 1.0 109.134 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.674 ' NE2' HG21 ' A' ' 17' ' ' ILE . 5.5 tp-100 -130.67 63.65 70.58 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.938 . . . . 1.0 109.66 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.561 ' HD3' HG12 ' A' ' 19' ' ' VAL . 36.0 Cg_endo -78.09 -177.96 4.26 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.513 2.142 . . . . 1.0 110.449 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -50.36 161.01 0.33 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.229 -0.919 . . . . 1.0 109.383 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.411 ' O ' ' CG1' ' A' ' 172' ' ' ILE . 2.1 t -154.62 58.72 0.69 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.263 -0.898 . . . . 1.0 109.871 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -103.5 166.22 10.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 1.0 109.411 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.566 ' CE1' ' N ' ' A' ' 38' ' ' VAL . 11.5 t-160 -163.86 113.12 1.23 Allowed 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.405 -0.81 . . . . 1.0 109.827 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.439 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 5.1 ttp180 -89.57 75.95 7.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.406 -0.808 . . . . 1.0 109.103 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.354 -0.841 . . . . 1.0 109.767 -179.774 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.566 ' N ' ' CE1' ' A' ' 25' ' ' HIS . 2.5 p -54.84 106.08 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.329 -0.857 . . . . 1.0 109.468 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.4 98.92 4.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 1.0 109.583 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.449 ' O ' ' O ' ' A' ' 41' ' ' SER . . . -158.23 95.92 1.4 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.896 . . . . 1.0 109.548 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 43' ' ' GLY . 1.9 t 60.87 144.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 1.0 109.465 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 51.45 -90.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.888 . . . . 1.0 109.423 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 41' ' ' SER . . . -167.92 34.88 0.21 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.442 -1.463 . . . . 1.0 109.442 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.558 ' HA3' HG22 ' A' ' 38' ' ' VAL . . . 109.69 -84.83 0.38 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.563 -1.415 . . . . 1.0 109.563 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.477 ' HB3' ' HD2' ' A' ' 46' ' ' PRO . 74.0 m-70 -77.14 159.88 77.18 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.358 -1.084 . . . . 1.0 109.504 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 45' ' ' HIS . 35.1 Cg_endo -77.47 -176.79 3.4 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 122.598 2.199 . . . . 1.0 110.679 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.767 HG23 HG12 ' A' ' 117' ' ' VAL . 3.8 mm -94.04 159.51 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.496 -0.753 . . . . 1.0 109.142 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.78 135.68 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.154 -0.966 . . . . 1.0 109.895 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.455 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 2.6 pt20 -150.23 143.43 24.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.827 . . . . 1.0 109.111 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.689 HD12 HD13 ' A' ' 15' ' ' LEU . 3.0 tt -113.48 140.12 48.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.17 -0.957 . . . . 1.0 109.772 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 51' ' ' HIS . 14.6 p80 -140.08 81.59 1.82 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 1.0 109.093 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . -156.65 -97.92 0.14 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.049 -1.22 . . . . 1.0 110.049 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.477 ' HB3' ' CG ' ' A' ' 111' ' ' GLU . 0.4 OUTLIER -39.56 129.51 1.9 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.835 -0.803 . . . . 1.0 110.145 -179.519 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.5 mt -101.54 3.66 40.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.321 -0.862 . . . . 1.0 109.561 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 111' ' ' GLU . 2.7 tm-20 -79.71 138.5 37.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.179 -0.95 . . . . 1.0 109.362 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.452 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 5.0 p-10 -85.96 56.74 4.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.913 . . . . 1.0 109.599 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.483 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 5.0 mt-10 -105.64 143.2 26.35 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 1.0 109.245 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.537 ' O ' HD23 ' A' ' 59' ' ' LEU . 36.2 Cg_endo -78.62 120.19 4.7 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.394 2.063 . . . . 1.0 110.451 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.537 HD23 ' O ' ' A' ' 58' ' ' PRO . 20.6 mt -119.94 164.51 15.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 1.0 109.138 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -111.26 132.83 54.06 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.172 -0.955 . . . . 1.0 109.61 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.521 ' CD2' ' HB3' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -86.54 121.79 29.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.39 -0.819 . . . . 1.0 109.265 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.472 ' O ' ' HG2' ' A' ' 152' ' ' ARG . 9.4 mm-40 -92.48 75.68 5.14 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.203 -0.936 . . . . 1.0 108.872 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.818 HD22 ' CE1' ' A' ' 151' ' ' PHE . 0.4 OUTLIER -116.06 155.61 27.82 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.372 -0.83 . . . . 1.0 109.672 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 1.03 ' HA ' HD12 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -165.6 -178.91 5.12 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.381 -0.824 . . . . 1.0 108.909 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.75 HG23 ' O ' ' A' ' 65' ' ' ILE . 0.8 OUTLIER -112.77 100.58 11.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.068 -1.02 . . . . 1.0 109.091 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 74' ' ' ARG . . . -118.99 149.94 18.06 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.942 -1.263 . . . . 1.0 109.942 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.461 HG22 ' ND1' ' A' ' 76' ' ' HIS . 20.4 p -78.4 146.78 34.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.421 -1.046 . . . . 1.0 109.151 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.756 ' HB3' ' HG3' ' A' ' 148' ' ' ARG . . . -152.49 116.16 4.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.148 -0.97 . . . . 1.0 109.535 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.511 ' HA ' ' NE ' ' A' ' 146' ' ' ARG . 1.6 p30 -85.0 -25.86 27.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.37 -0.832 . . . . 1.0 109.334 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -133.0 -49.49 0.87 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.192 -0.942 . . . . 1.0 109.322 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -175.06 -38.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 1.0 109.565 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.546 HD23 ' H ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -55.89 89.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.907 . . . . 1.0 109.601 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -51.9 171.79 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.178 -0.951 . . . . 1.0 109.613 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.517 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 2.1 mtm180 -168.99 163.17 7.72 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.354 -0.841 . . . . 1.0 109.284 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 76' ' ' HIS . 35.3 Cg_endo -77.64 108.33 2.54 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.352 2.035 . . . . 1.0 110.437 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.53 ' CD2' ' CG ' ' A' ' 79' ' ' TYR . 5.9 t60 -42.07 161.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.423 -0.798 . . . . 1.0 110.01 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -48.83 -74.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.303 -0.873 . . . . 1.0 109.369 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -135.32 22.79 3.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -0.929 . . . . 1.0 109.39 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.53 ' CG ' ' CD2' ' A' ' 76' ' ' HIS . 4.7 m-30 -80.21 118.45 21.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.262 -0.899 . . . . 1.0 109.354 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.541 ' HB2' ' CG ' ' A' ' 102' ' ' LYS . 0.1 OUTLIER -163.32 23.69 0.08 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.973 . . . . 1.0 109.804 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 122' ' ' GLY . 15.1 m -86.14 150.93 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.098 -1.001 . . . . 1.0 109.307 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.559 ' ND1' ' HB2' ' A' ' 121' ' ' ALA . 12.5 t60 -175.38 75.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.286 -0.884 . . . . 1.0 109.414 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 120' ' ' CYS . 15.2 mmm180 -109.7 130.24 55.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.295 -0.878 . . . . 1.0 109.64 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.565 HG23 ' CB ' ' A' ' 120' ' ' CYS . 4.6 mp -104.22 136.18 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 1.0 109.455 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.4 p . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.393 -0.817 . . . . 1.0 109.288 179.731 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.555 HG13 ' H ' ' A' ' 91' ' ' THR . 9.8 p . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.26 0.552 . . . . 1.0 109.537 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.36 12.78 7.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -0.94 . . . . 1.0 109.589 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.555 ' H ' HG13 ' A' ' 89' ' ' VAL . 16.0 m -103.14 104.88 15.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 1.0 109.472 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.762 ' O ' HG23 ' A' ' 106' ' ' ILE . 10.0 t -54.22 158.56 2.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.16 -0.962 . . . . 1.0 109.338 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.24 172.79 12.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 1.0 109.7 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -155.07 151.78 28.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.361 -0.837 . . . . 1.0 109.534 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -125.7 132.84 52.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 1.0 109.313 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -125.27 120.65 31.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.13 -0.981 . . . . 1.0 109.699 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.889 HD12 ' O ' ' A' ' 101' ' ' THR . 9.9 tp -125.0 133.7 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 1.0 109.293 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.531 HD23 ' N ' ' A' ' 98' ' ' LEU . 1.0 OUTLIER -133.34 50.86 2.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.222 -0.924 . . . . 1.0 109.53 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER 76.66 114.16 0.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.309 -0.87 . . . . 1.0 109.742 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.43 ' CG ' ' O ' ' A' ' 99' ' ' SER . 3.9 p-10 43.49 35.03 0.86 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.665 -0.647 . . . . 1.0 110.476 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.889 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -156.15 102.63 2.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.927 -1.108 . . . . 1.0 109.743 179.642 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.798 ' HD2' HD13 ' A' ' 97' ' ' ILE . 4.5 tptt -112.29 153.68 26.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 1.0 109.386 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.964 HG12 ' HB3' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -158.54 168.66 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.271 -0.893 . . . . 1.0 109.113 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.03 HD12 ' HA ' ' A' ' 64' ' ' PHE . 1.1 mt -116.79 134.85 54.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 1.0 109.734 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -127.08 112.32 15.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.368 -0.833 . . . . 1.0 109.273 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 1.029 HG22 HD21 ' A' ' 108' ' ' LEU . 3.4 mt -121.69 107.0 36.59 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.907 . . . . 1.0 109.606 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.759 ' O ' HD23 ' A' ' 108' ' ' LEU . 33.8 Cg_endo -75.46 104.39 1.9 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 122.09 1.86 . . . . 1.0 110.133 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.029 HD21 HG22 ' A' ' 106' ' ' ILE . 3.0 mt -129.02 163.67 24.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.399 -0.813 . . . . 1.0 109.695 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -129.86 69.23 81.55 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.386 -0.821 . . . . 1.0 109.238 179.796 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.465 ' HA ' ' CG ' ' A' ' 114' ' ' MET . 36.8 Cg_endo -81.02 45.47 2.01 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 122.703 2.269 . . . . 1.0 110.908 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 55' ' ' GLU . 53.6 mp0 -97.85 -11.48 23.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.99 -1.069 . . . . 1.0 109.684 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 113' ' ' SER . 0.3 OUTLIER -107.85 -55.6 2.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.18 -0.95 . . . . 1.0 109.429 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.1 OUTLIER 169.8 102.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 1.0 109.501 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.465 ' CG ' ' HA ' ' A' ' 110' ' ' PRO . 1.0 OUTLIER -164.79 122.31 1.62 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 1.0 109.574 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.641 ' HD3' HG21 ' A' ' 47' ' ' ILE . 7.5 ttm180 -102.01 136.08 42.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.883 . . . . 1.0 109.477 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.06 139.67 53.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 1.0 109.349 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.767 HG12 HG23 ' A' ' 47' ' ' ILE . 4.3 m -114.99 127.03 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 1.0 109.547 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.463 ' O ' ' HB2' ' A' ' 45' ' ' HIS . 16.1 mt -113.06 100.96 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 1.0 109.387 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.487 ' HB2' ' CA ' ' A' ' 43' ' ' GLY . 4.9 p-10 -153.71 50.72 0.68 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 1.0 109.486 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.565 ' CB ' HG23 ' A' ' 84' ' ' ILE . 96.0 m -137.77 42.85 2.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.221 -0.925 . . . . 1.0 109.589 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.559 ' HB2' ' ND1' ' A' ' 82' ' ' HIS . . . -129.59 172.21 11.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.867 . . . . 1.0 108.95 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -145.36 -165.5 11.3 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.794 -1.322 . . . . 1.0 109.794 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.548 HD11 ' ND1' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -125.42 157.18 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.32 -1.106 . . . . 1.0 108.93 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.538 ' HB2' HG11 ' A' ' 81' ' ' VAL . 7.6 tp -140.05 147.05 39.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.098 -1.001 . . . . 1.0 109.725 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.6 tttm . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 1.0 109.232 179.801 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.495 -0.558 . . . . 1.0 109.495 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.511 ' NE ' ' HA ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -98.45 175.13 6.14 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.219 -0.925 . . . . 1.0 109.439 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.409 HG23 ' OD1' ' A' ' 170' ' ' ASN . 17.3 m -138.83 167.19 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.357 -0.84 . . . . 1.0 109.567 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.756 ' HG3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -155.44 111.7 3.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.854 . . . . 1.0 109.534 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.678 HD12 ' O ' ' A' ' 64' ' ' PHE . 11.2 tp -81.44 113.25 19.38 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.213 -0.929 . . . . 1.0 108.947 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.567 HG21 ' HE1' ' A' ' 64' ' ' PHE . 10.6 t -93.46 143.5 11.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.399 -0.813 . . . . 1.0 110.237 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.818 ' CE1' HD22 ' A' ' 63' ' ' LEU . 10.4 m-85 -133.49 113.36 12.4 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.517 ' CB ' ' O ' ' A' ' 165' ' ' LEU . 10.2 ptt85 -145.45 106.76 4.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.933 -1.105 . . . . 1.0 110.529 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 153' ' ' VAL . 9.8 p -92.55 128.83 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.256 -1.016 . . . . 1.0 108.256 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.697 ' CD2' ' HB2' ' A' ' 164' ' ' SER . 37.8 m80 -121.39 117.4 26.83 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.034 -1.041 . . . . 1.0 110.43 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.695 ' HB ' HD23 ' A' ' 163' ' ' LEU . 8.1 p -99.61 141.13 22.25 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.779 -0.823 . . . . 1.0 108.779 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.534 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 33.4 Cg_endo -75.29 115.04 4.13 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.16 1.907 . . . . 1.0 110.501 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.73 ' HG3' HG21 ' A' ' 162' ' ' THR . 0.9 OUTLIER -136.3 169.13 14.28 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.532 -0.73 . . . . 1.0 109.058 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.525 ' HD2' ' NE2' ' A' ' 157' ' ' GLN . 34.3 Cg_endo -76.69 -65.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.316 2.01 . . . . 1.0 110.284 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.28 -84.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 1.0 109.25 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 152.42 -43.7 0.65 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.565 -1.414 . . . . 1.0 109.565 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -79.01 80.25 5.36 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.987 -1.116 . . . . 1.0 107.987 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.815 HG22 ' N ' ' A' ' 163' ' ' LEU . 1.3 m -133.55 -89.56 0.39 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.56 -0.712 . . . . 1.0 109.374 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.815 ' N ' HG22 ' A' ' 162' ' ' THR . 8.9 tp -125.91 96.91 4.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.83 -1.169 . . . . 1.0 108.737 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.888 ' O ' HD23 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -163.25 119.26 1.76 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.016 -1.052 . . . . 1.0 109.229 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.888 HD23 ' O ' ' A' ' 164' ' ' SER . 22.3 mt -142.63 175.07 10.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.976 -1.078 . . . . 1.0 110.428 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.496 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 10.7 mt-30 -142.27 70.84 1.34 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.607 -0.683 . . . . 1.0 109.201 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 37.9 t -87.79 106.04 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 1.0 110.066 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 150' ' ' VAL . . . -112.03 112.75 24.61 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.543 -0.91 . . . . 1.0 108.543 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 0.0 OUTLIER -136.8 140.99 42.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.989 -1.07 . . . . 1.0 110.261 -179.153 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.501 ' HB3' ' HA ' ' A' ' 148' ' ' ARG . 22.7 t-20 175.93 97.73 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.41 74.38 4.73 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.284 1.99 . . . . 1.0 110.588 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.467 ' HB ' ' OD1' ' A' ' 170' ' ' ASN . 27.6 mt -138.96 126.37 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.331 -0.856 . . . . 1.0 109.287 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 1.0 109.532 -179.874 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 C--O 1.215 -0.654 0 N-CA-C 110.255 -0.71 . . . . 1.0 110.255 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.569 ' CE2' ' O ' ' A' ' 162' ' ' THR . 6.6 m-85 -102.61 169.72 8.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -0.934 . . . . 1.0 109.758 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -160.86 130.82 5.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 1.0 109.456 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' O ' HG21 ' A' ' 167' ' ' VAL . 23.3 tp -126.83 84.4 2.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.362 -0.836 . . . . 1.0 109.327 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -127.35 154.53 44.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.285 -0.884 . . . . 1.0 109.715 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -67.01 148.33 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.336 -0.853 . . . . 1.0 108.774 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.525 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.0 OUTLIER -70.97 -34.61 71.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.381 -0.824 . . . . 1.0 109.535 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 18' ' ' GLU . 72.3 t -157.78 135.6 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 121.206 -0.934 . . . . 1.0 109.435 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.09 80.45 7.04 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 1.0 109.522 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 19' ' ' VAL . 36.2 Cg_endo -78.52 179.23 6.69 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.519 2.146 . . . . 1.0 110.21 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 21' ' ' PRO . 9.7 mttt -44.56 108.6 0.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.087 -1.008 . . . . 1.0 109.185 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.1 p -130.72 39.41 3.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.126 -0.984 . . . . 1.0 109.945 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.481 ' HA ' HG12 ' A' ' 172' ' ' ILE . 2.0 p-80 -99.69 166.39 11.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.082 -1.011 . . . . 1.0 109.395 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.821 ' NE2' HD11 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -135.45 105.26 6.15 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.671 -0.812 . . . . 1.0 109.843 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.4 ttm-85 -92.4 70.98 5.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.429 -0.795 . . . . 1.0 109.053 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.432 0 O-C-N 121.465 -0.772 . . . . 1.0 109.469 -179.883 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.402 0.62 . . . . 1.0 109.593 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.576 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 2.2 p -54.99 113.77 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.4 -0.813 . . . . 1.0 109.451 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.434 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -137.3 99.48 3.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.347 -0.846 . . . . 1.0 109.598 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.66 -154.34 0.6 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.377 -0.827 . . . . 1.0 109.458 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.5 t -69.84 -72.48 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 1.0 109.636 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.36 69.03 2.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 1.0 109.405 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.92 -82.12 0.87 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.31 -1.516 . . . . 1.0 109.31 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -165.97 -37.2 0.02 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.64 -1.384 . . . . 1.0 109.64 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -100.69 160.21 27.47 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.267 -1.137 . . . . 1.0 109.72 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.5 ' C ' HD13 ' A' ' 47' ' ' ILE . 35.8 Cg_endo -78.59 -176.64 3.38 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.539 2.159 . . . . 1.0 110.482 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.901 ' CG2' HG12 ' A' ' 117' ' ' VAL . 1.0 OUTLIER -94.14 158.07 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.607 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 2.9 t -134.54 135.94 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.983 -1.073 . . . . 1.0 110.399 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.606 ' HB3' ' CE1' ' A' ' 51' ' ' HIS . 5.0 tt0 -151.41 144.28 24.47 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.914 -0.773 . . . . 1.0 108.914 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.9 tt -113.23 138.51 49.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.085 -1.009 . . . . 1.0 109.994 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.606 ' CE1' ' HB3' ' A' ' 49' ' ' GLN . 4.3 m80 -140.33 77.9 1.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.401 -0.812 . . . . 1.0 109.25 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . -177.03 84.69 0.07 OUTLIER Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.687 -1.244 . . . . 1.0 110.049 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.569 ' CD2' ' OE2' ' A' ' 111' ' ' GLU . 3.5 t80 177.16 132.09 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -1.196 . . . . 1.0 109.619 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.2 -10.84 17.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 1.0 109.437 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.415 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 2.4 mt-10 -89.75 145.25 25.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 1.0 109.502 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -103.73 57.13 0.73 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.309 -0.87 . . . . 1.0 109.35 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -110.1 156.46 40.05 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 1.0 109.454 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.979 ' O ' HD23 ' A' ' 59' ' ' LEU . 35.8 Cg_endo -78.31 131.07 10.45 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.5 2.133 . . . . 1.0 110.49 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.979 HD23 ' O ' ' A' ' 58' ' ' PRO . 6.5 mt -128.88 162.79 26.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 1.0 109.225 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.458 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 2.1 mpp? -105.78 131.63 52.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.275 -0.891 . . . . 1.0 109.355 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.818 HD21 ' HB2' ' A' ' 63' ' ' LEU . 1.1 tt -90.26 141.27 28.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.376 -0.828 . . . . 1.0 109.388 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 62' ' ' GLN . 0.9 OUTLIER -104.64 78.12 1.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.184 -0.948 . . . . 1.0 109.681 -179.764 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.135 HD13 ' CE1' ' A' ' 151' ' ' PHE . 23.4 tp -100.87 135.18 42.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 1.0 109.086 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.718 ' HB2' HG12 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -165.45 159.67 17.16 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.542 -0.911 . . . . 1.0 108.542 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.497 HG23 ' O ' ' A' ' 65' ' ' ILE . 1.2 tp -110.84 125.49 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 1.0 109.057 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 74' ' ' ARG . . . -145.08 142.38 10.77 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.619 -1.392 . . . . 1.0 109.619 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.681 HG23 ' HA ' ' A' ' 76' ' ' HIS . 72.4 p -66.64 178.85 1.17 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.496 -1.003 . . . . 1.0 109.945 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.422 ' HB3' ' HD2' ' A' ' 148' ' ' ARG . . . -170.23 125.37 0.76 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.465 -0.772 . . . . 1.0 109.072 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.83 -38.03 20.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 1.0 108.962 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -140.45 -56.43 0.53 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.167 -0.958 . . . . 1.0 109.699 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.492 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -152.14 -47.57 0.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.875 . . . . 1.0 109.524 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mt -52.47 89.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.353 -0.842 . . . . 1.0 109.684 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.778 HD13 ' H ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -48.11 171.93 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.105 -0.997 . . . . 1.0 110.362 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -168.91 167.22 5.97 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.384 -0.823 . . . . 1.0 108.867 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 74' ' ' ARG . 32.7 Cg_endo -74.06 142.69 31.39 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.072 1.848 . . . . 1.0 109.96 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.774 ' NE2' HG12 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -50.72 146.84 5.31 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.252 -0.905 . . . . 1.0 109.763 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.19 -59.54 4.9 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.363 -0.836 . . . . 1.0 109.294 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -136.34 4.04 2.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -0.908 . . . . 1.0 109.912 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.572 ' HB2' ' CG ' ' A' ' 76' ' ' HIS . 6.7 m-30 -99.02 103.19 15.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.984 -1.072 . . . . 1.0 109.25 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.518 ' HB2' ' CG ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -138.88 7.64 2.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.064 -1.023 . . . . 1.0 109.643 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.828 HG11 HD13 ' A' ' 124' ' ' LEU . 35.6 m -64.39 157.89 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.182 -0.949 . . . . 1.0 109.464 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.783 ' CE1' HD11 ' A' ' 84' ' ' ILE . 35.0 t-80 -175.83 90.53 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.478 -0.763 . . . . 1.0 109.296 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.539 ' C ' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -122.53 144.71 48.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.117 -0.99 . . . . 1.0 109.742 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.798 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.3 mp -110.45 125.09 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.29 -0.881 . . . . 1.0 109.51 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 1.0 109.701 -179.97 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 89' ' ' VAL . 5.4 p . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.57 31.89 0.9 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.11 -0.994 . . . . 1.0 109.627 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.601 HG22 ' N ' ' A' ' 92' ' ' THR . 19.6 m -91.94 -91.09 0.16 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.316 -0.865 . . . . 1.0 109.14 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.854 ' O ' HG23 ' A' ' 106' ' ' ILE . 0.2 OUTLIER -174.54 82.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 1.0 109.383 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.51 160.99 13.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.937 . . . . 1.0 110.048 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.524 ' CB ' ' HG3' ' A' ' 105' ' ' GLU . 0.2 OUTLIER -155.53 160.91 40.91 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.007 -0.738 . . . . 1.0 109.007 179.786 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' A' ' 94' ' ' HIS . 0.7 OUTLIER -132.82 150.66 52.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.988 -1.07 . . . . 1.0 109.813 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -153.84 124.17 7.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.845 . . . . 1.0 109.225 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.952 HD13 ' N ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -119.52 131.61 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 1.0 109.606 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.952 ' N ' HD13 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -126.05 68.7 1.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 1.0 109.207 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 1.4 m 76.35 93.82 0.07 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -0.843 . . . . 1.0 109.333 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 99' ' ' SER . 1.1 p-10 42.85 55.12 4.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.492 -0.755 . . . . 1.0 109.721 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.479 ' HB ' ' HG ' ' A' ' 98' ' ' LEU . 6.1 m -160.05 80.43 0.7 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.124 -0.985 . . . . 1.0 109.551 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.525 ' CD ' ' HB ' ' A' ' 97' ' ' ILE . 2.1 mmmp? -85.38 131.21 34.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 1.0 109.374 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.718 HG12 ' HB2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -129.49 165.82 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.22 -0.925 . . . . 1.0 109.154 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.611 HD11 ' NE2' ' A' ' 82' ' ' HIS . 0.3 OUTLIER -120.15 141.66 49.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 1.0 109.595 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.524 ' HG3' ' CB ' ' A' ' 94' ' ' HIS . 2.1 pt-20 -137.46 117.07 12.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.332 -0.855 . . . . 1.0 109.147 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.854 HG23 ' O ' ' A' ' 92' ' ' THR . 12.4 mt -118.11 98.84 51.76 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.853 . . . . 1.0 109.849 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.463 ' HD2' ' O ' ' A' ' 92' ' ' THR . 35.3 Cg_endo -76.73 97.61 1.15 Allowed 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.379 2.052 . . . . 1.0 110.302 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.72 ' CD2' HG22 ' A' ' 106' ' ' ILE . 0.6 OUTLIER -145.12 165.26 28.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 1.0 109.657 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -115.37 81.52 8.59 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.303 -0.873 . . . . 1.0 109.698 -179.841 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 108' ' ' LEU . 37.1 Cg_endo -81.0 42.54 1.36 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.634 2.223 . . . . 1.0 110.706 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.569 ' OE2' ' CD2' ' A' ' 53' ' ' TYR . 0.9 OUTLIER -100.33 28.79 4.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.124 -0.985 . . . . 1.0 109.597 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 113' ' ' SER . 0.0 OUTLIER -138.01 -70.31 0.44 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.198 -0.939 . . . . 1.0 109.142 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 112' ' ' ASN . 3.5 t 178.19 101.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 1.0 109.237 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 4.5 ptm -164.04 131.11 3.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 1.0 109.562 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.451 ' HD2' ' OE1' ' A' ' 18' ' ' GLU . 35.7 ttp180 -106.68 131.65 53.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 1.0 109.373 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -116.07 101.96 9.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 1.0 109.377 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.901 HG12 ' CG2' ' A' ' 47' ' ' ILE . 4.6 m -81.06 127.01 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.334 -0.854 . . . . 1.0 109.445 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.574 ' CD1' ' CD2' ' A' ' 63' ' ' LEU . 10.6 mt -107.55 115.01 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.295 -0.878 . . . . 1.0 109.4 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 118' ' ' ILE . 0.6 OUTLIER -156.8 53.41 0.52 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 1.0 109.03 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.481 ' SG ' HG13 ' A' ' 84' ' ' ILE . 1.8 p -141.95 57.07 1.48 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.259 -0.9 . . . . 1.0 109.59 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.12 167.25 22.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 1.0 109.131 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.686 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -137.63 -176.07 14.23 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.833 -1.307 . . . . 1.0 109.833 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.821 HD11 ' NE2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -116.41 171.72 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.354 -1.086 . . . . 1.0 109.083 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.828 HD13 HG11 ' A' ' 81' ' ' VAL . 13.5 tp -128.86 157.72 40.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 1.0 109.811 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.462 ' HD2' ' O ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.358 -0.839 . . . . 1.0 109.157 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 121.4 0.619 . . . . 1.0 109.751 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.538 ' N ' ' HD2' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -154.86 154.77 33.22 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.419 -0.801 . . . . 1.0 109.433 179.619 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.774 HG12 ' NE2' ' A' ' 76' ' ' HIS . 32.6 m -139.25 162.44 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.908 . . . . 1.0 109.226 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.422 ' HD2' ' HB3' ' A' ' 68' ' ' ALA . 8.0 ttt180 -141.61 112.47 7.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -0.95 . . . . 1.0 109.655 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.808 HD11 HD11 ' A' ' 63' ' ' LEU . 44.0 tp -79.12 123.84 27.75 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.317 -0.865 . . . . 1.0 109.051 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 37.2 t -95.0 146.0 7.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.233 -0.917 . . . . 1.0 109.773 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 1.135 ' CE1' HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -148.1 99.43 3.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 1.0 109.021 -179.792 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.524 ' CB ' ' HA ' ' A' ' 166' ' ' GLN . 14.1 ptt180 -150.33 136.4 18.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.98 -1.075 . . . . 1.0 110.255 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 153' ' ' VAL . 9.8 p -115.42 129.02 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.708 ' CD2' ' HB2' ' A' ' 164' ' ' SER . 33.9 m80 -126.88 118.46 24.64 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.129 -0.982 . . . . 1.0 110.119 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.59 ' HB ' HD23 ' A' ' 163' ' ' LEU . 13.0 p -99.04 140.98 22.11 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.363 -0.836 . . . . 1.0 108.769 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.535 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 33.2 Cg_endo -75.25 115.29 4.21 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.161 1.907 . . . . 1.0 110.245 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.812 ' HG3' HG21 ' A' ' 162' ' ' THR . 9.8 mm-40 -136.51 167.28 22.16 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.541 -0.724 . . . . 1.0 109.292 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.448 ' HD2' ' CD ' ' A' ' 157' ' ' GLN . 34.6 Cg_endo -77.32 -63.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.299 1.999 . . . . 1.0 110.21 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.6 t -55.74 -75.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.385 -0.822 . . . . 1.0 109.346 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 142.09 -43.27 1.08 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.482 -1.447 . . . . 1.0 109.482 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.86 80.48 5.2 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.879 -1.156 . . . . 1.0 107.879 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.812 HG21 ' HG3' ' A' ' 157' ' ' GLN . 1.3 m -136.2 -78.23 0.42 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.462 -0.774 . . . . 1.0 109.432 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.63 ' N ' HG22 ' A' ' 162' ' ' THR . 8.3 tp -141.06 100.93 3.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.074 -1.016 . . . . 1.0 108.962 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.708 ' HB2' ' CD2' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -162.21 98.27 1.04 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.025 -1.047 . . . . 1.0 109.534 179.576 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.77 HD13 ' H ' ' A' ' 166' ' ' GLN . 0.2 OUTLIER -126.73 151.88 47.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.331 -0.856 . . . . 1.0 109.625 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.77 ' H ' HD13 ' A' ' 165' ' ' LEU . 15.8 mt-30 -118.51 145.53 45.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.902 . . . . 1.0 109.535 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.575 HG21 ' O ' ' A' ' 15' ' ' LEU . 47.0 t -152.39 93.26 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.124 -0.985 . . . . 1.0 109.78 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 149' ' ' LEU . . . -112.44 110.46 20.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.198 -0.939 . . . . 1.0 109.362 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 0.1 OUTLIER -159.51 136.63 9.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.158 -0.964 . . . . 1.0 109.872 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 169' ' ' SER . 0.2 OUTLIER 176.67 99.14 0.11 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.385 -0.822 . . . . 1.0 109.07 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.46 95.3 1.04 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.311 2.008 . . . . 1.0 110.964 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.54 ' HB ' ' CG2' ' A' ' 147' ' ' VAL . 14.9 mt -150.36 161.36 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.432 -0.793 . . . . 1.0 109.137 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.494 ' N ' HG22 ' A' ' 172' ' ' ILE . 3.3 mt-10 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.247 -0.908 . . . . 1.0 109.803 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo . . . . . 0 C--O 1.216 -0.601 0 N-CA-C 110.374 -0.664 . . . . 1.0 110.374 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.507 ' HA ' ' HA3' ' A' ' 52' ' ' GLY . 3.1 m-85 -56.72 145.74 28.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.2 -0.937 . . . . 1.0 109.326 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -157.13 124.14 5.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.903 -1.123 . . . . 1.0 110.089 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.612 HD22 ' HB ' ' A' ' 153' ' ' VAL . 17.5 tp -107.8 81.72 1.55 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.395 -0.815 . . . . 1.0 108.867 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -116.34 157.1 25.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.87 . . . . 1.0 109.903 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.79 HG23 ' O ' ' A' ' 47' ' ' ILE . 1.4 mp -62.96 149.81 9.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.296 -0.878 . . . . 1.0 108.664 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 1.022 ' HB3' HD12 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -64.65 -42.71 95.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.923 . . . . 1.0 109.11 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.723 ' HB ' HD11 ' A' ' 47' ' ' ILE . 71.3 t -151.81 126.76 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.277 -0.89 . . . . 1.0 109.092 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.601 ' HG2' HG21 ' A' ' 17' ' ' ILE . 9.0 mm-40 -115.28 79.14 6.48 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.905 . . . . 1.0 109.484 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.477 ' HD3' HG12 ' A' ' 19' ' ' VAL . 36.2 Cg_endo -77.8 -179.35 5.36 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.352 2.035 . . . . 1.0 110.453 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.68 113.97 5.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 1.0 109.062 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.54 ' HA ' ' CB ' ' A' ' 40' ' ' ALA . 3.0 t -139.29 72.46 1.4 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.226 -0.921 . . . . 1.0 109.855 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.415 ' HA ' HG12 ' A' ' 172' ' ' ILE . 1.7 p-80 -99.69 166.89 10.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.244 -0.91 . . . . 1.0 109.256 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.639 ' CD2' ' HA ' ' A' ' 38' ' ' VAL . 3.8 t-160 -135.78 104.19 5.67 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 119.852 -0.739 . . . . 1.0 109.339 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -79.08 77.83 5.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.426 -0.796 . . . . 1.0 109.212 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.394 -0.816 . . . . 1.0 109.648 -179.696 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.248 0.547 . . . . 1.0 109.607 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.639 ' HA ' ' CD2' ' A' ' 25' ' ' HIS . 2.2 p -57.48 122.79 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.365 -0.835 . . . . 1.0 109.43 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.32 109.93 3.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 1.0 109.439 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.54 ' CB ' ' HA ' ' A' ' 23' ' ' SER . . . -136.34 -91.63 0.27 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 1.0 109.77 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.55 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 58.8 m -102.61 135.26 44.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.222 -0.924 . . . . 1.0 109.662 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.558 ' HB1' ' NE2' ' A' ' 45' ' ' HIS . . . 67.45 10.1 7.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.928 . . . . 1.0 109.38 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.8 10.8 42.3 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.413 -1.475 . . . . 1.0 109.413 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 45' ' ' HIS . . . 77.06 83.4 0.52 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.644 -1.383 . . . . 1.0 109.644 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.601 ' CG ' ' HB3' ' A' ' 119' ' ' ASP . 20.8 p80 -179.81 123.0 0.23 Allowed Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.168 -1.195 . . . . 1.0 109.962 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.24 146.61 19.97 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 122.0 1.8 . . . . 1.0 109.416 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.022 HD12 ' HB3' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -97.31 135.1 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.909 -1.119 . . . . 1.0 109.142 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.562 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 3.0 t -118.63 130.79 72.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.017 -1.052 . . . . 1.0 109.814 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.553 ' NE2' ' CG ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -161.4 117.74 2.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.338 -0.852 . . . . 1.0 109.465 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.554 HD11 HG11 ' A' ' 153' ' ' VAL . 3.0 tt -77.07 136.37 38.65 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.126 -0.984 . . . . 1.0 109.154 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.0 87.47 2.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.182 -0.949 . . . . 1.0 109.262 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 163.92 64.48 0.02 OUTLIER Glycine 0 N--CA 1.483 1.807 0 C-N-CA 119.56 -1.305 . . . . 1.0 110.166 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.57 ' CE1' ' HB2' ' A' ' 55' ' ' GLU . 0.2 OUTLIER 175.62 121.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.109 -1.23 . . . . 1.0 109.687 179.611 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.7 mt -104.0 22.6 14.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.323 -0.861 . . . . 1.0 109.31 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.57 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -87.35 145.22 26.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.179 -0.951 . . . . 1.0 109.685 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -90.83 46.43 1.33 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.2 -0.938 . . . . 1.0 109.712 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 17.1 pt-20 -122.98 127.75 25.59 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.255 -0.903 . . . . 1.0 109.185 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.596 ' O ' HD23 ' A' ' 59' ' ' LEU . 36.4 Cg_endo -79.44 151.18 22.61 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 122.147 1.898 . . . . 1.0 110.624 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.596 HD23 ' O ' ' A' ' 58' ' ' PRO . 18.6 mt -128.48 142.7 51.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.309 -0.869 . . . . 1.0 108.91 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.444 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -79.95 102.05 8.98 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.074 -1.016 . . . . 1.0 109.423 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.865 HD21 ' HB2' ' A' ' 63' ' ' LEU . 3.0 tt -59.59 135.11 57.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.405 -0.809 . . . . 1.0 109.612 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -102.45 97.06 7.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.359 -0.838 . . . . 1.0 108.998 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.971 HD13 ' CE1' ' A' ' 151' ' ' PHE . 26.8 tp -123.35 139.21 54.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.179 -0.951 . . . . 1.0 109.634 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.495 ' HB3' HG12 ' A' ' 103' ' ' VAL . 2.3 p90 -159.96 -163.9 1.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.325 -0.86 . . . . 1.0 108.928 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.689 HG23 ' O ' ' A' ' 65' ' ' ILE . 2.8 tp -125.36 115.62 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.827 . . . . 1.0 108.828 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.434 ' CA ' ' O ' ' A' ' 74' ' ' ARG . . . -135.09 148.07 19.43 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.677 -1.249 . . . . 1.0 109.996 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.861 HG22 ' CD2' ' A' ' 76' ' ' HIS . 17.4 p -83.97 156.34 22.35 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.519 -0.989 . . . . 1.0 109.225 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.994 ' HB3' ' HG3' ' A' ' 148' ' ' ARG . . . -159.42 120.39 3.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.067 -1.021 . . . . 1.0 109.724 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.438 ' OD1' HD11 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -84.93 -10.91 56.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 1.0 109.374 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -166.65 -44.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.887 . . . . 1.0 109.38 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.487 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -168.33 -36.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 1.0 109.619 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.438 HD11 ' OD1' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -53.98 89.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -0.886 . . . . 1.0 109.548 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.599 ' H ' HD23 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -54.21 169.21 0.19 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.243 -0.911 . . . . 1.0 109.6 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.434 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -175.19 155.17 1.75 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 1.0 109.486 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.426 ' HD2' ' HG2' ' A' ' 74' ' ' ARG . 36.0 Cg_endo -77.67 116.93 4.14 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.483 2.122 . . . . 1.0 110.342 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.861 ' CD2' HG22 ' A' ' 67' ' ' THR . 1.7 t-80 -54.07 154.48 4.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.186 -0.947 . . . . 1.0 109.699 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.95 -72.2 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 1.0 109.796 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.72 ' O ' HD21 ' A' ' 124' ' ' LEU . 1.1 p90 -130.97 12.83 5.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.091 -1.006 . . . . 1.0 109.858 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.668 ' O ' HG21 ' A' ' 65' ' ' ILE . 5.8 m-85 -79.98 117.18 20.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.061 -1.024 . . . . 1.0 108.943 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.543 ' CB ' ' HB3' ' A' ' 102' ' ' LYS . 1.5 pp0? -174.55 33.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.148 -0.97 . . . . 1.0 109.984 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 122' ' ' GLY . 5.6 m -91.94 140.91 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 1.0 109.641 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 1.01 ' CD2' ' HB2' ' A' ' 121' ' ' ALA . 13.4 t-80 -175.58 111.26 0.11 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.401 -0.812 . . . . 1.0 108.94 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.4 OUTLIER -145.08 135.18 23.88 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.09 -1.006 . . . . 1.0 110.116 -179.685 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.814 HD11 ' HE1' ' A' ' 82' ' ' HIS . 4.0 mp -99.75 128.45 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.596 -0.69 . . . . 1.0 109.379 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.7 p . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 1.0 109.356 -179.976 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.6 p -102.94 -13.8 16.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.22 -0.925 . . . . 1.0 109.452 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.657 ' O ' HG23 ' A' ' 91' ' ' THR . 11.4 t -65.05 115.55 5.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.263 -0.898 . . . . 1.0 109.618 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . 1.023 ' O ' HG23 ' A' ' 106' ' ' ILE . 14.5 t -78.62 148.78 33.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.947 . . . . 1.0 109.142 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.46 ' HB3' HG12 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -137.18 174.39 10.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.129 -0.982 . . . . 1.0 110.043 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.76 159.56 43.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.495 -0.753 . . . . 1.0 109.139 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.493 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 27.8 mm-40 -127.14 147.79 50.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.979 . . . . 1.0 109.819 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -151.76 121.55 7.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 1.0 109.427 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.495 ' HB ' ' HD2' ' A' ' 102' ' ' LYS . 2.6 tp -110.27 142.32 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 1.0 109.648 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.637 HD11 HG21 ' A' ' 101' ' ' THR . 0.5 OUTLIER -130.81 49.62 2.3 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.329 -0.857 . . . . 1.0 109.367 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 98' ' ' LEU . 2.0 p 73.92 112.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.864 . . . . 1.0 110.213 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.429 ' CG ' ' O ' ' A' ' 99' ' ' SER . 2.2 p-10 42.71 32.65 0.4 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.603 -0.686 . . . . 1.0 110.502 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.637 HG21 HD11 ' A' ' 98' ' ' LEU . 43.7 m -160.24 88.66 0.82 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.883 -1.135 . . . . 1.0 109.971 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.543 ' HB3' ' CB ' ' A' ' 80' ' ' GLN . 3.8 tptt -91.88 147.5 22.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 1.0 109.239 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.524 ' N ' ' HG3' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -136.8 167.43 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.205 -0.934 . . . . 1.0 109.104 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.583 HD22 HG13 ' A' ' 106' ' ' ILE . 1.0 OUTLIER -121.59 124.43 44.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 1.0 109.65 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.459 ' N ' HD23 ' A' ' 104' ' ' LEU . 1.0 OUTLIER -114.85 120.36 39.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.28 -0.887 . . . . 1.0 109.152 179.684 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 1.023 HG23 ' O ' ' A' ' 92' ' ' THR . 71.3 mt -133.24 108.61 12.45 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.107 -0.996 . . . . 1.0 109.684 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.638 ' O ' HD23 ' A' ' 108' ' ' LEU . 33.9 Cg_endo -75.17 115.6 4.31 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 122.079 1.853 . . . . 1.0 109.844 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.638 HD23 ' O ' ' A' ' 107' ' ' PRO . 21.1 mt -123.45 165.45 17.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.261 -0.899 . . . . 1.0 110.787 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.533 ' N ' ' HD3' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -139.21 59.7 15.5 Favored Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 108.788 -0.819 . . . . 1.0 108.788 179.199 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 109' ' ' LEU . 35.6 Cg_endo -76.95 -3.88 14.28 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.373 2.049 . . . . 1.0 110.622 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 55' ' ' GLU . 3.2 mt-10 -43.63 -36.01 1.99 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.502 -0.749 . . . . 1.0 109.115 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 113' ' ' SER . 3.4 p30 -94.77 -44.33 7.82 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.476 -0.765 . . . . 1.0 109.202 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 1.4 p 164.72 107.54 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 1.0 109.261 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -154.69 94.08 1.64 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.32 -0.863 . . . . 1.0 109.358 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.54 129.77 42.6 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 1.0 109.233 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -136.09 134.7 38.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.895 . . . . 1.0 109.636 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.997 HG12 HG22 ' A' ' 47' ' ' ILE . 3.3 m -106.35 145.78 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.279 -0.888 . . . . 1.0 109.238 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 45' ' ' HIS . 14.3 mt -112.76 93.93 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.176 -0.952 . . . . 1.0 109.509 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.601 ' HB3' ' CG ' ' A' ' 45' ' ' HIS . 9.4 p-10 -127.66 26.44 5.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.591 -0.693 . . . . 1.0 109.257 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.494 ' HB3' HG13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -122.42 44.65 2.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.245 -0.909 . . . . 1.0 110.003 -179.406 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 1.01 ' HB2' ' CD2' ' A' ' 82' ' ' HIS . . . -129.56 177.01 7.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.967 . . . . 1.0 109.102 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.898 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -155.95 -169.84 20.63 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.548 -1.421 . . . . 1.0 109.548 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.498 ' CG2' ' CD2' ' A' ' 79' ' ' TYR . 1.8 mt -125.68 173.41 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -1.129 . . . . 1.0 109.437 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.72 HD21 ' O ' ' A' ' 78' ' ' PHE . 1.4 pp -140.12 158.14 44.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -0.826 . . . . 1.0 109.396 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 1.0 109.552 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 121.15 0.5 . . . . 1.0 109.828 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.476 ' HD2' ' O ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -101.98 158.85 15.84 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.103 -0.998 . . . . 1.0 109.374 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.44 ' O ' ' HG2' ' A' ' 148' ' ' ARG . 2.2 m -141.49 165.33 18.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.437 -0.79 . . . . 1.0 109.147 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.994 ' HG3' ' HB3' ' A' ' 68' ' ' ALA . 20.7 mmm-85 -150.31 119.0 6.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.074 -1.017 . . . . 1.0 109.865 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.96 HD12 HD11 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -79.82 120.25 23.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.292 -0.88 . . . . 1.0 109.278 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 47.4 t -96.74 126.15 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.263 -0.898 . . . . 1.0 109.535 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.971 ' CE1' HD13 ' A' ' 63' ' ' LEU . 3.1 m-85 -127.71 118.3 23.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.849 . . . . 1.0 109.062 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 1.9 ptm180 -150.33 141.17 22.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.131 -0.98 . . . . 1.0 109.977 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.635 ' CG1' HD11 ' A' ' 163' ' ' LEU . 8.8 p -117.32 128.46 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.683 -0.858 . . . . 1.0 108.683 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.452 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 55.1 m-70 -121.69 115.13 22.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.139 -0.975 . . . . 1.0 110.329 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.597 ' HB ' HD23 ' A' ' 163' ' ' LEU . 13.9 p -99.66 141.93 23.69 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.901 -0.778 . . . . 1.0 108.901 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.534 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 32.8 Cg_endo -75.16 114.52 4.03 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.065 1.843 . . . . 1.0 110.357 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.674 ' HG3' HG21 ' A' ' 162' ' ' THR . 3.9 mm-40 -133.41 168.33 18.45 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.553 -0.717 . . . . 1.0 109.069 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.465 ' HD2' ' CD ' ' A' ' 157' ' ' GLN . 34.4 Cg_endo -77.0 -64.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.259 1.973 . . . . 1.0 110.249 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.4 m -62.1 -58.05 9.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.935 . . . . 1.0 109.245 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 124.55 -36.19 2.96 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.738 -1.345 . . . . 1.0 109.738 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -79.14 80.04 5.51 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.498 -1.001 . . . . 1.0 108.312 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.674 HG21 ' HG3' ' A' ' 157' ' ' GLN . 1.3 m -140.54 -74.18 0.34 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.958 -0.756 . . . . 1.0 108.958 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.635 HD11 ' CG1' ' A' ' 153' ' ' VAL . 7.8 tp -142.25 97.62 3.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.09 -1.006 . . . . 1.0 108.644 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.452 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.2 OUTLIER -163.11 87.14 0.55 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.071 -1.018 . . . . 1.0 109.245 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.778 ' H ' HD23 ' A' ' 165' ' ' LEU . 1.8 pt? -132.31 170.78 14.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -0.956 . . . . 1.0 109.805 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.472 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 5.8 tt0 -117.44 157.44 26.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.327 -0.858 . . . . 1.0 109.498 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.57 ' O ' HG12 ' A' ' 167' ' ' VAL . 48.3 t -149.32 81.87 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 1.0 109.653 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 149' ' ' LEU . . . -90.8 103.46 16.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.198 -0.939 . . . . 1.0 109.354 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 170' ' ' ASN . 0.0 OUTLIER -120.07 136.5 54.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -0.967 . . . . 1.0 109.657 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.652 HD21 HD23 ' A' ' 149' ' ' LEU . 1.8 m-20 163.27 85.5 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 1.0 109.383 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.91 72.24 6.24 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.461 2.107 . . . . 1.0 110.574 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 146' ' ' ARG . 12.3 mt -126.71 134.44 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 1.0 109.284 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 1.0 109.631 -179.922 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo . . . . . 0 C--O 1.215 -0.638 0 N-CA-C 110.381 -0.661 . . . . 1.0 110.381 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.66 ' CE2' ' CD1' ' A' ' 53' ' ' TYR . 3.6 m-30 -58.36 145.06 39.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.167 -0.958 . . . . 1.0 109.215 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.657 ' HA ' HD11 ' A' ' 165' ' ' LEU . 53.1 tt0 179.48 142.96 0.14 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.148 -0.97 . . . . 1.0 109.271 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 151' ' ' PHE . 0.9 OUTLIER -98.79 116.8 31.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.339 -0.851 . . . . 1.0 109.213 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -110.76 132.84 53.85 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.338 -0.851 . . . . 1.0 109.916 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 47' ' ' ILE . 1.1 mp -60.83 143.36 14.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.358 -0.979 . . . . 1.0 108.358 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -71.96 -54.23 10.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 1.0 109.676 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.562 HG12 ' HD3' ' A' ' 21' ' ' PRO . 30.5 t -120.33 133.61 66.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.239 -0.913 . . . . 1.0 109.61 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.559 ' OE1' HG21 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -127.0 76.24 76.1 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.214 -0.929 . . . . 1.0 109.429 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.562 ' HD3' HG12 ' A' ' 19' ' ' VAL . 35.5 Cg_endo -77.69 -175.71 2.83 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.511 2.141 . . . . 1.0 110.51 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -43.46 131.08 5.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.451 -0.781 . . . . 1.0 109.406 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 23' ' ' SER . 7.9 t -112.86 40.07 2.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.189 -0.944 . . . . 1.0 109.841 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.881 ' HA ' HG23 ' A' ' 172' ' ' ILE . 8.3 p-80 -103.04 166.16 10.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.05 -1.031 . . . . 1.0 109.505 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.67 ' NE2' HD11 ' A' ' 123' ' ' ILE . 1.0 OUTLIER -154.49 89.83 1.29 Allowed 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.901 -0.72 . . . . 1.0 109.674 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.42 72.63 10.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.307 -0.871 . . . . 1.0 109.138 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.636 ' HB2' HD12 ' A' ' 123' ' ' ILE . . . . . . . . 0 N--CA 1.487 1.424 0 O-C-N 121.471 -0.768 . . . . 1.0 109.811 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.452 0.644 . . . . 1.0 109.751 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.578 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 2.4 p -89.67 119.23 36.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.539 -0.725 . . . . 1.0 109.269 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -155.18 105.37 2.51 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -0.936 . . . . 1.0 109.577 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.51 -88.29 0.54 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 1.0 109.449 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 p -114.97 -92.2 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 1.0 109.652 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.27 -69.45 0.12 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 1.0 109.457 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -167.25 26.68 0.15 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.522 -1.431 . . . . 1.0 109.522 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.502 ' HA3' ' CG2' ' A' ' 38' ' ' VAL . . . 112.34 -59.5 0.37 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.487 ' HB3' ' HD2' ' A' ' 46' ' ' PRO . 13.1 m-70 -104.64 161.03 24.06 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.307 -1.113 . . . . 1.0 109.472 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 45' ' ' HIS . 35.4 Cg_endo -78.0 -179.59 5.59 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.505 2.136 . . . . 1.0 110.512 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.15 HG23 HG12 ' A' ' 117' ' ' VAL . 2.5 mm -94.11 156.64 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.374 -0.829 . . . . 1.0 109.075 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.606 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 10.8 t -129.31 141.76 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.112 -0.992 . . . . 1.0 110.117 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.468 ' HB2' ' HG3' ' A' ' 115' ' ' ARG . 39.5 tt0 -160.4 147.06 15.65 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.4 HD13 ' OE2' ' A' ' 111' ' ' GLU . 0.6 OUTLIER -78.5 148.13 33.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.886 -1.134 . . . . 1.0 109.617 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -140.14 77.65 1.62 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.445 -0.785 . . . . 1.0 109.37 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 163.87 -109.97 0.4 Allowed Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.455 -1.355 . . . . 1.0 110.476 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.66 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 1.5 t80 -39.18 141.22 0.34 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.826 -0.808 . . . . 1.0 110.178 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.591 HD12 ' O ' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -136.62 46.67 2.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.331 -0.856 . . . . 1.0 109.492 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.596 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 1.2 tt0 -87.25 145.41 26.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 1.0 109.331 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -85.62 49.98 1.87 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.202 -0.936 . . . . 1.0 109.853 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.419 ' HG3' ' CD ' ' A' ' 55' ' ' GLU . 47.3 mm-40 -122.36 153.54 62.06 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 1.0 109.432 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.997 ' O ' HD23 ' A' ' 59' ' ' LEU . 35.3 Cg_endo -78.11 131.03 10.62 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.521 2.148 . . . . 1.0 110.462 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.017 HD22 HG23 ' A' ' 155' ' ' VAL . 4.3 mt -128.14 163.02 25.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 1.0 109.16 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.447 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 4.4 ptt? -110.48 138.72 46.5 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.238 -0.914 . . . . 1.0 109.771 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.605 HD22 HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -91.71 147.44 22.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.413 -0.804 . . . . 1.0 109.391 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.455 ' O ' ' HG2' ' A' ' 152' ' ' ARG . 0.9 OUTLIER -124.48 77.6 1.59 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.307 -0.871 . . . . 1.0 109.041 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.966 HD22 ' CE1' ' A' ' 151' ' ' PHE . 0.5 OUTLIER -125.64 156.89 38.52 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.205 -0.934 . . . . 1.0 109.842 -179.569 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.864 ' HB3' HG12 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -166.16 -164.93 0.73 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.38 -0.97 . . . . 1.0 108.38 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.785 HD12 ' CD2' ' A' ' 149' ' ' LEU . 0.5 OUTLIER -117.56 112.51 39.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.889 -1.132 . . . . 1.0 108.53 178.656 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.8 147.31 16.8 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.829 -1.308 . . . . 1.0 109.829 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.933 HG22 ' CD2' ' A' ' 76' ' ' HIS . 4.7 p -83.26 134.02 34.96 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.476 -1.014 . . . . 1.0 109.404 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.14 121.28 3.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.218 -0.926 . . . . 1.0 109.371 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.513 ' OD2' HD21 ' A' ' 72' ' ' LEU . 3.1 p30 -84.84 -26.52 27.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.9 . . . . 1.0 109.503 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.96 -38.75 0.34 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 1.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' LEU . 2.7 ttm180 -168.96 -35.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.121 -0.987 . . . . 1.0 109.674 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.572 ' H ' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -44.06 94.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 1.0 109.701 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -80.17 136.36 36.48 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.222 -0.924 . . . . 1.0 109.623 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -157.83 166.48 16.47 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.285 -0.884 . . . . 1.0 109.136 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.943 ' HB3' HG23 ' A' ' 101' ' ' THR . 33.4 Cg_endo -75.47 137.26 20.49 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.147 1.898 . . . . 1.0 110.223 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.995 ' NE2' HG12 ' A' ' 147' ' ' VAL . 0.3 OUTLIER -65.27 157.53 28.74 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.29 -0.882 . . . . 1.0 109.848 -179.529 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.3 -58.88 2.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.299 -0.876 . . . . 1.0 109.467 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -128.31 2.86 5.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.203 -0.936 . . . . 1.0 109.794 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.579 ' HB2' ' CD2' ' A' ' 76' ' ' HIS . 5.7 m-85 -100.72 76.15 1.78 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.13 -0.981 . . . . 1.0 109.414 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.512 ' HB2' ' CB ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -141.97 8.68 1.89 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 1.0 110.002 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.892 HG11 HD23 ' A' ' 124' ' ' LEU . 10.2 m -67.64 143.69 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.034 -1.041 . . . . 1.0 109.52 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.527 ' ND1' ' HB2' ' A' ' 121' ' ' ALA . 0.3 OUTLIER -175.48 107.23 0.09 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.47 -0.769 . . . . 1.0 109.438 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -144.8 142.84 30.3 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.165 -0.96 . . . . 1.0 109.711 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.742 HD12 ' N ' ' A' ' 84' ' ' ILE . 4.1 mp -101.01 158.98 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.349 -0.844 . . . . 1.0 109.196 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.434 ' N ' HG22 ' A' ' 84' ' ' ILE . 23.8 p . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.149 -0.969 . . . . 1.0 109.275 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.57 HG22 ' H ' ' A' ' 90' ' ' SER . 8.7 p . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.57 ' H ' HG22 ' A' ' 89' ' ' VAL . 1.5 t -86.85 -30.16 21.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 1.0 109.561 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.657 HG23 ' HG ' ' A' ' 108' ' ' LEU . 11.5 m -108.57 105.06 14.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.328 -0.857 . . . . 1.0 109.505 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.517 ' O ' HG23 ' A' ' 106' ' ' ILE . 6.9 m -52.63 157.46 1.56 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 1.0 109.338 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.664 ' HB3' HD12 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -140.69 174.99 9.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 1.0 109.917 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -152.41 160.77 43.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.479 -0.763 . . . . 1.0 109.505 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.16 148.69 52.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.139 -0.976 . . . . 1.0 109.668 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.521 ' O ' HG23 ' A' ' 103' ' ' VAL . . . -158.66 121.14 3.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 1.0 109.571 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.444 HD12 ' C ' ' A' ' 101' ' ' THR . 2.7 tp -107.44 141.06 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 1.0 109.412 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.516 ' O ' ' CB ' ' A' ' 99' ' ' SER . 0.5 OUTLIER -132.9 50.33 2.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 1.0 109.511 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 1.6 m 77.75 108.03 0.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.454 -0.779 . . . . 1.0 109.748 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.616 ' ND2' ' O ' ' A' ' 100' ' ' ASN . 2.1 p-10 44.25 41.28 4.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.493 -0.754 . . . . 1.0 110.364 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.943 HG23 ' HB3' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -158.91 79.32 0.77 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.971 -1.08 . . . . 1.0 109.77 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.512 ' CB ' ' HB2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -82.09 119.14 23.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.944 . . . . 1.0 109.131 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.864 HG12 ' HB3' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -122.41 161.18 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.214 -0.929 . . . . 1.0 109.528 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.92 HD11 HD11 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -129.67 121.9 27.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.463 -0.773 . . . . 1.0 109.388 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.826 ' O ' HD13 ' A' ' 106' ' ' ILE . 0.7 OUTLIER -99.59 139.47 35.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 1.0 109.28 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.826 HD13 ' O ' ' A' ' 105' ' ' GLU . 2.9 mm -133.12 96.71 17.27 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 1.0 109.956 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.867 ' O ' HD22 ' A' ' 108' ' ' LEU . 34.7 Cg_endo -76.25 108.19 2.62 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.349 2.033 . . . . 1.0 109.738 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.867 HD22 ' O ' ' A' ' 107' ' ' PRO . 0.4 OUTLIER -144.56 165.48 27.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 1.0 110.247 -179.195 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.517 HD12 HD21 ' A' ' 112' ' ' ASN . 0.8 OUTLIER -131.6 66.71 78.82 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.489 -0.757 . . . . 1.0 109.205 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.523 ' HB3' ' CG ' ' A' ' 114' ' ' MET . 36.7 Cg_endo -81.06 42.33 1.32 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.652 2.235 . . . . 1.0 110.635 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.516 ' CB ' ' O ' ' A' ' 55' ' ' GLU . 1.5 mp0 -93.83 -0.35 55.83 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.023 -1.048 . . . . 1.0 109.665 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.517 HD21 HD12 ' A' ' 109' ' ' LEU . 0.6 OUTLIER -108.24 -51.82 2.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.107 -0.996 . . . . 1.0 109.278 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.3 OUTLIER 164.79 97.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 1.0 109.237 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.646 ' CE ' HD12 ' A' ' 108' ' ' LEU . 5.4 ptm -162.39 133.46 5.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.146 -0.972 . . . . 1.0 109.972 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.497 ' NH1' HG21 ' A' ' 47' ' ' ILE . 14.2 ttp180 -112.25 131.85 55.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.205 -0.935 . . . . 1.0 109.21 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.533 ' HB2' ' OG1' ' A' ' 91' ' ' THR . . . -120.54 117.28 27.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 1.0 109.512 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 1.15 HG12 HG23 ' A' ' 47' ' ' ILE . 5.1 m -92.83 135.8 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.296 -0.878 . . . . 1.0 109.371 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 45' ' ' HIS . 7.8 mt -112.75 116.52 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.216 -0.927 . . . . 1.0 109.549 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 17.3 p30 -156.88 52.35 0.5 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 1.0 109.477 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.486 ' HB3' HG13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -135.54 53.5 1.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -0.872 . . . . 1.0 109.5 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.527 ' HB2' ' ND1' ' A' ' 82' ' ' HIS . . . -139.84 175.95 9.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.842 . . . . 1.0 109.338 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.872 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -143.69 -178.04 19.12 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.376 -1.49 . . . . 1.0 109.376 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.67 HD11 ' NE2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -117.75 158.73 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.177 -1.19 . . . . 1.0 109.131 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.892 HD23 HG11 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -123.57 147.69 47.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 1.0 109.425 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.546 ' H ' HD13 ' A' ' 124' ' ' LEU . 1.7 ttpm? . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.238 -0.914 . . . . 1.0 109.425 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 74.8 p . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 121.273 0.559 . . . . 1.0 110.354 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.522 ' O ' ' CD ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -157.13 124.39 5.23 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.381 -0.824 . . . . 1.0 110.204 179.37 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.995 HG12 ' NE2' ' A' ' 76' ' ' HIS . 13.9 m -137.48 165.55 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.248 -0.907 . . . . 1.0 108.803 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 170' ' ' ASN . 0.0 OUTLIER -155.46 139.14 16.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.054 -1.029 . . . . 1.0 110.14 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.785 ' CD2' HD12 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -99.75 101.01 12.04 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.385 -0.822 . . . . 1.0 108.875 179.405 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 21.5 t -77.16 140.88 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.933 . . . . 1.0 109.692 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.966 ' CE1' HD22 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -136.66 111.16 8.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.277 -0.89 . . . . 1.0 109.484 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.508 ' HD3' ' NE2' ' A' ' 166' ' ' GLN . 12.6 ptt180 -144.22 133.16 22.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.884 -1.135 . . . . 1.0 109.922 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.512 ' CG1' HD11 ' A' ' 163' ' ' LEU . 12.3 p -109.53 127.89 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.53 -0.915 . . . . 1.0 108.53 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.551 ' CD2' ' HB2' ' A' ' 164' ' ' SER . 39.4 m80 -123.17 114.1 19.84 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.199 -0.938 . . . . 1.0 110.132 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 1.017 HG23 HD22 ' A' ' 59' ' ' LEU . 11.4 p -99.4 141.12 22.27 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.242 -0.911 . . . . 1.0 108.938 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.519 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 33.9 Cg_endo -75.93 117.0 4.56 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.294 1.996 . . . . 1.0 110.561 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.536 ' NE2' ' HD2' ' A' ' 158' ' ' PRO . 4.1 mm100 -154.83 168.92 11.07 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.312 -0.867 . . . . 1.0 109.116 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.536 ' HD2' ' NE2' ' A' ' 157' ' ' GLN . 34.4 Cg_endo -77.2 -65.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.326 2.017 . . . . 1.0 110.25 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.4 104.54 0.79 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.193 -0.942 . . . . 1.0 109.191 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -46.45 -28.1 3.22 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.465 -1.454 . . . . 1.0 109.465 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.4 mtt-85 -79.22 79.64 5.63 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.37 -1.076 . . . . 1.0 108.259 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.811 HG22 ' N ' ' A' ' 163' ' ' LEU . 1.3 m -140.04 -90.04 0.18 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.441 -0.787 . . . . 1.0 109.15 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.811 ' N ' HG22 ' A' ' 162' ' ' THR . 8.9 tp -140.34 97.9 3.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.958 -1.089 . . . . 1.0 108.986 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.551 ' HB2' ' CD2' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -163.3 94.81 0.82 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.084 -1.01 . . . . 1.0 109.408 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.778 ' N ' HD23 ' A' ' 165' ' ' LEU . 1.8 pt? -138.37 175.32 9.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 1.0 109.984 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.508 ' NE2' ' HD3' ' A' ' 152' ' ' ARG . 0.7 OUTLIER -119.22 161.84 19.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.434 -0.791 . . . . 1.0 109.843 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.7 HG12 ' O ' ' A' ' 167' ' ' VAL . 41.5 t -151.74 74.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.448 -0.782 . . . . 1.0 109.036 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' A' ' 148' ' ' ARG . . . -89.48 102.86 15.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.093 -1.004 . . . . 1.0 109.104 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 t -143.41 88.68 2.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.917 . . . . 1.0 110.057 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.529 ' N ' ' HD3' ' A' ' 171' ' ' PRO . 1.1 m-20 -179.69 60.6 0.11 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 1.0 109.341 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 170' ' ' ASN . 36.4 Cg_endo -78.67 96.91 1.1 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.383 2.056 . . . . 1.0 111.011 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.881 HG23 ' HA ' ' A' ' 24' ' ' HIS . 1.6 mt -101.53 147.05 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.166 -0.959 . . . . 1.0 108.679 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.46 0 O-C-N 121.088 -1.007 . . . . 1.0 110.132 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo . . . . . 0 C--O 1.215 -0.625 0 N-CA-C 110.613 -0.572 . . . . 1.0 110.613 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.576 ' CZ ' ' O ' ' A' ' 162' ' ' THR . 5.8 m-85 -67.82 152.11 46.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.872 . . . . 1.0 109.277 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.28 129.72 13.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.918 -1.114 . . . . 1.0 109.855 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.919 HD13 HD12 ' A' ' 50' ' ' LEU . 58.4 tp -121.04 75.02 1.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.42 155.27 33.82 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.44 -0.787 . . . . 1.0 109.982 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.542 HG21 ' NE2' ' A' ' 20' ' ' GLN . 0.6 OUTLIER -66.81 145.8 13.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.532 -0.914 . . . . 1.0 108.532 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.637 ' HG3' HG23 ' A' ' 19' ' ' VAL . 3.8 tp10 -72.51 -53.52 11.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 1.0 109.749 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.637 HG23 ' HG3' ' A' ' 18' ' ' GLU . 21.7 t -127.99 142.04 44.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.262 -0.899 . . . . 1.0 109.618 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.542 ' NE2' HG21 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -120.58 82.49 33.36 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 1.0 109.354 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 22' ' ' LYS . 35.0 Cg_endo -77.72 -177.53 3.92 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.436 2.09 . . . . 1.0 110.376 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 21' ' ' PRO . 12.7 mttt -43.86 112.69 0.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.37 -0.831 . . . . 1.0 109.227 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.546 ' HB3' ' CG ' ' A' ' 171' ' ' PRO . 2.1 t -110.24 29.64 7.48 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.198 -0.939 . . . . 1.0 109.89 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -103.21 165.9 10.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 1.0 109.476 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.63 ' CD2' ' HA ' ' A' ' 38' ' ' VAL . 24.4 t-80 -157.21 118.07 3.6 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.516 -0.74 . . . . 1.0 109.894 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.441 ' HD2' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -90.98 89.17 7.32 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.408 -0.807 . . . . 1.0 108.881 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.472 0 O-C-N 121.172 -0.955 . . . . 1.0 109.395 -179.676 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.43 0.633 . . . . 1.0 109.665 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.63 ' HA ' ' CD2' ' A' ' 25' ' ' HIS . 1.7 p -73.33 121.49 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.418 -0.801 . . . . 1.0 109.372 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -153.23 110.58 3.51 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.307 -0.871 . . . . 1.0 109.506 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 44' ' ' GLY . . . -165.17 150.31 9.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.373 -0.829 . . . . 1.0 109.563 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 40' ' ' ALA . 80.6 p 43.78 -118.08 0.55 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 1.0 109.39 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.6 57.47 4.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.304 -1.498 . . . . 1.0 109.524 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.46 ' HA3' ' HB2' ' A' ' 119' ' ' ASP . . . 88.25 -19.14 36.96 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.568 -1.413 . . . . 1.0 109.568 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 40' ' ' ALA . . . 116.41 -71.03 0.27 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.582 -1.407 . . . . 1.0 109.582 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 21.9 m80 -60.11 154.25 51.88 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.249 -1.148 . . . . 1.0 109.578 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.419 ' HB2' HG21 ' A' ' 17' ' ' ILE . 35.5 Cg_endo -78.09 178.7 7.27 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.492 2.128 . . . . 1.0 110.472 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.774 HG23 HG12 ' A' ' 117' ' ' VAL . 2.3 mm -94.53 160.87 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 1.0 109.266 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.8 t -135.81 127.3 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.234 -0.916 . . . . 1.0 109.732 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.501 ' NE2' ' HB2' ' A' ' 18' ' ' GLU . 14.2 pt20 -151.17 142.14 23.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.339 -0.851 . . . . 1.0 109.348 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.919 HD12 HD13 ' A' ' 15' ' ' LEU . 1.3 tt -98.62 138.99 35.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 1.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.78 76.23 1.54 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.169 -0.957 . . . . 1.0 109.331 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 171.05 96.03 0.1 Allowed Glycine 0 N--CA 1.486 2.01 0 N-CA-C 110.038 -1.225 . . . . 1.0 110.038 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.634 ' CE2' ' CB ' ' A' ' 55' ' ' GLU . 6.2 t80 178.02 129.01 0.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -1.14 . . . . 1.0 109.425 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.92 13.74 32.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 1.0 109.394 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.634 ' CB ' ' CE2' ' A' ' 53' ' ' TYR . 0.7 OUTLIER -116.8 144.49 44.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 1.0 109.432 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.499 ' C ' HD11 ' A' ' 109' ' ' LEU . 5.9 p30 -101.83 50.85 0.84 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 1.0 109.472 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.916 ' C ' HD12 ' A' ' 109' ' ' LEU . 1.9 mp0 -108.89 146.0 32.88 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 1.0 109.458 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 1.011 ' O ' HD23 ' A' ' 59' ' ' LEU . 35.5 Cg_endo -77.96 145.99 22.8 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.441 2.094 . . . . 1.0 110.363 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.011 HD23 ' O ' ' A' ' 58' ' ' PRO . 7.4 mt -139.27 162.76 34.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.262 -0.898 . . . . 1.0 109.51 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -98.34 110.42 23.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.315 -0.866 . . . . 1.0 109.534 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.872 HD21 ' HB2' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -60.77 143.45 54.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.257 -0.902 . . . . 1.0 109.312 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.495 ' N ' ' HG ' ' A' ' 61' ' ' LEU . 6.3 mm-40 -105.21 80.38 1.59 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.189 -0.945 . . . . 1.0 109.718 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.935 HD13 ' CZ ' ' A' ' 151' ' ' PHE . 18.2 tp -99.94 121.43 41.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.303 -0.873 . . . . 1.0 109.129 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.632 ' HB2' HG12 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -143.43 146.84 33.79 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 -179.434 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.691 ' C ' HD13 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -109.23 115.63 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 1.0 108.779 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.645 ' N ' HD13 ' A' ' 65' ' ' ILE . . . -132.8 144.26 16.11 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.548 -1.311 . . . . 1.0 110.204 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.978 HG22 ' CD2' ' A' ' 76' ' ' HIS . 14.8 p -71.2 161.44 31.09 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.525 -0.985 . . . . 1.0 108.959 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 1.043 ' HB3' ' HG3' ' A' ' 148' ' ' ARG . . . -172.52 124.72 0.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.129 -0.982 . . . . 1.0 109.77 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.6 -13.42 24.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -0.881 . . . . 1.0 109.16 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -156.08 -67.34 0.11 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.352 -0.843 . . . . 1.0 109.357 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.553 ' CD ' ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -144.82 -39.18 0.26 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 1.0 109.67 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.553 ' N ' ' CD ' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -51.84 88.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.41 -0.806 . . . . 1.0 109.848 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 71' ' ' ARG . 2.3 pp -66.63 143.9 56.72 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.26 -0.9 . . . . 1.0 109.59 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.525 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -152.87 165.44 17.59 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.158 -0.964 . . . . 1.0 109.452 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.51 146.03 24.03 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.414 2.076 . . . . 1.0 110.211 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.978 ' CD2' HG22 ' A' ' 67' ' ' THR . 0.7 OUTLIER -76.87 160.54 29.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 1.0 109.656 -179.743 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.81 -67.09 0.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -0.866 . . . . 1.0 109.786 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -130.83 23.56 4.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.163 -0.96 . . . . 1.0 109.934 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.578 ' HB2' ' CG ' ' A' ' 76' ' ' HIS . 4.8 m-85 -101.46 74.26 1.52 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.054 -1.029 . . . . 1.0 109.418 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.5 ' CB ' ' HB3' ' A' ' 102' ' ' LYS . 11.0 pt20 -139.49 7.46 2.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.163 -0.96 . . . . 1.0 109.669 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.957 HG23 ' O ' ' A' ' 122' ' ' GLY . 1.3 m -60.91 140.58 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.092 -1.005 . . . . 1.0 109.067 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.604 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 1.0 OUTLIER -176.3 114.05 0.11 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.092 -1.043 . . . . 1.0 109.791 -179.612 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.2 OUTLIER -136.74 126.32 25.29 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.215 -0.928 . . . . 1.0 109.557 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.674 HD12 ' N ' ' A' ' 84' ' ' ILE . 4.4 mp -99.68 137.43 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.256 -0.903 . . . . 1.0 109.628 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 N--CA 1.488 1.47 0 O-C-N 121.403 -0.811 . . . . 1.0 109.137 179.785 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.508 HG21 ' H ' ' A' ' 117' ' ' VAL . 1.7 t . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.5 m -165.53 31.64 0.05 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.499 -0.881 . . . . 1.0 109.668 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.409 HG23 ' N ' ' A' ' 92' ' ' THR . 9.8 t -64.96 -36.48 84.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.206 -0.934 . . . . 1.0 109.558 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.756 ' O ' HG23 ' A' ' 106' ' ' ILE . 58.4 m -163.17 135.91 5.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.199 -0.938 . . . . 1.0 109.587 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -168.39 169.13 10.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -0.882 . . . . 1.0 109.56 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -155.22 145.63 22.01 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.844 . . . . 1.0 109.51 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.515 ' OE1' ' NE2' ' A' ' 82' ' ' HIS . 8.0 tt0 -114.58 146.11 41.17 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.305 -0.872 . . . . 1.0 109.428 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -142.82 122.36 13.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 1.0 109.367 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.973 HD13 ' N ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -135.55 134.95 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.239 -0.913 . . . . 1.0 109.475 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.973 ' N ' HD13 ' A' ' 97' ' ' ILE . 0.7 OUTLIER -138.49 64.82 1.48 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.064 -1.023 . . . . 1.0 109.675 -179.628 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.462 ' O ' ' OD1' ' A' ' 100' ' ' ASN . 1.7 p 62.29 117.44 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.894 . . . . 1.0 109.586 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 99' ' ' SER . 3.7 p-10 44.46 37.03 1.87 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.622 -0.674 . . . . 1.0 110.715 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.482 ' HB ' ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -159.32 85.16 0.79 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.972 -1.08 . . . . 1.0 109.401 179.248 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.5 ' HB3' ' CB ' ' A' ' 80' ' ' GLN . 6.0 tptm -105.91 95.02 5.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.892 . . . . 1.0 109.727 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.632 HG12 ' HB2' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -96.49 171.4 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.326 -0.859 . . . . 1.0 108.963 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.885 HD22 ' N ' ' A' ' 105' ' ' GLU . 0.5 OUTLIER -139.91 122.81 16.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 1.0 109.351 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.885 ' N ' HD22 ' A' ' 104' ' ' LEU . 7.1 mm-40 -123.1 140.14 53.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.303 -0.873 . . . . 1.0 109.292 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.756 HG23 ' O ' ' A' ' 92' ' ' THR . 28.1 mt -129.03 107.31 18.02 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 1.0 109.528 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 60' ' ' MET . 34.6 Cg_endo -76.64 107.81 2.53 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.218 1.945 . . . . 1.0 110.35 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.66 HD23 ' O ' ' A' ' 106' ' ' ILE . 0.6 OUTLIER -146.0 165.18 29.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.876 . . . . 1.0 109.752 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.916 HD12 ' C ' ' A' ' 57' ' ' GLU . 3.5 tt -117.07 85.84 19.06 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.408 -0.807 . . . . 1.0 109.451 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.471 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 37.1 Cg_endo -81.84 30.53 0.52 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.711 2.274 . . . . 1.0 111.199 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.523 ' OE1' ' CB ' ' A' ' 53' ' ' TYR . 9.7 mm-40 -102.96 49.95 0.82 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.842 -1.161 . . . . 1.0 109.512 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 113' ' ' SER . 0.6 OUTLIER -161.78 -61.63 0.05 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.216 -0.928 . . . . 1.0 109.478 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 6.1 p 167.8 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.324 -0.86 . . . . 1.0 109.19 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -155.14 125.23 6.66 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.235 -0.915 . . . . 1.0 109.616 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.658 ' HD3' HG21 ' A' ' 47' ' ' ILE . 6.1 ttm180 -94.61 129.78 41.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 1.0 109.191 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.36 99.71 8.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.318 -0.864 . . . . 1.0 109.518 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.774 HG12 HG23 ' A' ' 47' ' ' ILE . 4.4 m -86.85 143.28 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 1.0 109.425 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.452 ' O ' ' HB2' ' A' ' 45' ' ' HIS . 2.7 mt -133.29 123.86 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.891 . . . . 1.0 109.552 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.46 ' HB2' ' HA3' ' A' ' 43' ' ' GLY . 8.3 p-10 -175.28 46.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 1.0 109.566 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 84' ' ' ILE . 9.9 m -132.95 43.45 2.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 1.0 109.565 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.604 ' HB2' ' HB2' ' A' ' 82' ' ' HIS . . . -134.42 128.29 33.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.253 -0.905 . . . . 1.0 109.13 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.957 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -93.51 -172.08 39.6 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.395 -1.482 . . . . 1.0 109.395 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.716 ' O ' HD12 ' A' ' 124' ' ' LEU . 0.6 OUTLIER -125.48 166.92 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.363 -1.081 . . . . 1.0 108.818 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.738 HD13 HG11 ' A' ' 81' ' ' VAL . 0.8 OUTLIER -140.94 164.45 30.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.905 . . . . 1.0 109.622 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 41.6 mttt . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.383 -0.823 . . . . 1.0 109.096 179.769 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.46 ' HD2' ' O ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -105.04 157.38 17.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.886 . . . . 1.0 109.254 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.69 HG12 ' CD2' ' A' ' 76' ' ' HIS . 1.6 m -140.49 168.25 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.382 -0.823 . . . . 1.0 109.406 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 1.043 ' HG3' ' HB3' ' A' ' 68' ' ' ALA . 5.2 mmt180 -148.82 99.32 2.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 1.0 109.563 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.636 HD12 ' CD2' ' A' ' 151' ' ' PHE . 0.7 OUTLIER -79.77 115.93 19.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.104 -0.997 . . . . 1.0 108.889 179.635 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 168' ' ' ALA . 4.3 t -87.09 114.43 26.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.204 -0.935 . . . . 1.0 109.87 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.935 ' CZ ' HD13 ' A' ' 63' ' ' LEU . 1.6 m-85 -108.39 113.33 26.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 1.0 109.228 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.473 ' CB ' ' HA ' ' A' ' 166' ' ' GLN . 5.4 ptt180 -150.6 159.41 44.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.899 -1.126 . . . . 1.0 109.95 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 153' ' ' VAL . 10.4 p -143.41 128.51 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.281 -0.887 . . . . 1.0 108.659 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.62 ' CD2' ' HB2' ' A' ' 164' ' ' SER . 24.0 m80 -132.46 113.63 13.35 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.073 -1.017 . . . . 1.0 110.372 -179.077 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.551 HG11 ' HB3' ' A' ' 163' ' ' LEU . 12.6 p -99.04 141.85 23.6 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 108.556 -0.905 . . . . 1.0 108.556 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 32.0 Cg_endo -73.64 115.88 4.49 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.093 1.862 . . . . 1.0 110.881 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.468 ' HB2' ' HD2' ' A' ' 158' ' ' PRO . 1.6 pm0 -133.14 160.94 66.66 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 157' ' ' GLN . 34.9 Cg_endo -77.56 -66.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.305 2.003 . . . . 1.0 110.675 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.5 t -59.38 -93.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 1.0 109.621 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 171.38 -33.91 0.15 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.412 -1.475 . . . . 1.0 109.412 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -79.08 80.3 5.44 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.92 -1.141 . . . . 1.0 107.92 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.802 HG22 ' N ' ' A' ' 163' ' ' LEU . 1.3 m -138.9 -90.17 0.2 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.509 -0.744 . . . . 1.0 109.486 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.802 ' N ' HG22 ' A' ' 162' ' ' THR . 7.4 tp -146.96 109.19 4.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.58 -1.325 . . . . 1.0 109.615 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.62 ' HB2' ' CD2' ' A' ' 154' ' ' HIS . 0.0 OUTLIER -162.94 91.49 0.73 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.035 -1.041 . . . . 1.0 109.38 178.793 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.749 HD13 ' H ' ' A' ' 166' ' ' GLN . 0.2 OUTLIER -120.64 155.46 33.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.345 -0.847 . . . . 1.0 109.495 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.749 ' H ' HD13 ' A' ' 165' ' ' LEU . 3.5 tt0 -134.16 142.34 47.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.163 -0.96 . . . . 1.0 109.568 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 168' ' ' ALA . 46.3 t -146.07 161.28 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 1.0 109.398 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.517 ' N ' HG12 ' A' ' 167' ' ' VAL . . . -151.29 92.71 1.82 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.389 -0.82 . . . . 1.0 108.847 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.53 ' HB2' HD11 ' A' ' 149' ' ' LEU . 20.4 m -82.93 160.43 22.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.954 . . . . 1.0 109.632 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.53 ' N ' ' HD3' ' A' ' 171' ' ' PRO . 14.7 p-10 -174.51 63.04 0.25 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.162 -0.961 . . . . 1.0 110.059 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.546 ' CG ' ' HB3' ' A' ' 23' ' ' SER . 37.5 Cg_endo -83.23 52.04 3.81 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.477 2.118 . . . . 1.0 110.296 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 13.0 mt -151.06 128.02 2.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.456 -0.778 . . . . 1.0 109.534 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 1.0 109.362 179.873 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo . . . . . 0 C--O 1.214 -0.69 0 N-CA-C 110.293 -0.695 . . . . 1.0 110.293 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.518 ' HA ' ' HA3' ' A' ' 52' ' ' GLY . 3.6 m-85 -105.5 137.95 42.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.152 -0.967 . . . . 1.0 109.63 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.453 ' CG ' ' O ' ' A' ' 13' ' ' TYR . 1.6 mt-10 179.72 139.16 0.12 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 1.0 109.764 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.489 ' O ' ' CG ' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -99.87 98.82 9.57 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.291 -0.881 . . . . 1.0 109.055 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -99.96 155.14 17.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.191 -0.943 . . . . 1.0 109.768 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.942 HG21 ' NE2' ' A' ' 20' ' ' GLN . 12.7 mm -72.95 134.44 29.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.398 -0.813 . . . . 1.0 109.266 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.421 ' HB2' ' CD ' ' A' ' 49' ' ' GLN . 44.2 tt0 -68.89 -55.1 12.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.137 -0.977 . . . . 1.0 108.967 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.88 HG22 ' HD3' ' A' ' 21' ' ' PRO . 9.8 p -118.58 130.22 73.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.376 -0.827 . . . . 1.0 108.871 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.942 ' NE2' HG21 ' A' ' 17' ' ' ILE . 9.2 tp-100 -129.94 63.97 70.51 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.08 -1.012 . . . . 1.0 110.023 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.88 ' HD3' HG22 ' A' ' 19' ' ' VAL . 35.8 Cg_endo -78.44 -175.34 2.67 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.406 2.07 . . . . 1.0 109.88 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -48.45 94.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.917 . . . . 1.0 108.78 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 21' ' ' PRO . 1.4 p -94.02 40.24 1.08 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.25 -0.906 . . . . 1.0 110.252 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.475 ' HA ' HG12 ' A' ' 172' ' ' ILE . 0.0 OUTLIER -99.49 167.25 10.73 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.969 -1.082 . . . . 1.0 108.284 179.205 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.439 ' ND1' ' CD1' ' A' ' 123' ' ' ILE . 11.4 t-160 -133.7 134.03 42.57 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 119.341 -0.944 . . . . 1.0 110.068 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.479 ' HD2' ' O ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -106.1 75.73 1.12 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 179.356 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.47 -0.769 . . . . 1.0 109.79 -179.064 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 p -57.03 135.4 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 1.0 109.34 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.06 115.26 4.1 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.417 -0.802 . . . . 1.0 109.698 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 42' ' ' ALA . . . -156.5 114.84 3.33 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.509 -0.745 . . . . 1.0 109.548 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 50.91 -88.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.473 -0.767 . . . . 1.0 110.085 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 45' ' ' HIS . . . -85.03 46.25 1.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.099 -1.0 . . . . 1.0 109.832 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.39 9.32 42.62 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.887 -1.285 . . . . 1.0 109.887 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.401 ' N ' ' H ' ' A' ' 40' ' ' ALA . . . 135.71 -80.06 0.31 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.643 -1.383 . . . . 1.0 109.643 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.668 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 5.5 m-70 -88.36 157.53 50.15 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.317 -1.108 . . . . 1.0 109.672 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.458 ' HG3' ' OE1' ' A' ' 20' ' ' GLN . 35.8 Cg_endo -78.41 178.74 7.21 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.601 2.201 . . . . 1.0 110.528 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.951 ' CG2' HG12 ' A' ' 117' ' ' VAL . 5.0 mt -94.45 157.05 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.481 -0.762 . . . . 1.0 109.199 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.637 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 2.1 t -131.66 128.1 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.207 -0.933 . . . . 1.0 109.829 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.421 ' CD ' ' HB2' ' A' ' 18' ' ' GLU . 7.1 pt20 -140.95 138.17 33.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 1.0 109.353 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.479 ' HG ' ' HB3' ' A' ' 15' ' ' LEU . 2.7 tt -98.2 136.68 38.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 1.0 109.75 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.442 ' N ' HD23 ' A' ' 50' ' ' LEU . 5.7 p80 -140.52 97.98 3.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.333 -0.854 . . . . 1.0 109.16 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . -178.89 -86.5 0.07 OUTLIER Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.631 -1.271 . . . . 1.0 110.133 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.514 ' OH ' ' NE2' ' A' ' 157' ' ' GLN . 0.8 OUTLIER -38.37 121.86 1.03 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 122.1 -0.647 . . . . 1.0 110.345 -179.414 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.85 1.72 37.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.361 -0.837 . . . . 1.0 109.538 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.473 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -79.82 145.66 32.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.148 -0.97 . . . . 1.0 109.423 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -84.61 44.68 1.07 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 1.0 109.824 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.687 ' O ' HD23 ' A' ' 109' ' ' LEU . 5.1 mm-40 -99.23 150.59 36.86 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 1.0 109.304 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.992 ' O ' HD23 ' A' ' 59' ' ' LEU . 36.0 Cg_endo -77.68 139.48 17.95 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.306 2.004 . . . . 1.0 110.385 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.992 HD23 ' O ' ' A' ' 58' ' ' PRO . 5.8 mt -128.26 159.04 36.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 1.0 109.452 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.419 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.3 OUTLIER -121.31 107.84 13.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.133 -0.979 . . . . 1.0 109.519 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.645 HD21 ' HD1' ' A' ' 151' ' ' PHE . 0.3 OUTLIER -61.92 116.59 5.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.903 . . . . 1.0 109.543 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.437 ' O ' ' HG2' ' A' ' 152' ' ' ARG . 17.6 mm100 -94.99 78.18 3.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.12 -0.988 . . . . 1.0 109.067 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.835 HD22 ' CE1' ' A' ' 151' ' ' PHE . 0.6 OUTLIER -112.85 157.84 20.9 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.377 -0.827 . . . . 1.0 109.714 -179.598 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.888 ' O ' HD23 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -165.74 176.95 7.58 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 179.354 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.639 ' CD1' ' CE1' ' A' ' 76' ' ' HIS . 0.2 OUTLIER -114.75 118.6 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.109 -0.994 . . . . 1.0 108.862 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.44 150.28 19.64 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.611 -1.28 . . . . 1.0 110.06 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.933 HG22 ' CD2' ' A' ' 76' ' ' HIS . 0.6 OUTLIER -89.2 151.23 22.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.456 -1.026 . . . . 1.0 109.269 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.92 113.08 6.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.17 -0.956 . . . . 1.0 109.538 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.2 -27.89 25.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.351 -0.843 . . . . 1.0 109.245 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -136.43 -52.48 0.71 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.302 -0.874 . . . . 1.0 109.311 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.5 OUTLIER -175.17 -34.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.9 . . . . 1.0 109.627 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 mt -55.9 91.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 1.0 109.74 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -47.39 166.64 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.224 -0.922 . . . . 1.0 109.474 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.48 ' HB2' ' HD2' ' A' ' 75' ' ' PRO . 5.1 ptm180 -175.15 162.03 2.3 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.901 . . . . 1.0 109.086 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.681 ' HB3' HG23 ' A' ' 101' ' ' THR . 34.3 Cg_endo -76.97 137.64 17.68 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.229 1.953 . . . . 1.0 110.334 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.95 ' NE2' HG12 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -64.16 156.5 28.33 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.246 -0.909 . . . . 1.0 109.625 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.11 -78.72 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.323 -0.86 . . . . 1.0 109.663 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -107.99 19.54 19.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 1.0 109.503 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.581 ' HB2' ' CD2' ' A' ' 76' ' ' HIS . 88.8 m-85 -111.57 112.25 23.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.903 . . . . 1.0 109.463 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.5 ' NE2' ' HD3' ' A' ' 102' ' ' LYS . 8.1 pt20 -167.32 30.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -0.845 . . . . 1.0 108.843 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.85 HG11 ' HA ' ' A' ' 123' ' ' ILE . 31.3 m -52.94 158.6 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 121.62 0.724 . . . . 1.0 110.139 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 1.026 ' CD2' HD11 ' A' ' 104' ' ' LEU . 11.6 t-160 -176.06 66.73 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.464 -0.773 . . . . 1.0 108.961 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.0 OUTLIER -113.38 157.99 21.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.873 . . . . 1.0 109.855 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.408 HG22 ' N ' ' A' ' 85' ' ' THR . 2.0 mp -130.34 156.75 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.413 -0.804 . . . . 1.0 108.991 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.408 ' N ' HG22 ' A' ' 84' ' ' ILE . 40.9 p . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.083 -1.011 . . . . 1.0 109.755 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.763 ' O ' HG13 ' A' ' 89' ' ' VAL . 13.2 p . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.304 0.573 . . . . 1.0 109.575 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.4 m -90.39 32.07 0.98 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 1.0 109.395 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.434 ' H ' HG22 ' A' ' 89' ' ' VAL . 22.4 m -66.06 137.32 56.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 1.0 109.437 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.6 m -52.55 106.11 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 1.0 109.542 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.447 ' HA ' HG23 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -117.65 170.1 9.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -0.87 . . . . 1.0 109.603 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -155.26 161.03 41.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.342 -0.849 . . . . 1.0 109.392 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 103' ' ' VAL . 0.5 OUTLIER -141.24 148.65 40.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 1.0 109.334 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 103' ' ' VAL . . . -152.51 127.96 9.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 1.0 109.731 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.457 ' HB ' ' HD2' ' A' ' 102' ' ' LYS . 2.7 tp -106.29 142.55 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 1.0 109.346 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.522 ' O ' ' CB ' ' A' ' 99' ' ' SER . 0.6 OUTLIER -132.99 53.0 2.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.912 . . . . 1.0 109.787 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 1.6 m 77.08 104.17 0.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.327 -0.858 . . . . 1.0 110.021 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.616 ' ND2' ' O ' ' A' ' 100' ' ' ASN . 2.2 p-10 44.32 43.14 5.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.532 -0.73 . . . . 1.0 110.334 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.681 HG23 ' HB3' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -159.3 77.64 0.72 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.987 -1.071 . . . . 1.0 109.774 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.5 ' HD3' ' NE2' ' A' ' 80' ' ' GLN . 4.2 tptm -81.96 129.75 34.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.861 . . . . 1.0 109.003 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.709 HG12 ' HB3' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -128.1 169.58 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.157 -0.965 . . . . 1.0 109.861 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.026 HD11 ' CD2' ' A' ' 82' ' ' HIS . 0.2 OUTLIER -131.21 130.59 43.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.462 -0.774 . . . . 1.0 109.236 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -128.21 132.33 48.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -0.913 . . . . 1.0 109.683 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.678 HG22 ' CD2' ' A' ' 108' ' ' LEU . 5.3 mt -129.67 102.69 17.9 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 1.0 109.279 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 34.1 Cg_endo -75.43 98.4 1.17 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.196 1.93 . . . . 1.0 110.539 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.678 ' CD2' HG22 ' A' ' 106' ' ' ILE . 0.4 OUTLIER -145.23 165.33 28.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.376 -0.827 . . . . 1.0 109.41 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -114.41 80.65 6.13 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 1.0 109.697 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 108' ' ' LEU . 36.3 Cg_endo -78.7 75.74 4.84 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.501 2.134 . . . . 1.0 110.268 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 53' ' ' TYR . 3.4 mt-10 -138.6 -49.3 0.53 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.267 -0.896 . . . . 1.0 109.603 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -79.89 -49.82 11.37 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.331 -0.855 . . . . 1.0 109.495 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.6 t -175.53 98.69 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.347 -0.846 . . . . 1.0 109.319 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.454 ' HB3' ' HA ' ' A' ' 110' ' ' PRO . 5.0 tpp -165.8 108.46 0.78 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 1.0 109.343 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -99.98 139.23 35.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.346 -0.846 . . . . 1.0 109.092 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.36 92.46 3.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -0.971 . . . . 1.0 109.547 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.951 HG12 ' CG2' ' A' ' 47' ' ' ILE . 3.5 m -91.78 128.34 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.225 -0.922 . . . . 1.0 109.322 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 99.1 mt -118.57 111.81 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.178 -0.951 . . . . 1.0 109.656 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -163.12 28.57 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 1.0 109.449 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 83' ' ' ARG . 4.2 p -116.38 42.89 2.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 1.0 109.347 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.75 164.43 28.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 1.0 109.478 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.736 ' O ' HG21 ' A' ' 81' ' ' VAL . . . -125.39 -173.77 13.76 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.904 -1.678 . . . . 1.0 108.904 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.85 ' HA ' HG11 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -116.27 170.75 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.978 -1.307 . . . . 1.0 109.231 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.414 HD23 ' H ' ' A' ' 125' ' ' LYS . 0.6 OUTLIER -115.39 146.26 41.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 1.0 109.517 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.414 ' H ' HD23 ' A' ' 124' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 1.0 109.405 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.43 -0.581 . . . . 1.0 109.43 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -93.91 154.83 17.49 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.121 -0.987 . . . . 1.0 109.685 -179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.95 HG12 ' NE2' ' A' ' 76' ' ' HIS . 14.1 m -140.26 145.12 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.502 ' HA ' ' HB3' ' A' ' 170' ' ' ASN . 2.5 ptt180 -149.73 135.43 18.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.016 -1.052 . . . . 1.0 110.106 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.888 HD23 ' O ' ' A' ' 64' ' ' PHE . 1.6 mt -87.49 121.33 29.79 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.462 -0.774 . . . . 1.0 109.51 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.494 HG21 ' HE1' ' A' ' 64' ' ' PHE . 21.6 t -92.18 132.9 35.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.194 -0.941 . . . . 1.0 109.29 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.835 ' CE1' HD22 ' A' ' 63' ' ' LEU . 5.8 m-85 -125.69 114.48 18.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.14 -0.975 . . . . 1.0 109.414 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.488 ' HB3' ' HA ' ' A' ' 166' ' ' GLN . 19.5 ptt180 -150.59 127.41 11.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.944 . . . . 1.0 109.6 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.407 HG11 HD11 ' A' ' 50' ' ' LEU . 3.1 p -106.9 129.34 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.039 -1.038 . . . . 1.0 109.37 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -111.57 107.78 17.06 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.272 -0.892 . . . . 1.0 108.736 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.911 ' CG2' HD23 ' A' ' 163' ' ' LEU . 40.1 t -99.09 136.1 20.63 Favored Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.245 -0.909 . . . . 1.0 109.034 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.431 ' O ' ' CD ' ' A' ' 157' ' ' GLN . 35.7 Cg_endo -77.72 141.65 19.65 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 122.534 2.156 . . . . 1.0 111.323 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.636 ' OE1' HG12 ' A' ' 155' ' ' VAL . 0.9 OUTLIER -160.35 179.12 1.42 Allowed Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.565 ' HD2' ' CG ' ' A' ' 157' ' ' GLN . 33.8 Cg_endo -78.27 -53.32 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.393 2.062 . . . . 1.0 110.094 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 158' ' ' PRO . 17.3 m -59.22 -148.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.662 -0.649 . . . . 1.0 109.583 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -125.05 -80.74 0.43 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.105 -1.198 . . . . 1.0 110.105 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 40.7 mtt-85 -78.14 80.96 4.55 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.482 -1.01 . . . . 1.0 108.809 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.563 ' CG2' ' N ' ' A' ' 163' ' ' LEU . 0.7 OUTLIER -102.76 -52.69 3.02 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.583 -0.698 . . . . 1.0 109.338 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.911 HD23 ' CG2' ' A' ' 155' ' ' VAL . 9.9 tp -155.49 96.17 1.76 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.399 -0.963 . . . . 1.0 108.399 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.86 101.71 1.01 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.069 -1.02 . . . . 1.0 109.165 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.857 ' H ' HD23 ' A' ' 165' ' ' LEU . 2.2 pt? -137.1 170.04 16.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 1.0 109.777 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.488 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 9.3 mt-30 -113.61 155.03 26.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.361 -0.837 . . . . 1.0 109.781 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.597 ' O ' HG12 ' A' ' 167' ' ' VAL . 45.6 t -149.74 80.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.883 . . . . 1.0 109.63 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.71 105.59 17.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 1.0 109.162 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.609 ' O ' ' ND2' ' A' ' 170' ' ' ASN . 79.7 p -120.18 117.86 29.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.939 . . . . 1.0 109.772 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.609 ' ND2' ' O ' ' A' ' 169' ' ' SER . 1.4 m-80 163.03 73.72 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.366 -0.834 . . . . 1.0 109.418 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.68 85.8 1.74 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.419 2.079 . . . . 1.0 110.399 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.525 ' O ' ' CG ' ' A' ' 146' ' ' ARG . 4.3 mt -123.07 164.95 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -0.929 . . . . 1.0 108.996 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 172' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 O-C-N 121.168 -0.958 . . . . 1.0 109.692 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.443 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 35.8 Cg_endo . . . . . 0 C--O 1.214 -0.691 0 N-CA-C 110.49 -0.619 . . . . 1.0 110.49 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.556 ' HB3' HD13 ' A' ' 163' ' ' LEU . 7.5 m-85 -73.12 131.58 42.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 1.0 109.446 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -145.7 124.57 12.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.997 -1.064 . . . . 1.0 109.806 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.724 ' HB3' HD11 ' A' ' 165' ' ' LEU . 20.1 tp -120.07 82.74 1.94 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.363 -0.835 . . . . 1.0 109.038 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.62 159.43 26.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.31 -0.869 . . . . 1.0 109.863 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.852 HG23 ' O ' ' A' ' 47' ' ' ILE . 1.3 mp -75.98 142.18 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.338 -0.851 . . . . 1.0 108.774 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.27 -42.75 92.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.339 -0.851 . . . . 1.0 109.618 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.44 ' C ' ' HD3' ' A' ' 21' ' ' PRO . 20.2 t -141.49 133.07 27.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.294 -0.879 . . . . 1.0 109.463 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -119.05 77.16 15.76 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.153 -0.967 . . . . 1.0 109.561 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 23' ' ' SER . 35.9 Cg_endo -78.36 -176.91 3.51 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.513 2.142 . . . . 1.0 110.221 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 21' ' ' PRO . 2.4 mptt -44.35 99.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.317 -0.864 . . . . 1.0 109.008 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 21' ' ' PRO . 2.1 t -96.63 40.92 1.12 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 1.0 109.956 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -99.9 166.96 10.81 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.089 -1.007 . . . . 1.0 109.318 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.58 ' CE1' ' HA ' ' A' ' 38' ' ' VAL . 3.2 t60 -143.23 133.7 24.85 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.723 -0.791 . . . . 1.0 109.64 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.455 ' HD3' ' O ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -105.68 74.31 1.06 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.345 -0.847 . . . . 1.0 109.047 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 1.0 109.54 -179.766 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.528 0.68 . . . . 1.0 109.619 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.883 HG12 ' HA2' ' A' ' 122' ' ' GLY . 2.4 p -54.5 119.63 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.367 -0.833 . . . . 1.0 109.535 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -142.65 99.3 3.45 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.27 -0.894 . . . . 1.0 109.852 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.423 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -93.85 -147.21 0.25 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.322 -0.861 . . . . 1.0 109.142 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.94 171.55 10.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.046 -1.034 . . . . 1.0 109.471 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 54.64 64.33 1.85 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 1.0 109.393 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.12 -68.68 3.48 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.345 -1.502 . . . . 1.0 109.345 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.543 ' CA ' ' HB2' ' A' ' 119' ' ' ASP . . . 173.11 36.16 0.03 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.578 -1.409 . . . . 1.0 109.578 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.599 ' CG ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER 165.42 177.67 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.195 -1.18 . . . . 1.0 109.294 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.599 ' HD2' ' CG ' ' A' ' 45' ' ' HIS . 35.0 Cg_endo -77.34 172.05 16.64 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.426 2.084 . . . . 1.0 110.506 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.912 HG23 HG12 ' A' ' 117' ' ' VAL . 4.2 mm -105.33 161.71 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 1.0 109.659 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.425 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 5.3 t -139.9 125.5 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.393 -0.817 . . . . 1.0 109.245 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -146.64 157.18 43.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.927 . . . . 1.0 109.547 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.662 HD13 ' HG3' ' A' ' 110' ' ' PRO . 5.4 tt -114.63 134.67 54.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 1.0 109.419 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.638 ' N ' HD23 ' A' ' 50' ' ' LEU . 1.1 p80 -140.59 79.04 1.68 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 1.0 109.308 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 177.45 64.31 0.06 OUTLIER Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.806 -1.318 . . . . 1.0 109.806 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.568 ' CD2' HD11 ' A' ' 59' ' ' LEU . 0.4 OUTLIER 177.0 118.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.158 -1.201 . . . . 1.0 109.594 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.437 ' HA ' ' OE1' ' A' ' 111' ' ' GLU . 0.7 OUTLIER -106.98 25.46 11.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.241 -0.912 . . . . 1.0 109.299 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.549 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 38.8 tp10 -89.98 145.15 25.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.236 -0.915 . . . . 1.0 109.482 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -89.0 35.92 0.8 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.221 -0.924 . . . . 1.0 109.532 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.655 ' HG3' HD21 ' A' ' 59' ' ' LEU . 26.2 pt-20 -112.76 147.67 37.66 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 1.0 109.422 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.749 ' O ' HD23 ' A' ' 59' ' ' LEU . 35.3 Cg_endo -78.11 141.06 18.29 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.374 2.049 . . . . 1.0 110.527 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.836 HD22 ' CG2' ' A' ' 155' ' ' VAL . 7.5 mt -120.09 163.77 17.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.898 . . . . 1.0 109.19 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -116.22 100.18 7.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.208 -0.933 . . . . 1.0 109.981 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.906 HD21 ' HB2' ' A' ' 63' ' ' LEU . 1.6 tt -65.72 127.94 33.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.879 . . . . 1.0 108.923 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 152' ' ' ARG . 90.4 mt-30 -91.34 92.22 8.5 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.217 -0.927 . . . . 1.0 109.208 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.906 ' HB2' HD21 ' A' ' 61' ' ' LEU . 15.0 tp -99.6 139.84 34.67 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.316 -0.865 . . . . 1.0 109.022 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.711 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -163.86 168.36 19.61 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.159 -0.963 . . . . 1.0 108.79 -179.314 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.805 HD11 ' HB ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -132.47 116.8 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.814 . . . . 1.0 108.869 179.735 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.663 ' N ' HD13 ' A' ' 65' ' ' ILE . . . -130.98 152.6 20.0 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.843 -1.303 . . . . 1.0 109.843 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.591 HG23 ' CD2' ' A' ' 76' ' ' HIS . 40.7 p -74.03 157.39 36.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.389 -1.065 . . . . 1.0 109.433 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.696 ' HB3' ' HD2' ' A' ' 148' ' ' ARG . . . -169.06 113.58 0.56 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.262 -0.899 . . . . 1.0 109.632 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.39 9.54 37.91 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.273 -0.892 . . . . 1.0 109.346 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -168.67 -54.39 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.31 -0.868 . . . . 1.0 109.192 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 73' ' ' LEU . 3.0 tpt180 -175.23 -33.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.87 . . . . 1.0 109.698 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.59 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -54.12 92.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.295 -0.878 . . . . 1.0 109.774 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.44 ' H ' HD23 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -56.62 164.88 1.3 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.236 -0.915 . . . . 1.0 109.733 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.54 ' CD ' ' HD2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -175.15 170.86 1.34 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 1.0 109.22 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.54 ' HD2' ' CD ' ' A' ' 74' ' ' ARG . 35.2 Cg_endo -77.23 136.67 16.3 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.338 2.026 . . . . 1.0 110.414 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.687 ' ND1' HD12 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -59.2 147.3 35.96 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.278 -0.889 . . . . 1.0 109.719 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 76' ' ' HIS . . . -46.02 -77.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' A' ' 125' ' ' LYS . 79.3 m-85 -140.66 23.71 2.27 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.95 -0.759 . . . . 1.0 108.95 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.654 ' HD2' HG22 ' A' ' 123' ' ' ILE . 63.0 m-85 -78.32 106.97 10.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 1.0 109.31 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 80' ' ' GLN . 3.4 tt0 -119.48 85.27 2.34 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.038 HG12 ' O ' ' A' ' 122' ' ' GLY . 3.8 m -69.75 138.15 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.322 -0.861 . . . . 1.0 110.037 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -175.96 85.45 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.467 -0.771 . . . . 1.0 109.096 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.21 81.04 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.05 -1.031 . . . . 1.0 110.309 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.7 mp -109.34 147.85 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 1.0 108.724 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 67.6 p . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.145 -0.972 . . . . 1.0 109.819 -179.6 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.653 HG22 ' H ' ' A' ' 90' ' ' SER . 5.9 p . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.653 ' H ' HG22 ' A' ' 89' ' ' VAL . 16.9 t -74.41 -42.03 59.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.065 -1.022 . . . . 1.0 109.389 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.599 ' OG1' HD22 ' A' ' 108' ' ' LEU . 6.4 t -72.86 -168.96 0.52 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.921 . . . . 1.0 109.385 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 106' ' ' ILE . 4.4 m -103.48 158.32 16.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 1.0 109.461 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.39 157.35 46.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 1.0 109.786 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -155.86 119.03 4.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.404 -0.81 . . . . 1.0 109.449 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.96 141.9 32.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.127 -0.983 . . . . 1.0 109.473 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.67 120.67 24.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.92 . . . . 1.0 109.574 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 1.012 HD12 ' O ' ' A' ' 101' ' ' THR . 5.1 tp -117.2 144.98 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.36 -0.838 . . . . 1.0 109.323 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.51 HD21 HG21 ' A' ' 101' ' ' THR . 0.5 OUTLIER -135.89 49.42 2.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.115 -0.991 . . . . 1.0 109.676 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER 74.34 114.85 0.06 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.199 -0.938 . . . . 1.0 109.666 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 99' ' ' SER . 3.7 p-10 43.91 35.52 1.14 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.584 -0.698 . . . . 1.0 110.623 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . 1.012 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -149.85 105.19 3.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.841 -1.162 . . . . 1.0 109.952 179.543 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -90.33 106.23 18.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 1.0 109.13 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -109.8 172.03 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.289 -0.882 . . . . 1.0 109.229 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 1.9 mp -128.22 137.67 52.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.816 . . . . 1.0 109.518 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -133.58 112.81 11.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 1.0 109.264 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.944 HG22 HD21 ' A' ' 108' ' ' LEU . 51.9 mt -123.2 107.87 32.4 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 1.0 109.741 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 1.068 ' O ' HD23 ' A' ' 108' ' ' LEU . 34.7 Cg_endo -76.98 125.32 7.92 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.097 1.865 . . . . 1.0 110.231 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.068 HD23 ' O ' ' A' ' 107' ' ' PRO . 3.4 mt -134.12 151.63 51.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 1.0 110.006 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.558 HD12 ' SD ' ' A' ' 114' ' ' MET . 0.2 OUTLIER -123.38 91.29 49.9 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.416 -0.802 . . . . 1.0 108.93 179.505 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.662 ' HG3' HD13 ' A' ' 50' ' ' LEU . 35.9 Cg_endo -78.07 70.49 7.07 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.515 2.143 . . . . 1.0 110.631 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.494 ' O ' ' CG ' ' A' ' 111' ' ' GLU . 19.8 tp10 -118.56 0.71 11.61 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.284 -0.885 . . . . 1.0 109.639 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.498 ' O ' ' CB ' ' A' ' 113' ' ' SER . 0.0 OUTLIER -143.55 -65.11 0.38 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.105 -0.997 . . . . 1.0 109.496 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.4 OUTLIER 164.61 109.95 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.147 -0.971 . . . . 1.0 109.157 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.558 ' SD ' HD12 ' A' ' 109' ' ' LEU . 9.4 ptm -154.09 117.43 4.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.2 -0.938 . . . . 1.0 109.915 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.518 ' HD3' HG12 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -88.29 136.45 32.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.435 -0.79 . . . . 1.0 109.415 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.03 108.99 16.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 1.0 109.365 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.912 HG12 HG23 ' A' ' 47' ' ' ILE . 4.3 m -95.25 159.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -0.934 . . . . 1.0 109.667 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.486 ' O ' ' CB ' ' A' ' 45' ' ' HIS . 8.3 mt -146.95 102.6 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 1.0 109.228 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.543 ' HB2' ' CA ' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -147.56 47.39 1.11 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 1.0 109.71 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 63.8 m -145.04 54.2 1.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.881 . . . . 1.0 109.355 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.793 ' HB1' ' HB ' ' A' ' 81' ' ' VAL . . . -145.26 87.24 1.8 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.917 . . . . 1.0 109.845 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 1.038 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -56.44 -166.36 0.06 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 108.389 -1.884 . . . . 1.0 108.389 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.654 HG22 ' HD2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -114.29 151.77 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.707 -1.466 . . . . 1.0 109.178 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -143.44 82.57 1.74 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.438 -0.789 . . . . 1.0 109.702 -179.642 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.584 ' HB3' ' CD2' ' A' ' 79' ' ' TYR . 4.3 ptmt . . . . . 0 N--CA 1.494 1.74 0 O-C-N 120.822 -1.174 . . . . 1.0 110.207 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.1 p . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 121.482 0.658 . . . . 1.0 109.68 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.12 128.02 7.41 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.388 -0.82 . . . . 1.0 109.187 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.805 ' HB ' HD11 ' A' ' 65' ' ' ILE . 6.8 m -136.2 161.28 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.964 . . . . 1.0 109.517 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.696 ' HD2' ' HB3' ' A' ' 68' ' ' ALA . 10.7 mtt-85 -145.24 126.41 14.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.189 -0.945 . . . . 1.0 109.667 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.801 HD22 HG12 ' A' ' 65' ' ' ILE . 2.0 mm? -79.86 114.52 18.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.335 -0.853 . . . . 1.0 108.997 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 45.6 t -85.93 122.74 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.235 -0.916 . . . . 1.0 109.497 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.863 ' CE1' HD13 ' A' ' 63' ' ' LEU . 8.0 m-85 -119.76 95.75 4.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.33 -0.856 . . . . 1.0 109.125 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.475 ' O ' ' HG3' ' A' ' 152' ' ' ARG . 19.5 ptt180 -135.63 129.93 33.59 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.141 -0.974 . . . . 1.0 109.566 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.571 ' HB ' HD22 ' A' ' 15' ' ' LEU . 11.9 p -108.19 128.6 63.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.306 -0.871 . . . . 1.0 108.763 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.674 ' CD2' ' HB2' ' A' ' 164' ' ' SER . 34.9 m80 -124.34 108.54 12.31 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.197 -0.94 . . . . 1.0 109.76 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.836 ' CG2' HD22 ' A' ' 59' ' ' LEU . 7.7 p -99.22 141.24 22.51 Favored Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 121.314 -0.866 . . . . 1.0 109.172 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.529 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 34.5 Cg_endo -77.19 115.34 3.95 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.174 1.916 . . . . 1.0 109.994 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.491 ' OE1' ' HD2' ' A' ' 158' ' ' PRO . 72.2 mm-40 -143.23 163.58 36.52 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.424 -0.797 . . . . 1.0 109.52 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.491 ' HD2' ' OE1' ' A' ' 157' ' ' GLN . 35.0 Cg_endo -77.92 -55.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.402 2.068 . . . . 1.0 109.777 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 158' ' ' PRO . 0.2 OUTLIER -45.71 171.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.628 -0.67 . . . . 1.0 109.466 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -93.86 -66.37 1.04 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.173 -1.171 . . . . 1.0 110.173 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.6 mtm-85 -78.98 79.21 5.39 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.399 -1.334 . . . . 1.0 107.399 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.556 HG23 ' H ' ' A' ' 163' ' ' LEU . 2.7 t -102.03 -108.34 0.24 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.673 -0.642 . . . . 1.0 110.518 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.556 HD13 ' HB3' ' A' ' 13' ' ' TYR . 8.6 tp -129.1 96.46 4.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.295 -1.503 . . . . 1.0 108.299 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.674 ' HB2' ' CD2' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -162.85 100.34 1.0 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.874 -1.141 . . . . 1.0 109.699 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.864 HD23 ' N ' ' A' ' 165' ' ' LEU . 1.0 OUTLIER -134.61 170.04 16.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.178 -0.952 . . . . 1.0 109.64 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.461 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 3.1 mm-40 -121.73 147.31 46.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 1.0 109.557 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.74 ' O ' HG12 ' A' ' 167' ' ' VAL . 41.8 t -145.47 70.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.871 . . . . 1.0 109.407 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.77 107.72 19.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.222 -0.924 . . . . 1.0 109.192 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 0.3 OUTLIER -156.33 123.49 5.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 1.0 109.7 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 169' ' ' SER . 1.8 t30 172.2 94.94 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.37 -0.831 . . . . 1.0 109.287 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.65 107.9 2.46 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.414 2.076 . . . . 1.0 110.48 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.62 ' HB ' HG22 ' A' ' 147' ' ' VAL . 24.6 mt -137.43 159.47 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.874 . . . . 1.0 108.99 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 145' ' ' THR . 2.9 mt-10 . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.127 -0.983 . . . . 1.0 109.854 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.447 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 36.3 Cg_endo . . . . . 0 C--O 1.216 -0.602 0 N-CA-C 110.596 -0.578 . . . . 1.0 110.596 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.575 ' CE2' ' O ' ' A' ' 162' ' ' THR . 8.3 m-85 -56.09 155.75 6.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 1.0 109.063 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 12' ' ' PRO . 20.7 mt-10 -152.21 103.01 2.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.885 -1.134 . . . . 1.0 110.25 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.665 ' HB3' HD12 ' A' ' 165' ' ' LEU . 17.3 tp -112.24 76.78 1.0 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.436 -0.95 . . . . 1.0 108.436 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.6 ' O ' ' NE2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -114.87 176.25 5.14 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.322 -0.861 . . . . 1.0 110.188 -179.022 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.583 HG21 ' HG2' ' A' ' 20' ' ' GLN . 0.8 OUTLIER -86.75 146.48 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 108.705 -0.85 . . . . 1.0 108.705 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.06 -61.13 2.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 1.0 109.261 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.752 HG22 ' HD3' ' A' ' 21' ' ' PRO . 9.7 p -109.67 136.02 46.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.385 -0.822 . . . . 1.0 109.307 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.583 ' HG2' HG21 ' A' ' 17' ' ' ILE . 9.4 mm-40 -129.06 66.02 75.34 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.143 -0.973 . . . . 1.0 109.599 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.752 ' HD3' HG22 ' A' ' 19' ' ' VAL . 35.4 Cg_endo -77.62 -177.03 3.54 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.464 2.109 . . . . 1.0 110.575 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -61.85 151.7 33.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.366 -0.834 . . . . 1.0 109.129 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.47 ' HB3' ' HG2' ' A' ' 171' ' ' PRO . 2.2 t -163.76 61.58 0.16 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.14 -0.975 . . . . 1.0 110.038 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' HIS . . . . . 0.442 ' HA ' HG12 ' A' ' 172' ' ' ILE . 8.1 p-80 -99.52 165.52 11.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.084 -1.01 . . . . 1.0 108.881 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.599 ' CE1' ' HA ' ' A' ' 38' ' ' VAL . 1.1 m-70 -139.54 110.41 6.8 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.703 -0.799 . . . . 1.0 109.894 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -87.12 64.98 8.68 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.424 -0.954 . . . . 1.0 108.424 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.504 0 CA-C-O 121.367 0.603 . . . . 1.0 109.88 -179.226 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.598 0.713 . . . . 1.0 109.762 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.659 HG11 ' O ' ' A' ' 121' ' ' ALA . 2.4 p -100.27 102.3 13.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.939 -0.704 . . . . 1.0 109.732 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 12.5 ptpt -153.9 110.43 3.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.898 . . . . 1.0 109.614 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.66 -45.25 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.14 -0.975 . . . . 1.0 109.517 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.528 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 0.3 OUTLIER -100.68 102.1 13.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 1.0 109.621 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 41' ' ' SER . . . 61.52 42.32 11.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 1.0 109.521 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 92.09 -21.39 37.42 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.653 -1.379 . . . . 1.0 109.653 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.516 ' N ' ' OD2' ' A' ' 119' ' ' ASP . . . 155.22 106.79 0.27 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.486 ' HB3' ' O ' ' A' ' 118' ' ' ILE . 0.3 OUTLIER 73.92 146.18 0.11 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.254 -1.145 . . . . 1.0 109.758 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.12 -178.81 4.9 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.651 2.234 . . . . 1.0 110.577 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 1.016 HG23 HG12 ' A' ' 117' ' ' VAL . 5.2 mt -94.32 158.34 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.513 -0.742 . . . . 1.0 109.278 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.589 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 11.1 t -140.35 88.1 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.159 -0.963 . . . . 1.0 110.108 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.724 HE21 ' C ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -98.8 175.74 5.86 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 1.0 108.903 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.652 HD12 HD13 ' A' ' 15' ' ' LEU . 8.2 tt -134.81 136.73 42.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.933 -1.104 . . . . 1.0 110.036 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.455 ' HA ' ' HG3' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -140.55 79.08 1.68 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.353 -0.842 . . . . 1.0 108.844 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . -174.33 88.22 0.08 OUTLIER Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.544 -1.312 . . . . 1.0 110.234 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.835 ' CE2' HD11 ' A' ' 59' ' ' LEU . 2.0 t80 176.8 131.83 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -1.109 . . . . 1.0 109.654 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.9 mt -108.89 4.42 23.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 1.0 109.539 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.471 ' HB3' ' HG2' ' A' ' 57' ' ' GLU . 2.7 mt-10 -95.24 143.39 26.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 1.0 109.507 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -90.73 35.12 0.89 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.918 . . . . 1.0 109.337 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.576 ' HG3' HD21 ' A' ' 59' ' ' LEU . 17.3 pt-20 -110.83 151.97 43.25 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 1.0 109.357 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.58 ' O ' HD23 ' A' ' 59' ' ' LEU . 35.8 Cg_endo -78.31 134.2 12.55 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.436 2.091 . . . . 1.0 110.534 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.835 HD11 ' CE2' ' A' ' 53' ' ' TYR . 16.1 mt -118.63 165.44 13.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.238 -0.914 . . . . 1.0 109.077 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -105.13 136.03 45.38 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.174 -0.954 . . . . 1.0 109.583 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.793 HD21 ' HB2' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -89.41 136.15 33.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.36 -0.838 . . . . 1.0 109.224 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -97.2 85.96 3.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.204 -0.935 . . . . 1.0 109.536 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 1.096 HD13 ' CE1' ' A' ' 151' ' ' PHE . 18.8 tp -99.36 130.95 45.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 1.0 108.822 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.502 ' HB2' ' CG1' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -155.44 143.54 20.05 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -0.968 . . . . 1.0 109.113 -179.326 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.817 HD13 ' N ' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -103.99 124.54 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.446 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.817 ' N ' HD13 ' A' ' 65' ' ' ILE . . . -136.8 149.17 20.1 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.915 -1.274 . . . . 1.0 109.915 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.732 HG23 ' HA ' ' A' ' 76' ' ' HIS . 73.5 p -83.14 156.51 23.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.28 -1.13 . . . . 1.0 109.362 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.572 ' HB3' ' HG3' ' A' ' 148' ' ' ARG . . . -160.56 116.99 2.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 1.0 109.694 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -85.45 -25.13 27.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.169 -0.957 . . . . 1.0 109.14 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.12 -42.02 0.21 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.382 -0.824 . . . . 1.0 109.425 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' LEU . 13.0 ttm180 -175.35 -34.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 1.0 109.569 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.723 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.7 OUTLIER -48.67 91.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 1.0 109.865 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.7 OUTLIER -58.21 155.73 10.93 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.163 -0.961 . . . . 1.0 109.656 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.513 ' NE ' ' OG1' ' A' ' 67' ' ' THR . 10.8 ptt180 -175.27 172.19 1.14 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.88 . . . . 1.0 108.7 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.512 ' HD2' ' HB2' ' A' ' 74' ' ' ARG . 33.7 Cg_endo -77.18 161.73 32.06 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.141 1.894 . . . . 1.0 110.312 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.732 ' HA ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -64.35 156.03 30.47 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.227 -0.921 . . . . 1.0 109.708 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.28 -48.92 4.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 1.0 109.84 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -120.39 26.83 8.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.18 -0.95 . . . . 1.0 109.899 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.756 ' OH ' HG22 ' A' ' 145' ' ' THR . 0.2 OUTLIER -140.86 148.68 40.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.148 -0.97 . . . . 1.0 109.127 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.479 ' HG3' ' HB2' ' A' ' 102' ' ' LYS . 20.5 tt0 -165.05 -36.41 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.122 -0.986 . . . . 1.0 109.589 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 m -50.78 143.22 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.052 -1.03 . . . . 1.0 109.633 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.402 ' O ' ' OE2' ' A' ' 95' ' ' GLU . 3.9 t-80 -175.93 67.98 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.532 -0.73 . . . . 1.0 109.319 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.0 OUTLIER -134.41 153.97 51.62 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.236 -0.915 . . . . 1.0 109.815 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 0.513 ' CG1' ' HB2' ' A' ' 120' ' ' CYS . 3.8 mp -100.01 143.63 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.447 -0.783 . . . . 1.0 109.486 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.4 p . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 1.0 109.404 -179.986 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.558 HG13 ' H ' ' A' ' 91' ' ' THR . 11.0 p . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.441 ' N ' HG22 ' A' ' 89' ' ' VAL . 2.5 m -78.71 3.78 15.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 1.0 109.606 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.623 HG23 HD22 ' A' ' 108' ' ' LEU . 16.3 m -104.82 101.36 10.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.213 -0.93 . . . . 1.0 109.539 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.883 ' O ' HG23 ' A' ' 106' ' ' ILE . 22.7 m -46.08 115.71 1.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -0.935 . . . . 1.0 109.652 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.607 ' HA ' HG23 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -114.21 173.68 6.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 1.0 109.654 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.1 162.67 40.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.375 -0.828 . . . . 1.0 109.519 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.402 ' OE2' ' O ' ' A' ' 82' ' ' HIS . 1.2 tt0 -124.31 133.59 53.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.864 . . . . 1.0 109.492 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.474 ' O ' HG23 ' A' ' 103' ' ' VAL . . . -124.66 121.53 34.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 1.0 109.55 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.56 HD12 ' O ' ' A' ' 101' ' ' THR . 6.1 tp -111.79 140.12 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 1.0 109.444 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.51 ' O ' ' CB ' ' A' ' 99' ' ' SER . 0.5 OUTLIER -132.32 49.41 2.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.138 -0.976 . . . . 1.0 109.691 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 3.1 t 76.8 112.34 0.07 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.897 . . . . 1.0 110.279 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.432 ' CG ' ' O ' ' A' ' 99' ' ' SER . 3.5 p-10 43.64 31.96 0.51 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.689 -0.632 . . . . 1.0 111.032 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.56 ' O ' HD12 ' A' ' 97' ' ' ILE . 2.5 m -160.2 96.29 1.19 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.737 -1.227 . . . . 1.0 110.226 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.479 ' HB2' ' HG3' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -88.87 153.71 20.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.229 -0.919 . . . . 1.0 108.943 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.502 ' CG1' ' HB2' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -144.18 173.57 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.071 -1.018 . . . . 1.0 109.211 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.561 HD22 HD23 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -123.92 130.81 53.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.924 . . . . 1.0 109.954 -179.571 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -133.1 122.64 24.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.358 -0.839 . . . . 1.0 108.864 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 1.062 HG22 HD21 ' A' ' 108' ' ' LEU . 26.8 mt -133.94 112.73 12.48 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.035 -1.04 . . . . 1.0 110.119 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.946 ' C ' HD23 ' A' ' 108' ' ' LEU . 34.0 Cg_endo -76.56 121.24 5.89 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 122.091 1.861 . . . . 1.0 109.712 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.062 HD21 HG22 ' A' ' 106' ' ' ILE . 2.5 mt -126.36 165.55 18.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 1.0 110.667 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.773 HD23 ' N ' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -72.26 -170.82 0.17 Allowed Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 108.081 -1.081 . . . . 1.0 108.081 179.259 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.59 ' CD ' ' CB ' ' A' ' 109' ' ' LEU . 33.4 Cg_endo -77.64 -76.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 121.532 1.488 . . . . 1.0 110.848 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.455 ' HG3' ' HA ' ' A' ' 51' ' ' HIS . 1.8 tt0 -170.46 52.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.897 -1.127 . . . . 1.0 110.131 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.474 ' O ' ' CB ' ' A' ' 113' ' ' SER . 13.2 p30 -79.73 -40.65 28.37 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.086 -1.009 . . . . 1.0 109.166 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.5 OUTLIER 164.68 87.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.361 -0.837 . . . . 1.0 109.157 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.584 ' HE1' ' N ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -162.51 139.71 8.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.155 -0.966 . . . . 1.0 110.19 -179.647 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -119.6 137.75 53.66 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.386 -0.821 . . . . 1.0 108.937 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -112.49 97.91 6.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.158 -0.964 . . . . 1.0 109.749 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 1.016 HG12 HG23 ' A' ' 47' ' ' ILE . 5.4 m -96.42 127.22 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 1.0 109.349 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.486 ' O ' ' HB3' ' A' ' 45' ' ' HIS . 65.9 mt -102.56 111.26 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 1.0 109.358 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.516 ' OD2' ' N ' ' A' ' 44' ' ' GLY . 3.9 t0 -147.12 41.83 1.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.943 . . . . 1.0 109.619 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.513 ' HB2' ' CG1' ' A' ' 84' ' ' ILE . 63.8 m -145.22 57.77 1.26 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -0.956 . . . . 1.0 109.824 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.659 ' O ' HG11 ' A' ' 38' ' ' VAL . . . -128.33 152.94 47.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 1.0 108.881 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -114.21 -174.35 18.53 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.838 -1.305 . . . . 1.0 109.838 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.2 mt -125.23 171.79 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -1.104 . . . . 1.0 109.055 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.31 161.36 37.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 1.0 109.569 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.303 -0.873 . . . . 1.0 109.377 179.883 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.756 HG22 ' OH ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.158 0.504 . . . . 1.0 109.654 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 172' ' ' ILE . 6.4 ptm180 -86.73 176.59 7.66 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.233 -0.917 . . . . 1.0 109.288 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.583 HG12 ' NE2' ' A' ' 76' ' ' HIS . 27.7 m -134.7 -174.68 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.403 -0.811 . . . . 1.0 109.877 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.603 ' HA ' ' ND2' ' A' ' 170' ' ' ASN . 0.0 OUTLIER -149.29 95.97 2.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.33 -0.856 . . . . 1.0 109.319 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.526 ' CD2' HG12 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -78.0 124.51 28.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.986 -1.071 . . . . 1.0 109.035 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.6 t -110.04 114.41 46.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.233 -0.917 . . . . 1.0 109.776 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 1.096 ' CE1' HD13 ' A' ' 63' ' ' LEU . 21.6 m-85 -110.43 113.29 25.83 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.769 -0.826 . . . . 1.0 108.769 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.486 ' HB3' ' HA ' ' A' ' 166' ' ' GLN . 10.0 ptt180 -149.46 138.73 21.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.171 -0.955 . . . . 1.0 109.781 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.537 ' HB ' HD22 ' A' ' 15' ' ' LEU . 8.7 p -112.66 128.52 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.471 -0.937 . . . . 1.0 108.471 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.693 ' CD2' ' HB2' ' A' ' 164' ' ' SER . 41.5 m80 -128.89 118.45 22.71 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.16 -0.962 . . . . 1.0 110.002 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.546 HG11 ' HB3' ' A' ' 163' ' ' LEU . 14.7 p -98.52 141.2 22.53 Favored Pre-proline 0 N--CA 1.487 1.406 0 O-C-N 121.279 -0.888 . . . . 1.0 108.788 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.541 ' HD2' HG23 ' A' ' 155' ' ' VAL . 33.0 Cg_endo -74.73 114.05 3.94 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.197 1.931 . . . . 1.0 110.615 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.633 ' HG3' HG21 ' A' ' 162' ' ' THR . 0.6 OUTLIER -135.71 166.05 31.42 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.506 -0.746 . . . . 1.0 109.006 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.463 ' HD2' ' OE1' ' A' ' 157' ' ' GLN . 34.4 Cg_endo -76.34 -64.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.261 1.974 . . . . 1.0 110.373 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.0 m -53.77 -78.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.195 -0.94 . . . . 1.0 109.349 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 144.44 -42.07 1.06 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.458 -1.457 . . . . 1.0 109.458 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.01 79.96 5.37 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.022 -1.103 . . . . 1.0 108.022 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.786 HG22 ' N ' ' A' ' 163' ' ' LEU . 1.3 m -135.05 -88.38 0.36 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.533 -0.73 . . . . 1.0 109.367 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.786 ' N ' HG22 ' A' ' 162' ' ' THR . 7.6 tp -131.15 102.89 6.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.021 -1.049 . . . . 1.0 109.08 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.693 ' HB2' ' CD2' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -162.11 114.31 1.71 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.08 -1.012 . . . . 1.0 109.593 179.377 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.665 HD12 ' HB3' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -122.81 175.36 6.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.335 -0.853 . . . . 1.0 109.753 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.486 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -147.87 105.66 3.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.425 -0.797 . . . . 1.0 109.426 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 151' ' ' PHE . 43.8 t -118.28 154.01 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 1.0 109.332 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 149' ' ' LEU . . . -151.41 102.83 2.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 1.0 109.214 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.581 ' C ' HD21 ' A' ' 170' ' ' ASN . 0.4 OUTLIER -130.71 161.78 30.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.957 . . . . 1.0 109.693 -179.695 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.603 ' ND2' ' HA ' ' A' ' 148' ' ' ARG . 1.4 p30 164.93 97.77 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.343 -0.848 . . . . 1.0 109.567 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.47 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 36.1 Cg_endo -79.45 67.81 8.48 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.419 2.08 . . . . 1.0 110.48 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 23' ' ' SER . 16.1 mt -136.6 124.45 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.104 -0.997 . . . . 1.0 109.443 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 1.0 109.363 179.891 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo . . . . . 0 C--O 1.215 -0.638 0 N-CA-C 110.486 -0.621 . . . . 1.0 110.486 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.565 ' CD1' ' O ' ' A' ' 162' ' ' THR . 1.8 m-85 -95.65 162.9 13.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 1.0 109.459 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -152.42 142.69 22.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.138 -0.976 . . . . 1.0 109.918 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.939 HD13 HD12 ' A' ' 50' ' ' LEU . 22.8 tp -136.31 98.05 3.74 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.784 -0.821 . . . . 1.0 108.784 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.47 164.23 29.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 1.0 110.227 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 47' ' ' ILE . 0.8 OUTLIER -92.36 145.29 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.547 -0.909 . . . . 1.0 108.547 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.421 ' C ' HG23 ' A' ' 19' ' ' VAL . 1.3 tp10 -75.4 -35.83 60.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.936 . . . . 1.0 110.3 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.499 ' HB ' HG13 ' A' ' 47' ' ' ILE . 80.0 t -154.48 98.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 O-C-N 120.814 -1.179 . . . . 1.0 110.157 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.589 ' NE2' HG21 ' A' ' 17' ' ' ILE . 0.6 OUTLIER -51.63 160.34 1.06 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.442 -0.786 . . . . 1.0 109.037 179.422 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.496 ' HB3' ' O ' ' A' ' 44' ' ' GLY . 36.2 Cg_endo -78.38 154.92 28.36 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.458 2.106 . . . . 1.0 110.415 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.6 mmtm -46.09 165.12 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.266 -0.896 . . . . 1.0 109.453 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.457 ' O ' ' OG ' ' A' ' 23' ' ' SER . 5.2 t -94.19 24.39 4.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 1.0 110.142 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -136.04 166.38 23.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.94 -1.1 . . . . 1.0 110.003 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.85 ' CD2' HD11 ' A' ' 123' ' ' ILE . 0.8 OUTLIER -162.48 106.76 1.15 Allowed 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.303 -0.629 . . . . 1.0 109.303 179.428 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.1 ttp85 -75.17 91.74 2.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.255 -0.903 . . . . 1.0 109.36 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.312 0 O-C-N 121.315 -0.866 . . . . 1.0 109.523 179.906 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.442 0.639 . . . . 1.0 109.517 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.592 ' HB ' ' CE1' ' A' ' 25' ' ' HIS . 2.4 p -68.33 142.06 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.403 -0.81 . . . . 1.0 109.445 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -143.8 105.41 4.3 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.278 -0.889 . . . . 1.0 109.766 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 43' ' ' GLY . . . -161.16 105.8 1.34 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.411 -0.806 . . . . 1.0 108.905 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.471 ' HG ' ' C ' ' A' ' 40' ' ' ALA . 19.2 p 44.17 -105.56 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 1.0 108.903 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.503 ' O ' ' CB ' ' A' ' 119' ' ' ASP . . . -88.57 48.0 1.58 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.582 -1.324 . . . . 1.0 108.232 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.601 ' O ' ' HB3' ' A' ' 40' ' ' ALA . . . 67.82 -111.11 3.82 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.039 -2.024 . . . . 1.0 108.039 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 45' ' ' HIS . . . -89.61 -22.15 37.87 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.219 -1.952 . . . . 1.0 108.219 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.606 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 2.3 t-80 79.43 27.96 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.355 0 N-CA-C 113.315 0.857 . . . . 1.0 113.315 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 45' ' ' HIS . 37.3 Cg_endo -79.34 114.25 3.27 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 N-CA-C 108.935 -1.217 . . . . 1.0 108.935 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.636 ' O ' HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -102.32 144.95 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.967 -1.083 . . . . 1.0 108.802 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.602 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 5.2 t -137.27 124.49 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.033 -1.042 . . . . 1.0 110.369 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.634 ' NE2' ' HG2' ' A' ' 115' ' ' ARG . 23.2 tt0 -140.06 142.51 36.16 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.524 -0.917 . . . . 1.0 108.524 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.939 HD12 HD13 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -118.04 141.05 48.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.939 -1.1 . . . . 1.0 109.897 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -140.66 84.98 1.97 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.349 -0.844 . . . . 1.0 109.449 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 170.01 105.22 0.18 Allowed Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.304 -1.427 . . . . 1.0 110.648 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.595 ' CD2' ' HB2' ' A' ' 111' ' ' GLU . 3.5 t80 175.9 156.95 0.22 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.426 -1.044 . . . . 1.0 109.965 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.748 ' C ' HD12 ' A' ' 54' ' ' LEU . 3.3 pp -140.71 11.02 2.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.421 -0.799 . . . . 1.0 109.255 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.449 ' O ' ' CE2' ' A' ' 53' ' ' TYR . 1.6 tm-20 -120.77 145.67 47.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.303 -0.873 . . . . 1.0 109.658 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -90.25 35.81 0.87 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 1.0 109.96 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.677 ' HG3' HD21 ' A' ' 59' ' ' LEU . 15.1 pt-20 -100.62 137.84 19.97 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.146 -0.971 . . . . 1.0 109.424 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 1.05 ' O ' HD23 ' A' ' 59' ' ' LEU . 36.7 Cg_endo -79.92 154.23 22.78 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.511 2.141 . . . . 1.0 110.501 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.05 HD23 ' O ' ' A' ' 58' ' ' PRO . 2.3 mt -141.27 156.29 45.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 1.0 109.172 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -87.26 135.55 33.27 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.223 -0.923 . . . . 1.0 109.104 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -87.94 131.15 34.71 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.275 -0.89 . . . . 1.0 109.499 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -98.52 82.66 2.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -0.911 . . . . 1.0 109.572 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.93 HD13 ' CZ ' ' A' ' 151' ' ' PHE . 58.9 tp -99.64 135.98 40.25 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.247 -0.908 . . . . 1.0 108.81 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.692 ' HB2' HG12 ' A' ' 103' ' ' VAL . 1.7 t80 -148.4 164.05 35.28 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.226 -0.921 . . . . 1.0 109.042 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.757 ' O ' HG23 ' A' ' 65' ' ' ILE . 8.1 tp -129.38 102.85 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.581 ' HA3' ' CZ ' ' A' ' 64' ' ' PHE . . . -124.65 153.69 17.83 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 110.067 -1.213 . . . . 1.0 110.067 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.901 HG22 ' CD2' ' A' ' 76' ' ' HIS . 1.1 p -77.22 149.56 35.47 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.464 -1.021 . . . . 1.0 109.23 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.459 ' HB3' ' HD2' ' A' ' 148' ' ' ARG . . . -153.72 115.74 4.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 1.0 109.752 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.25 -7.95 58.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 1.0 109.522 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -159.91 -44.34 0.05 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -0.929 . . . . 1.0 109.452 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -175.08 -34.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.262 -0.899 . . . . 1.0 109.625 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.08 89.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.9 . . . . 1.0 109.739 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 71' ' ' ARG . 2.2 pp -65.35 129.72 40.76 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.283 -0.885 . . . . 1.0 109.666 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.486 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 13.5 mmt180 -145.13 160.31 46.49 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 1.0 109.247 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -75.99 142.67 25.21 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.342 2.028 . . . . 1.0 110.202 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.901 ' CD2' HG22 ' A' ' 67' ' ' THR . 0.3 OUTLIER -67.44 160.97 26.36 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.221 -0.924 . . . . 1.0 109.569 -179.642 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.87 -65.21 0.86 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.307 -0.871 . . . . 1.0 110.308 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.683 ' CE2' ' CE1' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -111.91 -4.34 14.59 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.033 -1.042 . . . . 1.0 110.219 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.683 ' CE1' ' CE2' ' A' ' 78' ' ' PHE . 52.3 m-85 -83.89 105.94 15.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.98 -1.075 . . . . 1.0 108.963 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.53 ' HB2' ' CG ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -143.66 10.11 1.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.073 -1.017 . . . . 1.0 110.081 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 122' ' ' GLY . 11.9 m -75.68 146.91 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.983 -1.073 . . . . 1.0 109.497 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.734 ' CE1' HD12 ' A' ' 104' ' ' LEU . 5.7 t-80 -175.49 67.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.476 -0.765 . . . . 1.0 109.237 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.6 OUTLIER -122.66 139.9 53.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.235 -0.916 . . . . 1.0 109.746 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . 1.104 HG23 ' CB ' ' A' ' 120' ' ' CYS . 4.5 mp -100.11 133.52 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.343 -0.848 . . . . 1.0 109.675 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.275 -0.891 . . . . 1.0 109.302 179.802 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.569 HG22 ' H ' ' A' ' 91' ' ' THR . 8.7 p . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.3 m -74.65 -0.43 17.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 1.0 109.806 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.569 ' H ' HG22 ' A' ' 89' ' ' VAL . 16.4 m -80.75 -83.01 0.11 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.069 -1.019 . . . . 1.0 109.387 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.569 ' O ' HG21 ' A' ' 106' ' ' ILE . 0.0 OUTLIER 179.33 162.46 0.85 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.302 -0.874 . . . . 1.0 109.459 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.533 ' HA ' ' CG1' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -165.19 156.98 15.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.263 -0.898 . . . . 1.0 110.014 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.488 ' HB2' ' O ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -155.61 150.08 26.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.467 -0.77 . . . . 1.0 109.064 179.78 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -120.45 148.48 43.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.136 -0.978 . . . . 1.0 109.837 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.29 121.22 9.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.303 -0.873 . . . . 1.0 109.557 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.887 HD13 ' HG2' ' A' ' 102' ' ' LYS . 2.1 tp -110.75 106.12 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.342 -0.849 . . . . 1.0 109.606 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.722 HD23 ' H ' ' A' ' 98' ' ' LEU . 2.1 pt? -110.15 130.28 55.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.205 -0.934 . . . . 1.0 109.48 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.465 ' O ' ' OG1' ' A' ' 101' ' ' THR . 16.6 m 35.07 83.98 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.077 -0.39 . . . . 1.0 111.379 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.426 ' CG ' ' O ' ' A' ' 99' ' ' SER . 13.4 p30 42.72 29.42 0.17 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.684 -0.635 . . . . 1.0 112.482 178.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.612 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -132.34 109.4 9.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.247 -1.533 . . . . 1.0 109.969 179.141 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . 0.887 ' HG2' HD13 ' A' ' 97' ' ' ILE . 9.9 mmtp -85.96 137.93 32.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.1 -1.0 . . . . 1.0 109.358 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.692 HG12 ' HB2' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -143.98 172.68 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.331 -0.855 . . . . 1.0 109.089 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.003 HD22 HD11 ' A' ' 106' ' ' ILE . 0.5 OUTLIER -124.31 135.55 53.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.27 -0.894 . . . . 1.0 110.147 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 0.4 OUTLIER -139.99 125.03 18.58 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.601 -0.889 . . . . 1.0 108.601 179.405 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 1.003 HD11 HD22 ' A' ' 104' ' ' LEU . 4.1 mp -128.94 115.81 19.03 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.976 -1.077 . . . . 1.0 110.115 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.41 97.3 1.12 Allowed 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 121.946 1.764 . . . . 1.0 109.64 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.559 HD11 ' HG3' ' A' ' 110' ' ' PRO . 0.7 OUTLIER -145.75 167.59 22.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 1.0 109.485 -179.205 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.772 HD23 ' OD1' ' A' ' 112' ' ' ASN . 3.9 tt -115.03 78.56 5.6 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.921 . . . . 1.0 110.346 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.559 ' HG3' HD11 ' A' ' 108' ' ' LEU . 38.1 Cg_endo -83.25 40.13 0.9 Allowed 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.589 2.192 . . . . 1.0 110.082 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.595 ' HB2' ' CD2' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -120.81 22.39 11.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.047 -1.033 . . . . 1.0 110.056 -178.799 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.772 ' OD1' HD23 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -122.32 -52.9 1.93 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.114 -0.991 . . . . 1.0 109.119 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 1.4 p 164.59 86.01 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.371 -0.831 . . . . 1.0 108.989 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' MET . . . . . 0.451 ' CE ' ' HB3' ' A' ' 110' ' ' PRO . 0.5 OUTLIER -154.7 144.55 21.66 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.14 -0.975 . . . . 1.0 109.829 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.634 ' HG2' ' NE2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -101.44 142.73 32.39 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.541 -0.911 . . . . 1.0 108.541 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.508 ' N ' ' HD3' ' A' ' 115' ' ' ARG . . . -134.78 96.55 3.56 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.994 -1.066 . . . . 1.0 109.87 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 117' ' ' VAL . 3.9 m -86.45 131.37 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.346 -0.846 . . . . 1.0 109.145 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.464 ' O ' ' HG2' ' A' ' 46' ' ' PRO . 2.2 mt -117.27 130.1 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.217 -0.927 . . . . 1.0 109.153 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 42' ' ' ALA . 0.7 OUTLIER -171.66 57.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.863 . . . . 1.0 109.695 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 1.104 ' CB ' HG23 ' A' ' 84' ' ' ILE . 60.7 m -145.19 43.73 1.32 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.137 -0.977 . . . . 1.0 109.845 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . 0.501 ' O ' HG12 ' A' ' 38' ' ' VAL . . . -126.64 165.95 18.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 1.0 108.833 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.848 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -139.76 -179.48 17.76 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.697 -1.361 . . . . 1.0 109.697 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.85 HD11 ' CD2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -119.43 158.54 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.357 -1.084 . . . . 1.0 109.072 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.571 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -99.9 126.24 46.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 1.0 109.459 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.0 mttt . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.191 -0.943 . . . . 1.0 109.495 -179.85 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.476 ' O ' ' HB ' ' A' ' 67' ' ' THR . 11.2 mtt180 -85.1 166.62 16.49 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.267 -0.896 . . . . 1.0 109.417 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.761 ' CG2' HG21 ' A' ' 172' ' ' ILE . 2.9 m -140.57 151.7 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -0.841 . . . . 1.0 109.422 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.507 ' HA ' ' CB ' ' A' ' 170' ' ' ASN . 42.6 mtt180 -154.52 125.72 7.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.132 -0.98 . . . . 1.0 109.448 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.486 HD23 ' ND2' ' A' ' 170' ' ' ASN . 0.4 OUTLIER -81.26 109.48 15.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.161 -0.962 . . . . 1.0 109.717 -179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.561 HG13 ' OE1' ' A' ' 166' ' ' GLN . 44.0 t -81.47 123.85 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.377 -0.827 . . . . 1.0 109.846 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.93 ' CZ ' HD13 ' A' ' 63' ' ' LEU . 1.9 m-85 -110.4 121.51 45.46 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.656 -0.868 . . . . 1.0 108.656 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ARG . . . . . 0.526 ' CG ' ' HA ' ' A' ' 166' ' ' GLN . 1.8 mtt180 -145.03 123.12 12.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.92 -1.112 . . . . 1.0 110.184 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.56 HG13 ' CD1' ' A' ' 163' ' ' LEU . 7.1 p -114.85 129.71 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.476 -0.935 . . . . 1.0 108.476 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' HIS . . . . . 0.574 ' CD2' ' HB2' ' A' ' 164' ' ' SER . 37.7 m80 -130.35 113.43 14.35 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.116 -0.99 . . . . 1.0 109.718 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.808 HG23 HD22 ' A' ' 59' ' ' LEU . 5.2 p -98.74 140.94 22.12 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.306 -0.871 . . . . 1.0 109.019 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PRO . . . . . 0.543 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 33.6 Cg_endo -75.04 116.17 4.5 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.319 2.012 . . . . 1.0 110.791 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLN . . . . . 0.483 ' HB2' ' HD2' ' A' ' 158' ' ' PRO . 0.8 OUTLIER -132.71 165.24 37.95 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.506 -0.746 . . . . 1.0 109.247 -179.556 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 157' ' ' GLN . 33.8 Cg_endo -76.4 -63.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.194 1.93 . . . . 1.0 109.985 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.6 t -64.91 -90.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -0.862 . . . . 1.0 109.184 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . 0.433 ' HA2' ' CD ' ' A' ' 157' ' ' GLN . . . 164.06 -28.21 0.22 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.641 -1.383 . . . . 1.0 109.641 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -79.28 79.62 5.7 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.363 -1.081 . . . . 1.0 108.556 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.668 HG22 ' N ' ' A' ' 163' ' ' LEU . 1.3 m -134.97 -82.21 0.43 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.839 -0.8 . . . . 1.0 108.839 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LEU . . . . . 0.696 ' HG ' HG12 ' A' ' 155' ' ' VAL . 2.1 pp -159.69 106.96 1.69 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.957 -1.09 . . . . 1.0 109.728 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.574 ' HB2' ' CD2' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -164.95 85.02 0.4 Allowed 'General case' 0 C--N 1.294 -1.833 0 O-C-N 120.803 -1.186 . . . . 1.0 109.141 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.75 ' N ' HD23 ' A' ' 165' ' ' LEU . 1.5 pt? -131.38 168.82 16.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.034 -1.042 . . . . 1.0 110.026 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.561 ' OE1' HG13 ' A' ' 150' ' ' VAL . 7.0 tp-100 -101.97 149.74 23.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.452 -0.78 . . . . 1.0 109.548 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 167' ' ' VAL . 39.0 t -144.18 71.51 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 1.0 109.521 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.44 136.19 42.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.089 -1.007 . . . . 1.0 109.5 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 7.3 t -175.3 133.96 0.31 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 1.0 109.613 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.507 ' CB ' ' HA ' ' A' ' 148' ' ' ARG . 1.9 t30 170.03 97.72 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.356 -0.84 . . . . 1.0 109.436 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 23' ' ' SER . 35.3 Cg_endo -77.57 72.18 6.15 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.404 2.069 . . . . 1.0 110.615 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ILE . . . . . 0.761 HG21 ' CG2' ' A' ' 147' ' ' VAL . 13.9 mm -107.79 126.92 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.202 -0.937 . . . . 1.0 109.251 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.468 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 9.9 pt-20 . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 1.0 109.575 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.337 0.589 . . . . 1.0 109.424 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.44 -153.77 0.47 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.2 -0.938 . . . . 1.0 109.395 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.51 57.82 1.24 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 1.0 109.583 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.797 ' CE2' HD21 ' A' ' 6' ' ' LEU . 31.1 p90 -68.3 -38.97 82.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.227 -0.921 . . . . 1.0 109.495 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.727 ' C ' HD22 ' A' ' 6' ' ' LEU . 10.4 tt0 174.42 77.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.257 -0.902 . . . . 1.0 109.368 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.797 HD21 ' CE2' ' A' ' 4' ' ' TRP . 3.1 mm? -118.03 85.0 22.71 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.289 -0.882 . . . . 1.0 109.5 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.1 79.82 3.16 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.324 2.016 . . . . 1.0 110.586 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.68 41.35 0.4 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.444 -0.785 . . . . 1.0 109.283 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -140.22 172.15 13.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.863 . . . . 1.0 109.592 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.5 m -166.23 55.1 0.1 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.356 -0.84 . . . . 1.0 109.357 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.13 97.02 0.19 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.563 -1.415 . . . . 1.0 109.563 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.504 ' O ' ' HA3' ' A' ' 52' ' ' GLY . 34.7 Cg_endo -77.18 -163.03 0.19 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.367 2.044 . . . . 1.0 110.238 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.577 ' CE2' ' O ' ' A' ' 162' ' ' THR . 2.8 m-85 -69.31 135.19 50.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 1.0 109.568 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 51' ' ' HIS . 3.3 pt-20 -172.31 126.8 0.54 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.964 -1.085 . . . . 1.0 109.838 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.686 ' O ' HD12 ' A' ' 15' ' ' LEU . 1.3 pp -108.55 87.81 2.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.333 -0.854 . . . . 1.0 109.264 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -101.63 148.31 25.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.187 -0.945 . . . . 1.0 109.768 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.539 HG23 ' O ' ' A' ' 47' ' ' ILE . 1.2 mp -69.55 141.74 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.378 -0.826 . . . . 1.0 108.824 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.495 ' OE2' ' CZ ' ' A' ' 115' ' ' ARG . 4.9 tt0 -76.6 -32.93 58.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.296 -0.878 . . . . 1.0 109.816 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.488 ' HB ' HG12 ' A' ' 47' ' ' ILE . 98.2 t -142.29 134.54 26.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.186 -0.946 . . . . 1.0 109.631 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.402 ' HG2' ' CG2' ' A' ' 17' ' ' ILE . 0.7 OUTLIER -122.79 99.92 41.18 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.357 -0.84 . . . . 1.0 109.287 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.489 ' HG3' ' HB3' ' A' ' 42' ' ' ALA . 34.9 Cg_endo -76.53 -179.21 5.1 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.396 2.064 . . . . 1.0 110.576 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -43.18 162.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 1.0 109.476 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.488 ' CB ' ' HG2' ' A' ' 171' ' ' PRO . 8.4 t -119.48 50.02 1.29 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -0.886 . . . . 1.0 109.988 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.29 167.07 17.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.115 -0.991 . . . . 1.0 109.283 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 1.042 ' CE1' HG22 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -170.4 118.6 0.55 Allowed 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 120.154 -0.618 . . . . 1.0 109.63 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.555 ' HA ' ' CE1' ' A' ' 28' ' ' HIS . 0.0 OUTLIER -80.23 76.59 7.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.317 -0.864 . . . . 1.0 109.259 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.428 ' HB2' ' CD1' ' A' ' 123' ' ' ILE . . . -83.26 68.45 9.64 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.328 -0.858 . . . . 1.0 109.929 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.555 ' CE1' ' HA ' ' A' ' 26' ' ' ARG . 1.8 p-80 -162.75 55.93 0.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.957 . . . . 1.0 109.635 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.574 ' O ' ' CG ' ' A' ' 29' ' ' TYR . 9.7 p90 -179.93 115.03 0.05 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 120.066 -0.653 . . . . 1.0 109.614 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 1.3 pt-20 173.42 74.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.142 -0.974 . . . . 1.0 109.604 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.709 HG22 ' O ' ' A' ' 31' ' ' THR . 86.4 m -145.69 32.64 1.05 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.913 . . . . 1.0 108.954 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.72 -72.62 0.69 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.484 -0.76 . . . . 1.0 109.469 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.45 -91.95 0.03 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.488 -1.445 . . . . 1.0 109.488 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.75 -38.99 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -1.117 . . . . 1.0 109.423 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 36' ' ' GLY . 19.6 mtt180 -161.57 42.5 0.15 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 1.0 109.573 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 35' ' ' ARG . . . -50.35 -179.66 0.03 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.359 -1.496 . . . . 1.0 109.359 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.28 176.83 7.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.074 -1.251 . . . . 1.0 110.832 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 1.042 HG22 ' CE1' ' A' ' 25' ' ' HIS . 3.9 p -133.74 121.28 39.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 107.131 -1.433 . . . . 1.0 107.131 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 121' ' ' ALA . 24.8 mmtt -155.32 116.16 3.9 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.297 -0.877 . . . . 1.0 109.56 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.24 -152.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.6 -0.688 . . . . 1.0 110.081 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 42' ' ' ALA . 1.8 m -51.56 158.39 0.92 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.23 -0.919 . . . . 1.0 109.963 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.489 ' HB3' ' HG3' ' A' ' 21' ' ' PRO . . . 43.0 47.04 4.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.434 -0.791 . . . . 1.0 109.425 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.515 ' HA3' ' CA ' ' A' ' 119' ' ' ASP . . . 44.46 51.66 7.7 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.386 -1.485 . . . . 1.0 109.386 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.466 ' HA3' ' HD2' ' A' ' 39' ' ' LYS . . . 63.89 -87.58 0.07 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.686 -1.365 . . . . 1.0 109.686 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.46 ' NE2' HD12 ' A' ' 149' ' ' LEU . 36.7 m170 -50.96 144.93 12.85 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.213 -1.169 . . . . 1.0 109.852 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . 36.2 Cg_endo -79.43 -167.93 0.57 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.763 2.309 . . . . 1.0 110.522 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.989 ' CG2' HG12 ' A' ' 117' ' ' VAL . 0.9 OUTLIER -93.23 158.57 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.557 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 3.4 t -136.76 132.84 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 120.925 -1.109 . . . . 1.0 110.359 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.485 ' O ' ' CG ' ' A' ' 49' ' ' GLN . 2.6 pt20 -145.36 120.22 9.94 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.913 -0.773 . . . . 1.0 108.913 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.475 ' HG ' ' HB3' ' A' ' 15' ' ' LEU . 0.3 OUTLIER -86.22 124.11 32.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.149 -0.97 . . . . 1.0 109.893 -179.545 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.484 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 51.4 p-80 -141.23 132.59 26.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.28 -0.887 . . . . 1.0 108.802 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 12' ' ' PRO . . . 137.0 -2.79 3.32 Favored Glycine 0 N--CA 1.483 1.798 0 C-N-CA 119.262 -1.447 . . . . 1.0 110.578 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.583 ' CE2' ' HB2' ' A' ' 163' ' ' LEU . 0.5 OUTLIER -129.32 117.8 21.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.062 -1.257 . . . . 1.0 109.492 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.844 HD12 ' O ' ' A' ' 54' ' ' LEU . 1.3 pp -99.96 35.61 2.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.156 -0.965 . . . . 1.0 109.567 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.56 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 3.9 tp10 -80.0 144.22 33.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 1.0 109.583 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 21.7 p-10 -87.72 34.6 0.71 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.232 -0.917 . . . . 1.0 109.957 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.655 ' HG3' HD21 ' A' ' 59' ' ' LEU . 11.7 pt-20 -133.96 143.92 49.45 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.266 -0.897 . . . . 1.0 109.276 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.576 ' O ' HD23 ' A' ' 59' ' ' LEU . 35.6 Cg_endo -78.57 134.15 12.16 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.307 2.005 . . . . 1.0 110.63 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.655 HD21 ' HG3' ' A' ' 57' ' ' GLU . 12.8 mt -115.59 165.07 13.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.199 -0.938 . . . . 1.0 108.683 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.426 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 40.7 mtt -106.13 112.99 26.25 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.147 -0.971 . . . . 1.0 109.993 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.896 HD21 ' HB2' ' A' ' 63' ' ' LEU . 1.9 tt -70.18 142.08 52.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.578 -0.701 . . . . 1.0 109.349 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.468 ' OE1' ' NH2' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -99.03 96.57 7.9 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.219 -0.926 . . . . 1.0 108.858 179.588 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.137 HD13 ' CE1' ' A' ' 151' ' ' PHE . 20.8 tp -119.15 132.07 55.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.296 -0.878 . . . . 1.0 109.911 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.59 ' HB3' HG12 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -164.96 165.83 19.9 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.717 -0.845 . . . . 1.0 108.717 179.304 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.759 HD13 ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -105.13 120.94 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.937 -1.102 . . . . 1.0 109.242 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.759 ' N ' HD13 ' A' ' 65' ' ' ILE . . . -132.2 149.1 19.35 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.696 -1.361 . . . . 1.0 109.696 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.746 HG22 ' CD2' ' A' ' 76' ' ' HIS . 16.2 p -83.66 154.45 23.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.371 -1.076 . . . . 1.0 109.319 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.555 ' HB3' ' HD2' ' A' ' 148' ' ' ARG . . . -159.82 118.1 2.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 1.0 109.773 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.447 ' CG ' ' NH2' ' A' ' 146' ' ' ARG . 0.4 OUTLIER -102.23 -13.52 17.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.908 . . . . 1.0 109.164 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -142.5 -55.26 0.43 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.363 -0.836 . . . . 1.0 109.412 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.66 -34.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.955 . . . . 1.0 109.697 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 72' ' ' LEU . 70.3 mt -66.34 86.8 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.914 . . . . 1.0 109.587 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.662 ' O ' HD12 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -50.03 154.77 1.05 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.265 -0.897 . . . . 1.0 109.686 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.497 ' HB3' ' HD2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -144.37 162.24 40.59 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.317 -0.864 . . . . 1.0 108.748 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 74' ' ' ARG . 33.1 Cg_endo -76.32 121.18 5.95 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.213 1.942 . . . . 1.0 110.051 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.915 ' NE2' HG12 ' A' ' 147' ' ' VAL . 1.6 t-80 -57.89 163.4 2.7 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.361 -0.837 . . . . 1.0 110.016 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.12 -76.29 0.08 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 1.0 109.548 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.728 ' CE1' HD11 ' A' ' 131' ' ' ILE . 8.3 m-85 -125.41 21.86 7.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 1.0 109.706 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.586 ' HB2' ' CG ' ' A' ' 76' ' ' HIS . 3.9 m-30 -79.91 75.99 6.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.213 -0.93 . . . . 1.0 109.077 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.553 ' CB ' ' HB3' ' A' ' 102' ' ' LYS . 1.1 pt20 -139.0 4.41 2.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.945 -1.097 . . . . 1.0 110.307 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.91 HG23 ' O ' ' A' ' 122' ' ' GLY . 15.0 m -78.65 144.77 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.958 -1.089 . . . . 1.0 109.182 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.588 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 3.1 p80 -175.93 59.38 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 118.998 -1.081 . . . . 1.0 110.194 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 120' ' ' CYS . 2.9 mmt85 -81.44 140.15 34.82 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.112 -0.993 . . . . 1.0 109.325 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.516 ' CG1' ' HB2' ' A' ' 120' ' ' CYS . 3.5 mp -106.32 135.58 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.205 -0.934 . . . . 1.0 109.764 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 87' ' ' LYS . 49.9 p -145.52 -147.39 0.21 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.406 -0.808 . . . . 1.0 109.106 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 85' ' ' THR . . . 41.42 -94.15 0.01 OUTLIER Glycine 0 N--CA 1.482 1.755 0 N-CA-C 110.37 -1.092 . . . . 1.0 110.37 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.0 OUTLIER -74.51 148.17 41.19 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.237 -1.155 . . . . 1.0 109.608 -179.67 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.06 118.41 36.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 1.0 109.604 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.863 HG13 HG22 ' A' ' 91' ' ' THR . 6.6 p -108.9 139.43 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 1.0 109.318 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.3 m -86.78 16.02 5.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 1.0 109.524 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.863 HG22 HG13 ' A' ' 89' ' ' VAL . 7.4 t -69.89 125.95 28.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -0.952 . . . . 1.0 109.575 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.829 ' O ' HG23 ' A' ' 106' ' ' ILE . 18.3 m -93.88 91.21 6.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.92 . . . . 1.0 109.235 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.55 ' HA ' HG23 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -103.3 173.28 6.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -0.974 . . . . 1.0 109.951 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -145.76 161.66 39.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.477 -0.765 . . . . 1.0 109.167 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.523 ' HG2' ' NE2' ' A' ' 82' ' ' HIS . 43.5 mt-10 -128.51 120.54 26.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 1.0 109.872 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 102' ' ' LYS . . . -114.18 124.56 52.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 1.0 108.94 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.688 HD13 ' N ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -124.73 126.39 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.09 -1.006 . . . . 1.0 109.876 -179.421 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.688 ' N ' HD13 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -126.22 59.77 1.32 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.938 . . . . 1.0 109.448 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER 77.03 103.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 1.0 109.612 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' A' ' 99' ' ' SER . 3.2 p-10 42.88 43.31 3.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.694 -0.629 . . . . 1.0 110.18 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.463 ' HB ' ' HG ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -159.58 87.96 0.84 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.993 -1.067 . . . . 1.0 109.776 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.553 ' HB3' ' CB ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -97.32 152.67 18.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.343 -0.848 . . . . 1.0 109.159 179.549 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.59 HG12 ' HB3' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -146.36 169.97 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.217 -0.927 . . . . 1.0 109.06 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.019 HD12 ' HG ' ' A' ' 63' ' ' LEU . 3.3 mt -120.31 128.56 53.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.933 . . . . 1.0 109.615 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -123.94 106.73 10.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.269 -0.894 . . . . 1.0 108.835 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.829 HG23 ' O ' ' A' ' 92' ' ' THR . 4.5 mt -119.38 115.95 33.88 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 1.0 109.832 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.742 ' C ' HD23 ' A' ' 108' ' ' LEU . 33.7 Cg_endo -75.87 119.0 5.23 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 121.96 1.773 . . . . 1.0 109.448 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.742 HD23 ' C ' ' A' ' 107' ' ' PRO . 6.1 mt -115.52 165.18 13.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.193 -0.942 . . . . 1.0 110.494 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.862 HD23 ' HB2' ' A' ' 112' ' ' ASN . 1.0 OUTLIER -97.3 126.69 40.92 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.485 ' CG ' ' O ' ' A' ' 57' ' ' GLU . 36.5 Cg_endo -79.96 -30.65 2.14 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 122.345 2.03 . . . . 1.0 112.03 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 54' ' ' LEU . 2.1 tt0 -139.35 66.99 1.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.773 -1.204 . . . . 1.0 110.526 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.862 ' HB2' HD23 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -165.39 -67.52 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 1.0 109.505 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.4 OUTLIER 164.63 108.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.05 -1.032 . . . . 1.0 109.343 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.45 ' O ' ' HG3' ' A' ' 114' ' ' MET . 5.9 tpt -154.67 49.83 0.6 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.911 . . . . 1.0 110.129 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.495 ' CZ ' ' OE2' ' A' ' 18' ' ' GLU . 10.0 ttt-85 -74.69 134.33 41.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.966 . . . . 1.0 108.633 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -138.37 153.12 48.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.902 -1.124 . . . . 1.0 110.294 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.989 HG12 ' CG2' ' A' ' 47' ' ' ILE . 4.5 m -126.14 126.46 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.476 ' CD1' HD21 ' A' ' 63' ' ' LEU . 32.4 mt -99.17 104.3 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 1.0 109.604 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.515 ' CA ' ' HA3' ' A' ' 43' ' ' GLY . 14.6 p-10 -149.5 39.48 0.81 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 1.0 109.353 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.516 ' HB2' ' CG1' ' A' ' 84' ' ' ILE . 60.7 m -145.05 59.03 1.3 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 1.0 109.51 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.522 ' O ' ' CG ' ' A' ' 39' ' ' LYS . . . -143.47 -176.38 4.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.417 -0.802 . . . . 1.0 109.119 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.91 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -154.6 168.66 32.77 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.575 -1.41 . . . . 1.0 109.575 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -114.55 154.63 15.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.236 -1.155 . . . . 1.0 108.836 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.517 HD23 HG21 ' A' ' 81' ' ' VAL . 0.5 OUTLIER -118.62 109.58 16.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.129 -0.982 . . . . 1.0 109.506 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.509 ' CD ' ' O ' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -99.67 110.3 22.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.303 -0.873 . . . . 1.0 109.434 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.77 24.13 2.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.319 -0.863 . . . . 1.0 109.355 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -53.06 163.89 0.47 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.44 -0.787 . . . . 1.0 109.569 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -168.66 27.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.286 -0.884 . . . . 1.0 109.397 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.512 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 0.1 OUTLIER 54.7 36.79 27.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -0.88 . . . . 1.0 109.469 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 129' ' ' SER . 0.6 OUTLIER 163.93 68.23 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 1.0 109.418 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.728 HD11 ' CE1' ' A' ' 78' ' ' PHE . 1.2 tt -66.19 116.77 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.257 -0.902 . . . . 1.0 109.501 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.3 162.31 39.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -0.919 . . . . 1.0 109.562 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.417 ' C ' ' HG2' ' A' ' 134' ' ' ARG . 13.5 mt -73.28 83.02 1.38 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.344 -0.847 . . . . 1.0 109.528 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -167.06 -61.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 1.0 109.545 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 134' ' ' ARG . 0.1 OUTLIER 164.73 142.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.17 -0.956 . . . . 1.0 109.464 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.38 97.05 1.07 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.49 -1.444 . . . . 1.0 109.49 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -127.03 117.92 23.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -1.151 . . . . 1.0 109.469 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.492 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 46.5 p -152.16 -49.06 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.892 . . . . 1.0 109.478 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 138' ' ' THR . 0.5 OUTLIER 166.13 -70.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.925 . . . . 1.0 109.387 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.47 ' CG1' ' N ' ' A' ' 141' ' ' GLY . 11.6 pt -145.22 -42.3 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 1.0 109.467 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.47 ' N ' ' CG1' ' A' ' 140' ' ' ILE . . . 140.99 152.65 5.79 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.635 -1.386 . . . . 1.0 109.635 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.417 ' HG3' ' C ' ' A' ' 141' ' ' GLY . 17.6 mtt180 -140.95 52.2 1.6 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -1.15 . . . . 1.0 109.412 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -157.63 154.14 27.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 1.0 109.441 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -47.11 164.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.936 . . . . 1.0 109.436 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.442 ' HB ' ' SG ' ' A' ' 174' ' ' CYS . 0.1 OUTLIER -154.43 51.48 0.64 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.346 -0.846 . . . . 1.0 109.467 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -89.58 164.78 14.62 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.27 -0.894 . . . . 1.0 109.594 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.915 HG12 ' NE2' ' A' ' 76' ' ' HIS . 31.6 m -140.84 163.49 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.472 -0.768 . . . . 1.0 109.254 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.555 ' HD2' ' HB3' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -155.58 113.31 3.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.958 . . . . 1.0 109.706 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.911 HD21 ' CD1' ' A' ' 63' ' ' LEU . 1.7 tt -79.76 121.56 25.51 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.208 -0.932 . . . . 1.0 109.217 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 36.0 t -96.42 123.55 48.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.232 -0.917 . . . . 1.0 109.574 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 1.137 ' CE1' HD13 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -120.5 92.33 3.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 1.0 108.954 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.537 ' CB ' ' HA ' ' A' ' 166' ' ' GLN . 24.4 ptt85 -139.28 137.59 36.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.139 -0.976 . . . . 1.0 110.219 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.701 ' CG1' HD21 ' A' ' 163' ' ' LEU . 9.8 p -115.42 128.28 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.264 -0.897 . . . . 1.0 108.669 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.582 ' CD2' ' HB2' ' A' ' 164' ' ' SER . 46.6 m80 -126.69 116.63 21.26 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.11 -0.994 . . . . 1.0 109.542 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 1.04 ' HB ' HD12 ' A' ' 163' ' ' LEU . 9.8 p -99.16 141.35 22.7 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.206 -0.934 . . . . 1.0 109.169 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 35.4 Cg_endo -77.32 119.03 4.82 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.422 2.081 . . . . 1.0 110.634 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.461 ' OE1' ' HD2' ' A' ' 158' ' ' PRO . 0.1 OUTLIER -160.19 173.03 5.22 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.266 -0.896 . . . . 1.0 109.44 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.461 ' HD2' ' OE1' ' A' ' 157' ' ' GLN . 35.1 Cg_endo -77.87 -67.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.327 2.018 . . . . 1.0 110.44 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 36.6 m -64.15 109.38 1.83 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.905 . . . . 1.0 109.345 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.28 -30.27 11.14 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.542 -1.423 . . . . 1.0 109.542 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.7 mtp85 -79.59 79.06 6.1 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.257 -1.016 . . . . 1.0 108.257 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.647 HG22 ' N ' ' A' ' 163' ' ' LEU . 1.3 m -136.39 -79.77 0.4 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.001 -0.74 . . . . 1.0 109.001 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 1.04 HD12 ' HB ' ' A' ' 155' ' ' VAL . 0.1 OUTLIER -149.26 106.31 3.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.984 -1.072 . . . . 1.0 108.189 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.666 ' N ' HD22 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -163.83 106.34 0.95 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.608 -1.307 . . . . 1.0 109.466 -179.284 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.691 HD13 ' H ' ' A' ' 166' ' ' GLN . 0.2 OUTLIER -134.19 151.36 51.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.081 -1.012 . . . . 1.0 109.696 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.691 ' H ' HD13 ' A' ' 165' ' ' LEU . 27.9 mt-30 -123.69 139.44 53.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 1.0 109.374 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 167' ' ' VAL . 46.7 t -142.54 71.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.214 -0.929 . . . . 1.0 109.674 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.6 108.89 20.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 1.0 109.212 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 2.7 m -148.6 137.83 21.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.945 . . . . 1.0 109.674 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 169' ' ' SER . 0.6 OUTLIER 171.74 92.49 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.359 -0.838 . . . . 1.0 109.52 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.488 ' HG2' ' CB ' ' A' ' 23' ' ' SER . 34.8 Cg_endo -77.42 72.02 6.16 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.373 2.049 . . . . 1.0 110.694 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 172' ' ' ILE . 13.8 mm -115.21 78.74 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 1.0 109.233 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.54 135.92 33.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 1.0 109.746 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.442 ' SG ' ' HB ' ' A' ' 145' ' ' THR . 1.4 m -104.7 -177.02 3.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.371 -0.83 . . . . 1.0 109.299 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.2 p -167.76 -178.46 3.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.144 -0.972 . . . . 1.0 109.605 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.525 ' O ' ' CG ' ' A' ' 177' ' ' ARG . 3.2 pm0 -57.58 146.55 29.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 1.0 109.513 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 176' ' ' GLN . 2.0 ptp180 41.91 35.53 0.54 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.492 -0.755 . . . . 1.0 109.694 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.028 -0.987 . . . . 1.0 109.46 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mtm . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.265 0.555 . . . . 1.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.494 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -132.45 63.83 1.62 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.242 -0.911 . . . . 1.0 109.53 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.83 76.83 2.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.293 -0.879 . . . . 1.0 109.448 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.488 ' CD1' ' N ' ' A' ' 5' ' ' GLN . 13.8 p90 -66.44 -31.97 73.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 1.0 109.494 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.488 ' N ' ' CD1' ' A' ' 4' ' ' TRP . 0.2 OUTLIER 170.47 79.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.905 . . . . 1.0 109.515 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 tp -146.61 66.7 11.03 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 1.0 109.488 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.9 96.32 1.09 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.45 2.1 . . . . 1.0 110.378 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 p -119.89 41.58 3.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.204 -0.935 . . . . 1.0 109.324 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.447 ' O ' ' HB2' ' A' ' 10' ' ' SER . 6.9 p80 -139.68 105.3 5.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.869 . . . . 1.0 109.403 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 9' ' ' HIS . 19.1 m 64.82 -175.05 0.17 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 1.0 109.436 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 160.68 -91.77 0.11 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.587 -1.405 . . . . 1.0 109.587 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.2 173.72 13.48 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.527 2.151 . . . . 1.0 110.395 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.498 ' HA ' ' HA3' ' A' ' 52' ' ' GLY . 13.0 m-30 -80.06 123.32 27.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 1.0 109.469 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -152.2 130.07 11.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.942 . . . . 1.0 109.616 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.689 HD13 HD12 ' A' ' 50' ' ' LEU . 53.8 tp -107.41 83.47 1.82 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.237 -0.914 . . . . 1.0 109.198 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.61 157.48 23.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 1.0 109.805 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.674 HG21 ' NE2' ' A' ' 20' ' ' GLN . 1.1 mp -79.86 144.35 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.412 ' OE1' ' CD ' ' A' ' 49' ' ' GLN . 27.6 tp10 -80.7 -63.88 1.31 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 1.0 109.094 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.561 HG12 ' HD3' ' A' ' 21' ' ' PRO . 2.0 t -92.69 126.21 45.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.339 -0.851 . . . . 1.0 109.134 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.674 ' NE2' HG21 ' A' ' 17' ' ' ILE . 5.5 tp-100 -130.67 63.65 70.58 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.938 . . . . 1.0 109.66 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.561 ' HD3' HG12 ' A' ' 19' ' ' VAL . 36.0 Cg_endo -78.09 -177.96 4.26 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.513 2.142 . . . . 1.0 110.449 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.1 ttpt -50.36 161.01 0.33 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.229 -0.919 . . . . 1.0 109.383 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.411 ' O ' ' CG1' ' A' ' 172' ' ' ILE . 2.1 t -154.62 58.72 0.69 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.263 -0.898 . . . . 1.0 109.871 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -103.5 166.22 10.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 1.0 109.411 179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.566 ' CE1' ' N ' ' A' ' 38' ' ' VAL . 11.5 t-160 -163.86 113.12 1.23 Allowed 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.405 -0.81 . . . . 1.0 109.827 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.439 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 5.1 ttp180 -89.57 75.95 7.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.406 -0.808 . . . . 1.0 109.103 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.79 165.44 0.9 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.354 -0.841 . . . . 1.0 109.767 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.413 ' ND1' ' O ' ' A' ' 28' ' ' HIS . 10.5 p80 -94.99 111.69 23.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.877 . . . . 1.0 109.417 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -81.68 -14.66 56.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 1.0 109.663 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -114.49 -148.41 0.43 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.91 . . . . 1.0 109.516 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.2 p -120.62 38.27 4.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 1.0 109.281 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.422 ' O ' ' HG3' ' A' ' 32' ' ' GLU . 4.8 pt-20 -135.27 51.75 2.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.862 . . . . 1.0 109.501 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 34' ' ' SER . . . -115.36 -13.35 9.01 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.537 -1.425 . . . . 1.0 109.537 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 16.6 t 61.18 -90.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -1.162 . . . . 1.0 109.484 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -141.85 96.86 3.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.174 -0.954 . . . . 1.0 109.563 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -131.38 82.13 0.32 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.572 -1.411 . . . . 1.0 109.572 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -91.49 165.69 13.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -1.167 . . . . 1.0 109.449 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.566 ' N ' ' CE1' ' A' ' 25' ' ' HIS . 2.5 p -54.84 106.08 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.329 -0.857 . . . . 1.0 109.468 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.4 98.92 4.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 1.0 109.583 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.449 ' O ' ' O ' ' A' ' 41' ' ' SER . . . -158.23 95.92 1.4 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.896 . . . . 1.0 109.548 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 43' ' ' GLY . 1.9 t 60.87 144.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 1.0 109.465 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 51.45 -90.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.888 . . . . 1.0 109.423 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 41' ' ' SER . . . -167.92 34.88 0.21 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.442 -1.463 . . . . 1.0 109.442 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.558 ' HA3' HG22 ' A' ' 38' ' ' VAL . . . 109.69 -84.83 0.38 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.563 -1.415 . . . . 1.0 109.563 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.477 ' HB3' ' HD2' ' A' ' 46' ' ' PRO . 74.0 m-70 -77.14 159.88 77.18 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.358 -1.084 . . . . 1.0 109.504 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 45' ' ' HIS . 35.1 Cg_endo -77.47 -176.79 3.4 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 122.598 2.199 . . . . 1.0 110.679 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.767 HG23 HG12 ' A' ' 117' ' ' VAL . 3.8 mm -94.04 159.51 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.496 -0.753 . . . . 1.0 109.142 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.78 135.68 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.154 -0.966 . . . . 1.0 109.895 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 49' ' ' GLN . 2.6 pt20 -150.23 143.43 24.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.827 . . . . 1.0 109.111 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.689 HD12 HD13 ' A' ' 15' ' ' LEU . 3.0 tt -113.48 140.12 48.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.17 -0.957 . . . . 1.0 109.772 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 51' ' ' HIS . 14.6 p80 -140.08 81.59 1.82 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 1.0 109.093 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . -156.65 -97.92 0.14 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.049 -1.22 . . . . 1.0 110.049 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.477 ' HB3' ' CG ' ' A' ' 111' ' ' GLU . 0.4 OUTLIER -39.56 129.51 1.9 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.835 -0.803 . . . . 1.0 110.145 -179.519 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.5 mt -101.54 3.66 40.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.321 -0.862 . . . . 1.0 109.561 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 111' ' ' GLU . 2.7 tm-20 -79.71 138.5 37.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.179 -0.95 . . . . 1.0 109.362 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.452 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 5.0 p-10 -85.96 56.74 4.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.913 . . . . 1.0 109.599 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.483 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 5.0 mt-10 -105.64 143.2 26.35 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 1.0 109.245 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.537 ' O ' HD23 ' A' ' 59' ' ' LEU . 36.2 Cg_endo -78.62 120.19 4.7 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.394 2.063 . . . . 1.0 110.451 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.537 HD23 ' O ' ' A' ' 58' ' ' PRO . 20.6 mt -119.94 164.51 15.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 1.0 109.138 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -111.26 132.83 54.06 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.172 -0.955 . . . . 1.0 109.61 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.521 ' CD2' ' HB3' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -86.54 121.79 29.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.39 -0.819 . . . . 1.0 109.265 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.472 ' O ' ' HG2' ' A' ' 152' ' ' ARG . 9.4 mm-40 -92.48 75.68 5.14 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.203 -0.936 . . . . 1.0 108.872 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.818 HD22 ' CE1' ' A' ' 151' ' ' PHE . 0.4 OUTLIER -116.06 155.61 27.82 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.372 -0.83 . . . . 1.0 109.672 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 1.03 ' HA ' HD12 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -165.6 -178.91 5.12 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.381 -0.824 . . . . 1.0 108.909 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.75 ' O ' HG23 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -112.77 100.58 11.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.068 -1.02 . . . . 1.0 109.091 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 74' ' ' ARG . . . -118.99 149.94 18.06 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.942 -1.263 . . . . 1.0 109.942 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.461 HG22 ' ND1' ' A' ' 76' ' ' HIS . 20.4 p -78.4 146.78 34.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.421 -1.046 . . . . 1.0 109.151 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.756 ' HB3' ' HG3' ' A' ' 148' ' ' ARG . . . -152.49 116.16 4.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.148 -0.97 . . . . 1.0 109.535 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.511 ' HA ' ' NE ' ' A' ' 146' ' ' ARG . 1.6 p30 -85.0 -25.86 27.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.37 -0.832 . . . . 1.0 109.334 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -133.0 -49.49 0.87 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.192 -0.942 . . . . 1.0 109.322 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -175.06 -38.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 1.0 109.565 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.546 ' H ' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -55.89 89.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.907 . . . . 1.0 109.601 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -51.9 171.79 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.178 -0.951 . . . . 1.0 109.613 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.517 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 2.1 mtm180 -168.99 163.17 7.72 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.354 -0.841 . . . . 1.0 109.284 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 76' ' ' HIS . 35.3 Cg_endo -77.64 108.33 2.54 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.352 2.035 . . . . 1.0 110.437 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.53 ' CD2' ' CG ' ' A' ' 79' ' ' TYR . 5.9 t60 -42.07 161.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.423 -0.798 . . . . 1.0 110.01 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -48.83 -74.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.303 -0.873 . . . . 1.0 109.369 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.913 ' CD2' HD13 ' A' ' 126' ' ' LEU . 54.5 m-85 -135.32 22.79 3.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -0.929 . . . . 1.0 109.39 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.53 ' CG ' ' CD2' ' A' ' 76' ' ' HIS . 4.7 m-30 -80.21 118.45 21.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.262 -0.899 . . . . 1.0 109.354 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.541 ' HB2' ' CG ' ' A' ' 102' ' ' LYS . 0.1 OUTLIER -163.32 23.69 0.08 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.973 . . . . 1.0 109.804 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 122' ' ' GLY . 15.1 m -86.14 150.93 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.098 -1.001 . . . . 1.0 109.307 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.559 ' ND1' ' HB2' ' A' ' 121' ' ' ALA . 12.5 t60 -175.38 75.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.286 -0.884 . . . . 1.0 109.414 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 120' ' ' CYS . 15.2 mmm180 -109.7 130.24 55.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.295 -0.878 . . . . 1.0 109.64 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.565 HG23 ' CB ' ' A' ' 120' ' ' CYS . 4.6 mp -104.22 136.18 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 1.0 109.455 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 87' ' ' LYS . 69.4 p -141.28 -162.71 1.42 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.393 -0.817 . . . . 1.0 109.288 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 85' ' ' THR . . . 41.3 -96.48 0.01 OUTLIER Glycine 0 N--CA 1.482 1.741 0 N-CA-C 110.259 -1.137 . . . . 1.0 110.259 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.4 OUTLIER -74.62 111.44 9.82 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.24 -1.153 . . . . 1.0 109.626 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.07 143.54 26.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.275 -0.89 . . . . 1.0 109.357 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.555 HG13 ' H ' ' A' ' 91' ' ' THR . 9.8 p -105.07 154.04 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.186 -0.946 . . . . 1.0 109.537 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.36 12.78 7.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -0.94 . . . . 1.0 109.589 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.555 ' H ' HG13 ' A' ' 89' ' ' VAL . 16.0 m -103.14 104.88 15.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 1.0 109.472 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.762 ' O ' HG23 ' A' ' 106' ' ' ILE . 10.0 t -54.22 158.56 2.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.16 -0.962 . . . . 1.0 109.338 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.24 172.79 12.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 1.0 109.7 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -155.07 151.78 28.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.361 -0.837 . . . . 1.0 109.534 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -125.7 132.84 52.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 1.0 109.313 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -125.27 120.65 31.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.13 -0.981 . . . . 1.0 109.699 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.889 HD12 ' O ' ' A' ' 101' ' ' THR . 9.9 tp -125.0 133.7 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 1.0 109.293 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.531 ' N ' HD23 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -133.34 50.86 2.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.222 -0.924 . . . . 1.0 109.53 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER 76.66 114.16 0.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.309 -0.87 . . . . 1.0 109.742 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.43 ' CG ' ' O ' ' A' ' 99' ' ' SER . 3.9 p-10 43.49 35.03 0.86 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.665 -0.647 . . . . 1.0 110.476 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.889 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -156.15 102.63 2.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.927 -1.108 . . . . 1.0 109.743 179.642 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.798 ' HD2' HD13 ' A' ' 97' ' ' ILE . 4.5 tptt -112.29 153.68 26.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 1.0 109.386 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.964 HG12 ' HB3' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -158.54 168.66 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.271 -0.893 . . . . 1.0 109.113 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.03 HD12 ' HA ' ' A' ' 64' ' ' PHE . 1.1 mt -116.79 134.85 54.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 1.0 109.734 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -127.08 112.32 15.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.368 -0.833 . . . . 1.0 109.273 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 1.029 HG22 HD21 ' A' ' 108' ' ' LEU . 3.4 mt -121.69 107.0 36.59 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.907 . . . . 1.0 109.606 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.759 ' O ' HD23 ' A' ' 108' ' ' LEU . 33.8 Cg_endo -75.46 104.39 1.9 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 122.09 1.86 . . . . 1.0 110.133 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.029 HD21 HG22 ' A' ' 106' ' ' ILE . 3.0 mt -129.02 163.67 24.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.399 -0.813 . . . . 1.0 109.695 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.525 ' O ' ' CD1' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -129.86 69.23 81.55 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.386 -0.821 . . . . 1.0 109.238 179.796 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.465 ' HA ' ' CG ' ' A' ' 114' ' ' MET . 36.8 Cg_endo -81.02 45.47 2.01 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 122.703 2.269 . . . . 1.0 110.908 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 55' ' ' GLU . 53.6 mp0 -97.85 -11.48 23.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.99 -1.069 . . . . 1.0 109.684 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 113' ' ' SER . 0.3 OUTLIER -107.85 -55.6 2.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.18 -0.95 . . . . 1.0 109.429 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.1 OUTLIER 169.8 102.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 1.0 109.501 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.465 ' CG ' ' HA ' ' A' ' 110' ' ' PRO . 1.0 OUTLIER -164.79 122.31 1.62 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 1.0 109.574 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.641 ' HD3' HG21 ' A' ' 47' ' ' ILE . 7.5 ttm180 -102.01 136.08 42.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.883 . . . . 1.0 109.477 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.06 139.67 53.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 1.0 109.349 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.767 HG12 HG23 ' A' ' 47' ' ' ILE . 4.3 m -114.99 127.03 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 1.0 109.547 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.463 ' O ' ' HB2' ' A' ' 45' ' ' HIS . 16.1 mt -113.06 100.96 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 1.0 109.387 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.487 ' HB2' ' CA ' ' A' ' 43' ' ' GLY . 4.9 p-10 -153.71 50.72 0.68 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 1.0 109.486 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.565 ' CB ' HG23 ' A' ' 84' ' ' ILE . 96.0 m -137.77 42.85 2.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.221 -0.925 . . . . 1.0 109.589 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.559 ' HB2' ' ND1' ' A' ' 82' ' ' HIS . . . -129.59 172.21 11.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.867 . . . . 1.0 108.95 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -145.36 -165.5 11.3 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.794 -1.322 . . . . 1.0 109.794 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.548 HD11 ' ND1' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -125.42 157.18 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.32 -1.106 . . . . 1.0 108.93 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.538 ' HB2' HG11 ' A' ' 81' ' ' VAL . 7.6 tp -140.05 147.05 39.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.098 -1.001 . . . . 1.0 109.725 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -112.1 115.83 29.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 1.0 109.232 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.913 HD13 ' CD2' ' A' ' 78' ' ' PHE . 2.3 pt? -79.81 -16.05 56.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 1.0 109.748 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER 63.09 -87.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.352 -0.842 . . . . 1.0 109.61 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.449 ' O ' ' ND2' ' A' ' 128' ' ' ASN . 3.7 p-10 -42.06 107.75 0.08 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.461 -0.774 . . . . 1.0 109.789 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 38.1 p 175.96 -39.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 1.0 109.053 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 129' ' ' SER . 4.4 m-20 83.3 54.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.3 0.571 . . . . 1.0 109.936 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.775 ' O ' HG23 ' A' ' 131' ' ' ILE . 2.8 tt -135.19 59.94 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.367 -0.833 . . . . 1.0 109.335 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 131' ' ' ILE . 3.0 tt0 177.02 98.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.588 -0.695 . . . . 1.0 109.349 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 53.4 tp -154.28 131.68 11.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.193 -0.942 . . . . 1.0 109.567 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -109.8 -19.29 13.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -0.936 . . . . 1.0 109.497 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 136' ' ' GLY . 16.9 mttm -84.65 77.67 10.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 1.0 109.449 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 137' ' ' GLU . . . -61.17 -115.97 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.657 -1.377 . . . . 1.0 109.657 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.536 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 1.9 tt0 83.0 -43.47 0.11 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.904 -0.762 . . . . 1.0 109.887 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.457 ' O ' ' OG1' ' A' ' 138' ' ' THR . 0.0 OUTLIER -134.97 57.66 1.8 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.022 -1.049 . . . . 1.0 109.418 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 139' ' ' ASP . 24.1 p-10 178.94 -175.1 0.2 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 1.0 109.468 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.4 tp -86.8 -14.92 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 1.0 109.447 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.77 131.78 0.03 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.69 -1.364 . . . . 1.0 109.69 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -147.05 116.79 7.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -1.147 . . . . 1.0 109.503 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -123.71 104.42 8.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 1.0 109.392 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -168.62 136.68 2.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 1.0 109.5 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.535 ' CB ' ' HB2' ' A' ' 174' ' ' CYS . 0.0 OUTLIER -159.99 53.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 1.0 109.495 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.511 ' NE ' ' HA ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -98.45 175.13 6.14 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.219 -0.925 . . . . 1.0 109.439 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.409 HG23 ' OD1' ' A' ' 170' ' ' ASN . 17.3 m -138.83 167.19 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.357 -0.84 . . . . 1.0 109.567 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.756 ' HG3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -155.44 111.7 3.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.854 . . . . 1.0 109.534 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.678 HD12 ' O ' ' A' ' 64' ' ' PHE . 11.2 tp -81.44 113.25 19.38 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.213 -0.929 . . . . 1.0 108.947 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.567 HG21 ' HE1' ' A' ' 64' ' ' PHE . 10.6 t -93.46 143.5 11.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.399 -0.813 . . . . 1.0 110.237 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.818 ' CE1' HD22 ' A' ' 63' ' ' LEU . 10.4 m-85 -133.49 113.36 12.4 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.517 ' CB ' ' O ' ' A' ' 165' ' ' LEU . 10.2 ptt85 -145.45 106.76 4.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.933 -1.105 . . . . 1.0 110.529 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 153' ' ' VAL . 9.8 p -92.55 128.83 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.256 -1.016 . . . . 1.0 108.256 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.697 ' CD2' ' HB2' ' A' ' 164' ' ' SER . 37.8 m80 -121.39 117.4 26.83 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.034 -1.041 . . . . 1.0 110.43 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.695 ' HB ' HD23 ' A' ' 163' ' ' LEU . 8.1 p -99.61 141.13 22.25 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.779 -0.823 . . . . 1.0 108.779 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.534 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 33.4 Cg_endo -75.29 115.04 4.13 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.16 1.907 . . . . 1.0 110.501 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.73 ' HG3' HG21 ' A' ' 162' ' ' THR . 0.9 OUTLIER -136.3 169.13 14.28 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.532 -0.73 . . . . 1.0 109.058 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.525 ' HD2' ' NE2' ' A' ' 157' ' ' GLN . 34.3 Cg_endo -76.69 -65.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.316 2.01 . . . . 1.0 110.284 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.28 -84.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 1.0 109.25 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 152.42 -43.7 0.65 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.565 -1.414 . . . . 1.0 109.565 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -79.01 80.25 5.36 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.987 -1.116 . . . . 1.0 107.987 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.815 HG22 ' N ' ' A' ' 163' ' ' LEU . 1.3 m -133.55 -89.56 0.39 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.56 -0.712 . . . . 1.0 109.374 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.815 ' N ' HG22 ' A' ' 162' ' ' THR . 8.9 tp -125.91 96.91 4.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.83 -1.169 . . . . 1.0 108.737 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.888 ' O ' HD23 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -163.25 119.26 1.76 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.016 -1.052 . . . . 1.0 109.229 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.888 HD23 ' O ' ' A' ' 164' ' ' SER . 22.3 mt -142.63 175.07 10.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.976 -1.078 . . . . 1.0 110.428 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.496 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 10.7 mt-30 -142.27 70.84 1.34 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.607 -0.683 . . . . 1.0 109.201 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 37.9 t -87.79 106.04 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 1.0 110.066 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 150' ' ' VAL . . . -112.03 112.75 24.61 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.543 -0.91 . . . . 1.0 108.543 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 0.0 OUTLIER -136.8 140.99 42.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.989 -1.07 . . . . 1.0 110.261 -179.153 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.501 ' HB3' ' HA ' ' A' ' 148' ' ' ARG . 22.7 t-20 175.93 97.73 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.41 74.38 4.73 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.284 1.99 . . . . 1.0 110.588 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.467 ' HB ' ' OD1' ' A' ' 170' ' ' ASN . 27.6 mt -138.96 126.37 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.331 -0.856 . . . . 1.0 109.287 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -141.46 144.57 34.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 1.0 109.532 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.535 ' HB2' ' CB ' ' A' ' 145' ' ' THR . 35.8 m -114.67 -171.71 1.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 1.0 109.452 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.435 ' HB3' ' O ' ' A' ' 174' ' ' CYS . 5.8 p 178.52 34.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -0.883 . . . . 1.0 109.365 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.419 ' O ' ' O ' ' A' ' 175' ' ' SER . 0.8 OUTLIER 56.33 166.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 1.0 109.446 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 178' ' ' SER . 0.4 OUTLIER -154.61 -39.11 0.09 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.198 -0.938 . . . . 1.0 109.526 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 177' ' ' ARG . 10.4 t . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.0 -1.0 . . . . 1.0 109.442 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.7 pttp -112.51 129.05 56.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.225 -0.922 . . . . 1.0 109.424 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -56.81 -179.85 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 1.0 109.521 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.413 ' CG ' ' N ' ' A' ' 5' ' ' GLN . 31.6 p-90 -67.37 -37.22 82.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.222 -0.924 . . . . 1.0 109.544 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.413 ' N ' ' CG ' ' A' ' 4' ' ' TRP . 0.0 OUTLIER -178.22 79.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 1.0 109.463 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 tp -151.29 121.44 3.64 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.32 -0.862 . . . . 1.0 109.227 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.26 94.45 1.07 Allowed 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 122.058 1.839 . . . . 1.0 110.5 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 p -143.52 40.59 1.44 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 1.0 109.419 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.404 ' O ' ' HB2' ' A' ' 10' ' ' SER . 3.2 p80 -140.33 145.94 37.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.316 -0.865 . . . . 1.0 109.502 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 9' ' ' HIS . 4.4 m 68.59 123.92 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 1.0 109.682 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.479 ' N ' ' HD3' ' A' ' 12' ' ' PRO . . . 46.59 62.74 3.46 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.681 -1.367 . . . . 1.0 109.681 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' A' ' 11' ' ' GLY . 35.9 Cg_endo -78.15 117.29 4.09 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.523 2.149 . . . . 1.0 110.255 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.569 ' CE2' ' O ' ' A' ' 162' ' ' THR . 6.6 m-85 -102.61 169.72 8.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -0.934 . . . . 1.0 109.758 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -160.86 130.82 5.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 1.0 109.456 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' O ' HG21 ' A' ' 167' ' ' VAL . 23.3 tp -126.83 84.4 2.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.362 -0.836 . . . . 1.0 109.327 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -127.35 154.53 44.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.285 -0.884 . . . . 1.0 109.715 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -67.01 148.33 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.336 -0.853 . . . . 1.0 108.774 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.525 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.0 OUTLIER -70.97 -34.61 71.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.381 -0.824 . . . . 1.0 109.535 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 18' ' ' GLU . 72.3 t -157.78 135.6 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 121.206 -0.934 . . . . 1.0 109.435 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.09 80.45 7.04 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 1.0 109.522 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 19' ' ' VAL . 36.2 Cg_endo -78.52 179.23 6.69 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.519 2.146 . . . . 1.0 110.21 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 21' ' ' PRO . 9.7 mttt -44.56 108.6 0.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.087 -1.008 . . . . 1.0 109.185 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.1 p -130.72 39.41 3.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.126 -0.984 . . . . 1.0 109.945 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.481 ' HA ' HG12 ' A' ' 172' ' ' ILE . 2.0 p-80 -99.69 166.39 11.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.082 -1.011 . . . . 1.0 109.395 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.821 ' NE2' HD11 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -135.45 105.26 6.15 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.671 -0.812 . . . . 1.0 109.843 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.4 ttm-85 -92.4 70.98 5.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.429 -0.795 . . . . 1.0 109.053 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.554 ' O ' ' CE1' ' A' ' 29' ' ' TYR . . . -68.31 123.51 20.94 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.465 -0.772 . . . . 1.0 109.469 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -50.19 172.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.346 -0.846 . . . . 1.0 109.375 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.554 ' CE1' ' O ' ' A' ' 27' ' ' ALA . 9.6 m-85 -136.97 -53.69 0.7 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 1.0 109.482 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -104.31 -87.93 0.43 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 1.0 109.487 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.3 t -144.85 68.27 1.25 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.283 -0.886 . . . . 1.0 109.432 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -137.25 54.43 1.85 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 1.0 109.588 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.86 178.03 28.76 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.583 -1.407 . . . . 1.0 109.583 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -138.16 117.1 12.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -1.124 . . . . 1.0 109.426 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.48 ' CG ' ' C ' ' A' ' 34' ' ' SER . 0.0 OUTLIER 40.55 -94.0 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.639 -0.663 . . . . 1.0 109.85 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 34' ' ' SER . . . 61.06 68.25 1.76 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.509 -1.437 . . . . 1.0 109.509 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 36' ' ' GLY . . . -46.41 172.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.237 -1.155 . . . . 1.0 109.593 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.576 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 2.2 p -54.99 113.77 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.4 -0.813 . . . . 1.0 109.451 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.434 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -137.3 99.48 3.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.347 -0.846 . . . . 1.0 109.598 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.66 -154.34 0.6 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.377 -0.827 . . . . 1.0 109.458 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.5 t -69.84 -72.48 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 1.0 109.636 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.36 69.03 2.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 1.0 109.405 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.92 -82.12 0.87 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.31 -1.516 . . . . 1.0 109.31 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -165.97 -37.2 0.02 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.64 -1.384 . . . . 1.0 109.64 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -100.69 160.21 27.47 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.267 -1.137 . . . . 1.0 109.72 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.5 ' C ' HD13 ' A' ' 47' ' ' ILE . 35.8 Cg_endo -78.59 -176.64 3.38 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.539 2.159 . . . . 1.0 110.482 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.901 ' CG2' HG12 ' A' ' 117' ' ' VAL . 1.0 OUTLIER -94.14 158.07 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.607 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 2.9 t -134.54 135.94 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.983 -1.073 . . . . 1.0 110.399 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.606 ' HB3' ' CE1' ' A' ' 51' ' ' HIS . 5.0 tt0 -151.41 144.28 24.47 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.914 -0.773 . . . . 1.0 108.914 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.9 tt -113.23 138.51 49.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.085 -1.009 . . . . 1.0 109.994 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.606 ' CE1' ' HB3' ' A' ' 49' ' ' GLN . 4.3 m80 -140.33 77.9 1.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.401 -0.812 . . . . 1.0 109.25 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . -177.03 84.69 0.07 OUTLIER Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.687 -1.244 . . . . 1.0 110.049 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.569 ' CD2' ' OE2' ' A' ' 111' ' ' GLU . 3.5 t80 177.16 132.09 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -1.196 . . . . 1.0 109.619 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.2 -10.84 17.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 1.0 109.437 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.415 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 2.4 mt-10 -89.75 145.25 25.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 1.0 109.502 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -103.73 57.13 0.73 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.309 -0.87 . . . . 1.0 109.35 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -110.1 156.46 40.05 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 1.0 109.454 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.979 ' O ' HD23 ' A' ' 59' ' ' LEU . 35.8 Cg_endo -78.31 131.07 10.45 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.5 2.133 . . . . 1.0 110.49 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.979 HD23 ' O ' ' A' ' 58' ' ' PRO . 6.5 mt -128.88 162.79 26.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 1.0 109.225 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.458 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 2.1 mpp? -105.78 131.63 52.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.275 -0.891 . . . . 1.0 109.355 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.818 HD21 ' HB2' ' A' ' 63' ' ' LEU . 1.1 tt -90.26 141.27 28.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.376 -0.828 . . . . 1.0 109.388 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.434 ' O ' ' OE1' ' A' ' 62' ' ' GLN . 0.9 OUTLIER -104.64 78.12 1.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.184 -0.948 . . . . 1.0 109.681 -179.764 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.135 HD13 ' CE1' ' A' ' 151' ' ' PHE . 23.4 tp -100.87 135.18 42.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 1.0 109.086 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.718 ' HB2' HG12 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -165.45 159.67 17.16 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.542 -0.911 . . . . 1.0 108.542 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 65' ' ' ILE . 1.2 tp -110.84 125.49 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 1.0 109.057 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 74' ' ' ARG . . . -145.08 142.38 10.77 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.619 -1.392 . . . . 1.0 109.619 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.681 HG23 ' HA ' ' A' ' 76' ' ' HIS . 72.4 p -66.64 178.85 1.17 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.496 -1.003 . . . . 1.0 109.945 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.422 ' HB3' ' HD2' ' A' ' 148' ' ' ARG . . . -170.23 125.37 0.76 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.465 -0.772 . . . . 1.0 109.072 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.83 -38.03 20.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 1.0 108.962 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -140.45 -56.43 0.53 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.167 -0.958 . . . . 1.0 109.699 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.492 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -152.14 -47.57 0.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.875 . . . . 1.0 109.524 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mt -52.47 89.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.353 -0.842 . . . . 1.0 109.684 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.778 ' H ' HD13 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -48.11 171.93 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.105 -0.997 . . . . 1.0 110.362 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -168.91 167.22 5.97 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.384 -0.823 . . . . 1.0 108.867 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 74' ' ' ARG . 32.7 Cg_endo -74.06 142.69 31.39 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.072 1.848 . . . . 1.0 109.96 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.774 ' NE2' HG12 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -50.72 146.84 5.31 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.252 -0.905 . . . . 1.0 109.763 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.19 -59.54 4.9 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.363 -0.836 . . . . 1.0 109.294 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.825 ' CD1' HD22 ' A' ' 126' ' ' LEU . 74.9 m-85 -136.34 4.04 2.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -0.908 . . . . 1.0 109.912 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.572 ' HB2' ' CG ' ' A' ' 76' ' ' HIS . 6.7 m-30 -99.02 103.19 15.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.984 -1.072 . . . . 1.0 109.25 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.518 ' HB2' ' CG ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -138.88 7.64 2.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.064 -1.023 . . . . 1.0 109.643 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.828 HG11 HD13 ' A' ' 124' ' ' LEU . 35.6 m -64.39 157.89 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.182 -0.949 . . . . 1.0 109.464 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.783 ' CE1' HD11 ' A' ' 84' ' ' ILE . 35.0 t-80 -175.83 90.53 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.478 -0.763 . . . . 1.0 109.296 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.539 ' C ' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -122.53 144.71 48.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.117 -0.99 . . . . 1.0 109.742 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.798 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.3 mp -110.45 125.09 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.29 -0.881 . . . . 1.0 109.51 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 86' ' ' GLY . 10.2 p -136.49 -95.75 0.23 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 1.0 109.701 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 85' ' ' THR . . . -41.15 -68.67 0.61 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 110.091 -1.204 . . . . 1.0 110.091 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 120' ' ' CYS . 0.0 OUTLIER -74.74 120.32 20.13 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.22 -1.165 . . . . 1.0 109.072 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.27 136.27 53.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -0.906 . . . . 1.0 109.642 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 89' ' ' VAL . 5.4 p -111.0 120.87 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 1.0 109.054 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.57 31.89 0.9 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.11 -0.994 . . . . 1.0 109.627 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.601 HG22 ' N ' ' A' ' 92' ' ' THR . 19.6 m -91.94 -91.09 0.16 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.316 -0.865 . . . . 1.0 109.14 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.854 ' O ' HG23 ' A' ' 106' ' ' ILE . 0.2 OUTLIER -174.54 82.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 1.0 109.383 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.51 160.99 13.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.937 . . . . 1.0 110.048 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.524 ' CB ' ' HG3' ' A' ' 105' ' ' GLU . 0.2 OUTLIER -155.53 160.91 40.91 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.007 -0.738 . . . . 1.0 109.007 179.786 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' A' ' 94' ' ' HIS . 0.7 OUTLIER -132.82 150.66 52.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.988 -1.07 . . . . 1.0 109.813 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -153.84 124.17 7.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.845 . . . . 1.0 109.225 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.952 HD13 ' N ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -119.52 131.61 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 1.0 109.606 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.952 ' N ' HD13 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -126.05 68.7 1.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 1.0 109.207 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 1.4 m 76.35 93.82 0.07 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -0.843 . . . . 1.0 109.333 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 99' ' ' SER . 1.1 p-10 42.85 55.12 4.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.492 -0.755 . . . . 1.0 109.721 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.479 ' HB ' ' HG ' ' A' ' 98' ' ' LEU . 6.1 m -160.05 80.43 0.7 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.124 -0.985 . . . . 1.0 109.551 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.525 ' CD ' ' HB ' ' A' ' 97' ' ' ILE . 2.1 mmmp? -85.38 131.21 34.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 1.0 109.374 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.718 HG12 ' HB2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -129.49 165.82 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.22 -0.925 . . . . 1.0 109.154 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.611 HD11 ' NE2' ' A' ' 82' ' ' HIS . 0.3 OUTLIER -120.15 141.66 49.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 1.0 109.595 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.524 ' HG3' ' CB ' ' A' ' 94' ' ' HIS . 2.1 pt-20 -137.46 117.07 12.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.332 -0.855 . . . . 1.0 109.147 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.854 HG23 ' O ' ' A' ' 92' ' ' THR . 12.4 mt -118.11 98.84 51.76 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.853 . . . . 1.0 109.849 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.463 ' HD2' ' O ' ' A' ' 92' ' ' THR . 35.3 Cg_endo -76.73 97.61 1.15 Allowed 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.379 2.052 . . . . 1.0 110.302 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.72 ' CD2' HG22 ' A' ' 106' ' ' ILE . 0.6 OUTLIER -145.12 165.26 28.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 1.0 109.657 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.524 ' O ' ' CD1' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -115.37 81.52 8.59 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.303 -0.873 . . . . 1.0 109.698 -179.841 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 108' ' ' LEU . 37.1 Cg_endo -81.0 42.54 1.36 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.634 2.223 . . . . 1.0 110.706 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.569 ' OE2' ' CD2' ' A' ' 53' ' ' TYR . 0.9 OUTLIER -100.33 28.79 4.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.124 -0.985 . . . . 1.0 109.597 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 113' ' ' SER . 0.0 OUTLIER -138.01 -70.31 0.44 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.198 -0.939 . . . . 1.0 109.142 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 112' ' ' ASN . 3.5 t 178.19 101.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 1.0 109.237 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 4.5 ptm -164.04 131.11 3.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 1.0 109.562 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.451 ' HD2' ' OE1' ' A' ' 18' ' ' GLU . 35.7 ttp180 -106.68 131.65 53.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 1.0 109.373 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -116.07 101.96 9.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 1.0 109.377 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.901 HG12 ' CG2' ' A' ' 47' ' ' ILE . 4.6 m -81.06 127.01 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.334 -0.854 . . . . 1.0 109.445 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.574 ' CD1' ' CD2' ' A' ' 63' ' ' LEU . 10.6 mt -107.55 115.01 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.295 -0.878 . . . . 1.0 109.4 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 118' ' ' ILE . 0.6 OUTLIER -156.8 53.41 0.52 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 1.0 109.03 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.481 ' SG ' HG13 ' A' ' 84' ' ' ILE . 1.8 p -141.95 57.07 1.48 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.259 -0.9 . . . . 1.0 109.59 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.12 167.25 22.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 1.0 109.131 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.686 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -137.63 -176.07 14.23 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.833 -1.307 . . . . 1.0 109.833 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.821 HD11 ' NE2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -116.41 171.72 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.354 -1.086 . . . . 1.0 109.083 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.828 HD13 HG11 ' A' ' 81' ' ' VAL . 13.5 tp -128.86 157.72 40.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 1.0 109.811 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.462 ' O ' ' HD2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -113.23 155.58 24.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.358 -0.839 . . . . 1.0 109.157 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.825 HD22 ' CD1' ' A' ' 78' ' ' PHE . 51.2 tp -117.62 -93.4 0.51 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.104 -0.997 . . . . 1.0 109.54 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.523 ' N ' ' HG ' ' A' ' 126' ' ' LEU . 0.2 OUTLIER 170.03 -78.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 1.0 109.063 180.0 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -123.48 113.24 18.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.248 -0.907 . . . . 1.0 109.326 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.6 p -81.31 126.22 31.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.208 -0.932 . . . . 1.0 109.579 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -165.07 56.84 0.12 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.209 -0.932 . . . . 1.0 109.517 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.731 ' O ' HG23 ' A' ' 131' ' ' ILE . 2.9 tt -121.05 70.4 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.428 -0.795 . . . . 1.0 109.51 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.83 119.08 29.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.907 . . . . 1.0 109.643 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.25 -47.05 37.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.888 . . . . 1.0 109.431 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 34.4 ptt85 176.15 144.91 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 1.0 109.542 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.46 124.93 4.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -0.939 . . . . 1.0 109.489 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -92.34 -3.25 67.34 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.692 -1.363 . . . . 1.0 109.692 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.401 ' N ' ' CD ' ' A' ' 137' ' ' GLU . 2.1 pm0 -177.49 156.53 1.19 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -1.177 . . . . 1.0 109.391 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 139' ' ' ASP . 0.9 OUTLIER -154.29 -44.49 0.09 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 1.0 109.579 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.573 ' O ' HG23 ' A' ' 140' ' ' ILE . 11.4 m-20 65.51 10.33 6.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.907 . . . . 1.0 109.529 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 139' ' ' ASP . 0.2 OUTLIER -160.01 -72.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 1.0 109.294 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 142' ' ' ARG . . . 100.25 -70.78 0.47 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.649 -1.38 . . . . 1.0 109.649 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 141' ' ' GLY . 28.0 mmm180 65.25 170.38 0.21 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.193 -1.181 . . . . 1.0 109.39 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 144' ' ' ASN . 0.3 OUTLIER -125.94 56.89 1.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.905 . . . . 1.0 109.495 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 143' ' ' LYS . 3.4 p30 40.64 93.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.679 -0.638 . . . . 1.0 109.904 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.821 HG22 ' O ' ' A' ' 174' ' ' CYS . 0.0 OUTLIER -143.47 46.7 1.5 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.214 -0.929 . . . . 1.0 109.751 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.538 ' N ' ' HD2' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -154.86 154.77 33.22 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.419 -0.801 . . . . 1.0 109.433 179.619 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.774 HG12 ' NE2' ' A' ' 76' ' ' HIS . 32.6 m -139.25 162.44 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.908 . . . . 1.0 109.226 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.422 ' HD2' ' HB3' ' A' ' 68' ' ' ALA . 8.0 ttt180 -141.61 112.47 7.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -0.95 . . . . 1.0 109.655 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.808 HD11 HD11 ' A' ' 63' ' ' LEU . 44.0 tp -79.12 123.84 27.75 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.317 -0.865 . . . . 1.0 109.051 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 37.2 t -95.0 146.0 7.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.233 -0.917 . . . . 1.0 109.773 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 1.135 ' CE1' HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -148.1 99.43 3.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 1.0 109.021 -179.792 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.524 ' CB ' ' HA ' ' A' ' 166' ' ' GLN . 14.1 ptt180 -150.33 136.4 18.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.98 -1.075 . . . . 1.0 110.255 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 153' ' ' VAL . 9.8 p -115.42 129.02 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.708 ' CD2' ' HB2' ' A' ' 164' ' ' SER . 33.9 m80 -126.88 118.46 24.64 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.129 -0.982 . . . . 1.0 110.119 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.59 ' HB ' HD23 ' A' ' 163' ' ' LEU . 13.0 p -99.04 140.98 22.11 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.363 -0.836 . . . . 1.0 108.769 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.535 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 33.2 Cg_endo -75.25 115.29 4.21 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.161 1.907 . . . . 1.0 110.245 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.812 ' HG3' HG21 ' A' ' 162' ' ' THR . 9.8 mm-40 -136.51 167.28 22.16 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.541 -0.724 . . . . 1.0 109.292 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.448 ' HD2' ' CD ' ' A' ' 157' ' ' GLN . 34.6 Cg_endo -77.32 -63.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.299 1.999 . . . . 1.0 110.21 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.6 t -55.74 -75.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.385 -0.822 . . . . 1.0 109.346 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 142.09 -43.27 1.08 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.482 -1.447 . . . . 1.0 109.482 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.86 80.48 5.2 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.879 -1.156 . . . . 1.0 107.879 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.812 HG21 ' HG3' ' A' ' 157' ' ' GLN . 1.3 m -136.2 -78.23 0.42 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.462 -0.774 . . . . 1.0 109.432 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.63 ' N ' HG22 ' A' ' 162' ' ' THR . 8.3 tp -141.06 100.93 3.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.074 -1.016 . . . . 1.0 108.962 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.708 ' HB2' ' CD2' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -162.21 98.27 1.04 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.025 -1.047 . . . . 1.0 109.534 179.576 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.77 HD13 ' H ' ' A' ' 166' ' ' GLN . 0.2 OUTLIER -126.73 151.88 47.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.331 -0.856 . . . . 1.0 109.625 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.77 ' H ' HD13 ' A' ' 165' ' ' LEU . 15.8 mt-30 -118.51 145.53 45.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.902 . . . . 1.0 109.535 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.575 HG21 ' O ' ' A' ' 15' ' ' LEU . 47.0 t -152.39 93.26 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.124 -0.985 . . . . 1.0 109.78 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 149' ' ' LEU . . . -112.44 110.46 20.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.198 -0.939 . . . . 1.0 109.362 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 0.1 OUTLIER -159.51 136.63 9.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.158 -0.964 . . . . 1.0 109.872 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 169' ' ' SER . 0.2 OUTLIER 176.67 99.14 0.11 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.385 -0.822 . . . . 1.0 109.07 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.46 95.3 1.04 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.311 2.008 . . . . 1.0 110.964 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.54 ' HB ' ' CG2' ' A' ' 147' ' ' VAL . 14.9 mt -150.36 161.36 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.432 -0.793 . . . . 1.0 109.137 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.494 ' N ' HG22 ' A' ' 172' ' ' ILE . 3.3 mt-10 -118.32 172.6 7.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.247 -0.908 . . . . 1.0 109.803 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.821 ' O ' HG22 ' A' ' 145' ' ' THR . 6.0 m -114.71 153.29 30.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 1.0 109.315 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.532 ' OG ' ' HB1' ' A' ' 27' ' ' ALA . 1.3 p -164.96 166.65 19.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.293 -0.879 . . . . 1.0 109.541 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.97 -176.23 3.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.203 -0.935 . . . . 1.0 109.384 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.31 -83.58 0.48 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.147 -0.971 . . . . 1.0 109.411 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.036 -0.983 . . . . 1.0 109.471 -179.979 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.66 135.51 15.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.228 -0.92 . . . . 1.0 109.476 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 174.49 -67.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.235 -0.916 . . . . 1.0 109.434 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.555 ' CG ' ' N ' ' A' ' 5' ' ' GLN . 23.5 p-90 -78.62 -46.0 20.29 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.304 -0.873 . . . . 1.0 109.54 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.555 ' N ' ' CG ' ' A' ' 4' ' ' TRP . 2.2 tt0 -179.75 81.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.138 -0.976 . . . . 1.0 109.371 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.481 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 0.2 OUTLIER -166.52 62.68 0.73 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.254 -0.904 . . . . 1.0 109.557 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 6' ' ' LEU . 35.4 Cg_endo -77.91 94.62 1.07 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.404 2.069 . . . . 1.0 110.357 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.9 p -155.04 46.4 0.52 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.839 . . . . 1.0 109.508 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.07 114.24 27.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 1.0 109.482 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.8 m -154.76 52.06 0.63 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.173 -0.955 . . . . 1.0 109.549 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.81 73.56 0.54 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.594 -1.402 . . . . 1.0 109.594 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.04 -162.46 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.532 2.155 . . . . 1.0 110.374 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.507 ' HA ' ' HA3' ' A' ' 52' ' ' GLY . 3.1 m-85 -56.72 145.74 28.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.2 -0.937 . . . . 1.0 109.326 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -157.13 124.14 5.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.903 -1.123 . . . . 1.0 110.089 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.612 HD22 ' HB ' ' A' ' 153' ' ' VAL . 17.5 tp -107.8 81.72 1.55 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.395 -0.815 . . . . 1.0 108.867 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -116.34 157.1 25.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.87 . . . . 1.0 109.903 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.79 HG23 ' O ' ' A' ' 47' ' ' ILE . 1.4 mp -62.96 149.81 9.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.296 -0.878 . . . . 1.0 108.664 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 1.022 ' HB3' HD12 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -64.65 -42.71 95.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.923 . . . . 1.0 109.11 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.723 ' HB ' HD11 ' A' ' 47' ' ' ILE . 71.3 t -151.81 126.76 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.277 -0.89 . . . . 1.0 109.092 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.601 ' HG2' HG21 ' A' ' 17' ' ' ILE . 9.0 mm-40 -115.28 79.14 6.48 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.905 . . . . 1.0 109.484 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.477 ' HD3' HG12 ' A' ' 19' ' ' VAL . 36.2 Cg_endo -77.8 -179.35 5.36 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.352 2.035 . . . . 1.0 110.453 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.68 113.97 5.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 1.0 109.062 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.54 ' HA ' ' CB ' ' A' ' 40' ' ' ALA . 3.0 t -139.29 72.46 1.4 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.226 -0.921 . . . . 1.0 109.855 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.415 ' HA ' HG12 ' A' ' 172' ' ' ILE . 1.7 p-80 -99.69 166.89 10.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.244 -0.91 . . . . 1.0 109.256 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.639 ' CD2' ' HA ' ' A' ' 38' ' ' VAL . 3.8 t-160 -135.78 104.19 5.67 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 119.852 -0.739 . . . . 1.0 109.339 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -79.08 77.83 5.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.426 -0.796 . . . . 1.0 109.212 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 28' ' ' HIS . . . -60.03 93.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.394 -0.816 . . . . 1.0 109.648 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 27' ' ' ALA . 2.4 t-160 176.58 33.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.847 . . . . 1.0 109.32 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -95.44 -168.89 1.86 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.292 -0.88 . . . . 1.0 109.551 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -70.16 145.76 51.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.314 -0.866 . . . . 1.0 109.59 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 31' ' ' THR . 13.3 t -145.05 38.23 1.17 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.358 -0.839 . . . . 1.0 109.521 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.4 20.89 13.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -0.931 . . . . 1.0 109.525 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -177.24 -50.24 0.07 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.583 -1.407 . . . . 1.0 109.583 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.13 150.46 22.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -1.151 . . . . 1.0 109.497 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 -88.83 -89.74 0.14 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 1.0 109.509 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.89 175.97 21.0 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.567 -1.413 . . . . 1.0 109.567 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -175.17 170.09 3.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -1.138 . . . . 1.0 109.607 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.639 ' HA ' ' CD2' ' A' ' 25' ' ' HIS . 2.2 p -57.48 122.79 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.365 -0.835 . . . . 1.0 109.43 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.32 109.93 3.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 1.0 109.439 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.54 ' CB ' ' HA ' ' A' ' 23' ' ' SER . . . -136.34 -91.63 0.27 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 1.0 109.77 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.55 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 58.8 m -102.61 135.26 44.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.222 -0.924 . . . . 1.0 109.662 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.558 ' HB1' ' NE2' ' A' ' 45' ' ' HIS . . . 67.45 10.1 7.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.928 . . . . 1.0 109.38 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.8 10.8 42.3 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.413 -1.475 . . . . 1.0 109.413 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 45' ' ' HIS . . . 77.06 83.4 0.52 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.644 -1.383 . . . . 1.0 109.644 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.601 ' CG ' ' HB3' ' A' ' 119' ' ' ASP . 20.8 p80 -179.81 123.0 0.23 Allowed Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.168 -1.195 . . . . 1.0 109.962 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.24 146.61 19.97 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 122.0 1.8 . . . . 1.0 109.416 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.022 HD12 ' HB3' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -97.31 135.1 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.909 -1.119 . . . . 1.0 109.142 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.562 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 3.0 t -118.63 130.79 72.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.017 -1.052 . . . . 1.0 109.814 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.553 ' NE2' ' CG ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -161.4 117.74 2.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.338 -0.852 . . . . 1.0 109.465 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.554 HD11 HG11 ' A' ' 153' ' ' VAL . 3.0 tt -77.07 136.37 38.65 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.126 -0.984 . . . . 1.0 109.154 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.0 87.47 2.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.182 -0.949 . . . . 1.0 109.262 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 163.92 64.48 0.02 OUTLIER Glycine 0 N--CA 1.483 1.807 0 C-N-CA 119.56 -1.305 . . . . 1.0 110.166 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.57 ' CE1' ' HB2' ' A' ' 55' ' ' GLU . 0.2 OUTLIER 175.62 121.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.109 -1.23 . . . . 1.0 109.687 179.611 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.7 mt -104.0 22.6 14.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.323 -0.861 . . . . 1.0 109.31 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.57 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -87.35 145.22 26.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.179 -0.951 . . . . 1.0 109.685 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.9 p30 -90.83 46.43 1.33 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.2 -0.938 . . . . 1.0 109.712 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 17.1 pt-20 -122.98 127.75 25.59 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.255 -0.903 . . . . 1.0 109.185 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.596 ' O ' HD23 ' A' ' 59' ' ' LEU . 36.4 Cg_endo -79.44 151.18 22.61 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 122.147 1.898 . . . . 1.0 110.624 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.596 HD23 ' O ' ' A' ' 58' ' ' PRO . 18.6 mt -128.48 142.7 51.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.309 -0.869 . . . . 1.0 108.91 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.444 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -79.95 102.05 8.98 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.074 -1.016 . . . . 1.0 109.423 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.865 HD21 ' HB2' ' A' ' 63' ' ' LEU . 3.0 tt -59.59 135.11 57.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.405 -0.809 . . . . 1.0 109.612 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -102.45 97.06 7.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.359 -0.838 . . . . 1.0 108.998 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.971 HD13 ' CE1' ' A' ' 151' ' ' PHE . 26.8 tp -123.35 139.21 54.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.179 -0.951 . . . . 1.0 109.634 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.495 ' HB3' HG12 ' A' ' 103' ' ' VAL . 2.3 p90 -159.96 -163.9 1.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.325 -0.86 . . . . 1.0 108.928 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.689 HG23 ' O ' ' A' ' 65' ' ' ILE . 2.8 tp -125.36 115.62 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.827 . . . . 1.0 108.828 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.434 ' CA ' ' O ' ' A' ' 74' ' ' ARG . . . -135.09 148.07 19.43 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.677 -1.249 . . . . 1.0 109.996 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.861 HG22 ' CD2' ' A' ' 76' ' ' HIS . 17.4 p -83.97 156.34 22.35 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.519 -0.989 . . . . 1.0 109.225 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.994 ' HB3' ' HG3' ' A' ' 148' ' ' ARG . . . -159.42 120.39 3.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.067 -1.021 . . . . 1.0 109.724 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.438 ' OD1' HD11 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -84.93 -10.91 56.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 1.0 109.374 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -166.65 -44.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.887 . . . . 1.0 109.38 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.487 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -168.33 -36.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 1.0 109.619 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.438 HD11 ' OD1' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -53.98 89.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -0.886 . . . . 1.0 109.548 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.599 ' H ' HD23 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -54.21 169.21 0.19 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.243 -0.911 . . . . 1.0 109.6 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.434 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -175.19 155.17 1.75 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 1.0 109.486 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.426 ' HD2' ' HG2' ' A' ' 74' ' ' ARG . 36.0 Cg_endo -77.67 116.93 4.14 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.483 2.122 . . . . 1.0 110.342 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.861 ' CD2' HG22 ' A' ' 67' ' ' THR . 1.7 t-80 -54.07 154.48 4.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.186 -0.947 . . . . 1.0 109.699 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.95 -72.2 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 1.0 109.796 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.934 ' CG ' HD12 ' A' ' 126' ' ' LEU . 1.1 p90 -130.97 12.83 5.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.091 -1.006 . . . . 1.0 109.858 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.668 ' O ' HG21 ' A' ' 65' ' ' ILE . 5.8 m-85 -79.98 117.18 20.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.061 -1.024 . . . . 1.0 108.943 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.543 ' CB ' ' HB3' ' A' ' 102' ' ' LYS . 1.5 pp0? -174.55 33.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.148 -0.97 . . . . 1.0 109.984 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 122' ' ' GLY . 5.6 m -91.94 140.91 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 1.0 109.641 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 1.01 ' CD2' ' HB2' ' A' ' 121' ' ' ALA . 13.4 t-80 -175.58 111.26 0.11 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.401 -0.812 . . . . 1.0 108.94 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.4 OUTLIER -145.08 135.18 23.88 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.09 -1.006 . . . . 1.0 110.116 -179.685 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.814 HD11 ' HE1' ' A' ' 82' ' ' HIS . 4.0 mp -99.75 128.45 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.596 -0.69 . . . . 1.0 109.379 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 86' ' ' GLY . 38.7 p -99.98 -154.37 0.47 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 1.0 109.356 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 85' ' ' THR . . . 41.07 -152.12 0.12 Allowed Glycine 0 N--CA 1.484 1.881 0 N-CA-C 110.071 -1.212 . . . . 1.0 110.071 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -155.2 69.56 0.72 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.265 -1.138 . . . . 1.0 109.576 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.54 40.01 3.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.203 -0.936 . . . . 1.0 109.67 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -148.16 135.97 14.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.178 -0.951 . . . . 1.0 108.982 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.6 p -102.94 -13.8 16.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.22 -0.925 . . . . 1.0 109.452 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.657 ' O ' HG23 ' A' ' 91' ' ' THR . 11.4 t -65.05 115.55 5.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.263 -0.898 . . . . 1.0 109.618 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 1.023 ' O ' HG23 ' A' ' 106' ' ' ILE . 14.5 t -78.62 148.78 33.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.947 . . . . 1.0 109.142 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.46 ' HB3' HG12 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -137.18 174.39 10.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.129 -0.982 . . . . 1.0 110.043 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.76 159.56 43.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.495 -0.753 . . . . 1.0 109.139 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.493 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 27.8 mm-40 -127.14 147.79 50.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.979 . . . . 1.0 109.819 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -151.76 121.55 7.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 1.0 109.427 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.495 ' HB ' ' HD2' ' A' ' 102' ' ' LYS . 2.6 tp -110.27 142.32 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 1.0 109.648 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.637 HD11 HG21 ' A' ' 101' ' ' THR . 0.5 OUTLIER -130.81 49.62 2.3 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.329 -0.857 . . . . 1.0 109.367 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 98' ' ' LEU . 2.0 p 73.92 112.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.864 . . . . 1.0 110.213 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.429 ' CG ' ' O ' ' A' ' 99' ' ' SER . 2.2 p-10 42.71 32.65 0.4 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.603 -0.686 . . . . 1.0 110.502 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.637 HG21 HD11 ' A' ' 98' ' ' LEU . 43.7 m -160.24 88.66 0.82 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.883 -1.135 . . . . 1.0 109.971 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.543 ' HB3' ' CB ' ' A' ' 80' ' ' GLN . 3.8 tptt -91.88 147.5 22.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 1.0 109.239 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.524 ' N ' ' HG3' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -136.8 167.43 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.205 -0.934 . . . . 1.0 109.104 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.583 HD22 HG13 ' A' ' 106' ' ' ILE . 1.0 OUTLIER -121.59 124.43 44.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 1.0 109.65 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.459 ' N ' HD23 ' A' ' 104' ' ' LEU . 1.0 OUTLIER -114.85 120.36 39.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.28 -0.887 . . . . 1.0 109.152 179.684 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 1.023 HG23 ' O ' ' A' ' 92' ' ' THR . 71.3 mt -133.24 108.61 12.45 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.107 -0.996 . . . . 1.0 109.684 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.638 ' O ' HD23 ' A' ' 108' ' ' LEU . 33.9 Cg_endo -75.17 115.6 4.31 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 122.079 1.853 . . . . 1.0 109.844 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.638 HD23 ' O ' ' A' ' 107' ' ' PRO . 21.1 mt -123.45 165.45 17.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.261 -0.899 . . . . 1.0 110.787 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.533 ' N ' ' HD3' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -139.21 59.7 15.5 Favored Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 108.788 -0.819 . . . . 1.0 108.788 179.199 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 109' ' ' LEU . 35.6 Cg_endo -76.95 -3.88 14.28 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.373 2.049 . . . . 1.0 110.622 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 55' ' ' GLU . 3.2 mt-10 -43.63 -36.01 1.99 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.502 -0.749 . . . . 1.0 109.115 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 113' ' ' SER . 3.4 p30 -94.77 -44.33 7.82 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.476 -0.765 . . . . 1.0 109.202 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 1.4 p 164.72 107.54 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 1.0 109.261 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -154.69 94.08 1.64 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.32 -0.863 . . . . 1.0 109.358 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.54 129.77 42.6 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 1.0 109.233 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -136.09 134.7 38.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.895 . . . . 1.0 109.636 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.997 HG12 HG22 ' A' ' 47' ' ' ILE . 3.3 m -106.35 145.78 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.279 -0.888 . . . . 1.0 109.238 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 45' ' ' HIS . 14.3 mt -112.76 93.93 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.176 -0.952 . . . . 1.0 109.509 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.601 ' HB3' ' CG ' ' A' ' 45' ' ' HIS . 9.4 p-10 -127.66 26.44 5.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.591 -0.693 . . . . 1.0 109.257 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.494 ' HB3' HG13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -122.42 44.65 2.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.245 -0.909 . . . . 1.0 110.003 -179.406 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 1.01 ' HB2' ' CD2' ' A' ' 82' ' ' HIS . . . -129.56 177.01 7.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.967 . . . . 1.0 109.102 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.898 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -155.95 -169.84 20.63 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.548 -1.421 . . . . 1.0 109.548 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.498 ' CG2' ' CD2' ' A' ' 79' ' ' TYR . 1.8 mt -125.68 173.41 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -1.129 . . . . 1.0 109.437 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.72 HD21 ' O ' ' A' ' 78' ' ' PHE . 1.4 pp -140.12 158.14 44.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -0.826 . . . . 1.0 109.396 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.9 139.23 50.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 1.0 109.552 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.934 HD12 ' CG ' ' A' ' 78' ' ' PHE . 10.5 mt -116.06 -170.7 1.85 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 1.0 109.394 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.35 -58.64 1.85 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 1.0 109.523 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -163.15 118.84 1.75 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.282 -0.886 . . . . 1.0 109.448 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.537 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 52.2 p -100.79 -27.3 13.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.884 . . . . 1.0 109.476 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 129' ' ' SER . 16.6 t0 83.39 59.42 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.264 0.554 . . . . 1.0 109.517 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.3 tp -103.98 134.46 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.208 -0.932 . . . . 1.0 109.456 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -84.04 111.92 19.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 1.0 109.518 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.577 HD13 ' O ' ' A' ' 133' ' ' LEU . 0.5 OUTLIER -170.98 -57.64 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.216 -0.927 . . . . 1.0 109.463 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.03 -35.86 67.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 1.0 109.322 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.32 155.42 28.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 1.0 109.488 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 179.19 -86.17 0.07 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.517 -1.433 . . . . 1.0 109.517 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -122.54 -64.45 1.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -1.119 . . . . 1.0 109.42 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.89 149.2 52.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 1.0 109.429 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 139' ' ' ASP . 24.6 p-10 -59.84 155.28 16.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.953 . . . . 1.0 109.448 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 141' ' ' GLY . 1.0 OUTLIER -119.18 -69.2 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.199 -0.938 . . . . 1.0 108.856 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 140' ' ' ILE . . . -115.09 -147.99 9.36 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.588 -1.405 . . . . 1.0 109.588 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.97 -85.62 0.56 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -1.135 . . . . 1.0 109.506 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.401 ' O ' ' CG ' ' A' ' 143' ' ' LYS . 0.0 OUTLIER -87.85 73.09 9.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.278 -0.889 . . . . 1.0 109.525 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -59.94 128.51 37.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 1.0 109.348 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.11 53.42 0.34 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.092 -1.005 . . . . 1.0 109.828 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.476 ' HD2' ' O ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -101.98 158.85 15.84 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.103 -0.998 . . . . 1.0 109.374 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.44 ' O ' ' HG2' ' A' ' 148' ' ' ARG . 2.2 m -141.49 165.33 18.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.437 -0.79 . . . . 1.0 109.147 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.994 ' HG3' ' HB3' ' A' ' 68' ' ' ALA . 20.7 mmm-85 -150.31 119.0 6.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.074 -1.017 . . . . 1.0 109.865 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.96 HD12 HD11 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -79.82 120.25 23.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.292 -0.88 . . . . 1.0 109.278 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 47.4 t -96.74 126.15 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.263 -0.898 . . . . 1.0 109.535 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.971 ' CE1' HD13 ' A' ' 63' ' ' LEU . 3.1 m-85 -127.71 118.3 23.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.849 . . . . 1.0 109.062 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 1.9 ptm180 -150.33 141.17 22.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.131 -0.98 . . . . 1.0 109.977 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.635 ' CG1' HD11 ' A' ' 163' ' ' LEU . 8.8 p -117.32 128.46 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.683 -0.858 . . . . 1.0 108.683 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.452 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 55.1 m-70 -121.69 115.13 22.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.139 -0.975 . . . . 1.0 110.329 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.597 ' HB ' HD23 ' A' ' 163' ' ' LEU . 13.9 p -99.66 141.93 23.69 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.901 -0.778 . . . . 1.0 108.901 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.534 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 32.8 Cg_endo -75.16 114.52 4.03 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.065 1.843 . . . . 1.0 110.357 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.674 ' HG3' HG21 ' A' ' 162' ' ' THR . 3.9 mm-40 -133.41 168.33 18.45 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.553 -0.717 . . . . 1.0 109.069 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.465 ' HD2' ' CD ' ' A' ' 157' ' ' GLN . 34.4 Cg_endo -77.0 -64.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.259 1.973 . . . . 1.0 110.249 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.4 m -62.1 -58.05 9.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.935 . . . . 1.0 109.245 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 124.55 -36.19 2.96 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.738 -1.345 . . . . 1.0 109.738 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -79.14 80.04 5.51 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.498 -1.001 . . . . 1.0 108.312 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.674 HG21 ' HG3' ' A' ' 157' ' ' GLN . 1.3 m -140.54 -74.18 0.34 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.958 -0.756 . . . . 1.0 108.958 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.635 HD11 ' CG1' ' A' ' 153' ' ' VAL . 7.8 tp -142.25 97.62 3.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.09 -1.006 . . . . 1.0 108.644 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.452 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.2 OUTLIER -163.11 87.14 0.55 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.071 -1.018 . . . . 1.0 109.245 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.778 ' H ' HD23 ' A' ' 165' ' ' LEU . 1.8 pt? -132.31 170.78 14.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -0.956 . . . . 1.0 109.805 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.472 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 5.8 tt0 -117.44 157.44 26.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.327 -0.858 . . . . 1.0 109.498 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.57 ' O ' HG12 ' A' ' 167' ' ' VAL . 48.3 t -149.32 81.87 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 1.0 109.653 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 149' ' ' LEU . . . -90.8 103.46 16.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.198 -0.939 . . . . 1.0 109.354 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 170' ' ' ASN . 0.0 OUTLIER -120.07 136.5 54.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -0.967 . . . . 1.0 109.657 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.652 HD21 HD23 ' A' ' 149' ' ' LEU . 1.8 m-20 163.27 85.5 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 1.0 109.383 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.91 72.24 6.24 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.461 2.107 . . . . 1.0 110.574 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 146' ' ' ARG . 12.3 mt -126.71 134.44 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 1.0 109.284 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -156.0 125.1 6.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 1.0 109.631 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 1.3 m -95.37 -173.8 3.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 1.0 109.491 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 4.9 p 63.28 159.11 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 1.0 109.659 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 177' ' ' ARG . 0.3 OUTLIER 61.06 45.57 9.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 1.0 109.627 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 176' ' ' GLN . 0.0 OUTLIER 48.18 -176.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -0.9 . . . . 1.0 109.483 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.973 -1.013 . . . . 1.0 109.457 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.459 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -160.66 151.08 18.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.186 -0.946 . . . . 1.0 109.428 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 2' ' ' LYS . 0.3 OUTLIER 74.13 -162.62 0.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.29 -0.882 . . . . 1.0 109.525 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.44 ' CG ' ' N ' ' A' ' 5' ' ' GLN . 52.4 p-90 -103.73 -46.2 4.58 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.309 -0.869 . . . . 1.0 109.538 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.456 ' C ' ' HD3' ' A' ' 7' ' ' PRO . 0.3 OUTLIER 172.94 85.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 1.0 109.483 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.513 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 1.2 mt -133.05 60.82 52.06 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.326 -0.858 . . . . 1.0 109.411 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' A' ' 6' ' ' LEU . 35.6 Cg_endo -78.18 106.81 2.21 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.399 2.066 . . . . 1.0 110.46 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.6 p -139.16 41.1 2.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.241 -0.912 . . . . 1.0 109.47 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -140.2 132.55 28.36 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.33 -0.856 . . . . 1.0 109.511 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.4 t -120.44 128.72 53.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 1.0 109.507 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.25 146.15 7.38 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.48 -1.448 . . . . 1.0 109.48 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.3 -91.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.389 2.059 . . . . 1.0 110.381 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.66 ' CE2' ' CD1' ' A' ' 53' ' ' TYR . 3.6 m-30 -58.36 145.06 39.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.167 -0.958 . . . . 1.0 109.215 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.657 ' HA ' HD11 ' A' ' 165' ' ' LEU . 53.1 tt0 179.48 142.96 0.14 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.148 -0.97 . . . . 1.0 109.271 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 151' ' ' PHE . 0.9 OUTLIER -98.79 116.8 31.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.339 -0.851 . . . . 1.0 109.213 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -110.76 132.84 53.85 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.338 -0.851 . . . . 1.0 109.916 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 47' ' ' ILE . 1.1 mp -60.83 143.36 14.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.358 -0.979 . . . . 1.0 108.358 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -71.96 -54.23 10.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 1.0 109.676 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.562 HG12 ' HD3' ' A' ' 21' ' ' PRO . 30.5 t -120.33 133.61 66.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.239 -0.913 . . . . 1.0 109.61 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.559 ' OE1' HG21 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -127.0 76.24 76.1 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.214 -0.929 . . . . 1.0 109.429 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.562 ' HD3' HG12 ' A' ' 19' ' ' VAL . 35.5 Cg_endo -77.69 -175.71 2.83 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.511 2.141 . . . . 1.0 110.51 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -43.46 131.08 5.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.451 -0.781 . . . . 1.0 109.406 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 23' ' ' SER . 7.9 t -112.86 40.07 2.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.189 -0.944 . . . . 1.0 109.841 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.881 ' HA ' HG23 ' A' ' 172' ' ' ILE . 8.3 p-80 -103.04 166.16 10.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.05 -1.031 . . . . 1.0 109.505 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.67 ' NE2' HD11 ' A' ' 123' ' ' ILE . 1.0 OUTLIER -154.49 89.83 1.29 Allowed 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.901 -0.72 . . . . 1.0 109.674 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.42 72.63 10.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.307 -0.871 . . . . 1.0 109.138 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.636 ' HB2' HD12 ' A' ' 123' ' ' ILE . . . -70.66 148.95 47.5 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.471 -0.768 . . . . 1.0 109.811 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -69.76 146.54 51.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.289 -0.882 . . . . 1.0 109.341 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.479 ' HB2' ' HA ' ' A' ' 176' ' ' GLN . 78.6 m-85 -132.35 86.57 2.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 1.0 109.504 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER 169.62 -157.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -0.924 . . . . 1.0 109.459 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.7 t -122.32 34.69 5.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 1.0 109.496 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.47 ' HG3' ' N ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -122.83 -27.2 4.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.348 -0.845 . . . . 1.0 109.601 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.47 ' N ' ' HG3' ' A' ' 32' ' ' GLU . . . -68.92 133.59 26.98 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.624 -1.391 . . . . 1.0 109.624 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.08 -67.58 0.85 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -1.122 . . . . 1.0 109.447 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.0 mmt85 -76.62 88.11 3.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 1.0 109.342 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -110.7 121.95 6.05 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.637 -1.385 . . . . 1.0 109.637 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -173.25 175.13 3.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -1.186 . . . . 1.0 109.751 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.578 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 2.4 p -89.67 119.23 36.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.539 -0.725 . . . . 1.0 109.269 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -155.18 105.37 2.51 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -0.936 . . . . 1.0 109.577 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.51 -88.29 0.54 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 1.0 109.449 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 p -114.97 -92.2 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 1.0 109.652 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.27 -69.45 0.12 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 1.0 109.457 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -167.25 26.68 0.15 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.522 -1.431 . . . . 1.0 109.522 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.502 ' HA3' ' CG2' ' A' ' 38' ' ' VAL . . . 112.34 -59.5 0.37 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.487 ' HB3' ' HD2' ' A' ' 46' ' ' PRO . 13.1 m-70 -104.64 161.03 24.06 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.307 -1.113 . . . . 1.0 109.472 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 45' ' ' HIS . 35.4 Cg_endo -78.0 -179.59 5.59 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.505 2.136 . . . . 1.0 110.512 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.15 HG23 HG12 ' A' ' 117' ' ' VAL . 2.5 mm -94.11 156.64 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.374 -0.829 . . . . 1.0 109.075 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.606 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 10.8 t -129.31 141.76 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.112 -0.992 . . . . 1.0 110.117 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.468 ' HB2' ' HG3' ' A' ' 115' ' ' ARG . 39.5 tt0 -160.4 147.06 15.65 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.4 HD13 ' OE2' ' A' ' 111' ' ' GLU . 0.6 OUTLIER -78.5 148.13 33.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.886 -1.134 . . . . 1.0 109.617 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -140.14 77.65 1.62 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.445 -0.785 . . . . 1.0 109.37 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 163.87 -109.97 0.4 Allowed Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.455 -1.355 . . . . 1.0 110.476 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.66 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 1.5 t80 -39.18 141.22 0.34 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.826 -0.808 . . . . 1.0 110.178 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.591 HD12 ' O ' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -136.62 46.67 2.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.331 -0.856 . . . . 1.0 109.492 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.596 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 1.2 tt0 -87.25 145.41 26.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 1.0 109.331 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -85.62 49.98 1.87 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.202 -0.936 . . . . 1.0 109.853 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.419 ' HG3' ' CD ' ' A' ' 55' ' ' GLU . 47.3 mm-40 -122.36 153.54 62.06 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 1.0 109.432 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.997 ' O ' HD23 ' A' ' 59' ' ' LEU . 35.3 Cg_endo -78.11 131.03 10.62 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.521 2.148 . . . . 1.0 110.462 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.017 HD22 HG23 ' A' ' 155' ' ' VAL . 4.3 mt -128.14 163.02 25.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 1.0 109.16 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.447 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 4.4 ptt? -110.48 138.72 46.5 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.238 -0.914 . . . . 1.0 109.771 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.605 HD22 HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -91.71 147.44 22.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.413 -0.804 . . . . 1.0 109.391 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.455 ' O ' ' HG2' ' A' ' 152' ' ' ARG . 0.9 OUTLIER -124.48 77.6 1.59 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.307 -0.871 . . . . 1.0 109.041 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.966 HD22 ' CE1' ' A' ' 151' ' ' PHE . 0.5 OUTLIER -125.64 156.89 38.52 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.205 -0.934 . . . . 1.0 109.842 -179.569 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.864 ' HB3' HG12 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -166.16 -164.93 0.73 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.38 -0.97 . . . . 1.0 108.38 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.785 HD12 ' CD2' ' A' ' 149' ' ' LEU . 0.5 OUTLIER -117.56 112.51 39.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.889 -1.132 . . . . 1.0 108.53 178.656 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.8 147.31 16.8 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.829 -1.308 . . . . 1.0 109.829 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.933 HG22 ' CD2' ' A' ' 76' ' ' HIS . 4.7 p -83.26 134.02 34.96 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.476 -1.014 . . . . 1.0 109.404 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.14 121.28 3.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.218 -0.926 . . . . 1.0 109.371 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.513 ' OD2' HD21 ' A' ' 72' ' ' LEU . 3.1 p30 -84.84 -26.52 27.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.9 . . . . 1.0 109.503 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.96 -38.75 0.34 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 1.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' LEU . 2.7 ttm180 -168.96 -35.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.121 -0.987 . . . . 1.0 109.674 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.572 ' H ' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -44.06 94.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 1.0 109.701 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -80.17 136.36 36.48 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.222 -0.924 . . . . 1.0 109.623 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -157.83 166.48 16.47 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.285 -0.884 . . . . 1.0 109.136 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.943 ' HB3' HG23 ' A' ' 101' ' ' THR . 33.4 Cg_endo -75.47 137.26 20.49 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.147 1.898 . . . . 1.0 110.223 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.995 ' NE2' HG12 ' A' ' 147' ' ' VAL . 0.3 OUTLIER -65.27 157.53 28.74 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.29 -0.882 . . . . 1.0 109.848 -179.529 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.3 -58.88 2.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.299 -0.876 . . . . 1.0 109.467 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.575 ' CD1' ' CD2' ' A' ' 126' ' ' LEU . 2.3 m-85 -128.31 2.86 5.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.203 -0.936 . . . . 1.0 109.794 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.579 ' HB2' ' CD2' ' A' ' 76' ' ' HIS . 5.7 m-85 -100.72 76.15 1.78 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.13 -0.981 . . . . 1.0 109.414 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.512 ' HB2' ' CB ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -141.97 8.68 1.89 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 1.0 110.002 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.892 HG11 HD23 ' A' ' 124' ' ' LEU . 10.2 m -67.64 143.69 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.034 -1.041 . . . . 1.0 109.52 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.527 ' ND1' ' HB2' ' A' ' 121' ' ' ALA . 0.3 OUTLIER -175.48 107.23 0.09 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.47 -0.769 . . . . 1.0 109.438 179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -144.8 142.84 30.3 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.165 -0.96 . . . . 1.0 109.711 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.742 HD12 ' N ' ' A' ' 84' ' ' ILE . 4.1 mp -101.01 158.98 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.349 -0.844 . . . . 1.0 109.196 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.434 ' N ' HG22 ' A' ' 84' ' ' ILE . 23.8 p -99.93 -105.17 0.22 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.149 -0.969 . . . . 1.0 109.275 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 85' ' ' THR . . . -44.51 109.14 0.24 Allowed Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.716 -1.353 . . . . 1.0 109.716 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.1 tptt -74.58 82.34 2.01 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.104 -1.233 . . . . 1.0 109.417 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.55 44.85 0.46 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.302 -0.874 . . . . 1.0 109.579 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.57 HG22 ' H ' ' A' ' 90' ' ' SER . 8.7 p -86.98 171.93 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.255 -0.903 . . . . 1.0 109.402 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.57 ' H ' HG22 ' A' ' 89' ' ' VAL . 1.5 t -86.85 -30.16 21.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 1.0 109.561 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.657 HG23 ' HG ' ' A' ' 108' ' ' LEU . 11.5 m -108.57 105.06 14.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.328 -0.857 . . . . 1.0 109.505 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.517 ' O ' HG23 ' A' ' 106' ' ' ILE . 6.9 m -52.63 157.46 1.56 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 1.0 109.338 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.664 ' HB3' HD12 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -140.69 174.99 9.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 1.0 109.917 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -152.41 160.77 43.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.479 -0.763 . . . . 1.0 109.505 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.16 148.69 52.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.139 -0.976 . . . . 1.0 109.668 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.521 ' O ' HG23 ' A' ' 103' ' ' VAL . . . -158.66 121.14 3.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 1.0 109.571 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.444 HD12 ' C ' ' A' ' 101' ' ' THR . 2.7 tp -107.44 141.06 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 1.0 109.412 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.516 ' O ' ' CB ' ' A' ' 99' ' ' SER . 0.5 OUTLIER -132.9 50.33 2.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 1.0 109.511 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 1.6 m 77.75 108.03 0.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.454 -0.779 . . . . 1.0 109.748 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.616 ' ND2' ' O ' ' A' ' 100' ' ' ASN . 2.1 p-10 44.25 41.28 4.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.493 -0.754 . . . . 1.0 110.364 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.943 HG23 ' HB3' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -158.91 79.32 0.77 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.971 -1.08 . . . . 1.0 109.77 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.512 ' CB ' ' HB2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -82.09 119.14 23.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.944 . . . . 1.0 109.131 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.864 HG12 ' HB3' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -122.41 161.18 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.214 -0.929 . . . . 1.0 109.528 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.92 HD11 HD11 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -129.67 121.9 27.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.463 -0.773 . . . . 1.0 109.388 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.826 ' O ' HD13 ' A' ' 106' ' ' ILE . 0.7 OUTLIER -99.59 139.47 35.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 1.0 109.28 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.826 HD13 ' O ' ' A' ' 105' ' ' GLU . 2.9 mm -133.12 96.71 17.27 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 1.0 109.956 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.867 ' O ' HD22 ' A' ' 108' ' ' LEU . 34.7 Cg_endo -76.25 108.19 2.62 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.349 2.033 . . . . 1.0 109.738 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.867 HD22 ' O ' ' A' ' 107' ' ' PRO . 0.4 OUTLIER -144.56 165.48 27.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 1.0 110.247 -179.195 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.517 HD12 HD21 ' A' ' 112' ' ' ASN . 0.8 OUTLIER -131.6 66.71 78.82 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.489 -0.757 . . . . 1.0 109.205 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.523 ' HB3' ' CG ' ' A' ' 114' ' ' MET . 36.7 Cg_endo -81.06 42.33 1.32 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.652 2.235 . . . . 1.0 110.635 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.516 ' CB ' ' O ' ' A' ' 55' ' ' GLU . 1.5 mp0 -93.83 -0.35 55.83 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.023 -1.048 . . . . 1.0 109.665 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.517 HD21 HD12 ' A' ' 109' ' ' LEU . 0.6 OUTLIER -108.24 -51.82 2.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.107 -0.996 . . . . 1.0 109.278 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.3 OUTLIER 164.79 97.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 1.0 109.237 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.646 ' CE ' HD12 ' A' ' 108' ' ' LEU . 5.4 ptm -162.39 133.46 5.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.146 -0.972 . . . . 1.0 109.972 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.497 ' NH1' HG21 ' A' ' 47' ' ' ILE . 14.2 ttp180 -112.25 131.85 55.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.205 -0.935 . . . . 1.0 109.21 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.533 ' HB2' ' OG1' ' A' ' 91' ' ' THR . . . -120.54 117.28 27.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 1.0 109.512 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 1.15 HG12 HG23 ' A' ' 47' ' ' ILE . 5.1 m -92.83 135.8 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.296 -0.878 . . . . 1.0 109.371 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 45' ' ' HIS . 7.8 mt -112.75 116.52 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.216 -0.927 . . . . 1.0 109.549 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 17.3 p30 -156.88 52.35 0.5 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 1.0 109.477 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.486 ' HB3' HG13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -135.54 53.5 1.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -0.872 . . . . 1.0 109.5 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.527 ' HB2' ' ND1' ' A' ' 82' ' ' HIS . . . -139.84 175.95 9.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.842 . . . . 1.0 109.338 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.872 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -143.69 -178.04 19.12 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.376 -1.49 . . . . 1.0 109.376 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.67 HD11 ' NE2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -117.75 158.73 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.177 -1.19 . . . . 1.0 109.131 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.892 HD23 HG11 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -123.57 147.69 47.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 1.0 109.425 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.546 ' H ' HD13 ' A' ' 124' ' ' LEU . 1.7 ttpm? -116.83 154.88 29.96 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.238 -0.914 . . . . 1.0 109.425 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.575 ' CD2' ' CD1' ' A' ' 78' ' ' PHE . 14.8 mt -79.85 125.58 29.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -0.882 . . . . 1.0 109.354 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.72 -41.06 79.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 1.0 109.599 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.493 ' O ' ' CB ' ' A' ' 129' ' ' SER . 14.0 p30 -179.95 -165.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 1.0 109.547 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 128' ' ' ASN . 1.5 p 74.55 -152.87 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 1.0 109.518 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.49 ' N ' ' OG ' ' A' ' 129' ' ' SER . 2.3 t70 -179.7 66.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 1.0 109.405 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.529 HG12 ' CD2' ' A' ' 133' ' ' LEU . 1.5 tt -67.08 151.32 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.311 -0.868 . . . . 1.0 109.504 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -122.85 92.45 3.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.888 . . . . 1.0 109.393 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.529 ' CD2' HG12 ' A' ' 131' ' ' ILE . 1.6 mm? -87.86 16.98 5.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.369 -0.832 . . . . 1.0 109.558 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.487 ' HB2' ' NH2' ' A' ' 134' ' ' ARG . 0.0 OUTLIER 174.94 88.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.202 -0.936 . . . . 1.0 109.477 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -170.79 104.4 0.25 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.261 -0.899 . . . . 1.0 109.533 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.93 -65.62 2.24 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.487 -1.445 . . . . 1.0 109.487 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 137' ' ' GLU . 11.8 pt-20 -110.88 120.02 41.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -1.13 . . . . 1.0 109.48 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.414 ' H ' HG22 ' A' ' 138' ' ' THR . 0.7 OUTLIER -85.28 127.41 34.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 1.0 109.512 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 140' ' ' ILE . 0.7 OUTLIER -71.42 -76.84 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.279 -0.888 . . . . 1.0 109.448 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 139' ' ' ASP . 7.2 pt -153.34 20.62 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.166 -0.958 . . . . 1.0 109.585 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 158.46 -167.4 34.55 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.666 -1.374 . . . . 1.0 109.666 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -154.96 151.68 28.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.354 -1.086 . . . . 1.0 109.308 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -148.25 139.89 23.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.183 -0.948 . . . . 1.0 109.822 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 174' ' ' CYS . 73.7 m-80 -109.72 107.5 17.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.33 -0.856 . . . . 1.0 109.192 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.743 HG22 ' C ' ' A' ' 174' ' ' CYS . 74.8 p -148.19 43.85 1.05 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.292 -0.963 . . . . 1.0 110.354 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.522 ' O ' ' CD ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -157.13 124.39 5.23 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.381 -0.824 . . . . 1.0 110.204 179.37 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.995 HG12 ' NE2' ' A' ' 76' ' ' HIS . 13.9 m -137.48 165.55 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.248 -0.907 . . . . 1.0 108.803 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 170' ' ' ASN . 0.0 OUTLIER -155.46 139.14 16.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.054 -1.029 . . . . 1.0 110.14 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.785 ' CD2' HD12 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -99.75 101.01 12.04 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.385 -0.822 . . . . 1.0 108.875 179.405 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 21.5 t -77.16 140.88 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.933 . . . . 1.0 109.692 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.966 ' CE1' HD22 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -136.66 111.16 8.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.277 -0.89 . . . . 1.0 109.484 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.508 ' HD3' ' NE2' ' A' ' 166' ' ' GLN . 12.6 ptt180 -144.22 133.16 22.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.884 -1.135 . . . . 1.0 109.922 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.512 ' CG1' HD11 ' A' ' 163' ' ' LEU . 12.3 p -109.53 127.89 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.53 -0.915 . . . . 1.0 108.53 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.551 ' CD2' ' HB2' ' A' ' 164' ' ' SER . 39.4 m80 -123.17 114.1 19.84 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.199 -0.938 . . . . 1.0 110.132 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 1.017 HG23 HD22 ' A' ' 59' ' ' LEU . 11.4 p -99.4 141.12 22.27 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.242 -0.911 . . . . 1.0 108.938 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.519 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 33.9 Cg_endo -75.93 117.0 4.56 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.294 1.996 . . . . 1.0 110.561 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.536 ' NE2' ' HD2' ' A' ' 158' ' ' PRO . 4.1 mm100 -154.83 168.92 11.07 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.312 -0.867 . . . . 1.0 109.116 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.536 ' HD2' ' NE2' ' A' ' 157' ' ' GLN . 34.4 Cg_endo -77.2 -65.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.326 2.017 . . . . 1.0 110.25 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.4 104.54 0.79 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.193 -0.942 . . . . 1.0 109.191 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -46.45 -28.1 3.22 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.465 -1.454 . . . . 1.0 109.465 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.4 mtt-85 -79.22 79.64 5.63 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.37 -1.076 . . . . 1.0 108.259 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.811 HG22 ' N ' ' A' ' 163' ' ' LEU . 1.3 m -140.04 -90.04 0.18 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.441 -0.787 . . . . 1.0 109.15 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.811 ' N ' HG22 ' A' ' 162' ' ' THR . 8.9 tp -140.34 97.9 3.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.958 -1.089 . . . . 1.0 108.986 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.551 ' HB2' ' CD2' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -163.3 94.81 0.82 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.084 -1.01 . . . . 1.0 109.408 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.778 ' N ' HD23 ' A' ' 165' ' ' LEU . 1.8 pt? -138.37 175.32 9.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 1.0 109.984 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.508 ' NE2' ' HD3' ' A' ' 152' ' ' ARG . 0.7 OUTLIER -119.22 161.84 19.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.434 -0.791 . . . . 1.0 109.843 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.7 HG12 ' O ' ' A' ' 167' ' ' VAL . 41.5 t -151.74 74.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.448 -0.782 . . . . 1.0 109.036 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' A' ' 148' ' ' ARG . . . -89.48 102.86 15.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.093 -1.004 . . . . 1.0 109.104 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 t -143.41 88.68 2.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.917 . . . . 1.0 110.057 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.529 ' N ' ' HD3' ' A' ' 171' ' ' PRO . 1.1 m-20 -179.69 60.6 0.11 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 1.0 109.341 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 170' ' ' ASN . 36.4 Cg_endo -78.67 96.91 1.1 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.383 2.056 . . . . 1.0 111.011 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.881 HG23 ' HA ' ' A' ' 24' ' ' HIS . 1.6 mt -101.53 147.05 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.166 -0.959 . . . . 1.0 108.679 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.56 119.6 37.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.088 -1.007 . . . . 1.0 110.132 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.743 ' C ' HG22 ' A' ' 145' ' ' THR . 2.8 m -95.06 -167.71 1.68 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.9 -1.148 . . . . 1.0 107.9 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.584 ' N ' HG22 ' A' ' 145' ' ' THR . 3.3 p 165.18 -94.78 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.215 -0.928 . . . . 1.0 109.837 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.506 ' CG ' ' O ' ' A' ' 175' ' ' SER . 31.5 mt-30 -157.74 -150.63 0.27 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.961 -1.087 . . . . 1.0 109.491 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.415 ' CG ' ' O ' ' A' ' 176' ' ' GLN . 0.8 OUTLIER -177.3 83.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.327 -0.858 . . . . 1.0 109.512 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.995 -1.002 . . . . 1.0 109.409 -179.955 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.248 0.547 . . . . 1.0 109.555 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.474 ' HB2' HD12 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -79.75 -179.72 7.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.18 -0.95 . . . . 1.0 109.426 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -133.35 -91.7 0.36 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 1.0 109.349 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.611 ' CD1' ' N ' ' A' ' 5' ' ' GLN . 40.1 p90 -87.06 -45.68 10.51 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.248 -0.908 . . . . 1.0 109.569 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.611 ' N ' ' CD1' ' A' ' 4' ' ' TRP . 0.6 OUTLIER -178.95 77.35 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.234 -0.916 . . . . 1.0 109.515 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.789 ' C ' HD22 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -64.48 160.63 49.95 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.27 -0.894 . . . . 1.0 109.96 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.489 ' HD2' ' HB2' ' A' ' 6' ' ' LEU . 35.7 Cg_endo -78.92 124.55 6.2 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.303 2.002 . . . . 1.0 110.366 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.0 p -129.33 45.81 2.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 1.0 109.501 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.507 ' O ' ' CB ' ' A' ' 10' ' ' SER . 6.7 p80 -99.92 157.88 16.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.926 . . . . 1.0 109.328 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 9' ' ' HIS . 4.3 t 75.36 83.94 0.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 1.0 109.354 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.31 -87.2 0.06 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.76 -1.336 . . . . 1.0 109.76 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.29 172.04 16.01 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.501 2.134 . . . . 1.0 110.613 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.576 ' CZ ' ' O ' ' A' ' 162' ' ' THR . 5.8 m-85 -67.82 152.11 46.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.872 . . . . 1.0 109.277 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.28 129.72 13.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.918 -1.114 . . . . 1.0 109.855 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.919 HD13 HD12 ' A' ' 50' ' ' LEU . 58.4 tp -121.04 75.02 1.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.42 155.27 33.82 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.44 -0.787 . . . . 1.0 109.982 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.542 HG21 ' NE2' ' A' ' 20' ' ' GLN . 0.6 OUTLIER -66.81 145.8 13.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.532 -0.914 . . . . 1.0 108.532 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.637 ' HG3' HG23 ' A' ' 19' ' ' VAL . 3.8 tp10 -72.51 -53.52 11.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 1.0 109.749 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.637 HG23 ' HG3' ' A' ' 18' ' ' GLU . 21.7 t -127.99 142.04 44.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.262 -0.899 . . . . 1.0 109.618 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.542 ' NE2' HG21 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -120.58 82.49 33.36 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 1.0 109.354 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 22' ' ' LYS . 35.0 Cg_endo -77.72 -177.53 3.92 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.436 2.09 . . . . 1.0 110.376 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 21' ' ' PRO . 12.7 mttt -43.86 112.69 0.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.37 -0.831 . . . . 1.0 109.227 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.546 ' HB3' ' CG ' ' A' ' 171' ' ' PRO . 2.1 t -110.24 29.64 7.48 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.198 -0.939 . . . . 1.0 109.89 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 7.8 p-80 -103.21 165.9 10.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 1.0 109.476 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.63 ' CD2' ' HA ' ' A' ' 38' ' ' VAL . 24.4 t-80 -157.21 118.07 3.6 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.516 -0.74 . . . . 1.0 109.894 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.441 ' O ' ' HD2' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -90.98 89.17 7.32 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.408 -0.807 . . . . 1.0 108.881 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' A' ' 28' ' ' HIS . . . -54.49 118.5 4.21 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.172 -0.955 . . . . 1.0 109.395 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.412 ' C ' ' O ' ' A' ' 27' ' ' ALA . 3.1 m-70 -42.21 156.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.421 -0.799 . . . . 1.0 109.946 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.427 ' O ' ' C ' ' A' ' 30' ' ' GLU . 76.8 m-85 -132.65 -92.77 0.37 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.373 -0.83 . . . . 1.0 109.219 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 29' ' ' TYR . 1.1 mt-10 42.89 -154.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.271 -0.893 . . . . 1.0 109.757 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.6 p -144.09 35.47 1.23 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.36 -0.837 . . . . 1.0 109.316 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.12 72.9 1.52 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.341 -0.85 . . . . 1.0 109.473 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.07 120.97 0.03 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.55 -1.42 . . . . 1.0 109.55 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.4 m -69.85 -87.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -1.166 . . . . 1.0 109.463 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.29 -168.61 0.16 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.949 . . . . 1.0 109.465 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.43 147.09 17.42 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.496 -1.441 . . . . 1.0 109.496 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.49 171.4 14.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -1.195 . . . . 1.0 109.665 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.63 ' HA ' ' CD2' ' A' ' 25' ' ' HIS . 1.7 p -73.33 121.49 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.418 -0.801 . . . . 1.0 109.372 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -153.23 110.58 3.51 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.307 -0.871 . . . . 1.0 109.506 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 44' ' ' GLY . . . -165.17 150.31 9.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.373 -0.829 . . . . 1.0 109.563 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 40' ' ' ALA . 80.6 p 43.78 -118.08 0.55 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 1.0 109.39 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.6 57.47 4.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.304 -1.498 . . . . 1.0 109.524 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.46 ' HA3' ' HB2' ' A' ' 119' ' ' ASP . . . 88.25 -19.14 36.96 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.568 -1.413 . . . . 1.0 109.568 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 40' ' ' ALA . . . 116.41 -71.03 0.27 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.582 -1.407 . . . . 1.0 109.582 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 21.9 m80 -60.11 154.25 51.88 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.249 -1.148 . . . . 1.0 109.578 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.419 ' HB2' HG21 ' A' ' 17' ' ' ILE . 35.5 Cg_endo -78.09 178.7 7.27 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.492 2.128 . . . . 1.0 110.472 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.774 HG23 HG12 ' A' ' 117' ' ' VAL . 2.3 mm -94.53 160.87 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 1.0 109.266 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.8 t -135.81 127.3 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.234 -0.916 . . . . 1.0 109.732 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.501 ' NE2' ' HB2' ' A' ' 18' ' ' GLU . 14.2 pt20 -151.17 142.14 23.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.339 -0.851 . . . . 1.0 109.348 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.919 HD12 HD13 ' A' ' 15' ' ' LEU . 1.3 tt -98.62 138.99 35.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 1.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.78 76.23 1.54 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.169 -0.957 . . . . 1.0 109.331 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 171.05 96.03 0.1 Allowed Glycine 0 N--CA 1.486 2.01 0 N-CA-C 110.038 -1.225 . . . . 1.0 110.038 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.634 ' CE2' ' CB ' ' A' ' 55' ' ' GLU . 6.2 t80 178.02 129.01 0.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -1.14 . . . . 1.0 109.425 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.92 13.74 32.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 1.0 109.394 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.634 ' CB ' ' CE2' ' A' ' 53' ' ' TYR . 0.7 OUTLIER -116.8 144.49 44.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 1.0 109.432 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.499 ' C ' HD11 ' A' ' 109' ' ' LEU . 5.9 p30 -101.83 50.85 0.84 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 1.0 109.472 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.916 ' C ' HD12 ' A' ' 109' ' ' LEU . 1.9 mp0 -108.89 146.0 32.88 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 1.0 109.458 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 1.011 ' O ' HD23 ' A' ' 59' ' ' LEU . 35.5 Cg_endo -77.96 145.99 22.8 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.441 2.094 . . . . 1.0 110.363 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.011 HD23 ' O ' ' A' ' 58' ' ' PRO . 7.4 mt -139.27 162.76 34.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.262 -0.898 . . . . 1.0 109.51 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -98.34 110.42 23.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.315 -0.866 . . . . 1.0 109.534 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.872 HD21 ' HB2' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -60.77 143.45 54.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.257 -0.902 . . . . 1.0 109.312 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.495 ' N ' ' HG ' ' A' ' 61' ' ' LEU . 6.3 mm-40 -105.21 80.38 1.59 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.189 -0.945 . . . . 1.0 109.718 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.935 HD13 ' CZ ' ' A' ' 151' ' ' PHE . 18.2 tp -99.94 121.43 41.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.303 -0.873 . . . . 1.0 109.129 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.632 ' HB2' HG12 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -143.43 146.84 33.79 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 -179.434 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.691 ' C ' HD13 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -109.23 115.63 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 1.0 108.779 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.645 ' N ' HD13 ' A' ' 65' ' ' ILE . . . -132.8 144.26 16.11 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.548 -1.311 . . . . 1.0 110.204 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.978 HG22 ' CD2' ' A' ' 76' ' ' HIS . 14.8 p -71.2 161.44 31.09 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.525 -0.985 . . . . 1.0 108.959 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 1.043 ' HB3' ' HG3' ' A' ' 148' ' ' ARG . . . -172.52 124.72 0.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.129 -0.982 . . . . 1.0 109.77 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.6 -13.42 24.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -0.881 . . . . 1.0 109.16 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -156.08 -67.34 0.11 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.352 -0.843 . . . . 1.0 109.357 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.553 ' CD ' ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -144.82 -39.18 0.26 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 1.0 109.67 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.553 ' N ' ' CD ' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -51.84 88.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.41 -0.806 . . . . 1.0 109.848 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 71' ' ' ARG . 2.3 pp -66.63 143.9 56.72 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.26 -0.9 . . . . 1.0 109.59 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.525 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -152.87 165.44 17.59 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.158 -0.964 . . . . 1.0 109.452 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.51 146.03 24.03 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.414 2.076 . . . . 1.0 110.211 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.978 ' CD2' HG22 ' A' ' 67' ' ' THR . 0.7 OUTLIER -76.87 160.54 29.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 1.0 109.656 -179.743 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.81 -67.09 0.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -0.866 . . . . 1.0 109.786 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.541 ' HB3' HD23 ' A' ' 126' ' ' LEU . 4.9 m-85 -130.83 23.56 4.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.163 -0.96 . . . . 1.0 109.934 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.578 ' HB2' ' CG ' ' A' ' 76' ' ' HIS . 4.8 m-85 -101.46 74.26 1.52 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.054 -1.029 . . . . 1.0 109.418 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.5 ' CB ' ' HB3' ' A' ' 102' ' ' LYS . 11.0 pt20 -139.49 7.46 2.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.163 -0.96 . . . . 1.0 109.669 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.957 HG23 ' O ' ' A' ' 122' ' ' GLY . 1.3 m -60.91 140.58 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.092 -1.005 . . . . 1.0 109.067 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.604 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 1.0 OUTLIER -176.3 114.05 0.11 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.092 -1.043 . . . . 1.0 109.791 -179.612 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.2 OUTLIER -136.74 126.32 25.29 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.215 -0.928 . . . . 1.0 109.557 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.674 HD12 ' N ' ' A' ' 84' ' ' ILE . 4.4 mp -99.68 137.43 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.256 -0.903 . . . . 1.0 109.628 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 86' ' ' GLY . 39.9 p -145.05 -149.27 0.27 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.403 -0.811 . . . . 1.0 109.137 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 85' ' ' THR . . . 42.1 -165.46 0.02 OUTLIER Glycine 0 N--CA 1.483 1.787 0 N-CA-C 110.083 -1.207 . . . . 1.0 110.083 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.61 68.54 3.42 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.239 -1.154 . . . . 1.0 109.541 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.8 -164.99 0.95 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 1.0 109.299 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.508 HG21 ' H ' ' A' ' 117' ' ' VAL . 1.7 t -66.08 123.54 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.207 -0.933 . . . . 1.0 109.035 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.5 m -165.53 31.64 0.05 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.499 -0.881 . . . . 1.0 109.668 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.409 HG23 ' N ' ' A' ' 92' ' ' THR . 9.8 t -64.96 -36.48 84.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.206 -0.934 . . . . 1.0 109.558 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.756 ' O ' HG23 ' A' ' 106' ' ' ILE . 58.4 m -163.17 135.91 5.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.199 -0.938 . . . . 1.0 109.587 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -168.39 169.13 10.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -0.882 . . . . 1.0 109.56 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -155.22 145.63 22.01 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.844 . . . . 1.0 109.51 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.515 ' OE1' ' NE2' ' A' ' 82' ' ' HIS . 8.0 tt0 -114.58 146.11 41.17 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.305 -0.872 . . . . 1.0 109.428 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -142.82 122.36 13.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 1.0 109.367 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.973 HD13 ' N ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -135.55 134.95 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.239 -0.913 . . . . 1.0 109.475 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.973 ' N ' HD13 ' A' ' 97' ' ' ILE . 0.7 OUTLIER -138.49 64.82 1.48 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.064 -1.023 . . . . 1.0 109.675 -179.628 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.462 ' O ' ' OD1' ' A' ' 100' ' ' ASN . 1.7 p 62.29 117.44 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.894 . . . . 1.0 109.586 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 99' ' ' SER . 3.7 p-10 44.46 37.03 1.87 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.622 -0.674 . . . . 1.0 110.715 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.482 ' HB ' ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -159.32 85.16 0.79 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.972 -1.08 . . . . 1.0 109.401 179.248 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.5 ' HB3' ' CB ' ' A' ' 80' ' ' GLN . 6.0 tptm -105.91 95.02 5.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.892 . . . . 1.0 109.727 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.632 HG12 ' HB2' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -96.49 171.4 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.326 -0.859 . . . . 1.0 108.963 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.885 HD22 ' N ' ' A' ' 105' ' ' GLU . 0.5 OUTLIER -139.91 122.81 16.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 1.0 109.351 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.885 ' N ' HD22 ' A' ' 104' ' ' LEU . 7.1 mm-40 -123.1 140.14 53.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.303 -0.873 . . . . 1.0 109.292 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.756 HG23 ' O ' ' A' ' 92' ' ' THR . 28.1 mt -129.03 107.31 18.02 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 1.0 109.528 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 60' ' ' MET . 34.6 Cg_endo -76.64 107.81 2.53 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.218 1.945 . . . . 1.0 110.35 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.66 HD23 ' O ' ' A' ' 106' ' ' ILE . 0.6 OUTLIER -146.0 165.18 29.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.876 . . . . 1.0 109.752 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.916 HD12 ' C ' ' A' ' 57' ' ' GLU . 3.5 tt -117.07 85.84 19.06 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.408 -0.807 . . . . 1.0 109.451 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.471 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 37.1 Cg_endo -81.84 30.53 0.52 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.711 2.274 . . . . 1.0 111.199 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.523 ' OE1' ' CB ' ' A' ' 53' ' ' TYR . 9.7 mm-40 -102.96 49.95 0.82 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.842 -1.161 . . . . 1.0 109.512 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 113' ' ' SER . 0.6 OUTLIER -161.78 -61.63 0.05 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.216 -0.928 . . . . 1.0 109.478 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 6.1 p 167.8 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.324 -0.86 . . . . 1.0 109.19 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -155.14 125.23 6.66 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.235 -0.915 . . . . 1.0 109.616 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.658 ' HD3' HG21 ' A' ' 47' ' ' ILE . 6.1 ttm180 -94.61 129.78 41.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 1.0 109.191 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.36 99.71 8.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.318 -0.864 . . . . 1.0 109.518 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.774 HG12 HG23 ' A' ' 47' ' ' ILE . 4.4 m -86.85 143.28 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 1.0 109.425 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.452 ' O ' ' HB2' ' A' ' 45' ' ' HIS . 2.7 mt -133.29 123.86 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.891 . . . . 1.0 109.552 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.46 ' HB2' ' HA3' ' A' ' 43' ' ' GLY . 8.3 p-10 -175.28 46.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 1.0 109.566 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 84' ' ' ILE . 9.9 m -132.95 43.45 2.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 1.0 109.565 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.604 ' HB2' ' HB2' ' A' ' 82' ' ' HIS . . . -134.42 128.29 33.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.253 -0.905 . . . . 1.0 109.13 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.957 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -93.51 -172.08 39.6 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.395 -1.482 . . . . 1.0 109.395 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.716 ' O ' HD12 ' A' ' 124' ' ' LEU . 0.6 OUTLIER -125.48 166.92 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.363 -1.081 . . . . 1.0 108.818 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.738 HD13 HG11 ' A' ' 81' ' ' VAL . 0.8 OUTLIER -140.94 164.45 30.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.905 . . . . 1.0 109.622 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.461 ' C ' HD13 ' A' ' 126' ' ' LEU . 41.6 mttt -147.49 97.04 2.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.383 -0.823 . . . . 1.0 109.096 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.857 HD22 ' N ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER -104.99 -165.67 1.15 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 1.0 109.753 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.513 ' HG3' ' N ' ' A' ' 128' ' ' ASN . 6.9 ptt180 -166.14 -147.69 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.407 -0.808 . . . . 1.0 109.172 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.513 ' N ' ' HG3' ' A' ' 127' ' ' ARG . 0.5 OUTLIER 64.3 57.1 1.24 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.127 -0.983 . . . . 1.0 109.578 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 66.4 p 178.95 -167.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 1.0 109.426 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.19 60.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 1.0 109.426 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.449 ' O ' ' CG1' ' A' ' 131' ' ' ILE . 0.3 OUTLIER -93.88 69.99 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.313 -0.867 . . . . 1.0 109.504 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.427 ' OE1' ' O ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -154.67 161.58 41.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.219 -0.925 . . . . 1.0 109.479 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.429 ' O ' ' HG2' ' A' ' 135' ' ' LYS . 0.4 OUTLIER -64.94 110.42 2.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -0.945 . . . . 1.0 109.481 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.93 119.3 8.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.28 -0.887 . . . . 1.0 109.48 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 133' ' ' LEU . 0.9 OUTLIER 173.99 174.77 0.16 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 1.0 109.437 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.58 125.34 28.49 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.601 -1.4 . . . . 1.0 109.601 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -111.53 16.53 20.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.252 -1.146 . . . . 1.0 109.445 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 20.3 p -100.17 139.63 35.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 1.0 109.445 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -153.81 -39.33 0.1 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.923 . . . . 1.0 109.402 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.867 ' H ' HD13 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -142.83 30.06 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.315 -0.865 . . . . 1.0 109.424 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 166.83 -132.07 2.52 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.563 -1.415 . . . . 1.0 109.563 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.9 ttm-85 -150.93 -41.71 0.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -1.161 . . . . 1.0 109.468 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -104.0 134.9 46.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 1.0 109.43 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -113.9 141.81 46.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 1.0 109.492 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.532 ' CB ' ' HB2' ' A' ' 174' ' ' CYS . 0.2 OUTLIER -157.59 53.02 0.47 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.245 -0.909 . . . . 1.0 109.394 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.46 ' HD2' ' O ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -105.04 157.38 17.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.886 . . . . 1.0 109.254 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.69 HG12 ' CD2' ' A' ' 76' ' ' HIS . 1.6 m -140.49 168.25 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.382 -0.823 . . . . 1.0 109.406 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 1.043 ' HG3' ' HB3' ' A' ' 68' ' ' ALA . 5.2 mmt180 -148.82 99.32 2.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 1.0 109.563 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.636 HD12 ' CD2' ' A' ' 151' ' ' PHE . 0.7 OUTLIER -79.77 115.93 19.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.104 -0.997 . . . . 1.0 108.889 179.635 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 168' ' ' ALA . 4.3 t -87.09 114.43 26.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.204 -0.935 . . . . 1.0 109.87 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.935 ' CZ ' HD13 ' A' ' 63' ' ' LEU . 1.6 m-85 -108.39 113.33 26.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 1.0 109.228 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.473 ' CB ' ' HA ' ' A' ' 166' ' ' GLN . 5.4 ptt180 -150.6 159.41 44.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.899 -1.126 . . . . 1.0 109.95 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 153' ' ' VAL . 10.4 p -143.41 128.51 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.281 -0.887 . . . . 1.0 108.659 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.62 ' CD2' ' HB2' ' A' ' 164' ' ' SER . 24.0 m80 -132.46 113.63 13.35 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.073 -1.017 . . . . 1.0 110.372 -179.077 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.551 HG11 ' HB3' ' A' ' 163' ' ' LEU . 12.6 p -99.04 141.85 23.6 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 108.556 -0.905 . . . . 1.0 108.556 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 32.0 Cg_endo -73.64 115.88 4.49 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.093 1.862 . . . . 1.0 110.881 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.468 ' HB2' ' HD2' ' A' ' 158' ' ' PRO . 1.6 pm0 -133.14 160.94 66.66 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 157' ' ' GLN . 34.9 Cg_endo -77.56 -66.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.305 2.003 . . . . 1.0 110.675 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.5 t -59.38 -93.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 1.0 109.621 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 171.38 -33.91 0.15 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.412 -1.475 . . . . 1.0 109.412 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -79.08 80.3 5.44 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.92 -1.141 . . . . 1.0 107.92 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.802 HG22 ' N ' ' A' ' 163' ' ' LEU . 1.3 m -138.9 -90.17 0.2 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.509 -0.744 . . . . 1.0 109.486 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.802 ' N ' HG22 ' A' ' 162' ' ' THR . 7.4 tp -146.96 109.19 4.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.58 -1.325 . . . . 1.0 109.615 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.62 ' HB2' ' CD2' ' A' ' 154' ' ' HIS . 0.0 OUTLIER -162.94 91.49 0.73 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.035 -1.041 . . . . 1.0 109.38 178.793 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.749 HD13 ' H ' ' A' ' 166' ' ' GLN . 0.2 OUTLIER -120.64 155.46 33.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.345 -0.847 . . . . 1.0 109.495 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.749 ' H ' HD13 ' A' ' 165' ' ' LEU . 3.5 tt0 -134.16 142.34 47.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.163 -0.96 . . . . 1.0 109.568 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 168' ' ' ALA . 46.3 t -146.07 161.28 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 1.0 109.398 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.517 ' N ' HG12 ' A' ' 167' ' ' VAL . . . -151.29 92.71 1.82 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.389 -0.82 . . . . 1.0 108.847 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.53 ' HB2' HD11 ' A' ' 149' ' ' LEU . 20.4 m -82.93 160.43 22.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.954 . . . . 1.0 109.632 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.53 ' N ' ' HD3' ' A' ' 171' ' ' PRO . 14.7 p-10 -174.51 63.04 0.25 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.162 -0.961 . . . . 1.0 110.059 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.546 ' CG ' ' HB3' ' A' ' 23' ' ' SER . 37.5 Cg_endo -83.23 52.04 3.81 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.477 2.118 . . . . 1.0 110.296 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 13.0 mt -151.06 128.02 2.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.456 -0.778 . . . . 1.0 109.534 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -155.86 102.29 2.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 1.0 109.362 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.532 ' HB2' ' CB ' ' A' ' 145' ' ' THR . 61.0 m -89.94 174.47 7.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 1.0 109.579 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 174' ' ' CYS . 5.9 p 178.89 -149.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 1.0 109.356 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -50.53 -22.58 2.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 1.0 109.506 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 23.7 ttt-85 -50.68 -76.06 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -0.872 . . . . 1.0 109.475 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.021 -0.99 . . . . 1.0 109.412 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.454 ' O ' ' O ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.226 0.536 . . . . 1.0 109.594 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' A' ' 1' ' ' MET . 0.1 OUTLIER 46.14 -170.16 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.175 -0.953 . . . . 1.0 109.241 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 2' ' ' LYS . 90.1 m-20 -135.45 -95.36 0.26 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.112 -0.992 . . . . 1.0 109.603 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.576 ' CE3' ' HB3' ' A' ' 5' ' ' GLN . 44.4 p-90 -115.27 -49.31 2.77 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.009 -1.057 . . . . 1.0 109.704 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.576 ' HB3' ' CE3' ' A' ' 4' ' ' TRP . 4.8 tt0 -179.22 75.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.122 -0.986 . . . . 1.0 109.634 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.773 ' C ' HD22 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -164.37 160.28 16.09 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 1.0 109.692 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 6' ' ' LEU . 36.0 Cg_endo -79.49 102.66 1.51 Allowed 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.438 2.092 . . . . 1.0 110.323 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.764 ' HB3' HD21 ' A' ' 6' ' ' LEU . 38.4 p -125.74 43.5 3.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 1.0 109.517 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -127.99 164.6 21.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 1.0 109.434 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 m -179.43 118.95 0.07 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.318 -0.864 . . . . 1.0 109.522 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.9 -144.87 1.07 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.425 -1.47 . . . . 1.0 109.425 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.52 -175.3 2.61 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.395 2.063 . . . . 1.0 110.293 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.518 ' HA ' ' HA3' ' A' ' 52' ' ' GLY . 3.6 m-85 -105.5 137.95 42.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.152 -0.967 . . . . 1.0 109.63 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.453 ' CG ' ' O ' ' A' ' 13' ' ' TYR . 1.6 mt-10 179.72 139.16 0.12 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 1.0 109.764 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.489 ' O ' ' CG ' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -99.87 98.82 9.57 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.291 -0.881 . . . . 1.0 109.055 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -99.96 155.14 17.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.191 -0.943 . . . . 1.0 109.768 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.942 HG21 ' NE2' ' A' ' 20' ' ' GLN . 12.7 mm -72.95 134.44 29.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.398 -0.813 . . . . 1.0 109.266 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.421 ' HB2' ' CD ' ' A' ' 49' ' ' GLN . 44.2 tt0 -68.89 -55.1 12.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.137 -0.977 . . . . 1.0 108.967 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.88 HG22 ' HD3' ' A' ' 21' ' ' PRO . 9.8 p -118.58 130.22 73.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.376 -0.827 . . . . 1.0 108.871 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.942 ' NE2' HG21 ' A' ' 17' ' ' ILE . 9.2 tp-100 -129.94 63.97 70.51 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.08 -1.012 . . . . 1.0 110.023 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.88 ' HD3' HG22 ' A' ' 19' ' ' VAL . 35.8 Cg_endo -78.44 -175.34 2.67 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.406 2.07 . . . . 1.0 109.88 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -48.45 94.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.917 . . . . 1.0 108.78 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 21' ' ' PRO . 1.4 p -94.02 40.24 1.08 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.25 -0.906 . . . . 1.0 110.252 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.475 ' HA ' HG12 ' A' ' 172' ' ' ILE . 0.0 OUTLIER -99.49 167.25 10.73 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.969 -1.082 . . . . 1.0 108.284 179.205 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.439 ' ND1' ' CD1' ' A' ' 123' ' ' ILE . 11.4 t-160 -133.7 134.03 42.57 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 119.341 -0.944 . . . . 1.0 110.068 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.481 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -106.1 75.73 1.12 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 179.356 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.57 ' O ' ' CE2' ' A' ' 29' ' ' TYR . . . -54.2 165.05 0.56 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.47 -0.769 . . . . 1.0 109.79 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.99 149.73 35.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.385 -0.822 . . . . 1.0 110.289 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.57 ' CE2' ' O ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -166.51 69.32 0.11 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER 78.37 28.1 0.49 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.553 -0.717 . . . . 1.0 109.397 -179.621 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 31' ' ' THR . 15.4 t -145.49 59.77 1.27 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 1.0 109.272 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.9 156.13 17.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 1.0 109.738 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.58 -35.73 0.03 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.516 -1.434 . . . . 1.0 109.516 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.09 149.28 34.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -1.123 . . . . 1.0 109.446 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 mmm-85 -75.07 121.85 22.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -0.893 . . . . 1.0 109.475 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.54 -134.97 3.2 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.571 -1.412 . . . . 1.0 109.571 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -179.04 171.85 1.33 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -1.155 . . . . 1.0 109.434 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.8 p -57.03 135.4 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 1.0 109.34 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.06 115.26 4.1 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.417 -0.802 . . . . 1.0 109.698 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 42' ' ' ALA . . . -156.5 114.84 3.33 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.509 -0.745 . . . . 1.0 109.548 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 50.91 -88.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.473 -0.767 . . . . 1.0 110.085 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 45' ' ' HIS . . . -85.03 46.25 1.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.099 -1.0 . . . . 1.0 109.832 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.39 9.32 42.62 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.887 -1.285 . . . . 1.0 109.887 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.401 ' N ' ' H ' ' A' ' 40' ' ' ALA . . . 135.71 -80.06 0.31 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.643 -1.383 . . . . 1.0 109.643 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.668 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 5.5 m-70 -88.36 157.53 50.15 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.317 -1.108 . . . . 1.0 109.672 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.458 ' HG3' ' OE1' ' A' ' 20' ' ' GLN . 35.8 Cg_endo -78.41 178.74 7.21 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.601 2.201 . . . . 1.0 110.528 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.951 ' CG2' HG12 ' A' ' 117' ' ' VAL . 5.0 mt -94.45 157.05 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.481 -0.762 . . . . 1.0 109.199 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.637 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 2.1 t -131.66 128.1 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.207 -0.933 . . . . 1.0 109.829 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.421 ' CD ' ' HB2' ' A' ' 18' ' ' GLU . 7.1 pt20 -140.95 138.17 33.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 1.0 109.353 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.479 ' HG ' ' HB3' ' A' ' 15' ' ' LEU . 2.7 tt -98.2 136.68 38.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 1.0 109.75 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.442 ' N ' HD23 ' A' ' 50' ' ' LEU . 5.7 p80 -140.52 97.98 3.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.333 -0.854 . . . . 1.0 109.16 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . -178.89 -86.5 0.07 OUTLIER Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.631 -1.271 . . . . 1.0 110.133 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.514 ' OH ' ' NE2' ' A' ' 157' ' ' GLN . 0.8 OUTLIER -38.37 121.86 1.03 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 122.1 -0.647 . . . . 1.0 110.345 -179.414 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.85 1.72 37.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.361 -0.837 . . . . 1.0 109.538 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.473 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -79.82 145.66 32.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.148 -0.97 . . . . 1.0 109.423 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -84.61 44.68 1.07 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 1.0 109.824 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.687 ' O ' HD23 ' A' ' 109' ' ' LEU . 5.1 mm-40 -99.23 150.59 36.86 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 1.0 109.304 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.992 ' O ' HD23 ' A' ' 59' ' ' LEU . 36.0 Cg_endo -77.68 139.48 17.95 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.306 2.004 . . . . 1.0 110.385 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.992 HD23 ' O ' ' A' ' 58' ' ' PRO . 5.8 mt -128.26 159.04 36.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 1.0 109.452 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.419 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.3 OUTLIER -121.31 107.84 13.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.133 -0.979 . . . . 1.0 109.519 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.645 HD21 ' HD1' ' A' ' 151' ' ' PHE . 0.3 OUTLIER -61.92 116.59 5.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.903 . . . . 1.0 109.543 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.437 ' O ' ' HG2' ' A' ' 152' ' ' ARG . 17.6 mm100 -94.99 78.18 3.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.12 -0.988 . . . . 1.0 109.067 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.835 HD22 ' CE1' ' A' ' 151' ' ' PHE . 0.6 OUTLIER -112.85 157.84 20.9 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.377 -0.827 . . . . 1.0 109.714 -179.598 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.888 ' O ' HD23 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -165.74 176.95 7.58 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 179.354 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.639 ' CD1' ' CE1' ' A' ' 76' ' ' HIS . 0.2 OUTLIER -114.75 118.6 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.109 -0.994 . . . . 1.0 108.862 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.44 150.28 19.64 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.611 -1.28 . . . . 1.0 110.06 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.933 HG22 ' CD2' ' A' ' 76' ' ' HIS . 0.6 OUTLIER -89.2 151.23 22.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.456 -1.026 . . . . 1.0 109.269 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.92 113.08 6.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.17 -0.956 . . . . 1.0 109.538 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' A' ' 144' ' ' ASN . 0.2 OUTLIER -85.2 -27.89 25.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.351 -0.843 . . . . 1.0 109.245 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -136.43 -52.48 0.71 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.302 -0.874 . . . . 1.0 109.311 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.5 OUTLIER -175.17 -34.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.9 . . . . 1.0 109.627 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 mt -55.9 91.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 1.0 109.74 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -47.39 166.64 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.224 -0.922 . . . . 1.0 109.474 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.48 ' HB2' ' HD2' ' A' ' 75' ' ' PRO . 5.1 ptm180 -175.15 162.03 2.3 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.901 . . . . 1.0 109.086 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.681 ' HB3' HG23 ' A' ' 101' ' ' THR . 34.3 Cg_endo -76.97 137.64 17.68 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.229 1.953 . . . . 1.0 110.334 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.95 ' NE2' HG12 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -64.16 156.5 28.33 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.246 -0.909 . . . . 1.0 109.625 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.11 -78.72 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.323 -0.86 . . . . 1.0 109.663 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -107.99 19.54 19.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 1.0 109.503 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.581 ' HB2' ' CD2' ' A' ' 76' ' ' HIS . 88.8 m-85 -111.57 112.25 23.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.903 . . . . 1.0 109.463 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.5 ' NE2' ' HD3' ' A' ' 102' ' ' LYS . 8.1 pt20 -167.32 30.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -0.845 . . . . 1.0 108.843 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.85 HG11 ' HA ' ' A' ' 123' ' ' ILE . 31.3 m -52.94 158.6 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 121.62 0.724 . . . . 1.0 110.139 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 1.026 ' CD2' HD11 ' A' ' 104' ' ' LEU . 11.6 t-160 -176.06 66.73 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.464 -0.773 . . . . 1.0 108.961 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.0 OUTLIER -113.38 157.99 21.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.873 . . . . 1.0 109.855 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.408 HG22 ' N ' ' A' ' 85' ' ' THR . 2.0 mp -130.34 156.75 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.413 -0.804 . . . . 1.0 108.991 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.457 ' O ' ' OG1' ' A' ' 88' ' ' THR . 40.9 p -99.93 167.84 10.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.083 -1.011 . . . . 1.0 109.755 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -50.13 -75.98 0.18 Allowed Glycine 0 N--CA 1.478 1.437 0 N-CA-C 109.808 -1.317 . . . . 1.0 109.808 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 100.71 8.72 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.319 -1.107 . . . . 1.0 109.961 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 85' ' ' THR . 0.0 OUTLIER -165.32 -165.03 0.81 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.241 -0.912 . . . . 1.0 109.435 179.637 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.763 ' O ' HG13 ' A' ' 89' ' ' VAL . 13.2 p -64.94 104.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.231 -0.918 . . . . 1.0 109.575 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.4 m -90.39 32.07 0.98 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 1.0 109.395 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.434 ' H ' HG22 ' A' ' 89' ' ' VAL . 22.4 m -66.06 137.32 56.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 1.0 109.437 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.6 m -52.55 106.11 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 1.0 109.542 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.447 ' HA ' HG23 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -117.65 170.1 9.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -0.87 . . . . 1.0 109.603 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -155.26 161.03 41.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.342 -0.849 . . . . 1.0 109.392 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 103' ' ' VAL . 0.5 OUTLIER -141.24 148.65 40.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 1.0 109.334 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 103' ' ' VAL . . . -152.51 127.96 9.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 1.0 109.731 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.457 ' HB ' ' HD2' ' A' ' 102' ' ' LYS . 2.7 tp -106.29 142.55 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 1.0 109.346 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.522 ' O ' ' CB ' ' A' ' 99' ' ' SER . 0.6 OUTLIER -132.99 53.0 2.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.912 . . . . 1.0 109.787 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 1.6 m 77.08 104.17 0.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.327 -0.858 . . . . 1.0 110.021 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.616 ' ND2' ' O ' ' A' ' 100' ' ' ASN . 2.2 p-10 44.32 43.14 5.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.532 -0.73 . . . . 1.0 110.334 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.681 HG23 ' HB3' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -159.3 77.64 0.72 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.987 -1.071 . . . . 1.0 109.774 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.5 ' HD3' ' NE2' ' A' ' 80' ' ' GLN . 4.2 tptm -81.96 129.75 34.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.861 . . . . 1.0 109.003 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.709 HG12 ' HB3' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -128.1 169.58 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.157 -0.965 . . . . 1.0 109.861 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.026 HD11 ' CD2' ' A' ' 82' ' ' HIS . 0.2 OUTLIER -131.21 130.59 43.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.462 -0.774 . . . . 1.0 109.236 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -128.21 132.33 48.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -0.913 . . . . 1.0 109.683 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.678 HG22 ' CD2' ' A' ' 108' ' ' LEU . 5.3 mt -129.67 102.69 17.9 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 1.0 109.279 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 34.1 Cg_endo -75.43 98.4 1.17 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.196 1.93 . . . . 1.0 110.539 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.678 ' CD2' HG22 ' A' ' 106' ' ' ILE . 0.4 OUTLIER -145.23 165.33 28.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.376 -0.827 . . . . 1.0 109.41 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -114.41 80.65 6.13 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 1.0 109.697 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 108' ' ' LEU . 36.3 Cg_endo -78.7 75.74 4.84 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.501 2.134 . . . . 1.0 110.268 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 53' ' ' TYR . 3.4 mt-10 -138.6 -49.3 0.53 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.267 -0.896 . . . . 1.0 109.603 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -79.89 -49.82 11.37 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.331 -0.855 . . . . 1.0 109.495 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.6 t -175.53 98.69 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.347 -0.846 . . . . 1.0 109.319 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.454 ' HB3' ' HA ' ' A' ' 110' ' ' PRO . 5.0 tpp -165.8 108.46 0.78 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 1.0 109.343 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -99.98 139.23 35.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.346 -0.846 . . . . 1.0 109.092 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.36 92.46 3.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -0.971 . . . . 1.0 109.547 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.951 HG12 ' CG2' ' A' ' 47' ' ' ILE . 3.5 m -91.78 128.34 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.225 -0.922 . . . . 1.0 109.322 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 99.1 mt -118.57 111.81 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.178 -0.951 . . . . 1.0 109.656 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -163.12 28.57 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 1.0 109.449 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 83' ' ' ARG . 4.2 p -116.38 42.89 2.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 1.0 109.347 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.75 164.43 28.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 1.0 109.478 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.736 ' O ' HG21 ' A' ' 81' ' ' VAL . . . -125.39 -173.77 13.76 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.904 -1.678 . . . . 1.0 108.904 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.85 ' HA ' HG11 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -116.27 170.75 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.978 -1.307 . . . . 1.0 109.231 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.414 HD23 ' H ' ' A' ' 125' ' ' LYS . 0.6 OUTLIER -115.39 146.26 41.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 1.0 109.517 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.48 ' C ' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -114.76 124.31 51.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 1.0 109.405 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.867 ' N ' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -120.74 64.36 0.85 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.214 -0.929 . . . . 1.0 109.794 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 126' ' ' LEU . 1.5 mtt85 44.46 -93.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.852 . . . . 1.0 109.633 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -153.68 60.22 0.74 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.096 -1.003 . . . . 1.0 109.502 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 29.9 t -109.01 160.85 15.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.894 . . . . 1.0 109.537 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.92 64.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 1.0 109.48 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.655 ' O ' HG23 ' A' ' 131' ' ' ILE . 6.8 tt -68.0 117.65 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.905 . . . . 1.0 109.402 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -131.5 145.86 51.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -0.896 . . . . 1.0 109.515 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.94 125.68 51.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.319 -0.863 . . . . 1.0 109.508 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.49 ' O ' ' N ' ' A' ' 136' ' ' GLY . 0.0 OUTLIER -135.11 169.58 17.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 1.0 109.439 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.22 91.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.91 . . . . 1.0 109.42 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 134' ' ' ARG . . . 126.92 164.72 11.78 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.591 -1.403 . . . . 1.0 109.591 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -142.75 66.4 1.33 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.203 -1.175 . . . . 1.0 109.474 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 139' ' ' ASP . 72.9 p -127.52 21.6 6.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 1.0 109.472 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 138' ' ' THR . 6.5 m-20 61.7 132.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 1.0 109.443 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -110.7 -38.7 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.305 -0.872 . . . . 1.0 109.426 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 144.34 -148.05 19.61 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.494 -1.443 . . . . 1.0 109.494 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.2 32.06 1.23 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.197 -1.178 . . . . 1.0 109.509 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.527 ' O ' ' ND2' ' A' ' 144' ' ' ASN . 36.7 mmtm -89.82 -174.71 4.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.894 . . . . 1.0 109.372 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.527 ' ND2' ' O ' ' A' ' 143' ' ' LYS . 2.5 p30 58.12 133.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.514 0.673 . . . . 1.0 110.343 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.503 ' CB ' ' HB2' ' A' ' 174' ' ' CYS . 0.0 OUTLIER -160.23 53.86 0.33 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 1.0 109.43 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -93.91 154.83 17.49 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.121 -0.987 . . . . 1.0 109.685 -179.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.95 HG12 ' NE2' ' A' ' 76' ' ' HIS . 14.1 m -140.26 145.12 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.502 ' HA ' ' HB3' ' A' ' 170' ' ' ASN . 2.5 ptt180 -149.73 135.43 18.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.016 -1.052 . . . . 1.0 110.106 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.888 HD23 ' O ' ' A' ' 64' ' ' PHE . 1.6 mt -87.49 121.33 29.79 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.462 -0.774 . . . . 1.0 109.51 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.494 HG21 ' HE1' ' A' ' 64' ' ' PHE . 21.6 t -92.18 132.9 35.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.194 -0.941 . . . . 1.0 109.29 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.835 ' CE1' HD22 ' A' ' 63' ' ' LEU . 5.8 m-85 -125.69 114.48 18.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.14 -0.975 . . . . 1.0 109.414 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.488 ' HB3' ' HA ' ' A' ' 166' ' ' GLN . 19.5 ptt180 -150.59 127.41 11.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.944 . . . . 1.0 109.6 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.407 HG11 HD11 ' A' ' 50' ' ' LEU . 3.1 p -106.9 129.34 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.039 -1.038 . . . . 1.0 109.37 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -111.57 107.78 17.06 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.272 -0.892 . . . . 1.0 108.736 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.911 ' CG2' HD23 ' A' ' 163' ' ' LEU . 40.1 t -99.09 136.1 20.63 Favored Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.245 -0.909 . . . . 1.0 109.034 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.431 ' O ' ' CD ' ' A' ' 157' ' ' GLN . 35.7 Cg_endo -77.72 141.65 19.65 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 122.534 2.156 . . . . 1.0 111.323 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.636 ' OE1' HG12 ' A' ' 155' ' ' VAL . 0.9 OUTLIER -160.35 179.12 1.42 Allowed Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.565 ' HD2' ' CG ' ' A' ' 157' ' ' GLN . 33.8 Cg_endo -78.27 -53.32 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.393 2.062 . . . . 1.0 110.094 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 158' ' ' PRO . 17.3 m -59.22 -148.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.662 -0.649 . . . . 1.0 109.583 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -125.05 -80.74 0.43 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.105 -1.198 . . . . 1.0 110.105 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 40.7 mtt-85 -78.14 80.96 4.55 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.482 -1.01 . . . . 1.0 108.809 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.563 ' CG2' ' N ' ' A' ' 163' ' ' LEU . 0.7 OUTLIER -102.76 -52.69 3.02 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.583 -0.698 . . . . 1.0 109.338 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.911 HD23 ' CG2' ' A' ' 155' ' ' VAL . 9.9 tp -155.49 96.17 1.76 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.399 -0.963 . . . . 1.0 108.399 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.86 101.71 1.01 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.069 -1.02 . . . . 1.0 109.165 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.857 HD23 ' H ' ' A' ' 165' ' ' LEU . 2.2 pt? -137.1 170.04 16.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 1.0 109.777 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.488 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 9.3 mt-30 -113.61 155.03 26.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.361 -0.837 . . . . 1.0 109.781 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.597 HG12 ' O ' ' A' ' 167' ' ' VAL . 45.6 t -149.74 80.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.883 . . . . 1.0 109.63 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.71 105.59 17.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 1.0 109.162 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.609 ' O ' ' ND2' ' A' ' 170' ' ' ASN . 79.7 p -120.18 117.86 29.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.939 . . . . 1.0 109.772 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.609 ' ND2' ' O ' ' A' ' 169' ' ' SER . 1.4 m-80 163.03 73.72 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.366 -0.834 . . . . 1.0 109.418 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.68 85.8 1.74 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.419 2.079 . . . . 1.0 110.399 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.525 ' O ' ' CG ' ' A' ' 146' ' ' ARG . 4.3 mt -123.07 164.95 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -0.929 . . . . 1.0 108.996 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 172' ' ' ILE . 0.4 OUTLIER -155.73 139.35 16.01 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.168 -0.958 . . . . 1.0 109.692 -179.79 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.503 ' HB2' ' CB ' ' A' ' 145' ' ' THR . 9.9 m -119.59 -168.55 1.61 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.334 -0.854 . . . . 1.0 109.228 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 176' ' ' GLN . 4.3 p -164.76 30.7 0.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.164 -0.96 . . . . 1.0 109.542 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.51 ' O ' ' CB ' ' A' ' 177' ' ' ARG . 0.0 OUTLIER 44.14 27.97 0.24 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 1.0 109.481 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.51 ' CB ' ' O ' ' A' ' 176' ' ' GLN . 0.3 OUTLIER 76.18 98.8 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.332 -0.855 . . . . 1.0 109.503 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.072 -0.966 . . . . 1.0 109.538 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.0 -45.55 34.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 1.0 109.624 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.05 117.75 0.09 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 1.0 109.545 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.531 ' CE3' ' HB2' ' A' ' 5' ' ' GLN . 33.0 p-90 -86.19 -32.44 21.22 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.332 -0.855 . . . . 1.0 109.476 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.531 ' HB2' ' CE3' ' A' ' 4' ' ' TRP . 0.1 OUTLIER -178.03 82.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 1.0 109.479 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 6' ' ' LEU . 4.8 tp -163.19 97.03 1.05 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 1.0 109.426 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.45 144.7 23.02 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.416 2.077 . . . . 1.0 110.474 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.4 p -154.01 58.64 0.72 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.293 -0.879 . . . . 1.0 109.387 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 36.5 t60 -99.99 130.68 46.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 1.0 109.469 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.6 p -177.82 54.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.903 . . . . 1.0 109.625 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.23 -161.93 12.38 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.514 -1.434 . . . . 1.0 109.514 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.443 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 35.8 Cg_endo -77.93 -9.21 16.83 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.433 2.089 . . . . 1.0 110.49 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.556 ' HB3' HD13 ' A' ' 163' ' ' LEU . 7.5 m-85 -73.12 131.58 42.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 1.0 109.446 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -145.7 124.57 12.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.997 -1.064 . . . . 1.0 109.806 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.724 ' HB3' HD11 ' A' ' 165' ' ' LEU . 20.1 tp -120.07 82.74 1.94 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.363 -0.835 . . . . 1.0 109.038 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.62 159.43 26.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.31 -0.869 . . . . 1.0 109.863 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.852 HG23 ' O ' ' A' ' 47' ' ' ILE . 1.3 mp -75.98 142.18 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.338 -0.851 . . . . 1.0 108.774 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.27 -42.75 92.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.339 -0.851 . . . . 1.0 109.618 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.44 ' C ' ' HD3' ' A' ' 21' ' ' PRO . 20.2 t -141.49 133.07 27.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.294 -0.879 . . . . 1.0 109.463 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -119.05 77.16 15.76 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.153 -0.967 . . . . 1.0 109.561 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 23' ' ' SER . 35.9 Cg_endo -78.36 -176.91 3.51 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.513 2.142 . . . . 1.0 110.221 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 21' ' ' PRO . 2.4 mptt -44.35 99.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.317 -0.864 . . . . 1.0 109.008 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 21' ' ' PRO . 2.1 t -96.63 40.92 1.12 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 1.0 109.956 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -99.9 166.96 10.81 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.089 -1.007 . . . . 1.0 109.318 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.58 ' CE1' ' HA ' ' A' ' 38' ' ' VAL . 3.2 t60 -143.23 133.7 24.85 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.723 -0.791 . . . . 1.0 109.64 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.455 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -105.68 74.31 1.06 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.345 -0.847 . . . . 1.0 109.047 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.81 161.45 2.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 1.0 109.54 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.516 ' NE2' ' O ' ' A' ' 34' ' ' SER . 1.7 m-70 -61.88 156.77 19.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 1.0 109.703 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 30' ' ' GLU . 69.7 m-85 -120.94 -145.04 0.36 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.304 -0.873 . . . . 1.0 109.195 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 29' ' ' TYR . 9.3 mt-10 -43.88 -84.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.086 -1.009 . . . . 1.0 109.442 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.87 48.06 1.62 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 1.0 109.364 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -139.01 84.43 2.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.269 -0.894 . . . . 1.0 109.531 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.3 152.89 23.56 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.615 -1.394 . . . . 1.0 109.615 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.516 ' O ' ' NE2' ' A' ' 28' ' ' HIS . 0.8 OUTLIER -84.2 -147.93 0.1 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -1.147 . . . . 1.0 109.415 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.475 ' O ' ' HD3' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -132.26 56.53 1.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 1.0 109.39 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.85 129.48 6.17 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.553 -1.419 . . . . 1.0 109.553 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.95 173.02 1.16 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -1.16 . . . . 1.0 109.619 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.883 HG12 ' HA2' ' A' ' 122' ' ' GLY . 2.4 p -54.5 119.63 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.367 -0.833 . . . . 1.0 109.535 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -142.65 99.3 3.45 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.27 -0.894 . . . . 1.0 109.852 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.423 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -93.85 -147.21 0.25 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.322 -0.861 . . . . 1.0 109.142 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.94 171.55 10.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.046 -1.034 . . . . 1.0 109.471 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 54.64 64.33 1.85 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 1.0 109.393 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.12 -68.68 3.48 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.345 -1.502 . . . . 1.0 109.345 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.543 ' CA ' ' HB2' ' A' ' 119' ' ' ASP . . . 173.11 36.16 0.03 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.578 -1.409 . . . . 1.0 109.578 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.599 ' CG ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER 165.42 177.67 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.195 -1.18 . . . . 1.0 109.294 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.599 ' HD2' ' CG ' ' A' ' 45' ' ' HIS . 35.0 Cg_endo -77.34 172.05 16.64 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.426 2.084 . . . . 1.0 110.506 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.912 HG23 HG12 ' A' ' 117' ' ' VAL . 4.2 mm -105.33 161.71 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 1.0 109.659 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.425 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 5.3 t -139.9 125.5 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.393 -0.817 . . . . 1.0 109.245 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 65.7 tt0 -146.64 157.18 43.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.927 . . . . 1.0 109.547 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.662 HD13 ' HG3' ' A' ' 110' ' ' PRO . 5.4 tt -114.63 134.67 54.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 1.0 109.419 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.638 ' N ' HD23 ' A' ' 50' ' ' LEU . 1.1 p80 -140.59 79.04 1.68 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 1.0 109.308 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 177.45 64.31 0.06 OUTLIER Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.806 -1.318 . . . . 1.0 109.806 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.568 ' CD2' HD11 ' A' ' 59' ' ' LEU . 0.4 OUTLIER 177.0 118.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.158 -1.201 . . . . 1.0 109.594 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.437 ' HA ' ' OE1' ' A' ' 111' ' ' GLU . 0.7 OUTLIER -106.98 25.46 11.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.241 -0.912 . . . . 1.0 109.299 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.549 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 38.8 tp10 -89.98 145.15 25.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.236 -0.915 . . . . 1.0 109.482 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -89.0 35.92 0.8 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.221 -0.924 . . . . 1.0 109.532 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.655 ' HG3' HD21 ' A' ' 59' ' ' LEU . 26.2 pt-20 -112.76 147.67 37.66 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 1.0 109.422 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.749 ' O ' HD23 ' A' ' 59' ' ' LEU . 35.3 Cg_endo -78.11 141.06 18.29 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.374 2.049 . . . . 1.0 110.527 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.836 HD22 ' CG2' ' A' ' 155' ' ' VAL . 7.5 mt -120.09 163.77 17.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.898 . . . . 1.0 109.19 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -116.22 100.18 7.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.208 -0.933 . . . . 1.0 109.981 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.906 HD21 ' HB2' ' A' ' 63' ' ' LEU . 1.6 tt -65.72 127.94 33.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.879 . . . . 1.0 108.923 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 152' ' ' ARG . 90.4 mt-30 -91.34 92.22 8.5 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.217 -0.927 . . . . 1.0 109.208 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.906 ' HB2' HD21 ' A' ' 61' ' ' LEU . 15.0 tp -99.6 139.84 34.67 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.316 -0.865 . . . . 1.0 109.022 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.711 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -163.86 168.36 19.61 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.159 -0.963 . . . . 1.0 108.79 -179.314 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.805 HD11 ' HB ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -132.47 116.8 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.814 . . . . 1.0 108.869 179.735 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.663 ' N ' HD13 ' A' ' 65' ' ' ILE . . . -130.98 152.6 20.0 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.843 -1.303 . . . . 1.0 109.843 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.591 HG23 ' CD2' ' A' ' 76' ' ' HIS . 40.7 p -74.03 157.39 36.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.389 -1.065 . . . . 1.0 109.433 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.696 ' HB3' ' HD2' ' A' ' 148' ' ' ARG . . . -169.06 113.58 0.56 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.262 -0.899 . . . . 1.0 109.632 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.39 9.54 37.91 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.273 -0.892 . . . . 1.0 109.346 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -168.67 -54.39 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.31 -0.868 . . . . 1.0 109.192 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 73' ' ' LEU . 3.0 tpt180 -175.23 -33.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.87 . . . . 1.0 109.698 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.59 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -54.12 92.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.295 -0.878 . . . . 1.0 109.774 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.5 OUTLIER -56.62 164.88 1.3 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.236 -0.915 . . . . 1.0 109.733 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.54 ' CD ' ' HD2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -175.15 170.86 1.34 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 1.0 109.22 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.54 ' HD2' ' CD ' ' A' ' 74' ' ' ARG . 35.2 Cg_endo -77.23 136.67 16.3 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.338 2.026 . . . . 1.0 110.414 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.687 ' ND1' HD12 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -59.2 147.3 35.96 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.278 -0.889 . . . . 1.0 109.719 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 76' ' ' HIS . . . -46.02 -77.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' A' ' 125' ' ' LYS . 79.3 m-85 -140.66 23.71 2.27 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.95 -0.759 . . . . 1.0 108.95 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.654 ' HD2' HG22 ' A' ' 123' ' ' ILE . 63.0 m-85 -78.32 106.97 10.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 1.0 109.31 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 80' ' ' GLN . 3.4 tt0 -119.48 85.27 2.34 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.038 HG12 ' O ' ' A' ' 122' ' ' GLY . 3.8 m -69.75 138.15 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.322 -0.861 . . . . 1.0 110.037 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -175.96 85.45 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.467 -0.771 . . . . 1.0 109.096 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.21 81.04 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.05 -1.031 . . . . 1.0 110.309 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.869 HG21 HG22 ' A' ' 88' ' ' THR . 2.7 mp -109.34 147.85 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 1.0 108.724 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 86' ' ' GLY . 67.6 p -99.8 170.18 8.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.145 -0.972 . . . . 1.0 109.819 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 85' ' ' THR . . . -41.29 -46.21 4.3 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 109.857 -1.297 . . . . 1.0 109.857 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -74.62 84.92 2.08 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.301 -1.117 . . . . 1.0 109.133 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.869 HG22 HG21 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -74.61 -172.17 1.45 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.342 -0.849 . . . . 1.0 109.538 -179.643 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.653 HG22 ' H ' ' A' ' 90' ' ' SER . 5.9 p -74.44 176.36 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.296 -0.877 . . . . 1.0 109.107 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.653 ' H ' HG22 ' A' ' 89' ' ' VAL . 16.9 t -74.41 -42.03 59.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.065 -1.022 . . . . 1.0 109.389 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.599 ' OG1' HD22 ' A' ' 108' ' ' LEU . 6.4 t -72.86 -168.96 0.52 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.921 . . . . 1.0 109.385 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 106' ' ' ILE . 4.4 m -103.48 158.32 16.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 1.0 109.461 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.39 157.35 46.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 1.0 109.786 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -155.86 119.03 4.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.404 -0.81 . . . . 1.0 109.449 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.96 141.9 32.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.127 -0.983 . . . . 1.0 109.473 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.67 120.67 24.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.92 . . . . 1.0 109.574 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 1.012 HD12 ' O ' ' A' ' 101' ' ' THR . 5.1 tp -117.2 144.98 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.36 -0.838 . . . . 1.0 109.323 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.51 HD21 HG21 ' A' ' 101' ' ' THR . 0.5 OUTLIER -135.89 49.42 2.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.115 -0.991 . . . . 1.0 109.676 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER 74.34 114.85 0.06 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.199 -0.938 . . . . 1.0 109.666 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.484 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 3.7 p-10 43.91 35.52 1.14 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.584 -0.698 . . . . 1.0 110.623 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . 1.012 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -149.85 105.19 3.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.841 -1.162 . . . . 1.0 109.952 179.543 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -90.33 106.23 18.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 1.0 109.13 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -109.8 172.03 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.289 -0.882 . . . . 1.0 109.229 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 1.9 mp -128.22 137.67 52.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.816 . . . . 1.0 109.518 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -133.58 112.81 11.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 1.0 109.264 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.944 HG22 HD21 ' A' ' 108' ' ' LEU . 51.9 mt -123.2 107.87 32.4 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 1.0 109.741 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 1.068 ' O ' HD23 ' A' ' 108' ' ' LEU . 34.7 Cg_endo -76.98 125.32 7.92 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.097 1.865 . . . . 1.0 110.231 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.068 HD23 ' O ' ' A' ' 107' ' ' PRO . 3.4 mt -134.12 151.63 51.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 1.0 110.006 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.558 HD12 ' SD ' ' A' ' 114' ' ' MET . 0.2 OUTLIER -123.38 91.29 49.9 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.416 -0.802 . . . . 1.0 108.93 179.505 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.662 ' HG3' HD13 ' A' ' 50' ' ' LEU . 35.9 Cg_endo -78.07 70.49 7.07 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.515 2.143 . . . . 1.0 110.631 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.494 ' O ' ' CG ' ' A' ' 111' ' ' GLU . 19.8 tp10 -118.56 0.71 11.61 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.284 -0.885 . . . . 1.0 109.639 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.498 ' O ' ' CB ' ' A' ' 113' ' ' SER . 0.0 OUTLIER -143.55 -65.11 0.38 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.105 -0.997 . . . . 1.0 109.496 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.4 OUTLIER 164.61 109.95 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.147 -0.971 . . . . 1.0 109.157 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.558 ' SD ' HD12 ' A' ' 109' ' ' LEU . 9.4 ptm -154.09 117.43 4.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.2 -0.938 . . . . 1.0 109.915 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.518 ' HD3' HG12 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -88.29 136.45 32.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.435 -0.79 . . . . 1.0 109.415 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.03 108.99 16.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 1.0 109.365 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.912 HG12 HG23 ' A' ' 47' ' ' ILE . 4.3 m -95.25 159.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -0.934 . . . . 1.0 109.667 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.486 ' O ' ' CB ' ' A' ' 45' ' ' HIS . 8.3 mt -146.95 102.6 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 1.0 109.228 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.543 ' HB2' ' CA ' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -147.56 47.39 1.11 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 1.0 109.71 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 63.8 m -145.04 54.2 1.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.881 . . . . 1.0 109.355 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.793 ' HB1' ' HB ' ' A' ' 81' ' ' VAL . . . -145.26 87.24 1.8 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.917 . . . . 1.0 109.845 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 1.038 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -56.44 -166.36 0.06 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 108.389 -1.884 . . . . 1.0 108.389 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.654 HG22 ' HD2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -114.29 151.77 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.707 -1.466 . . . . 1.0 109.178 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -143.44 82.57 1.74 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.438 -0.789 . . . . 1.0 109.702 -179.642 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.931 ' C ' HD22 ' A' ' 126' ' ' LEU . 4.3 ptmt -108.74 65.68 0.63 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.822 -1.174 . . . . 1.0 110.207 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.931 HD22 ' C ' ' A' ' 125' ' ' LYS . 2.4 mm? -146.31 75.59 1.41 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.466 -0.771 . . . . 1.0 109.104 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -141.91 -155.9 0.63 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.886 . . . . 1.0 109.454 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.507 ' O ' ' N ' ' A' ' 130' ' ' ASP . 1.2 p30 -153.19 -50.82 0.1 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 1.0 109.424 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.484 ' HB3' ' HB3' ' A' ' 100' ' ' ASN . 7.9 m 44.31 -94.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 1.0 109.493 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 128' ' ' ASN . 6.1 p-10 177.17 59.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.125 -0.985 . . . . 1.0 109.582 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.695 HD13 ' N ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -74.37 117.64 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.224 -0.923 . . . . 1.0 109.443 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.695 ' N ' HD13 ' A' ' 131' ' ' ILE . 47.7 tt0 -64.81 140.53 58.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 1.0 109.549 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.64 153.66 43.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 1.0 109.419 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -174.37 -38.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.166 -0.959 . . . . 1.0 109.624 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.02 139.01 43.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.947 . . . . 1.0 109.559 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -144.14 152.81 24.59 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.433 -1.467 . . . . 1.0 109.433 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.91 145.96 42.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -1.147 . . . . 1.0 109.509 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.96 57.73 1.03 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.34 -0.85 . . . . 1.0 109.459 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -72.93 -32.52 65.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.343 -0.848 . . . . 1.0 109.452 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.849 ' H ' HD13 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -147.73 34.87 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.924 . . . . 1.0 109.459 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 108.19 -172.14 16.74 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.435 -1.466 . . . . 1.0 109.435 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.29 156.62 37.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -1.13 . . . . 1.0 109.521 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.1 26.3 9.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 1.0 109.425 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.667 ' O ' HG23 ' A' ' 145' ' ' THR . 1.7 t-20 -91.58 70.81 5.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 1.0 109.513 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.806 HG22 ' C ' ' A' ' 174' ' ' CYS . 1.1 p -160.47 47.5 0.24 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.449 -0.782 . . . . 1.0 109.68 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.12 128.02 7.41 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.388 -0.82 . . . . 1.0 109.187 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.805 ' HB ' HD11 ' A' ' 65' ' ' ILE . 6.8 m -136.2 161.28 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.964 . . . . 1.0 109.517 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.696 ' HD2' ' HB3' ' A' ' 68' ' ' ALA . 10.7 mtt-85 -145.24 126.41 14.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.189 -0.945 . . . . 1.0 109.667 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.801 HD22 HG12 ' A' ' 65' ' ' ILE . 2.0 mm? -79.86 114.52 18.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.335 -0.853 . . . . 1.0 108.997 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 45.6 t -85.93 122.74 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.235 -0.916 . . . . 1.0 109.497 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.863 ' CE1' HD13 ' A' ' 63' ' ' LEU . 8.0 m-85 -119.76 95.75 4.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.33 -0.856 . . . . 1.0 109.125 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.475 ' O ' ' HG3' ' A' ' 152' ' ' ARG . 19.5 ptt180 -135.63 129.93 33.59 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.141 -0.974 . . . . 1.0 109.566 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.571 ' HB ' HD22 ' A' ' 15' ' ' LEU . 11.9 p -108.19 128.6 63.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.306 -0.871 . . . . 1.0 108.763 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.674 ' CD2' ' HB2' ' A' ' 164' ' ' SER . 34.9 m80 -124.34 108.54 12.31 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.197 -0.94 . . . . 1.0 109.76 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.836 ' CG2' HD22 ' A' ' 59' ' ' LEU . 7.7 p -99.22 141.24 22.51 Favored Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 121.314 -0.866 . . . . 1.0 109.172 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.529 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 34.5 Cg_endo -77.19 115.34 3.95 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.174 1.916 . . . . 1.0 109.994 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.491 ' OE1' ' HD2' ' A' ' 158' ' ' PRO . 72.2 mm-40 -143.23 163.58 36.52 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.424 -0.797 . . . . 1.0 109.52 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.491 ' HD2' ' OE1' ' A' ' 157' ' ' GLN . 35.0 Cg_endo -77.92 -55.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.402 2.068 . . . . 1.0 109.777 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 158' ' ' PRO . 0.2 OUTLIER -45.71 171.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.628 -0.67 . . . . 1.0 109.466 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -93.86 -66.37 1.04 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.173 -1.171 . . . . 1.0 110.173 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.6 mtm-85 -78.98 79.21 5.39 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.399 -1.334 . . . . 1.0 107.399 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.556 HG23 ' H ' ' A' ' 163' ' ' LEU . 2.7 t -102.03 -108.34 0.24 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.673 -0.642 . . . . 1.0 110.518 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.556 HD13 ' HB3' ' A' ' 13' ' ' TYR . 8.6 tp -129.1 96.46 4.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.295 -1.503 . . . . 1.0 108.299 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.674 ' HB2' ' CD2' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -162.85 100.34 1.0 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.874 -1.141 . . . . 1.0 109.699 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.864 ' N ' HD23 ' A' ' 165' ' ' LEU . 1.0 OUTLIER -134.61 170.04 16.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.178 -0.952 . . . . 1.0 109.64 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.461 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 3.1 mm-40 -121.73 147.31 46.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 1.0 109.557 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.74 HG12 ' O ' ' A' ' 167' ' ' VAL . 41.8 t -145.47 70.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.871 . . . . 1.0 109.407 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.77 107.72 19.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.222 -0.924 . . . . 1.0 109.192 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 0.3 OUTLIER -156.33 123.49 5.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 1.0 109.7 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 169' ' ' SER . 1.8 t30 172.2 94.94 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.37 -0.831 . . . . 1.0 109.287 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.65 107.9 2.46 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.414 2.076 . . . . 1.0 110.48 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.62 ' HB ' HG22 ' A' ' 147' ' ' VAL . 24.6 mt -137.43 159.47 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.874 . . . . 1.0 108.99 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 145' ' ' THR . 2.9 mt-10 -130.34 123.12 29.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.127 -0.983 . . . . 1.0 109.854 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.806 ' C ' HG22 ' A' ' 145' ' ' THR . 3.3 m -84.7 -169.28 2.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -0.872 . . . . 1.0 109.047 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 177' ' ' ARG . 1.2 p 176.47 -33.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.171 -0.955 . . . . 1.0 109.665 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.468 ' HB3' ' HD3' ' A' ' 125' ' ' LYS . 6.3 tp60 -44.38 95.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.989 . . . . 1.0 109.46 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 175' ' ' SER . 0.0 OUTLIER -168.51 154.76 7.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.273 -0.892 . . . . 1.0 109.424 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.941 -1.028 . . . . 1.0 109.507 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.9 ttp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.8 40.42 0.65 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -0.893 . . . . 1.0 109.45 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.415 ' HB3' HD11 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -174.95 -156.46 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 1.0 109.249 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.885 ' NE1' HD12 ' A' ' 6' ' ' LEU . 53.9 p-90 -97.48 -49.09 5.03 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.253 -0.905 . . . . 1.0 109.611 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.711 ' C ' HD13 ' A' ' 6' ' ' LEU . 2.3 mm-40 163.04 90.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.366 -0.834 . . . . 1.0 109.481 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.885 HD12 ' NE1' ' A' ' 4' ' ' TRP . 0.0 OUTLIER -130.61 154.53 81.74 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.197 -0.939 . . . . 1.0 109.577 179.497 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.75 95.55 1.03 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.479 2.12 . . . . 1.0 110.296 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.61 43.97 1.61 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.166 -0.959 . . . . 1.0 109.495 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.446 ' HA ' HD13 ' A' ' 54' ' ' LEU . 18.8 m170 -116.0 87.04 2.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.298 -0.876 . . . . 1.0 109.461 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.94 99.74 3.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 1.0 109.573 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.411 ' HA2' ' HD3' ' A' ' 12' ' ' PRO . . . -158.31 142.67 8.64 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.387 -1.485 . . . . 1.0 109.387 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.447 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 36.3 Cg_endo -78.92 110.27 2.74 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.441 2.094 . . . . 1.0 110.596 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.575 ' CE2' ' O ' ' A' ' 162' ' ' THR . 8.3 m-85 -56.09 155.75 6.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 1.0 109.063 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 12' ' ' PRO . 20.7 mt-10 -152.21 103.01 2.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.885 -1.134 . . . . 1.0 110.25 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.665 ' HB3' HD12 ' A' ' 165' ' ' LEU . 17.3 tp -112.24 76.78 1.0 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.436 -0.95 . . . . 1.0 108.436 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.6 ' O ' ' NE2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -114.87 176.25 5.14 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.322 -0.861 . . . . 1.0 110.188 -179.022 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.583 HG21 ' HG2' ' A' ' 20' ' ' GLN . 0.8 OUTLIER -86.75 146.48 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 108.705 -0.85 . . . . 1.0 108.705 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.06 -61.13 2.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 1.0 109.261 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.752 HG22 ' HD3' ' A' ' 21' ' ' PRO . 9.7 p -109.67 136.02 46.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.385 -0.822 . . . . 1.0 109.307 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.583 ' HG2' HG21 ' A' ' 17' ' ' ILE . 9.4 mm-40 -129.06 66.02 75.34 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.143 -0.973 . . . . 1.0 109.599 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.752 ' HD3' HG22 ' A' ' 19' ' ' VAL . 35.4 Cg_endo -77.62 -177.03 3.54 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.464 2.109 . . . . 1.0 110.575 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -61.85 151.7 33.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.366 -0.834 . . . . 1.0 109.129 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.47 ' HB3' ' HG2' ' A' ' 171' ' ' PRO . 2.2 t -163.76 61.58 0.16 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.14 -0.975 . . . . 1.0 110.038 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' HIS . . . . . 0.442 ' HA ' HG12 ' A' ' 172' ' ' ILE . 8.1 p-80 -99.52 165.52 11.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.084 -1.01 . . . . 1.0 108.881 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.599 ' CE1' ' HA ' ' A' ' 38' ' ' VAL . 1.1 m-70 -139.54 110.41 6.8 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.703 -0.799 . . . . 1.0 109.894 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.507 ' O ' ' CE2' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -87.12 64.98 8.68 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.424 -0.954 . . . . 1.0 108.424 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.3 82.8 3.77 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.367 0.603 . . . . 1.0 109.88 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.54 ' C ' ' CG ' ' A' ' 29' ' ' TYR . 10.4 p80 174.63 113.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.322 -0.861 . . . . 1.0 109.295 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER 169.55 171.97 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.553 -0.717 . . . . 1.0 109.305 -179.481 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -161.4 31.35 0.13 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.916 . . . . 1.0 109.544 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 31' ' ' THR . 13.3 m -144.63 43.45 1.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 1.0 109.489 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.404 ' OE1' ' CD2' ' A' ' 29' ' ' TYR . 5.2 pt-20 -133.7 -41.31 0.85 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 1.0 109.481 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.08 -131.29 5.77 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.607 -1.397 . . . . 1.0 109.607 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 35' ' ' ARG . 1.2 t -128.08 117.49 21.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.162 -1.199 . . . . 1.0 109.581 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.44 ' O ' ' HD3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER 172.48 70.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.302 -0.874 . . . . 1.0 109.517 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -120.29 92.57 0.52 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.695 -1.362 . . . . 1.0 109.695 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.57 175.23 8.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.201 -1.176 . . . . 1.0 109.762 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.659 HG11 ' O ' ' A' ' 121' ' ' ALA . 2.4 p -100.27 102.3 13.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.939 -0.704 . . . . 1.0 109.732 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 12.5 ptpt -153.9 110.43 3.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.898 . . . . 1.0 109.614 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.66 -45.25 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.14 -0.975 . . . . 1.0 109.517 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.528 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 0.3 OUTLIER -100.68 102.1 13.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 1.0 109.621 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 41' ' ' SER . . . 61.52 42.32 11.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 1.0 109.521 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 92.09 -21.39 37.42 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.653 -1.379 . . . . 1.0 109.653 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.516 ' N ' ' OD2' ' A' ' 119' ' ' ASP . . . 155.22 106.79 0.27 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.486 ' HB3' ' O ' ' A' ' 118' ' ' ILE . 0.3 OUTLIER 73.92 146.18 0.11 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.254 -1.145 . . . . 1.0 109.758 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.12 -178.81 4.9 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.651 2.234 . . . . 1.0 110.577 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 1.016 HG23 HG12 ' A' ' 117' ' ' VAL . 5.2 mt -94.32 158.34 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.513 -0.742 . . . . 1.0 109.278 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.589 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 11.1 t -140.35 88.1 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.159 -0.963 . . . . 1.0 110.108 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.724 ' C ' HE21 ' A' ' 49' ' ' GLN . 0.0 OUTLIER -98.8 175.74 5.86 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 1.0 108.903 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.652 HD12 HD13 ' A' ' 15' ' ' LEU . 8.2 tt -134.81 136.73 42.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.933 -1.104 . . . . 1.0 110.036 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.455 ' HA ' ' HG3' ' A' ' 111' ' ' GLU . 0.0 OUTLIER -140.55 79.08 1.68 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.353 -0.842 . . . . 1.0 108.844 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . -174.33 88.22 0.08 OUTLIER Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.544 -1.312 . . . . 1.0 110.234 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.835 ' CE2' HD11 ' A' ' 59' ' ' LEU . 2.0 t80 176.8 131.83 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -1.109 . . . . 1.0 109.654 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 9' ' ' HIS . 18.9 mt -108.89 4.42 23.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 1.0 109.539 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.471 ' HB3' ' HG2' ' A' ' 57' ' ' GLU . 2.7 mt-10 -95.24 143.39 26.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 1.0 109.507 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -90.73 35.12 0.89 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.918 . . . . 1.0 109.337 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.576 ' HG3' HD21 ' A' ' 59' ' ' LEU . 17.3 pt-20 -110.83 151.97 43.25 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 1.0 109.357 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.58 ' O ' HD23 ' A' ' 59' ' ' LEU . 35.8 Cg_endo -78.31 134.2 12.55 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.436 2.091 . . . . 1.0 110.534 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.835 HD11 ' CE2' ' A' ' 53' ' ' TYR . 16.1 mt -118.63 165.44 13.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.238 -0.914 . . . . 1.0 109.077 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -105.13 136.03 45.38 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.174 -0.954 . . . . 1.0 109.583 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.793 HD21 ' HB2' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -89.41 136.15 33.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.36 -0.838 . . . . 1.0 109.224 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -97.2 85.96 3.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.204 -0.935 . . . . 1.0 109.536 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 1.096 HD13 ' CE1' ' A' ' 151' ' ' PHE . 18.8 tp -99.36 130.95 45.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 1.0 108.822 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.502 ' HB2' ' CG1' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -155.44 143.54 20.05 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -0.968 . . . . 1.0 109.113 -179.326 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.817 HD13 ' N ' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -103.99 124.54 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.446 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.817 ' N ' HD13 ' A' ' 65' ' ' ILE . . . -136.8 149.17 20.1 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.915 -1.274 . . . . 1.0 109.915 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.732 HG23 ' HA ' ' A' ' 76' ' ' HIS . 73.5 p -83.14 156.51 23.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.28 -1.13 . . . . 1.0 109.362 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.572 ' HB3' ' HG3' ' A' ' 148' ' ' ARG . . . -160.56 116.99 2.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 1.0 109.694 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -85.45 -25.13 27.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.169 -0.957 . . . . 1.0 109.14 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.12 -42.02 0.21 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.382 -0.824 . . . . 1.0 109.425 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' LEU . 13.0 ttm180 -175.35 -34.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 1.0 109.569 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.723 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.7 OUTLIER -48.67 91.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 1.0 109.865 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.7 OUTLIER -58.21 155.73 10.93 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.163 -0.961 . . . . 1.0 109.656 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.513 ' NE ' ' OG1' ' A' ' 67' ' ' THR . 10.8 ptt180 -175.27 172.19 1.14 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.88 . . . . 1.0 108.7 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.512 ' HD2' ' HB2' ' A' ' 74' ' ' ARG . 33.7 Cg_endo -77.18 161.73 32.06 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.141 1.894 . . . . 1.0 110.312 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.732 ' HA ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -64.35 156.03 30.47 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.227 -0.921 . . . . 1.0 109.708 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.28 -48.92 4.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 1.0 109.84 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.506 ' HD1' HD22 ' A' ' 126' ' ' LEU . 18.6 m-85 -120.39 26.83 8.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.18 -0.95 . . . . 1.0 109.899 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.756 ' OH ' HG22 ' A' ' 145' ' ' THR . 0.2 OUTLIER -140.86 148.68 40.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.148 -0.97 . . . . 1.0 109.127 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.479 ' HG3' ' HB2' ' A' ' 102' ' ' LYS . 20.5 tt0 -165.05 -36.41 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.122 -0.986 . . . . 1.0 109.589 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 m -50.78 143.22 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.052 -1.03 . . . . 1.0 109.633 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.402 ' O ' ' OE2' ' A' ' 95' ' ' GLU . 3.9 t-80 -175.93 67.98 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.532 -0.73 . . . . 1.0 109.319 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.0 OUTLIER -134.41 153.97 51.62 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.236 -0.915 . . . . 1.0 109.815 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 0.513 ' CG1' ' HB2' ' A' ' 120' ' ' CYS . 3.8 mp -100.01 143.63 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.447 -0.783 . . . . 1.0 109.486 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 86' ' ' GLY . 34.4 p -135.41 -166.35 1.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 1.0 109.404 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 85' ' ' THR . . . 41.47 -107.99 0.11 Allowed Glycine 0 N--CA 1.484 1.84 0 N-CA-C 110.046 -1.222 . . . . 1.0 110.046 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.84 118.9 18.33 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.244 -1.15 . . . . 1.0 109.601 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.19 169.64 12.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 1.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.558 HG13 ' H ' ' A' ' 91' ' ' THR . 11.0 p -103.8 160.23 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.332 -0.855 . . . . 1.0 109.418 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.441 ' N ' HG22 ' A' ' 89' ' ' VAL . 2.5 m -78.71 3.78 15.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 1.0 109.606 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.623 HG23 HD22 ' A' ' 108' ' ' LEU . 16.3 m -104.82 101.36 10.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.213 -0.93 . . . . 1.0 109.539 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.883 ' O ' HG23 ' A' ' 106' ' ' ILE . 22.7 m -46.08 115.71 1.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -0.935 . . . . 1.0 109.652 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.607 ' HA ' HG23 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -114.21 173.68 6.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 1.0 109.654 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.1 162.67 40.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.375 -0.828 . . . . 1.0 109.519 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.402 ' OE2' ' O ' ' A' ' 82' ' ' HIS . 1.2 tt0 -124.31 133.59 53.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.864 . . . . 1.0 109.492 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.474 ' O ' HG23 ' A' ' 103' ' ' VAL . . . -124.66 121.53 34.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 1.0 109.55 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.56 HD12 ' O ' ' A' ' 101' ' ' THR . 6.1 tp -111.79 140.12 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 1.0 109.444 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.51 ' O ' ' CB ' ' A' ' 99' ' ' SER . 0.5 OUTLIER -132.32 49.41 2.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.138 -0.976 . . . . 1.0 109.691 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 3.1 t 76.8 112.34 0.07 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.897 . . . . 1.0 110.279 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.432 ' CG ' ' O ' ' A' ' 99' ' ' SER . 3.5 p-10 43.64 31.96 0.51 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.689 -0.632 . . . . 1.0 111.032 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.56 ' O ' HD12 ' A' ' 97' ' ' ILE . 2.5 m -160.2 96.29 1.19 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.737 -1.227 . . . . 1.0 110.226 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.479 ' HB2' ' HG3' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -88.87 153.71 20.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.229 -0.919 . . . . 1.0 108.943 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.502 ' CG1' ' HB2' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -144.18 173.57 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.071 -1.018 . . . . 1.0 109.211 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.561 HD22 HD23 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -123.92 130.81 53.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.924 . . . . 1.0 109.954 -179.571 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -133.1 122.64 24.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.358 -0.839 . . . . 1.0 108.864 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 1.062 HG22 HD21 ' A' ' 108' ' ' LEU . 26.8 mt -133.94 112.73 12.48 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.035 -1.04 . . . . 1.0 110.119 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.946 ' C ' HD23 ' A' ' 108' ' ' LEU . 34.0 Cg_endo -76.56 121.24 5.89 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 122.091 1.861 . . . . 1.0 109.712 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.062 HD21 HG22 ' A' ' 106' ' ' ILE . 2.5 mt -126.36 165.55 18.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 1.0 110.667 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.773 ' N ' HD23 ' A' ' 109' ' ' LEU . 0.6 OUTLIER -72.26 -170.82 0.17 Allowed Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 108.081 -1.081 . . . . 1.0 108.081 179.259 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.59 ' CD ' ' CB ' ' A' ' 109' ' ' LEU . 33.4 Cg_endo -77.64 -76.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 121.532 1.488 . . . . 1.0 110.848 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.455 ' HG3' ' HA ' ' A' ' 51' ' ' HIS . 1.8 tt0 -170.46 52.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.897 -1.127 . . . . 1.0 110.131 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.474 ' O ' ' CB ' ' A' ' 113' ' ' SER . 13.2 p30 -79.73 -40.65 28.37 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.086 -1.009 . . . . 1.0 109.166 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.5 OUTLIER 164.68 87.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.361 -0.837 . . . . 1.0 109.157 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.584 ' HE1' ' N ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -162.51 139.71 8.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.155 -0.966 . . . . 1.0 110.19 -179.647 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -119.6 137.75 53.66 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.386 -0.821 . . . . 1.0 108.937 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -112.49 97.91 6.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.158 -0.964 . . . . 1.0 109.749 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 1.016 HG12 HG23 ' A' ' 47' ' ' ILE . 5.4 m -96.42 127.22 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 1.0 109.349 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.486 ' O ' ' HB3' ' A' ' 45' ' ' HIS . 65.9 mt -102.56 111.26 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 1.0 109.358 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.516 ' OD2' ' N ' ' A' ' 44' ' ' GLY . 3.9 t0 -147.12 41.83 1.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.943 . . . . 1.0 109.619 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.513 ' HB2' ' CG1' ' A' ' 84' ' ' ILE . 63.8 m -145.22 57.77 1.26 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -0.956 . . . . 1.0 109.824 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.659 ' O ' HG11 ' A' ' 38' ' ' VAL . . . -128.33 152.94 47.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 1.0 108.881 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -114.21 -174.35 18.53 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.838 -1.305 . . . . 1.0 109.838 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.2 mt -125.23 171.79 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -1.104 . . . . 1.0 109.055 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.31 161.36 37.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 1.0 109.569 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -136.51 124.68 23.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -0.873 . . . . 1.0 109.377 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.506 HD22 ' HD1' ' A' ' 78' ' ' PHE . 1.4 mp -89.77 166.15 13.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 1.0 109.487 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -160.7 28.53 0.15 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.253 -0.905 . . . . 1.0 109.413 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -133.46 12.53 4.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 1.0 109.496 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -137.11 -85.43 0.32 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.181 -0.949 . . . . 1.0 109.53 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 129' ' ' SER . 9.1 t0 83.45 59.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.313 0.578 . . . . 1.0 109.468 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.571 ' O ' HG23 ' A' ' 131' ' ' ILE . 12.1 tt -99.34 121.96 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.232 -0.918 . . . . 1.0 109.489 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -169.57 111.18 0.46 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 1.0 109.509 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.665 ' O ' HD12 ' A' ' 133' ' ' LEU . 3.9 pp -127.9 133.81 49.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 1.0 109.415 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 33.5 ptt85 -178.55 -168.4 0.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 1.0 109.524 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -94.56 147.77 22.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 1.0 109.492 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 110.7 174.66 20.34 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.544 -1.422 . . . . 1.0 109.544 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -146.47 147.49 31.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -1.135 . . . . 1.0 109.428 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.444 HG21 ' HA ' ' A' ' 143' ' ' LYS . 72.2 p -125.31 -166.32 1.53 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 1.0 109.527 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -76.74 -85.97 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.912 . . . . 1.0 109.386 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 20.2 pt -135.18 16.19 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 1.0 109.445 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 142' ' ' ARG . . . 169.22 -149.05 12.82 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.548 -1.421 . . . . 1.0 109.548 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.526 ' CG ' ' O ' ' A' ' 141' ' ' GLY . 9.1 ptt180 40.53 57.39 2.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.693 -0.887 . . . . 1.0 110.097 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.444 ' HA ' HG21 ' A' ' 138' ' ' THR . 0.0 OUTLIER -97.61 78.13 2.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.314 -0.866 . . . . 1.0 109.304 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.474 ' HA ' ' HB3' ' A' ' 175' ' ' SER . 0.1 OUTLIER 66.2 137.91 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 1.0 109.272 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.756 HG22 ' OH ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -159.38 53.02 0.38 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.188 -0.945 . . . . 1.0 109.654 -179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 172' ' ' ILE . 6.4 ptm180 -86.73 176.59 7.66 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.233 -0.917 . . . . 1.0 109.288 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.583 HG12 ' NE2' ' A' ' 76' ' ' HIS . 27.7 m -134.7 -174.68 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.403 -0.811 . . . . 1.0 109.877 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.603 ' HA ' ' ND2' ' A' ' 170' ' ' ASN . 0.0 OUTLIER -149.29 95.97 2.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.33 -0.856 . . . . 1.0 109.319 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.526 ' CD2' HG12 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -78.0 124.51 28.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.986 -1.071 . . . . 1.0 109.035 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.6 t -110.04 114.41 46.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.233 -0.917 . . . . 1.0 109.776 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 1.096 ' CE1' HD13 ' A' ' 63' ' ' LEU . 21.6 m-85 -110.43 113.29 25.83 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.769 -0.826 . . . . 1.0 108.769 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.486 ' HB3' ' HA ' ' A' ' 166' ' ' GLN . 10.0 ptt180 -149.46 138.73 21.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.171 -0.955 . . . . 1.0 109.781 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.537 ' HB ' HD22 ' A' ' 15' ' ' LEU . 8.7 p -112.66 128.52 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.471 -0.937 . . . . 1.0 108.471 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.693 ' CD2' ' HB2' ' A' ' 164' ' ' SER . 41.5 m80 -128.89 118.45 22.71 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.16 -0.962 . . . . 1.0 110.002 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.546 HG11 ' HB3' ' A' ' 163' ' ' LEU . 14.7 p -98.52 141.2 22.53 Favored Pre-proline 0 N--CA 1.487 1.406 0 O-C-N 121.279 -0.888 . . . . 1.0 108.788 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.541 ' HD2' HG23 ' A' ' 155' ' ' VAL . 33.0 Cg_endo -74.73 114.05 3.94 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.197 1.931 . . . . 1.0 110.615 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.633 ' HG3' HG21 ' A' ' 162' ' ' THR . 0.6 OUTLIER -135.71 166.05 31.42 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.506 -0.746 . . . . 1.0 109.006 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.463 ' HD2' ' OE1' ' A' ' 157' ' ' GLN . 34.4 Cg_endo -76.34 -64.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.261 1.974 . . . . 1.0 110.373 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.0 m -53.77 -78.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.195 -0.94 . . . . 1.0 109.349 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 144.44 -42.07 1.06 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.458 -1.457 . . . . 1.0 109.458 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.01 79.96 5.37 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.022 -1.103 . . . . 1.0 108.022 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.786 HG22 ' N ' ' A' ' 163' ' ' LEU . 1.3 m -135.05 -88.38 0.36 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.533 -0.73 . . . . 1.0 109.367 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.786 ' N ' HG22 ' A' ' 162' ' ' THR . 7.6 tp -131.15 102.89 6.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.021 -1.049 . . . . 1.0 109.08 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.693 ' HB2' ' CD2' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -162.11 114.31 1.71 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.08 -1.012 . . . . 1.0 109.593 179.377 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.665 HD12 ' HB3' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -122.81 175.36 6.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.335 -0.853 . . . . 1.0 109.753 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.486 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -147.87 105.66 3.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.425 -0.797 . . . . 1.0 109.426 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 151' ' ' PHE . 43.8 t -118.28 154.01 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 1.0 109.332 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 149' ' ' LEU . . . -151.41 102.83 2.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 1.0 109.214 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.581 ' C ' HD21 ' A' ' 170' ' ' ASN . 0.4 OUTLIER -130.71 161.78 30.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.957 . . . . 1.0 109.693 -179.695 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.603 ' ND2' ' HA ' ' A' ' 148' ' ' ARG . 1.4 p30 164.93 97.77 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.343 -0.848 . . . . 1.0 109.567 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.47 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 36.1 Cg_endo -79.45 67.81 8.48 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.419 2.08 . . . . 1.0 110.48 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 23' ' ' SER . 16.1 mt -136.6 124.45 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.104 -0.997 . . . . 1.0 109.443 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -147.17 108.0 4.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 1.0 109.363 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 175' ' ' SER . 63.9 m -85.17 175.95 8.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.206 -0.933 . . . . 1.0 109.462 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 174' ' ' CYS . 1.0 OUTLIER 82.57 -42.78 0.12 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.783 -0.573 . . . . 1.0 110.053 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.42 ' CB ' ' O ' ' A' ' 175' ' ' SER . 27.0 tt0 70.32 78.68 0.19 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.981 -1.074 . . . . 1.0 109.597 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.93 -44.91 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.946 . . . . 1.0 109.474 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' SER . . . . . 0.426 ' OXT' ' OG ' ' A' ' 178' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.988 -1.006 . . . . 1.0 109.471 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.417 ' O ' ' OD2' ' A' ' 3' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 3' ' ' ASP . 9.0 tttt -69.91 -32.58 70.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.858 . . . . 1.0 109.408 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.559 ' CB ' HD23 ' A' ' 6' ' ' LEU . 11.5 m-20 62.02 169.44 0.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 1.0 109.493 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.569 ' CG ' ' N ' ' A' ' 5' ' ' GLN . 21.9 p-90 -77.41 -46.73 21.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.192 -0.943 . . . . 1.0 109.874 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.569 ' N ' ' CG ' ' A' ' 4' ' ' TRP . 1.1 tt0 176.56 83.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 1.0 109.625 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.559 HD23 ' CB ' ' A' ' 3' ' ' ASP . 0.4 OUTLIER -96.38 161.17 27.81 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.305 -0.872 . . . . 1.0 109.253 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 6' ' ' LEU . 34.5 Cg_endo -76.41 160.51 35.43 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.312 2.008 . . . . 1.0 110.274 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.7 p -130.62 46.95 2.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 1.0 109.663 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.559 ' CG ' ' N ' ' A' ' 10' ' ' SER . 73.9 t60 -99.77 165.73 11.44 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.178 -0.951 . . . . 1.0 109.343 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.559 ' N ' ' CG ' ' A' ' 9' ' ' HIS . 1.5 p 73.35 146.69 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.126 -0.984 . . . . 1.0 109.417 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.7 -145.26 6.43 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.604 -1.399 . . . . 1.0 109.604 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.5 -158.79 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.425 2.083 . . . . 1.0 110.486 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.565 ' CD1' ' O ' ' A' ' 162' ' ' THR . 1.8 m-85 -95.65 162.9 13.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 1.0 109.459 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -152.42 142.69 22.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.138 -0.976 . . . . 1.0 109.918 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.939 HD13 HD12 ' A' ' 50' ' ' LEU . 22.8 tp -136.31 98.05 3.74 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.784 -0.821 . . . . 1.0 108.784 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.47 164.23 29.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 1.0 110.227 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 47' ' ' ILE . 0.8 OUTLIER -92.36 145.29 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.547 -0.909 . . . . 1.0 108.547 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.421 ' C ' HG23 ' A' ' 19' ' ' VAL . 1.3 tp10 -75.4 -35.83 60.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.936 . . . . 1.0 110.3 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.499 ' HB ' HG13 ' A' ' 47' ' ' ILE . 80.0 t -154.48 98.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 O-C-N 120.814 -1.179 . . . . 1.0 110.157 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.589 ' NE2' HG21 ' A' ' 17' ' ' ILE . 0.6 OUTLIER -51.63 160.34 1.06 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.442 -0.786 . . . . 1.0 109.037 179.422 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.496 ' HB3' ' O ' ' A' ' 44' ' ' GLY . 36.2 Cg_endo -78.38 154.92 28.36 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.458 2.106 . . . . 1.0 110.415 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.6 mmtm -46.09 165.12 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.266 -0.896 . . . . 1.0 109.453 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.457 ' O ' ' OG ' ' A' ' 23' ' ' SER . 5.2 t -94.19 24.39 4.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 1.0 110.142 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -136.04 166.38 23.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.94 -1.1 . . . . 1.0 110.003 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.85 ' CD2' HD11 ' A' ' 123' ' ' ILE . 0.8 OUTLIER -162.48 106.76 1.15 Allowed 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.303 -0.629 . . . . 1.0 109.303 179.428 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.569 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . 24.1 ttp85 -75.17 91.74 2.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.255 -0.903 . . . . 1.0 109.36 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.416 ' O ' ' CB ' ' A' ' 28' ' ' HIS . . . -143.22 88.94 2.06 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.315 -0.866 . . . . 1.0 109.523 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.416 ' CB ' ' O ' ' A' ' 27' ' ' ALA . 0.2 OUTLIER 169.97 38.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.92 . . . . 1.0 109.503 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.569 ' CE1' ' HG3' ' A' ' 26' ' ' ARG . 32.2 m-85 -129.54 -70.32 0.65 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.239 -0.913 . . . . 1.0 109.542 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 30' ' ' GLU . 6.8 pt-20 -86.16 118.8 25.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.272 -0.893 . . . . 1.0 109.548 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 t -145.1 36.32 1.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 1.0 109.435 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.05 52.32 1.68 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.179 -0.951 . . . . 1.0 109.475 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.2 149.45 6.3 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.774 -1.331 . . . . 1.0 109.774 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 36' ' ' GLY . 8.2 t 65.88 9.75 6.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.328 -1.101 . . . . 1.0 109.516 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 52.01 -90.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.88 . . . . 1.0 109.434 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 34' ' ' SER . . . 117.12 112.33 2.65 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.643 -1.383 . . . . 1.0 109.643 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -119.77 174.19 6.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -1.112 . . . . 1.0 109.517 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.592 ' HB ' ' CE1' ' A' ' 25' ' ' HIS . 2.4 p -68.33 142.06 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.403 -0.81 . . . . 1.0 109.445 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -143.8 105.41 4.3 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.278 -0.889 . . . . 1.0 109.766 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 43' ' ' GLY . . . -161.16 105.8 1.34 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.411 -0.806 . . . . 1.0 108.905 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.471 ' HG ' ' C ' ' A' ' 40' ' ' ALA . 19.2 p 44.17 -105.56 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 1.0 108.903 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.503 ' O ' ' CB ' ' A' ' 119' ' ' ASP . . . -88.57 48.0 1.58 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.582 -1.324 . . . . 1.0 108.232 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.601 ' O ' ' HB3' ' A' ' 40' ' ' ALA . . . 67.82 -111.11 3.82 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.039 -2.024 . . . . 1.0 108.039 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 45' ' ' HIS . . . -89.61 -22.15 37.87 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.219 -1.952 . . . . 1.0 108.219 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.606 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 2.3 t-80 79.43 27.96 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.355 0 N-CA-C 113.315 0.857 . . . . 1.0 113.315 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 45' ' ' HIS . 37.3 Cg_endo -79.34 114.25 3.27 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 N-CA-C 108.935 -1.217 . . . . 1.0 108.935 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.636 ' O ' HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -102.32 144.95 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.967 -1.083 . . . . 1.0 108.802 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.602 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 5.2 t -137.27 124.49 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.033 -1.042 . . . . 1.0 110.369 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.634 ' NE2' ' HG2' ' A' ' 115' ' ' ARG . 23.2 tt0 -140.06 142.51 36.16 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.524 -0.917 . . . . 1.0 108.524 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.939 HD12 HD13 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -118.04 141.05 48.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.939 -1.1 . . . . 1.0 109.897 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -140.66 84.98 1.97 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.349 -0.844 . . . . 1.0 109.449 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 170.01 105.22 0.18 Allowed Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.304 -1.427 . . . . 1.0 110.648 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.595 ' CD2' ' HB2' ' A' ' 111' ' ' GLU . 3.5 t80 175.9 156.95 0.22 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.426 -1.044 . . . . 1.0 109.965 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.748 ' C ' HD12 ' A' ' 54' ' ' LEU . 3.3 pp -140.71 11.02 2.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.421 -0.799 . . . . 1.0 109.255 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.449 ' O ' ' CE2' ' A' ' 53' ' ' TYR . 1.6 tm-20 -120.77 145.67 47.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.303 -0.873 . . . . 1.0 109.658 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -90.25 35.81 0.87 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 1.0 109.96 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.677 ' HG3' HD21 ' A' ' 59' ' ' LEU . 15.1 pt-20 -100.62 137.84 19.97 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.146 -0.971 . . . . 1.0 109.424 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 1.05 ' O ' HD23 ' A' ' 59' ' ' LEU . 36.7 Cg_endo -79.92 154.23 22.78 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.511 2.141 . . . . 1.0 110.501 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.05 HD23 ' O ' ' A' ' 58' ' ' PRO . 2.3 mt -141.27 156.29 45.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 1.0 109.172 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -87.26 135.55 33.27 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.223 -0.923 . . . . 1.0 109.104 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -87.94 131.15 34.71 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.275 -0.89 . . . . 1.0 109.499 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -98.52 82.66 2.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -0.911 . . . . 1.0 109.572 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.93 HD13 ' CZ ' ' A' ' 151' ' ' PHE . 58.9 tp -99.64 135.98 40.25 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.247 -0.908 . . . . 1.0 108.81 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.692 ' HB2' HG12 ' A' ' 103' ' ' VAL . 1.7 t80 -148.4 164.05 35.28 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.226 -0.921 . . . . 1.0 109.042 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.757 ' O ' HG23 ' A' ' 65' ' ' ILE . 8.1 tp -129.38 102.85 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.581 ' HA3' ' CZ ' ' A' ' 64' ' ' PHE . . . -124.65 153.69 17.83 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 110.067 -1.213 . . . . 1.0 110.067 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.901 HG22 ' CD2' ' A' ' 76' ' ' HIS . 1.1 p -77.22 149.56 35.47 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.464 -1.021 . . . . 1.0 109.23 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.459 ' HB3' ' HD2' ' A' ' 148' ' ' ARG . . . -153.72 115.74 4.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 1.0 109.752 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.25 -7.95 58.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 1.0 109.522 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -159.91 -44.34 0.05 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -0.929 . . . . 1.0 109.452 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -175.08 -34.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.262 -0.899 . . . . 1.0 109.625 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.08 89.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.9 . . . . 1.0 109.739 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 71' ' ' ARG . 2.2 pp -65.35 129.72 40.76 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.283 -0.885 . . . . 1.0 109.666 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.635 ' NH2' HG21 ' A' ' 138' ' ' THR . 13.5 mmt180 -145.13 160.31 46.49 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 1.0 109.247 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -75.99 142.67 25.21 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.342 2.028 . . . . 1.0 110.202 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.901 ' CD2' HG22 ' A' ' 67' ' ' THR . 0.3 OUTLIER -67.44 160.97 26.36 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.221 -0.924 . . . . 1.0 109.569 -179.642 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.87 -65.21 0.86 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.307 -0.871 . . . . 1.0 110.308 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.683 ' CE2' ' CE1' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -111.91 -4.34 14.59 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.033 -1.042 . . . . 1.0 110.219 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.683 ' CE1' ' CE2' ' A' ' 78' ' ' PHE . 52.3 m-85 -83.89 105.94 15.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.98 -1.075 . . . . 1.0 108.963 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.53 ' HB2' ' CG ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -143.66 10.11 1.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.073 -1.017 . . . . 1.0 110.081 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 122' ' ' GLY . 11.9 m -75.68 146.91 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.983 -1.073 . . . . 1.0 109.497 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.734 ' CE1' HD12 ' A' ' 104' ' ' LEU . 5.7 t-80 -175.49 67.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.476 -0.765 . . . . 1.0 109.237 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.6 OUTLIER -122.66 139.9 53.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.235 -0.916 . . . . 1.0 109.746 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . 1.104 HG23 ' CB ' ' A' ' 120' ' ' CYS . 4.5 mp -100.11 133.52 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.343 -0.848 . . . . 1.0 109.675 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 86' ' ' GLY . 2.0 p -126.41 -163.88 1.27 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.275 -0.891 . . . . 1.0 109.302 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 85' ' ' THR . . . 41.66 -124.21 3.2 Favored Glycine 0 N--CA 1.483 1.829 0 N-CA-C 110.039 -1.224 . . . . 1.0 110.039 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.93 108.5 7.7 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.234 -1.156 . . . . 1.0 109.513 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.4 HG22 ' CG2' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -94.64 -177.17 4.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.363 -0.836 . . . . 1.0 109.409 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.569 HG22 ' H ' ' A' ' 91' ' ' THR . 8.7 p -88.49 132.61 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.321 -0.862 . . . . 1.0 109.306 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.3 m -74.65 -0.43 17.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 1.0 109.806 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.569 ' H ' HG22 ' A' ' 89' ' ' VAL . 16.4 m -80.75 -83.01 0.11 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.069 -1.019 . . . . 1.0 109.387 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.569 ' O ' HG21 ' A' ' 106' ' ' ILE . 0.0 OUTLIER 179.33 162.46 0.85 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.302 -0.874 . . . . 1.0 109.459 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.533 ' HA ' ' CG1' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -165.19 156.98 15.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.263 -0.898 . . . . 1.0 110.014 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.488 ' HB2' ' O ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -155.61 150.08 26.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.467 -0.77 . . . . 1.0 109.064 179.78 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -120.45 148.48 43.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.136 -0.978 . . . . 1.0 109.837 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.29 121.22 9.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.303 -0.873 . . . . 1.0 109.557 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.887 HD13 ' HG2' ' A' ' 102' ' ' LYS . 2.1 tp -110.75 106.12 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.342 -0.849 . . . . 1.0 109.606 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.722 HD23 ' H ' ' A' ' 98' ' ' LEU . 2.1 pt? -110.15 130.28 55.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.205 -0.934 . . . . 1.0 109.48 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.465 ' O ' ' OG1' ' A' ' 101' ' ' THR . 16.6 m 35.07 83.98 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.077 -0.39 . . . . 1.0 111.379 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.426 ' CG ' ' O ' ' A' ' 99' ' ' SER . 13.4 p30 42.72 29.42 0.17 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.684 -0.635 . . . . 1.0 112.482 178.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.612 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -132.34 109.4 9.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.247 -1.533 . . . . 1.0 109.969 179.141 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.887 ' HG2' HD13 ' A' ' 97' ' ' ILE . 9.9 mmtp -85.96 137.93 32.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.1 -1.0 . . . . 1.0 109.358 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.692 HG12 ' HB2' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -143.98 172.68 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.331 -0.855 . . . . 1.0 109.089 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.003 HD22 HD11 ' A' ' 106' ' ' ILE . 0.5 OUTLIER -124.31 135.55 53.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.27 -0.894 . . . . 1.0 110.147 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 0.4 OUTLIER -139.99 125.03 18.58 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.601 -0.889 . . . . 1.0 108.601 179.405 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 1.003 HD11 HD22 ' A' ' 104' ' ' LEU . 4.1 mp -128.94 115.81 19.03 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.976 -1.077 . . . . 1.0 110.115 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.41 97.3 1.12 Allowed 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 121.946 1.764 . . . . 1.0 109.64 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.559 HD11 ' HG3' ' A' ' 110' ' ' PRO . 0.7 OUTLIER -145.75 167.59 22.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 1.0 109.485 -179.205 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.772 HD23 ' OD1' ' A' ' 112' ' ' ASN . 3.9 tt -115.03 78.56 5.6 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.921 . . . . 1.0 110.346 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.559 ' HG3' HD11 ' A' ' 108' ' ' LEU . 38.1 Cg_endo -83.25 40.13 0.9 Allowed 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.589 2.192 . . . . 1.0 110.082 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.595 ' HB2' ' CD2' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -120.81 22.39 11.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.047 -1.033 . . . . 1.0 110.056 -178.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.772 ' OD1' HD23 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -122.32 -52.9 1.93 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.114 -0.991 . . . . 1.0 109.119 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 1.4 p 164.59 86.01 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.371 -0.831 . . . . 1.0 108.989 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' MET . . . . . 0.451 ' CE ' ' HB3' ' A' ' 110' ' ' PRO . 0.5 OUTLIER -154.7 144.55 21.66 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.14 -0.975 . . . . 1.0 109.829 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.634 ' HG2' ' NE2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -101.44 142.73 32.39 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.541 -0.911 . . . . 1.0 108.541 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.508 ' N ' ' HD3' ' A' ' 115' ' ' ARG . . . -134.78 96.55 3.56 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.994 -1.066 . . . . 1.0 109.87 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 117' ' ' VAL . 3.9 m -86.45 131.37 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.346 -0.846 . . . . 1.0 109.145 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.464 ' O ' ' HG2' ' A' ' 46' ' ' PRO . 2.2 mt -117.27 130.1 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.217 -0.927 . . . . 1.0 109.153 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 42' ' ' ALA . 0.7 OUTLIER -171.66 57.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.863 . . . . 1.0 109.695 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 1.104 ' CB ' HG23 ' A' ' 84' ' ' ILE . 60.7 m -145.19 43.73 1.32 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.137 -0.977 . . . . 1.0 109.845 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . 0.501 ' O ' HG12 ' A' ' 38' ' ' VAL . . . -126.64 165.95 18.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 1.0 108.833 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.848 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -139.76 -179.48 17.76 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.697 -1.361 . . . . 1.0 109.697 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.85 HD11 ' CD2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -119.43 158.54 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.357 -1.084 . . . . 1.0 109.072 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.571 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -99.9 126.24 46.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 1.0 109.459 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -99.76 88.76 3.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.191 -0.943 . . . . 1.0 109.495 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.846 ' O ' HD23 ' A' ' 126' ' ' LEU . 1.7 tt -113.25 -3.6 13.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 1.0 109.648 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 63.69 160.18 0.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.141 -0.974 . . . . 1.0 109.505 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 40.8 p30 -115.83 47.81 1.31 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -0.91 . . . . 1.0 109.477 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 4.4 t -66.43 -28.48 68.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 1.0 109.482 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 129' ' ' SER . 0.3 OUTLIER 167.32 63.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.196 -0.94 . . . . 1.0 109.508 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.748 ' O ' HG23 ' A' ' 131' ' ' ILE . 0.6 OUTLIER -72.64 106.04 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.253 -0.904 . . . . 1.0 109.448 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.3 88.43 6.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 1.0 109.578 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.734 ' H ' HD13 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -74.31 159.88 31.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.293 -0.88 . . . . 1.0 109.96 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.462 ' O ' HD23 ' A' ' 133' ' ' LEU . 4.2 ptp85 -65.99 -168.29 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 1.0 109.526 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 134' ' ' ARG . 5.6 mmtm -44.03 106.78 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.928 . . . . 1.0 109.466 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -106.37 -146.9 14.1 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.604 -1.398 . . . . 1.0 109.604 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -177.3 -34.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -1.082 . . . . 1.0 109.367 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.635 HG21 ' NH2' ' A' ' 74' ' ' ARG . 12.7 t -144.89 177.03 9.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.273 -0.892 . . . . 1.0 109.332 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 138' ' ' THR . 1.8 m-20 66.54 99.79 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -0.932 . . . . 1.0 109.458 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.576 HG23 ' O ' ' A' ' 140' ' ' ILE . 1.1 tp -177.84 42.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 1.0 109.422 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.469 ' O ' ' HD3' ' A' ' 142' ' ' ARG . . . -98.78 -8.66 54.06 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.747 -1.341 . . . . 1.0 109.747 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . 0.469 ' HD3' ' O ' ' A' ' 141' ' ' GLY . 0.0 OUTLIER 38.52 37.19 0.16 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.788 -0.831 . . . . 1.0 110.305 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 144' ' ' ASN . 1.5 mtpt -127.13 138.96 53.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 1.0 109.458 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 143' ' ' LYS . 1.2 m-20 67.38 163.28 0.19 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 1.0 109.516 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.501 ' HB ' ' CB ' ' A' ' 174' ' ' CYS . 0.0 OUTLIER -156.73 52.45 0.51 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.348 -0.845 . . . . 1.0 109.386 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.476 ' O ' ' HB ' ' A' ' 67' ' ' THR . 11.2 mtt180 -85.1 166.62 16.49 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.267 -0.896 . . . . 1.0 109.417 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.761 ' CG2' HG21 ' A' ' 172' ' ' ILE . 2.9 m -140.57 151.7 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -0.841 . . . . 1.0 109.422 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.507 ' HA ' ' CB ' ' A' ' 170' ' ' ASN . 42.6 mtt180 -154.52 125.72 7.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.132 -0.98 . . . . 1.0 109.448 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.486 HD23 ' ND2' ' A' ' 170' ' ' ASN . 0.4 OUTLIER -81.26 109.48 15.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.161 -0.962 . . . . 1.0 109.717 -179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.561 HG13 ' OE1' ' A' ' 166' ' ' GLN . 44.0 t -81.47 123.85 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.377 -0.827 . . . . 1.0 109.846 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.93 ' CZ ' HD13 ' A' ' 63' ' ' LEU . 1.9 m-85 -110.4 121.51 45.46 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.656 -0.868 . . . . 1.0 108.656 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . 0.526 ' CG ' ' HA ' ' A' ' 166' ' ' GLN . 1.8 mtt180 -145.03 123.12 12.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.92 -1.112 . . . . 1.0 110.184 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.56 HG13 ' CD1' ' A' ' 163' ' ' LEU . 7.1 p -114.85 129.71 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.476 -0.935 . . . . 1.0 108.476 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' HIS . . . . . 0.574 ' CD2' ' HB2' ' A' ' 164' ' ' SER . 37.7 m80 -130.35 113.43 14.35 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.116 -0.99 . . . . 1.0 109.718 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.808 HG23 HD22 ' A' ' 59' ' ' LEU . 5.2 p -98.74 140.94 22.12 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.306 -0.871 . . . . 1.0 109.019 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PRO . . . . . 0.543 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 33.6 Cg_endo -75.04 116.17 4.5 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.319 2.012 . . . . 1.0 110.791 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLN . . . . . 0.483 ' HB2' ' HD2' ' A' ' 158' ' ' PRO . 0.8 OUTLIER -132.71 165.24 37.95 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.506 -0.746 . . . . 1.0 109.247 -179.556 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 157' ' ' GLN . 33.8 Cg_endo -76.4 -63.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.194 1.93 . . . . 1.0 109.985 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.6 t -64.91 -90.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -0.862 . . . . 1.0 109.184 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . 0.433 ' HA2' ' CD ' ' A' ' 157' ' ' GLN . . . 164.06 -28.21 0.22 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.641 -1.383 . . . . 1.0 109.641 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -79.28 79.62 5.7 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.363 -1.081 . . . . 1.0 108.556 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.668 HG22 ' N ' ' A' ' 163' ' ' LEU . 1.3 m -134.97 -82.21 0.43 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.839 -0.8 . . . . 1.0 108.839 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LEU . . . . . 0.696 ' HG ' HG12 ' A' ' 155' ' ' VAL . 2.1 pp -159.69 106.96 1.69 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.957 -1.09 . . . . 1.0 109.728 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.574 ' HB2' ' CD2' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -164.95 85.02 0.4 Allowed 'General case' 0 C--N 1.294 -1.833 0 O-C-N 120.803 -1.186 . . . . 1.0 109.141 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.75 ' N ' HD23 ' A' ' 165' ' ' LEU . 1.5 pt? -131.38 168.82 16.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.034 -1.042 . . . . 1.0 110.026 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.561 ' OE1' HG13 ' A' ' 150' ' ' VAL . 7.0 tp-100 -101.97 149.74 23.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.452 -0.78 . . . . 1.0 109.548 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 167' ' ' VAL . 39.0 t -144.18 71.51 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 1.0 109.521 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.44 136.19 42.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.089 -1.007 . . . . 1.0 109.5 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 7.3 t -175.3 133.96 0.31 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 1.0 109.613 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.507 ' CB ' ' HA ' ' A' ' 148' ' ' ARG . 1.9 t30 170.03 97.72 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.356 -0.84 . . . . 1.0 109.436 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 23' ' ' SER . 35.3 Cg_endo -77.57 72.18 6.15 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.404 2.069 . . . . 1.0 110.615 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ILE . . . . . 0.761 HG21 ' CG2' ' A' ' 147' ' ' VAL . 13.9 mm -107.79 126.92 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.202 -0.937 . . . . 1.0 109.251 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.468 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 9.9 pt-20 -116.0 145.94 42.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 1.0 109.575 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' CYS . . . . . 0.501 ' CB ' ' HB ' ' A' ' 145' ' ' THR . 4.4 m -114.31 -170.35 1.71 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 1.0 109.414 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.415 ' C ' ' HG2' ' A' ' 176' ' ' GLN . 1.2 p 65.64 113.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 1.0 109.479 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLN . . . . . 0.415 ' HG2' ' C ' ' A' ' 175' ' ' SER . 1.0 OUTLIER -131.53 -153.29 0.55 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.875 . . . . 1.0 109.404 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -67.55 160.65 27.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 1.0 109.501 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 25.2 p . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.968 -1.015 . . . . 1.0 109.45 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.504 ' O ' ' HA3' ' A' ' 52' ' ' GLY . 34.7 Cg_endo . . . . . 0 C--O 1.213 -0.753 0 N-CA-C 110.238 -0.716 . . . . 1.0 110.238 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.577 ' CE2' ' O ' ' A' ' 162' ' ' THR . 2.8 m-85 -69.31 135.19 50.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 1.0 109.568 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 51' ' ' HIS . 3.3 pt-20 -172.31 126.8 0.54 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.964 -1.085 . . . . 1.0 109.838 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.686 ' O ' HD12 ' A' ' 15' ' ' LEU . 1.3 pp -108.55 87.81 2.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.333 -0.854 . . . . 1.0 109.264 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -101.63 148.31 25.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.187 -0.945 . . . . 1.0 109.768 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.539 HG23 ' O ' ' A' ' 47' ' ' ILE . 1.2 mp -69.55 141.74 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.378 -0.826 . . . . 1.0 108.824 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.495 ' OE2' ' CZ ' ' A' ' 115' ' ' ARG . 4.9 tt0 -76.6 -32.93 58.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.296 -0.878 . . . . 1.0 109.816 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.488 ' HB ' HG12 ' A' ' 47' ' ' ILE . 98.2 t -142.29 134.54 26.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.186 -0.946 . . . . 1.0 109.631 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.402 ' HG2' ' CG2' ' A' ' 17' ' ' ILE . 0.7 OUTLIER -122.79 99.92 41.18 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.357 -0.84 . . . . 1.0 109.287 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.489 ' HG3' ' HB3' ' A' ' 42' ' ' ALA . 34.9 Cg_endo -76.53 -179.21 5.1 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.396 2.064 . . . . 1.0 110.576 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -43.18 162.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 1.0 109.476 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.488 ' CB ' ' HG2' ' A' ' 171' ' ' PRO . 8.4 t -119.48 50.02 1.29 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -0.886 . . . . 1.0 109.988 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.29 167.07 17.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.115 -0.991 . . . . 1.0 109.283 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 1.042 ' CE1' HG22 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -170.4 118.6 0.55 Allowed 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 120.154 -0.618 . . . . 1.0 109.63 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.23 76.59 7.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.317 -0.864 . . . . 1.0 109.259 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.428 ' HB2' ' CD1' ' A' ' 123' ' ' ILE . . . . . . . . 0 N--CA 1.487 1.422 0 O-C-N 121.328 -0.858 . . . . 1.0 109.929 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 122.684 1.231 . . . . 1.0 110.832 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 1.042 HG22 ' CE1' ' A' ' 25' ' ' HIS . 3.9 p -133.74 121.28 39.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 107.131 -1.433 . . . . 1.0 107.131 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 121' ' ' ALA . 24.8 mmtt -155.32 116.16 3.9 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.297 -0.877 . . . . 1.0 109.56 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.24 -152.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.6 -0.688 . . . . 1.0 110.081 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 42' ' ' ALA . 1.8 m -51.56 158.39 0.92 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.23 -0.919 . . . . 1.0 109.963 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.489 ' HB3' ' HG3' ' A' ' 21' ' ' PRO . . . 43.0 47.04 4.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.434 -0.791 . . . . 1.0 109.425 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.515 ' HA3' ' CA ' ' A' ' 119' ' ' ASP . . . 44.46 51.66 7.7 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.386 -1.485 . . . . 1.0 109.386 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.466 ' HA3' ' HD2' ' A' ' 39' ' ' LYS . . . 63.89 -87.58 0.07 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.686 -1.365 . . . . 1.0 109.686 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.66 ' CE1' HD12 ' A' ' 149' ' ' LEU . 2.1 m-70 -50.96 144.93 12.85 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.213 -1.169 . . . . 1.0 109.852 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . 36.2 Cg_endo -79.43 -167.93 0.57 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.763 2.309 . . . . 1.0 110.522 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.989 ' CG2' HG12 ' A' ' 117' ' ' VAL . 0.9 OUTLIER -93.23 158.57 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.557 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 3.4 t -136.76 132.84 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 120.925 -1.109 . . . . 1.0 110.359 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.485 ' O ' ' CG ' ' A' ' 49' ' ' GLN . 2.6 pt20 -145.36 120.22 9.94 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.913 -0.773 . . . . 1.0 108.913 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.475 ' HG ' ' HB3' ' A' ' 15' ' ' LEU . 0.3 OUTLIER -86.22 124.11 32.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.149 -0.97 . . . . 1.0 109.893 -179.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.484 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 18.0 p80 -141.23 132.59 26.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.28 -0.887 . . . . 1.0 108.802 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 12' ' ' PRO . . . 137.0 -2.79 3.32 Favored Glycine 0 N--CA 1.483 1.798 0 C-N-CA 119.262 -1.447 . . . . 1.0 110.578 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.583 ' CE2' ' HB2' ' A' ' 163' ' ' LEU . 0.5 OUTLIER -129.32 117.8 21.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.062 -1.257 . . . . 1.0 109.492 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.844 HD12 ' O ' ' A' ' 54' ' ' LEU . 1.3 pp -99.96 35.61 2.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.156 -0.965 . . . . 1.0 109.567 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.56 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 3.9 tp10 -80.0 144.22 33.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 1.0 109.583 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.411 ' ND2' ' C ' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -87.72 34.6 0.71 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.232 -0.917 . . . . 1.0 109.957 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.655 ' HG3' HD21 ' A' ' 59' ' ' LEU . 11.7 pt-20 -133.96 143.92 49.45 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.266 -0.897 . . . . 1.0 109.276 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.576 ' O ' HD23 ' A' ' 59' ' ' LEU . 35.6 Cg_endo -78.57 134.15 12.16 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.307 2.005 . . . . 1.0 110.63 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.655 HD21 ' HG3' ' A' ' 57' ' ' GLU . 12.8 mt -115.59 165.07 13.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.199 -0.938 . . . . 1.0 108.683 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.426 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 40.7 mtt -106.13 112.99 26.25 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.147 -0.971 . . . . 1.0 109.993 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.896 HD21 ' HB2' ' A' ' 63' ' ' LEU . 1.9 tt -70.18 142.08 52.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.578 -0.701 . . . . 1.0 109.349 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.468 ' OE1' ' NH2' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -99.03 96.57 7.9 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.219 -0.926 . . . . 1.0 108.858 179.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.137 HD13 ' CE1' ' A' ' 151' ' ' PHE . 20.8 tp -119.15 132.07 55.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.296 -0.878 . . . . 1.0 109.911 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.59 ' HB3' HG12 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -164.96 165.83 19.9 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.717 -0.845 . . . . 1.0 108.717 179.304 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.759 HD13 ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -105.13 120.94 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.937 -1.102 . . . . 1.0 109.242 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.759 ' N ' HD13 ' A' ' 65' ' ' ILE . . . -132.2 149.1 19.35 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.696 -1.361 . . . . 1.0 109.696 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.746 HG22 ' CD2' ' A' ' 76' ' ' HIS . 16.2 p -83.66 154.45 23.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.371 -1.076 . . . . 1.0 109.319 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.555 ' HB3' ' HD2' ' A' ' 148' ' ' ARG . . . -159.82 118.1 2.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 1.0 109.773 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.447 ' CG ' ' NH2' ' A' ' 146' ' ' ARG . 0.4 OUTLIER -102.23 -13.52 17.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.908 . . . . 1.0 109.164 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -142.5 -55.26 0.43 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.363 -0.836 . . . . 1.0 109.412 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.66 -34.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.955 . . . . 1.0 109.697 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 72' ' ' LEU . 70.3 mt -66.34 86.8 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.914 . . . . 1.0 109.587 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.662 ' O ' HD12 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -50.03 154.77 1.05 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.265 -0.897 . . . . 1.0 109.686 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.497 ' HB3' ' HD2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -144.37 162.24 40.59 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.317 -0.864 . . . . 1.0 108.748 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 74' ' ' ARG . 33.1 Cg_endo -76.32 121.18 5.95 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.213 1.942 . . . . 1.0 110.051 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.915 ' NE2' HG12 ' A' ' 147' ' ' VAL . 1.6 t-80 -57.89 163.4 2.7 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.361 -0.837 . . . . 1.0 110.016 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.12 -76.29 0.08 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 1.0 109.548 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -125.41 21.86 7.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 1.0 109.706 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.586 ' HB2' ' CG ' ' A' ' 76' ' ' HIS . 3.9 m-30 -79.91 75.99 6.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.213 -0.93 . . . . 1.0 109.077 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.553 ' CB ' ' HB3' ' A' ' 102' ' ' LYS . 4.2 pt20 -139.0 4.41 2.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.945 -1.097 . . . . 1.0 110.307 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.91 HG23 ' O ' ' A' ' 122' ' ' GLY . 15.0 m -78.65 144.77 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.958 -1.089 . . . . 1.0 109.182 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.588 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 3.1 p80 -175.93 59.38 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 118.998 -1.081 . . . . 1.0 110.194 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 120' ' ' CYS . 2.9 mmt85 -81.44 140.15 34.82 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.112 -0.993 . . . . 1.0 109.325 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.516 ' CG1' ' HB2' ' A' ' 120' ' ' CYS . 3.5 mp -106.32 135.58 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.205 -0.934 . . . . 1.0 109.764 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 49.9 p . . . . . 0 C--N 1.303 -1.453 0 O-C-N 121.406 -0.808 . . . . 1.0 109.106 179.915 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.863 HG13 HG22 ' A' ' 91' ' ' THR . 6.6 p . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.318 -0.623 . . . . 1.0 109.318 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.3 m -86.78 16.02 5.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 1.0 109.524 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.863 HG22 HG13 ' A' ' 89' ' ' VAL . 7.4 t -69.89 125.95 28.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -0.952 . . . . 1.0 109.575 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.829 ' O ' HG23 ' A' ' 106' ' ' ILE . 18.3 m -93.88 91.21 6.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.92 . . . . 1.0 109.235 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.55 ' HA ' HG23 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -103.3 173.28 6.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -0.974 . . . . 1.0 109.951 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -145.76 161.66 39.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.477 -0.765 . . . . 1.0 109.167 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.523 ' HG2' ' NE2' ' A' ' 82' ' ' HIS . 43.5 mt-10 -128.51 120.54 26.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 1.0 109.872 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 102' ' ' LYS . . . -114.18 124.56 52.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 1.0 108.94 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.688 HD13 ' N ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -124.73 126.39 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.09 -1.006 . . . . 1.0 109.876 -179.421 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.688 ' N ' HD13 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -126.22 59.77 1.32 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.938 . . . . 1.0 109.448 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER 77.03 103.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 1.0 109.612 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' A' ' 99' ' ' SER . 3.2 p-10 42.88 43.31 3.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.694 -0.629 . . . . 1.0 110.18 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.463 ' HB ' ' HG ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -159.58 87.96 0.84 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.993 -1.067 . . . . 1.0 109.776 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.553 ' HB3' ' CB ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -97.32 152.67 18.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.343 -0.848 . . . . 1.0 109.159 179.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.59 HG12 ' HB3' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -146.36 169.97 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.217 -0.927 . . . . 1.0 109.06 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.019 HD12 ' HG ' ' A' ' 63' ' ' LEU . 3.3 mt -120.31 128.56 53.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.933 . . . . 1.0 109.615 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -123.94 106.73 10.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.269 -0.894 . . . . 1.0 108.835 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.829 HG23 ' O ' ' A' ' 92' ' ' THR . 4.5 mt -119.38 115.95 33.88 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 1.0 109.832 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.742 ' C ' HD23 ' A' ' 108' ' ' LEU . 33.7 Cg_endo -75.87 119.0 5.23 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 121.96 1.773 . . . . 1.0 109.448 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.742 HD23 ' C ' ' A' ' 107' ' ' PRO . 6.1 mt -115.52 165.18 13.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.193 -0.942 . . . . 1.0 110.494 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.862 HD23 ' HB2' ' A' ' 112' ' ' ASN . 1.0 OUTLIER -97.3 126.69 40.92 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.485 ' CG ' ' O ' ' A' ' 57' ' ' GLU . 36.5 Cg_endo -79.96 -30.65 2.14 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 122.345 2.03 . . . . 1.0 112.03 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 54' ' ' LEU . 2.1 tt0 -139.35 66.99 1.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.773 -1.204 . . . . 1.0 110.526 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.862 ' HB2' HD23 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -165.39 -67.52 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 1.0 109.505 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.4 OUTLIER 164.63 108.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.05 -1.032 . . . . 1.0 109.343 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.45 ' O ' ' HG3' ' A' ' 114' ' ' MET . 5.9 tpt -154.67 49.83 0.6 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.911 . . . . 1.0 110.129 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.495 ' CZ ' ' OE2' ' A' ' 18' ' ' GLU . 10.0 ttt-85 -74.69 134.33 41.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.966 . . . . 1.0 108.633 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -138.37 153.12 48.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.902 -1.124 . . . . 1.0 110.294 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.989 HG12 ' CG2' ' A' ' 47' ' ' ILE . 4.5 m -126.14 126.46 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.476 ' CD1' HD21 ' A' ' 63' ' ' LEU . 32.4 mt -99.17 104.3 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 1.0 109.604 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.515 ' CA ' ' HA3' ' A' ' 43' ' ' GLY . 14.6 p-10 -149.5 39.48 0.81 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 1.0 109.353 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.516 ' HB2' ' CG1' ' A' ' 84' ' ' ILE . 60.7 m -145.05 59.03 1.3 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 1.0 109.51 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.522 ' O ' ' CG ' ' A' ' 39' ' ' LYS . . . -143.47 -176.38 4.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.417 -0.802 . . . . 1.0 109.119 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.91 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -154.6 168.66 32.77 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.575 -1.41 . . . . 1.0 109.575 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -114.55 154.63 15.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.236 -1.155 . . . . 1.0 108.836 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.517 HD23 HG21 ' A' ' 81' ' ' VAL . 0.5 OUTLIER -118.62 109.58 16.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.129 -0.982 . . . . 1.0 109.506 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.509 ' CD ' ' O ' ' A' ' 125' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.303 -0.873 . . . . 1.0 109.434 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.31 0.576 . . . . 1.0 109.467 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -89.58 164.78 14.62 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.27 -0.894 . . . . 1.0 109.594 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.915 HG12 ' NE2' ' A' ' 76' ' ' HIS . 31.6 m -140.84 163.49 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.472 -0.768 . . . . 1.0 109.254 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.555 ' HD2' ' HB3' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -155.58 113.31 3.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.958 . . . . 1.0 109.706 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.911 HD21 ' CD1' ' A' ' 63' ' ' LEU . 1.7 tt -79.76 121.56 25.51 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.208 -0.932 . . . . 1.0 109.217 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 36.0 t -96.42 123.55 48.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.232 -0.917 . . . . 1.0 109.574 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 1.137 ' CE1' HD13 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -120.5 92.33 3.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 1.0 108.954 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.537 ' CB ' ' HA ' ' A' ' 166' ' ' GLN . 24.4 ptt85 -139.28 137.59 36.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.139 -0.976 . . . . 1.0 110.219 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.701 ' CG1' HD21 ' A' ' 163' ' ' LEU . 9.8 p -115.42 128.28 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.264 -0.897 . . . . 1.0 108.669 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.432 ' CD2' ' NH1' ' A' ' 152' ' ' ARG . 64.3 m-70 -126.69 116.63 21.26 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.11 -0.994 . . . . 1.0 109.542 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 1.04 ' HB ' HD12 ' A' ' 163' ' ' LEU . 9.8 p -99.16 141.35 22.7 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.206 -0.934 . . . . 1.0 109.169 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 35.4 Cg_endo -77.32 119.03 4.82 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.422 2.081 . . . . 1.0 110.634 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.461 ' OE1' ' HD2' ' A' ' 158' ' ' PRO . 0.1 OUTLIER -160.19 173.03 5.22 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.266 -0.896 . . . . 1.0 109.44 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.461 ' HD2' ' OE1' ' A' ' 157' ' ' GLN . 35.1 Cg_endo -77.87 -67.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.327 2.018 . . . . 1.0 110.44 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 36.6 m -64.15 109.38 1.83 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.905 . . . . 1.0 109.345 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.28 -30.27 11.14 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.542 -1.423 . . . . 1.0 109.542 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.7 mtp85 -79.59 79.06 6.1 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.257 -1.016 . . . . 1.0 108.257 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.647 HG22 ' N ' ' A' ' 163' ' ' LEU . 1.3 m -136.39 -79.77 0.4 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.001 -0.74 . . . . 1.0 109.001 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 1.04 HD12 ' HB ' ' A' ' 155' ' ' VAL . 0.1 OUTLIER -149.26 106.31 3.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.984 -1.072 . . . . 1.0 108.189 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.666 ' N ' HD22 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -163.83 106.34 0.95 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.608 -1.307 . . . . 1.0 109.466 -179.284 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.691 HD13 ' H ' ' A' ' 166' ' ' GLN . 0.2 OUTLIER -134.19 151.36 51.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.081 -1.012 . . . . 1.0 109.696 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.691 ' H ' HD13 ' A' ' 165' ' ' LEU . 15.4 mt-30 -123.69 139.44 53.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 1.0 109.374 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 167' ' ' VAL . 46.7 t -142.54 71.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.214 -0.929 . . . . 1.0 109.674 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.6 108.89 20.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 1.0 109.212 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 2.7 m -148.6 137.83 21.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.945 . . . . 1.0 109.674 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 169' ' ' SER . 0.6 OUTLIER 171.74 92.49 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.359 -0.838 . . . . 1.0 109.52 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.488 ' HG2' ' CB ' ' A' ' 23' ' ' SER . 34.8 Cg_endo -77.42 72.02 6.16 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.373 2.049 . . . . 1.0 110.694 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 172' ' ' ILE . 13.8 mm -115.21 78.74 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 1.0 109.233 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 1.0 109.746 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo . . . . . 0 C--O 1.216 -0.603 0 N-CA-C 110.395 -0.656 . . . . 1.0 110.395 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.498 ' HA ' ' HA3' ' A' ' 52' ' ' GLY . 13.0 m-30 -80.06 123.32 27.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 1.0 109.469 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -152.2 130.07 11.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.942 . . . . 1.0 109.616 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.689 HD13 HD12 ' A' ' 50' ' ' LEU . 53.8 tp -107.41 83.47 1.82 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.237 -0.914 . . . . 1.0 109.198 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.61 157.48 23.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 1.0 109.805 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.674 HG21 ' NE2' ' A' ' 20' ' ' GLN . 1.1 mp -79.86 144.35 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.412 ' OE1' ' CD ' ' A' ' 49' ' ' GLN . 27.6 tp10 -80.7 -63.88 1.31 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 1.0 109.094 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.561 HG12 ' HD3' ' A' ' 21' ' ' PRO . 2.0 t -92.69 126.21 45.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.339 -0.851 . . . . 1.0 109.134 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.674 ' NE2' HG21 ' A' ' 17' ' ' ILE . 5.5 tp-100 -130.67 63.65 70.58 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.938 . . . . 1.0 109.66 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.561 ' HD3' HG12 ' A' ' 19' ' ' VAL . 36.0 Cg_endo -78.09 -177.96 4.26 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.513 2.142 . . . . 1.0 110.449 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.439 ' HE2' ' CD2' ' A' ' 24' ' ' HIS . 2.1 ttpt -50.36 161.01 0.33 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.229 -0.919 . . . . 1.0 109.383 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.411 ' O ' ' CG1' ' A' ' 172' ' ' ILE . 2.1 t -154.62 58.72 0.69 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.263 -0.898 . . . . 1.0 109.871 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.439 ' CD2' ' HE2' ' A' ' 22' ' ' LYS . 1.9 p80 -103.5 166.22 10.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 1.0 109.411 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.845 ' HD2' HD11 ' A' ' 123' ' ' ILE . 3.7 t60 -163.86 113.12 1.23 Allowed 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.405 -0.81 . . . . 1.0 109.827 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.439 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 5.1 ttp180 -89.57 75.95 7.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.406 -0.808 . . . . 1.0 109.103 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.354 -0.841 . . . . 1.0 109.767 -179.774 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.541 ' C ' ' CE1' ' A' ' 25' ' ' HIS . . . . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.58 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 2.5 p -54.84 106.08 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.329 -0.857 . . . . 1.0 109.468 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.4 98.92 4.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 1.0 109.583 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.449 ' O ' ' O ' ' A' ' 41' ' ' SER . . . -158.23 95.92 1.4 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.896 . . . . 1.0 109.548 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 43' ' ' GLY . 1.9 t 60.87 144.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 1.0 109.465 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 51.45 -90.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.888 . . . . 1.0 109.423 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 41' ' ' SER . . . -167.92 34.88 0.21 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.442 -1.463 . . . . 1.0 109.442 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.558 ' HA3' HG22 ' A' ' 38' ' ' VAL . . . 109.69 -84.83 0.38 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.563 -1.415 . . . . 1.0 109.563 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.477 ' HB3' ' HD2' ' A' ' 46' ' ' PRO . 74.0 m-70 -77.14 159.88 77.18 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.358 -1.084 . . . . 1.0 109.504 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 45' ' ' HIS . 35.1 Cg_endo -77.47 -176.79 3.4 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 122.598 2.199 . . . . 1.0 110.679 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.767 HG23 HG12 ' A' ' 117' ' ' VAL . 3.8 mm -94.04 159.51 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.496 -0.753 . . . . 1.0 109.142 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.78 135.68 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.154 -0.966 . . . . 1.0 109.895 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.455 ' O ' ' HG3' ' A' ' 49' ' ' GLN . 2.6 pt20 -150.23 143.43 24.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.827 . . . . 1.0 109.111 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.689 HD12 HD13 ' A' ' 15' ' ' LEU . 3.0 tt -113.48 140.12 48.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.17 -0.957 . . . . 1.0 109.772 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 51' ' ' HIS . 14.6 p80 -140.08 81.59 1.82 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 1.0 109.093 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . -156.65 -97.92 0.14 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.049 -1.22 . . . . 1.0 110.049 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.477 ' HB3' ' CG ' ' A' ' 111' ' ' GLU . 0.4 OUTLIER -39.56 129.51 1.9 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.835 -0.803 . . . . 1.0 110.145 -179.519 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.5 mt -101.54 3.66 40.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.321 -0.862 . . . . 1.0 109.561 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 111' ' ' GLU . 2.7 tm-20 -79.71 138.5 37.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.179 -0.95 . . . . 1.0 109.362 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.452 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 4.6 p30 -85.96 56.74 4.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.913 . . . . 1.0 109.599 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.483 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 5.0 mt-10 -105.64 143.2 26.35 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 1.0 109.245 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.537 ' O ' HD23 ' A' ' 59' ' ' LEU . 36.2 Cg_endo -78.62 120.19 4.7 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.394 2.063 . . . . 1.0 110.451 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.537 HD23 ' O ' ' A' ' 58' ' ' PRO . 20.6 mt -119.94 164.51 15.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 1.0 109.138 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -111.26 132.83 54.06 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.172 -0.955 . . . . 1.0 109.61 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.521 ' CD2' ' HB3' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -86.54 121.79 29.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.39 -0.819 . . . . 1.0 109.265 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.472 ' O ' ' HG2' ' A' ' 152' ' ' ARG . 9.4 mm-40 -92.48 75.68 5.14 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.203 -0.936 . . . . 1.0 108.872 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.818 HD22 ' CE1' ' A' ' 151' ' ' PHE . 0.4 OUTLIER -116.06 155.61 27.82 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.372 -0.83 . . . . 1.0 109.672 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 1.03 ' HA ' HD12 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -165.6 -178.91 5.12 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.381 -0.824 . . . . 1.0 108.909 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.75 HG23 ' O ' ' A' ' 65' ' ' ILE . 0.8 OUTLIER -112.77 100.58 11.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.068 -1.02 . . . . 1.0 109.091 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 74' ' ' ARG . . . -118.99 149.94 18.06 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.942 -1.263 . . . . 1.0 109.942 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.661 HG22 ' CD2' ' A' ' 76' ' ' HIS . 20.4 p -78.4 146.78 34.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.421 -1.046 . . . . 1.0 109.151 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.756 ' HB3' ' HG3' ' A' ' 148' ' ' ARG . . . -152.49 116.16 4.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.148 -0.97 . . . . 1.0 109.535 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.511 ' HA ' ' NE ' ' A' ' 146' ' ' ARG . 1.6 p30 -85.0 -25.86 27.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.37 -0.832 . . . . 1.0 109.334 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -133.0 -49.49 0.87 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.192 -0.942 . . . . 1.0 109.322 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -175.06 -38.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 1.0 109.565 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.546 HD23 ' H ' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -55.89 89.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.907 . . . . 1.0 109.601 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -51.9 171.79 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.178 -0.951 . . . . 1.0 109.613 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.517 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 2.1 mtm180 -168.99 163.17 7.72 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.354 -0.841 . . . . 1.0 109.284 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 76' ' ' HIS . 35.3 Cg_endo -77.64 108.33 2.54 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.352 2.035 . . . . 1.0 110.437 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.661 ' CD2' HG22 ' A' ' 67' ' ' THR . 19.1 t-80 -42.07 161.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.423 -0.798 . . . . 1.0 110.01 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -48.83 -74.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.303 -0.873 . . . . 1.0 109.369 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.5 m-85 -135.32 22.79 3.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -0.929 . . . . 1.0 109.39 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.491 ' CD2' HG22 ' A' ' 123' ' ' ILE . 4.7 m-30 -80.21 118.45 21.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.262 -0.899 . . . . 1.0 109.354 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.541 ' HB2' ' CG ' ' A' ' 102' ' ' LYS . 0.1 OUTLIER -163.32 23.69 0.08 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.973 . . . . 1.0 109.804 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 122' ' ' GLY . 15.1 m -86.14 150.93 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.098 -1.001 . . . . 1.0 109.307 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.559 ' ND1' ' HB2' ' A' ' 121' ' ' ALA . 12.5 t60 -175.38 75.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.286 -0.884 . . . . 1.0 109.414 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 120' ' ' CYS . 15.2 mmm180 -109.7 130.24 55.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.295 -0.878 . . . . 1.0 109.64 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.565 HG23 ' CB ' ' A' ' 120' ' ' CYS . 4.6 mp -104.22 136.18 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 1.0 109.455 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 69.4 p . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.393 -0.817 . . . . 1.0 109.288 179.731 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.555 HG13 ' H ' ' A' ' 91' ' ' THR . 9.8 p . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.26 0.552 . . . . 1.0 109.537 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.36 12.78 7.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -0.94 . . . . 1.0 109.589 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.555 ' H ' HG13 ' A' ' 89' ' ' VAL . 16.0 m -103.14 104.88 15.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 1.0 109.472 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.762 ' O ' HG23 ' A' ' 106' ' ' ILE . 10.0 t -54.22 158.56 2.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.16 -0.962 . . . . 1.0 109.338 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.24 172.79 12.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 1.0 109.7 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -155.07 151.78 28.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.361 -0.837 . . . . 1.0 109.534 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -125.7 132.84 52.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 1.0 109.313 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -125.27 120.65 31.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.13 -0.981 . . . . 1.0 109.699 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.889 HD12 ' O ' ' A' ' 101' ' ' THR . 9.9 tp -125.0 133.7 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 1.0 109.293 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.531 HD23 ' N ' ' A' ' 98' ' ' LEU . 1.0 OUTLIER -133.34 50.86 2.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.222 -0.924 . . . . 1.0 109.53 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER 76.66 114.16 0.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.309 -0.87 . . . . 1.0 109.742 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.43 ' CG ' ' O ' ' A' ' 99' ' ' SER . 3.9 p-10 43.49 35.03 0.86 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.665 -0.647 . . . . 1.0 110.476 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.889 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -156.15 102.63 2.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.927 -1.108 . . . . 1.0 109.743 179.642 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.798 ' HD2' HD13 ' A' ' 97' ' ' ILE . 4.5 tptt -112.29 153.68 26.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 1.0 109.386 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.964 HG12 ' HB3' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -158.54 168.66 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.271 -0.893 . . . . 1.0 109.113 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.03 HD12 ' HA ' ' A' ' 64' ' ' PHE . 1.1 mt -116.79 134.85 54.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 1.0 109.734 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -127.08 112.32 15.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.368 -0.833 . . . . 1.0 109.273 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 1.029 HG22 HD21 ' A' ' 108' ' ' LEU . 3.4 mt -121.69 107.0 36.59 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.907 . . . . 1.0 109.606 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.759 ' O ' HD23 ' A' ' 108' ' ' LEU . 33.8 Cg_endo -75.46 104.39 1.9 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 122.09 1.86 . . . . 1.0 110.133 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.029 HD21 HG22 ' A' ' 106' ' ' ILE . 3.0 mt -129.02 163.67 24.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.399 -0.813 . . . . 1.0 109.695 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -129.86 69.23 81.55 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.386 -0.821 . . . . 1.0 109.238 179.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.465 ' HA ' ' CG ' ' A' ' 114' ' ' MET . 36.8 Cg_endo -81.02 45.47 2.01 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 122.703 2.269 . . . . 1.0 110.908 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 55' ' ' GLU . 53.6 mp0 -97.85 -11.48 23.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.99 -1.069 . . . . 1.0 109.684 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 113' ' ' SER . 0.3 OUTLIER -107.85 -55.6 2.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.18 -0.95 . . . . 1.0 109.429 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.1 OUTLIER 169.8 102.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 1.0 109.501 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.465 ' CG ' ' HA ' ' A' ' 110' ' ' PRO . 1.0 OUTLIER -164.79 122.31 1.62 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 1.0 109.574 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.641 ' HD3' HG21 ' A' ' 47' ' ' ILE . 7.5 ttm180 -102.01 136.08 42.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.883 . . . . 1.0 109.477 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.06 139.67 53.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 1.0 109.349 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.767 HG12 HG23 ' A' ' 47' ' ' ILE . 4.3 m -114.99 127.03 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 1.0 109.547 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.463 ' O ' ' HB2' ' A' ' 45' ' ' HIS . 16.1 mt -113.06 100.96 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 1.0 109.387 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.487 ' HB2' ' CA ' ' A' ' 43' ' ' GLY . 4.9 p-10 -153.71 50.72 0.68 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 1.0 109.486 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.565 ' CB ' HG23 ' A' ' 84' ' ' ILE . 96.0 m -137.77 42.85 2.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.221 -0.925 . . . . 1.0 109.589 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.559 ' HB2' ' ND1' ' A' ' 82' ' ' HIS . . . -129.59 172.21 11.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.867 . . . . 1.0 108.95 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -145.36 -165.5 11.3 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.794 -1.322 . . . . 1.0 109.794 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.845 HD11 ' HD2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -125.42 157.18 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.32 -1.106 . . . . 1.0 108.93 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.538 ' HB2' HG11 ' A' ' 81' ' ' VAL . 7.6 tp -140.05 147.05 39.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.098 -1.001 . . . . 1.0 109.725 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.6 tttm . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 1.0 109.232 179.801 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.495 -0.558 . . . . 1.0 109.495 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.511 ' NE ' ' HA ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -98.45 175.13 6.14 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.219 -0.925 . . . . 1.0 109.439 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.409 HG23 ' OD1' ' A' ' 170' ' ' ASN . 17.3 m -138.83 167.19 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.357 -0.84 . . . . 1.0 109.567 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.756 ' HG3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -155.44 111.7 3.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.854 . . . . 1.0 109.534 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.678 HD12 ' O ' ' A' ' 64' ' ' PHE . 11.2 tp -81.44 113.25 19.38 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.213 -0.929 . . . . 1.0 108.947 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.567 HG21 ' HE1' ' A' ' 64' ' ' PHE . 10.6 t -93.46 143.5 11.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.399 -0.813 . . . . 1.0 110.237 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.818 ' CE1' HD22 ' A' ' 63' ' ' LEU . 10.4 m-85 -133.49 113.36 12.4 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.517 ' CB ' ' O ' ' A' ' 165' ' ' LEU . 10.2 ptt85 -145.45 106.76 4.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.933 -1.105 . . . . 1.0 110.529 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 153' ' ' VAL . 9.8 p -92.55 128.83 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.256 -1.016 . . . . 1.0 108.256 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.501 ' ND1' ' HB2' ' A' ' 164' ' ' SER . 48.7 m-70 -121.39 117.4 26.83 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.034 -1.041 . . . . 1.0 110.43 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.695 ' HB ' HD23 ' A' ' 163' ' ' LEU . 8.1 p -99.61 141.13 22.25 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.779 -0.823 . . . . 1.0 108.779 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.534 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 33.4 Cg_endo -75.29 115.04 4.13 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.16 1.907 . . . . 1.0 110.501 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.73 ' HG3' HG21 ' A' ' 162' ' ' THR . 0.9 OUTLIER -136.3 169.13 14.28 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.532 -0.73 . . . . 1.0 109.058 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.525 ' HD2' ' NE2' ' A' ' 157' ' ' GLN . 34.3 Cg_endo -76.69 -65.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.316 2.01 . . . . 1.0 110.284 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.28 -84.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 1.0 109.25 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 152.42 -43.7 0.65 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.565 -1.414 . . . . 1.0 109.565 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -79.01 80.25 5.36 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.987 -1.116 . . . . 1.0 107.987 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.815 HG22 ' N ' ' A' ' 163' ' ' LEU . 1.3 m -133.55 -89.56 0.39 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.56 -0.712 . . . . 1.0 109.374 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.815 ' N ' HG22 ' A' ' 162' ' ' THR . 8.9 tp -125.91 96.91 4.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.83 -1.169 . . . . 1.0 108.737 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.888 ' O ' HD23 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -163.25 119.26 1.76 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.016 -1.052 . . . . 1.0 109.229 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.888 HD23 ' O ' ' A' ' 164' ' ' SER . 22.3 mt -142.63 175.07 10.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.976 -1.078 . . . . 1.0 110.428 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.496 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 2.6 mt-30 -142.27 70.84 1.34 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.607 -0.683 . . . . 1.0 109.201 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 37.9 t -87.79 106.04 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 1.0 110.066 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 150' ' ' VAL . . . -112.03 112.75 24.61 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.543 -0.91 . . . . 1.0 108.543 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 0.0 OUTLIER -136.8 140.99 42.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.989 -1.07 . . . . 1.0 110.261 -179.153 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.501 ' HB3' ' HA ' ' A' ' 148' ' ' ARG . 22.7 t-20 175.93 97.73 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.41 74.38 4.73 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.284 1.99 . . . . 1.0 110.588 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.467 ' HB ' ' OD1' ' A' ' 170' ' ' ASN . 27.6 mt -138.96 126.37 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.331 -0.856 . . . . 1.0 109.287 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 1.0 109.532 -179.874 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 C--O 1.215 -0.654 0 N-CA-C 110.255 -0.71 . . . . 1.0 110.255 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.569 ' CE2' ' O ' ' A' ' 162' ' ' THR . 6.6 m-85 -102.61 169.72 8.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -0.934 . . . . 1.0 109.758 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -160.86 130.82 5.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 1.0 109.456 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.575 ' O ' HG21 ' A' ' 167' ' ' VAL . 23.3 tp -126.83 84.4 2.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.362 -0.836 . . . . 1.0 109.327 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -127.35 154.53 44.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.285 -0.884 . . . . 1.0 109.715 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -67.01 148.33 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.336 -0.853 . . . . 1.0 108.774 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.525 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.0 OUTLIER -70.97 -34.61 71.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.381 -0.824 . . . . 1.0 109.535 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 18' ' ' GLU . 72.3 t -157.78 135.6 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 121.206 -0.934 . . . . 1.0 109.435 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.09 80.45 7.04 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 1.0 109.522 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 19' ' ' VAL . 36.2 Cg_endo -78.52 179.23 6.69 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.519 2.146 . . . . 1.0 110.21 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 21' ' ' PRO . 9.7 mttt -44.56 108.6 0.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.087 -1.008 . . . . 1.0 109.185 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.1 p -130.72 39.41 3.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.126 -0.984 . . . . 1.0 109.945 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.481 ' HA ' HG12 ' A' ' 172' ' ' ILE . 2.0 p-80 -99.69 166.39 11.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.082 -1.011 . . . . 1.0 109.395 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.821 ' NE2' HD11 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -135.45 105.26 6.15 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.671 -0.812 . . . . 1.0 109.843 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.4 ttm-85 -92.4 70.98 5.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.429 -0.795 . . . . 1.0 109.053 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.432 0 O-C-N 121.465 -0.772 . . . . 1.0 109.469 -179.883 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.402 0.62 . . . . 1.0 109.593 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.576 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 2.2 p -54.99 113.77 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.4 -0.813 . . . . 1.0 109.451 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.434 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -137.3 99.48 3.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.347 -0.846 . . . . 1.0 109.598 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.66 -154.34 0.6 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.377 -0.827 . . . . 1.0 109.458 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.5 t -69.84 -72.48 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 1.0 109.636 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.36 69.03 2.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 1.0 109.405 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.92 -82.12 0.87 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.31 -1.516 . . . . 1.0 109.31 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -165.97 -37.2 0.02 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.64 -1.384 . . . . 1.0 109.64 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -100.69 160.21 27.47 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.267 -1.137 . . . . 1.0 109.72 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.5 ' C ' HD13 ' A' ' 47' ' ' ILE . 35.8 Cg_endo -78.59 -176.64 3.38 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.539 2.159 . . . . 1.0 110.482 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.901 ' CG2' HG12 ' A' ' 117' ' ' VAL . 1.0 OUTLIER -94.14 158.07 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.607 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 2.9 t -134.54 135.94 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.983 -1.073 . . . . 1.0 110.399 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.558 ' HG2' ' CE1' ' A' ' 51' ' ' HIS . 5.0 tt0 -151.41 144.28 24.47 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.914 -0.773 . . . . 1.0 108.914 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.9 tt -113.23 138.51 49.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.085 -1.009 . . . . 1.0 109.994 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.558 ' CE1' ' HG2' ' A' ' 49' ' ' GLN . 7.5 m-70 -140.33 77.9 1.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.401 -0.812 . . . . 1.0 109.25 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . -177.03 84.69 0.07 OUTLIER Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.687 -1.244 . . . . 1.0 110.049 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.569 ' CD2' ' OE2' ' A' ' 111' ' ' GLU . 3.5 t80 177.16 132.09 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -1.196 . . . . 1.0 109.619 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.2 -10.84 17.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 1.0 109.437 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.415 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 2.4 mt-10 -89.75 145.25 25.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 1.0 109.502 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.411 ' H ' ' ND2' ' A' ' 56' ' ' ASN . 2.1 p30 -103.73 57.13 0.73 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.309 -0.87 . . . . 1.0 109.35 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -110.1 156.46 40.05 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 1.0 109.454 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.979 ' O ' HD23 ' A' ' 59' ' ' LEU . 35.8 Cg_endo -78.31 131.07 10.45 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.5 2.133 . . . . 1.0 110.49 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.979 HD23 ' O ' ' A' ' 58' ' ' PRO . 6.5 mt -128.88 162.79 26.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 1.0 109.225 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.458 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 2.1 mpp? -105.78 131.63 52.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.275 -0.891 . . . . 1.0 109.355 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.818 HD21 ' HB2' ' A' ' 63' ' ' LEU . 1.1 tt -90.26 141.27 28.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.376 -0.828 . . . . 1.0 109.388 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.434 ' OE1' ' O ' ' A' ' 62' ' ' GLN . 0.9 OUTLIER -104.64 78.12 1.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.184 -0.948 . . . . 1.0 109.681 -179.764 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.135 HD13 ' CE1' ' A' ' 151' ' ' PHE . 23.4 tp -100.87 135.18 42.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 1.0 109.086 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.718 ' HB2' HG12 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -165.45 159.67 17.16 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.542 -0.911 . . . . 1.0 108.542 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.497 HG23 ' O ' ' A' ' 65' ' ' ILE . 1.2 tp -110.84 125.49 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 1.0 109.057 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 74' ' ' ARG . . . -145.08 142.38 10.77 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.619 -1.392 . . . . 1.0 109.619 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.681 HG23 ' HA ' ' A' ' 76' ' ' HIS . 72.4 p -66.64 178.85 1.17 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.496 -1.003 . . . . 1.0 109.945 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.422 ' HB3' ' HD2' ' A' ' 148' ' ' ARG . . . -170.23 125.37 0.76 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.465 -0.772 . . . . 1.0 109.072 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.83 -38.03 20.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 1.0 108.962 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -140.45 -56.43 0.53 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.167 -0.958 . . . . 1.0 109.699 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.492 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -152.14 -47.57 0.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.875 . . . . 1.0 109.524 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mt -52.47 89.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.353 -0.842 . . . . 1.0 109.684 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.778 HD13 ' H ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -48.11 171.93 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.105 -0.997 . . . . 1.0 110.362 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -168.91 167.22 5.97 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.384 -0.823 . . . . 1.0 108.867 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 74' ' ' ARG . 32.7 Cg_endo -74.06 142.69 31.39 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.072 1.848 . . . . 1.0 109.96 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.774 ' NE2' HG12 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -50.72 146.84 5.31 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.252 -0.905 . . . . 1.0 109.763 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.19 -59.54 4.9 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.363 -0.836 . . . . 1.0 109.294 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 74.9 m-85 -136.34 4.04 2.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -0.908 . . . . 1.0 109.912 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.572 ' HB2' ' CG ' ' A' ' 76' ' ' HIS . 6.7 m-30 -99.02 103.19 15.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.984 -1.072 . . . . 1.0 109.25 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.518 ' HB2' ' CG ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -138.88 7.64 2.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.064 -1.023 . . . . 1.0 109.643 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.828 HG11 HD13 ' A' ' 124' ' ' LEU . 35.6 m -64.39 157.89 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.182 -0.949 . . . . 1.0 109.464 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.783 ' CE1' HD11 ' A' ' 84' ' ' ILE . 35.0 t-80 -175.83 90.53 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.478 -0.763 . . . . 1.0 109.296 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.539 ' C ' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -122.53 144.71 48.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.117 -0.99 . . . . 1.0 109.742 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.798 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.3 mp -110.45 125.09 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.29 -0.881 . . . . 1.0 109.51 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.2 p . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 1.0 109.701 -179.97 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 89' ' ' VAL . 5.4 p . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.054 -0.721 . . . . 1.0 109.054 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.57 31.89 0.9 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.11 -0.994 . . . . 1.0 109.627 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.601 HG22 ' N ' ' A' ' 92' ' ' THR . 19.6 m -91.94 -91.09 0.16 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.316 -0.865 . . . . 1.0 109.14 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.854 ' O ' HG23 ' A' ' 106' ' ' ILE . 0.2 OUTLIER -174.54 82.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 1.0 109.383 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.51 160.99 13.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.937 . . . . 1.0 110.048 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.524 ' CB ' ' HG3' ' A' ' 105' ' ' GLU . 0.2 OUTLIER -155.53 160.91 40.91 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.007 -0.738 . . . . 1.0 109.007 179.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' A' ' 94' ' ' HIS . 0.7 OUTLIER -132.82 150.66 52.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.988 -1.07 . . . . 1.0 109.813 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -153.84 124.17 7.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.845 . . . . 1.0 109.225 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.952 HD13 ' N ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -119.52 131.61 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 1.0 109.606 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.952 ' N ' HD13 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -126.05 68.7 1.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 1.0 109.207 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 1.4 m 76.35 93.82 0.07 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -0.843 . . . . 1.0 109.333 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 99' ' ' SER . 1.1 p-10 42.85 55.12 4.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.492 -0.755 . . . . 1.0 109.721 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.479 ' HB ' ' HG ' ' A' ' 98' ' ' LEU . 6.1 m -160.05 80.43 0.7 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.124 -0.985 . . . . 1.0 109.551 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.525 ' CD ' ' HB ' ' A' ' 97' ' ' ILE . 2.1 mmmp? -85.38 131.21 34.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 1.0 109.374 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.718 HG12 ' HB2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -129.49 165.82 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.22 -0.925 . . . . 1.0 109.154 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.611 HD11 ' NE2' ' A' ' 82' ' ' HIS . 0.3 OUTLIER -120.15 141.66 49.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 1.0 109.595 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.524 ' HG3' ' CB ' ' A' ' 94' ' ' HIS . 2.1 pt-20 -137.46 117.07 12.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.332 -0.855 . . . . 1.0 109.147 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.854 HG23 ' O ' ' A' ' 92' ' ' THR . 12.4 mt -118.11 98.84 51.76 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.853 . . . . 1.0 109.849 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.463 ' HD2' ' O ' ' A' ' 92' ' ' THR . 35.3 Cg_endo -76.73 97.61 1.15 Allowed 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.379 2.052 . . . . 1.0 110.302 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.72 ' CD2' HG22 ' A' ' 106' ' ' ILE . 0.6 OUTLIER -145.12 165.26 28.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 1.0 109.657 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -115.37 81.52 8.59 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.303 -0.873 . . . . 1.0 109.698 -179.841 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 108' ' ' LEU . 37.1 Cg_endo -81.0 42.54 1.36 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.634 2.223 . . . . 1.0 110.706 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.569 ' OE2' ' CD2' ' A' ' 53' ' ' TYR . 0.9 OUTLIER -100.33 28.79 4.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.124 -0.985 . . . . 1.0 109.597 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 113' ' ' SER . 0.0 OUTLIER -138.01 -70.31 0.44 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.198 -0.939 . . . . 1.0 109.142 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 112' ' ' ASN . 3.5 t 178.19 101.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 1.0 109.237 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 4.5 ptm -164.04 131.11 3.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 1.0 109.562 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.451 ' HD2' ' OE1' ' A' ' 18' ' ' GLU . 35.7 ttp180 -106.68 131.65 53.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 1.0 109.373 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -116.07 101.96 9.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 1.0 109.377 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.901 HG12 ' CG2' ' A' ' 47' ' ' ILE . 4.6 m -81.06 127.01 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.334 -0.854 . . . . 1.0 109.445 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.574 ' CD1' ' CD2' ' A' ' 63' ' ' LEU . 10.6 mt -107.55 115.01 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.295 -0.878 . . . . 1.0 109.4 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 118' ' ' ILE . 0.6 OUTLIER -156.8 53.41 0.52 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 1.0 109.03 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.481 ' SG ' HG13 ' A' ' 84' ' ' ILE . 1.8 p -141.95 57.07 1.48 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.259 -0.9 . . . . 1.0 109.59 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.12 167.25 22.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 1.0 109.131 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.686 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -137.63 -176.07 14.23 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.833 -1.307 . . . . 1.0 109.833 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.821 HD11 ' NE2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -116.41 171.72 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.354 -1.086 . . . . 1.0 109.083 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.828 HD13 HG11 ' A' ' 81' ' ' VAL . 13.5 tp -128.86 157.72 40.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 1.0 109.811 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.462 ' HD2' ' O ' ' A' ' 125' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.358 -0.839 . . . . 1.0 109.157 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.437 0 CA-C-O 121.4 0.619 . . . . 1.0 109.751 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.538 ' N ' ' HD2' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -154.86 154.77 33.22 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.419 -0.801 . . . . 1.0 109.433 179.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.774 HG12 ' NE2' ' A' ' 76' ' ' HIS . 32.6 m -139.25 162.44 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.908 . . . . 1.0 109.226 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.422 ' HD2' ' HB3' ' A' ' 68' ' ' ALA . 8.0 ttt180 -141.61 112.47 7.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -0.95 . . . . 1.0 109.655 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.808 HD11 HD11 ' A' ' 63' ' ' LEU . 44.0 tp -79.12 123.84 27.75 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.317 -0.865 . . . . 1.0 109.051 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 37.2 t -95.0 146.0 7.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.233 -0.917 . . . . 1.0 109.773 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 1.135 ' CE1' HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -148.1 99.43 3.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 1.0 109.021 -179.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.524 ' CB ' ' HA ' ' A' ' 166' ' ' GLN . 14.1 ptt180 -150.33 136.4 18.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.98 -1.075 . . . . 1.0 110.255 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 153' ' ' VAL . 9.8 p -115.42 129.02 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.568 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 33.2 m-70 -126.88 118.46 24.64 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.129 -0.982 . . . . 1.0 110.119 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.59 ' HB ' HD23 ' A' ' 163' ' ' LEU . 13.0 p -99.04 140.98 22.11 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.363 -0.836 . . . . 1.0 108.769 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.535 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 33.2 Cg_endo -75.25 115.29 4.21 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.161 1.907 . . . . 1.0 110.245 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.812 ' HG3' HG21 ' A' ' 162' ' ' THR . 9.8 mm-40 -136.51 167.28 22.16 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.541 -0.724 . . . . 1.0 109.292 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.448 ' HD2' ' CD ' ' A' ' 157' ' ' GLN . 34.6 Cg_endo -77.32 -63.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.299 1.999 . . . . 1.0 110.21 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.6 t -55.74 -75.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.385 -0.822 . . . . 1.0 109.346 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 142.09 -43.27 1.08 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.482 -1.447 . . . . 1.0 109.482 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.86 80.48 5.2 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.879 -1.156 . . . . 1.0 107.879 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.812 HG21 ' HG3' ' A' ' 157' ' ' GLN . 1.3 m -136.2 -78.23 0.42 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.462 -0.774 . . . . 1.0 109.432 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.63 ' N ' HG22 ' A' ' 162' ' ' THR . 8.3 tp -141.06 100.93 3.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.074 -1.016 . . . . 1.0 108.962 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.568 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -162.21 98.27 1.04 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.025 -1.047 . . . . 1.0 109.534 179.576 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.77 HD13 ' H ' ' A' ' 166' ' ' GLN . 0.2 OUTLIER -126.73 151.88 47.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.331 -0.856 . . . . 1.0 109.625 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.77 ' H ' HD13 ' A' ' 165' ' ' LEU . 5.6 mt-30 -118.51 145.53 45.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.902 . . . . 1.0 109.535 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.575 HG21 ' O ' ' A' ' 15' ' ' LEU . 47.0 t -152.39 93.26 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.124 -0.985 . . . . 1.0 109.78 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 149' ' ' LEU . . . -112.44 110.46 20.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.198 -0.939 . . . . 1.0 109.362 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 0.1 OUTLIER -159.51 136.63 9.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.158 -0.964 . . . . 1.0 109.872 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 169' ' ' SER . 0.2 OUTLIER 176.67 99.14 0.11 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.385 -0.822 . . . . 1.0 109.07 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.46 95.3 1.04 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.311 2.008 . . . . 1.0 110.964 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.54 ' HB ' ' CG2' ' A' ' 147' ' ' VAL . 14.9 mt -150.36 161.36 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.432 -0.793 . . . . 1.0 109.137 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.494 ' N ' HG22 ' A' ' 172' ' ' ILE . 3.3 mt-10 . . . . . 0 N--CA 1.492 1.638 0 O-C-N 121.247 -0.908 . . . . 1.0 109.803 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo . . . . . 0 C--O 1.216 -0.601 0 N-CA-C 110.374 -0.664 . . . . 1.0 110.374 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.507 ' HA ' ' HA3' ' A' ' 52' ' ' GLY . 3.1 m-85 -56.72 145.74 28.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.2 -0.937 . . . . 1.0 109.326 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -157.13 124.14 5.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.903 -1.123 . . . . 1.0 110.089 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.612 HD22 ' HB ' ' A' ' 153' ' ' VAL . 17.5 tp -107.8 81.72 1.55 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.395 -0.815 . . . . 1.0 108.867 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -116.34 157.1 25.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.87 . . . . 1.0 109.903 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.79 HG23 ' O ' ' A' ' 47' ' ' ILE . 1.4 mp -62.96 149.81 9.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.296 -0.878 . . . . 1.0 108.664 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 1.022 ' HB3' HD12 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -64.65 -42.71 95.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.923 . . . . 1.0 109.11 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.723 ' HB ' HD11 ' A' ' 47' ' ' ILE . 71.3 t -151.81 126.76 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.277 -0.89 . . . . 1.0 109.092 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.601 ' HG2' HG21 ' A' ' 17' ' ' ILE . 9.0 mm-40 -115.28 79.14 6.48 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.905 . . . . 1.0 109.484 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.477 ' HD3' HG12 ' A' ' 19' ' ' VAL . 36.2 Cg_endo -77.8 -179.35 5.36 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.352 2.035 . . . . 1.0 110.453 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.68 113.97 5.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 1.0 109.062 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.54 ' HA ' ' CB ' ' A' ' 40' ' ' ALA . 3.0 t -139.29 72.46 1.4 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.226 -0.921 . . . . 1.0 109.855 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.415 ' HA ' HG12 ' A' ' 172' ' ' ILE . 1.7 p-80 -99.69 166.89 10.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.244 -0.91 . . . . 1.0 109.256 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.573 ' CE1' ' HA ' ' A' ' 38' ' ' VAL . 9.3 t60 -135.78 104.19 5.67 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 119.852 -0.739 . . . . 1.0 109.339 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -79.08 77.83 5.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.426 -0.796 . . . . 1.0 109.212 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.394 -0.816 . . . . 1.0 109.648 -179.696 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.248 0.547 . . . . 1.0 109.607 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.573 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 2.2 p -57.48 122.79 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.365 -0.835 . . . . 1.0 109.43 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.32 109.93 3.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 1.0 109.439 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.54 ' CB ' ' HA ' ' A' ' 23' ' ' SER . . . -136.34 -91.63 0.27 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 1.0 109.77 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.55 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 58.8 m -102.61 135.26 44.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.222 -0.924 . . . . 1.0 109.662 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.77 ' HB1' ' CE1' ' A' ' 45' ' ' HIS . . . 67.45 10.1 7.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.928 . . . . 1.0 109.38 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.8 10.8 42.3 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.413 -1.475 . . . . 1.0 109.413 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 45' ' ' HIS . . . 77.06 83.4 0.52 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.644 -1.383 . . . . 1.0 109.644 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.77 ' CE1' ' HB1' ' A' ' 42' ' ' ALA . 23.4 p-80 -179.81 123.0 0.23 Allowed Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.168 -1.195 . . . . 1.0 109.962 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.24 146.61 19.97 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 122.0 1.8 . . . . 1.0 109.416 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.022 HD12 ' HB3' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -97.31 135.1 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.909 -1.119 . . . . 1.0 109.142 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.562 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 3.0 t -118.63 130.79 72.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.017 -1.052 . . . . 1.0 109.814 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.553 ' NE2' ' CG ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -161.4 117.74 2.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.338 -0.852 . . . . 1.0 109.465 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.554 HD11 HG11 ' A' ' 153' ' ' VAL . 3.0 tt -77.07 136.37 38.65 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.126 -0.984 . . . . 1.0 109.154 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.0 87.47 2.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.182 -0.949 . . . . 1.0 109.262 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 163.92 64.48 0.02 OUTLIER Glycine 0 N--CA 1.483 1.807 0 C-N-CA 119.56 -1.305 . . . . 1.0 110.166 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.57 ' CE1' ' HB2' ' A' ' 55' ' ' GLU . 0.2 OUTLIER 175.62 121.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.109 -1.23 . . . . 1.0 109.687 179.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.7 mt -104.0 22.6 14.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.323 -0.861 . . . . 1.0 109.31 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.57 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -87.35 145.22 26.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.179 -0.951 . . . . 1.0 109.685 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.83 46.43 1.33 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.2 -0.938 . . . . 1.0 109.712 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 17.1 pt-20 -122.98 127.75 25.59 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.255 -0.903 . . . . 1.0 109.185 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.596 ' O ' HD23 ' A' ' 59' ' ' LEU . 36.4 Cg_endo -79.44 151.18 22.61 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 122.147 1.898 . . . . 1.0 110.624 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.596 HD23 ' O ' ' A' ' 58' ' ' PRO . 18.6 mt -128.48 142.7 51.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.309 -0.869 . . . . 1.0 108.91 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.444 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -79.95 102.05 8.98 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.074 -1.016 . . . . 1.0 109.423 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.865 HD21 ' HB2' ' A' ' 63' ' ' LEU . 3.0 tt -59.59 135.11 57.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.405 -0.809 . . . . 1.0 109.612 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -102.45 97.06 7.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.359 -0.838 . . . . 1.0 108.998 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.971 HD13 ' CE1' ' A' ' 151' ' ' PHE . 26.8 tp -123.35 139.21 54.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.179 -0.951 . . . . 1.0 109.634 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.495 ' HB3' HG12 ' A' ' 103' ' ' VAL . 2.3 p90 -159.96 -163.9 1.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.325 -0.86 . . . . 1.0 108.928 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.689 HG23 ' O ' ' A' ' 65' ' ' ILE . 2.8 tp -125.36 115.62 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.827 . . . . 1.0 108.828 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.434 ' CA ' ' O ' ' A' ' 74' ' ' ARG . . . -135.09 148.07 19.43 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.677 -1.249 . . . . 1.0 109.996 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.861 HG22 ' CD2' ' A' ' 76' ' ' HIS . 17.4 p -83.97 156.34 22.35 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.519 -0.989 . . . . 1.0 109.225 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.994 ' HB3' ' HG3' ' A' ' 148' ' ' ARG . . . -159.42 120.39 3.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.067 -1.021 . . . . 1.0 109.724 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.438 ' OD1' HD11 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -84.93 -10.91 56.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 1.0 109.374 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -166.65 -44.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.887 . . . . 1.0 109.38 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.487 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -168.33 -36.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 1.0 109.619 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.438 HD11 ' OD1' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -53.98 89.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -0.886 . . . . 1.0 109.548 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.599 ' H ' HD23 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -54.21 169.21 0.19 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.243 -0.911 . . . . 1.0 109.6 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.434 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -175.19 155.17 1.75 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 1.0 109.486 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.426 ' HD2' ' HG2' ' A' ' 74' ' ' ARG . 36.0 Cg_endo -77.67 116.93 4.14 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.483 2.122 . . . . 1.0 110.342 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.861 ' CD2' HG22 ' A' ' 67' ' ' THR . 1.7 t-80 -54.07 154.48 4.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.186 -0.947 . . . . 1.0 109.699 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.95 -72.2 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 1.0 109.796 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.72 ' O ' HD21 ' A' ' 124' ' ' LEU . 1.1 p90 -130.97 12.83 5.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.091 -1.006 . . . . 1.0 109.858 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.668 ' O ' HG21 ' A' ' 65' ' ' ILE . 5.8 m-85 -79.98 117.18 20.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.061 -1.024 . . . . 1.0 108.943 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.543 ' CB ' ' HB3' ' A' ' 102' ' ' LYS . 1.5 pp0? -174.55 33.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.148 -0.97 . . . . 1.0 109.984 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 122' ' ' GLY . 5.6 m -91.94 140.91 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 1.0 109.641 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 1.01 ' CD2' ' HB2' ' A' ' 121' ' ' ALA . 13.4 t-80 -175.58 111.26 0.11 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.401 -0.812 . . . . 1.0 108.94 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.4 OUTLIER -145.08 135.18 23.88 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.09 -1.006 . . . . 1.0 110.116 -179.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.814 HD11 ' HE1' ' A' ' 82' ' ' HIS . 4.0 mp -99.75 128.45 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.596 -0.69 . . . . 1.0 109.379 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.7 p . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 1.0 109.356 -179.976 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.486 1.355 0 N-CA-C 108.982 -0.747 . . . . 1.0 108.982 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.6 p -102.94 -13.8 16.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.22 -0.925 . . . . 1.0 109.452 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.657 ' O ' HG23 ' A' ' 91' ' ' THR . 11.4 t -65.05 115.55 5.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.263 -0.898 . . . . 1.0 109.618 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 1.023 ' O ' HG23 ' A' ' 106' ' ' ILE . 14.5 t -78.62 148.78 33.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.947 . . . . 1.0 109.142 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.46 ' HB3' HG12 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -137.18 174.39 10.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.129 -0.982 . . . . 1.0 110.043 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.76 159.56 43.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.495 -0.753 . . . . 1.0 109.139 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.493 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 27.8 mm-40 -127.14 147.79 50.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.979 . . . . 1.0 109.819 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -151.76 121.55 7.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 1.0 109.427 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.495 ' HB ' ' HD2' ' A' ' 102' ' ' LYS . 2.6 tp -110.27 142.32 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 1.0 109.648 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.637 HD11 HG21 ' A' ' 101' ' ' THR . 0.5 OUTLIER -130.81 49.62 2.3 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.329 -0.857 . . . . 1.0 109.367 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 98' ' ' LEU . 2.0 p 73.92 112.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.864 . . . . 1.0 110.213 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.429 ' CG ' ' O ' ' A' ' 99' ' ' SER . 2.2 p-10 42.71 32.65 0.4 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.603 -0.686 . . . . 1.0 110.502 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.637 HG21 HD11 ' A' ' 98' ' ' LEU . 43.7 m -160.24 88.66 0.82 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.883 -1.135 . . . . 1.0 109.971 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.543 ' HB3' ' CB ' ' A' ' 80' ' ' GLN . 3.8 tptt -91.88 147.5 22.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 1.0 109.239 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.524 ' N ' ' HG3' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -136.8 167.43 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.205 -0.934 . . . . 1.0 109.104 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.583 HD22 HG13 ' A' ' 106' ' ' ILE . 1.0 OUTLIER -121.59 124.43 44.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 1.0 109.65 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.459 ' N ' HD23 ' A' ' 104' ' ' LEU . 1.0 OUTLIER -114.85 120.36 39.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.28 -0.887 . . . . 1.0 109.152 179.684 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 1.023 HG23 ' O ' ' A' ' 92' ' ' THR . 71.3 mt -133.24 108.61 12.45 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.107 -0.996 . . . . 1.0 109.684 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.638 ' O ' HD23 ' A' ' 108' ' ' LEU . 33.9 Cg_endo -75.17 115.6 4.31 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 122.079 1.853 . . . . 1.0 109.844 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.638 HD23 ' O ' ' A' ' 107' ' ' PRO . 21.1 mt -123.45 165.45 17.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.261 -0.899 . . . . 1.0 110.787 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.533 ' N ' ' HD3' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -139.21 59.7 15.5 Favored Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 108.788 -0.819 . . . . 1.0 108.788 179.199 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 109' ' ' LEU . 35.6 Cg_endo -76.95 -3.88 14.28 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.373 2.049 . . . . 1.0 110.622 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 55' ' ' GLU . 3.2 mt-10 -43.63 -36.01 1.99 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.502 -0.749 . . . . 1.0 109.115 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 113' ' ' SER . 3.4 p30 -94.77 -44.33 7.82 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.476 -0.765 . . . . 1.0 109.202 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 1.4 p 164.72 107.54 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 1.0 109.261 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -154.69 94.08 1.64 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.32 -0.863 . . . . 1.0 109.358 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.54 129.77 42.6 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 1.0 109.233 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -136.09 134.7 38.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.895 . . . . 1.0 109.636 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.997 HG12 HG22 ' A' ' 47' ' ' ILE . 3.3 m -106.35 145.78 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.279 -0.888 . . . . 1.0 109.238 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 45' ' ' HIS . 14.3 mt -112.76 93.93 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.176 -0.952 . . . . 1.0 109.509 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.601 ' HB3' ' CG ' ' A' ' 45' ' ' HIS . 9.4 p-10 -127.66 26.44 5.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.591 -0.693 . . . . 1.0 109.257 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.494 ' HB3' HG13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -122.42 44.65 2.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.245 -0.909 . . . . 1.0 110.003 -179.406 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 1.01 ' HB2' ' CD2' ' A' ' 82' ' ' HIS . . . -129.56 177.01 7.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.967 . . . . 1.0 109.102 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.898 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -155.95 -169.84 20.63 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.548 -1.421 . . . . 1.0 109.548 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.542 HD12 ' HD2' ' A' ' 25' ' ' HIS . 1.8 mt -125.68 173.41 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -1.129 . . . . 1.0 109.437 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.72 HD21 ' O ' ' A' ' 78' ' ' PHE . 1.4 pp -140.12 158.14 44.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -0.826 . . . . 1.0 109.396 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 1.0 109.552 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.475 0 CA-C-O 121.15 0.5 . . . . 1.0 109.828 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.476 ' HD2' ' O ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -101.98 158.85 15.84 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.103 -0.998 . . . . 1.0 109.374 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.44 ' O ' ' HG2' ' A' ' 148' ' ' ARG . 2.2 m -141.49 165.33 18.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.437 -0.79 . . . . 1.0 109.147 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.994 ' HG3' ' HB3' ' A' ' 68' ' ' ALA . 20.7 mmm-85 -150.31 119.0 6.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.074 -1.017 . . . . 1.0 109.865 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.96 HD12 HD11 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -79.82 120.25 23.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.292 -0.88 . . . . 1.0 109.278 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 47.4 t -96.74 126.15 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.263 -0.898 . . . . 1.0 109.535 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.971 ' CE1' HD13 ' A' ' 63' ' ' LEU . 3.1 m-85 -127.71 118.3 23.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.849 . . . . 1.0 109.062 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 1.9 ptm180 -150.33 141.17 22.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.131 -0.98 . . . . 1.0 109.977 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.635 ' CG1' HD11 ' A' ' 163' ' ' LEU . 8.8 p -117.32 128.46 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.683 -0.858 . . . . 1.0 108.683 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.452 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 55.1 m-70 -121.69 115.13 22.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.139 -0.975 . . . . 1.0 110.329 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.597 ' HB ' HD23 ' A' ' 163' ' ' LEU . 13.9 p -99.66 141.93 23.69 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.901 -0.778 . . . . 1.0 108.901 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.534 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 32.8 Cg_endo -75.16 114.52 4.03 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.065 1.843 . . . . 1.0 110.357 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.674 ' HG3' HG21 ' A' ' 162' ' ' THR . 3.9 mm-40 -133.41 168.33 18.45 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.553 -0.717 . . . . 1.0 109.069 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.465 ' HD2' ' CD ' ' A' ' 157' ' ' GLN . 34.4 Cg_endo -77.0 -64.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.259 1.973 . . . . 1.0 110.249 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.4 m -62.1 -58.05 9.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.935 . . . . 1.0 109.245 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 124.55 -36.19 2.96 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.738 -1.345 . . . . 1.0 109.738 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -79.14 80.04 5.51 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.498 -1.001 . . . . 1.0 108.312 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.674 HG21 ' HG3' ' A' ' 157' ' ' GLN . 1.3 m -140.54 -74.18 0.34 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.958 -0.756 . . . . 1.0 108.958 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.635 HD11 ' CG1' ' A' ' 153' ' ' VAL . 7.8 tp -142.25 97.62 3.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.09 -1.006 . . . . 1.0 108.644 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.452 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.2 OUTLIER -163.11 87.14 0.55 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.071 -1.018 . . . . 1.0 109.245 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.778 ' H ' HD23 ' A' ' 165' ' ' LEU . 1.8 pt? -132.31 170.78 14.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -0.956 . . . . 1.0 109.805 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.472 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 2.5 tt0 -117.44 157.44 26.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.327 -0.858 . . . . 1.0 109.498 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.57 ' O ' HG12 ' A' ' 167' ' ' VAL . 48.3 t -149.32 81.87 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 1.0 109.653 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 149' ' ' LEU . . . -90.8 103.46 16.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.198 -0.939 . . . . 1.0 109.354 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 170' ' ' ASN . 0.0 OUTLIER -120.07 136.5 54.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -0.967 . . . . 1.0 109.657 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.652 HD21 HD23 ' A' ' 149' ' ' LEU . 1.8 m-20 163.27 85.5 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 1.0 109.383 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.91 72.24 6.24 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.461 2.107 . . . . 1.0 110.574 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 146' ' ' ARG . 12.3 mt -126.71 134.44 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 1.0 109.284 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 1.0 109.631 -179.922 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo . . . . . 0 C--O 1.215 -0.638 0 N-CA-C 110.381 -0.661 . . . . 1.0 110.381 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.66 ' CE2' ' CD1' ' A' ' 53' ' ' TYR . 3.6 m-30 -58.36 145.06 39.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.167 -0.958 . . . . 1.0 109.215 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.657 ' HA ' HD11 ' A' ' 165' ' ' LEU . 53.1 tt0 179.48 142.96 0.14 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.148 -0.97 . . . . 1.0 109.271 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 151' ' ' PHE . 0.9 OUTLIER -98.79 116.8 31.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.339 -0.851 . . . . 1.0 109.213 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -110.76 132.84 53.85 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.338 -0.851 . . . . 1.0 109.916 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.709 HG21 ' NE2' ' A' ' 20' ' ' GLN . 1.1 mp -60.83 143.36 14.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.358 -0.979 . . . . 1.0 108.358 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -71.96 -54.23 10.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 1.0 109.676 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.562 HG12 ' HD3' ' A' ' 21' ' ' PRO . 30.5 t -120.33 133.61 66.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.239 -0.913 . . . . 1.0 109.61 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.709 ' NE2' HG21 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -127.0 76.24 76.1 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.214 -0.929 . . . . 1.0 109.429 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.562 ' HD3' HG12 ' A' ' 19' ' ' VAL . 35.5 Cg_endo -77.69 -175.71 2.83 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.511 2.141 . . . . 1.0 110.51 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -43.46 131.08 5.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.451 -0.781 . . . . 1.0 109.406 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 23' ' ' SER . 7.9 t -112.86 40.07 2.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.189 -0.944 . . . . 1.0 109.841 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.881 ' HA ' HG23 ' A' ' 172' ' ' ILE . 1.9 p80 -103.04 166.16 10.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.05 -1.031 . . . . 1.0 109.505 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.67 ' NE2' HD11 ' A' ' 123' ' ' ILE . 1.0 OUTLIER -154.49 89.83 1.29 Allowed 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.901 -0.72 . . . . 1.0 109.674 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.42 72.63 10.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.307 -0.871 . . . . 1.0 109.138 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.636 ' HB2' HD12 ' A' ' 123' ' ' ILE . . . . . . . . 0 N--CA 1.487 1.424 0 O-C-N 121.471 -0.768 . . . . 1.0 109.811 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.452 0.644 . . . . 1.0 109.751 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.578 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 2.4 p -89.67 119.23 36.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.539 -0.725 . . . . 1.0 109.269 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -155.18 105.37 2.51 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -0.936 . . . . 1.0 109.577 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.51 -88.29 0.54 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 1.0 109.449 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 p -114.97 -92.2 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 1.0 109.652 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.27 -69.45 0.12 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 1.0 109.457 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -167.25 26.68 0.15 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.522 -1.431 . . . . 1.0 109.522 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.502 ' HA3' ' CG2' ' A' ' 38' ' ' VAL . . . 112.34 -59.5 0.37 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.487 ' HB3' ' HD2' ' A' ' 46' ' ' PRO . 13.1 m-70 -104.64 161.03 24.06 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.307 -1.113 . . . . 1.0 109.472 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 45' ' ' HIS . 35.4 Cg_endo -78.0 -179.59 5.59 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.505 2.136 . . . . 1.0 110.512 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.15 HG23 HG12 ' A' ' 117' ' ' VAL . 2.5 mm -94.11 156.64 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.374 -0.829 . . . . 1.0 109.075 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.606 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 10.8 t -129.31 141.76 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.112 -0.992 . . . . 1.0 110.117 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.468 ' HB2' ' HG3' ' A' ' 115' ' ' ARG . 7.1 tt0 -160.4 147.06 15.65 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.4 HD13 ' OE2' ' A' ' 111' ' ' GLU . 0.6 OUTLIER -78.5 148.13 33.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.886 -1.134 . . . . 1.0 109.617 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -140.14 77.65 1.62 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.445 -0.785 . . . . 1.0 109.37 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 163.87 -109.97 0.4 Allowed Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.455 -1.355 . . . . 1.0 110.476 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.66 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 1.5 t80 -39.18 141.22 0.34 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.826 -0.808 . . . . 1.0 110.178 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.591 HD12 ' O ' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -136.62 46.67 2.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.331 -0.856 . . . . 1.0 109.492 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.596 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 1.2 tt0 -87.25 145.41 26.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 1.0 109.331 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.62 49.98 1.87 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.202 -0.936 . . . . 1.0 109.853 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.419 ' HG3' ' CD ' ' A' ' 55' ' ' GLU . 47.3 mm-40 -122.36 153.54 62.06 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 1.0 109.432 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.997 ' O ' HD23 ' A' ' 59' ' ' LEU . 35.3 Cg_endo -78.11 131.03 10.62 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.521 2.148 . . . . 1.0 110.462 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.017 HD22 HG23 ' A' ' 155' ' ' VAL . 4.3 mt -128.14 163.02 25.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 1.0 109.16 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.447 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 4.4 ptt? -110.48 138.72 46.5 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.238 -0.914 . . . . 1.0 109.771 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.605 HD22 HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -91.71 147.44 22.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.413 -0.804 . . . . 1.0 109.391 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.455 ' O ' ' HG2' ' A' ' 152' ' ' ARG . 0.9 OUTLIER -124.48 77.6 1.59 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.307 -0.871 . . . . 1.0 109.041 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.966 HD22 ' CE1' ' A' ' 151' ' ' PHE . 0.5 OUTLIER -125.64 156.89 38.52 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.205 -0.934 . . . . 1.0 109.842 -179.569 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.864 ' HB3' HG12 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -166.16 -164.93 0.73 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.38 -0.97 . . . . 1.0 108.38 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.785 HD12 ' CD2' ' A' ' 149' ' ' LEU . 0.5 OUTLIER -117.56 112.51 39.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.889 -1.132 . . . . 1.0 108.53 178.656 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.8 147.31 16.8 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.829 -1.308 . . . . 1.0 109.829 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.933 HG22 ' CD2' ' A' ' 76' ' ' HIS . 4.7 p -83.26 134.02 34.96 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.476 -1.014 . . . . 1.0 109.404 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.14 121.28 3.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.218 -0.926 . . . . 1.0 109.371 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.513 ' OD2' HD21 ' A' ' 72' ' ' LEU . 3.1 p30 -84.84 -26.52 27.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.9 . . . . 1.0 109.503 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.96 -38.75 0.34 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 1.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' LEU . 2.7 ttm180 -168.96 -35.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.121 -0.987 . . . . 1.0 109.674 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.572 ' H ' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -44.06 94.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 1.0 109.701 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -80.17 136.36 36.48 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.222 -0.924 . . . . 1.0 109.623 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -157.83 166.48 16.47 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.285 -0.884 . . . . 1.0 109.136 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.943 ' HB3' HG23 ' A' ' 101' ' ' THR . 33.4 Cg_endo -75.47 137.26 20.49 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.147 1.898 . . . . 1.0 110.223 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.995 ' NE2' HG12 ' A' ' 147' ' ' VAL . 0.3 OUTLIER -65.27 157.53 28.74 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.29 -0.882 . . . . 1.0 109.848 -179.529 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.3 -58.88 2.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.299 -0.876 . . . . 1.0 109.467 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -128.31 2.86 5.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.203 -0.936 . . . . 1.0 109.794 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.579 ' HB2' ' CD2' ' A' ' 76' ' ' HIS . 5.7 m-85 -100.72 76.15 1.78 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.13 -0.981 . . . . 1.0 109.414 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.512 ' HB2' ' CB ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -141.97 8.68 1.89 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 1.0 110.002 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.892 HG11 HD23 ' A' ' 124' ' ' LEU . 10.2 m -67.64 143.69 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.034 -1.041 . . . . 1.0 109.52 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.727 ' CD2' ' HB2' ' A' ' 121' ' ' ALA . 10.2 t-160 -175.48 107.23 0.09 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.47 -0.769 . . . . 1.0 109.438 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -144.8 142.84 30.3 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.165 -0.96 . . . . 1.0 109.711 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.742 HD12 ' N ' ' A' ' 84' ' ' ILE . 4.1 mp -101.01 158.98 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.349 -0.844 . . . . 1.0 109.196 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.434 ' N ' HG22 ' A' ' 84' ' ' ILE . 23.8 p . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.149 -0.969 . . . . 1.0 109.275 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.57 HG22 ' H ' ' A' ' 90' ' ' SER . 8.7 p . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.402 -0.592 . . . . 1.0 109.402 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.57 ' H ' HG22 ' A' ' 89' ' ' VAL . 1.5 t -86.85 -30.16 21.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 1.0 109.561 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.657 HG23 ' HG ' ' A' ' 108' ' ' LEU . 11.5 m -108.57 105.06 14.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.328 -0.857 . . . . 1.0 109.505 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.517 ' O ' HG23 ' A' ' 106' ' ' ILE . 6.9 m -52.63 157.46 1.56 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 1.0 109.338 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.664 ' HB3' HD12 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -140.69 174.99 9.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 1.0 109.917 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -152.41 160.77 43.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.479 -0.763 . . . . 1.0 109.505 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.16 148.69 52.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.139 -0.976 . . . . 1.0 109.668 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.521 ' O ' HG23 ' A' ' 103' ' ' VAL . . . -158.66 121.14 3.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 1.0 109.571 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.444 HD12 ' C ' ' A' ' 101' ' ' THR . 2.7 tp -107.44 141.06 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 1.0 109.412 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.516 ' O ' ' CB ' ' A' ' 99' ' ' SER . 0.5 OUTLIER -132.9 50.33 2.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 1.0 109.511 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 1.6 m 77.75 108.03 0.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.454 -0.779 . . . . 1.0 109.748 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 99' ' ' SER . 9.1 p30 44.25 41.28 4.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.493 -0.754 . . . . 1.0 110.364 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.943 HG23 ' HB3' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -158.91 79.32 0.77 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.971 -1.08 . . . . 1.0 109.77 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.512 ' CB ' ' HB2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -82.09 119.14 23.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.944 . . . . 1.0 109.131 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.864 HG12 ' HB3' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -122.41 161.18 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.214 -0.929 . . . . 1.0 109.528 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.92 HD11 HD11 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -129.67 121.9 27.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.463 -0.773 . . . . 1.0 109.388 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.826 ' O ' HD13 ' A' ' 106' ' ' ILE . 0.7 OUTLIER -99.59 139.47 35.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 1.0 109.28 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.826 HD13 ' O ' ' A' ' 105' ' ' GLU . 2.9 mm -133.12 96.71 17.27 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 1.0 109.956 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.867 ' O ' HD22 ' A' ' 108' ' ' LEU . 34.7 Cg_endo -76.25 108.19 2.62 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.349 2.033 . . . . 1.0 109.738 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.867 HD22 ' O ' ' A' ' 107' ' ' PRO . 0.4 OUTLIER -144.56 165.48 27.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 1.0 110.247 -179.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.517 HD12 HD21 ' A' ' 112' ' ' ASN . 0.8 OUTLIER -131.6 66.71 78.82 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.489 -0.757 . . . . 1.0 109.205 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.523 ' HB3' ' CG ' ' A' ' 114' ' ' MET . 36.7 Cg_endo -81.06 42.33 1.32 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.652 2.235 . . . . 1.0 110.635 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.516 ' CB ' ' O ' ' A' ' 55' ' ' GLU . 1.5 mp0 -93.83 -0.35 55.83 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.023 -1.048 . . . . 1.0 109.665 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.517 HD21 HD12 ' A' ' 109' ' ' LEU . 0.6 OUTLIER -108.24 -51.82 2.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.107 -0.996 . . . . 1.0 109.278 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.3 OUTLIER 164.79 97.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 1.0 109.237 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.646 ' CE ' HD12 ' A' ' 108' ' ' LEU . 5.4 ptm -162.39 133.46 5.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.146 -0.972 . . . . 1.0 109.972 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.497 ' NH1' HG21 ' A' ' 47' ' ' ILE . 14.2 ttp180 -112.25 131.85 55.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.205 -0.935 . . . . 1.0 109.21 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.533 ' HB2' ' OG1' ' A' ' 91' ' ' THR . . . -120.54 117.28 27.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 1.0 109.512 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 1.15 HG12 HG23 ' A' ' 47' ' ' ILE . 5.1 m -92.83 135.8 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.296 -0.878 . . . . 1.0 109.371 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 45' ' ' HIS . 7.8 mt -112.75 116.52 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.216 -0.927 . . . . 1.0 109.549 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 17.3 p30 -156.88 52.35 0.5 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 1.0 109.477 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.486 ' HB3' HG13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -135.54 53.5 1.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -0.872 . . . . 1.0 109.5 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.727 ' HB2' ' CD2' ' A' ' 82' ' ' HIS . . . -139.84 175.95 9.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.842 . . . . 1.0 109.338 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.872 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -143.69 -178.04 19.12 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.376 -1.49 . . . . 1.0 109.376 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.67 HD11 ' NE2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -117.75 158.73 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.177 -1.19 . . . . 1.0 109.131 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.892 HD23 HG11 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -123.57 147.69 47.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 1.0 109.425 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.546 ' H ' HD13 ' A' ' 124' ' ' LEU . 1.7 ttpm? . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.238 -0.914 . . . . 1.0 109.425 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 74.8 p . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 121.273 0.559 . . . . 1.0 110.354 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.522 ' O ' ' CD ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -157.13 124.39 5.23 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.381 -0.824 . . . . 1.0 110.204 179.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.995 HG12 ' NE2' ' A' ' 76' ' ' HIS . 13.9 m -137.48 165.55 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.248 -0.907 . . . . 1.0 108.803 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 170' ' ' ASN . 0.0 OUTLIER -155.46 139.14 16.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.054 -1.029 . . . . 1.0 110.14 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.785 ' CD2' HD12 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -99.75 101.01 12.04 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.385 -0.822 . . . . 1.0 108.875 179.405 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 21.5 t -77.16 140.88 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.933 . . . . 1.0 109.692 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.966 ' CE1' HD22 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -136.66 111.16 8.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.277 -0.89 . . . . 1.0 109.484 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.508 ' HD3' ' NE2' ' A' ' 166' ' ' GLN . 12.6 ptt180 -144.22 133.16 22.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.884 -1.135 . . . . 1.0 109.922 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.512 ' CG1' HD11 ' A' ' 163' ' ' LEU . 12.3 p -109.53 127.89 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.53 -0.915 . . . . 1.0 108.53 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.498 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 51.0 m-70 -123.17 114.1 19.84 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.199 -0.938 . . . . 1.0 110.132 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 1.017 HG23 HD22 ' A' ' 59' ' ' LEU . 11.4 p -99.4 141.12 22.27 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.242 -0.911 . . . . 1.0 108.938 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.519 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 33.9 Cg_endo -75.93 117.0 4.56 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.294 1.996 . . . . 1.0 110.561 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.536 ' NE2' ' HD2' ' A' ' 158' ' ' PRO . 4.1 mm100 -154.83 168.92 11.07 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.312 -0.867 . . . . 1.0 109.116 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.536 ' HD2' ' NE2' ' A' ' 157' ' ' GLN . 34.4 Cg_endo -77.2 -65.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.326 2.017 . . . . 1.0 110.25 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.4 104.54 0.79 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.193 -0.942 . . . . 1.0 109.191 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -46.45 -28.1 3.22 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.465 -1.454 . . . . 1.0 109.465 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.4 mtt-85 -79.22 79.64 5.63 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.37 -1.076 . . . . 1.0 108.259 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.811 HG22 ' N ' ' A' ' 163' ' ' LEU . 1.3 m -140.04 -90.04 0.18 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.441 -0.787 . . . . 1.0 109.15 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.811 ' N ' HG22 ' A' ' 162' ' ' THR . 8.9 tp -140.34 97.9 3.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.958 -1.089 . . . . 1.0 108.986 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.498 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -163.3 94.81 0.82 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.084 -1.01 . . . . 1.0 109.408 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.778 ' N ' HD23 ' A' ' 165' ' ' LEU . 1.8 pt? -138.37 175.32 9.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 1.0 109.984 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.508 ' NE2' ' HD3' ' A' ' 152' ' ' ARG . 0.7 OUTLIER -119.22 161.84 19.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.434 -0.791 . . . . 1.0 109.843 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.7 HG12 ' O ' ' A' ' 167' ' ' VAL . 41.5 t -151.74 74.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.448 -0.782 . . . . 1.0 109.036 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' A' ' 148' ' ' ARG . . . -89.48 102.86 15.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.093 -1.004 . . . . 1.0 109.104 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 t -143.41 88.68 2.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.917 . . . . 1.0 110.057 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.529 ' N ' ' HD3' ' A' ' 171' ' ' PRO . 1.1 m-20 -179.69 60.6 0.11 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 1.0 109.341 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 170' ' ' ASN . 36.4 Cg_endo -78.67 96.91 1.1 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.383 2.056 . . . . 1.0 111.011 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.881 HG23 ' HA ' ' A' ' 24' ' ' HIS . 1.6 mt -101.53 147.05 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.166 -0.959 . . . . 1.0 108.679 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.46 0 O-C-N 121.088 -1.007 . . . . 1.0 110.132 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo . . . . . 0 C--O 1.215 -0.625 0 N-CA-C 110.613 -0.572 . . . . 1.0 110.613 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.576 ' CZ ' ' O ' ' A' ' 162' ' ' THR . 5.8 m-85 -67.82 152.11 46.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.872 . . . . 1.0 109.277 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.28 129.72 13.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.918 -1.114 . . . . 1.0 109.855 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.919 HD13 HD12 ' A' ' 50' ' ' LEU . 58.4 tp -121.04 75.02 1.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.42 155.27 33.82 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.44 -0.787 . . . . 1.0 109.982 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.542 HG21 ' NE2' ' A' ' 20' ' ' GLN . 0.6 OUTLIER -66.81 145.8 13.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.532 -0.914 . . . . 1.0 108.532 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.637 ' HG3' HG23 ' A' ' 19' ' ' VAL . 3.8 tp10 -72.51 -53.52 11.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 1.0 109.749 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.637 HG23 ' HG3' ' A' ' 18' ' ' GLU . 21.7 t -127.99 142.04 44.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.262 -0.899 . . . . 1.0 109.618 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.542 ' NE2' HG21 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -120.58 82.49 33.36 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 1.0 109.354 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 22' ' ' LYS . 35.0 Cg_endo -77.72 -177.53 3.92 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.436 2.09 . . . . 1.0 110.376 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 21' ' ' PRO . 12.7 mttt -43.86 112.69 0.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.37 -0.831 . . . . 1.0 109.227 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.546 ' HB3' ' CG ' ' A' ' 171' ' ' PRO . 2.1 t -110.24 29.64 7.48 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.198 -0.939 . . . . 1.0 109.89 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -103.21 165.9 10.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 1.0 109.476 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.581 ' CE1' ' HA ' ' A' ' 38' ' ' VAL . 76.6 t60 -157.21 118.07 3.6 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.516 -0.74 . . . . 1.0 109.894 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.441 ' HD2' ' O ' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -90.98 89.17 7.32 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.408 -0.807 . . . . 1.0 108.881 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.472 0 O-C-N 121.172 -0.955 . . . . 1.0 109.395 -179.676 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.43 0.633 . . . . 1.0 109.665 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.581 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 1.7 p -73.33 121.49 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.418 -0.801 . . . . 1.0 109.372 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -153.23 110.58 3.51 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.307 -0.871 . . . . 1.0 109.506 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 44' ' ' GLY . . . -165.17 150.31 9.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.373 -0.829 . . . . 1.0 109.563 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 40' ' ' ALA . 80.6 p 43.78 -118.08 0.55 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 1.0 109.39 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.6 57.47 4.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.304 -1.498 . . . . 1.0 109.524 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.46 ' HA3' ' HB2' ' A' ' 119' ' ' ASP . . . 88.25 -19.14 36.96 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.568 -1.413 . . . . 1.0 109.568 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 40' ' ' ALA . . . 116.41 -71.03 0.27 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.582 -1.407 . . . . 1.0 109.582 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 21.9 m80 -60.11 154.25 51.88 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.249 -1.148 . . . . 1.0 109.578 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.419 ' HB2' HG21 ' A' ' 17' ' ' ILE . 35.5 Cg_endo -78.09 178.7 7.27 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.492 2.128 . . . . 1.0 110.472 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.774 HG23 HG12 ' A' ' 117' ' ' VAL . 2.3 mm -94.53 160.87 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 1.0 109.266 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.8 t -135.81 127.3 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.234 -0.916 . . . . 1.0 109.732 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.527 ' HG3' ' CE1' ' A' ' 51' ' ' HIS . 14.2 pt20 -151.17 142.14 23.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.339 -0.851 . . . . 1.0 109.348 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.919 HD12 HD13 ' A' ' 15' ' ' LEU . 1.3 tt -98.62 138.99 35.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 1.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.527 ' CE1' ' HG3' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -140.78 76.23 1.54 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.169 -0.957 . . . . 1.0 109.331 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 171.05 96.03 0.1 Allowed Glycine 0 N--CA 1.486 2.01 0 N-CA-C 110.038 -1.225 . . . . 1.0 110.038 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.634 ' CE2' ' CB ' ' A' ' 55' ' ' GLU . 6.2 t80 178.02 129.01 0.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -1.14 . . . . 1.0 109.425 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.92 13.74 32.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 1.0 109.394 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.634 ' CB ' ' CE2' ' A' ' 53' ' ' TYR . 0.7 OUTLIER -116.8 144.49 44.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 1.0 109.432 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.499 ' C ' HD11 ' A' ' 109' ' ' LEU . 5.9 p30 -101.83 50.85 0.84 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 1.0 109.472 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.916 ' C ' HD12 ' A' ' 109' ' ' LEU . 1.9 mp0 -108.89 146.0 32.88 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 1.0 109.458 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 1.011 ' O ' HD23 ' A' ' 59' ' ' LEU . 35.5 Cg_endo -77.96 145.99 22.8 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.441 2.094 . . . . 1.0 110.363 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.011 HD23 ' O ' ' A' ' 58' ' ' PRO . 7.4 mt -139.27 162.76 34.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.262 -0.898 . . . . 1.0 109.51 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -98.34 110.42 23.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.315 -0.866 . . . . 1.0 109.534 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.872 HD21 ' HB2' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -60.77 143.45 54.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.257 -0.902 . . . . 1.0 109.312 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.495 ' N ' ' HG ' ' A' ' 61' ' ' LEU . 6.3 mm-40 -105.21 80.38 1.59 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.189 -0.945 . . . . 1.0 109.718 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.935 HD13 ' CZ ' ' A' ' 151' ' ' PHE . 18.2 tp -99.94 121.43 41.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.303 -0.873 . . . . 1.0 109.129 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.632 ' HB2' HG12 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -143.43 146.84 33.79 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 -179.434 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.691 ' C ' HD13 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -109.23 115.63 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 1.0 108.779 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.645 ' N ' HD13 ' A' ' 65' ' ' ILE . . . -132.8 144.26 16.11 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.548 -1.311 . . . . 1.0 110.204 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.978 HG22 ' CD2' ' A' ' 76' ' ' HIS . 14.8 p -71.2 161.44 31.09 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.525 -0.985 . . . . 1.0 108.959 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 1.043 ' HB3' ' HG3' ' A' ' 148' ' ' ARG . . . -172.52 124.72 0.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.129 -0.982 . . . . 1.0 109.77 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.6 -13.42 24.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -0.881 . . . . 1.0 109.16 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -156.08 -67.34 0.11 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.352 -0.843 . . . . 1.0 109.357 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.553 ' CD ' ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -144.82 -39.18 0.26 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 1.0 109.67 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.553 ' N ' ' CD ' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -51.84 88.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.41 -0.806 . . . . 1.0 109.848 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 71' ' ' ARG . 2.3 pp -66.63 143.9 56.72 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.26 -0.9 . . . . 1.0 109.59 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.525 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -152.87 165.44 17.59 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.158 -0.964 . . . . 1.0 109.452 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.51 146.03 24.03 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.414 2.076 . . . . 1.0 110.211 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.978 ' CD2' HG22 ' A' ' 67' ' ' THR . 0.7 OUTLIER -76.87 160.54 29.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 1.0 109.656 -179.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.81 -67.09 0.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -0.866 . . . . 1.0 109.786 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -130.83 23.56 4.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.163 -0.96 . . . . 1.0 109.934 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.578 ' HB2' ' CG ' ' A' ' 76' ' ' HIS . 4.8 m-85 -101.46 74.26 1.52 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.054 -1.029 . . . . 1.0 109.418 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.5 ' CB ' ' HB3' ' A' ' 102' ' ' LYS . 11.0 pt20 -139.49 7.46 2.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.163 -0.96 . . . . 1.0 109.669 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.957 HG23 ' O ' ' A' ' 122' ' ' GLY . 1.3 m -60.91 140.58 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.092 -1.005 . . . . 1.0 109.067 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.604 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 1.0 OUTLIER -176.3 114.05 0.11 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.092 -1.043 . . . . 1.0 109.791 -179.612 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.2 OUTLIER -136.74 126.32 25.29 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.215 -0.928 . . . . 1.0 109.557 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.674 HD12 ' N ' ' A' ' 84' ' ' ILE . 4.4 mp -99.68 137.43 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.256 -0.903 . . . . 1.0 109.628 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 39.9 p . . . . . 0 N--CA 1.488 1.47 0 O-C-N 121.403 -0.811 . . . . 1.0 109.137 179.785 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.508 HG21 ' H ' ' A' ' 117' ' ' VAL . 1.7 t . . . . . 0 N--CA 1.488 1.448 0 N-CA-C 109.035 -0.728 . . . . 1.0 109.035 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.5 m -165.53 31.64 0.05 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.499 -0.881 . . . . 1.0 109.668 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.409 HG23 ' N ' ' A' ' 92' ' ' THR . 9.8 t -64.96 -36.48 84.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.206 -0.934 . . . . 1.0 109.558 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.756 ' O ' HG23 ' A' ' 106' ' ' ILE . 58.4 m -163.17 135.91 5.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.199 -0.938 . . . . 1.0 109.587 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -168.39 169.13 10.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -0.882 . . . . 1.0 109.56 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -155.22 145.63 22.01 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.844 . . . . 1.0 109.51 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.515 ' OE1' ' NE2' ' A' ' 82' ' ' HIS . 8.0 tt0 -114.58 146.11 41.17 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.305 -0.872 . . . . 1.0 109.428 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -142.82 122.36 13.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 1.0 109.367 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.973 HD13 ' N ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -135.55 134.95 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.239 -0.913 . . . . 1.0 109.475 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.973 ' N ' HD13 ' A' ' 97' ' ' ILE . 0.7 OUTLIER -138.49 64.82 1.48 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.064 -1.023 . . . . 1.0 109.675 -179.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.462 ' O ' ' OD1' ' A' ' 100' ' ' ASN . 1.7 p 62.29 117.44 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.894 . . . . 1.0 109.586 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 99' ' ' SER . 3.7 p-10 44.46 37.03 1.87 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.622 -0.674 . . . . 1.0 110.715 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.482 ' HB ' ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -159.32 85.16 0.79 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.972 -1.08 . . . . 1.0 109.401 179.248 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.5 ' HB3' ' CB ' ' A' ' 80' ' ' GLN . 6.0 tptm -105.91 95.02 5.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.892 . . . . 1.0 109.727 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.632 HG12 ' HB2' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -96.49 171.4 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.326 -0.859 . . . . 1.0 108.963 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.885 HD22 ' N ' ' A' ' 105' ' ' GLU . 0.5 OUTLIER -139.91 122.81 16.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 1.0 109.351 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.885 ' N ' HD22 ' A' ' 104' ' ' LEU . 7.1 mm-40 -123.1 140.14 53.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.303 -0.873 . . . . 1.0 109.292 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.756 HG23 ' O ' ' A' ' 92' ' ' THR . 28.1 mt -129.03 107.31 18.02 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 1.0 109.528 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 60' ' ' MET . 34.6 Cg_endo -76.64 107.81 2.53 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.218 1.945 . . . . 1.0 110.35 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.66 HD23 ' O ' ' A' ' 106' ' ' ILE . 0.6 OUTLIER -146.0 165.18 29.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.876 . . . . 1.0 109.752 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.916 HD12 ' C ' ' A' ' 57' ' ' GLU . 3.5 tt -117.07 85.84 19.06 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.408 -0.807 . . . . 1.0 109.451 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.471 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 37.1 Cg_endo -81.84 30.53 0.52 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.711 2.274 . . . . 1.0 111.199 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.523 ' OE1' ' CB ' ' A' ' 53' ' ' TYR . 9.7 mm-40 -102.96 49.95 0.82 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.842 -1.161 . . . . 1.0 109.512 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 113' ' ' SER . 0.6 OUTLIER -161.78 -61.63 0.05 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.216 -0.928 . . . . 1.0 109.478 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 6.1 p 167.8 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.324 -0.86 . . . . 1.0 109.19 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -155.14 125.23 6.66 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.235 -0.915 . . . . 1.0 109.616 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.658 ' HD3' HG21 ' A' ' 47' ' ' ILE . 6.1 ttm180 -94.61 129.78 41.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 1.0 109.191 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.36 99.71 8.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.318 -0.864 . . . . 1.0 109.518 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.774 HG12 HG23 ' A' ' 47' ' ' ILE . 4.4 m -86.85 143.28 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 1.0 109.425 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.452 ' O ' ' HB2' ' A' ' 45' ' ' HIS . 2.7 mt -133.29 123.86 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.891 . . . . 1.0 109.552 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.46 ' HB2' ' HA3' ' A' ' 43' ' ' GLY . 8.3 p-10 -175.28 46.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 1.0 109.566 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 84' ' ' ILE . 9.9 m -132.95 43.45 2.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 1.0 109.565 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.604 ' HB2' ' HB2' ' A' ' 82' ' ' HIS . . . -134.42 128.29 33.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.253 -0.905 . . . . 1.0 109.13 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.957 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -93.51 -172.08 39.6 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.395 -1.482 . . . . 1.0 109.395 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.716 ' O ' HD12 ' A' ' 124' ' ' LEU . 0.6 OUTLIER -125.48 166.92 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.363 -1.081 . . . . 1.0 108.818 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.738 HD13 HG11 ' A' ' 81' ' ' VAL . 0.8 OUTLIER -140.94 164.45 30.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.905 . . . . 1.0 109.622 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 41.6 mttt . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.383 -0.823 . . . . 1.0 109.096 179.769 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.402 0 N-CA-C 109.394 -0.595 . . . . 1.0 109.394 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.46 ' HD2' ' O ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -105.04 157.38 17.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.886 . . . . 1.0 109.254 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.69 HG12 ' CD2' ' A' ' 76' ' ' HIS . 1.6 m -140.49 168.25 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.382 -0.823 . . . . 1.0 109.406 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 1.043 ' HG3' ' HB3' ' A' ' 68' ' ' ALA . 5.2 mmt180 -148.82 99.32 2.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 1.0 109.563 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.636 HD12 ' CD2' ' A' ' 151' ' ' PHE . 0.7 OUTLIER -79.77 115.93 19.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.104 -0.997 . . . . 1.0 108.889 179.635 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 168' ' ' ALA . 4.3 t -87.09 114.43 26.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.204 -0.935 . . . . 1.0 109.87 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.935 ' CZ ' HD13 ' A' ' 63' ' ' LEU . 1.6 m-85 -108.39 113.33 26.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 1.0 109.228 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.473 ' CB ' ' HA ' ' A' ' 166' ' ' GLN . 5.4 ptt180 -150.6 159.41 44.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.899 -1.126 . . . . 1.0 109.95 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 153' ' ' VAL . 10.4 p -143.41 128.51 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.281 -0.887 . . . . 1.0 108.659 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.504 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 20.9 m-70 -132.46 113.63 13.35 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.073 -1.017 . . . . 1.0 110.372 -179.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.551 HG11 ' HB3' ' A' ' 163' ' ' LEU . 12.6 p -99.04 141.85 23.6 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 108.556 -0.905 . . . . 1.0 108.556 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 32.0 Cg_endo -73.64 115.88 4.49 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.093 1.862 . . . . 1.0 110.881 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.468 ' HB2' ' HD2' ' A' ' 158' ' ' PRO . 1.6 pm0 -133.14 160.94 66.66 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 157' ' ' GLN . 34.9 Cg_endo -77.56 -66.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.305 2.003 . . . . 1.0 110.675 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.5 t -59.38 -93.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 1.0 109.621 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 171.38 -33.91 0.15 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.412 -1.475 . . . . 1.0 109.412 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -79.08 80.3 5.44 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.92 -1.141 . . . . 1.0 107.92 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.802 HG22 ' N ' ' A' ' 163' ' ' LEU . 1.3 m -138.9 -90.17 0.2 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.509 -0.744 . . . . 1.0 109.486 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.802 ' N ' HG22 ' A' ' 162' ' ' THR . 7.4 tp -146.96 109.19 4.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.58 -1.325 . . . . 1.0 109.615 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.504 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.0 OUTLIER -162.94 91.49 0.73 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.035 -1.041 . . . . 1.0 109.38 178.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.749 HD13 ' H ' ' A' ' 166' ' ' GLN . 0.2 OUTLIER -120.64 155.46 33.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.345 -0.847 . . . . 1.0 109.495 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.749 ' H ' HD13 ' A' ' 165' ' ' LEU . 3.5 tt0 -134.16 142.34 47.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.163 -0.96 . . . . 1.0 109.568 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 168' ' ' ALA . 46.3 t -146.07 161.28 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 1.0 109.398 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.517 ' N ' HG12 ' A' ' 167' ' ' VAL . . . -151.29 92.71 1.82 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.389 -0.82 . . . . 1.0 108.847 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.53 ' HB2' HD11 ' A' ' 149' ' ' LEU . 20.4 m -82.93 160.43 22.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.954 . . . . 1.0 109.632 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.53 ' N ' ' HD3' ' A' ' 171' ' ' PRO . 0.7 OUTLIER -174.51 63.04 0.25 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.162 -0.961 . . . . 1.0 110.059 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.546 ' CG ' ' HB3' ' A' ' 23' ' ' SER . 37.5 Cg_endo -83.23 52.04 3.81 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.477 2.118 . . . . 1.0 110.296 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 13.0 mt -151.06 128.02 2.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.456 -0.778 . . . . 1.0 109.534 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 1.0 109.362 179.873 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo . . . . . 0 C--O 1.214 -0.69 0 N-CA-C 110.293 -0.695 . . . . 1.0 110.293 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.518 ' HA ' ' HA3' ' A' ' 52' ' ' GLY . 3.6 m-85 -105.5 137.95 42.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.152 -0.967 . . . . 1.0 109.63 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.453 ' CG ' ' O ' ' A' ' 13' ' ' TYR . 1.6 mt-10 179.72 139.16 0.12 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 1.0 109.764 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.489 ' O ' ' CG ' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -99.87 98.82 9.57 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.291 -0.881 . . . . 1.0 109.055 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -99.96 155.14 17.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.191 -0.943 . . . . 1.0 109.768 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.942 HG21 ' NE2' ' A' ' 20' ' ' GLN . 12.7 mm -72.95 134.44 29.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.398 -0.813 . . . . 1.0 109.266 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.421 ' HB2' ' CD ' ' A' ' 49' ' ' GLN . 44.2 tt0 -68.89 -55.1 12.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.137 -0.977 . . . . 1.0 108.967 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.88 HG22 ' HD3' ' A' ' 21' ' ' PRO . 9.8 p -118.58 130.22 73.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.376 -0.827 . . . . 1.0 108.871 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.942 ' NE2' HG21 ' A' ' 17' ' ' ILE . 9.2 tp-100 -129.94 63.97 70.51 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.08 -1.012 . . . . 1.0 110.023 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.88 ' HD3' HG22 ' A' ' 19' ' ' VAL . 35.8 Cg_endo -78.44 -175.34 2.67 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.406 2.07 . . . . 1.0 109.88 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -48.45 94.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.917 . . . . 1.0 108.78 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 21' ' ' PRO . 1.4 p -94.02 40.24 1.08 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.25 -0.906 . . . . 1.0 110.252 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.475 ' HA ' HG12 ' A' ' 172' ' ' ILE . 0.0 OUTLIER -99.49 167.25 10.73 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.969 -1.082 . . . . 1.0 108.284 179.205 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.635 ' CD2' ' CD1' ' A' ' 123' ' ' ILE . 16.0 t60 -133.7 134.03 42.57 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 119.341 -0.944 . . . . 1.0 110.068 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.479 ' HD2' ' O ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -106.1 75.73 1.12 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 179.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.47 -0.769 . . . . 1.0 109.79 -179.064 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.514 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 1.8 p -57.03 135.4 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 1.0 109.34 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.06 115.26 4.1 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.417 -0.802 . . . . 1.0 109.698 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 42' ' ' ALA . . . -156.5 114.84 3.33 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.509 -0.745 . . . . 1.0 109.548 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 50.91 -88.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.473 -0.767 . . . . 1.0 110.085 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 45' ' ' HIS . . . -85.03 46.25 1.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.099 -1.0 . . . . 1.0 109.832 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.39 9.32 42.62 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.887 -1.285 . . . . 1.0 109.887 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.401 ' N ' ' H ' ' A' ' 40' ' ' ALA . . . 135.71 -80.06 0.31 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.643 -1.383 . . . . 1.0 109.643 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.668 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 5.5 m-70 -88.36 157.53 50.15 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.317 -1.108 . . . . 1.0 109.672 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.458 ' HG3' ' OE1' ' A' ' 20' ' ' GLN . 35.8 Cg_endo -78.41 178.74 7.21 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.601 2.201 . . . . 1.0 110.528 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.951 ' CG2' HG12 ' A' ' 117' ' ' VAL . 5.0 mt -94.45 157.05 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.481 -0.762 . . . . 1.0 109.199 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.637 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 2.1 t -131.66 128.1 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.207 -0.933 . . . . 1.0 109.829 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.421 ' CD ' ' HB2' ' A' ' 18' ' ' GLU . 7.1 pt20 -140.95 138.17 33.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 1.0 109.353 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.479 ' HG ' ' HB3' ' A' ' 15' ' ' LEU . 2.7 tt -98.2 136.68 38.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 1.0 109.75 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.442 ' N ' HD23 ' A' ' 50' ' ' LEU . 5.7 p80 -140.52 97.98 3.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.333 -0.854 . . . . 1.0 109.16 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . -178.89 -86.5 0.07 OUTLIER Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.631 -1.271 . . . . 1.0 110.133 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.514 ' OH ' ' NE2' ' A' ' 157' ' ' GLN . 0.8 OUTLIER -38.37 121.86 1.03 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 122.1 -0.647 . . . . 1.0 110.345 -179.414 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.85 1.72 37.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.361 -0.837 . . . . 1.0 109.538 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.473 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -79.82 145.66 32.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.148 -0.97 . . . . 1.0 109.423 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.431 ' C ' ' ND2' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -84.61 44.68 1.07 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 1.0 109.824 -179.683 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.687 ' O ' HD23 ' A' ' 109' ' ' LEU . 5.1 mm-40 -99.23 150.59 36.86 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 1.0 109.304 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.992 ' O ' HD23 ' A' ' 59' ' ' LEU . 36.0 Cg_endo -77.68 139.48 17.95 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.306 2.004 . . . . 1.0 110.385 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.992 HD23 ' O ' ' A' ' 58' ' ' PRO . 5.8 mt -128.26 159.04 36.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 1.0 109.452 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.419 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.3 OUTLIER -121.31 107.84 13.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.133 -0.979 . . . . 1.0 109.519 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.645 HD21 ' HD1' ' A' ' 151' ' ' PHE . 0.3 OUTLIER -61.92 116.59 5.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.903 . . . . 1.0 109.543 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.437 ' O ' ' HG2' ' A' ' 152' ' ' ARG . 73.4 mm-40 -94.99 78.18 3.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.12 -0.988 . . . . 1.0 109.067 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.835 HD22 ' CE1' ' A' ' 151' ' ' PHE . 0.6 OUTLIER -112.85 157.84 20.9 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.377 -0.827 . . . . 1.0 109.714 -179.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.888 ' O ' HD23 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -165.74 176.95 7.58 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 179.354 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.639 ' CD1' ' CE1' ' A' ' 76' ' ' HIS . 0.2 OUTLIER -114.75 118.6 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.109 -0.994 . . . . 1.0 108.862 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.44 150.28 19.64 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.611 -1.28 . . . . 1.0 110.06 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.933 HG22 ' CD2' ' A' ' 76' ' ' HIS . 0.6 OUTLIER -89.2 151.23 22.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.456 -1.026 . . . . 1.0 109.269 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.92 113.08 6.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.17 -0.956 . . . . 1.0 109.538 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.2 -27.89 25.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.351 -0.843 . . . . 1.0 109.245 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -136.43 -52.48 0.71 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.302 -0.874 . . . . 1.0 109.311 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.5 OUTLIER -175.17 -34.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.9 . . . . 1.0 109.627 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 mt -55.9 91.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 1.0 109.74 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -47.39 166.64 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.224 -0.922 . . . . 1.0 109.474 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.48 ' HB2' ' HD2' ' A' ' 75' ' ' PRO . 5.1 ptm180 -175.15 162.03 2.3 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.901 . . . . 1.0 109.086 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.681 ' HB3' HG23 ' A' ' 101' ' ' THR . 34.3 Cg_endo -76.97 137.64 17.68 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.229 1.953 . . . . 1.0 110.334 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.95 ' NE2' HG12 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -64.16 156.5 28.33 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.246 -0.909 . . . . 1.0 109.625 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.11 -78.72 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.323 -0.86 . . . . 1.0 109.663 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -107.99 19.54 19.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 1.0 109.503 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.581 ' HB2' ' CD2' ' A' ' 76' ' ' HIS . 88.8 m-85 -111.57 112.25 23.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.903 . . . . 1.0 109.463 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.5 ' NE2' ' HD3' ' A' ' 102' ' ' LYS . 8.1 pt20 -167.32 30.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -0.845 . . . . 1.0 108.843 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.85 HG11 ' HA ' ' A' ' 123' ' ' ILE . 31.3 m -52.94 158.6 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 121.62 0.724 . . . . 1.0 110.139 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.839 ' CE1' HD11 ' A' ' 104' ' ' LEU . 14.3 t60 -176.06 66.73 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.464 -0.773 . . . . 1.0 108.961 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.0 OUTLIER -113.38 157.99 21.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.873 . . . . 1.0 109.855 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.408 HG22 ' N ' ' A' ' 85' ' ' THR . 2.0 mp -130.34 156.75 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.413 -0.804 . . . . 1.0 108.991 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.408 ' N ' HG22 ' A' ' 84' ' ' ILE . 40.9 p . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.083 -1.011 . . . . 1.0 109.755 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.763 ' O ' HG13 ' A' ' 89' ' ' VAL . 13.2 p . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 121.304 0.573 . . . . 1.0 109.575 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.4 m -90.39 32.07 0.98 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 1.0 109.395 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.434 ' H ' HG22 ' A' ' 89' ' ' VAL . 22.4 m -66.06 137.32 56.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 1.0 109.437 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.6 m -52.55 106.11 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 1.0 109.542 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.447 ' HA ' HG23 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -117.65 170.1 9.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -0.87 . . . . 1.0 109.603 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -155.26 161.03 41.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.342 -0.849 . . . . 1.0 109.392 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.57 ' HG3' ' CD2' ' A' ' 82' ' ' HIS . 0.5 OUTLIER -141.24 148.65 40.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 1.0 109.334 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 103' ' ' VAL . . . -152.51 127.96 9.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 1.0 109.731 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.457 ' HB ' ' HD2' ' A' ' 102' ' ' LYS . 2.7 tp -106.29 142.55 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 1.0 109.346 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.522 ' O ' ' CB ' ' A' ' 99' ' ' SER . 0.6 OUTLIER -132.99 53.0 2.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.912 . . . . 1.0 109.787 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 1.6 m 77.08 104.17 0.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.327 -0.858 . . . . 1.0 110.021 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 99' ' ' SER . 9.0 p30 44.32 43.14 5.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.532 -0.73 . . . . 1.0 110.334 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.681 HG23 ' HB3' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -159.3 77.64 0.72 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.987 -1.071 . . . . 1.0 109.774 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.5 ' HD3' ' NE2' ' A' ' 80' ' ' GLN . 4.2 tptm -81.96 129.75 34.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.861 . . . . 1.0 109.003 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.709 HG12 ' HB3' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -128.1 169.58 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.157 -0.965 . . . . 1.0 109.861 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.839 HD11 ' CE1' ' A' ' 82' ' ' HIS . 0.2 OUTLIER -131.21 130.59 43.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.462 -0.774 . . . . 1.0 109.236 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -128.21 132.33 48.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -0.913 . . . . 1.0 109.683 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.678 HG22 ' CD2' ' A' ' 108' ' ' LEU . 5.3 mt -129.67 102.69 17.9 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 1.0 109.279 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 34.1 Cg_endo -75.43 98.4 1.17 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.196 1.93 . . . . 1.0 110.539 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.678 ' CD2' HG22 ' A' ' 106' ' ' ILE . 0.4 OUTLIER -145.23 165.33 28.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.376 -0.827 . . . . 1.0 109.41 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -114.41 80.65 6.13 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 1.0 109.697 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 108' ' ' LEU . 36.3 Cg_endo -78.7 75.74 4.84 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.501 2.134 . . . . 1.0 110.268 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 53' ' ' TYR . 3.4 mt-10 -138.6 -49.3 0.53 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.267 -0.896 . . . . 1.0 109.603 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -79.89 -49.82 11.37 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.331 -0.855 . . . . 1.0 109.495 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.6 t -175.53 98.69 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.347 -0.846 . . . . 1.0 109.319 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.454 ' HB3' ' HA ' ' A' ' 110' ' ' PRO . 5.0 tpp -165.8 108.46 0.78 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 1.0 109.343 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -99.98 139.23 35.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.346 -0.846 . . . . 1.0 109.092 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.36 92.46 3.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -0.971 . . . . 1.0 109.547 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.951 HG12 ' CG2' ' A' ' 47' ' ' ILE . 3.5 m -91.78 128.34 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.225 -0.922 . . . . 1.0 109.322 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 99.1 mt -118.57 111.81 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.178 -0.951 . . . . 1.0 109.656 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -163.12 28.57 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 1.0 109.449 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 83' ' ' ARG . 4.2 p -116.38 42.89 2.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 1.0 109.347 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.75 164.43 28.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 1.0 109.478 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.736 ' O ' HG21 ' A' ' 81' ' ' VAL . . . -125.39 -173.77 13.76 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.904 -1.678 . . . . 1.0 108.904 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.85 ' HA ' HG11 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -116.27 170.75 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.978 -1.307 . . . . 1.0 109.231 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.414 HD23 ' H ' ' A' ' 125' ' ' LYS . 0.6 OUTLIER -115.39 146.26 41.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 1.0 109.517 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.414 ' H ' HD23 ' A' ' 124' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 1.0 109.405 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.43 -0.581 . . . . 1.0 109.43 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -93.91 154.83 17.49 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.121 -0.987 . . . . 1.0 109.685 -179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.95 HG12 ' NE2' ' A' ' 76' ' ' HIS . 14.1 m -140.26 145.12 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.502 ' HA ' ' HB3' ' A' ' 170' ' ' ASN . 2.5 ptt180 -149.73 135.43 18.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.016 -1.052 . . . . 1.0 110.106 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.888 HD23 ' O ' ' A' ' 64' ' ' PHE . 1.6 mt -87.49 121.33 29.79 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.462 -0.774 . . . . 1.0 109.51 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.494 HG21 ' HE1' ' A' ' 64' ' ' PHE . 21.6 t -92.18 132.9 35.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.194 -0.941 . . . . 1.0 109.29 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.835 ' CE1' HD22 ' A' ' 63' ' ' LEU . 5.8 m-85 -125.69 114.48 18.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.14 -0.975 . . . . 1.0 109.414 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.488 ' HB3' ' HA ' ' A' ' 166' ' ' GLN . 19.5 ptt180 -150.59 127.41 11.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.944 . . . . 1.0 109.6 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.407 HG11 HD11 ' A' ' 50' ' ' LEU . 3.1 p -106.9 129.34 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.039 -1.038 . . . . 1.0 109.37 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -111.57 107.78 17.06 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.272 -0.892 . . . . 1.0 108.736 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.911 ' CG2' HD23 ' A' ' 163' ' ' LEU . 40.1 t -99.09 136.1 20.63 Favored Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.245 -0.909 . . . . 1.0 109.034 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.431 ' O ' ' CD ' ' A' ' 157' ' ' GLN . 35.7 Cg_endo -77.72 141.65 19.65 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 122.534 2.156 . . . . 1.0 111.323 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.636 ' OE1' HG12 ' A' ' 155' ' ' VAL . 0.9 OUTLIER -160.35 179.12 1.42 Allowed Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.565 ' HD2' ' CG ' ' A' ' 157' ' ' GLN . 33.8 Cg_endo -78.27 -53.32 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.393 2.062 . . . . 1.0 110.094 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 158' ' ' PRO . 17.3 m -59.22 -148.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.662 -0.649 . . . . 1.0 109.583 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -125.05 -80.74 0.43 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.105 -1.198 . . . . 1.0 110.105 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 40.7 mtt-85 -78.14 80.96 4.55 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.482 -1.01 . . . . 1.0 108.809 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.563 ' CG2' ' N ' ' A' ' 163' ' ' LEU . 0.7 OUTLIER -102.76 -52.69 3.02 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.583 -0.698 . . . . 1.0 109.338 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.911 HD23 ' CG2' ' A' ' 155' ' ' VAL . 9.9 tp -155.49 96.17 1.76 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.399 -0.963 . . . . 1.0 108.399 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.86 101.71 1.01 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.069 -1.02 . . . . 1.0 109.165 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.857 ' H ' HD23 ' A' ' 165' ' ' LEU . 2.2 pt? -137.1 170.04 16.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 1.0 109.777 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.488 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 2.8 mt-30 -113.61 155.03 26.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.361 -0.837 . . . . 1.0 109.781 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.597 ' O ' HG12 ' A' ' 167' ' ' VAL . 45.6 t -149.74 80.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.883 . . . . 1.0 109.63 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.71 105.59 17.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 1.0 109.162 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 170' ' ' ASN . 79.7 p -120.18 117.86 29.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.939 . . . . 1.0 109.772 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 169' ' ' SER . 0.7 OUTLIER 163.03 73.72 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.366 -0.834 . . . . 1.0 109.418 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.68 85.8 1.74 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.419 2.079 . . . . 1.0 110.399 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.525 ' O ' ' CG ' ' A' ' 146' ' ' ARG . 4.3 mt -123.07 164.95 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -0.929 . . . . 1.0 108.996 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 172' ' ' ILE . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 O-C-N 121.168 -0.958 . . . . 1.0 109.692 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.443 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 35.8 Cg_endo . . . . . 0 C--O 1.214 -0.691 0 N-CA-C 110.49 -0.619 . . . . 1.0 110.49 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.556 ' HB3' HD13 ' A' ' 163' ' ' LEU . 7.5 m-85 -73.12 131.58 42.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 1.0 109.446 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -145.7 124.57 12.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.997 -1.064 . . . . 1.0 109.806 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.724 ' HB3' HD11 ' A' ' 165' ' ' LEU . 20.1 tp -120.07 82.74 1.94 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.363 -0.835 . . . . 1.0 109.038 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.62 159.43 26.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.31 -0.869 . . . . 1.0 109.863 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.852 HG23 ' O ' ' A' ' 47' ' ' ILE . 1.3 mp -75.98 142.18 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.338 -0.851 . . . . 1.0 108.774 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.27 -42.75 92.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.339 -0.851 . . . . 1.0 109.618 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.44 ' C ' ' HD3' ' A' ' 21' ' ' PRO . 20.2 t -141.49 133.07 27.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.294 -0.879 . . . . 1.0 109.463 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -119.05 77.16 15.76 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.153 -0.967 . . . . 1.0 109.561 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 23' ' ' SER . 35.9 Cg_endo -78.36 -176.91 3.51 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.513 2.142 . . . . 1.0 110.221 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 21' ' ' PRO . 2.4 mptt -44.35 99.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.317 -0.864 . . . . 1.0 109.008 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 21' ' ' PRO . 2.1 t -96.63 40.92 1.12 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 1.0 109.956 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -99.9 166.96 10.81 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.089 -1.007 . . . . 1.0 109.318 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.58 ' CE1' ' HA ' ' A' ' 38' ' ' VAL . 3.2 t60 -143.23 133.7 24.85 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.723 -0.791 . . . . 1.0 109.64 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.455 ' HD3' ' O ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -105.68 74.31 1.06 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.345 -0.847 . . . . 1.0 109.047 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 1.0 109.54 -179.766 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.528 0.68 . . . . 1.0 109.619 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.883 HG12 ' HA2' ' A' ' 122' ' ' GLY . 2.4 p -54.5 119.63 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.367 -0.833 . . . . 1.0 109.535 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -142.65 99.3 3.45 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.27 -0.894 . . . . 1.0 109.852 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.423 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -93.85 -147.21 0.25 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.322 -0.861 . . . . 1.0 109.142 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.94 171.55 10.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.046 -1.034 . . . . 1.0 109.471 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 54.64 64.33 1.85 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 1.0 109.393 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.12 -68.68 3.48 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.345 -1.502 . . . . 1.0 109.345 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.543 ' CA ' ' HB2' ' A' ' 119' ' ' ASP . . . 173.11 36.16 0.03 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.578 -1.409 . . . . 1.0 109.578 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.599 ' CG ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER 165.42 177.67 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.195 -1.18 . . . . 1.0 109.294 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.599 ' HD2' ' CG ' ' A' ' 45' ' ' HIS . 35.0 Cg_endo -77.34 172.05 16.64 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.426 2.084 . . . . 1.0 110.506 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.912 HG23 HG12 ' A' ' 117' ' ' VAL . 4.2 mm -105.33 161.71 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 1.0 109.659 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.425 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 5.3 t -139.9 125.5 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.393 -0.817 . . . . 1.0 109.245 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -146.64 157.18 43.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.927 . . . . 1.0 109.547 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.662 HD13 ' HG3' ' A' ' 110' ' ' PRO . 5.4 tt -114.63 134.67 54.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 1.0 109.419 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.638 ' N ' HD23 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -140.59 79.04 1.68 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 1.0 109.308 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 177.45 64.31 0.06 OUTLIER Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.806 -1.318 . . . . 1.0 109.806 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.568 ' CD2' HD11 ' A' ' 59' ' ' LEU . 0.4 OUTLIER 177.0 118.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.158 -1.201 . . . . 1.0 109.594 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.437 ' HA ' ' OE1' ' A' ' 111' ' ' GLU . 0.7 OUTLIER -106.98 25.46 11.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.241 -0.912 . . . . 1.0 109.299 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.549 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 38.8 tp10 -89.98 145.15 25.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.236 -0.915 . . . . 1.0 109.482 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -89.0 35.92 0.8 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.221 -0.924 . . . . 1.0 109.532 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.655 ' HG3' HD21 ' A' ' 59' ' ' LEU . 26.2 pt-20 -112.76 147.67 37.66 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 1.0 109.422 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.749 ' O ' HD23 ' A' ' 59' ' ' LEU . 35.3 Cg_endo -78.11 141.06 18.29 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.374 2.049 . . . . 1.0 110.527 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.836 HD22 ' CG2' ' A' ' 155' ' ' VAL . 7.5 mt -120.09 163.77 17.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.898 . . . . 1.0 109.19 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -116.22 100.18 7.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.208 -0.933 . . . . 1.0 109.981 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.906 HD21 ' HB2' ' A' ' 63' ' ' LEU . 1.6 tt -65.72 127.94 33.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.879 . . . . 1.0 108.923 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 152' ' ' ARG . 90.4 mt-30 -91.34 92.22 8.5 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.217 -0.927 . . . . 1.0 109.208 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.906 ' HB2' HD21 ' A' ' 61' ' ' LEU . 15.0 tp -99.6 139.84 34.67 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.316 -0.865 . . . . 1.0 109.022 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.711 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -163.86 168.36 19.61 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.159 -0.963 . . . . 1.0 108.79 -179.314 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.805 HD11 ' HB ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -132.47 116.8 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.814 . . . . 1.0 108.869 179.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.663 ' N ' HD13 ' A' ' 65' ' ' ILE . . . -130.98 152.6 20.0 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.843 -1.303 . . . . 1.0 109.843 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.591 HG23 ' CD2' ' A' ' 76' ' ' HIS . 40.7 p -74.03 157.39 36.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.389 -1.065 . . . . 1.0 109.433 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.696 ' HB3' ' HD2' ' A' ' 148' ' ' ARG . . . -169.06 113.58 0.56 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.262 -0.899 . . . . 1.0 109.632 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.39 9.54 37.91 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.273 -0.892 . . . . 1.0 109.346 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -168.67 -54.39 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.31 -0.868 . . . . 1.0 109.192 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 73' ' ' LEU . 3.0 tpt180 -175.23 -33.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.87 . . . . 1.0 109.698 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.59 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -54.12 92.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.295 -0.878 . . . . 1.0 109.774 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.44 ' H ' HD23 ' A' ' 73' ' ' LEU . 0.5 OUTLIER -56.62 164.88 1.3 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.236 -0.915 . . . . 1.0 109.733 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.54 ' CD ' ' HD2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -175.15 170.86 1.34 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 1.0 109.22 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.54 ' HD2' ' CD ' ' A' ' 74' ' ' ARG . 35.2 Cg_endo -77.23 136.67 16.3 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.338 2.026 . . . . 1.0 110.414 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.687 ' ND1' HD12 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -59.2 147.3 35.96 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.278 -0.889 . . . . 1.0 109.719 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 76' ' ' HIS . . . -46.02 -77.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' A' ' 125' ' ' LYS . 79.3 m-85 -140.66 23.71 2.27 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.95 -0.759 . . . . 1.0 108.95 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.654 ' HD2' HG22 ' A' ' 123' ' ' ILE . 63.0 m-85 -78.32 106.97 10.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 1.0 109.31 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 80' ' ' GLN . 11.2 tt0 -119.48 85.27 2.34 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.038 HG12 ' O ' ' A' ' 122' ' ' GLY . 3.8 m -69.75 138.15 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.322 -0.861 . . . . 1.0 110.037 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -175.96 85.45 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.467 -0.771 . . . . 1.0 109.096 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.21 81.04 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.05 -1.031 . . . . 1.0 110.309 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.7 mp -109.34 147.85 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 1.0 108.724 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 67.6 p . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.145 -0.972 . . . . 1.0 109.819 -179.6 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.653 HG22 ' H ' ' A' ' 90' ' ' SER . 5.9 p . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 109.107 -0.701 . . . . 1.0 109.107 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.653 ' H ' HG22 ' A' ' 89' ' ' VAL . 16.9 t -74.41 -42.03 59.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.065 -1.022 . . . . 1.0 109.389 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.599 ' OG1' HD22 ' A' ' 108' ' ' LEU . 6.4 t -72.86 -168.96 0.52 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.921 . . . . 1.0 109.385 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 106' ' ' ILE . 4.4 m -103.48 158.32 16.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 1.0 109.461 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.39 157.35 46.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 1.0 109.786 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -155.86 119.03 4.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.404 -0.81 . . . . 1.0 109.449 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.96 141.9 32.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.127 -0.983 . . . . 1.0 109.473 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.67 120.67 24.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.92 . . . . 1.0 109.574 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 1.012 HD12 ' O ' ' A' ' 101' ' ' THR . 5.1 tp -117.2 144.98 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.36 -0.838 . . . . 1.0 109.323 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.51 HD21 HG21 ' A' ' 101' ' ' THR . 0.5 OUTLIER -135.89 49.42 2.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.115 -0.991 . . . . 1.0 109.676 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER 74.34 114.85 0.06 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.199 -0.938 . . . . 1.0 109.666 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 99' ' ' SER . 3.7 p-10 43.91 35.52 1.14 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.584 -0.698 . . . . 1.0 110.623 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 1.012 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -149.85 105.19 3.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.841 -1.162 . . . . 1.0 109.952 179.543 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -90.33 106.23 18.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 1.0 109.13 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -109.8 172.03 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.289 -0.882 . . . . 1.0 109.229 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 1.9 mp -128.22 137.67 52.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.816 . . . . 1.0 109.518 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -133.58 112.81 11.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 1.0 109.264 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.944 HG22 HD21 ' A' ' 108' ' ' LEU . 51.9 mt -123.2 107.87 32.4 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 1.0 109.741 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 1.068 ' O ' HD23 ' A' ' 108' ' ' LEU . 34.7 Cg_endo -76.98 125.32 7.92 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.097 1.865 . . . . 1.0 110.231 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.068 HD23 ' O ' ' A' ' 107' ' ' PRO . 3.4 mt -134.12 151.63 51.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 1.0 110.006 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.558 HD12 ' SD ' ' A' ' 114' ' ' MET . 0.2 OUTLIER -123.38 91.29 49.9 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.416 -0.802 . . . . 1.0 108.93 179.505 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.662 ' HG3' HD13 ' A' ' 50' ' ' LEU . 35.9 Cg_endo -78.07 70.49 7.07 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.515 2.143 . . . . 1.0 110.631 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.494 ' O ' ' CG ' ' A' ' 111' ' ' GLU . 19.8 tp10 -118.56 0.71 11.61 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.284 -0.885 . . . . 1.0 109.639 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.498 ' O ' ' CB ' ' A' ' 113' ' ' SER . 0.0 OUTLIER -143.55 -65.11 0.38 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.105 -0.997 . . . . 1.0 109.496 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.4 OUTLIER 164.61 109.95 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.147 -0.971 . . . . 1.0 109.157 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.558 ' SD ' HD12 ' A' ' 109' ' ' LEU . 9.4 ptm -154.09 117.43 4.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.2 -0.938 . . . . 1.0 109.915 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.518 ' HD3' HG12 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -88.29 136.45 32.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.435 -0.79 . . . . 1.0 109.415 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.03 108.99 16.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 1.0 109.365 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.912 HG12 HG23 ' A' ' 47' ' ' ILE . 4.3 m -95.25 159.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -0.934 . . . . 1.0 109.667 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.486 ' O ' ' CB ' ' A' ' 45' ' ' HIS . 8.3 mt -146.95 102.6 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 1.0 109.228 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.543 ' HB2' ' CA ' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -147.56 47.39 1.11 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 1.0 109.71 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 63.8 m -145.04 54.2 1.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.881 . . . . 1.0 109.355 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.793 ' HB1' ' HB ' ' A' ' 81' ' ' VAL . . . -145.26 87.24 1.8 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.917 . . . . 1.0 109.845 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 1.038 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -56.44 -166.36 0.06 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 108.389 -1.884 . . . . 1.0 108.389 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.654 HG22 ' HD2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -114.29 151.77 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.707 -1.466 . . . . 1.0 109.178 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -143.44 82.57 1.74 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.438 -0.789 . . . . 1.0 109.702 -179.642 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.584 ' HB3' ' CD2' ' A' ' 79' ' ' TYR . 4.3 ptmt . . . . . 0 N--CA 1.494 1.74 0 O-C-N 120.822 -1.174 . . . . 1.0 110.207 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 173' ' ' GLU . 1.1 p . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 121.482 0.658 . . . . 1.0 109.68 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.12 128.02 7.41 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.388 -0.82 . . . . 1.0 109.187 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.805 ' HB ' HD11 ' A' ' 65' ' ' ILE . 6.8 m -136.2 161.28 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.964 . . . . 1.0 109.517 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.696 ' HD2' ' HB3' ' A' ' 68' ' ' ALA . 10.7 mtt-85 -145.24 126.41 14.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.189 -0.945 . . . . 1.0 109.667 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.801 HD22 HG12 ' A' ' 65' ' ' ILE . 2.0 mm? -79.86 114.52 18.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.335 -0.853 . . . . 1.0 108.997 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 45.6 t -85.93 122.74 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.235 -0.916 . . . . 1.0 109.497 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.863 ' CE1' HD13 ' A' ' 63' ' ' LEU . 8.0 m-85 -119.76 95.75 4.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.33 -0.856 . . . . 1.0 109.125 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.475 ' O ' ' HG3' ' A' ' 152' ' ' ARG . 19.5 ptt180 -135.63 129.93 33.59 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.141 -0.974 . . . . 1.0 109.566 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.571 ' HB ' HD22 ' A' ' 15' ' ' LEU . 11.9 p -108.19 128.6 63.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.306 -0.871 . . . . 1.0 108.763 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.567 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 41.0 m-70 -124.34 108.54 12.31 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.197 -0.94 . . . . 1.0 109.76 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.836 ' CG2' HD22 ' A' ' 59' ' ' LEU . 7.7 p -99.22 141.24 22.51 Favored Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 121.314 -0.866 . . . . 1.0 109.172 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.529 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 34.5 Cg_endo -77.19 115.34 3.95 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.174 1.916 . . . . 1.0 109.994 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.491 ' OE1' ' HD2' ' A' ' 158' ' ' PRO . 72.2 mm-40 -143.23 163.58 36.52 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.424 -0.797 . . . . 1.0 109.52 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.491 ' HD2' ' OE1' ' A' ' 157' ' ' GLN . 35.0 Cg_endo -77.92 -55.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.402 2.068 . . . . 1.0 109.777 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 158' ' ' PRO . 0.2 OUTLIER -45.71 171.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.628 -0.67 . . . . 1.0 109.466 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -93.86 -66.37 1.04 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.173 -1.171 . . . . 1.0 110.173 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.6 mtm-85 -78.98 79.21 5.39 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.399 -1.334 . . . . 1.0 107.399 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.556 HG23 ' H ' ' A' ' 163' ' ' LEU . 2.7 t -102.03 -108.34 0.24 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.673 -0.642 . . . . 1.0 110.518 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.556 HD13 ' HB3' ' A' ' 13' ' ' TYR . 8.6 tp -129.1 96.46 4.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.295 -1.503 . . . . 1.0 108.299 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.567 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -162.85 100.34 1.0 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.874 -1.141 . . . . 1.0 109.699 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.864 HD23 ' N ' ' A' ' 165' ' ' LEU . 1.0 OUTLIER -134.61 170.04 16.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.178 -0.952 . . . . 1.0 109.64 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.461 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 3.1 mm-40 -121.73 147.31 46.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 1.0 109.557 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.74 ' O ' HG12 ' A' ' 167' ' ' VAL . 41.8 t -145.47 70.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.871 . . . . 1.0 109.407 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.77 107.72 19.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.222 -0.924 . . . . 1.0 109.192 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 0.3 OUTLIER -156.33 123.49 5.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 1.0 109.7 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 169' ' ' SER . 1.8 t30 172.2 94.94 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.37 -0.831 . . . . 1.0 109.287 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.65 107.9 2.46 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.414 2.076 . . . . 1.0 110.48 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.62 ' HB ' HG22 ' A' ' 147' ' ' VAL . 24.6 mt -137.43 159.47 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.874 . . . . 1.0 108.99 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 145' ' ' THR . 2.9 mt-10 . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.127 -0.983 . . . . 1.0 109.854 -179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.447 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 36.3 Cg_endo . . . . . 0 C--O 1.216 -0.602 0 N-CA-C 110.596 -0.578 . . . . 1.0 110.596 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.575 ' CE2' ' O ' ' A' ' 162' ' ' THR . 8.3 m-85 -56.09 155.75 6.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 1.0 109.063 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 12' ' ' PRO . 20.7 mt-10 -152.21 103.01 2.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.885 -1.134 . . . . 1.0 110.25 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.665 ' HB3' HD12 ' A' ' 165' ' ' LEU . 17.3 tp -112.24 76.78 1.0 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.436 -0.95 . . . . 1.0 108.436 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.45 ' O ' ' OE1' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -114.87 176.25 5.14 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.322 -0.861 . . . . 1.0 110.188 -179.022 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.583 HG21 ' HG2' ' A' ' 20' ' ' GLN . 0.8 OUTLIER -86.75 146.48 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 108.705 -0.85 . . . . 1.0 108.705 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.496 ' HB2' ' NE2' ' A' ' 49' ' ' GLN . 0.8 OUTLIER -77.06 -61.13 2.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 1.0 109.261 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.752 HG22 ' HD3' ' A' ' 21' ' ' PRO . 9.7 p -109.67 136.02 46.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.385 -0.822 . . . . 1.0 109.307 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.583 ' HG2' HG21 ' A' ' 17' ' ' ILE . 9.4 mm-40 -129.06 66.02 75.34 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.143 -0.973 . . . . 1.0 109.599 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.752 ' HD3' HG22 ' A' ' 19' ' ' VAL . 35.4 Cg_endo -77.62 -177.03 3.54 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.464 2.109 . . . . 1.0 110.575 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -61.85 151.7 33.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.366 -0.834 . . . . 1.0 109.129 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.47 ' HB3' ' HG2' ' A' ' 171' ' ' PRO . 2.2 t -163.76 61.58 0.16 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.14 -0.975 . . . . 1.0 110.038 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . 0.442 ' HA ' HG12 ' A' ' 172' ' ' ILE . 1.9 p80 -99.52 165.52 11.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.084 -1.01 . . . . 1.0 108.881 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.599 ' CE1' ' HA ' ' A' ' 38' ' ' VAL . 1.1 m-70 -139.54 110.41 6.8 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.703 -0.799 . . . . 1.0 109.894 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -87.12 64.98 8.68 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.424 -0.954 . . . . 1.0 108.424 179.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.504 0 CA-C-O 121.367 0.603 . . . . 1.0 109.88 -179.226 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.598 0.713 . . . . 1.0 109.762 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.659 HG11 ' O ' ' A' ' 121' ' ' ALA . 2.4 p -100.27 102.3 13.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.939 -0.704 . . . . 1.0 109.732 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 12.5 ptpt -153.9 110.43 3.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.898 . . . . 1.0 109.614 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.66 -45.25 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.14 -0.975 . . . . 1.0 109.517 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.528 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 0.3 OUTLIER -100.68 102.1 13.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 1.0 109.621 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 41' ' ' SER . . . 61.52 42.32 11.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 1.0 109.521 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 92.09 -21.39 37.42 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.653 -1.379 . . . . 1.0 109.653 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.516 ' N ' ' OD2' ' A' ' 119' ' ' ASP . . . 155.22 106.79 0.27 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.486 ' HB3' ' O ' ' A' ' 118' ' ' ILE . 0.3 OUTLIER 73.92 146.18 0.11 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.254 -1.145 . . . . 1.0 109.758 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.12 -178.81 4.9 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.651 2.234 . . . . 1.0 110.577 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 1.016 HG23 HG12 ' A' ' 117' ' ' VAL . 5.2 mt -94.32 158.34 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.513 -0.742 . . . . 1.0 109.278 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.589 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 11.1 t -140.35 88.1 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.159 -0.963 . . . . 1.0 110.108 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.62 ' CG ' ' CE1' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -98.8 175.74 5.86 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 1.0 108.903 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.652 HD12 HD13 ' A' ' 15' ' ' LEU . 8.2 tt -134.81 136.73 42.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.933 -1.104 . . . . 1.0 110.036 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.62 ' CE1' ' CG ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -140.55 79.08 1.68 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.353 -0.842 . . . . 1.0 108.844 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . -174.33 88.22 0.08 OUTLIER Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.544 -1.312 . . . . 1.0 110.234 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.835 ' CE2' HD11 ' A' ' 59' ' ' LEU . 2.0 t80 176.8 131.83 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -1.109 . . . . 1.0 109.654 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 18.9 mt -108.89 4.42 23.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 1.0 109.539 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.471 ' HB3' ' HG2' ' A' ' 57' ' ' GLU . 2.7 mt-10 -95.24 143.39 26.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 1.0 109.507 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -90.73 35.12 0.89 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.918 . . . . 1.0 109.337 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.576 ' HG3' HD21 ' A' ' 59' ' ' LEU . 17.3 pt-20 -110.83 151.97 43.25 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 1.0 109.357 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.58 ' O ' HD23 ' A' ' 59' ' ' LEU . 35.8 Cg_endo -78.31 134.2 12.55 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.436 2.091 . . . . 1.0 110.534 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.835 HD11 ' CE2' ' A' ' 53' ' ' TYR . 16.1 mt -118.63 165.44 13.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.238 -0.914 . . . . 1.0 109.077 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -105.13 136.03 45.38 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.174 -0.954 . . . . 1.0 109.583 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.793 HD21 ' HB2' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -89.41 136.15 33.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.36 -0.838 . . . . 1.0 109.224 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -97.2 85.96 3.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.204 -0.935 . . . . 1.0 109.536 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 1.096 HD13 ' CE1' ' A' ' 151' ' ' PHE . 18.8 tp -99.36 130.95 45.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 1.0 108.822 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.502 ' HB2' ' CG1' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -155.44 143.54 20.05 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -0.968 . . . . 1.0 109.113 -179.326 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.817 HD13 ' N ' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -103.99 124.54 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.446 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.817 ' N ' HD13 ' A' ' 65' ' ' ILE . . . -136.8 149.17 20.1 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.915 -1.274 . . . . 1.0 109.915 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.732 HG23 ' HA ' ' A' ' 76' ' ' HIS . 73.5 p -83.14 156.51 23.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.28 -1.13 . . . . 1.0 109.362 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.572 ' HB3' ' HG3' ' A' ' 148' ' ' ARG . . . -160.56 116.99 2.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 1.0 109.694 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -85.45 -25.13 27.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.169 -0.957 . . . . 1.0 109.14 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.12 -42.02 0.21 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.382 -0.824 . . . . 1.0 109.425 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' LEU . 13.0 ttm180 -175.35 -34.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 1.0 109.569 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.723 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.7 OUTLIER -48.67 91.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 1.0 109.865 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.7 OUTLIER -58.21 155.73 10.93 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.163 -0.961 . . . . 1.0 109.656 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.513 ' NE ' ' OG1' ' A' ' 67' ' ' THR . 10.8 ptt180 -175.27 172.19 1.14 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.88 . . . . 1.0 108.7 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.512 ' HD2' ' HB2' ' A' ' 74' ' ' ARG . 33.7 Cg_endo -77.18 161.73 32.06 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.141 1.894 . . . . 1.0 110.312 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.732 ' HA ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -64.35 156.03 30.47 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.227 -0.921 . . . . 1.0 109.708 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.28 -48.92 4.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 1.0 109.84 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -120.39 26.83 8.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.18 -0.95 . . . . 1.0 109.899 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.756 ' OH ' HG22 ' A' ' 145' ' ' THR . 0.2 OUTLIER -140.86 148.68 40.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.148 -0.97 . . . . 1.0 109.127 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.479 ' HG3' ' HB2' ' A' ' 102' ' ' LYS . 20.5 tt0 -165.05 -36.41 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.122 -0.986 . . . . 1.0 109.589 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 m -50.78 143.22 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.052 -1.03 . . . . 1.0 109.633 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.402 ' O ' ' OE2' ' A' ' 95' ' ' GLU . 3.9 t-80 -175.93 67.98 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.532 -0.73 . . . . 1.0 109.319 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.0 OUTLIER -134.41 153.97 51.62 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.236 -0.915 . . . . 1.0 109.815 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 0.513 ' CG1' ' HB2' ' A' ' 120' ' ' CYS . 3.8 mp -100.01 143.63 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.447 -0.783 . . . . 1.0 109.486 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 34.4 p . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 1.0 109.404 -179.986 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.558 HG13 ' H ' ' A' ' 91' ' ' THR . 11.0 p . . . . . 0 N--CA 1.488 1.439 0 N-CA-C 109.418 -0.586 . . . . 1.0 109.418 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.441 ' N ' HG22 ' A' ' 89' ' ' VAL . 2.5 m -78.71 3.78 15.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 1.0 109.606 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.623 HG23 HD22 ' A' ' 108' ' ' LEU . 16.3 m -104.82 101.36 10.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.213 -0.93 . . . . 1.0 109.539 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.883 ' O ' HG23 ' A' ' 106' ' ' ILE . 22.7 m -46.08 115.71 1.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -0.935 . . . . 1.0 109.652 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.607 ' HA ' HG23 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -114.21 173.68 6.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 1.0 109.654 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.1 162.67 40.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.375 -0.828 . . . . 1.0 109.519 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.402 ' OE2' ' O ' ' A' ' 82' ' ' HIS . 1.2 tt0 -124.31 133.59 53.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.864 . . . . 1.0 109.492 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.474 ' O ' HG23 ' A' ' 103' ' ' VAL . . . -124.66 121.53 34.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 1.0 109.55 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.56 HD12 ' O ' ' A' ' 101' ' ' THR . 6.1 tp -111.79 140.12 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 1.0 109.444 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.51 ' O ' ' CB ' ' A' ' 99' ' ' SER . 0.5 OUTLIER -132.32 49.41 2.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.138 -0.976 . . . . 1.0 109.691 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 3.1 t 76.8 112.34 0.07 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.897 . . . . 1.0 110.279 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.432 ' CG ' ' O ' ' A' ' 99' ' ' SER . 3.5 p-10 43.64 31.96 0.51 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.689 -0.632 . . . . 1.0 111.032 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.56 ' O ' HD12 ' A' ' 97' ' ' ILE . 2.5 m -160.2 96.29 1.19 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.737 -1.227 . . . . 1.0 110.226 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.479 ' HB2' ' HG3' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -88.87 153.71 20.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.229 -0.919 . . . . 1.0 108.943 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.502 ' CG1' ' HB2' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -144.18 173.57 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.071 -1.018 . . . . 1.0 109.211 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.561 HD22 HD23 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -123.92 130.81 53.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.924 . . . . 1.0 109.954 -179.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -133.1 122.64 24.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.358 -0.839 . . . . 1.0 108.864 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 1.062 HG22 HD21 ' A' ' 108' ' ' LEU . 26.8 mt -133.94 112.73 12.48 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.035 -1.04 . . . . 1.0 110.119 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.946 ' C ' HD23 ' A' ' 108' ' ' LEU . 34.0 Cg_endo -76.56 121.24 5.89 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 122.091 1.861 . . . . 1.0 109.712 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.062 HD21 HG22 ' A' ' 106' ' ' ILE . 2.5 mt -126.36 165.55 18.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 1.0 110.667 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.773 HD23 ' N ' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -72.26 -170.82 0.17 Allowed Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 108.081 -1.081 . . . . 1.0 108.081 179.259 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.59 ' CD ' ' CB ' ' A' ' 109' ' ' LEU . 33.4 Cg_endo -77.64 -76.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 121.532 1.488 . . . . 1.0 110.848 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.455 ' HG3' ' HA ' ' A' ' 51' ' ' HIS . 1.8 tt0 -170.46 52.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.897 -1.127 . . . . 1.0 110.131 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.474 ' O ' ' CB ' ' A' ' 113' ' ' SER . 13.2 p30 -79.73 -40.65 28.37 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.086 -1.009 . . . . 1.0 109.166 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.5 OUTLIER 164.68 87.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.361 -0.837 . . . . 1.0 109.157 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.584 ' HE1' ' N ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -162.51 139.71 8.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.155 -0.966 . . . . 1.0 110.19 -179.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -119.6 137.75 53.66 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.386 -0.821 . . . . 1.0 108.937 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -112.49 97.91 6.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.158 -0.964 . . . . 1.0 109.749 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 1.016 HG12 HG23 ' A' ' 47' ' ' ILE . 5.4 m -96.42 127.22 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 1.0 109.349 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.486 ' O ' ' HB3' ' A' ' 45' ' ' HIS . 65.9 mt -102.56 111.26 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 1.0 109.358 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.516 ' OD2' ' N ' ' A' ' 44' ' ' GLY . 3.9 t0 -147.12 41.83 1.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.943 . . . . 1.0 109.619 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.513 ' HB2' ' CG1' ' A' ' 84' ' ' ILE . 63.8 m -145.22 57.77 1.26 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -0.956 . . . . 1.0 109.824 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.659 ' O ' HG11 ' A' ' 38' ' ' VAL . . . -128.33 152.94 47.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 1.0 108.881 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -114.21 -174.35 18.53 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.838 -1.305 . . . . 1.0 109.838 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.2 mt -125.23 171.79 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -1.104 . . . . 1.0 109.055 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.31 161.36 37.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 1.0 109.569 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.303 -0.873 . . . . 1.0 109.377 179.883 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.756 HG22 ' OH ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.158 0.504 . . . . 1.0 109.654 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.545 ' NH2' ' ND2' ' A' ' 170' ' ' ASN . 6.4 ptm180 -86.73 176.59 7.66 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.233 -0.917 . . . . 1.0 109.288 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.583 HG12 ' NE2' ' A' ' 76' ' ' HIS . 27.7 m -134.7 -174.68 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.403 -0.811 . . . . 1.0 109.877 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.572 ' HG3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -149.29 95.97 2.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.33 -0.856 . . . . 1.0 109.319 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.526 ' CD2' HG12 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -78.0 124.51 28.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.986 -1.071 . . . . 1.0 109.035 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.6 t -110.04 114.41 46.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.233 -0.917 . . . . 1.0 109.776 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 1.096 ' CE1' HD13 ' A' ' 63' ' ' LEU . 21.6 m-85 -110.43 113.29 25.83 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.769 -0.826 . . . . 1.0 108.769 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.486 ' HB3' ' HA ' ' A' ' 166' ' ' GLN . 10.0 ptt180 -149.46 138.73 21.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.171 -0.955 . . . . 1.0 109.781 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.537 ' HB ' HD22 ' A' ' 15' ' ' LEU . 8.7 p -112.66 128.52 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.471 -0.937 . . . . 1.0 108.471 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.567 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 41.7 m-70 -128.89 118.45 22.71 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.16 -0.962 . . . . 1.0 110.002 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.546 HG11 ' HB3' ' A' ' 163' ' ' LEU . 14.7 p -98.52 141.2 22.53 Favored Pre-proline 0 N--CA 1.487 1.406 0 O-C-N 121.279 -0.888 . . . . 1.0 108.788 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.541 ' HD2' HG23 ' A' ' 155' ' ' VAL . 33.0 Cg_endo -74.73 114.05 3.94 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.197 1.931 . . . . 1.0 110.615 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.633 ' HG3' HG21 ' A' ' 162' ' ' THR . 0.6 OUTLIER -135.71 166.05 31.42 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.506 -0.746 . . . . 1.0 109.006 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.463 ' HD2' ' OE1' ' A' ' 157' ' ' GLN . 34.4 Cg_endo -76.34 -64.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.261 1.974 . . . . 1.0 110.373 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.0 m -53.77 -78.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.195 -0.94 . . . . 1.0 109.349 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 144.44 -42.07 1.06 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.458 -1.457 . . . . 1.0 109.458 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.01 79.96 5.37 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.022 -1.103 . . . . 1.0 108.022 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.786 HG22 ' N ' ' A' ' 163' ' ' LEU . 1.3 m -135.05 -88.38 0.36 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.533 -0.73 . . . . 1.0 109.367 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.786 ' N ' HG22 ' A' ' 162' ' ' THR . 7.6 tp -131.15 102.89 6.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.021 -1.049 . . . . 1.0 109.08 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.567 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -162.11 114.31 1.71 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.08 -1.012 . . . . 1.0 109.593 179.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.665 HD12 ' HB3' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -122.81 175.36 6.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.335 -0.853 . . . . 1.0 109.753 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.486 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 0.7 OUTLIER -147.87 105.66 3.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.425 -0.797 . . . . 1.0 109.426 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 151' ' ' PHE . 43.8 t -118.28 154.01 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 1.0 109.332 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 149' ' ' LEU . . . -151.41 102.83 2.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 1.0 109.214 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 170' ' ' ASN . 0.4 OUTLIER -130.71 161.78 30.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.957 . . . . 1.0 109.693 -179.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.545 ' ND2' ' NH2' ' A' ' 146' ' ' ARG . 1.6 p-10 164.93 97.77 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.343 -0.848 . . . . 1.0 109.567 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.47 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 36.1 Cg_endo -79.45 67.81 8.48 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.419 2.08 . . . . 1.0 110.48 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 23' ' ' SER . 16.1 mt -136.6 124.45 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.104 -0.997 . . . . 1.0 109.443 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 1.0 109.363 179.891 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo . . . . . 0 C--O 1.215 -0.638 0 N-CA-C 110.486 -0.621 . . . . 1.0 110.486 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.565 ' CD1' ' O ' ' A' ' 162' ' ' THR . 1.8 m-85 -95.65 162.9 13.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 1.0 109.459 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -152.42 142.69 22.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.138 -0.976 . . . . 1.0 109.918 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.939 HD13 HD12 ' A' ' 50' ' ' LEU . 22.8 tp -136.31 98.05 3.74 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.784 -0.821 . . . . 1.0 108.784 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.47 164.23 29.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 1.0 110.227 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 47' ' ' ILE . 0.8 OUTLIER -92.36 145.29 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.547 -0.909 . . . . 1.0 108.547 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.421 ' C ' HG23 ' A' ' 19' ' ' VAL . 1.3 tp10 -75.4 -35.83 60.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.936 . . . . 1.0 110.3 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.499 ' HB ' HG13 ' A' ' 47' ' ' ILE . 80.0 t -154.48 98.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 O-C-N 120.814 -1.179 . . . . 1.0 110.157 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.589 ' NE2' HG21 ' A' ' 17' ' ' ILE . 0.6 OUTLIER -51.63 160.34 1.06 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.442 -0.786 . . . . 1.0 109.037 179.422 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.496 ' HB3' ' O ' ' A' ' 44' ' ' GLY . 36.2 Cg_endo -78.38 154.92 28.36 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.458 2.106 . . . . 1.0 110.415 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.6 mmtm -46.09 165.12 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.266 -0.896 . . . . 1.0 109.453 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.457 ' O ' ' OG ' ' A' ' 23' ' ' SER . 5.2 t -94.19 24.39 4.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 1.0 110.142 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.04 166.38 23.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.94 -1.1 . . . . 1.0 110.003 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.85 ' CD2' HD11 ' A' ' 123' ' ' ILE . 0.8 OUTLIER -162.48 106.76 1.15 Allowed 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.303 -0.629 . . . . 1.0 109.303 179.428 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 24.1 ttp85 -75.17 91.74 2.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.255 -0.903 . . . . 1.0 109.36 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.312 0 O-C-N 121.315 -0.866 . . . . 1.0 109.523 179.906 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.442 0.639 . . . . 1.0 109.517 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.592 ' HB ' ' CE1' ' A' ' 25' ' ' HIS . 2.4 p -68.33 142.06 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.403 -0.81 . . . . 1.0 109.445 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -143.8 105.41 4.3 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.278 -0.889 . . . . 1.0 109.766 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 43' ' ' GLY . . . -161.16 105.8 1.34 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.411 -0.806 . . . . 1.0 108.905 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.471 ' HG ' ' C ' ' A' ' 40' ' ' ALA . 19.2 p 44.17 -105.56 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 1.0 108.903 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.503 ' O ' ' CB ' ' A' ' 119' ' ' ASP . . . -88.57 48.0 1.58 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.582 -1.324 . . . . 1.0 108.232 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.601 ' O ' ' HB3' ' A' ' 40' ' ' ALA . . . 67.82 -111.11 3.82 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.039 -2.024 . . . . 1.0 108.039 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 45' ' ' HIS . . . -89.61 -22.15 37.87 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.219 -1.952 . . . . 1.0 108.219 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.606 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 2.3 t-80 79.43 27.96 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.355 0 N-CA-C 113.315 0.857 . . . . 1.0 113.315 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 45' ' ' HIS . 37.3 Cg_endo -79.34 114.25 3.27 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 N-CA-C 108.935 -1.217 . . . . 1.0 108.935 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.636 ' O ' HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -102.32 144.95 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.967 -1.083 . . . . 1.0 108.802 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.602 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 5.2 t -137.27 124.49 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.033 -1.042 . . . . 1.0 110.369 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.565 ' NE2' ' NH1' ' A' ' 115' ' ' ARG . 4.8 tt0 -140.06 142.51 36.16 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.524 -0.917 . . . . 1.0 108.524 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.939 HD12 HD13 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -118.04 141.05 48.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.939 -1.1 . . . . 1.0 109.897 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -140.66 84.98 1.97 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.349 -0.844 . . . . 1.0 109.449 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 170.01 105.22 0.18 Allowed Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.304 -1.427 . . . . 1.0 110.648 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.595 ' CD2' ' HB2' ' A' ' 111' ' ' GLU . 3.5 t80 175.9 156.95 0.22 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.426 -1.044 . . . . 1.0 109.965 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.748 ' C ' HD12 ' A' ' 54' ' ' LEU . 3.3 pp -140.71 11.02 2.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.421 -0.799 . . . . 1.0 109.255 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.449 ' O ' ' CE2' ' A' ' 53' ' ' TYR . 1.6 tm-20 -120.77 145.67 47.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.303 -0.873 . . . . 1.0 109.658 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.402 ' C ' ' ND2' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -90.25 35.81 0.87 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 1.0 109.96 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.677 ' HG3' HD21 ' A' ' 59' ' ' LEU . 15.1 pt-20 -100.62 137.84 19.97 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.146 -0.971 . . . . 1.0 109.424 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 1.05 ' O ' HD23 ' A' ' 59' ' ' LEU . 36.7 Cg_endo -79.92 154.23 22.78 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.511 2.141 . . . . 1.0 110.501 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.05 HD23 ' O ' ' A' ' 58' ' ' PRO . 2.3 mt -141.27 156.29 45.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 1.0 109.172 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -87.26 135.55 33.27 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.223 -0.923 . . . . 1.0 109.104 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -87.94 131.15 34.71 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.275 -0.89 . . . . 1.0 109.499 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -98.52 82.66 2.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -0.911 . . . . 1.0 109.572 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.93 HD13 ' CZ ' ' A' ' 151' ' ' PHE . 58.9 tp -99.64 135.98 40.25 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.247 -0.908 . . . . 1.0 108.81 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.692 ' HB2' HG12 ' A' ' 103' ' ' VAL . 1.7 t80 -148.4 164.05 35.28 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.226 -0.921 . . . . 1.0 109.042 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.757 ' O ' HG23 ' A' ' 65' ' ' ILE . 8.1 tp -129.38 102.85 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.581 ' HA3' ' CZ ' ' A' ' 64' ' ' PHE . . . -124.65 153.69 17.83 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 110.067 -1.213 . . . . 1.0 110.067 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.901 HG22 ' CD2' ' A' ' 76' ' ' HIS . 1.1 p -77.22 149.56 35.47 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.464 -1.021 . . . . 1.0 109.23 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.459 ' HB3' ' HD2' ' A' ' 148' ' ' ARG . . . -153.72 115.74 4.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 1.0 109.752 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.25 -7.95 58.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 1.0 109.522 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -159.91 -44.34 0.05 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -0.929 . . . . 1.0 109.452 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -175.08 -34.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.262 -0.899 . . . . 1.0 109.625 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.08 89.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.9 . . . . 1.0 109.739 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 71' ' ' ARG . 2.2 pp -65.35 129.72 40.76 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.283 -0.885 . . . . 1.0 109.666 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.486 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 13.5 mmt180 -145.13 160.31 46.49 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 1.0 109.247 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -75.99 142.67 25.21 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.342 2.028 . . . . 1.0 110.202 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.901 ' CD2' HG22 ' A' ' 67' ' ' THR . 0.3 OUTLIER -67.44 160.97 26.36 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.221 -0.924 . . . . 1.0 109.569 -179.642 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.87 -65.21 0.86 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.307 -0.871 . . . . 1.0 110.308 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.683 ' CE2' ' CE1' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -111.91 -4.34 14.59 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.033 -1.042 . . . . 1.0 110.219 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.683 ' CE1' ' CE2' ' A' ' 78' ' ' PHE . 52.3 m-85 -83.89 105.94 15.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.98 -1.075 . . . . 1.0 108.963 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.53 ' HB2' ' CG ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -143.66 10.11 1.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.073 -1.017 . . . . 1.0 110.081 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 122' ' ' GLY . 11.9 m -75.68 146.91 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.983 -1.073 . . . . 1.0 109.497 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.734 ' CE1' HD12 ' A' ' 104' ' ' LEU . 5.7 t-80 -175.49 67.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.476 -0.765 . . . . 1.0 109.237 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.6 OUTLIER -122.66 139.9 53.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.235 -0.916 . . . . 1.0 109.746 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . 1.104 HG23 ' CB ' ' A' ' 120' ' ' CYS . 4.5 mp -100.11 133.52 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.343 -0.848 . . . . 1.0 109.675 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.275 -0.891 . . . . 1.0 109.302 179.802 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.569 HG22 ' H ' ' A' ' 91' ' ' THR . 8.7 p . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.306 -0.627 . . . . 1.0 109.306 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.3 m -74.65 -0.43 17.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 1.0 109.806 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.569 ' H ' HG22 ' A' ' 89' ' ' VAL . 16.4 m -80.75 -83.01 0.11 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.069 -1.019 . . . . 1.0 109.387 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.569 ' O ' HG21 ' A' ' 106' ' ' ILE . 0.0 OUTLIER 179.33 162.46 0.85 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.302 -0.874 . . . . 1.0 109.459 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.533 ' HA ' ' CG1' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -165.19 156.98 15.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.263 -0.898 . . . . 1.0 110.014 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.488 ' HB2' ' O ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -155.61 150.08 26.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.467 -0.77 . . . . 1.0 109.064 179.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -120.45 148.48 43.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.136 -0.978 . . . . 1.0 109.837 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.29 121.22 9.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.303 -0.873 . . . . 1.0 109.557 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.887 HD13 ' HG2' ' A' ' 102' ' ' LYS . 2.1 tp -110.75 106.12 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.342 -0.849 . . . . 1.0 109.606 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.722 HD23 ' H ' ' A' ' 98' ' ' LEU . 2.1 pt? -110.15 130.28 55.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.205 -0.934 . . . . 1.0 109.48 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.535 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 16.6 m 35.07 83.98 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.077 -0.39 . . . . 1.0 111.379 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 99' ' ' SER . 0.7 OUTLIER 42.72 29.42 0.17 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.684 -0.635 . . . . 1.0 112.482 178.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.612 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -132.34 109.4 9.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.247 -1.533 . . . . 1.0 109.969 179.141 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . 0.887 ' HG2' HD13 ' A' ' 97' ' ' ILE . 9.9 mmtp -85.96 137.93 32.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.1 -1.0 . . . . 1.0 109.358 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.692 HG12 ' HB2' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -143.98 172.68 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.331 -0.855 . . . . 1.0 109.089 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.003 HD22 HD11 ' A' ' 106' ' ' ILE . 0.5 OUTLIER -124.31 135.55 53.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.27 -0.894 . . . . 1.0 110.147 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 0.4 OUTLIER -139.99 125.03 18.58 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.601 -0.889 . . . . 1.0 108.601 179.405 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 1.003 HD11 HD22 ' A' ' 104' ' ' LEU . 4.1 mp -128.94 115.81 19.03 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.976 -1.077 . . . . 1.0 110.115 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.41 97.3 1.12 Allowed 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 121.946 1.764 . . . . 1.0 109.64 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.559 HD11 ' HG3' ' A' ' 110' ' ' PRO . 0.7 OUTLIER -145.75 167.59 22.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 1.0 109.485 -179.205 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.772 HD23 ' OD1' ' A' ' 112' ' ' ASN . 3.9 tt -115.03 78.56 5.6 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.921 . . . . 1.0 110.346 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.559 ' HG3' HD11 ' A' ' 108' ' ' LEU . 38.1 Cg_endo -83.25 40.13 0.9 Allowed 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.589 2.192 . . . . 1.0 110.082 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.595 ' HB2' ' CD2' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -120.81 22.39 11.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.047 -1.033 . . . . 1.0 110.056 -178.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.772 ' OD1' HD23 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -122.32 -52.9 1.93 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.114 -0.991 . . . . 1.0 109.119 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 1.4 p 164.59 86.01 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.371 -0.831 . . . . 1.0 108.989 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' MET . . . . . 0.451 ' CE ' ' HB3' ' A' ' 110' ' ' PRO . 0.5 OUTLIER -154.7 144.55 21.66 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.14 -0.975 . . . . 1.0 109.829 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.616 ' NH2' HG22 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -101.44 142.73 32.39 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.541 -0.911 . . . . 1.0 108.541 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.508 ' N ' ' HD3' ' A' ' 115' ' ' ARG . . . -134.78 96.55 3.56 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.994 -1.066 . . . . 1.0 109.87 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 117' ' ' VAL . 3.9 m -86.45 131.37 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.346 -0.846 . . . . 1.0 109.145 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.464 ' O ' ' HG2' ' A' ' 46' ' ' PRO . 2.2 mt -117.27 130.1 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.217 -0.927 . . . . 1.0 109.153 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 42' ' ' ALA . 0.7 OUTLIER -171.66 57.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.863 . . . . 1.0 109.695 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 1.104 ' CB ' HG23 ' A' ' 84' ' ' ILE . 60.7 m -145.19 43.73 1.32 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.137 -0.977 . . . . 1.0 109.845 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . 0.501 ' O ' HG12 ' A' ' 38' ' ' VAL . . . -126.64 165.95 18.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 1.0 108.833 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.848 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -139.76 -179.48 17.76 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.697 -1.361 . . . . 1.0 109.697 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.85 HD11 ' CD2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -119.43 158.54 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.357 -1.084 . . . . 1.0 109.072 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.571 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -99.9 126.24 46.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 1.0 109.459 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.0 mttt . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.191 -0.943 . . . . 1.0 109.495 -179.85 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.386 -0.598 . . . . 1.0 109.386 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.476 ' O ' ' HB ' ' A' ' 67' ' ' THR . 11.2 mtt180 -85.1 166.62 16.49 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.267 -0.896 . . . . 1.0 109.417 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.761 ' CG2' HG21 ' A' ' 172' ' ' ILE . 2.9 m -140.57 151.7 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -0.841 . . . . 1.0 109.422 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.507 ' HA ' ' CB ' ' A' ' 170' ' ' ASN . 42.6 mtt180 -154.52 125.72 7.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.132 -0.98 . . . . 1.0 109.448 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.486 HD23 ' ND2' ' A' ' 170' ' ' ASN . 0.4 OUTLIER -81.26 109.48 15.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.161 -0.962 . . . . 1.0 109.717 -179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.561 HG13 ' OE1' ' A' ' 166' ' ' GLN . 44.0 t -81.47 123.85 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.377 -0.827 . . . . 1.0 109.846 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.93 ' CZ ' HD13 ' A' ' 63' ' ' LEU . 1.9 m-85 -110.4 121.51 45.46 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.656 -0.868 . . . . 1.0 108.656 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . 0.526 ' CG ' ' HA ' ' A' ' 166' ' ' GLN . 1.8 mtt180 -145.03 123.12 12.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.92 -1.112 . . . . 1.0 110.184 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.56 HG13 ' CD1' ' A' ' 163' ' ' LEU . 7.1 p -114.85 129.71 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.476 -0.935 . . . . 1.0 108.476 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' HIS . . . . . 0.555 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 49.8 m-70 -130.35 113.43 14.35 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.116 -0.99 . . . . 1.0 109.718 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.808 HG23 HD22 ' A' ' 59' ' ' LEU . 5.2 p -98.74 140.94 22.12 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.306 -0.871 . . . . 1.0 109.019 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PRO . . . . . 0.543 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 33.6 Cg_endo -75.04 116.17 4.5 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.319 2.012 . . . . 1.0 110.791 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLN . . . . . 0.483 ' HB2' ' HD2' ' A' ' 158' ' ' PRO . 0.8 OUTLIER -132.71 165.24 37.95 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.506 -0.746 . . . . 1.0 109.247 -179.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 157' ' ' GLN . 33.8 Cg_endo -76.4 -63.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.194 1.93 . . . . 1.0 109.985 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.6 t -64.91 -90.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -0.862 . . . . 1.0 109.184 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . 0.433 ' HA2' ' CD ' ' A' ' 157' ' ' GLN . . . 164.06 -28.21 0.22 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.641 -1.383 . . . . 1.0 109.641 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -79.28 79.62 5.7 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.363 -1.081 . . . . 1.0 108.556 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.668 HG22 ' N ' ' A' ' 163' ' ' LEU . 1.3 m -134.97 -82.21 0.43 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.839 -0.8 . . . . 1.0 108.839 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LEU . . . . . 0.696 ' HG ' HG12 ' A' ' 155' ' ' VAL . 2.1 pp -159.69 106.96 1.69 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.957 -1.09 . . . . 1.0 109.728 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.555 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -164.95 85.02 0.4 Allowed 'General case' 0 C--N 1.294 -1.833 0 O-C-N 120.803 -1.186 . . . . 1.0 109.141 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.75 ' N ' HD23 ' A' ' 165' ' ' LEU . 1.5 pt? -131.38 168.82 16.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.034 -1.042 . . . . 1.0 110.026 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.561 ' OE1' HG13 ' A' ' 150' ' ' VAL . 7.0 tp-100 -101.97 149.74 23.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.452 -0.78 . . . . 1.0 109.548 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 167' ' ' VAL . 39.0 t -144.18 71.51 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 1.0 109.521 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.44 136.19 42.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.089 -1.007 . . . . 1.0 109.5 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 7.3 t -175.3 133.96 0.31 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 1.0 109.613 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.507 ' CB ' ' HA ' ' A' ' 148' ' ' ARG . 1.9 t30 170.03 97.72 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.356 -0.84 . . . . 1.0 109.436 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 23' ' ' SER . 35.3 Cg_endo -77.57 72.18 6.15 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.404 2.069 . . . . 1.0 110.615 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ILE . . . . . 0.761 HG21 ' CG2' ' A' ' 147' ' ' VAL . 13.9 mm -107.79 126.92 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.202 -0.937 . . . . 1.0 109.251 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.468 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 9.9 pt-20 . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 1.0 109.575 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.337 0.589 . . . . 1.0 109.424 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -154.44 -153.77 0.47 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.2 -0.938 . . . . 1.0 109.395 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -124.51 57.82 1.24 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.185 -0.947 . . . . 1.0 109.583 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.797 ' CE2' HD21 ' A' ' 6' ' ' LEU . 31.1 p90 -68.3 -38.97 82.17 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.227 -0.921 . . . . 1.0 109.495 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.727 ' C ' HD22 ' A' ' 6' ' ' LEU . 10.4 tt0 174.42 77.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.257 -0.902 . . . . 1.0 109.368 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.797 HD21 ' CE2' ' A' ' 4' ' ' TRP . 3.1 mm? -118.03 85.0 22.71 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.289 -0.882 . . . . 1.0 109.5 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.1 79.82 3.16 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.324 2.016 . . . . 1.0 110.586 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.68 41.35 0.4 Allowed 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.444 -0.785 . . . . 1.0 109.283 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 25.3 m80 -140.22 172.15 13.16 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.32 -0.863 . . . . 1.0 109.592 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.5 m -166.23 55.1 0.1 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.356 -0.84 . . . . 1.0 109.357 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.13 97.02 0.19 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.563 -1.415 . . . . 1.0 109.563 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.504 ' O ' ' HA3' ' A' ' 52' ' ' GLY . 34.7 Cg_endo -77.18 -163.03 0.19 Allowed 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.367 2.044 . . . . 1.0 110.238 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.577 ' CE2' ' O ' ' A' ' 162' ' ' THR . 2.8 m-85 -69.31 135.19 50.08 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.314 -0.866 . . . . 1.0 109.568 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 51' ' ' HIS . 3.3 pt-20 -172.31 126.8 0.54 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.964 -1.085 . . . . 1.0 109.838 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.686 ' O ' HD12 ' A' ' 15' ' ' LEU . 1.3 pp -108.55 87.81 2.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.333 -0.854 . . . . 1.0 109.264 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -101.63 148.31 25.39 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.187 -0.945 . . . . 1.0 109.768 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.539 HG23 ' O ' ' A' ' 47' ' ' ILE . 1.2 mp -69.55 141.74 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.378 -0.826 . . . . 1.0 108.824 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.495 ' OE2' ' CZ ' ' A' ' 115' ' ' ARG . 4.9 tt0 -76.6 -32.93 58.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.296 -0.878 . . . . 1.0 109.816 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.488 ' HB ' HG12 ' A' ' 47' ' ' ILE . 98.2 t -142.29 134.54 26.77 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.186 -0.946 . . . . 1.0 109.631 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.402 ' HG2' ' CG2' ' A' ' 17' ' ' ILE . 0.7 OUTLIER -122.79 99.92 41.18 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.357 -0.84 . . . . 1.0 109.287 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.489 ' HG3' ' HB3' ' A' ' 42' ' ' ALA . 34.9 Cg_endo -76.53 -179.21 5.1 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.396 2.064 . . . . 1.0 110.576 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -43.18 162.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.302 -0.874 . . . . 1.0 109.476 -179.896 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.488 ' CB ' ' HG2' ' A' ' 171' ' ' PRO . 8.4 t -119.48 50.02 1.29 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.282 -0.886 . . . . 1.0 109.988 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.29 167.07 17.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.115 -0.991 . . . . 1.0 109.283 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 1.042 ' CE1' HG22 ' A' ' 38' ' ' VAL . 0.8 OUTLIER -170.4 118.6 0.55 Allowed 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 120.154 -0.618 . . . . 1.0 109.63 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.555 ' HA ' ' CE1' ' A' ' 28' ' ' HIS . 0.0 OUTLIER -80.23 76.59 7.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.317 -0.864 . . . . 1.0 109.259 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.428 ' HB2' ' CD1' ' A' ' 123' ' ' ILE . . . -83.26 68.45 9.64 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.328 -0.858 . . . . 1.0 109.929 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.555 ' CE1' ' HA ' ' A' ' 26' ' ' ARG . 1.8 p-80 -162.75 55.93 0.21 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.957 . . . . 1.0 109.635 179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.574 ' O ' ' CG ' ' A' ' 29' ' ' TYR . 9.7 p90 -179.93 115.03 0.05 Allowed 'General case' 0 C--N 1.294 -1.811 0 C-N-CA 120.066 -0.653 . . . . 1.0 109.614 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 29' ' ' TYR . 1.3 pt-20 173.42 74.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.142 -0.974 . . . . 1.0 109.604 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.709 HG22 ' O ' ' A' ' 31' ' ' THR . 86.4 m -145.69 32.64 1.05 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.24 -0.913 . . . . 1.0 108.954 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -102.72 -72.62 0.69 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.484 -0.76 . . . . 1.0 109.469 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -63.45 -91.95 0.03 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.488 -1.445 . . . . 1.0 109.488 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.75 -38.99 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -1.117 . . . . 1.0 109.423 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.448 ' O ' ' O ' ' A' ' 36' ' ' GLY . 19.6 mtt180 -161.57 42.5 0.15 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 1.0 109.573 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 35' ' ' ARG . . . -50.35 -179.66 0.03 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.359 -1.496 . . . . 1.0 109.359 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.28 176.83 7.11 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.074 -1.251 . . . . 1.0 110.832 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 1.042 HG22 ' CE1' ' A' ' 25' ' ' HIS . 3.9 p -133.74 121.28 39.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 N-CA-C 107.131 -1.433 . . . . 1.0 107.131 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 121' ' ' ALA . 24.8 mmtt -155.32 116.16 3.9 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.297 -0.877 . . . . 1.0 109.56 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.24 -152.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.6 -0.688 . . . . 1.0 110.081 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.41 ' O ' ' C ' ' A' ' 42' ' ' ALA . 1.8 m -51.56 158.39 0.92 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.23 -0.919 . . . . 1.0 109.963 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.489 ' HB3' ' HG3' ' A' ' 21' ' ' PRO . . . 43.0 47.04 4.91 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.434 -0.791 . . . . 1.0 109.425 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.515 ' HA3' ' CA ' ' A' ' 119' ' ' ASP . . . 44.46 51.66 7.7 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.386 -1.485 . . . . 1.0 109.386 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.466 ' HA3' ' HD2' ' A' ' 39' ' ' LYS . . . 63.89 -87.58 0.07 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.686 -1.365 . . . . 1.0 109.686 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.66 ' CE1' HD12 ' A' ' 149' ' ' LEU . 2.1 m-70 -50.96 144.93 12.85 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.213 -1.169 . . . . 1.0 109.852 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HB3' ' HD2' ' A' ' 21' ' ' PRO . 36.2 Cg_endo -79.43 -167.93 0.57 Allowed 'Trans proline' 0 C--N 1.313 -1.311 0 C-N-CA 122.763 2.309 . . . . 1.0 110.522 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.989 ' CG2' HG12 ' A' ' 117' ' ' VAL . 0.9 OUTLIER -93.23 158.57 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 108.402 -0.962 . . . . 1.0 108.402 179.782 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.557 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 3.4 t -136.76 132.84 48.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 120.925 -1.109 . . . . 1.0 110.359 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.485 ' O ' ' CG ' ' A' ' 49' ' ' GLN . 2.6 pt20 -145.36 120.22 9.94 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.913 -0.773 . . . . 1.0 108.913 179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.475 ' HG ' ' HB3' ' A' ' 15' ' ' LEU . 0.3 OUTLIER -86.22 124.11 32.24 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.149 -0.97 . . . . 1.0 109.893 -179.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.484 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 18.0 p80 -141.23 132.59 26.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.28 -0.887 . . . . 1.0 108.802 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 12' ' ' PRO . . . 137.0 -2.79 3.32 Favored Glycine 0 N--CA 1.483 1.798 0 C-N-CA 119.262 -1.447 . . . . 1.0 110.578 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.583 ' CE2' ' HB2' ' A' ' 163' ' ' LEU . 0.5 OUTLIER -129.32 117.8 21.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.062 -1.257 . . . . 1.0 109.492 179.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.844 HD12 ' O ' ' A' ' 54' ' ' LEU . 1.3 pp -99.96 35.61 2.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.156 -0.965 . . . . 1.0 109.567 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.56 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 3.9 tp10 -80.0 144.22 33.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 1.0 109.583 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.411 ' ND2' ' C ' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -87.72 34.6 0.71 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.232 -0.917 . . . . 1.0 109.957 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.655 ' HG3' HD21 ' A' ' 59' ' ' LEU . 11.7 pt-20 -133.96 143.92 49.45 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.266 -0.897 . . . . 1.0 109.276 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.576 ' O ' HD23 ' A' ' 59' ' ' LEU . 35.6 Cg_endo -78.57 134.15 12.16 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.307 2.005 . . . . 1.0 110.63 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.655 HD21 ' HG3' ' A' ' 57' ' ' GLU . 12.8 mt -115.59 165.07 13.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.199 -0.938 . . . . 1.0 108.683 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.426 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 40.7 mtt -106.13 112.99 26.25 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.147 -0.971 . . . . 1.0 109.993 -179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.896 HD21 ' HB2' ' A' ' 63' ' ' LEU . 1.9 tt -70.18 142.08 52.51 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.578 -0.701 . . . . 1.0 109.349 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.468 ' OE1' ' NH2' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -99.03 96.57 7.9 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.219 -0.926 . . . . 1.0 108.858 179.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.137 HD13 ' CE1' ' A' ' 151' ' ' PHE . 20.8 tp -119.15 132.07 55.94 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.296 -0.878 . . . . 1.0 109.911 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.59 ' HB3' HG12 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -164.96 165.83 19.9 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.717 -0.845 . . . . 1.0 108.717 179.304 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.759 HD13 ' N ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -105.13 120.94 56.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.937 -1.102 . . . . 1.0 109.242 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.759 ' N ' HD13 ' A' ' 65' ' ' ILE . . . -132.2 149.1 19.35 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.696 -1.361 . . . . 1.0 109.696 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.746 HG22 ' CD2' ' A' ' 76' ' ' HIS . 16.2 p -83.66 154.45 23.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.371 -1.076 . . . . 1.0 109.319 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.555 ' HB3' ' HD2' ' A' ' 148' ' ' ARG . . . -159.82 118.1 2.72 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 1.0 109.773 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.447 ' CG ' ' NH2' ' A' ' 146' ' ' ARG . 0.4 OUTLIER -102.23 -13.52 17.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.246 -0.908 . . . . 1.0 109.164 179.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -142.5 -55.26 0.43 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.363 -0.836 . . . . 1.0 109.412 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.66 -34.66 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.173 -0.955 . . . . 1.0 109.697 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.402 HD23 ' HA ' ' A' ' 72' ' ' LEU . 70.3 mt -66.34 86.8 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.914 . . . . 1.0 109.587 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.662 ' O ' HD12 ' A' ' 73' ' ' LEU . 0.2 OUTLIER -50.03 154.77 1.05 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.265 -0.897 . . . . 1.0 109.686 -179.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.497 ' HB3' ' HD2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -144.37 162.24 40.59 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.317 -0.864 . . . . 1.0 108.748 -179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 74' ' ' ARG . 33.1 Cg_endo -76.32 121.18 5.95 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.213 1.942 . . . . 1.0 110.051 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.915 ' NE2' HG12 ' A' ' 147' ' ' VAL . 1.6 t-80 -57.89 163.4 2.7 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.361 -0.837 . . . . 1.0 110.016 -179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.12 -76.29 0.08 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.4 -0.812 . . . . 1.0 109.548 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.728 ' CE1' HD11 ' A' ' 131' ' ' ILE . 8.3 m-85 -125.41 21.86 7.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.325 -0.859 . . . . 1.0 109.706 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.586 ' HB2' ' CG ' ' A' ' 76' ' ' HIS . 3.9 m-30 -79.91 75.99 6.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.213 -0.93 . . . . 1.0 109.077 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.553 ' CB ' ' HB3' ' A' ' 102' ' ' LYS . 4.2 pt20 -139.0 4.41 2.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.945 -1.097 . . . . 1.0 110.307 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.91 HG23 ' O ' ' A' ' 122' ' ' GLY . 15.0 m -78.65 144.77 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.958 -1.089 . . . . 1.0 109.182 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.588 ' O ' ' CG ' ' A' ' 82' ' ' HIS . 3.1 p80 -175.93 59.38 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 118.998 -1.081 . . . . 1.0 110.194 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.428 ' O ' ' O ' ' A' ' 120' ' ' CYS . 2.9 mmt85 -81.44 140.15 34.82 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.112 -0.993 . . . . 1.0 109.325 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.516 ' CG1' ' HB2' ' A' ' 120' ' ' CYS . 3.5 mp -106.32 135.58 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.205 -0.934 . . . . 1.0 109.764 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 87' ' ' LYS . 49.9 p -145.52 -147.39 0.21 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.406 -0.808 . . . . 1.0 109.106 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 85' ' ' THR . . . 41.42 -94.15 0.01 OUTLIER Glycine 0 N--CA 1.482 1.755 0 N-CA-C 110.37 -1.092 . . . . 1.0 110.37 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.0 OUTLIER -74.51 148.17 41.19 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.237 -1.155 . . . . 1.0 109.608 -179.67 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.06 118.41 36.95 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.25 -0.906 . . . . 1.0 109.604 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.863 HG13 HG22 ' A' ' 91' ' ' THR . 6.6 p -108.9 139.43 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 1.0 109.318 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.3 m -86.78 16.02 5.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 1.0 109.524 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.863 HG22 HG13 ' A' ' 89' ' ' VAL . 7.4 t -69.89 125.95 28.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -0.952 . . . . 1.0 109.575 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.829 ' O ' HG23 ' A' ' 106' ' ' ILE . 18.3 m -93.88 91.21 6.82 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.229 -0.92 . . . . 1.0 109.235 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.55 ' HA ' HG23 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -103.3 173.28 6.37 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.142 -0.974 . . . . 1.0 109.951 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -145.76 161.66 39.42 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.477 -0.765 . . . . 1.0 109.167 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.523 ' HG2' ' NE2' ' A' ' 82' ' ' HIS . 43.5 mt-10 -128.51 120.54 26.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 1.0 109.872 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.413 ' O ' ' HA ' ' A' ' 102' ' ' LYS . . . -114.18 124.56 52.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.264 -0.898 . . . . 1.0 108.94 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.688 HD13 ' N ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -124.73 126.39 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.09 -1.006 . . . . 1.0 109.876 -179.421 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.688 ' N ' HD13 ' A' ' 97' ' ' ILE . 0.6 OUTLIER -126.22 59.77 1.32 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.2 -0.938 . . . . 1.0 109.448 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER 77.03 103.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.309 -0.869 . . . . 1.0 109.612 -179.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.435 ' CG ' ' O ' ' A' ' 99' ' ' SER . 3.2 p-10 42.88 43.31 3.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.694 -0.629 . . . . 1.0 110.18 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.463 ' HB ' ' HG ' ' A' ' 98' ' ' LEU . 0.3 OUTLIER -159.58 87.96 0.84 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.993 -1.067 . . . . 1.0 109.776 179.741 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.553 ' HB3' ' CB ' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -97.32 152.67 18.66 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.343 -0.848 . . . . 1.0 109.159 179.549 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.59 HG12 ' HB3' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -146.36 169.97 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.217 -0.927 . . . . 1.0 109.06 179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.019 HD12 ' HG ' ' A' ' 63' ' ' LEU . 3.3 mt -120.31 128.56 53.4 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -0.933 . . . . 1.0 109.615 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -123.94 106.73 10.66 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.269 -0.894 . . . . 1.0 108.835 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.829 HG23 ' O ' ' A' ' 92' ' ' THR . 4.5 mt -119.38 115.95 33.88 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 1.0 109.832 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.742 ' C ' HD23 ' A' ' 108' ' ' LEU . 33.7 Cg_endo -75.87 119.0 5.23 Favored 'Trans proline' 0 C--N 1.315 -1.217 0 C-N-CA 121.96 1.773 . . . . 1.0 109.448 179.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.742 HD23 ' C ' ' A' ' 107' ' ' PRO . 6.1 mt -115.52 165.18 13.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.193 -0.942 . . . . 1.0 110.494 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.862 HD23 ' HB2' ' A' ' 112' ' ' ASN . 1.0 OUTLIER -97.3 126.69 40.92 Favored Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 109.067 -0.716 . . . . 1.0 109.067 -179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.485 ' CG ' ' O ' ' A' ' 57' ' ' GLU . 36.5 Cg_endo -79.96 -30.65 2.14 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 122.345 2.03 . . . . 1.0 112.03 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.455 ' HB2' ' HA ' ' A' ' 54' ' ' LEU . 2.1 tt0 -139.35 66.99 1.39 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.773 -1.204 . . . . 1.0 110.526 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.862 ' HB2' HD23 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -165.39 -67.52 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 1.0 109.505 179.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.49 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.4 OUTLIER 164.63 108.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.05 -1.032 . . . . 1.0 109.343 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.45 ' O ' ' HG3' ' A' ' 114' ' ' MET . 5.9 tpt -154.67 49.83 0.6 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.243 -0.911 . . . . 1.0 110.129 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.495 ' CZ ' ' OE2' ' A' ' 18' ' ' GLU . 10.0 ttt-85 -74.69 134.33 41.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.154 -0.966 . . . . 1.0 108.633 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -138.37 153.12 48.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.902 -1.124 . . . . 1.0 110.294 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.989 HG12 ' CG2' ' A' ' 47' ' ' ILE . 4.5 m -126.14 126.46 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.889 -0.782 . . . . 1.0 108.889 179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.476 ' CD1' HD21 ' A' ' 63' ' ' LEU . 32.4 mt -99.17 104.3 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.236 -0.915 . . . . 1.0 109.604 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.515 ' CA ' ' HA3' ' A' ' 43' ' ' GLY . 14.6 p-10 -149.5 39.48 0.81 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.329 -0.857 . . . . 1.0 109.353 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.516 ' HB2' ' CG1' ' A' ' 84' ' ' ILE . 60.7 m -145.05 59.03 1.3 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 1.0 109.51 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.522 ' O ' ' CG ' ' A' ' 39' ' ' LYS . . . -143.47 -176.38 4.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.417 -0.802 . . . . 1.0 109.119 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.91 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -154.6 168.66 32.77 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.575 -1.41 . . . . 1.0 109.575 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.428 ' CD1' ' HB2' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -114.55 154.63 15.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.236 -1.155 . . . . 1.0 108.836 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.517 HD23 HG21 ' A' ' 81' ' ' VAL . 0.5 OUTLIER -118.62 109.58 16.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.129 -0.982 . . . . 1.0 109.506 -179.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.509 ' CD ' ' O ' ' A' ' 125' ' ' LYS . 0.1 OUTLIER -99.67 110.3 22.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.303 -0.873 . . . . 1.0 109.434 179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.77 24.13 2.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.319 -0.863 . . . . 1.0 109.355 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.2 mtp180 -53.06 163.89 0.47 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.44 -0.787 . . . . 1.0 109.569 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -168.66 27.6 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.286 -0.884 . . . . 1.0 109.397 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.512 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 0.1 OUTLIER 54.7 36.79 27.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -0.88 . . . . 1.0 109.469 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 129' ' ' SER . 0.6 OUTLIER 163.93 68.23 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.294 -0.879 . . . . 1.0 109.418 -179.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.728 HD11 ' CE1' ' A' ' 78' ' ' PHE . 1.2 tt -66.19 116.77 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.257 -0.902 . . . . 1.0 109.501 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -148.3 162.31 39.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -0.919 . . . . 1.0 109.562 -179.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.417 ' C ' ' HG2' ' A' ' 134' ' ' ARG . 13.5 mt -73.28 83.02 1.38 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.344 -0.847 . . . . 1.0 109.528 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -167.06 -61.01 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 1.0 109.545 179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 134' ' ' ARG . 0.1 OUTLIER 164.73 142.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.17 -0.956 . . . . 1.0 109.464 179.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -108.38 97.05 1.07 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.49 -1.444 . . . . 1.0 109.49 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -127.03 117.92 23.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.244 -1.151 . . . . 1.0 109.469 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.492 ' O ' ' CB ' ' A' ' 139' ' ' ASP . 46.5 p -152.16 -49.06 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.892 . . . . 1.0 109.478 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.492 ' CB ' ' O ' ' A' ' 138' ' ' THR . 0.5 OUTLIER 166.13 -70.91 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.925 . . . . 1.0 109.387 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.47 ' CG1' ' N ' ' A' ' 141' ' ' GLY . 11.6 pt -145.22 -42.3 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 1.0 109.467 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.47 ' N ' ' CG1' ' A' ' 140' ' ' ILE . . . 140.99 152.65 5.79 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.635 -1.386 . . . . 1.0 109.635 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.417 ' HG3' ' C ' ' A' ' 141' ' ' GLY . 17.6 mtt180 -140.95 52.2 1.6 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -1.15 . . . . 1.0 109.412 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -157.63 154.14 27.92 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.225 -0.922 . . . . 1.0 109.441 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.541 ' ND2' ' NH1' ' A' ' 146' ' ' ARG . 0.8 OUTLIER -47.11 164.11 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.936 . . . . 1.0 109.436 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.442 ' HB ' ' SG ' ' A' ' 174' ' ' CYS . 0.1 OUTLIER -154.43 51.48 0.64 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.346 -0.846 . . . . 1.0 109.467 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.541 ' NH1' ' ND2' ' A' ' 144' ' ' ASN . 0.0 OUTLIER -89.58 164.78 14.62 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.27 -0.894 . . . . 1.0 109.594 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.915 HG12 ' NE2' ' A' ' 76' ' ' HIS . 31.6 m -140.84 163.49 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.472 -0.768 . . . . 1.0 109.254 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.555 ' HD2' ' HB3' ' A' ' 68' ' ' ALA . 0.2 OUTLIER -155.58 113.31 3.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.168 -0.958 . . . . 1.0 109.706 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.911 HD21 ' CD1' ' A' ' 63' ' ' LEU . 1.7 tt -79.76 121.56 25.51 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.208 -0.932 . . . . 1.0 109.217 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 36.0 t -96.42 123.55 48.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.232 -0.917 . . . . 1.0 109.574 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 1.137 ' CE1' HD13 ' A' ' 63' ' ' LEU . 0.7 OUTLIER -120.5 92.33 3.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.346 -0.846 . . . . 1.0 108.954 179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.537 ' CB ' ' HA ' ' A' ' 166' ' ' GLN . 24.4 ptt85 -139.28 137.59 36.01 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.139 -0.976 . . . . 1.0 110.219 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.701 ' CG1' HD21 ' A' ' 163' ' ' LEU . 9.8 p -115.42 128.28 72.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.264 -0.897 . . . . 1.0 108.669 178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.432 ' CD2' ' NH1' ' A' ' 152' ' ' ARG . 64.3 m-70 -126.69 116.63 21.26 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.11 -0.994 . . . . 1.0 109.542 -179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 1.04 ' HB ' HD12 ' A' ' 163' ' ' LEU . 9.8 p -99.16 141.35 22.7 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.206 -0.934 . . . . 1.0 109.169 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.531 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 35.4 Cg_endo -77.32 119.03 4.82 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.422 2.081 . . . . 1.0 110.634 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.461 ' OE1' ' HD2' ' A' ' 158' ' ' PRO . 0.1 OUTLIER -160.19 173.03 5.22 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.266 -0.896 . . . . 1.0 109.44 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.461 ' HD2' ' OE1' ' A' ' 157' ' ' GLN . 35.1 Cg_endo -77.87 -67.03 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.327 2.018 . . . . 1.0 110.44 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 36.6 m -64.15 109.38 1.83 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.251 -0.905 . . . . 1.0 109.345 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -49.28 -30.27 11.14 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.542 -1.423 . . . . 1.0 109.542 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.7 mtp85 -79.59 79.06 6.1 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.257 -1.016 . . . . 1.0 108.257 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.647 HG22 ' N ' ' A' ' 163' ' ' LEU . 1.3 m -136.39 -79.77 0.4 Allowed 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 109.001 -0.74 . . . . 1.0 109.001 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 1.04 HD12 ' HB ' ' A' ' 155' ' ' VAL . 0.1 OUTLIER -149.26 106.31 3.59 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.984 -1.072 . . . . 1.0 108.189 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.666 ' N ' HD22 ' A' ' 163' ' ' LEU . 0.0 OUTLIER -163.83 106.34 0.95 Allowed 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.608 -1.307 . . . . 1.0 109.466 -179.284 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.691 HD13 ' H ' ' A' ' 166' ' ' GLN . 0.2 OUTLIER -134.19 151.36 51.29 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.081 -1.012 . . . . 1.0 109.696 -179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.691 ' H ' HD13 ' A' ' 165' ' ' LEU . 15.4 mt-30 -123.69 139.44 53.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.299 -0.876 . . . . 1.0 109.374 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.717 HG12 ' O ' ' A' ' 167' ' ' VAL . 46.7 t -142.54 71.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.214 -0.929 . . . . 1.0 109.674 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -93.6 108.89 20.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.222 -0.924 . . . . 1.0 109.212 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 2.7 m -148.6 137.83 21.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.189 -0.945 . . . . 1.0 109.674 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 169' ' ' SER . 0.6 OUTLIER 171.74 92.49 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.359 -0.838 . . . . 1.0 109.52 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.488 ' HG2' ' CB ' ' A' ' 23' ' ' SER . 34.8 Cg_endo -77.42 72.02 6.16 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.373 2.049 . . . . 1.0 110.694 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.567 HG22 ' O ' ' A' ' 172' ' ' ILE . 13.8 mm -115.21 78.74 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 1.0 109.233 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.54 135.92 33.39 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 1.0 109.746 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.442 ' SG ' ' HB ' ' A' ' 145' ' ' THR . 1.4 m -104.7 -177.02 3.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.371 -0.83 . . . . 1.0 109.299 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 1.2 p -167.76 -178.46 3.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.144 -0.972 . . . . 1.0 109.605 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.525 ' O ' ' CG ' ' A' ' 177' ' ' ARG . 3.2 pm0 -57.58 146.55 29.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -0.895 . . . . 1.0 109.513 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 176' ' ' GLN . 2.0 ptp180 41.91 35.53 0.54 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.492 -0.755 . . . . 1.0 109.694 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.028 -0.987 . . . . 1.0 109.46 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mtm . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.265 0.555 . . . . 1.0 109.506 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.494 ' O ' ' CG ' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -132.45 63.83 1.62 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.242 -0.911 . . . . 1.0 109.53 179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -98.83 76.83 2.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.293 -0.879 . . . . 1.0 109.448 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.488 ' CD1' ' N ' ' A' ' 5' ' ' GLN . 13.8 p90 -66.44 -31.97 73.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.229 -0.919 . . . . 1.0 109.494 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.488 ' N ' ' CD1' ' A' ' 4' ' ' TRP . 0.2 OUTLIER 170.47 79.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.905 . . . . 1.0 109.515 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 tp -146.61 66.7 11.03 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 1.0 109.488 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.9 96.32 1.09 Allowed 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.45 2.1 . . . . 1.0 110.378 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.8 p -119.89 41.58 3.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.204 -0.935 . . . . 1.0 109.324 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.447 ' O ' ' HB2' ' A' ' 10' ' ' SER . 5.8 p-80 -139.68 105.3 5.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.309 -0.869 . . . . 1.0 109.403 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' A' ' 9' ' ' HIS . 19.1 m 64.82 -175.05 0.17 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 1.0 109.436 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 160.68 -91.77 0.11 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.587 -1.405 . . . . 1.0 109.587 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.2 173.72 13.48 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.527 2.151 . . . . 1.0 110.395 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.498 ' HA ' ' HA3' ' A' ' 52' ' ' GLY . 13.0 m-30 -80.06 123.32 27.75 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 1.0 109.469 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -152.2 130.07 11.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.942 . . . . 1.0 109.616 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.689 HD13 HD12 ' A' ' 50' ' ' LEU . 53.8 tp -107.41 83.47 1.82 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.237 -0.914 . . . . 1.0 109.198 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.61 157.48 23.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.281 -0.887 . . . . 1.0 109.805 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.674 HG21 ' NE2' ' A' ' 20' ' ' GLN . 1.1 mp -79.86 144.35 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 N-CA-C 108.645 -0.872 . . . . 1.0 108.645 179.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.412 ' OE1' ' CD ' ' A' ' 49' ' ' GLN . 27.6 tp10 -80.7 -63.88 1.31 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -0.9 . . . . 1.0 109.094 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.561 HG12 ' HD3' ' A' ' 21' ' ' PRO . 2.0 t -92.69 126.21 45.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.339 -0.851 . . . . 1.0 109.134 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.674 ' NE2' HG21 ' A' ' 17' ' ' ILE . 5.5 tp-100 -130.67 63.65 70.58 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.938 . . . . 1.0 109.66 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.561 ' HD3' HG12 ' A' ' 19' ' ' VAL . 36.0 Cg_endo -78.09 -177.96 4.26 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.513 2.142 . . . . 1.0 110.449 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.439 ' HE2' ' CD2' ' A' ' 24' ' ' HIS . 2.1 ttpt -50.36 161.01 0.33 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.229 -0.919 . . . . 1.0 109.383 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.411 ' O ' ' CG1' ' A' ' 172' ' ' ILE . 2.1 t -154.62 58.72 0.69 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.263 -0.898 . . . . 1.0 109.871 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.439 ' CD2' ' HE2' ' A' ' 22' ' ' LYS . 1.9 p80 -103.5 166.22 10.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.231 -0.918 . . . . 1.0 109.411 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.845 ' HD2' HD11 ' A' ' 123' ' ' ILE . 3.7 t60 -163.86 113.12 1.23 Allowed 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.405 -0.81 . . . . 1.0 109.827 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.439 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 5.1 ttp180 -89.57 75.95 7.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.406 -0.808 . . . . 1.0 109.103 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.79 165.44 0.9 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.354 -0.841 . . . . 1.0 109.767 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.413 ' ND1' ' O ' ' A' ' 28' ' ' HIS . 10.5 p80 -94.99 111.69 23.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.296 -0.877 . . . . 1.0 109.417 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -81.68 -14.66 56.33 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.207 -0.933 . . . . 1.0 109.663 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -114.49 -148.41 0.43 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.91 . . . . 1.0 109.516 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.2 p -120.62 38.27 4.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.238 -0.914 . . . . 1.0 109.281 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.422 ' O ' ' HG3' ' A' ' 32' ' ' GLU . 4.8 pt-20 -135.27 51.75 2.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.862 . . . . 1.0 109.501 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 34' ' ' SER . . . -115.36 -13.35 9.01 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.537 -1.425 . . . . 1.0 109.537 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 33' ' ' GLY . 16.6 t 61.18 -90.83 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -1.162 . . . . 1.0 109.484 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -141.85 96.86 3.04 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.174 -0.954 . . . . 1.0 109.563 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -131.38 82.13 0.32 Allowed Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.572 -1.411 . . . . 1.0 109.572 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.541 ' C ' ' CE1' ' A' ' 25' ' ' HIS . . . -91.49 165.69 13.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.215 -1.167 . . . . 1.0 109.449 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.58 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 2.5 p -54.84 106.08 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.329 -0.857 . . . . 1.0 109.468 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -133.4 98.92 4.36 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 1.0 109.583 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.449 ' O ' ' O ' ' A' ' 41' ' ' SER . . . -158.23 95.92 1.4 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.267 -0.896 . . . . 1.0 109.548 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 43' ' ' GLY . 1.9 t 60.87 144.69 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.262 -0.899 . . . . 1.0 109.465 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 51.45 -90.53 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.888 . . . . 1.0 109.423 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 41' ' ' SER . . . -167.92 34.88 0.21 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.442 -1.463 . . . . 1.0 109.442 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.558 ' HA3' HG22 ' A' ' 38' ' ' VAL . . . 109.69 -84.83 0.38 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.563 -1.415 . . . . 1.0 109.563 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.477 ' HB3' ' HD2' ' A' ' 46' ' ' PRO . 74.0 m-70 -77.14 159.88 77.18 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.358 -1.084 . . . . 1.0 109.504 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 45' ' ' HIS . 35.1 Cg_endo -77.47 -176.79 3.4 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 C-N-CA 122.598 2.199 . . . . 1.0 110.679 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.767 HG23 HG12 ' A' ' 117' ' ' VAL . 3.8 mm -94.04 159.51 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.496 -0.753 . . . . 1.0 109.142 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.9 t -132.78 135.68 56.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.154 -0.966 . . . . 1.0 109.895 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 49' ' ' GLN . 2.6 pt20 -150.23 143.43 24.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.376 -0.827 . . . . 1.0 109.111 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.689 HD12 HD13 ' A' ' 15' ' ' LEU . 3.0 tt -113.48 140.12 48.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.17 -0.957 . . . . 1.0 109.772 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 51' ' ' HIS . 14.6 p80 -140.08 81.59 1.82 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 1.0 109.093 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.498 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . -156.65 -97.92 0.14 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.049 -1.22 . . . . 1.0 110.049 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.477 ' HB3' ' CG ' ' A' ' 111' ' ' GLU . 0.4 OUTLIER -39.56 129.51 1.9 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.835 -0.803 . . . . 1.0 110.145 -179.519 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.5 mt -101.54 3.66 40.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.321 -0.862 . . . . 1.0 109.561 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 111' ' ' GLU . 2.7 tm-20 -79.71 138.5 37.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.179 -0.95 . . . . 1.0 109.362 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.452 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 4.6 p30 -85.96 56.74 4.11 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -0.913 . . . . 1.0 109.599 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.483 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 5.0 mt-10 -105.64 143.2 26.35 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 1.0 109.245 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.537 ' O ' HD23 ' A' ' 59' ' ' LEU . 36.2 Cg_endo -78.62 120.19 4.7 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.394 2.063 . . . . 1.0 110.451 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.537 HD23 ' O ' ' A' ' 58' ' ' PRO . 20.6 mt -119.94 164.51 15.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 1.0 109.138 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.438 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -111.26 132.83 54.06 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.172 -0.955 . . . . 1.0 109.61 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.521 ' CD2' ' HB3' ' A' ' 63' ' ' LEU . 0.3 OUTLIER -86.54 121.79 29.57 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.39 -0.819 . . . . 1.0 109.265 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.472 ' O ' ' HG2' ' A' ' 152' ' ' ARG . 9.4 mm-40 -92.48 75.68 5.14 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.203 -0.936 . . . . 1.0 108.872 179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.818 HD22 ' CE1' ' A' ' 151' ' ' PHE . 0.4 OUTLIER -116.06 155.61 27.82 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.372 -0.83 . . . . 1.0 109.672 -179.51 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 1.03 ' HA ' HD12 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -165.6 -178.91 5.12 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.381 -0.824 . . . . 1.0 108.909 179.358 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.75 ' O ' HG23 ' A' ' 65' ' ' ILE . 0.8 OUTLIER -112.77 100.58 11.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.068 -1.02 . . . . 1.0 109.091 179.608 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 74' ' ' ARG . . . -118.99 149.94 18.06 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.942 -1.263 . . . . 1.0 109.942 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.661 HG22 ' CD2' ' A' ' 76' ' ' HIS . 20.4 p -78.4 146.78 34.38 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.421 -1.046 . . . . 1.0 109.151 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.756 ' HB3' ' HG3' ' A' ' 148' ' ' ARG . . . -152.49 116.16 4.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.148 -0.97 . . . . 1.0 109.535 -179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.511 ' HA ' ' NE ' ' A' ' 146' ' ' ARG . 1.6 p30 -85.0 -25.86 27.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.37 -0.832 . . . . 1.0 109.334 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -133.0 -49.49 0.87 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.192 -0.942 . . . . 1.0 109.322 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -175.06 -38.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.234 -0.916 . . . . 1.0 109.565 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.546 ' H ' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -55.89 89.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.25 -0.907 . . . . 1.0 109.601 -179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -51.9 171.79 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.178 -0.951 . . . . 1.0 109.613 -179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.517 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 2.1 mtm180 -168.99 163.17 7.72 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.354 -0.841 . . . . 1.0 109.284 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.403 ' O ' ' C ' ' A' ' 76' ' ' HIS . 35.3 Cg_endo -77.64 108.33 2.54 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.352 2.035 . . . . 1.0 110.437 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.661 ' CD2' HG22 ' A' ' 67' ' ' THR . 19.1 t-80 -42.07 161.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.423 -0.798 . . . . 1.0 110.01 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -48.83 -74.91 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.303 -0.873 . . . . 1.0 109.369 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.913 ' CD2' HD13 ' A' ' 126' ' ' LEU . 54.5 m-85 -135.32 22.79 3.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.214 -0.929 . . . . 1.0 109.39 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.491 ' CD2' HG22 ' A' ' 123' ' ' ILE . 4.7 m-30 -80.21 118.45 21.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.262 -0.899 . . . . 1.0 109.354 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.541 ' HB2' ' CG ' ' A' ' 102' ' ' LYS . 0.1 OUTLIER -163.32 23.69 0.08 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.144 -0.973 . . . . 1.0 109.804 -179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.766 HG23 ' O ' ' A' ' 122' ' ' GLY . 15.1 m -86.14 150.93 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.098 -1.001 . . . . 1.0 109.307 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.559 ' ND1' ' HB2' ' A' ' 121' ' ' ALA . 12.5 t60 -175.38 75.53 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.286 -0.884 . . . . 1.0 109.414 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 120' ' ' CYS . 15.2 mmm180 -109.7 130.24 55.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.295 -0.878 . . . . 1.0 109.64 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.565 HG23 ' CB ' ' A' ' 120' ' ' CYS . 4.6 mp -104.22 136.18 38.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 1.0 109.455 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 87' ' ' LYS . 69.4 p -141.28 -162.71 1.42 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.393 -0.817 . . . . 1.0 109.288 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 85' ' ' THR . . . 41.3 -96.48 0.01 OUTLIER Glycine 0 N--CA 1.482 1.741 0 N-CA-C 110.259 -1.137 . . . . 1.0 110.259 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 85' ' ' THR . 0.4 OUTLIER -74.62 111.44 9.82 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.24 -1.153 . . . . 1.0 109.626 -179.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.07 143.54 26.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.275 -0.89 . . . . 1.0 109.357 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.555 HG13 ' H ' ' A' ' 91' ' ' THR . 9.8 p -105.07 154.04 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.186 -0.946 . . . . 1.0 109.537 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.36 12.78 7.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -0.94 . . . . 1.0 109.589 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.555 ' H ' HG13 ' A' ' 89' ' ' VAL . 16.0 m -103.14 104.88 15.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 1.0 109.472 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.762 ' O ' HG23 ' A' ' 106' ' ' ILE . 10.0 t -54.22 158.56 2.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.16 -0.962 . . . . 1.0 109.338 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -137.24 172.79 12.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.257 -0.902 . . . . 1.0 109.7 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 20.2 t-80 -155.07 151.78 28.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.361 -0.837 . . . . 1.0 109.534 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -125.7 132.84 52.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.874 . . . . 1.0 109.313 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -125.27 120.65 31.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.13 -0.981 . . . . 1.0 109.699 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.889 HD12 ' O ' ' A' ' 101' ' ' THR . 9.9 tp -125.0 133.7 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.33 -0.856 . . . . 1.0 109.293 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.531 ' N ' HD23 ' A' ' 98' ' ' LEU . 1.0 OUTLIER -133.34 50.86 2.19 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.222 -0.924 . . . . 1.0 109.53 -179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER 76.66 114.16 0.07 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.309 -0.87 . . . . 1.0 109.742 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.43 ' CG ' ' O ' ' A' ' 99' ' ' SER . 3.9 p-10 43.49 35.03 0.86 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.665 -0.647 . . . . 1.0 110.476 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.889 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -156.15 102.63 2.14 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.927 -1.108 . . . . 1.0 109.743 179.642 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.798 ' HD2' HD13 ' A' ' 97' ' ' ILE . 4.5 tptt -112.29 153.68 26.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 1.0 109.386 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.964 HG12 ' HB3' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -158.54 168.66 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.271 -0.893 . . . . 1.0 109.113 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.03 HD12 ' HA ' ' A' ' 64' ' ' PHE . 1.1 mt -116.79 134.85 54.28 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 1.0 109.734 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -127.08 112.32 15.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.368 -0.833 . . . . 1.0 109.273 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 1.029 HG22 HD21 ' A' ' 108' ' ' LEU . 3.4 mt -121.69 107.0 36.59 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.248 -0.907 . . . . 1.0 109.606 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.759 ' O ' HD23 ' A' ' 108' ' ' LEU . 33.8 Cg_endo -75.46 104.39 1.9 Allowed 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 122.09 1.86 . . . . 1.0 110.133 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.029 HD21 HG22 ' A' ' 106' ' ' ILE . 3.0 mt -129.02 163.67 24.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.399 -0.813 . . . . 1.0 109.695 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.525 ' O ' ' CD1' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -129.86 69.23 81.55 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.386 -0.821 . . . . 1.0 109.238 179.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.465 ' HA ' ' CG ' ' A' ' 114' ' ' MET . 36.8 Cg_endo -81.02 45.47 2.01 Favored 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 122.703 2.269 . . . . 1.0 110.908 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.525 ' CB ' ' O ' ' A' ' 55' ' ' GLU . 53.6 mp0 -97.85 -11.48 23.21 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 120.99 -1.069 . . . . 1.0 109.684 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.434 ' O ' ' CB ' ' A' ' 113' ' ' SER . 0.3 OUTLIER -107.85 -55.6 2.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.18 -0.95 . . . . 1.0 109.429 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.1 OUTLIER 169.8 102.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.23 -0.919 . . . . 1.0 109.501 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.465 ' CG ' ' HA ' ' A' ' 110' ' ' PRO . 1.0 OUTLIER -164.79 122.31 1.62 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.273 -0.892 . . . . 1.0 109.574 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.641 ' HD3' HG21 ' A' ' 47' ' ' ILE . 7.5 ttm180 -102.01 136.08 42.47 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.286 -0.883 . . . . 1.0 109.477 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -121.06 139.67 53.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 1.0 109.349 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.767 HG12 HG23 ' A' ' 47' ' ' ILE . 4.3 m -114.99 127.03 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.233 -0.917 . . . . 1.0 109.547 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.463 ' O ' ' HB2' ' A' ' 45' ' ' HIS . 16.1 mt -113.06 100.96 11.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.271 -0.893 . . . . 1.0 109.387 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.487 ' HB2' ' CA ' ' A' ' 43' ' ' GLY . 4.9 p-10 -153.71 50.72 0.68 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 1.0 109.486 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.565 ' CB ' HG23 ' A' ' 84' ' ' ILE . 96.0 m -137.77 42.85 2.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.221 -0.925 . . . . 1.0 109.589 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.559 ' HB2' ' ND1' ' A' ' 82' ' ' HIS . . . -129.59 172.21 11.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.312 -0.867 . . . . 1.0 108.95 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.766 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -145.36 -165.5 11.3 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.794 -1.322 . . . . 1.0 109.794 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.845 HD11 ' HD2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -125.42 157.18 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.32 -1.106 . . . . 1.0 108.93 179.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.538 ' HB2' HG11 ' A' ' 81' ' ' VAL . 7.6 tp -140.05 147.05 39.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.098 -1.001 . . . . 1.0 109.725 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.6 tttm -112.1 115.83 29.52 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 1.0 109.232 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.913 HD13 ' CD2' ' A' ' 78' ' ' PHE . 2.3 pt? -79.81 -16.05 56.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.244 -0.91 . . . . 1.0 109.748 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER 63.09 -87.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.352 -0.842 . . . . 1.0 109.61 -179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.449 ' O ' ' ND2' ' A' ' 128' ' ' ASN . 3.7 p-10 -42.06 107.75 0.08 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.461 -0.774 . . . . 1.0 109.789 -179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 38.1 p 175.96 -39.3 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 1.0 109.053 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.534 ' CB ' ' O ' ' A' ' 129' ' ' SER . 4.4 m-20 83.3 54.42 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.3 0.571 . . . . 1.0 109.936 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.775 ' O ' HG23 ' A' ' 131' ' ' ILE . 2.8 tt -135.19 59.94 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.367 -0.833 . . . . 1.0 109.335 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 131' ' ' ILE . 3.0 tt0 177.02 98.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.588 -0.695 . . . . 1.0 109.349 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 53.4 tp -154.28 131.68 11.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.193 -0.942 . . . . 1.0 109.567 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -109.8 -19.29 13.19 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.203 -0.936 . . . . 1.0 109.497 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.416 ' O ' ' O ' ' A' ' 136' ' ' GLY . 16.9 mttm -84.65 77.67 10.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 1.0 109.449 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.536 ' O ' ' CB ' ' A' ' 137' ' ' GLU . . . -61.17 -115.97 0.01 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.657 -1.377 . . . . 1.0 109.657 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.536 ' CB ' ' O ' ' A' ' 136' ' ' GLY . 1.9 tt0 83.0 -43.47 0.11 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.904 -0.762 . . . . 1.0 109.887 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.457 ' O ' ' OG1' ' A' ' 138' ' ' THR . 0.0 OUTLIER -134.97 57.66 1.8 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.022 -1.049 . . . . 1.0 109.418 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 139' ' ' ASP . 24.1 p-10 178.94 -175.1 0.2 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 1.0 109.468 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.4 tp -86.8 -14.92 10.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 1.0 109.447 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 66.77 131.78 0.03 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.69 -1.364 . . . . 1.0 109.69 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -147.05 116.79 7.14 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -1.147 . . . . 1.0 109.503 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 6.1 ttmt -123.71 104.42 8.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 1.0 109.392 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 30.9 p-10 -168.62 136.68 2.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.32 -0.862 . . . . 1.0 109.5 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.535 ' CB ' ' HB2' ' A' ' 174' ' ' CYS . 0.0 OUTLIER -159.99 53.53 0.35 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 1.0 109.495 -179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.511 ' NE ' ' HA ' ' A' ' 69' ' ' ASP . 0.1 OUTLIER -98.45 175.13 6.14 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.219 -0.925 . . . . 1.0 109.439 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.409 HG23 ' OD1' ' A' ' 170' ' ' ASN . 17.3 m -138.83 167.19 21.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.357 -0.84 . . . . 1.0 109.567 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.756 ' HG3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -155.44 111.7 3.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.854 . . . . 1.0 109.534 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.678 HD12 ' O ' ' A' ' 64' ' ' PHE . 11.2 tp -81.44 113.25 19.38 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.213 -0.929 . . . . 1.0 108.947 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.567 HG21 ' HE1' ' A' ' 64' ' ' PHE . 10.6 t -93.46 143.5 11.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.399 -0.813 . . . . 1.0 110.237 -178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.818 ' CE1' HD22 ' A' ' 63' ' ' LEU . 10.4 m-85 -133.49 113.36 12.4 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.634 -0.876 . . . . 1.0 108.634 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.517 ' CB ' ' O ' ' A' ' 165' ' ' LEU . 10.2 ptt85 -145.45 106.76 4.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.933 -1.105 . . . . 1.0 110.529 -179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 153' ' ' VAL . 9.8 p -92.55 128.83 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.256 -1.016 . . . . 1.0 108.256 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.501 ' ND1' ' HB2' ' A' ' 164' ' ' SER . 48.7 m-70 -121.39 117.4 26.83 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.034 -1.041 . . . . 1.0 110.43 -178.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.695 ' HB ' HD23 ' A' ' 163' ' ' LEU . 8.1 p -99.61 141.13 22.25 Favored Pre-proline 0 N--CA 1.488 1.458 0 N-CA-C 108.779 -0.823 . . . . 1.0 108.779 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.534 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 33.4 Cg_endo -75.29 115.04 4.13 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.16 1.907 . . . . 1.0 110.501 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.73 ' HG3' HG21 ' A' ' 162' ' ' THR . 0.9 OUTLIER -136.3 169.13 14.28 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.532 -0.73 . . . . 1.0 109.058 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.525 ' HD2' ' NE2' ' A' ' 157' ' ' GLN . 34.3 Cg_endo -76.69 -65.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.316 2.01 . . . . 1.0 110.284 179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.28 -84.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 1.0 109.25 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 152.42 -43.7 0.65 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.565 -1.414 . . . . 1.0 109.565 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -79.01 80.25 5.36 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 107.987 -1.116 . . . . 1.0 107.987 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.815 HG22 ' N ' ' A' ' 163' ' ' LEU . 1.3 m -133.55 -89.56 0.39 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.56 -0.712 . . . . 1.0 109.374 -178.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.815 ' N ' HG22 ' A' ' 162' ' ' THR . 8.9 tp -125.91 96.91 4.92 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.83 -1.169 . . . . 1.0 108.737 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.888 ' O ' HD23 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -163.25 119.26 1.76 Allowed 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.016 -1.052 . . . . 1.0 109.229 179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.888 HD23 ' O ' ' A' ' 164' ' ' SER . 22.3 mt -142.63 175.07 10.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.976 -1.078 . . . . 1.0 110.428 -179.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.496 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 2.6 mt-30 -142.27 70.84 1.34 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.607 -0.683 . . . . 1.0 109.201 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 37.9 t -87.79 106.04 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 1.0 110.066 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 150' ' ' VAL . . . -112.03 112.75 24.61 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.543 -0.91 . . . . 1.0 108.543 178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 0.0 OUTLIER -136.8 140.99 42.88 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.989 -1.07 . . . . 1.0 110.261 -179.153 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.501 ' HB3' ' HA ' ' A' ' 148' ' ' ARG . 22.7 t-20 175.93 97.73 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 109.048 -0.723 . . . . 1.0 109.048 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.41 74.38 4.73 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.284 1.99 . . . . 1.0 110.588 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.467 ' HB ' ' OD1' ' A' ' 170' ' ' ASN . 27.6 mt -138.96 126.37 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.331 -0.856 . . . . 1.0 109.287 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -141.46 144.57 34.48 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 1.0 109.532 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.535 ' HB2' ' CB ' ' A' ' 145' ' ' THR . 35.8 m -114.67 -171.71 1.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 1.0 109.452 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.435 ' HB3' ' O ' ' A' ' 174' ' ' CYS . 5.8 p 178.52 34.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.287 -0.883 . . . . 1.0 109.365 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.419 ' O ' ' O ' ' A' ' 175' ' ' SER . 0.8 OUTLIER 56.33 166.56 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 1.0 109.446 -179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.445 ' O ' ' O ' ' A' ' 178' ' ' SER . 0.4 OUTLIER -154.61 -39.11 0.09 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.198 -0.938 . . . . 1.0 109.526 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.445 ' O ' ' O ' ' A' ' 177' ' ' ARG . 10.4 t . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.0 -1.0 . . . . 1.0 109.442 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.434 -0.58 . . . . 1.0 109.434 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.7 pttp -112.51 129.05 56.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.225 -0.922 . . . . 1.0 109.424 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -56.81 -179.85 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.289 -0.882 . . . . 1.0 109.521 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.413 ' CG ' ' N ' ' A' ' 5' ' ' GLN . 31.6 p-90 -67.37 -37.22 82.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.222 -0.924 . . . . 1.0 109.544 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.413 ' N ' ' CG ' ' A' ' 4' ' ' TRP . 0.0 OUTLIER -178.22 79.42 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 1.0 109.463 -179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 tp -151.29 121.44 3.64 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.32 -0.862 . . . . 1.0 109.227 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.26 94.45 1.07 Allowed 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 122.058 1.839 . . . . 1.0 110.5 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.7 p -143.52 40.59 1.44 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 1.0 109.419 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.404 ' O ' ' HB2' ' A' ' 10' ' ' SER . 3.2 p80 -140.33 145.94 37.84 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.316 -0.865 . . . . 1.0 109.502 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.404 ' HB2' ' O ' ' A' ' 9' ' ' HIS . 4.4 m 68.59 123.92 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 1.0 109.682 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.479 ' N ' ' HD3' ' A' ' 12' ' ' PRO . . . 46.59 62.74 3.46 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.681 -1.367 . . . . 1.0 109.681 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.479 ' HD3' ' N ' ' A' ' 11' ' ' GLY . 35.9 Cg_endo -78.15 117.29 4.09 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.523 2.149 . . . . 1.0 110.255 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.569 ' CE2' ' O ' ' A' ' 162' ' ' THR . 6.6 m-85 -102.61 169.72 8.47 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -0.934 . . . . 1.0 109.758 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -160.86 130.82 5.04 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.335 -0.853 . . . . 1.0 109.456 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.575 ' O ' HG21 ' A' ' 167' ' ' VAL . 23.3 tp -126.83 84.4 2.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.362 -0.836 . . . . 1.0 109.327 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -127.35 154.53 44.85 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.285 -0.884 . . . . 1.0 109.715 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 47' ' ' ILE . 0.7 OUTLIER -67.01 148.33 12.17 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.336 -0.853 . . . . 1.0 108.774 179.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.525 ' O ' HG23 ' A' ' 19' ' ' VAL . 1.0 OUTLIER -70.97 -34.61 71.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.381 -0.824 . . . . 1.0 109.535 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 18' ' ' GLU . 72.3 t -157.78 135.6 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 121.206 -0.934 . . . . 1.0 109.435 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.09 80.45 7.04 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.222 -0.924 . . . . 1.0 109.522 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 19' ' ' VAL . 36.2 Cg_endo -78.52 179.23 6.69 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.519 2.146 . . . . 1.0 110.21 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 21' ' ' PRO . 9.7 mttt -44.56 108.6 0.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.087 -1.008 . . . . 1.0 109.185 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.1 p -130.72 39.41 3.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.126 -0.984 . . . . 1.0 109.945 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.481 ' HA ' HG12 ' A' ' 172' ' ' ILE . 2.0 p-80 -99.69 166.39 11.14 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.082 -1.011 . . . . 1.0 109.395 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.821 ' NE2' HD11 ' A' ' 123' ' ' ILE . 0.5 OUTLIER -135.45 105.26 6.15 Favored 'General case' 0 C--N 1.297 -1.714 0 C-N-CA 119.671 -0.812 . . . . 1.0 109.843 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.4 ttm-85 -92.4 70.98 5.16 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.429 -0.795 . . . . 1.0 109.053 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.554 ' O ' ' CE1' ' A' ' 29' ' ' TYR . . . -68.31 123.51 20.94 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.465 -0.772 . . . . 1.0 109.469 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -50.19 172.09 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.346 -0.846 . . . . 1.0 109.375 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.554 ' CE1' ' O ' ' A' ' 27' ' ' ALA . 9.6 m-85 -136.97 -53.69 0.7 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.217 -0.927 . . . . 1.0 109.482 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -104.31 -87.93 0.43 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 1.0 109.487 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 2.3 t -144.85 68.27 1.25 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.283 -0.886 . . . . 1.0 109.432 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -137.25 54.43 1.85 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 1.0 109.588 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 154.86 178.03 28.76 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.583 -1.407 . . . . 1.0 109.583 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -138.16 117.1 12.42 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -1.124 . . . . 1.0 109.426 -179.969 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.48 ' CG ' ' C ' ' A' ' 34' ' ' SER . 0.0 OUTLIER 40.55 -94.0 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.639 -0.663 . . . . 1.0 109.85 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 34' ' ' SER . . . 61.06 68.25 1.76 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.509 -1.437 . . . . 1.0 109.509 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.452 ' O ' ' O ' ' A' ' 36' ' ' GLY . . . -46.41 172.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.237 -1.155 . . . . 1.0 109.593 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.576 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 2.2 p -54.99 113.77 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.4 -0.813 . . . . 1.0 109.451 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.434 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 0.0 OUTLIER -137.3 99.48 3.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.347 -0.846 . . . . 1.0 109.598 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -123.66 -154.34 0.6 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.377 -0.827 . . . . 1.0 109.458 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 9.5 t -69.84 -72.48 0.19 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 1.0 109.636 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -96.36 69.03 2.62 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.156 -0.965 . . . . 1.0 109.405 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 74.92 -82.12 0.87 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.31 -1.516 . . . . 1.0 109.31 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -165.97 -37.2 0.02 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.64 -1.384 . . . . 1.0 109.64 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -100.69 160.21 27.47 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.267 -1.137 . . . . 1.0 109.72 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.5 ' C ' HD13 ' A' ' 47' ' ' ILE . 35.8 Cg_endo -78.59 -176.64 3.38 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.539 2.159 . . . . 1.0 110.482 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.901 ' CG2' HG12 ' A' ' 117' ' ' VAL . 1.0 OUTLIER -94.14 158.07 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 179.762 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.607 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 2.9 t -134.54 135.94 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.983 -1.073 . . . . 1.0 110.399 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.558 ' HG2' ' CE1' ' A' ' 51' ' ' HIS . 5.0 tt0 -151.41 144.28 24.47 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.914 -0.773 . . . . 1.0 108.914 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.9 tt -113.23 138.51 49.89 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.085 -1.009 . . . . 1.0 109.994 -179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.558 ' CE1' ' HG2' ' A' ' 49' ' ' GLN . 7.5 m-70 -140.33 77.9 1.63 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.401 -0.812 . . . . 1.0 109.25 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . -177.03 84.69 0.07 OUTLIER Glycine 0 N--CA 1.488 2.16 0 C-N-CA 119.687 -1.244 . . . . 1.0 110.049 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.569 ' CD2' ' OE2' ' A' ' 111' ' ' GLU . 3.5 t80 177.16 132.09 0.06 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.167 -1.196 . . . . 1.0 109.619 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.2 -10.84 17.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -0.909 . . . . 1.0 109.437 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.415 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 2.4 mt-10 -89.75 145.25 25.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.247 -0.908 . . . . 1.0 109.502 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.411 ' H ' ' ND2' ' A' ' 56' ' ' ASN . 2.1 p30 -103.73 57.13 0.73 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.309 -0.87 . . . . 1.0 109.35 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -110.1 156.46 40.05 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.294 -0.879 . . . . 1.0 109.454 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.979 ' O ' HD23 ' A' ' 59' ' ' LEU . 35.8 Cg_endo -78.31 131.07 10.45 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.5 2.133 . . . . 1.0 110.49 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.979 HD23 ' O ' ' A' ' 58' ' ' PRO . 6.5 mt -128.88 162.79 26.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.212 -0.93 . . . . 1.0 109.225 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.458 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 2.1 mpp? -105.78 131.63 52.9 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.275 -0.891 . . . . 1.0 109.355 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.818 HD21 ' HB2' ' A' ' 63' ' ' LEU . 1.1 tt -90.26 141.27 28.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.376 -0.828 . . . . 1.0 109.388 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.434 ' O ' ' OE1' ' A' ' 62' ' ' GLN . 0.9 OUTLIER -104.64 78.12 1.42 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.184 -0.948 . . . . 1.0 109.681 -179.764 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.135 HD13 ' CE1' ' A' ' 151' ' ' PHE . 23.4 tp -100.87 135.18 42.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.325 -0.859 . . . . 1.0 109.086 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.718 ' HB2' HG12 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -165.45 159.67 17.16 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.542 -0.911 . . . . 1.0 108.542 -179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 65' ' ' ILE . 1.2 tp -110.84 125.49 68.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.298 -0.876 . . . . 1.0 109.057 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 74' ' ' ARG . . . -145.08 142.38 10.77 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.619 -1.392 . . . . 1.0 109.619 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.681 HG23 ' HA ' ' A' ' 76' ' ' HIS . 72.4 p -66.64 178.85 1.17 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.496 -1.003 . . . . 1.0 109.945 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.422 ' HB3' ' HD2' ' A' ' 148' ' ' ARG . . . -170.23 125.37 0.76 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.465 -0.772 . . . . 1.0 109.072 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.83 -38.03 20.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.186 -0.946 . . . . 1.0 108.962 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -140.45 -56.43 0.53 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.167 -0.958 . . . . 1.0 109.699 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.492 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.1 OUTLIER -152.14 -47.57 0.11 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.299 -0.875 . . . . 1.0 109.524 -179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.1 mt -52.47 89.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.353 -0.842 . . . . 1.0 109.684 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.778 ' H ' HD13 ' A' ' 73' ' ' LEU . 0.0 OUTLIER -48.11 171.93 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.105 -0.997 . . . . 1.0 110.362 -179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 67' ' ' THR . 0.1 OUTLIER -168.91 167.22 5.97 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.384 -0.823 . . . . 1.0 108.867 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 74' ' ' ARG . 32.7 Cg_endo -74.06 142.69 31.39 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.072 1.848 . . . . 1.0 109.96 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.774 ' NE2' HG12 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -50.72 146.84 5.31 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.252 -0.905 . . . . 1.0 109.763 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.19 -59.54 4.9 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.363 -0.836 . . . . 1.0 109.294 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.825 ' CD1' HD22 ' A' ' 126' ' ' LEU . 74.9 m-85 -136.34 4.04 2.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.247 -0.908 . . . . 1.0 109.912 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.572 ' HB2' ' CG ' ' A' ' 76' ' ' HIS . 6.7 m-30 -99.02 103.19 15.12 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.984 -1.072 . . . . 1.0 109.25 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.518 ' HB2' ' CG ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -138.88 7.64 2.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.064 -1.023 . . . . 1.0 109.643 -179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.828 HG11 HD13 ' A' ' 124' ' ' LEU . 35.6 m -64.39 157.89 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.182 -0.949 . . . . 1.0 109.464 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.783 ' CE1' HD11 ' A' ' 84' ' ' ILE . 35.0 t-80 -175.83 90.53 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.478 -0.763 . . . . 1.0 109.296 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.539 ' C ' HD12 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -122.53 144.71 48.91 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.117 -0.99 . . . . 1.0 109.742 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.798 HD12 ' N ' ' A' ' 84' ' ' ILE . 3.3 mp -110.45 125.09 67.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.29 -0.881 . . . . 1.0 109.51 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.41 ' O ' ' C ' ' A' ' 86' ' ' GLY . 10.2 p -136.49 -95.75 0.23 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.234 -0.916 . . . . 1.0 109.701 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 85' ' ' THR . . . -41.15 -68.67 0.61 Allowed Glycine 0 N--CA 1.486 1.992 0 N-CA-C 110.091 -1.204 . . . . 1.0 110.091 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 120' ' ' CYS . 0.0 OUTLIER -74.74 120.32 20.13 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.22 -1.165 . . . . 1.0 109.072 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -118.27 136.27 53.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.25 -0.906 . . . . 1.0 109.642 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 89' ' ' VAL . 5.4 p -111.0 120.87 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 1.0 109.054 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -89.57 31.89 0.9 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.11 -0.994 . . . . 1.0 109.627 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.601 HG22 ' N ' ' A' ' 92' ' ' THR . 19.6 m -91.94 -91.09 0.16 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.316 -0.865 . . . . 1.0 109.14 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.854 ' O ' HG23 ' A' ' 106' ' ' ILE . 0.2 OUTLIER -174.54 82.02 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.282 -0.886 . . . . 1.0 109.383 179.713 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.51 160.99 13.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.2 -0.937 . . . . 1.0 110.048 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.524 ' CB ' ' HG3' ' A' ' 105' ' ' GLU . 0.2 OUTLIER -155.53 160.91 40.91 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 109.007 -0.738 . . . . 1.0 109.007 179.786 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.444 ' OE2' ' O ' ' A' ' 94' ' ' HIS . 0.7 OUTLIER -132.82 150.66 52.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.988 -1.07 . . . . 1.0 109.813 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -153.84 124.17 7.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.349 -0.845 . . . . 1.0 109.225 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.952 HD13 ' N ' ' A' ' 98' ' ' LEU . 0.0 OUTLIER -119.52 131.61 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.178 -0.951 . . . . 1.0 109.606 -179.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.952 ' N ' HD13 ' A' ' 97' ' ' ILE . 0.8 OUTLIER -126.05 68.7 1.2 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 1.0 109.207 179.647 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.521 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 1.4 m 76.35 93.82 0.07 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -0.843 . . . . 1.0 109.333 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.451 ' ND2' ' O ' ' A' ' 99' ' ' SER . 1.1 p-10 42.85 55.12 4.48 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.492 -0.755 . . . . 1.0 109.721 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.479 ' HB ' ' HG ' ' A' ' 98' ' ' LEU . 6.1 m -160.05 80.43 0.7 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.124 -0.985 . . . . 1.0 109.551 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.525 ' CD ' ' HB ' ' A' ' 97' ' ' ILE . 2.1 mmmp? -85.38 131.21 34.43 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 1.0 109.374 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.718 HG12 ' HB2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -129.49 165.82 28.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.22 -0.925 . . . . 1.0 109.154 179.866 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.611 HD11 ' NE2' ' A' ' 82' ' ' HIS . 0.3 OUTLIER -120.15 141.66 49.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.26 -0.9 . . . . 1.0 109.595 -179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.524 ' HG3' ' CB ' ' A' ' 94' ' ' HIS . 2.1 pt-20 -137.46 117.07 12.96 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.332 -0.855 . . . . 1.0 109.147 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.854 HG23 ' O ' ' A' ' 92' ' ' THR . 12.4 mt -118.11 98.84 51.76 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.336 -0.853 . . . . 1.0 109.849 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.463 ' HD2' ' O ' ' A' ' 92' ' ' THR . 35.3 Cg_endo -76.73 97.61 1.15 Allowed 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.379 2.052 . . . . 1.0 110.302 179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.72 ' CD2' HG22 ' A' ' 106' ' ' ILE . 0.6 OUTLIER -145.12 165.26 28.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 1.0 109.657 -179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.524 ' O ' ' CD1' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -115.37 81.52 8.59 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.303 -0.873 . . . . 1.0 109.698 -179.841 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 108' ' ' LEU . 37.1 Cg_endo -81.0 42.54 1.36 Allowed 'Trans proline' 0 C--N 1.312 -1.343 0 C-N-CA 122.634 2.223 . . . . 1.0 110.706 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.569 ' OE2' ' CD2' ' A' ' 53' ' ' TYR . 0.9 OUTLIER -100.33 28.79 4.73 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.124 -0.985 . . . . 1.0 109.597 -179.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.458 ' O ' ' HB2' ' A' ' 113' ' ' SER . 0.0 OUTLIER -138.01 -70.31 0.44 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.198 -0.939 . . . . 1.0 109.142 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.458 ' HB2' ' O ' ' A' ' 112' ' ' ASN . 3.5 t 178.19 101.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.324 -0.86 . . . . 1.0 109.237 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 4.5 ptm -164.04 131.11 3.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.918 . . . . 1.0 109.562 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.451 ' HD2' ' OE1' ' A' ' 18' ' ' GLU . 35.7 ttp180 -106.68 131.65 53.58 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.25 -0.906 . . . . 1.0 109.373 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -116.07 101.96 9.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 1.0 109.377 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.901 HG12 ' CG2' ' A' ' 47' ' ' ILE . 4.6 m -81.06 127.01 39.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.334 -0.854 . . . . 1.0 109.445 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.574 ' CD1' ' CD2' ' A' ' 63' ' ' LEU . 10.6 mt -107.55 115.01 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.295 -0.878 . . . . 1.0 109.4 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.411 ' OD1' ' C ' ' A' ' 118' ' ' ILE . 0.6 OUTLIER -156.8 53.41 0.52 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.268 -0.895 . . . . 1.0 109.03 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.481 ' SG ' HG13 ' A' ' 84' ' ' ILE . 1.8 p -141.95 57.07 1.48 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.259 -0.9 . . . . 1.0 109.59 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -140.12 167.25 22.57 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 1.0 109.131 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.686 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -137.63 -176.07 14.23 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.833 -1.307 . . . . 1.0 109.833 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.821 HD11 ' NE2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -116.41 171.72 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.354 -1.086 . . . . 1.0 109.083 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.828 HD13 HG11 ' A' ' 81' ' ' VAL . 13.5 tp -128.86 157.72 40.75 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.247 -0.908 . . . . 1.0 109.811 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.462 ' O ' ' HD2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER -113.23 155.58 24.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.358 -0.839 . . . . 1.0 109.157 179.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.825 HD22 ' CD1' ' A' ' 78' ' ' PHE . 51.2 tp -117.62 -93.4 0.51 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.104 -0.997 . . . . 1.0 109.54 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.523 ' N ' ' HG ' ' A' ' 126' ' ' LEU . 0.2 OUTLIER 170.03 -78.46 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 1.0 109.063 180.0 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 31.4 t30 -123.48 113.24 18.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.248 -0.907 . . . . 1.0 109.326 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 2.6 p -81.31 126.22 31.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.208 -0.932 . . . . 1.0 109.579 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -165.07 56.84 0.12 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.209 -0.932 . . . . 1.0 109.517 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.731 ' O ' HG23 ' A' ' 131' ' ' ILE . 2.9 tt -121.05 70.4 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.428 -0.795 . . . . 1.0 109.51 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.83 119.08 29.91 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.25 -0.907 . . . . 1.0 109.643 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.25 -47.05 37.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.28 -0.888 . . . . 1.0 109.431 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 34.4 ptt85 176.15 144.91 0.08 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.284 -0.885 . . . . 1.0 109.542 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.46 124.93 4.19 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -0.939 . . . . 1.0 109.489 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -92.34 -3.25 67.34 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.692 -1.363 . . . . 1.0 109.692 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.401 ' N ' ' CD ' ' A' ' 137' ' ' GLU . 2.1 pm0 -177.49 156.53 1.19 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -1.177 . . . . 1.0 109.391 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.424 ' O ' ' HB2' ' A' ' 139' ' ' ASP . 0.9 OUTLIER -154.29 -44.49 0.09 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 1.0 109.579 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.573 ' O ' HG23 ' A' ' 140' ' ' ILE . 11.4 m-20 65.51 10.33 6.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.907 . . . . 1.0 109.529 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.573 HG23 ' O ' ' A' ' 139' ' ' ASP . 0.2 OUTLIER -160.01 -72.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.316 -0.865 . . . . 1.0 109.294 179.909 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.444 ' O ' ' HB2' ' A' ' 142' ' ' ARG . . . 100.25 -70.78 0.47 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.649 -1.38 . . . . 1.0 109.649 179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 141' ' ' GLY . 28.0 mmm180 65.25 170.38 0.21 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.193 -1.181 . . . . 1.0 109.39 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 144' ' ' ASN . 0.3 OUTLIER -125.94 56.89 1.39 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.905 . . . . 1.0 109.495 -179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.457 ' O ' ' O ' ' A' ' 143' ' ' LYS . 3.4 p30 40.64 93.96 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.679 -0.638 . . . . 1.0 109.904 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.821 HG22 ' O ' ' A' ' 174' ' ' CYS . 0.0 OUTLIER -143.47 46.7 1.5 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.214 -0.929 . . . . 1.0 109.751 -179.993 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.538 ' N ' ' HD2' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -154.86 154.77 33.22 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.419 -0.801 . . . . 1.0 109.433 179.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.774 HG12 ' NE2' ' A' ' 76' ' ' HIS . 32.6 m -139.25 162.44 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.908 . . . . 1.0 109.226 179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.422 ' HD2' ' HB3' ' A' ' 68' ' ' ALA . 8.0 ttt180 -141.61 112.47 7.26 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -0.95 . . . . 1.0 109.655 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.808 HD11 HD11 ' A' ' 63' ' ' LEU . 44.0 tp -79.12 123.84 27.75 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.317 -0.865 . . . . 1.0 109.051 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 37.2 t -95.0 146.0 7.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 121.233 -0.917 . . . . 1.0 109.773 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 1.135 ' CE1' HD13 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -148.1 99.43 3.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.399 -0.813 . . . . 1.0 109.021 -179.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.524 ' CB ' ' HA ' ' A' ' 166' ' ' GLN . 14.1 ptt180 -150.33 136.4 18.59 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.98 -1.075 . . . . 1.0 110.255 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 153' ' ' VAL . 9.8 p -115.42 129.02 72.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 108.57 -0.9 . . . . 1.0 108.57 179.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.568 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 33.2 m-70 -126.88 118.46 24.64 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.129 -0.982 . . . . 1.0 110.119 -179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.59 ' HB ' HD23 ' A' ' 163' ' ' LEU . 13.0 p -99.04 140.98 22.11 Favored Pre-proline 0 N--CA 1.488 1.426 0 O-C-N 121.363 -0.836 . . . . 1.0 108.769 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.535 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 33.2 Cg_endo -75.25 115.29 4.21 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.161 1.907 . . . . 1.0 110.245 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.812 ' HG3' HG21 ' A' ' 162' ' ' THR . 9.8 mm-40 -136.51 167.28 22.16 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.541 -0.724 . . . . 1.0 109.292 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.448 ' HD2' ' CD ' ' A' ' 157' ' ' GLN . 34.6 Cg_endo -77.32 -63.78 0.03 OUTLIER 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.299 1.999 . . . . 1.0 110.21 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 3.6 t -55.74 -75.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.385 -0.822 . . . . 1.0 109.346 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 142.09 -43.27 1.08 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.482 -1.447 . . . . 1.0 109.482 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -78.86 80.48 5.2 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.879 -1.156 . . . . 1.0 107.879 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.812 HG21 ' HG3' ' A' ' 157' ' ' GLN . 1.3 m -136.2 -78.23 0.42 Allowed 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.462 -0.774 . . . . 1.0 109.432 -178.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.63 ' N ' HG22 ' A' ' 162' ' ' THR . 8.3 tp -141.06 100.93 3.93 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.074 -1.016 . . . . 1.0 108.962 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.568 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -162.21 98.27 1.04 Allowed 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.025 -1.047 . . . . 1.0 109.534 179.576 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.77 HD13 ' H ' ' A' ' 166' ' ' GLN . 0.2 OUTLIER -126.73 151.88 47.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.331 -0.856 . . . . 1.0 109.625 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.77 ' H ' HD13 ' A' ' 165' ' ' LEU . 5.6 mt-30 -118.51 145.53 45.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.256 -0.902 . . . . 1.0 109.535 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.575 HG21 ' O ' ' A' ' 15' ' ' LEU . 47.0 t -152.39 93.26 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.124 -0.985 . . . . 1.0 109.78 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' A' ' 149' ' ' LEU . . . -112.44 110.46 20.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.198 -0.939 . . . . 1.0 109.362 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 0.1 OUTLIER -159.51 136.63 9.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.158 -0.964 . . . . 1.0 109.872 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.442 ' HB2' ' O ' ' A' ' 169' ' ' SER . 0.2 OUTLIER 176.67 99.14 0.11 Allowed Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.385 -0.822 . . . . 1.0 109.07 179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -76.46 95.3 1.04 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.311 2.008 . . . . 1.0 110.964 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.54 ' HB ' ' CG2' ' A' ' 147' ' ' VAL . 14.9 mt -150.36 161.36 4.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.432 -0.793 . . . . 1.0 109.137 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.494 ' N ' HG22 ' A' ' 172' ' ' ILE . 3.3 mt-10 -118.32 172.6 7.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.247 -0.908 . . . . 1.0 109.803 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.821 ' O ' HG22 ' A' ' 145' ' ' THR . 6.0 m -114.71 153.29 30.53 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.305 -0.872 . . . . 1.0 109.315 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.532 ' OG ' ' HB1' ' A' ' 27' ' ' ALA . 1.3 p -164.96 166.65 19.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.293 -0.879 . . . . 1.0 109.541 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.97 -176.23 3.1 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.203 -0.935 . . . . 1.0 109.384 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.31 -83.58 0.48 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.147 -0.971 . . . . 1.0 109.411 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 118.036 -0.983 . . . . 1.0 109.471 -179.979 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.425 -0.583 . . . . 1.0 109.425 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.66 135.51 15.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.228 -0.92 . . . . 1.0 109.476 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 174.49 -67.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.235 -0.916 . . . . 1.0 109.434 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.555 ' CG ' ' N ' ' A' ' 5' ' ' GLN . 23.5 p-90 -78.62 -46.0 20.29 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.304 -0.873 . . . . 1.0 109.54 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.555 ' N ' ' CG ' ' A' ' 4' ' ' TRP . 2.2 tt0 -179.75 81.53 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.138 -0.976 . . . . 1.0 109.371 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.481 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 0.2 OUTLIER -166.52 62.68 0.73 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.254 -0.904 . . . . 1.0 109.557 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 6' ' ' LEU . 35.4 Cg_endo -77.91 94.62 1.07 Allowed 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.404 2.069 . . . . 1.0 110.357 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 83.9 p -155.04 46.4 0.52 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.357 -0.839 . . . . 1.0 109.508 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.07 114.24 27.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 1.0 109.482 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.8 m -154.76 52.06 0.63 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.173 -0.955 . . . . 1.0 109.549 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 63.81 73.56 0.54 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.594 -1.402 . . . . 1.0 109.594 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.04 -162.46 0.17 Allowed 'Trans proline' 0 C--N 1.312 -1.347 0 C-N-CA 122.532 2.155 . . . . 1.0 110.374 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.507 ' HA ' ' HA3' ' A' ' 52' ' ' GLY . 3.1 m-85 -56.72 145.74 28.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.2 -0.937 . . . . 1.0 109.326 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -157.13 124.14 5.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.903 -1.123 . . . . 1.0 110.089 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.612 HD22 ' HB ' ' A' ' 153' ' ' VAL . 17.5 tp -107.8 81.72 1.55 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.395 -0.815 . . . . 1.0 108.867 179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.9 ttm180 -116.34 157.1 25.56 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.309 -0.87 . . . . 1.0 109.903 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.79 HG23 ' O ' ' A' ' 47' ' ' ILE . 1.4 mp -62.96 149.81 9.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.296 -0.878 . . . . 1.0 108.664 179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 1.022 ' HB3' HD12 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -64.65 -42.71 95.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.923 . . . . 1.0 109.11 179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.723 ' HB ' HD11 ' A' ' 47' ' ' ILE . 71.3 t -151.81 126.76 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 O-C-N 121.277 -0.89 . . . . 1.0 109.092 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.601 ' HG2' HG21 ' A' ' 17' ' ' ILE . 9.0 mm-40 -115.28 79.14 6.48 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.905 . . . . 1.0 109.484 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.477 ' HD3' HG12 ' A' ' 19' ' ' VAL . 36.2 Cg_endo -77.8 -179.35 5.36 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.352 2.035 . . . . 1.0 110.453 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.68 113.97 5.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.308 -0.87 . . . . 1.0 109.062 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.54 ' HA ' ' CB ' ' A' ' 40' ' ' ALA . 3.0 t -139.29 72.46 1.4 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.226 -0.921 . . . . 1.0 109.855 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.415 ' HA ' HG12 ' A' ' 172' ' ' ILE . 1.7 p-80 -99.69 166.89 10.89 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.244 -0.91 . . . . 1.0 109.256 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.573 ' CE1' ' HA ' ' A' ' 38' ' ' VAL . 9.3 t60 -135.78 104.19 5.67 Favored 'General case' 0 C--N 1.295 -1.802 0 C-N-CA 119.852 -0.739 . . . . 1.0 109.339 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -79.08 77.83 5.55 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.426 -0.796 . . . . 1.0 109.212 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 28' ' ' HIS . . . -60.03 93.46 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.394 -0.816 . . . . 1.0 109.648 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 27' ' ' ALA . 2.4 t-160 176.58 33.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.344 -0.847 . . . . 1.0 109.32 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -95.44 -168.89 1.86 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.292 -0.88 . . . . 1.0 109.551 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -70.16 145.76 51.28 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.314 -0.866 . . . . 1.0 109.59 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 31' ' ' THR . 13.3 t -145.05 38.23 1.17 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.358 -0.839 . . . . 1.0 109.521 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.4 20.89 13.4 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -0.931 . . . . 1.0 109.525 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -177.24 -50.24 0.07 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.583 -1.407 . . . . 1.0 109.583 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.13 150.46 22.02 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.243 -1.151 . . . . 1.0 109.497 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 -88.83 -89.74 0.14 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.3 -0.875 . . . . 1.0 109.509 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 109.89 175.97 21.0 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.567 -1.413 . . . . 1.0 109.567 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -175.17 170.09 3.19 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -1.138 . . . . 1.0 109.607 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.573 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 2.2 p -57.48 122.79 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.365 -0.835 . . . . 1.0 109.43 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.32 109.93 3.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 1.0 109.439 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.54 ' CB ' ' HA ' ' A' ' 23' ' ' SER . . . -136.34 -91.63 0.27 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.183 -0.948 . . . . 1.0 109.77 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.55 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 58.8 m -102.61 135.26 44.57 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.222 -0.924 . . . . 1.0 109.662 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.77 ' HB1' ' CE1' ' A' ' 45' ' ' HIS . . . 67.45 10.1 7.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.928 . . . . 1.0 109.38 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.8 10.8 42.3 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.413 -1.475 . . . . 1.0 109.413 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 45' ' ' HIS . . . 77.06 83.4 0.52 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.644 -1.383 . . . . 1.0 109.644 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.77 ' CE1' ' HB1' ' A' ' 42' ' ' ALA . 23.4 p-80 -179.81 123.0 0.23 Allowed Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 121.168 -1.195 . . . . 1.0 109.962 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.24 146.61 19.97 Favored 'Trans proline' 0 C--N 1.315 -1.209 0 C-N-CA 122.0 1.8 . . . . 1.0 109.416 179.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.022 HD12 ' HB3' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -97.31 135.1 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.909 -1.119 . . . . 1.0 109.142 -179.672 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.562 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 3.0 t -118.63 130.79 72.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.017 -1.052 . . . . 1.0 109.814 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.553 ' NE2' ' CG ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -161.4 117.74 2.17 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.338 -0.852 . . . . 1.0 109.465 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.554 HD11 HG11 ' A' ' 153' ' ' VAL . 3.0 tt -77.07 136.37 38.65 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.126 -0.984 . . . . 1.0 109.154 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -141.0 87.47 2.1 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.182 -0.949 . . . . 1.0 109.262 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 163.92 64.48 0.02 OUTLIER Glycine 0 N--CA 1.483 1.807 0 C-N-CA 119.56 -1.305 . . . . 1.0 110.166 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.57 ' CE1' ' HB2' ' A' ' 55' ' ' GLU . 0.2 OUTLIER 175.62 121.79 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.109 -1.23 . . . . 1.0 109.687 179.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.7 mt -104.0 22.6 14.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.323 -0.861 . . . . 1.0 109.31 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.57 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -87.35 145.22 26.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.179 -0.951 . . . . 1.0 109.685 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.83 46.43 1.33 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.2 -0.938 . . . . 1.0 109.712 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 57' ' ' GLU . 17.1 pt-20 -122.98 127.75 25.59 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.255 -0.903 . . . . 1.0 109.185 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.596 ' O ' HD23 ' A' ' 59' ' ' LEU . 36.4 Cg_endo -79.44 151.18 22.61 Favored 'Trans proline' 0 C--N 1.315 -1.203 0 C-N-CA 122.147 1.898 . . . . 1.0 110.624 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.596 HD23 ' O ' ' A' ' 58' ' ' PRO . 18.6 mt -128.48 142.7 51.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.309 -0.869 . . . . 1.0 108.91 179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.444 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -79.95 102.05 8.98 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.074 -1.016 . . . . 1.0 109.423 -179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.865 HD21 ' HB2' ' A' ' 63' ' ' LEU . 3.0 tt -59.59 135.11 57.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.405 -0.809 . . . . 1.0 109.612 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 7.0 tp60 -102.45 97.06 7.35 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.359 -0.838 . . . . 1.0 108.998 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.971 HD13 ' CE1' ' A' ' 151' ' ' PHE . 26.8 tp -123.35 139.21 54.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.179 -0.951 . . . . 1.0 109.634 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.495 ' HB3' HG12 ' A' ' 103' ' ' VAL . 2.3 p90 -159.96 -163.9 1.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.325 -0.86 . . . . 1.0 108.928 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.689 ' O ' HG23 ' A' ' 65' ' ' ILE . 2.8 tp -125.36 115.62 44.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.827 . . . . 1.0 108.828 179.087 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.434 ' CA ' ' O ' ' A' ' 74' ' ' ARG . . . -135.09 148.07 19.43 Favored Glycine 0 N--CA 1.49 2.257 0 C-N-CA 119.677 -1.249 . . . . 1.0 109.996 -179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.861 HG22 ' CD2' ' A' ' 76' ' ' HIS . 17.4 p -83.97 156.34 22.35 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.519 -0.989 . . . . 1.0 109.225 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.994 ' HB3' ' HG3' ' A' ' 148' ' ' ARG . . . -159.42 120.39 3.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.067 -1.021 . . . . 1.0 109.724 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.438 ' OD1' HD11 ' A' ' 72' ' ' LEU . 0.5 OUTLIER -84.93 -10.91 56.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.337 -0.852 . . . . 1.0 109.374 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -166.65 -44.13 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.887 . . . . 1.0 109.38 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.487 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -168.33 -36.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 1.0 109.619 179.939 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.438 HD11 ' OD1' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -53.98 89.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.282 -0.886 . . . . 1.0 109.548 -179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.599 HD23 ' H ' ' A' ' 73' ' ' LEU . 0.2 OUTLIER -54.21 169.21 0.19 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.243 -0.911 . . . . 1.0 109.6 -179.979 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.434 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -175.19 155.17 1.75 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.27 -0.894 . . . . 1.0 109.486 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.426 ' HD2' ' HG2' ' A' ' 74' ' ' ARG . 36.0 Cg_endo -77.67 116.93 4.14 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.483 2.122 . . . . 1.0 110.342 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.861 ' CD2' HG22 ' A' ' 67' ' ' THR . 1.7 t-80 -54.07 154.48 4.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.186 -0.947 . . . . 1.0 109.699 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.95 -72.2 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.284 -0.885 . . . . 1.0 109.796 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.934 ' CG ' HD12 ' A' ' 126' ' ' LEU . 1.1 p90 -130.97 12.83 5.22 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.091 -1.006 . . . . 1.0 109.858 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.668 ' O ' HG21 ' A' ' 65' ' ' ILE . 5.8 m-85 -79.98 117.18 20.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.061 -1.024 . . . . 1.0 108.943 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.543 ' CB ' ' HB3' ' A' ' 102' ' ' LYS . 1.5 pp0? -174.55 33.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.148 -0.97 . . . . 1.0 109.984 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.898 HG23 ' O ' ' A' ' 122' ' ' GLY . 5.6 m -91.94 140.91 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.134 -0.979 . . . . 1.0 109.641 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 1.01 ' CD2' ' HB2' ' A' ' 121' ' ' ALA . 13.4 t-80 -175.58 111.26 0.11 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.401 -0.812 . . . . 1.0 108.94 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.452 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.4 OUTLIER -145.08 135.18 23.88 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.09 -1.006 . . . . 1.0 110.116 -179.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.814 HD11 ' HE1' ' A' ' 82' ' ' HIS . 4.0 mp -99.75 128.45 51.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.596 -0.69 . . . . 1.0 109.379 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 86' ' ' GLY . 38.7 p -99.98 -154.37 0.47 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.908 . . . . 1.0 109.356 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 85' ' ' THR . . . 41.07 -152.12 0.12 Allowed Glycine 0 N--CA 1.484 1.881 0 N-CA-C 110.071 -1.212 . . . . 1.0 110.071 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -155.2 69.56 0.72 Allowed 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.265 -1.138 . . . . 1.0 109.576 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -131.54 40.01 3.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.203 -0.936 . . . . 1.0 109.67 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -148.16 135.97 14.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 121.178 -0.951 . . . . 1.0 108.982 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.6 p -102.94 -13.8 16.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.22 -0.925 . . . . 1.0 109.452 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.657 HG23 ' O ' ' A' ' 91' ' ' THR . 11.4 t -65.05 115.55 5.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.263 -0.898 . . . . 1.0 109.618 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 1.023 ' O ' HG23 ' A' ' 106' ' ' ILE . 14.5 t -78.62 148.78 33.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.184 -0.947 . . . . 1.0 109.142 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.46 ' HB3' HG12 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -137.18 174.39 10.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.129 -0.982 . . . . 1.0 110.043 -179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -152.76 159.56 43.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.495 -0.753 . . . . 1.0 109.139 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.493 ' HB3' ' HE3' ' A' ' 102' ' ' LYS . 27.8 mm-40 -127.14 147.79 50.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.979 . . . . 1.0 109.819 -179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -151.76 121.55 7.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.286 -0.884 . . . . 1.0 109.427 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.495 ' HB ' ' HD2' ' A' ' 102' ' ' LYS . 2.6 tp -110.27 142.32 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 1.0 109.648 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.637 HD11 HG21 ' A' ' 101' ' ' THR . 0.5 OUTLIER -130.81 49.62 2.3 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.329 -0.857 . . . . 1.0 109.367 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 98' ' ' LEU . 2.0 p 73.92 112.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.317 -0.864 . . . . 1.0 110.213 179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.429 ' CG ' ' O ' ' A' ' 99' ' ' SER . 2.2 p-10 42.71 32.65 0.4 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.603 -0.686 . . . . 1.0 110.502 179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.637 HG21 HD11 ' A' ' 98' ' ' LEU . 43.7 m -160.24 88.66 0.82 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 120.883 -1.135 . . . . 1.0 109.971 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.543 ' HB3' ' CB ' ' A' ' 80' ' ' GLN . 3.8 tptt -91.88 147.5 22.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -0.922 . . . . 1.0 109.239 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.524 ' N ' ' HG3' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -136.8 167.43 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.205 -0.934 . . . . 1.0 109.104 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.583 HD22 HG13 ' A' ' 106' ' ' ILE . 1.0 OUTLIER -121.59 124.43 44.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.256 -0.903 . . . . 1.0 109.65 -179.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.459 ' N ' HD23 ' A' ' 104' ' ' LEU . 1.0 OUTLIER -114.85 120.36 39.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.28 -0.887 . . . . 1.0 109.152 179.684 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 1.023 HG23 ' O ' ' A' ' 92' ' ' THR . 71.3 mt -133.24 108.61 12.45 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.107 -0.996 . . . . 1.0 109.684 -179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.638 ' O ' HD23 ' A' ' 108' ' ' LEU . 33.9 Cg_endo -75.17 115.6 4.31 Favored 'Trans proline' 0 C--N 1.315 -1.191 0 C-N-CA 122.079 1.853 . . . . 1.0 109.844 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.638 HD23 ' O ' ' A' ' 107' ' ' PRO . 21.1 mt -123.45 165.45 17.05 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.261 -0.899 . . . . 1.0 110.787 -178.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.533 ' N ' ' HD3' ' A' ' 110' ' ' PRO . 0.1 OUTLIER -139.21 59.7 15.5 Favored Pre-proline 0 N--CA 1.487 1.418 0 N-CA-C 108.788 -0.819 . . . . 1.0 108.788 179.199 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 109' ' ' LEU . 35.6 Cg_endo -76.95 -3.88 14.28 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 122.373 2.049 . . . . 1.0 110.622 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 55' ' ' GLU . 3.2 mt-10 -43.63 -36.01 1.99 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.502 -0.749 . . . . 1.0 109.115 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.48 ' O ' ' CB ' ' A' ' 113' ' ' SER . 3.4 p30 -94.77 -44.33 7.82 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.476 -0.765 . . . . 1.0 109.202 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 1.4 p 164.72 107.54 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.219 -0.926 . . . . 1.0 109.261 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -154.69 94.08 1.64 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.32 -0.863 . . . . 1.0 109.358 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.54 129.77 42.6 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 1.0 109.233 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -136.09 134.7 38.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.895 . . . . 1.0 109.636 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.997 HG12 HG22 ' A' ' 47' ' ' ILE . 3.3 m -106.35 145.78 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.279 -0.888 . . . . 1.0 109.238 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.486 ' O ' ' HB2' ' A' ' 45' ' ' HIS . 14.3 mt -112.76 93.93 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.176 -0.952 . . . . 1.0 109.509 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.601 ' HB3' ' CG ' ' A' ' 45' ' ' HIS . 9.4 p-10 -127.66 26.44 5.91 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.591 -0.693 . . . . 1.0 109.257 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.494 ' HB3' HG13 ' A' ' 84' ' ' ILE . 0.0 OUTLIER -122.42 44.65 2.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.245 -0.909 . . . . 1.0 110.003 -179.406 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 1.01 ' HB2' ' CD2' ' A' ' 82' ' ' HIS . . . -129.56 177.01 7.52 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.154 -0.967 . . . . 1.0 109.102 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.898 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -155.95 -169.84 20.63 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.548 -1.421 . . . . 1.0 109.548 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.542 HD12 ' HD2' ' A' ' 25' ' ' HIS . 1.8 mt -125.68 173.41 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -1.129 . . . . 1.0 109.437 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.72 HD21 ' O ' ' A' ' 78' ' ' PHE . 1.4 pp -140.12 158.14 44.53 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -0.826 . . . . 1.0 109.396 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.9 139.23 50.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 1.0 109.552 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.934 HD12 ' CG ' ' A' ' 78' ' ' PHE . 10.5 mt -116.06 -170.7 1.85 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 1.0 109.394 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.35 -58.64 1.85 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 1.0 109.523 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -163.15 118.84 1.75 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.282 -0.886 . . . . 1.0 109.448 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.537 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 52.2 p -100.79 -27.3 13.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.285 -0.884 . . . . 1.0 109.476 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.537 ' CB ' ' O ' ' A' ' 129' ' ' SER . 16.6 t0 83.39 59.42 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.264 0.554 . . . . 1.0 109.517 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 3.3 tp -103.98 134.46 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.208 -0.932 . . . . 1.0 109.456 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -84.04 111.92 19.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.255 -0.903 . . . . 1.0 109.518 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.577 HD13 ' O ' ' A' ' 133' ' ' LEU . 0.5 OUTLIER -170.98 -57.64 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.216 -0.927 . . . . 1.0 109.463 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.03 -35.86 67.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 1.0 109.322 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.32 155.42 28.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 1.0 109.488 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 179.19 -86.17 0.07 OUTLIER Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.517 -1.433 . . . . 1.0 109.517 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -122.54 -64.45 1.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -1.119 . . . . 1.0 109.42 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -130.89 149.2 52.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 1.0 109.429 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 139' ' ' ASP . 24.6 p-10 -59.84 155.28 16.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.176 -0.953 . . . . 1.0 109.448 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 141' ' ' GLY . 1.0 OUTLIER -119.18 -69.2 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.199 -0.938 . . . . 1.0 108.856 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.435 ' N ' HG22 ' A' ' 140' ' ' ILE . . . -115.09 -147.99 9.36 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.588 -1.405 . . . . 1.0 109.588 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.97 -85.62 0.56 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.27 -1.135 . . . . 1.0 109.506 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.401 ' O ' ' CG ' ' A' ' 143' ' ' LYS . 0.0 OUTLIER -87.85 73.09 9.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.278 -0.889 . . . . 1.0 109.525 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -59.94 128.51 37.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.313 -0.867 . . . . 1.0 109.348 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.11 53.42 0.34 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.092 -1.005 . . . . 1.0 109.828 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.476 ' HD2' ' O ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -101.98 158.85 15.84 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.103 -0.998 . . . . 1.0 109.374 179.834 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.44 ' O ' ' HG2' ' A' ' 148' ' ' ARG . 2.2 m -141.49 165.33 18.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.437 -0.79 . . . . 1.0 109.147 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.994 ' HG3' ' HB3' ' A' ' 68' ' ' ALA . 20.7 mmm-85 -150.31 119.0 6.54 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.074 -1.017 . . . . 1.0 109.865 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.96 HD12 HD11 ' A' ' 63' ' ' LEU . 0.4 OUTLIER -79.82 120.25 23.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.292 -0.88 . . . . 1.0 109.278 179.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 47.4 t -96.74 126.15 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.263 -0.898 . . . . 1.0 109.535 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.971 ' CE1' HD13 ' A' ' 63' ' ' LEU . 3.1 m-85 -127.71 118.3 23.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.341 -0.849 . . . . 1.0 109.062 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 1.9 ptm180 -150.33 141.17 22.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.131 -0.98 . . . . 1.0 109.977 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.635 ' CG1' HD11 ' A' ' 163' ' ' LEU . 8.8 p -117.32 128.46 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 108.683 -0.858 . . . . 1.0 108.683 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.452 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 55.1 m-70 -121.69 115.13 22.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.139 -0.975 . . . . 1.0 110.329 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.597 ' HB ' HD23 ' A' ' 163' ' ' LEU . 13.9 p -99.66 141.93 23.69 Favored Pre-proline 0 N--CA 1.488 1.468 0 N-CA-C 108.901 -0.778 . . . . 1.0 108.901 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.534 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 32.8 Cg_endo -75.16 114.52 4.03 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.065 1.843 . . . . 1.0 110.357 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.674 ' HG3' HG21 ' A' ' 162' ' ' THR . 3.9 mm-40 -133.41 168.33 18.45 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.553 -0.717 . . . . 1.0 109.069 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.465 ' HD2' ' CD ' ' A' ' 157' ' ' GLN . 34.4 Cg_endo -77.0 -64.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.259 1.973 . . . . 1.0 110.249 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.4 m -62.1 -58.05 9.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.203 -0.935 . . . . 1.0 109.245 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 124.55 -36.19 2.96 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.738 -1.345 . . . . 1.0 109.738 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 5.0 mtm180 -79.14 80.04 5.51 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.498 -1.001 . . . . 1.0 108.312 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.674 HG21 ' HG3' ' A' ' 157' ' ' GLN . 1.3 m -140.54 -74.18 0.34 Allowed 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.958 -0.756 . . . . 1.0 108.958 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.635 HD11 ' CG1' ' A' ' 153' ' ' VAL . 7.8 tp -142.25 97.62 3.16 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.09 -1.006 . . . . 1.0 108.644 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.452 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.2 OUTLIER -163.11 87.14 0.55 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.071 -1.018 . . . . 1.0 109.245 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.778 HD23 ' H ' ' A' ' 165' ' ' LEU . 1.8 pt? -132.31 170.78 14.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.171 -0.956 . . . . 1.0 109.805 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.472 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 2.5 tt0 -117.44 157.44 26.23 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.327 -0.858 . . . . 1.0 109.498 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.57 HG12 ' O ' ' A' ' 167' ' ' VAL . 48.3 t -149.32 81.87 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.274 -0.891 . . . . 1.0 109.653 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 149' ' ' LEU . . . -90.8 103.46 16.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.198 -0.939 . . . . 1.0 109.354 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 170' ' ' ASN . 0.0 OUTLIER -120.07 136.5 54.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.152 -0.967 . . . . 1.0 109.657 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.652 HD21 HD23 ' A' ' 149' ' ' LEU . 1.8 m-20 163.27 85.5 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 1.0 109.383 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.91 72.24 6.24 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 C-N-CA 122.461 2.107 . . . . 1.0 110.574 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 146' ' ' ARG . 12.3 mt -126.71 134.44 66.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.295 -0.878 . . . . 1.0 109.284 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -156.0 125.1 6.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 1.0 109.631 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . . . . . . . . . 1.3 m -95.37 -173.8 3.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 1.0 109.491 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 4.9 p 63.28 159.11 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 1.0 109.659 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.456 ' O ' ' O ' ' A' ' 177' ' ' ARG . 0.3 OUTLIER 61.06 45.57 9.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 1.0 109.627 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 176' ' ' GLN . 0.0 OUTLIER 48.18 -176.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.259 -0.9 . . . . 1.0 109.483 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 117.973 -1.013 . . . . 1.0 109.457 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.449 -0.575 . . . . 1.0 109.449 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.459 ' O ' ' CB ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -160.66 151.08 18.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.186 -0.946 . . . . 1.0 109.428 -179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.459 ' CB ' ' O ' ' A' ' 2' ' ' LYS . 0.3 OUTLIER 74.13 -162.62 0.08 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.29 -0.882 . . . . 1.0 109.525 179.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.44 ' CG ' ' N ' ' A' ' 5' ' ' GLN . 52.4 p-90 -103.73 -46.2 4.58 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.309 -0.869 . . . . 1.0 109.538 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.456 ' C ' ' HD3' ' A' ' 7' ' ' PRO . 0.3 OUTLIER 172.94 85.05 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 1.0 109.483 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.513 ' N ' ' HD3' ' A' ' 7' ' ' PRO . 1.2 mt -133.05 60.82 52.06 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.326 -0.858 . . . . 1.0 109.411 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.513 ' HD3' ' N ' ' A' ' 6' ' ' LEU . 35.6 Cg_endo -78.18 106.81 2.21 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.399 2.066 . . . . 1.0 110.46 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 77.6 p -139.16 41.1 2.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.241 -0.912 . . . . 1.0 109.47 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 7.8 m80 -140.2 132.55 28.36 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.33 -0.856 . . . . 1.0 109.511 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 11.4 t -120.44 128.72 53.44 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.256 -0.903 . . . . 1.0 109.507 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 121.25 146.15 7.38 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.48 -1.448 . . . . 1.0 109.48 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.3 -91.83 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.389 2.059 . . . . 1.0 110.381 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.66 ' CE2' ' CD1' ' A' ' 53' ' ' TYR . 3.6 m-30 -58.36 145.06 39.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.167 -0.958 . . . . 1.0 109.215 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.657 ' HA ' HD11 ' A' ' 165' ' ' LEU . 53.1 tt0 179.48 142.96 0.14 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.148 -0.97 . . . . 1.0 109.271 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 151' ' ' PHE . 0.9 OUTLIER -98.79 116.8 31.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.339 -0.851 . . . . 1.0 109.213 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.2 ttp180 -110.76 132.84 53.85 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.338 -0.851 . . . . 1.0 109.916 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.709 HG21 ' NE2' ' A' ' 20' ' ' GLN . 1.1 mp -60.83 143.36 14.78 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.358 -0.979 . . . . 1.0 108.358 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 11.6 tp10 -71.96 -54.23 10.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.244 -0.91 . . . . 1.0 109.676 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.562 HG12 ' HD3' ' A' ' 21' ' ' PRO . 30.5 t -120.33 133.61 66.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.239 -0.913 . . . . 1.0 109.61 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.709 ' NE2' HG21 ' A' ' 17' ' ' ILE . 0.7 OUTLIER -127.0 76.24 76.1 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.214 -0.929 . . . . 1.0 109.429 179.933 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.562 ' HD3' HG12 ' A' ' 19' ' ' VAL . 35.5 Cg_endo -77.69 -175.71 2.83 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.511 2.141 . . . . 1.0 110.51 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 21' ' ' PRO . 0.0 OUTLIER -43.46 131.08 5.03 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.451 -0.781 . . . . 1.0 109.406 179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' A' ' 23' ' ' SER . 7.9 t -112.86 40.07 2.38 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.189 -0.944 . . . . 1.0 109.841 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.881 ' HA ' HG23 ' A' ' 172' ' ' ILE . 1.9 p80 -103.04 166.16 10.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.05 -1.031 . . . . 1.0 109.505 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.67 ' NE2' HD11 ' A' ' 123' ' ' ILE . 1.0 OUTLIER -154.49 89.83 1.29 Allowed 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.901 -0.72 . . . . 1.0 109.674 179.8 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.42 72.63 10.23 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.307 -0.871 . . . . 1.0 109.138 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.636 ' HB2' HD12 ' A' ' 123' ' ' ILE . . . -70.66 148.95 47.5 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.471 -0.768 . . . . 1.0 109.811 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.5 p80 -69.76 146.54 51.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.289 -0.882 . . . . 1.0 109.341 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.479 ' HB2' ' HA ' ' A' ' 176' ' ' GLN . 78.6 m-85 -132.35 86.57 2.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 1.0 109.504 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 29' ' ' TYR . 0.6 OUTLIER 169.62 -157.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -0.924 . . . . 1.0 109.459 -179.885 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 3.7 t -122.32 34.69 5.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.224 -0.922 . . . . 1.0 109.496 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.47 ' HG3' ' N ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -122.83 -27.2 4.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.348 -0.845 . . . . 1.0 109.601 -179.919 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.47 ' N ' ' HG3' ' A' ' 32' ' ' GLU . . . -68.92 133.59 26.98 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.624 -1.391 . . . . 1.0 109.624 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.08 -67.58 0.85 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -1.122 . . . . 1.0 109.447 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 4.0 mmt85 -76.62 88.11 3.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.333 -0.854 . . . . 1.0 109.342 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -110.7 121.95 6.05 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.637 -1.385 . . . . 1.0 109.637 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -173.25 175.13 3.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.184 -1.186 . . . . 1.0 109.751 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.578 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 2.4 p -89.67 119.23 36.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.539 -0.725 . . . . 1.0 109.269 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt -155.18 105.37 2.51 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.203 -0.936 . . . . 1.0 109.577 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.51 -88.29 0.54 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.224 -0.922 . . . . 1.0 109.449 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 p -114.97 -92.2 0.51 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.934 . . . . 1.0 109.652 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.27 -69.45 0.12 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.224 -0.923 . . . . 1.0 109.457 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -167.25 26.68 0.15 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.522 -1.431 . . . . 1.0 109.522 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.502 ' HA3' ' CG2' ' A' ' 38' ' ' VAL . . . 112.34 -59.5 0.37 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.487 ' HB3' ' HD2' ' A' ' 46' ' ' PRO . 13.1 m-70 -104.64 161.03 24.06 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.307 -1.113 . . . . 1.0 109.472 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 45' ' ' HIS . 35.4 Cg_endo -78.0 -179.59 5.59 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.505 2.136 . . . . 1.0 110.512 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.15 HG23 HG12 ' A' ' 117' ' ' VAL . 2.5 mm -94.11 156.64 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.374 -0.829 . . . . 1.0 109.075 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.606 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 10.8 t -129.31 141.76 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.112 -0.992 . . . . 1.0 110.117 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.468 ' HB2' ' HG3' ' A' ' 115' ' ' ARG . 7.1 tt0 -160.4 147.06 15.65 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.785 -0.82 . . . . 1.0 108.785 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.4 HD13 ' OE2' ' A' ' 111' ' ' GLU . 0.6 OUTLIER -78.5 148.13 33.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.886 -1.134 . . . . 1.0 109.617 -179.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -140.14 77.65 1.62 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.445 -0.785 . . . . 1.0 109.37 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.507 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 163.87 -109.97 0.4 Allowed Glycine 0 N--CA 1.488 2.121 0 C-N-CA 119.455 -1.355 . . . . 1.0 110.476 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.66 ' CD1' ' CE2' ' A' ' 13' ' ' TYR . 1.5 t80 -39.18 141.22 0.34 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.826 -0.808 . . . . 1.0 110.178 -179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.591 HD12 ' O ' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -136.62 46.67 2.22 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.331 -0.856 . . . . 1.0 109.492 179.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.596 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 1.2 tt0 -87.25 145.41 26.38 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 1.0 109.331 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -85.62 49.98 1.87 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.202 -0.936 . . . . 1.0 109.853 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.419 ' HG3' ' CD ' ' A' ' 55' ' ' GLU . 47.3 mm-40 -122.36 153.54 62.06 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 1.0 109.432 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.997 ' O ' HD23 ' A' ' 59' ' ' LEU . 35.3 Cg_endo -78.11 131.03 10.62 Favored 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 122.521 2.148 . . . . 1.0 110.462 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.017 HD22 HG23 ' A' ' 155' ' ' VAL . 4.3 mt -128.14 163.02 25.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.202 -0.936 . . . . 1.0 109.16 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.447 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 4.4 ptt? -110.48 138.72 46.5 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.238 -0.914 . . . . 1.0 109.771 -179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.605 HD22 HD23 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -91.71 147.44 22.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.413 -0.804 . . . . 1.0 109.391 179.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.455 ' O ' ' HG2' ' A' ' 152' ' ' ARG . 0.9 OUTLIER -124.48 77.6 1.59 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.307 -0.871 . . . . 1.0 109.041 179.71 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.966 HD22 ' CE1' ' A' ' 151' ' ' PHE . 0.5 OUTLIER -125.64 156.89 38.52 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.205 -0.934 . . . . 1.0 109.842 -179.569 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.864 ' HB3' HG12 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -166.16 -164.93 0.73 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.38 -0.97 . . . . 1.0 108.38 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.785 HD12 ' CD2' ' A' ' 149' ' ' LEU . 0.5 OUTLIER -117.56 112.51 39.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 120.889 -1.132 . . . . 1.0 108.53 178.656 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -126.8 147.31 16.8 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.829 -1.308 . . . . 1.0 109.829 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.933 HG22 ' CD2' ' A' ' 76' ' ' HIS . 4.7 p -83.26 134.02 34.96 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.476 -1.014 . . . . 1.0 109.404 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -160.14 121.28 3.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.218 -0.926 . . . . 1.0 109.371 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.513 ' OD2' HD21 ' A' ' 72' ' ' LEU . 3.1 p30 -84.84 -26.52 27.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.9 . . . . 1.0 109.503 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.96 -38.75 0.34 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 1.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.511 ' O ' ' N ' ' A' ' 73' ' ' LEU . 2.7 ttm180 -168.96 -35.75 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.121 -0.987 . . . . 1.0 109.674 -179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.572 ' H ' HD23 ' A' ' 72' ' ' LEU . 0.1 OUTLIER -44.06 94.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 1.0 109.701 -179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.511 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.6 OUTLIER -80.17 136.36 36.48 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.222 -0.924 . . . . 1.0 109.623 -179.922 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 67' ' ' THR . 0.0 OUTLIER -157.83 166.48 16.47 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.285 -0.884 . . . . 1.0 109.136 -179.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.943 ' HB3' HG23 ' A' ' 101' ' ' THR . 33.4 Cg_endo -75.47 137.26 20.49 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.147 1.898 . . . . 1.0 110.223 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.995 ' NE2' HG12 ' A' ' 147' ' ' VAL . 0.3 OUTLIER -65.27 157.53 28.74 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.29 -0.882 . . . . 1.0 109.848 -179.529 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.3 -58.88 2.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.299 -0.876 . . . . 1.0 109.467 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.575 ' CD1' ' CD2' ' A' ' 126' ' ' LEU . 2.3 m-85 -128.31 2.86 5.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.203 -0.936 . . . . 1.0 109.794 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.579 ' HB2' ' CD2' ' A' ' 76' ' ' HIS . 5.7 m-85 -100.72 76.15 1.78 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.13 -0.981 . . . . 1.0 109.414 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.512 ' HB2' ' CB ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -141.97 8.68 1.89 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 1.0 110.002 -179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.892 HG11 HD23 ' A' ' 124' ' ' LEU . 10.2 m -67.64 143.69 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.034 -1.041 . . . . 1.0 109.52 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.727 ' CD2' ' HB2' ' A' ' 121' ' ' ALA . 10.2 t-160 -175.48 107.23 0.09 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.47 -0.769 . . . . 1.0 109.438 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -144.8 142.84 30.3 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.165 -0.96 . . . . 1.0 109.711 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.742 HD12 ' N ' ' A' ' 84' ' ' ILE . 4.1 mp -101.01 158.98 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.349 -0.844 . . . . 1.0 109.196 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.434 ' N ' HG22 ' A' ' 84' ' ' ILE . 23.8 p -99.93 -105.17 0.22 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.149 -0.969 . . . . 1.0 109.275 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 85' ' ' THR . . . -44.51 109.14 0.24 Allowed Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.716 -1.353 . . . . 1.0 109.716 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 6.1 tptt -74.58 82.34 2.01 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.104 -1.233 . . . . 1.0 109.417 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -155.55 44.85 0.46 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.302 -0.874 . . . . 1.0 109.579 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.57 HG22 ' H ' ' A' ' 90' ' ' SER . 8.7 p -86.98 171.93 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.255 -0.903 . . . . 1.0 109.402 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.57 ' H ' HG22 ' A' ' 89' ' ' VAL . 1.5 t -86.85 -30.16 21.67 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.223 -0.923 . . . . 1.0 109.561 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.657 HG23 ' HG ' ' A' ' 108' ' ' LEU . 11.5 m -108.57 105.06 14.52 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.328 -0.857 . . . . 1.0 109.505 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.517 ' O ' HG23 ' A' ' 106' ' ' ILE . 6.9 m -52.63 157.46 1.56 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.249 -0.907 . . . . 1.0 109.338 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.664 ' HB3' HD12 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -140.69 174.99 9.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.27 -0.894 . . . . 1.0 109.917 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -152.41 160.77 43.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.479 -0.763 . . . . 1.0 109.505 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.16 148.69 52.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.139 -0.976 . . . . 1.0 109.668 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.521 ' O ' HG23 ' A' ' 103' ' ' VAL . . . -158.66 121.14 3.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.279 -0.888 . . . . 1.0 109.571 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.444 HD12 ' C ' ' A' ' 101' ' ' THR . 2.7 tp -107.44 141.06 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 1.0 109.412 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.516 ' O ' ' CB ' ' A' ' 99' ' ' SER . 0.5 OUTLIER -132.9 50.33 2.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 1.0 109.511 179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.516 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 1.6 m 77.75 108.03 0.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.454 -0.779 . . . . 1.0 109.748 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 99' ' ' SER . 9.1 p30 44.25 41.28 4.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.493 -0.754 . . . . 1.0 110.364 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.943 HG23 ' HB3' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -158.91 79.32 0.77 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.971 -1.08 . . . . 1.0 109.77 179.568 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.512 ' CB ' ' HB2' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -82.09 119.14 23.64 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.944 . . . . 1.0 109.131 179.811 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.864 HG12 ' HB3' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -122.41 161.18 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.214 -0.929 . . . . 1.0 109.528 -179.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.92 HD11 HD11 ' A' ' 63' ' ' LEU . 0.1 OUTLIER -129.67 121.9 27.89 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.463 -0.773 . . . . 1.0 109.388 179.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.826 ' O ' HD13 ' A' ' 106' ' ' ILE . 0.7 OUTLIER -99.59 139.47 35.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.343 -0.848 . . . . 1.0 109.28 -179.951 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.826 HD13 ' O ' ' A' ' 105' ' ' GLU . 2.9 mm -133.12 96.71 17.27 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.174 -0.954 . . . . 1.0 109.956 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.867 ' O ' HD22 ' A' ' 108' ' ' LEU . 34.7 Cg_endo -76.25 108.19 2.62 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.349 2.033 . . . . 1.0 109.738 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.867 HD22 ' O ' ' A' ' 107' ' ' PRO . 0.4 OUTLIER -144.56 165.48 27.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.257 -0.902 . . . . 1.0 110.247 -179.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.517 HD12 HD21 ' A' ' 112' ' ' ASN . 0.8 OUTLIER -131.6 66.71 78.82 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.489 -0.757 . . . . 1.0 109.205 179.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.523 ' HB3' ' CG ' ' A' ' 114' ' ' MET . 36.7 Cg_endo -81.06 42.33 1.32 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 C-N-CA 122.652 2.235 . . . . 1.0 110.635 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.516 ' CB ' ' O ' ' A' ' 55' ' ' GLU . 1.5 mp0 -93.83 -0.35 55.83 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.023 -1.048 . . . . 1.0 109.665 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.517 HD21 HD12 ' A' ' 109' ' ' LEU . 0.6 OUTLIER -108.24 -51.82 2.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.107 -0.996 . . . . 1.0 109.278 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.502 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.3 OUTLIER 164.79 97.39 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.301 -0.874 . . . . 1.0 109.237 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.646 ' CE ' HD12 ' A' ' 108' ' ' LEU . 5.4 ptm -162.39 133.46 5.04 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.146 -0.972 . . . . 1.0 109.972 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.497 ' NH1' HG21 ' A' ' 47' ' ' ILE . 14.2 ttp180 -112.25 131.85 55.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.205 -0.935 . . . . 1.0 109.21 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.533 ' HB2' ' OG1' ' A' ' 91' ' ' THR . . . -120.54 117.28 27.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.306 -0.871 . . . . 1.0 109.512 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 1.15 HG12 HG23 ' A' ' 47' ' ' ILE . 5.1 m -92.83 135.8 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.296 -0.878 . . . . 1.0 109.371 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 45' ' ' HIS . 7.8 mt -112.75 116.52 52.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.216 -0.927 . . . . 1.0 109.549 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.405 ' O ' ' OD1' ' A' ' 119' ' ' ASP . 17.3 p30 -156.88 52.35 0.5 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.244 -0.91 . . . . 1.0 109.477 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.486 ' HB3' HG13 ' A' ' 84' ' ' ILE . 0.8 OUTLIER -135.54 53.5 1.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.305 -0.872 . . . . 1.0 109.5 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.727 ' HB2' ' CD2' ' A' ' 82' ' ' HIS . . . -139.84 175.95 9.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.842 . . . . 1.0 109.338 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.872 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -143.69 -178.04 19.12 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.376 -1.49 . . . . 1.0 109.376 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.67 HD11 ' NE2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -117.75 158.73 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.177 -1.19 . . . . 1.0 109.131 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.892 HD23 HG11 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -123.57 147.69 47.06 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.172 -0.955 . . . . 1.0 109.425 179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.546 ' H ' HD13 ' A' ' 124' ' ' LEU . 1.7 ttpm? -116.83 154.88 29.96 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.238 -0.914 . . . . 1.0 109.425 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.575 ' CD2' ' CD1' ' A' ' 78' ' ' PHE . 14.8 mt -79.85 125.58 29.89 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -0.882 . . . . 1.0 109.354 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.72 -41.06 79.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.247 -0.908 . . . . 1.0 109.599 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.493 ' O ' ' CB ' ' A' ' 129' ' ' SER . 14.0 p30 -179.95 -165.94 0.07 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 1.0 109.547 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.493 ' CB ' ' O ' ' A' ' 128' ' ' ASN . 1.5 p 74.55 -152.87 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 1.0 109.518 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.49 ' N ' ' OG ' ' A' ' 129' ' ' SER . 2.3 t70 -179.7 66.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 1.0 109.405 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.529 HG12 ' CD2' ' A' ' 133' ' ' LEU . 1.5 tt -67.08 151.32 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.311 -0.868 . . . . 1.0 109.504 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -122.85 92.45 3.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.28 -0.888 . . . . 1.0 109.393 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.529 ' CD2' HG12 ' A' ' 131' ' ' ILE . 1.6 mm? -87.86 16.98 5.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.369 -0.832 . . . . 1.0 109.558 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.487 ' HB2' ' NH2' ' A' ' 134' ' ' ARG . 0.0 OUTLIER 174.94 88.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.202 -0.936 . . . . 1.0 109.477 180.0 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 15.2 tppt? -170.79 104.4 0.25 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.261 -0.899 . . . . 1.0 109.533 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -72.93 -65.62 2.24 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.487 -1.445 . . . . 1.0 109.487 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 137' ' ' GLU . 11.8 pt-20 -110.88 120.02 41.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.278 -1.13 . . . . 1.0 109.48 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.414 ' H ' HG22 ' A' ' 138' ' ' THR . 0.7 OUTLIER -85.28 127.41 34.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 1.0 109.512 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 140' ' ' ILE . 0.7 OUTLIER -71.42 -76.84 0.1 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.279 -0.888 . . . . 1.0 109.448 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 139' ' ' ASP . 7.2 pt -153.34 20.62 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.166 -0.958 . . . . 1.0 109.585 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 158.46 -167.4 34.55 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.666 -1.374 . . . . 1.0 109.666 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? -154.96 151.68 28.8 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.354 -1.086 . . . . 1.0 109.308 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -148.25 139.89 23.7 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.183 -0.948 . . . . 1.0 109.822 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 174' ' ' CYS . 73.7 m-80 -109.72 107.5 17.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.33 -0.856 . . . . 1.0 109.192 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.743 HG22 ' C ' ' A' ' 174' ' ' CYS . 74.8 p -148.19 43.85 1.05 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 119.292 -0.963 . . . . 1.0 110.354 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.522 ' O ' ' CD ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -157.13 124.39 5.23 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.381 -0.824 . . . . 1.0 110.204 179.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.995 HG12 ' NE2' ' A' ' 76' ' ' HIS . 13.9 m -137.48 165.55 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.248 -0.907 . . . . 1.0 108.803 179.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.469 ' HA ' ' O ' ' A' ' 170' ' ' ASN . 0.0 OUTLIER -155.46 139.14 16.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.054 -1.029 . . . . 1.0 110.14 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.785 ' CD2' HD12 ' A' ' 65' ' ' ILE . 0.1 OUTLIER -99.75 101.01 12.04 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.385 -0.822 . . . . 1.0 108.875 179.405 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 63' ' ' LEU . 21.5 t -77.16 140.88 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.933 . . . . 1.0 109.692 -179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.966 ' CE1' HD22 ' A' ' 63' ' ' LEU . 0.6 OUTLIER -136.66 111.16 8.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.277 -0.89 . . . . 1.0 109.484 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.508 ' HD3' ' NE2' ' A' ' 166' ' ' GLN . 12.6 ptt180 -144.22 133.16 22.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.884 -1.135 . . . . 1.0 109.922 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.512 ' CG1' HD11 ' A' ' 163' ' ' LEU . 12.3 p -109.53 127.89 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.53 -0.915 . . . . 1.0 108.53 179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.498 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 51.0 m-70 -123.17 114.1 19.84 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.199 -0.938 . . . . 1.0 110.132 -178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 1.017 HG23 HD22 ' A' ' 59' ' ' LEU . 11.4 p -99.4 141.12 22.27 Favored Pre-proline 0 C--N 1.304 -1.401 0 O-C-N 121.242 -0.911 . . . . 1.0 108.938 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.519 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 33.9 Cg_endo -75.93 117.0 4.56 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.294 1.996 . . . . 1.0 110.561 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.536 ' NE2' ' HD2' ' A' ' 158' ' ' PRO . 4.1 mm100 -154.83 168.92 11.07 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.312 -0.867 . . . . 1.0 109.116 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.536 ' HD2' ' NE2' ' A' ' 157' ' ' GLN . 34.4 Cg_endo -77.2 -65.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.326 2.017 . . . . 1.0 110.25 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.4 104.54 0.79 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.193 -0.942 . . . . 1.0 109.191 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -46.45 -28.1 3.22 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.465 -1.454 . . . . 1.0 109.465 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.4 mtt-85 -79.22 79.64 5.63 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.37 -1.076 . . . . 1.0 108.259 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.811 HG22 ' N ' ' A' ' 163' ' ' LEU . 1.3 m -140.04 -90.04 0.18 Allowed 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.441 -0.787 . . . . 1.0 109.15 -178.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.811 ' N ' HG22 ' A' ' 162' ' ' THR . 8.9 tp -140.34 97.9 3.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.958 -1.089 . . . . 1.0 108.986 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.498 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -163.3 94.81 0.82 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.084 -1.01 . . . . 1.0 109.408 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.778 ' N ' HD23 ' A' ' 165' ' ' LEU . 1.8 pt? -138.37 175.32 9.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -0.946 . . . . 1.0 109.984 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.508 ' NE2' ' HD3' ' A' ' 152' ' ' ARG . 0.7 OUTLIER -119.22 161.84 19.7 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.434 -0.791 . . . . 1.0 109.843 -179.994 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.7 HG12 ' O ' ' A' ' 167' ' ' VAL . 41.5 t -151.74 74.49 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.448 -0.782 . . . . 1.0 109.036 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.457 ' HB1' ' HD2' ' A' ' 148' ' ' ARG . . . -89.48 102.86 15.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.093 -1.004 . . . . 1.0 109.104 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.9 t -143.41 88.68 2.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.232 -0.917 . . . . 1.0 110.057 -179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.529 ' N ' ' HD3' ' A' ' 171' ' ' PRO . 1.1 m-20 -179.69 60.6 0.11 Allowed Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.255 -0.903 . . . . 1.0 109.341 179.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 170' ' ' ASN . 36.4 Cg_endo -78.67 96.91 1.1 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 C-N-CA 122.383 2.056 . . . . 1.0 111.011 -179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.881 HG23 ' HA ' ' A' ' 24' ' ' HIS . 1.6 mt -101.53 147.05 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.166 -0.959 . . . . 1.0 108.679 179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -114.56 119.6 37.35 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.088 -1.007 . . . . 1.0 110.132 -179.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.743 ' C ' HG22 ' A' ' 145' ' ' THR . 2.8 m -95.06 -167.71 1.68 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 107.9 -1.148 . . . . 1.0 107.9 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.584 ' N ' HG22 ' A' ' 145' ' ' THR . 3.3 p 165.18 -94.78 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.215 -0.928 . . . . 1.0 109.837 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.506 ' CG ' ' O ' ' A' ' 175' ' ' SER . 31.5 mt-30 -157.74 -150.63 0.27 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.961 -1.087 . . . . 1.0 109.491 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.415 ' CG ' ' O ' ' A' ' 176' ' ' GLN . 0.8 OUTLIER -177.3 83.31 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.327 -0.858 . . . . 1.0 109.512 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 1.9 t . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.995 -1.002 . . . . 1.0 109.409 -179.955 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.248 0.547 . . . . 1.0 109.555 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.474 ' HB2' HD12 ' A' ' 6' ' ' LEU . 0.4 OUTLIER -79.75 -179.72 7.07 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.18 -0.95 . . . . 1.0 109.426 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -133.35 -91.7 0.36 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.263 -0.898 . . . . 1.0 109.349 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.611 ' CD1' ' N ' ' A' ' 5' ' ' GLN . 40.1 p90 -87.06 -45.68 10.51 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.248 -0.908 . . . . 1.0 109.569 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.611 ' N ' ' CD1' ' A' ' 4' ' ' TRP . 0.6 OUTLIER -178.95 77.35 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.234 -0.916 . . . . 1.0 109.515 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.789 ' C ' HD22 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -64.48 160.63 49.95 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.27 -0.894 . . . . 1.0 109.96 -179.591 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.489 ' HD2' ' HB2' ' A' ' 6' ' ' LEU . 35.7 Cg_endo -78.92 124.55 6.2 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.303 2.002 . . . . 1.0 110.366 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.0 p -129.33 45.81 2.74 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.254 -0.904 . . . . 1.0 109.501 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.507 ' O ' ' CB ' ' A' ' 10' ' ' SER . 2.9 p-80 -99.92 157.88 16.21 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.219 -0.926 . . . . 1.0 109.328 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 9' ' ' HIS . 4.3 t 75.36 83.94 0.1 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.913 . . . . 1.0 109.354 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.31 -87.2 0.06 OUTLIER Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.76 -1.336 . . . . 1.0 109.76 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.29 172.04 16.01 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.501 2.134 . . . . 1.0 110.613 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.576 ' CZ ' ' O ' ' A' ' 162' ' ' THR . 5.8 m-85 -67.82 152.11 46.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.306 -0.872 . . . . 1.0 109.277 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.28 129.72 13.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.918 -1.114 . . . . 1.0 109.855 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.919 HD13 HD12 ' A' ' 50' ' ' LEU . 58.4 tp -121.04 75.02 1.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.583 -0.895 . . . . 1.0 108.583 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.42 155.27 33.82 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.44 -0.787 . . . . 1.0 109.982 -179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.542 HG21 ' NE2' ' A' ' 20' ' ' GLN . 0.6 OUTLIER -66.81 145.8 13.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 N-CA-C 108.532 -0.914 . . . . 1.0 108.532 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.637 ' HG3' HG23 ' A' ' 19' ' ' VAL . 3.8 tp10 -72.51 -53.52 11.82 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.281 -0.887 . . . . 1.0 109.749 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.637 HG23 ' HG3' ' A' ' 18' ' ' GLU . 21.7 t -127.99 142.04 44.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.262 -0.899 . . . . 1.0 109.618 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.542 ' NE2' HG21 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -120.58 82.49 33.36 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.269 -0.894 . . . . 1.0 109.354 -179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.417 ' O ' ' C ' ' A' ' 22' ' ' LYS . 35.0 Cg_endo -77.72 -177.53 3.92 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.436 2.09 . . . . 1.0 110.376 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 21' ' ' PRO . 12.7 mttt -43.86 112.69 0.42 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.37 -0.831 . . . . 1.0 109.227 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.546 ' HB3' ' CG ' ' A' ' 171' ' ' PRO . 2.1 t -110.24 29.64 7.48 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.198 -0.939 . . . . 1.0 109.89 -179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -103.21 165.9 10.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.158 -0.964 . . . . 1.0 109.476 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.581 ' CE1' ' HA ' ' A' ' 38' ' ' VAL . 76.6 t60 -157.21 118.07 3.6 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.516 -0.74 . . . . 1.0 109.894 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.441 ' O ' ' HD2' ' A' ' 26' ' ' ARG . 0.1 OUTLIER -90.98 89.17 7.32 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.408 -0.807 . . . . 1.0 108.881 179.468 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.412 ' O ' ' C ' ' A' ' 28' ' ' HIS . . . -54.49 118.5 4.21 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.172 -0.955 . . . . 1.0 109.395 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.412 ' C ' ' O ' ' A' ' 27' ' ' ALA . 17.1 m170 -42.21 156.06 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.421 -0.799 . . . . 1.0 109.946 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.427 ' O ' ' C ' ' A' ' 30' ' ' GLU . 76.8 m-85 -132.65 -92.77 0.37 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.373 -0.83 . . . . 1.0 109.219 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 29' ' ' TYR . 1.1 mt-10 42.89 -154.22 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.271 -0.893 . . . . 1.0 109.757 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 30.6 p -144.09 35.47 1.23 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.36 -0.837 . . . . 1.0 109.316 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.12 72.9 1.52 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.341 -0.85 . . . . 1.0 109.473 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 69.07 120.97 0.03 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.55 -1.42 . . . . 1.0 109.55 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 75.4 m -69.85 -87.28 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -1.166 . . . . 1.0 109.463 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.29 -168.61 0.16 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.181 -0.949 . . . . 1.0 109.465 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 90.43 147.09 17.42 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.496 -1.441 . . . . 1.0 109.496 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -139.49 171.4 14.31 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -1.195 . . . . 1.0 109.665 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.581 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 1.7 p -73.33 121.49 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.418 -0.801 . . . . 1.0 109.372 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 9.6 mttp -153.23 110.58 3.51 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.307 -0.871 . . . . 1.0 109.506 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.509 ' O ' ' N ' ' A' ' 44' ' ' GLY . . . -165.17 150.31 9.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.373 -0.829 . . . . 1.0 109.563 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 40' ' ' ALA . 80.6 p 43.78 -118.08 0.55 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.242 -0.911 . . . . 1.0 109.39 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.6 57.47 4.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.304 -1.498 . . . . 1.0 109.524 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.46 ' HA3' ' HB2' ' A' ' 119' ' ' ASP . . . 88.25 -19.14 36.96 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.568 -1.413 . . . . 1.0 109.568 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 40' ' ' ALA . . . 116.41 -71.03 0.27 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.582 -1.407 . . . . 1.0 109.582 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 118' ' ' ILE . 21.9 m80 -60.11 154.25 51.88 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.249 -1.148 . . . . 1.0 109.578 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.419 ' HB2' HG21 ' A' ' 17' ' ' ILE . 35.5 Cg_endo -78.09 178.7 7.27 Favored 'Trans proline' 0 C--N 1.314 -1.286 0 C-N-CA 122.492 2.128 . . . . 1.0 110.472 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.774 HG23 HG12 ' A' ' 117' ' ' VAL . 2.3 mm -94.53 160.87 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 1.0 109.266 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 6.8 t -135.81 127.3 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.234 -0.916 . . . . 1.0 109.732 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.527 ' HG3' ' CE1' ' A' ' 51' ' ' HIS . 14.2 pt20 -151.17 142.14 23.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.339 -0.851 . . . . 1.0 109.348 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.919 HD12 HD13 ' A' ' 15' ' ' LEU . 1.3 tt -98.62 138.99 35.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.929 . . . . 1.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.527 ' CE1' ' HG3' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -140.78 76.23 1.54 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.169 -0.957 . . . . 1.0 109.331 -179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 171.05 96.03 0.1 Allowed Glycine 0 N--CA 1.486 2.01 0 N-CA-C 110.038 -1.225 . . . . 1.0 110.038 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.634 ' CE2' ' CB ' ' A' ' 55' ' ' GLU . 6.2 t80 178.02 129.01 0.06 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -1.14 . . . . 1.0 109.425 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.92 13.74 32.86 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 1.0 109.394 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.634 ' CB ' ' CE2' ' A' ' 53' ' ' TYR . 0.7 OUTLIER -116.8 144.49 44.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 1.0 109.432 179.935 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.499 ' C ' HD11 ' A' ' 109' ' ' LEU . 5.9 p30 -101.83 50.85 0.84 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.297 -0.877 . . . . 1.0 109.472 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.916 ' C ' HD12 ' A' ' 109' ' ' LEU . 1.9 mp0 -108.89 146.0 32.88 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.317 -0.864 . . . . 1.0 109.458 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 1.011 ' O ' HD23 ' A' ' 59' ' ' LEU . 35.5 Cg_endo -77.96 145.99 22.8 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 C-N-CA 122.441 2.094 . . . . 1.0 110.363 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.011 HD23 ' O ' ' A' ' 58' ' ' PRO . 7.4 mt -139.27 162.76 34.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.262 -0.898 . . . . 1.0 109.51 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.6 OUTLIER -98.34 110.42 23.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.315 -0.866 . . . . 1.0 109.534 -179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.872 HD21 ' HB2' ' A' ' 63' ' ' LEU . 0.5 OUTLIER -60.77 143.45 54.48 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.257 -0.902 . . . . 1.0 109.312 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.495 ' N ' ' HG ' ' A' ' 61' ' ' LEU . 6.3 mm-40 -105.21 80.38 1.59 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.189 -0.945 . . . . 1.0 109.718 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.935 HD13 ' CZ ' ' A' ' 151' ' ' PHE . 18.2 tp -99.94 121.43 41.32 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.303 -0.873 . . . . 1.0 109.129 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.632 ' HB2' HG12 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -143.43 146.84 33.79 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.618 -0.882 . . . . 1.0 108.618 -179.434 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.691 ' C ' HD13 ' A' ' 65' ' ' ILE . 0.0 OUTLIER -109.23 115.63 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.265 -0.897 . . . . 1.0 108.779 179.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.645 ' N ' HD13 ' A' ' 65' ' ' ILE . . . -132.8 144.26 16.11 Favored Glycine 0 N--CA 1.489 2.207 0 C-N-CA 119.548 -1.311 . . . . 1.0 110.204 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.978 HG22 ' CD2' ' A' ' 76' ' ' HIS . 14.8 p -71.2 161.44 31.09 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.525 -0.985 . . . . 1.0 108.959 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 1.043 ' HB3' ' HG3' ' A' ' 148' ' ' ARG . . . -172.52 124.72 0.48 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.129 -0.982 . . . . 1.0 109.77 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.6 -13.42 24.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -0.881 . . . . 1.0 109.16 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -156.08 -67.34 0.11 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.352 -0.843 . . . . 1.0 109.357 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.553 ' CD ' ' N ' ' A' ' 72' ' ' LEU . 0.0 OUTLIER -144.82 -39.18 0.26 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.294 -0.879 . . . . 1.0 109.67 -179.827 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.553 ' N ' ' CD ' ' A' ' 71' ' ' ARG . 0.2 OUTLIER -51.84 88.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.41 -0.806 . . . . 1.0 109.848 -179.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.51 ' N ' ' O ' ' A' ' 71' ' ' ARG . 2.3 pp -66.63 143.9 56.72 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.26 -0.9 . . . . 1.0 109.59 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.525 ' O ' ' CA ' ' A' ' 66' ' ' GLY . 0.0 OUTLIER -152.87 165.44 17.59 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.158 -0.964 . . . . 1.0 109.452 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.51 146.03 24.03 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.414 2.076 . . . . 1.0 110.211 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.978 ' CD2' HG22 ' A' ' 67' ' ' THR . 0.7 OUTLIER -76.87 160.54 29.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 1.0 109.656 -179.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.81 -67.09 0.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -0.866 . . . . 1.0 109.786 -179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.541 ' HB3' HD23 ' A' ' 126' ' ' LEU . 4.9 m-85 -130.83 23.56 4.99 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.163 -0.96 . . . . 1.0 109.934 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.578 ' HB2' ' CG ' ' A' ' 76' ' ' HIS . 4.8 m-85 -101.46 74.26 1.52 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.054 -1.029 . . . . 1.0 109.418 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.5 ' CB ' ' HB3' ' A' ' 102' ' ' LYS . 11.0 pt20 -139.49 7.46 2.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.163 -0.96 . . . . 1.0 109.669 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.957 HG23 ' O ' ' A' ' 122' ' ' GLY . 1.3 m -60.91 140.58 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.092 -1.005 . . . . 1.0 109.067 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.604 ' HB2' ' HB2' ' A' ' 121' ' ' ALA . 1.0 OUTLIER -176.3 114.05 0.11 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.092 -1.043 . . . . 1.0 109.791 -179.612 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.462 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.2 OUTLIER -136.74 126.32 25.29 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.215 -0.928 . . . . 1.0 109.557 -179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.674 HD12 ' N ' ' A' ' 84' ' ' ILE . 4.4 mp -99.68 137.43 27.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.256 -0.903 . . . . 1.0 109.628 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 86' ' ' GLY . 39.9 p -145.05 -149.27 0.27 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.403 -0.811 . . . . 1.0 109.137 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 85' ' ' THR . . . 42.1 -165.46 0.02 OUTLIER Glycine 0 N--CA 1.483 1.787 0 N-CA-C 110.083 -1.207 . . . . 1.0 110.083 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -94.61 68.54 3.42 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.239 -1.154 . . . . 1.0 109.541 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -112.8 -164.99 0.95 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.244 -0.91 . . . . 1.0 109.299 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.508 HG21 ' H ' ' A' ' 117' ' ' VAL . 1.7 t -66.08 123.54 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.207 -0.933 . . . . 1.0 109.035 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.5 m -165.53 31.64 0.05 Allowed 'General case' 0 C--N 1.3 -1.576 0 C-N-CA 119.499 -0.881 . . . . 1.0 109.668 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.409 HG23 ' N ' ' A' ' 92' ' ' THR . 9.8 t -64.96 -36.48 84.51 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.206 -0.934 . . . . 1.0 109.558 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.756 ' O ' HG23 ' A' ' 106' ' ' ILE . 58.4 m -163.17 135.91 5.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.199 -0.938 . . . . 1.0 109.587 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -168.39 169.13 10.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.288 -0.882 . . . . 1.0 109.56 179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 43.9 t60 -155.22 145.63 22.01 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.349 -0.844 . . . . 1.0 109.51 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.515 ' OE1' ' NE2' ' A' ' 82' ' ' HIS . 8.0 tt0 -114.58 146.11 41.17 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.305 -0.872 . . . . 1.0 109.428 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -142.82 122.36 13.24 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.209 -0.932 . . . . 1.0 109.367 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.973 HD13 ' N ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER -135.55 134.95 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.239 -0.913 . . . . 1.0 109.475 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.973 ' N ' HD13 ' A' ' 97' ' ' ILE . 0.7 OUTLIER -138.49 64.82 1.48 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.064 -1.023 . . . . 1.0 109.675 -179.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.462 ' O ' ' OD1' ' A' ' 100' ' ' ASN . 1.7 p 62.29 117.44 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.269 -0.894 . . . . 1.0 109.586 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 99' ' ' SER . 3.7 p-10 44.46 37.03 1.87 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.622 -0.674 . . . . 1.0 110.715 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.482 ' HB ' ' HG ' ' A' ' 98' ' ' LEU . 0.2 OUTLIER -159.32 85.16 0.79 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.972 -1.08 . . . . 1.0 109.401 179.248 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.5 ' HB3' ' CB ' ' A' ' 80' ' ' GLN . 6.0 tptm -105.91 95.02 5.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.272 -0.892 . . . . 1.0 109.727 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.632 HG12 ' HB2' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -96.49 171.4 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.326 -0.859 . . . . 1.0 108.963 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.885 HD22 ' N ' ' A' ' 105' ' ' GLU . 0.5 OUTLIER -139.91 122.81 16.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.183 -0.948 . . . . 1.0 109.351 -179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.885 ' N ' HD22 ' A' ' 104' ' ' LEU . 7.1 mm-40 -123.1 140.14 53.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.303 -0.873 . . . . 1.0 109.292 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.756 HG23 ' O ' ' A' ' 92' ' ' THR . 28.1 mt -129.03 107.31 18.02 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.209 -0.932 . . . . 1.0 109.528 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.442 ' HA ' ' HA ' ' A' ' 60' ' ' MET . 34.6 Cg_endo -76.64 107.81 2.53 Favored 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.218 1.945 . . . . 1.0 110.35 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.66 HD23 ' O ' ' A' ' 106' ' ' ILE . 0.6 OUTLIER -146.0 165.18 29.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.876 . . . . 1.0 109.752 -179.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.916 HD12 ' C ' ' A' ' 57' ' ' GLU . 3.5 tt -117.07 85.84 19.06 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.408 -0.807 . . . . 1.0 109.451 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.471 ' HB2' ' HB3' ' A' ' 50' ' ' LEU . 37.1 Cg_endo -81.84 30.53 0.52 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.711 2.274 . . . . 1.0 111.199 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.523 ' OE1' ' CB ' ' A' ' 53' ' ' TYR . 9.7 mm-40 -102.96 49.95 0.82 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 120.842 -1.161 . . . . 1.0 109.512 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 113' ' ' SER . 0.6 OUTLIER -161.78 -61.63 0.05 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.216 -0.928 . . . . 1.0 109.478 -179.905 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 6.1 p 167.8 89.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.324 -0.86 . . . . 1.0 109.19 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -155.14 125.23 6.66 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.235 -0.915 . . . . 1.0 109.616 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.658 ' HD3' HG21 ' A' ' 47' ' ' ILE . 6.1 ttm180 -94.61 129.78 41.32 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.343 -0.848 . . . . 1.0 109.191 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -109.36 99.71 8.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.318 -0.864 . . . . 1.0 109.518 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.774 HG12 HG23 ' A' ' 47' ' ' ILE . 4.4 m -86.85 143.28 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 1.0 109.425 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.452 ' O ' ' HB2' ' A' ' 45' ' ' HIS . 2.7 mt -133.29 123.86 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.275 -0.891 . . . . 1.0 109.552 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.46 ' HB2' ' HA3' ' A' ' 43' ' ' GLY . 8.3 p-10 -175.28 46.61 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.238 -0.914 . . . . 1.0 109.566 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 84' ' ' ILE . 9.9 m -132.95 43.45 2.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 1.0 109.565 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.604 ' HB2' ' HB2' ' A' ' 82' ' ' HIS . . . -134.42 128.29 33.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.253 -0.905 . . . . 1.0 109.13 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.957 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -93.51 -172.08 39.6 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.395 -1.482 . . . . 1.0 109.395 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.716 ' O ' HD12 ' A' ' 124' ' ' LEU . 0.6 OUTLIER -125.48 166.92 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.363 -1.081 . . . . 1.0 108.818 179.699 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.738 HD13 HG11 ' A' ' 81' ' ' VAL . 0.8 OUTLIER -140.94 164.45 30.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.251 -0.905 . . . . 1.0 109.622 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.461 ' C ' HD13 ' A' ' 126' ' ' LEU . 41.6 mttt -147.49 97.04 2.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.383 -0.823 . . . . 1.0 109.096 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.857 HD22 ' N ' ' A' ' 126' ' ' LEU . 0.5 OUTLIER -104.99 -165.67 1.15 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.218 -0.926 . . . . 1.0 109.753 -179.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.513 ' HG3' ' N ' ' A' ' 128' ' ' ASN . 6.9 ptt180 -166.14 -147.69 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.407 -0.808 . . . . 1.0 109.172 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.513 ' N ' ' HG3' ' A' ' 127' ' ' ARG . 0.5 OUTLIER 64.3 57.1 1.24 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.127 -0.983 . . . . 1.0 109.578 179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 128' ' ' ASN . 66.4 p 178.95 -167.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.214 -0.929 . . . . 1.0 109.426 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -172.19 60.43 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.261 -0.899 . . . . 1.0 109.426 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.449 ' O ' ' CG1' ' A' ' 131' ' ' ILE . 0.3 OUTLIER -93.88 69.99 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.313 -0.867 . . . . 1.0 109.504 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.427 ' OE1' ' O ' ' A' ' 131' ' ' ILE . 0.0 OUTLIER -154.67 161.58 41.51 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.219 -0.925 . . . . 1.0 109.479 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.429 ' O ' ' HG2' ' A' ' 135' ' ' LYS . 0.4 OUTLIER -64.94 110.42 2.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.188 -0.945 . . . . 1.0 109.481 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.93 119.3 8.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.28 -0.887 . . . . 1.0 109.48 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 133' ' ' LEU . 0.9 OUTLIER 173.99 174.77 0.16 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 1.0 109.437 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -65.58 125.34 28.49 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.601 -1.4 . . . . 1.0 109.601 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -111.53 16.53 20.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.252 -1.146 . . . . 1.0 109.445 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 20.3 p -100.17 139.63 35.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 1.0 109.445 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -153.81 -39.33 0.1 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.923 . . . . 1.0 109.402 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.867 ' H ' HD13 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -142.83 30.06 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.315 -0.865 . . . . 1.0 109.424 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 166.83 -132.07 2.52 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.563 -1.415 . . . . 1.0 109.563 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.9 ttm-85 -150.93 -41.71 0.12 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -1.161 . . . . 1.0 109.468 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 6.3 tttp -104.0 134.9 46.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 1.0 109.43 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -113.9 141.81 46.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -0.954 . . . . 1.0 109.492 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.532 ' CB ' ' HB2' ' A' ' 174' ' ' CYS . 0.2 OUTLIER -157.59 53.02 0.47 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.245 -0.909 . . . . 1.0 109.394 -179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.46 ' HD2' ' O ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -105.04 157.38 17.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.283 -0.886 . . . . 1.0 109.254 179.869 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.69 HG12 ' CD2' ' A' ' 76' ' ' HIS . 1.6 m -140.49 168.25 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.382 -0.823 . . . . 1.0 109.406 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 1.043 ' HG3' ' HB3' ' A' ' 68' ' ' ALA . 5.2 mmt180 -148.82 99.32 2.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 1.0 109.563 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.636 HD12 ' CD2' ' A' ' 151' ' ' PHE . 0.7 OUTLIER -79.77 115.93 19.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.104 -0.997 . . . . 1.0 108.889 179.635 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.415 ' HA ' ' HA ' ' A' ' 168' ' ' ALA . 4.3 t -87.09 114.43 26.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.204 -0.935 . . . . 1.0 109.87 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.935 ' CZ ' HD13 ' A' ' 63' ' ' LEU . 1.6 m-85 -108.39 113.33 26.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 1.0 109.228 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.473 ' CB ' ' HA ' ' A' ' 166' ' ' GLN . 5.4 ptt180 -150.6 159.41 44.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.899 -1.126 . . . . 1.0 109.95 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.485 HG13 ' O ' ' A' ' 153' ' ' VAL . 10.4 p -143.41 128.51 15.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 121.281 -0.887 . . . . 1.0 108.659 179.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.504 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 20.9 m-70 -132.46 113.63 13.35 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.073 -1.017 . . . . 1.0 110.372 -179.077 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.551 HG11 ' HB3' ' A' ' 163' ' ' LEU . 12.6 p -99.04 141.85 23.6 Favored Pre-proline 0 C--N 1.303 -1.452 0 N-CA-C 108.556 -0.905 . . . . 1.0 108.556 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.544 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 32.0 Cg_endo -73.64 115.88 4.49 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.093 1.862 . . . . 1.0 110.881 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.468 ' HB2' ' HD2' ' A' ' 158' ' ' PRO . 1.6 pm0 -133.14 160.94 66.66 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.468 ' HD2' ' HB2' ' A' ' 157' ' ' GLN . 34.9 Cg_endo -77.56 -66.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.305 2.003 . . . . 1.0 110.675 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 8.5 t -59.38 -93.51 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -0.922 . . . . 1.0 109.621 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 171.38 -33.91 0.15 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.412 -1.475 . . . . 1.0 109.412 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 6.5 mtm180 -79.08 80.3 5.44 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.92 -1.141 . . . . 1.0 107.92 179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.802 HG22 ' N ' ' A' ' 163' ' ' LEU . 1.3 m -138.9 -90.17 0.2 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.509 -0.744 . . . . 1.0 109.486 -178.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.802 ' N ' HG22 ' A' ' 162' ' ' THR . 7.4 tp -146.96 109.19 4.48 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.58 -1.325 . . . . 1.0 109.615 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.504 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.0 OUTLIER -162.94 91.49 0.73 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.035 -1.041 . . . . 1.0 109.38 178.793 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.749 HD13 ' H ' ' A' ' 166' ' ' GLN . 0.2 OUTLIER -120.64 155.46 33.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.345 -0.847 . . . . 1.0 109.495 -179.545 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.749 ' H ' HD13 ' A' ' 165' ' ' LEU . 3.5 tt0 -134.16 142.34 47.41 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.163 -0.96 . . . . 1.0 109.568 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.517 HG12 ' N ' ' A' ' 168' ' ' ALA . 46.3 t -146.07 161.28 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.269 -0.894 . . . . 1.0 109.398 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.517 ' N ' HG12 ' A' ' 167' ' ' VAL . . . -151.29 92.71 1.82 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.389 -0.82 . . . . 1.0 108.847 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.53 ' HB2' HD11 ' A' ' 149' ' ' LEU . 20.4 m -82.93 160.43 22.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.173 -0.954 . . . . 1.0 109.632 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.53 ' N ' ' HD3' ' A' ' 171' ' ' PRO . 0.7 OUTLIER -174.51 63.04 0.25 Allowed Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.162 -0.961 . . . . 1.0 110.059 179.992 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.546 ' CG ' ' HB3' ' A' ' 23' ' ' SER . 37.5 Cg_endo -83.23 52.04 3.81 Favored 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.477 2.118 . . . . 1.0 110.296 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . . . . . . . . . 13.0 mt -151.06 128.02 2.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.456 -0.778 . . . . 1.0 109.534 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -155.86 102.29 2.17 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 1.0 109.362 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.532 ' HB2' ' CB ' ' A' ' 145' ' ' THR . 61.0 m -89.94 174.47 7.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 1.0 109.579 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 174' ' ' CYS . 5.9 p 178.89 -149.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 1.0 109.356 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -50.53 -22.58 2.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.279 -0.888 . . . . 1.0 109.506 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 23.7 ttt-85 -50.68 -76.06 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -0.872 . . . . 1.0 109.475 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.021 -0.99 . . . . 1.0 109.412 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.454 ' O ' ' O ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.226 0.536 . . . . 1.0 109.594 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.454 ' O ' ' O ' ' A' ' 1' ' ' MET . 0.1 OUTLIER 46.14 -170.16 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.175 -0.953 . . . . 1.0 109.241 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 2' ' ' LYS . 90.1 m-20 -135.45 -95.36 0.26 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.112 -0.992 . . . . 1.0 109.603 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.576 ' CE3' ' HB3' ' A' ' 5' ' ' GLN . 44.4 p-90 -115.27 -49.31 2.77 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.009 -1.057 . . . . 1.0 109.704 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.576 ' HB3' ' CE3' ' A' ' 4' ' ' TRP . 4.8 tt0 -179.22 75.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.122 -0.986 . . . . 1.0 109.634 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.773 ' C ' HD22 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -164.37 160.28 16.09 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 1.0 109.692 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 6' ' ' LEU . 36.0 Cg_endo -79.49 102.66 1.51 Allowed 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.438 2.092 . . . . 1.0 110.323 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.764 ' HB3' HD21 ' A' ' 6' ' ' LEU . 38.4 p -125.74 43.5 3.05 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.187 -0.946 . . . . 1.0 109.517 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 34.7 p80 -127.99 164.6 21.99 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.191 -0.943 . . . . 1.0 109.434 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.4 m -179.43 118.95 0.07 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.318 -0.864 . . . . 1.0 109.522 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.9 -144.87 1.07 Allowed Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.425 -1.47 . . . . 1.0 109.425 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.52 -175.3 2.61 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.395 2.063 . . . . 1.0 110.293 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.518 ' HA ' ' HA3' ' A' ' 52' ' ' GLY . 3.6 m-85 -105.5 137.95 42.5 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.152 -0.967 . . . . 1.0 109.63 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.453 ' CG ' ' O ' ' A' ' 13' ' ' TYR . 1.6 mt-10 179.72 139.16 0.12 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 1.0 109.764 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.489 ' O ' ' CG ' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -99.87 98.82 9.57 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.291 -0.881 . . . . 1.0 109.055 179.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 53.9 ttt180 -99.96 155.14 17.85 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.191 -0.943 . . . . 1.0 109.768 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.942 HG21 ' NE2' ' A' ' 20' ' ' GLN . 12.7 mm -72.95 134.44 29.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.398 -0.813 . . . . 1.0 109.266 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.421 ' HB2' ' CD ' ' A' ' 49' ' ' GLN . 44.2 tt0 -68.89 -55.1 12.13 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.137 -0.977 . . . . 1.0 108.967 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.88 HG22 ' HD3' ' A' ' 21' ' ' PRO . 9.8 p -118.58 130.22 73.74 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.376 -0.827 . . . . 1.0 108.871 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.942 ' NE2' HG21 ' A' ' 17' ' ' ILE . 9.2 tp-100 -129.94 63.97 70.51 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.08 -1.012 . . . . 1.0 110.023 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.88 ' HD3' HG22 ' A' ' 19' ' ' VAL . 35.8 Cg_endo -78.44 -175.34 2.67 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.406 2.07 . . . . 1.0 109.88 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -48.45 94.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.232 -0.917 . . . . 1.0 108.78 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 21' ' ' PRO . 1.4 p -94.02 40.24 1.08 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.25 -0.906 . . . . 1.0 110.252 -179.276 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.475 ' HA ' HG12 ' A' ' 172' ' ' ILE . 0.0 OUTLIER -99.49 167.25 10.73 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.969 -1.082 . . . . 1.0 108.284 179.205 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.635 ' CD2' ' CD1' ' A' ' 123' ' ' ILE . 16.0 t60 -133.7 134.03 42.57 Favored 'General case' 0 C--N 1.29 -2.01 0 C-N-CA 119.341 -0.944 . . . . 1.0 110.068 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.481 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . 0.0 OUTLIER -106.1 75.73 1.12 Allowed 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.362 -0.977 . . . . 1.0 108.362 179.356 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.57 ' O ' ' CE2' ' A' ' 29' ' ' TYR . . . -54.2 165.05 0.56 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.47 -0.769 . . . . 1.0 109.79 -179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.0 m170 -60.99 149.73 35.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.385 -0.822 . . . . 1.0 110.289 -179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.57 ' CE2' ' O ' ' A' ' 27' ' ' ALA . 0.1 OUTLIER -166.51 69.32 0.11 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.783 -0.821 . . . . 1.0 108.783 179.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.524 ' CB ' ' O ' ' A' ' 29' ' ' TYR . 0.4 OUTLIER 78.37 28.1 0.49 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.553 -0.717 . . . . 1.0 109.397 -179.621 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.74 HG23 ' O ' ' A' ' 31' ' ' THR . 15.4 t -145.49 59.77 1.27 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.213 -0.929 . . . . 1.0 109.272 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.9 156.13 17.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 1.0 109.738 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -170.58 -35.73 0.03 OUTLIER Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.516 -1.434 . . . . 1.0 109.516 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -145.09 149.28 34.78 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -1.123 . . . . 1.0 109.446 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 1.1 mmm-85 -75.07 121.85 22.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.271 -0.893 . . . . 1.0 109.475 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -139.54 -134.97 3.2 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.571 -1.412 . . . . 1.0 109.571 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -179.04 171.85 1.33 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.237 -1.155 . . . . 1.0 109.434 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.514 ' HA ' ' CE1' ' A' ' 25' ' ' HIS . 1.8 p -57.03 135.4 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.257 -0.902 . . . . 1.0 109.34 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.06 115.26 4.1 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.417 -0.802 . . . . 1.0 109.698 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.517 ' O ' ' N ' ' A' ' 42' ' ' ALA . . . -156.5 114.84 3.33 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.509 -0.745 . . . . 1.0 109.548 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 50.91 -88.21 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.473 -0.767 . . . . 1.0 110.085 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.668 ' HB3' ' O ' ' A' ' 45' ' ' HIS . . . -85.03 46.25 1.26 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.099 -1.0 . . . . 1.0 109.832 -179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 65.39 9.32 42.62 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.887 -1.285 . . . . 1.0 109.887 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.401 ' N ' ' H ' ' A' ' 40' ' ' ALA . . . 135.71 -80.06 0.31 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.643 -1.383 . . . . 1.0 109.643 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.668 ' O ' ' HB3' ' A' ' 42' ' ' ALA . 5.5 m-70 -88.36 157.53 50.15 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.317 -1.108 . . . . 1.0 109.672 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.458 ' HG3' ' OE1' ' A' ' 20' ' ' GLN . 35.8 Cg_endo -78.41 178.74 7.21 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 122.601 2.201 . . . . 1.0 110.528 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.951 ' CG2' HG12 ' A' ' 117' ' ' VAL . 5.0 mt -94.45 157.05 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.481 -0.762 . . . . 1.0 109.199 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.637 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 2.1 t -131.66 128.1 60.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.207 -0.933 . . . . 1.0 109.829 -179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.421 ' CD ' ' HB2' ' A' ' 18' ' ' GLU . 7.1 pt20 -140.95 138.17 33.61 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 1.0 109.353 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.479 ' HG ' ' HB3' ' A' ' 15' ' ' LEU . 2.7 tt -98.2 136.68 38.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.174 -0.954 . . . . 1.0 109.75 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.442 ' N ' HD23 ' A' ' 50' ' ' LEU . 5.7 p80 -140.52 97.98 3.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.333 -0.854 . . . . 1.0 109.16 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . -178.89 -86.5 0.07 OUTLIER Glycine 0 N--CA 1.489 2.167 0 C-N-CA 119.631 -1.271 . . . . 1.0 110.133 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.514 ' OH ' ' NE2' ' A' ' 157' ' ' GLN . 0.8 OUTLIER -38.37 121.86 1.03 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 122.1 -0.647 . . . . 1.0 110.345 -179.414 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -101.85 1.72 37.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.361 -0.837 . . . . 1.0 109.538 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.473 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -79.82 145.66 32.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.148 -0.97 . . . . 1.0 109.423 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.431 ' ND2' ' C ' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -84.61 44.68 1.07 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 1.0 109.824 -179.683 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.687 ' O ' HD23 ' A' ' 109' ' ' LEU . 5.1 mm-40 -99.23 150.59 36.86 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.284 -0.885 . . . . 1.0 109.304 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.992 ' O ' HD23 ' A' ' 59' ' ' LEU . 36.0 Cg_endo -77.68 139.48 17.95 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.306 2.004 . . . . 1.0 110.385 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.992 HD23 ' O ' ' A' ' 58' ' ' PRO . 5.8 mt -128.26 159.04 36.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.23 -0.919 . . . . 1.0 109.452 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.419 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.3 OUTLIER -121.31 107.84 13.0 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.133 -0.979 . . . . 1.0 109.519 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.645 HD21 ' HD1' ' A' ' 151' ' ' PHE . 0.3 OUTLIER -61.92 116.59 5.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.903 . . . . 1.0 109.543 -179.907 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.437 ' O ' ' HG2' ' A' ' 152' ' ' ARG . 73.4 mm-40 -94.99 78.18 3.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.12 -0.988 . . . . 1.0 109.067 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.835 HD22 ' CE1' ' A' ' 151' ' ' PHE . 0.6 OUTLIER -112.85 157.84 20.9 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.377 -0.827 . . . . 1.0 109.714 -179.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.888 ' O ' HD23 ' A' ' 149' ' ' LEU . 0.2 OUTLIER -165.74 176.95 7.58 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.628 -0.879 . . . . 1.0 108.628 179.354 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.639 ' CD1' ' CE1' ' A' ' 76' ' ' HIS . 0.2 OUTLIER -114.75 118.6 59.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.109 -0.994 . . . . 1.0 108.862 179.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -132.44 150.28 19.64 Favored Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.611 -1.28 . . . . 1.0 110.06 -179.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.933 HG22 ' CD2' ' A' ' 76' ' ' HIS . 0.6 OUTLIER -89.2 151.23 22.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.456 -1.026 . . . . 1.0 109.269 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.92 113.08 6.16 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.17 -0.956 . . . . 1.0 109.538 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' A' ' 144' ' ' ASN . 0.2 OUTLIER -85.2 -27.89 25.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.351 -0.843 . . . . 1.0 109.245 179.821 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -136.43 -52.48 0.71 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.302 -0.874 . . . . 1.0 109.311 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.423 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.5 OUTLIER -175.17 -34.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.261 -0.9 . . . . 1.0 109.627 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 1.3 mt -55.9 91.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 1.0 109.74 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.9 OUTLIER -47.39 166.64 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.224 -0.922 . . . . 1.0 109.474 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.48 ' HB2' ' HD2' ' A' ' 75' ' ' PRO . 5.1 ptm180 -175.15 162.03 2.3 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.259 -0.901 . . . . 1.0 109.086 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.681 ' HB3' HG23 ' A' ' 101' ' ' THR . 34.3 Cg_endo -76.97 137.64 17.68 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.229 1.953 . . . . 1.0 110.334 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.95 ' NE2' HG12 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -64.16 156.5 28.33 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.246 -0.909 . . . . 1.0 109.625 -179.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -78.11 -78.72 0.13 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.323 -0.86 . . . . 1.0 109.663 -179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -107.99 19.54 19.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 1.0 109.503 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.581 ' HB2' ' CD2' ' A' ' 76' ' ' HIS . 88.8 m-85 -111.57 112.25 23.84 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.903 . . . . 1.0 109.463 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.5 ' NE2' ' HD3' ' A' ' 102' ' ' LYS . 8.1 pt20 -167.32 30.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.348 -0.845 . . . . 1.0 108.843 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.85 HG11 ' HA ' ' A' ' 123' ' ' ILE . 31.3 m -52.94 158.6 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 121.62 0.724 . . . . 1.0 110.139 -179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.839 ' CE1' HD11 ' A' ' 104' ' ' LEU . 14.3 t60 -176.06 66.73 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.464 -0.773 . . . . 1.0 108.961 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.0 OUTLIER -113.38 157.99 21.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.304 -0.873 . . . . 1.0 109.855 -179.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.408 HG22 ' N ' ' A' ' 85' ' ' THR . 2.0 mp -130.34 156.75 42.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.413 -0.804 . . . . 1.0 108.991 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.457 ' O ' ' OG1' ' A' ' 88' ' ' THR . 40.9 p -99.93 167.84 10.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.083 -1.011 . . . . 1.0 109.755 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -50.13 -75.98 0.18 Allowed Glycine 0 N--CA 1.478 1.437 0 N-CA-C 109.808 -1.317 . . . . 1.0 109.808 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.55 100.71 8.72 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.319 -1.107 . . . . 1.0 109.961 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 85' ' ' THR . 0.0 OUTLIER -165.32 -165.03 0.81 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.241 -0.912 . . . . 1.0 109.435 179.637 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.763 ' O ' HG13 ' A' ' 89' ' ' VAL . 13.2 p -64.94 104.77 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.231 -0.918 . . . . 1.0 109.575 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.4 m -90.39 32.07 0.98 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.231 -0.918 . . . . 1.0 109.395 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.434 ' H ' HG22 ' A' ' 89' ' ' VAL . 22.4 m -66.06 137.32 56.99 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.207 -0.933 . . . . 1.0 109.437 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 16.6 m -52.55 106.11 0.14 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 1.0 109.542 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.447 ' HA ' HG23 ' A' ' 106' ' ' ILE . 0.0 OUTLIER -117.65 170.1 9.04 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -0.87 . . . . 1.0 109.603 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -155.26 161.03 41.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.342 -0.849 . . . . 1.0 109.392 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.57 ' HG3' ' CD2' ' A' ' 82' ' ' HIS . 0.5 OUTLIER -141.24 148.65 40.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.257 -0.902 . . . . 1.0 109.334 179.972 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.42 ' O ' HG23 ' A' ' 103' ' ' VAL . . . -152.51 127.96 9.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 1.0 109.731 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.457 ' HB ' ' HD2' ' A' ' 102' ' ' LYS . 2.7 tp -106.29 142.55 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.401 -0.812 . . . . 1.0 109.346 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.522 ' O ' ' CB ' ' A' ' 99' ' ' SER . 0.6 OUTLIER -132.99 53.0 2.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.912 . . . . 1.0 109.787 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.522 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 1.6 m 77.08 104.17 0.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.327 -0.858 . . . . 1.0 110.021 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 99' ' ' SER . 9.0 p30 44.32 43.14 5.81 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.532 -0.73 . . . . 1.0 110.334 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.681 HG23 ' HB3' ' A' ' 75' ' ' PRO . 0.2 OUTLIER -159.3 77.64 0.72 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.987 -1.071 . . . . 1.0 109.774 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.5 ' HD3' ' NE2' ' A' ' 80' ' ' GLN . 4.2 tptm -81.96 129.75 34.87 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.323 -0.861 . . . . 1.0 109.003 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.709 HG12 ' HB3' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -128.1 169.58 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.157 -0.965 . . . . 1.0 109.861 -179.54 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.839 HD11 ' CE1' ' A' ' 82' ' ' HIS . 0.2 OUTLIER -131.21 130.59 43.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.462 -0.774 . . . . 1.0 109.236 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -128.21 132.33 48.81 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.238 -0.913 . . . . 1.0 109.683 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.678 HG22 ' CD2' ' A' ' 108' ' ' LEU . 5.3 mt -129.67 102.69 17.9 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 1.0 109.279 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.498 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 34.1 Cg_endo -75.43 98.4 1.17 Allowed 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.196 1.93 . . . . 1.0 110.539 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.678 ' CD2' HG22 ' A' ' 106' ' ' ILE . 0.4 OUTLIER -145.23 165.33 28.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.376 -0.827 . . . . 1.0 109.41 -179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.687 HD23 ' O ' ' A' ' 57' ' ' GLU . 0.7 OUTLIER -114.41 80.65 6.13 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 1.0 109.697 179.97 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 108' ' ' LEU . 36.3 Cg_endo -78.7 75.74 4.84 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.501 2.134 . . . . 1.0 110.268 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.46 ' HB3' ' O ' ' A' ' 53' ' ' TYR . 3.4 mt-10 -138.6 -49.3 0.53 Allowed 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.267 -0.896 . . . . 1.0 109.603 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -79.89 -49.82 11.37 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.331 -0.855 . . . . 1.0 109.495 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 16.6 t -175.53 98.69 0.07 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.347 -0.846 . . . . 1.0 109.319 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.454 ' HB3' ' HA ' ' A' ' 110' ' ' PRO . 5.0 tpp -165.8 108.46 0.78 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.249 -0.907 . . . . 1.0 109.343 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 3.5 ttp180 -99.98 139.23 35.95 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.346 -0.846 . . . . 1.0 109.092 179.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -118.36 92.46 3.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -0.971 . . . . 1.0 109.547 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.951 HG12 ' CG2' ' A' ' 47' ' ' ILE . 3.5 m -91.78 128.34 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.225 -0.922 . . . . 1.0 109.322 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 99.1 mt -118.57 111.81 35.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.178 -0.951 . . . . 1.0 109.656 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -163.12 28.57 0.09 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 1.0 109.449 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.458 ' O ' ' O ' ' A' ' 83' ' ' ARG . 4.2 p -116.38 42.89 2.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 1.0 109.347 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -136.75 164.43 28.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 1.0 109.478 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.736 ' O ' HG21 ' A' ' 81' ' ' VAL . . . -125.39 -173.77 13.76 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 108.904 -1.678 . . . . 1.0 108.904 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.85 ' HA ' HG11 ' A' ' 81' ' ' VAL . 0.9 OUTLIER -116.27 170.75 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.978 -1.307 . . . . 1.0 109.231 179.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.414 HD23 ' H ' ' A' ' 125' ' ' LYS . 0.6 OUTLIER -115.39 146.26 41.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.242 -0.911 . . . . 1.0 109.517 -179.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.48 ' C ' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -114.76 124.31 51.45 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.293 -0.879 . . . . 1.0 109.405 179.912 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.867 ' N ' HD13 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -120.74 64.36 0.85 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.214 -0.929 . . . . 1.0 109.794 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.401 ' C ' ' O ' ' A' ' 126' ' ' LEU . 1.5 mtt85 44.46 -93.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.852 . . . . 1.0 109.633 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.514 ' N ' ' O ' ' A' ' 126' ' ' LEU . 0.3 OUTLIER -153.68 60.22 0.74 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.096 -1.003 . . . . 1.0 109.502 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 29.9 t -109.01 160.85 15.69 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.894 . . . . 1.0 109.537 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -179.92 64.96 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.234 -0.916 . . . . 1.0 109.48 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.655 ' O ' HG23 ' A' ' 131' ' ' ILE . 6.8 tt -68.0 117.65 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.905 . . . . 1.0 109.402 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -131.5 145.86 51.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.266 -0.896 . . . . 1.0 109.515 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.94 125.68 51.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.319 -0.863 . . . . 1.0 109.508 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.49 ' O ' ' N ' ' A' ' 136' ' ' GLY . 0.0 OUTLIER -135.11 169.58 17.23 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.21 -0.931 . . . . 1.0 109.439 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.22 91.57 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.91 . . . . 1.0 109.42 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 134' ' ' ARG . . . 126.92 164.72 11.78 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.591 -1.403 . . . . 1.0 109.591 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -142.75 66.4 1.33 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.203 -1.175 . . . . 1.0 109.474 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 139' ' ' ASP . 72.9 p -127.52 21.6 6.55 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.213 -0.929 . . . . 1.0 109.472 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 138' ' ' THR . 6.5 m-20 61.7 132.2 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 1.0 109.443 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 140' ' ' ILE . 0.3 OUTLIER -110.7 -38.7 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.305 -0.872 . . . . 1.0 109.426 -179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 144.34 -148.05 19.61 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.494 -1.443 . . . . 1.0 109.494 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.2 32.06 1.23 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.197 -1.178 . . . . 1.0 109.509 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 144' ' ' ASN . 36.7 mmtm -89.82 -174.71 4.38 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.894 . . . . 1.0 109.372 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.461 ' O ' ' O ' ' A' ' 143' ' ' LYS . 0.2 OUTLIER 58.12 133.19 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 121.514 0.673 . . . . 1.0 110.343 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.503 ' CB ' ' HB2' ' A' ' 174' ' ' CYS . 0.0 OUTLIER -160.23 53.86 0.33 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 1.0 109.43 -179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.525 ' CG ' ' O ' ' A' ' 172' ' ' ILE . 0.0 OUTLIER -93.91 154.83 17.49 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.121 -0.987 . . . . 1.0 109.685 -179.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.95 HG12 ' NE2' ' A' ' 76' ' ' HIS . 14.1 m -140.26 145.12 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.91 -0.774 . . . . 1.0 108.91 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.502 ' HA ' ' HB3' ' A' ' 170' ' ' ASN . 2.5 ptt180 -149.73 135.43 18.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.016 -1.052 . . . . 1.0 110.106 -179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.888 HD23 ' O ' ' A' ' 64' ' ' PHE . 1.6 mt -87.49 121.33 29.79 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.462 -0.774 . . . . 1.0 109.51 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.494 HG21 ' HE1' ' A' ' 64' ' ' PHE . 21.6 t -92.18 132.9 35.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 O-C-N 121.194 -0.941 . . . . 1.0 109.29 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.835 ' CE1' HD22 ' A' ' 63' ' ' LEU . 5.8 m-85 -125.69 114.48 18.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.14 -0.975 . . . . 1.0 109.414 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.488 ' HB3' ' HA ' ' A' ' 166' ' ' GLN . 19.5 ptt180 -150.59 127.41 11.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.189 -0.944 . . . . 1.0 109.6 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.407 HG11 HD11 ' A' ' 50' ' ' LEU . 3.1 p -106.9 129.34 60.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.039 -1.038 . . . . 1.0 109.37 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . . . . . . . . . 99.2 m-70 -111.57 107.78 17.06 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.272 -0.892 . . . . 1.0 108.736 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.911 ' CG2' HD23 ' A' ' 163' ' ' LEU . 40.1 t -99.09 136.1 20.63 Favored Pre-proline 0 C--N 1.3 -1.56 0 O-C-N 121.245 -0.909 . . . . 1.0 109.034 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.431 ' O ' ' CD ' ' A' ' 157' ' ' GLN . 35.7 Cg_endo -77.72 141.65 19.65 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 122.534 2.156 . . . . 1.0 111.323 -178.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.636 ' OE1' HG12 ' A' ' 155' ' ' VAL . 0.9 OUTLIER -160.35 179.12 1.42 Allowed Pre-proline 0 N--CA 1.492 1.648 0 N-CA-C 108.877 -0.786 . . . . 1.0 108.877 179.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.565 ' HD2' ' CG ' ' A' ' 157' ' ' GLN . 33.8 Cg_endo -78.27 -53.32 0.06 OUTLIER 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.393 2.062 . . . . 1.0 110.094 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 158' ' ' PRO . 17.3 m -59.22 -148.37 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.662 -0.649 . . . . 1.0 109.583 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -125.05 -80.74 0.43 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 110.105 -1.198 . . . . 1.0 110.105 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 40.7 mtt-85 -78.14 80.96 4.55 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.482 -1.01 . . . . 1.0 108.809 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.563 ' CG2' ' N ' ' A' ' 163' ' ' LEU . 0.7 OUTLIER -102.76 -52.69 3.02 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.583 -0.698 . . . . 1.0 109.338 -179.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.911 HD23 ' CG2' ' A' ' 155' ' ' VAL . 9.9 tp -155.49 96.17 1.76 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.399 -0.963 . . . . 1.0 108.399 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -162.86 101.71 1.01 Allowed 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.069 -1.02 . . . . 1.0 109.165 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.857 HD23 ' H ' ' A' ' 165' ' ' LEU . 2.2 pt? -137.1 170.04 16.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 1.0 109.777 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.488 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 2.8 mt-30 -113.61 155.03 26.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.361 -0.837 . . . . 1.0 109.781 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.597 HG12 ' O ' ' A' ' 167' ' ' VAL . 45.6 t -149.74 80.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.288 -0.883 . . . . 1.0 109.63 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.71 105.59 17.9 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.215 -0.928 . . . . 1.0 109.162 179.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 170' ' ' ASN . 79.7 p -120.18 117.86 29.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.197 -0.939 . . . . 1.0 109.772 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.503 ' CB ' ' O ' ' A' ' 169' ' ' SER . 0.7 OUTLIER 163.03 73.72 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.366 -0.834 . . . . 1.0 109.418 179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.68 85.8 1.74 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.419 2.079 . . . . 1.0 110.399 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.525 ' O ' ' CG ' ' A' ' 146' ' ' ARG . 4.3 mt -123.07 164.95 19.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -0.929 . . . . 1.0 108.996 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 172' ' ' ILE . 0.4 OUTLIER -155.73 139.35 16.01 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.168 -0.958 . . . . 1.0 109.692 -179.79 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.503 ' HB2' ' CB ' ' A' ' 145' ' ' THR . 9.9 m -119.59 -168.55 1.61 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.334 -0.854 . . . . 1.0 109.228 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 176' ' ' GLN . 4.3 p -164.76 30.7 0.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.164 -0.96 . . . . 1.0 109.542 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.51 ' O ' ' CB ' ' A' ' 177' ' ' ARG . 0.6 OUTLIER 44.14 27.97 0.24 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 1.0 109.481 179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.51 ' CB ' ' O ' ' A' ' 176' ' ' GLN . 0.3 OUTLIER 76.18 98.8 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.332 -0.855 . . . . 1.0 109.503 -179.885 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 118.072 -0.966 . . . . 1.0 109.538 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.424 -0.584 . . . . 1.0 109.424 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.0 -45.55 34.04 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.263 -0.898 . . . . 1.0 109.624 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -178.05 117.75 0.09 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 1.0 109.545 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.531 ' CE3' ' HB2' ' A' ' 5' ' ' GLN . 33.0 p-90 -86.19 -32.44 21.22 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.332 -0.855 . . . . 1.0 109.476 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.531 ' HB2' ' CE3' ' A' ' 4' ' ' TRP . 0.1 OUTLIER -178.03 82.12 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 1.0 109.479 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 6' ' ' LEU . 4.8 tp -163.19 97.03 1.05 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 1.0 109.426 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.45 144.7 23.02 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.416 2.077 . . . . 1.0 110.474 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 35.4 p -154.01 58.64 0.72 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.293 -0.879 . . . . 1.0 109.387 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 36.5 t60 -99.99 130.68 46.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.247 -0.908 . . . . 1.0 109.469 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 4.6 p -177.82 54.7 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.256 -0.903 . . . . 1.0 109.625 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -117.23 -161.93 12.38 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.514 -1.434 . . . . 1.0 109.514 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.443 ' HD2' ' CE2' ' A' ' 13' ' ' TYR . 35.8 Cg_endo -77.93 -9.21 16.83 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.433 2.089 . . . . 1.0 110.49 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.556 ' HB3' HD13 ' A' ' 163' ' ' LEU . 7.5 m-85 -73.12 131.58 42.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 1.0 109.446 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -145.7 124.57 12.69 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.997 -1.064 . . . . 1.0 109.806 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.724 ' HB3' HD11 ' A' ' 165' ' ' LEU . 20.1 tp -120.07 82.74 1.94 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.363 -0.835 . . . . 1.0 109.038 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.62 159.43 26.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.31 -0.869 . . . . 1.0 109.863 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.852 HG23 ' O ' ' A' ' 47' ' ' ILE . 1.3 mp -75.98 142.18 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 O-C-N 121.338 -0.851 . . . . 1.0 108.774 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.27 -42.75 92.9 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.339 -0.851 . . . . 1.0 109.618 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.44 ' C ' ' HD3' ' A' ' 21' ' ' PRO . 20.2 t -141.49 133.07 27.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.294 -0.879 . . . . 1.0 109.463 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -119.05 77.16 15.76 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.153 -0.967 . . . . 1.0 109.561 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 23' ' ' SER . 35.9 Cg_endo -78.36 -176.91 3.51 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 122.513 2.142 . . . . 1.0 110.221 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 21' ' ' PRO . 2.4 mptt -44.35 99.36 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.317 -0.864 . . . . 1.0 109.008 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 21' ' ' PRO . 2.1 t -96.63 40.92 1.12 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 1.0 109.956 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -99.9 166.96 10.81 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.089 -1.007 . . . . 1.0 109.318 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.58 ' CE1' ' HA ' ' A' ' 38' ' ' VAL . 3.2 t60 -143.23 133.7 24.85 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 119.723 -0.791 . . . . 1.0 109.64 179.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.455 ' O ' ' HD3' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -105.68 74.31 1.06 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.345 -0.847 . . . . 1.0 109.047 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -55.81 161.45 2.19 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 1.0 109.54 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.516 ' NE2' ' O ' ' A' ' 34' ' ' SER . 1.7 m-70 -61.88 156.77 19.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 1.0 109.703 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.421 ' O ' ' C ' ' A' ' 30' ' ' GLU . 69.7 m-85 -120.94 -145.04 0.36 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.304 -0.873 . . . . 1.0 109.195 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.421 ' C ' ' O ' ' A' ' 29' ' ' TYR . 9.3 mt-10 -43.88 -84.7 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.086 -1.009 . . . . 1.0 109.442 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.87 48.06 1.62 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 1.0 109.364 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -139.01 84.43 2.01 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.269 -0.894 . . . . 1.0 109.531 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -161.3 152.89 23.56 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.615 -1.394 . . . . 1.0 109.615 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.516 ' O ' ' NE2' ' A' ' 28' ' ' HIS . 0.8 OUTLIER -84.2 -147.93 0.1 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.25 -1.147 . . . . 1.0 109.415 179.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.475 ' O ' ' HD3' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -132.26 56.53 1.83 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.226 -0.921 . . . . 1.0 109.39 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.85 129.48 6.17 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.553 -1.419 . . . . 1.0 109.553 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.95 173.02 1.16 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -1.16 . . . . 1.0 109.619 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.883 HG12 ' HA2' ' A' ' 122' ' ' GLY . 2.4 p -54.5 119.63 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.367 -0.833 . . . . 1.0 109.535 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt -142.65 99.3 3.45 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.27 -0.894 . . . . 1.0 109.852 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.423 ' N ' ' HA2' ' A' ' 44' ' ' GLY . . . -93.85 -147.21 0.25 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.322 -0.861 . . . . 1.0 109.142 179.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.94 171.55 10.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.046 -1.034 . . . . 1.0 109.471 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . 54.64 64.33 1.85 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 1.0 109.393 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 84.12 -68.68 3.48 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.345 -1.502 . . . . 1.0 109.345 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.543 ' CA ' ' HB2' ' A' ' 119' ' ' ASP . . . 173.11 36.16 0.03 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.578 -1.409 . . . . 1.0 109.578 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.599 ' CG ' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER 165.42 177.67 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.195 -1.18 . . . . 1.0 109.294 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.599 ' HD2' ' CG ' ' A' ' 45' ' ' HIS . 35.0 Cg_endo -77.34 172.05 16.64 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.426 2.084 . . . . 1.0 110.506 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.912 HG23 HG12 ' A' ' 117' ' ' VAL . 4.2 mm -105.33 161.71 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 1.0 109.659 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.425 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 5.3 t -139.9 125.5 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.393 -0.817 . . . . 1.0 109.245 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -146.64 157.18 43.66 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.216 -0.927 . . . . 1.0 109.547 -179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.662 HD13 ' HG3' ' A' ' 110' ' ' PRO . 5.4 tt -114.63 134.67 54.88 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 1.0 109.419 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.638 ' N ' HD23 ' A' ' 50' ' ' LEU . 0.5 OUTLIER -140.59 79.04 1.68 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.194 -0.941 . . . . 1.0 109.308 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.486 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 177.45 64.31 0.06 OUTLIER Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.806 -1.318 . . . . 1.0 109.806 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.568 ' CD2' HD11 ' A' ' 59' ' ' LEU . 0.4 OUTLIER 177.0 118.61 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.158 -1.201 . . . . 1.0 109.594 179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.437 ' HA ' ' OE1' ' A' ' 111' ' ' GLU . 0.7 OUTLIER -106.98 25.46 11.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.241 -0.912 . . . . 1.0 109.299 179.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.549 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 38.8 tp10 -89.98 145.15 25.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.236 -0.915 . . . . 1.0 109.482 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 8.7 p30 -89.0 35.92 0.8 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.221 -0.924 . . . . 1.0 109.532 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.655 ' HG3' HD21 ' A' ' 59' ' ' LEU . 26.2 pt-20 -112.76 147.67 37.66 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.926 . . . . 1.0 109.422 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.749 ' O ' HD23 ' A' ' 59' ' ' LEU . 35.3 Cg_endo -78.11 141.06 18.29 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.374 2.049 . . . . 1.0 110.527 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.836 HD22 ' CG2' ' A' ' 155' ' ' VAL . 7.5 mt -120.09 163.77 17.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.264 -0.898 . . . . 1.0 109.19 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -116.22 100.18 7.74 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.208 -0.933 . . . . 1.0 109.981 -179.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.906 HD21 ' HB2' ' A' ' 63' ' ' LEU . 1.6 tt -65.72 127.94 33.96 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.293 -0.879 . . . . 1.0 108.923 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.457 ' HB2' ' O ' ' A' ' 152' ' ' ARG . 90.4 mt-30 -91.34 92.22 8.5 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.217 -0.927 . . . . 1.0 109.208 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.906 ' HB2' HD21 ' A' ' 61' ' ' LEU . 15.0 tp -99.6 139.84 34.67 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.316 -0.865 . . . . 1.0 109.022 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.711 ' H ' HD12 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -163.86 168.36 19.61 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.159 -0.963 . . . . 1.0 108.79 -179.314 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.805 HD11 ' HB ' ' A' ' 147' ' ' VAL . 0.0 OUTLIER -132.47 116.8 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.398 -0.814 . . . . 1.0 108.869 179.735 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.663 ' N ' HD13 ' A' ' 65' ' ' ILE . . . -130.98 152.6 20.0 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.843 -1.303 . . . . 1.0 109.843 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.591 HG23 ' CD2' ' A' ' 76' ' ' HIS . 40.7 p -74.03 157.39 36.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.389 -1.065 . . . . 1.0 109.433 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.696 ' HB3' ' HD2' ' A' ' 148' ' ' ARG . . . -169.06 113.58 0.56 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.262 -0.899 . . . . 1.0 109.632 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.39 9.54 37.91 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.273 -0.892 . . . . 1.0 109.346 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -168.67 -54.39 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.31 -0.868 . . . . 1.0 109.192 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.44 ' O ' ' N ' ' A' ' 73' ' ' LEU . 3.0 tpt180 -175.23 -33.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.87 . . . . 1.0 109.698 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.59 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.9 OUTLIER -54.12 92.05 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.295 -0.878 . . . . 1.0 109.774 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.44 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.5 OUTLIER -56.62 164.88 1.3 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.236 -0.915 . . . . 1.0 109.733 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.54 ' CD ' ' HD2' ' A' ' 75' ' ' PRO . 0.0 OUTLIER -175.15 170.86 1.34 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 1.0 109.22 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.54 ' HD2' ' CD ' ' A' ' 74' ' ' ARG . 35.2 Cg_endo -77.23 136.67 16.3 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.338 2.026 . . . . 1.0 110.414 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.687 ' ND1' HD12 ' A' ' 65' ' ' ILE . 0.2 OUTLIER -59.2 147.3 35.96 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.278 -0.889 . . . . 1.0 109.719 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' A' ' 76' ' ' HIS . . . -46.02 -77.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.416 -0.957 . . . . 1.0 108.416 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' A' ' 125' ' ' LYS . 79.3 m-85 -140.66 23.71 2.27 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.95 -0.759 . . . . 1.0 108.95 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.654 ' HD2' HG22 ' A' ' 123' ' ' ILE . 63.0 m-85 -78.32 106.97 10.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.353 -0.842 . . . . 1.0 109.31 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 80' ' ' GLN . 11.2 tt0 -119.48 85.27 2.34 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.665 -0.865 . . . . 1.0 108.665 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.038 HG12 ' O ' ' A' ' 122' ' ' GLY . 3.8 m -69.75 138.15 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.322 -0.861 . . . . 1.0 110.037 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 60.7 t-80 -175.96 85.45 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.467 -0.771 . . . . 1.0 109.096 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.21 81.04 1.36 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.05 -1.031 . . . . 1.0 110.309 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.869 HG21 HG22 ' A' ' 88' ' ' THR . 2.7 mp -109.34 147.85 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.252 -0.905 . . . . 1.0 108.724 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 86' ' ' GLY . 67.6 p -99.8 170.18 8.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.145 -0.972 . . . . 1.0 109.819 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 85' ' ' THR . . . -41.29 -46.21 4.3 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 109.857 -1.297 . . . . 1.0 109.857 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 12.0 mtpt -74.62 84.92 2.08 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.301 -1.117 . . . . 1.0 109.133 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.869 HG22 HG21 ' A' ' 84' ' ' ILE . 0.2 OUTLIER -74.61 -172.17 1.45 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.342 -0.849 . . . . 1.0 109.538 -179.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.653 HG22 ' H ' ' A' ' 90' ' ' SER . 5.9 p -74.44 176.36 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.296 -0.877 . . . . 1.0 109.107 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.653 ' H ' HG22 ' A' ' 89' ' ' VAL . 16.9 t -74.41 -42.03 59.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.065 -1.022 . . . . 1.0 109.389 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.599 ' OG1' HD22 ' A' ' 108' ' ' LEU . 6.4 t -72.86 -168.96 0.52 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.921 . . . . 1.0 109.385 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 106' ' ' ILE . 4.4 m -103.48 158.32 16.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.169 -0.957 . . . . 1.0 109.461 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -138.39 157.35 46.38 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 1.0 109.786 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -155.86 119.03 4.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.404 -0.81 . . . . 1.0 109.449 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -81.96 141.9 32.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.127 -0.983 . . . . 1.0 109.473 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.67 120.67 24.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.92 . . . . 1.0 109.574 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 1.012 HD12 ' O ' ' A' ' 101' ' ' THR . 5.1 tp -117.2 144.98 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.36 -0.838 . . . . 1.0 109.323 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.51 HD21 HG21 ' A' ' 101' ' ' THR . 0.5 OUTLIER -135.89 49.42 2.14 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.115 -0.991 . . . . 1.0 109.676 179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 0.1 OUTLIER 74.34 114.85 0.06 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.199 -0.938 . . . . 1.0 109.666 179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.484 ' HB3' ' HB3' ' A' ' 129' ' ' SER . 3.7 p-10 43.91 35.52 1.14 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.584 -0.698 . . . . 1.0 110.623 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 1.012 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -149.85 105.19 3.38 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.841 -1.162 . . . . 1.0 109.952 179.543 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 9.8 tptt -90.33 106.23 18.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 1.0 109.13 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -109.8 172.03 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.289 -0.882 . . . . 1.0 109.229 -179.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 1.9 mp -128.22 137.67 52.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.816 . . . . 1.0 109.518 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -133.58 112.81 11.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.212 -0.93 . . . . 1.0 109.264 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.944 HG22 HD21 ' A' ' 108' ' ' LEU . 51.9 mt -123.2 107.87 32.4 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 1.0 109.741 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 1.068 ' O ' HD23 ' A' ' 108' ' ' LEU . 34.7 Cg_endo -76.98 125.32 7.92 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 C-N-CA 122.097 1.865 . . . . 1.0 110.231 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.068 HD23 ' O ' ' A' ' 107' ' ' PRO . 3.4 mt -134.12 151.63 51.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.916 . . . . 1.0 110.006 -179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.558 HD12 ' SD ' ' A' ' 114' ' ' MET . 0.2 OUTLIER -123.38 91.29 49.9 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.416 -0.802 . . . . 1.0 108.93 179.505 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.662 ' HG3' HD13 ' A' ' 50' ' ' LEU . 35.9 Cg_endo -78.07 70.49 7.07 Favored 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 122.515 2.143 . . . . 1.0 110.631 -179.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.494 ' O ' ' CG ' ' A' ' 111' ' ' GLU . 19.8 tp10 -118.56 0.71 11.61 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.284 -0.885 . . . . 1.0 109.639 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.498 ' O ' ' CB ' ' A' ' 113' ' ' SER . 0.0 OUTLIER -143.55 -65.11 0.38 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.105 -0.997 . . . . 1.0 109.496 -179.846 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.4 OUTLIER 164.61 109.95 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.147 -0.971 . . . . 1.0 109.157 -179.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.558 ' SD ' HD12 ' A' ' 109' ' ' LEU . 9.4 ptm -154.09 117.43 4.57 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.2 -0.938 . . . . 1.0 109.915 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.518 ' HD3' HG12 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -88.29 136.45 32.97 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.435 -0.79 . . . . 1.0 109.415 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -117.03 108.99 16.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.298 -0.876 . . . . 1.0 109.365 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.912 HG12 HG23 ' A' ' 47' ' ' ILE . 4.3 m -95.25 159.39 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.205 -0.934 . . . . 1.0 109.667 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.486 ' O ' ' CB ' ' A' ' 45' ' ' HIS . 8.3 mt -146.95 102.6 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 1.0 109.228 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.543 ' HB2' ' CA ' ' A' ' 44' ' ' GLY . 0.6 OUTLIER -147.56 47.39 1.11 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.222 -0.924 . . . . 1.0 109.71 -179.765 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 63.8 m -145.04 54.2 1.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.881 . . . . 1.0 109.355 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.793 ' HB1' ' HB ' ' A' ' 81' ' ' VAL . . . -145.26 87.24 1.8 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.917 . . . . 1.0 109.845 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 1.038 ' O ' HG12 ' A' ' 81' ' ' VAL . . . -56.44 -166.36 0.06 OUTLIER Glycine 0 N--CA 1.492 2.432 0 N-CA-C 108.389 -1.884 . . . . 1.0 108.389 179.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.654 HG22 ' HD2' ' A' ' 79' ' ' TYR . 0.0 OUTLIER -114.29 151.77 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.707 -1.466 . . . . 1.0 109.178 179.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.454 ' O ' ' O ' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -143.44 82.57 1.74 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.438 -0.789 . . . . 1.0 109.702 -179.642 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.931 ' C ' HD22 ' A' ' 126' ' ' LEU . 4.3 ptmt -108.74 65.68 0.63 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.822 -1.174 . . . . 1.0 110.207 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.931 HD22 ' C ' ' A' ' 125' ' ' LYS . 2.4 mm? -146.31 75.59 1.41 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.466 -0.771 . . . . 1.0 109.104 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.432 ' HD2' ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -141.91 -155.9 0.63 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.886 . . . . 1.0 109.454 179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.507 ' O ' ' N ' ' A' ' 130' ' ' ASP . 1.2 p30 -153.19 -50.82 0.1 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 1.0 109.424 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.484 ' HB3' ' HB3' ' A' ' 100' ' ' ASN . 7.9 m 44.31 -94.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 1.0 109.493 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.507 ' N ' ' O ' ' A' ' 128' ' ' ASN . 6.1 p-10 177.17 59.51 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.125 -0.985 . . . . 1.0 109.582 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.695 HD13 ' N ' ' A' ' 132' ' ' GLU . 0.0 OUTLIER -74.37 117.64 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.224 -0.923 . . . . 1.0 109.443 -179.95 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.695 ' N ' HD13 ' A' ' 131' ' ' ILE . 47.7 tt0 -64.81 140.53 58.88 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 1.0 109.549 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -125.64 153.66 43.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -0.923 . . . . 1.0 109.419 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 8.3 ptm180 -174.37 -38.17 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.166 -0.959 . . . . 1.0 109.624 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.02 139.01 43.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.184 -0.947 . . . . 1.0 109.559 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -144.14 152.81 24.59 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.433 -1.467 . . . . 1.0 109.433 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -137.91 145.96 42.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -1.147 . . . . 1.0 109.509 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.96 57.73 1.03 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.34 -0.85 . . . . 1.0 109.459 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -72.93 -32.52 65.33 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.343 -0.848 . . . . 1.0 109.452 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.849 ' H ' HD13 ' A' ' 140' ' ' ILE . 0.2 OUTLIER -147.73 34.87 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.221 -0.924 . . . . 1.0 109.459 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 108.19 -172.14 16.74 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.435 -1.466 . . . . 1.0 109.435 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.29 156.62 37.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.278 -1.13 . . . . 1.0 109.521 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.1 26.3 9.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 1.0 109.425 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.667 ' O ' HG23 ' A' ' 145' ' ' THR . 1.7 t-20 -91.58 70.81 5.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 1.0 109.513 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.806 HG22 ' C ' ' A' ' 174' ' ' CYS . 1.1 p -160.47 47.5 0.24 Allowed 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.449 -0.782 . . . . 1.0 109.68 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.12 128.02 7.41 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.388 -0.82 . . . . 1.0 109.187 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.805 ' HB ' HD11 ' A' ' 65' ' ' ILE . 6.8 m -136.2 161.28 37.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.157 -0.964 . . . . 1.0 109.517 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.696 ' HD2' ' HB3' ' A' ' 68' ' ' ALA . 10.7 mtt-85 -145.24 126.41 14.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.189 -0.945 . . . . 1.0 109.667 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.801 HD22 HG12 ' A' ' 65' ' ' ILE . 2.0 mm? -79.86 114.52 18.84 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.335 -0.853 . . . . 1.0 108.997 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 45.6 t -85.93 122.74 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.235 -0.916 . . . . 1.0 109.497 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.863 ' CE1' HD13 ' A' ' 63' ' ' LEU . 8.0 m-85 -119.76 95.75 4.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.33 -0.856 . . . . 1.0 109.125 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.475 ' O ' ' HG3' ' A' ' 152' ' ' ARG . 19.5 ptt180 -135.63 129.93 33.59 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.141 -0.974 . . . . 1.0 109.566 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.571 ' HB ' HD22 ' A' ' 15' ' ' LEU . 11.9 p -108.19 128.6 63.52 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.306 -0.871 . . . . 1.0 108.763 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.567 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 41.0 m-70 -124.34 108.54 12.31 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.197 -0.94 . . . . 1.0 109.76 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.836 ' CG2' HD22 ' A' ' 59' ' ' LEU . 7.7 p -99.22 141.24 22.51 Favored Pre-proline 0 N--CA 1.487 1.378 0 O-C-N 121.314 -0.866 . . . . 1.0 109.172 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.529 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 34.5 Cg_endo -77.19 115.34 3.95 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.174 1.916 . . . . 1.0 109.994 179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.491 ' OE1' ' HD2' ' A' ' 158' ' ' PRO . 72.2 mm-40 -143.23 163.58 36.52 Favored Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.424 -0.797 . . . . 1.0 109.52 -179.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.491 ' HD2' ' OE1' ' A' ' 157' ' ' GLN . 35.0 Cg_endo -77.92 -55.25 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 122.402 2.068 . . . . 1.0 109.777 179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 158' ' ' PRO . 0.2 OUTLIER -45.71 171.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.628 -0.67 . . . . 1.0 109.466 179.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . -93.86 -66.37 1.04 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.173 -1.171 . . . . 1.0 110.173 -179.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.6 mtm-85 -78.98 79.21 5.39 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.399 -1.334 . . . . 1.0 107.399 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.556 HG23 ' H ' ' A' ' 163' ' ' LEU . 2.7 t -102.03 -108.34 0.24 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.673 -0.642 . . . . 1.0 110.518 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.556 HD13 ' HB3' ' A' ' 13' ' ' TYR . 8.6 tp -129.1 96.46 4.33 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.295 -1.503 . . . . 1.0 108.299 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.567 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -162.85 100.34 1.0 Allowed 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.874 -1.141 . . . . 1.0 109.699 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.864 ' N ' HD23 ' A' ' 165' ' ' LEU . 1.0 OUTLIER -134.61 170.04 16.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.178 -0.952 . . . . 1.0 109.64 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.461 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 3.1 mm-40 -121.73 147.31 46.08 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 1.0 109.557 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.74 HG12 ' O ' ' A' ' 167' ' ' VAL . 41.8 t -145.47 70.48 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.871 . . . . 1.0 109.407 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -89.77 107.72 19.27 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.222 -0.924 . . . . 1.0 109.192 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 0.3 OUTLIER -156.33 123.49 5.33 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.204 -0.935 . . . . 1.0 109.7 -179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 169' ' ' SER . 1.8 t30 172.2 94.94 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.37 -0.831 . . . . 1.0 109.287 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.65 107.9 2.46 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.414 2.076 . . . . 1.0 110.48 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.62 ' HB ' HG22 ' A' ' 147' ' ' VAL . 24.6 mt -137.43 159.47 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.301 -0.874 . . . . 1.0 108.99 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 145' ' ' THR . 2.9 mt-10 -130.34 123.12 29.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.127 -0.983 . . . . 1.0 109.854 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.806 ' C ' HG22 ' A' ' 145' ' ' THR . 3.3 m -84.7 -169.28 2.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -0.872 . . . . 1.0 109.047 179.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 177' ' ' ARG . 1.2 p 176.47 -33.04 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.171 -0.955 . . . . 1.0 109.665 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.468 ' HB3' ' HD3' ' A' ' 125' ' ' LYS . 6.3 tp60 -44.38 95.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.989 . . . . 1.0 109.46 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 175' ' ' SER . 0.0 OUTLIER -168.51 154.76 7.05 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.273 -0.892 . . . . 1.0 109.424 -179.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.941 -1.028 . . . . 1.0 109.507 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.9 ttp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.448 -0.575 . . . . 1.0 109.448 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.8 40.42 0.65 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.271 -0.893 . . . . 1.0 109.45 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.415 ' HB3' HD11 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -174.95 -156.46 0.06 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.29 -0.881 . . . . 1.0 109.249 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.885 ' NE1' HD12 ' A' ' 6' ' ' LEU . 53.9 p-90 -97.48 -49.09 5.03 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.253 -0.905 . . . . 1.0 109.611 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.711 ' C ' HD13 ' A' ' 6' ' ' LEU . 0.5 OUTLIER 163.04 90.41 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.366 -0.834 . . . . 1.0 109.481 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.885 HD12 ' NE1' ' A' ' 4' ' ' TRP . 0.0 OUTLIER -130.61 154.53 81.74 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.197 -0.939 . . . . 1.0 109.577 179.497 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.75 95.55 1.03 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.479 2.12 . . . . 1.0 110.296 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -142.61 43.97 1.61 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.166 -0.959 . . . . 1.0 109.495 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.446 ' HA ' HD13 ' A' ' 54' ' ' LEU . 18.8 m170 -116.0 87.04 2.59 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.298 -0.876 . . . . 1.0 109.461 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.94 99.74 3.3 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 1.0 109.573 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.411 ' HA2' ' HD3' ' A' ' 12' ' ' PRO . . . -158.31 142.67 8.64 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.387 -1.485 . . . . 1.0 109.387 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.447 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 36.3 Cg_endo -78.92 110.27 2.74 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.441 2.094 . . . . 1.0 110.596 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.575 ' CE2' ' O ' ' A' ' 162' ' ' THR . 8.3 m-85 -56.09 155.75 6.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 1.0 109.063 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 12' ' ' PRO . 20.7 mt-10 -152.21 103.01 2.82 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.885 -1.134 . . . . 1.0 110.25 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.665 ' HB3' HD12 ' A' ' 165' ' ' LEU . 17.3 tp -112.24 76.78 1.0 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.436 -0.95 . . . . 1.0 108.436 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.45 ' O ' ' OE1' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -114.87 176.25 5.14 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.322 -0.861 . . . . 1.0 110.188 -179.022 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.583 HG21 ' HG2' ' A' ' 20' ' ' GLN . 0.8 OUTLIER -86.75 146.48 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 108.705 -0.85 . . . . 1.0 108.705 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.496 ' HB2' ' NE2' ' A' ' 49' ' ' GLN . 0.8 OUTLIER -77.06 -61.13 2.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 1.0 109.261 -179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.752 HG22 ' HD3' ' A' ' 21' ' ' PRO . 9.7 p -109.67 136.02 46.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.385 -0.822 . . . . 1.0 109.307 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.583 ' HG2' HG21 ' A' ' 17' ' ' ILE . 9.4 mm-40 -129.06 66.02 75.34 Favored Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 121.143 -0.973 . . . . 1.0 109.599 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.752 ' HD3' HG22 ' A' ' 19' ' ' VAL . 35.4 Cg_endo -77.62 -177.03 3.54 Favored 'Trans proline' 0 C--N 1.312 -1.352 0 C-N-CA 122.464 2.109 . . . . 1.0 110.575 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -61.85 151.7 33.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.366 -0.834 . . . . 1.0 109.129 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.47 ' HB3' ' HG2' ' A' ' 171' ' ' PRO . 2.2 t -163.76 61.58 0.16 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.14 -0.975 . . . . 1.0 110.038 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . 0.442 ' HA ' HG12 ' A' ' 172' ' ' ILE . 1.9 p80 -99.52 165.52 11.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.084 -1.01 . . . . 1.0 108.881 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.599 ' CE1' ' HA ' ' A' ' 38' ' ' VAL . 1.1 m-70 -139.54 110.41 6.8 Favored 'General case' 0 C--N 1.297 -1.696 0 C-N-CA 119.703 -0.799 . . . . 1.0 109.894 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.507 ' O ' ' CE2' ' A' ' 29' ' ' TYR . 0.5 OUTLIER -87.12 64.98 8.68 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.424 -0.954 . . . . 1.0 108.424 179.02 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -77.3 82.8 3.77 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.367 0.603 . . . . 1.0 109.88 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.54 ' C ' ' CG ' ' A' ' 29' ' ' TYR . 5.6 p-80 174.63 113.12 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.322 -0.861 . . . . 1.0 109.295 179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.573 ' CD1' ' N ' ' A' ' 29' ' ' TYR . 0.1 OUTLIER 169.55 171.97 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.553 -0.717 . . . . 1.0 109.305 -179.481 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -161.4 31.35 0.13 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.235 -0.916 . . . . 1.0 109.544 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.414 HG22 ' O ' ' A' ' 31' ' ' THR . 13.3 m -144.63 43.45 1.37 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 1.0 109.489 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.404 ' OE1' ' CD2' ' A' ' 29' ' ' TYR . 5.2 pt-20 -133.7 -41.31 0.85 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.282 -0.886 . . . . 1.0 109.481 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.08 -131.29 5.77 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.607 -1.397 . . . . 1.0 109.607 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 35' ' ' ARG . 1.2 t -128.08 117.49 21.74 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.162 -1.199 . . . . 1.0 109.581 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.44 ' O ' ' HD3' ' A' ' 35' ' ' ARG . 0.0 OUTLIER 172.48 70.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.302 -0.874 . . . . 1.0 109.517 179.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -120.29 92.57 0.52 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.695 -1.362 . . . . 1.0 109.695 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -128.57 175.23 8.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.201 -1.176 . . . . 1.0 109.762 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.659 HG11 ' O ' ' A' ' 121' ' ' ALA . 2.4 p -100.27 102.3 13.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.939 -0.704 . . . . 1.0 109.732 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.476 ' O ' ' HG3' ' A' ' 39' ' ' LYS . 12.5 ptpt -153.9 110.43 3.34 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.898 . . . . 1.0 109.614 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -160.66 -45.25 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.14 -0.975 . . . . 1.0 109.517 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.528 ' CB ' ' HG2' ' A' ' 21' ' ' PRO . 0.3 OUTLIER -100.68 102.1 13.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 1.0 109.621 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 41' ' ' SER . . . 61.52 42.32 11.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.271 -0.893 . . . . 1.0 109.521 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 39' ' ' LYS . . . 92.09 -21.39 37.42 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.653 -1.379 . . . . 1.0 109.653 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.516 ' N ' ' OD2' ' A' ' 119' ' ' ASP . . . 155.22 106.79 0.27 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.642 -1.383 . . . . 1.0 109.642 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.486 ' HB3' ' O ' ' A' ' 118' ' ' ILE . 0.3 OUTLIER 73.92 146.18 0.11 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.254 -1.145 . . . . 1.0 109.758 179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -78.12 -178.81 4.9 Favored 'Trans proline' 0 C--N 1.312 -1.371 0 C-N-CA 122.651 2.234 . . . . 1.0 110.577 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 1.016 HG23 HG12 ' A' ' 117' ' ' VAL . 5.2 mt -94.32 158.34 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.513 -0.742 . . . . 1.0 109.278 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.589 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 11.1 t -140.35 88.1 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.159 -0.963 . . . . 1.0 110.108 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.62 ' CG ' ' CE1' ' A' ' 51' ' ' HIS . 0.0 OUTLIER -98.8 175.74 5.86 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.287 -0.883 . . . . 1.0 108.903 179.362 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.652 HD12 HD13 ' A' ' 15' ' ' LEU . 8.2 tt -134.81 136.73 42.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.933 -1.104 . . . . 1.0 110.036 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.62 ' CE1' ' CG ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -140.55 79.08 1.68 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.353 -0.842 . . . . 1.0 108.844 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.496 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . -174.33 88.22 0.08 OUTLIER Glycine 0 N--CA 1.49 2.248 0 C-N-CA 119.544 -1.312 . . . . 1.0 110.234 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.835 ' CE2' HD11 ' A' ' 59' ' ' LEU . 2.0 t80 176.8 131.83 0.05 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.314 -1.109 . . . . 1.0 109.654 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.446 HD13 ' HA ' ' A' ' 9' ' ' HIS . 18.9 mt -108.89 4.42 23.4 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 1.0 109.539 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.471 ' HB3' ' HG2' ' A' ' 57' ' ' GLU . 2.7 mt-10 -95.24 143.39 26.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.213 -0.929 . . . . 1.0 109.507 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.1 p30 -90.73 35.12 0.89 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.918 . . . . 1.0 109.337 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.576 ' HG3' HD21 ' A' ' 59' ' ' LEU . 17.3 pt-20 -110.83 151.97 43.25 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 1.0 109.357 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.58 ' O ' HD23 ' A' ' 59' ' ' LEU . 35.8 Cg_endo -78.31 134.2 12.55 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 122.436 2.091 . . . . 1.0 110.534 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.835 HD11 ' CE2' ' A' ' 53' ' ' TYR . 16.1 mt -118.63 165.44 13.96 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.238 -0.914 . . . . 1.0 109.077 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.453 ' HA ' ' HA ' ' A' ' 107' ' ' PRO . 0.0 OUTLIER -105.13 136.03 45.38 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.174 -0.954 . . . . 1.0 109.583 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.793 HD21 ' HB2' ' A' ' 63' ' ' LEU . 0.6 OUTLIER -89.41 136.15 33.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.36 -0.838 . . . . 1.0 109.224 179.9 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.469 ' HB2' ' O ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -97.2 85.96 3.82 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.204 -0.935 . . . . 1.0 109.536 -179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 1.096 HD13 ' CE1' ' A' ' 151' ' ' PHE . 18.8 tp -99.36 130.95 45.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.287 -0.883 . . . . 1.0 108.822 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.502 ' HB2' ' CG1' ' A' ' 103' ' ' VAL . 0.0 OUTLIER -155.44 143.54 20.05 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.15 -0.968 . . . . 1.0 109.113 -179.326 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.817 HD13 ' N ' ' A' ' 66' ' ' GLY . 0.1 OUTLIER -103.99 124.54 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 108.638 -0.875 . . . . 1.0 108.638 179.446 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.817 ' N ' HD13 ' A' ' 65' ' ' ILE . . . -136.8 149.17 20.1 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.915 -1.274 . . . . 1.0 109.915 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.732 HG23 ' HA ' ' A' ' 76' ' ' HIS . 73.5 p -83.14 156.51 23.22 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.28 -1.13 . . . . 1.0 109.362 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.572 ' HB3' ' HG3' ' A' ' 148' ' ' ARG . . . -160.56 116.99 2.35 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 1.0 109.694 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -85.45 -25.13 27.12 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.169 -0.957 . . . . 1.0 109.14 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.12 -42.02 0.21 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.382 -0.824 . . . . 1.0 109.425 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.514 ' O ' ' N ' ' A' ' 73' ' ' LEU . 13.0 ttm180 -175.35 -34.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.204 -0.935 . . . . 1.0 109.569 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.723 ' O ' HD12 ' A' ' 72' ' ' LEU . 0.7 OUTLIER -48.67 91.29 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 1.0 109.865 -179.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 71' ' ' ARG . 0.7 OUTLIER -58.21 155.73 10.93 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.163 -0.961 . . . . 1.0 109.656 -179.968 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.513 ' NE ' ' OG1' ' A' ' 67' ' ' THR . 10.8 ptt180 -175.27 172.19 1.14 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.88 . . . . 1.0 108.7 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.512 ' HD2' ' HB2' ' A' ' 74' ' ' ARG . 33.7 Cg_endo -77.18 161.73 32.06 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.141 1.894 . . . . 1.0 110.312 -179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.732 ' HA ' HG23 ' A' ' 67' ' ' THR . 0.0 OUTLIER -64.35 156.03 30.47 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.227 -0.921 . . . . 1.0 109.708 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.28 -48.92 4.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 1.0 109.84 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.506 ' HD1' HD22 ' A' ' 126' ' ' LEU . 18.6 m-85 -120.39 26.83 8.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.18 -0.95 . . . . 1.0 109.899 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.756 ' OH ' HG22 ' A' ' 145' ' ' THR . 0.2 OUTLIER -140.86 148.68 40.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.148 -0.97 . . . . 1.0 109.127 179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.479 ' HG3' ' HB2' ' A' ' 102' ' ' LYS . 20.5 tt0 -165.05 -36.41 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.122 -0.986 . . . . 1.0 109.589 -179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 12.8 m -50.78 143.22 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.052 -1.03 . . . . 1.0 109.633 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.402 ' O ' ' OE2' ' A' ' 95' ' ' GLU . 3.9 t-80 -175.93 67.98 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.532 -0.73 . . . . 1.0 109.319 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.458 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.0 OUTLIER -134.41 153.97 51.62 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.236 -0.915 . . . . 1.0 109.815 -179.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 0.513 ' CG1' ' HB2' ' A' ' 120' ' ' CYS . 3.8 mp -100.01 143.63 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.447 -0.783 . . . . 1.0 109.486 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 86' ' ' GLY . 34.4 p -135.41 -166.35 1.83 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.225 -0.922 . . . . 1.0 109.404 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 85' ' ' THR . . . 41.47 -107.99 0.11 Allowed Glycine 0 N--CA 1.484 1.84 0 N-CA-C 110.046 -1.222 . . . . 1.0 110.046 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.84 118.9 18.33 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.244 -1.15 . . . . 1.0 109.601 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.19 169.64 12.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.272 -0.892 . . . . 1.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.558 HG13 ' H ' ' A' ' 91' ' ' THR . 11.0 p -103.8 160.23 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.332 -0.855 . . . . 1.0 109.418 179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.441 ' N ' HG22 ' A' ' 89' ' ' VAL . 2.5 m -78.71 3.78 15.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 1.0 109.606 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.623 HG23 HD22 ' A' ' 108' ' ' LEU . 16.3 m -104.82 101.36 10.97 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.213 -0.93 . . . . 1.0 109.539 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.883 ' O ' HG23 ' A' ' 106' ' ' ILE . 22.7 m -46.08 115.71 1.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.204 -0.935 . . . . 1.0 109.652 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.607 ' HA ' HG23 ' A' ' 106' ' ' ILE . 0.1 OUTLIER -114.21 173.68 6.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 1.0 109.654 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -155.1 162.67 40.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.375 -0.828 . . . . 1.0 109.519 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.402 ' OE2' ' O ' ' A' ' 82' ' ' HIS . 1.2 tt0 -124.31 133.59 53.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.864 . . . . 1.0 109.492 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.474 ' O ' HG23 ' A' ' 103' ' ' VAL . . . -124.66 121.53 34.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 1.0 109.55 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.56 HD12 ' O ' ' A' ' 101' ' ' THR . 6.1 tp -111.79 140.12 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.225 -0.922 . . . . 1.0 109.444 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.51 ' O ' ' CB ' ' A' ' 99' ' ' SER . 0.5 OUTLIER -132.32 49.41 2.32 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.138 -0.976 . . . . 1.0 109.691 179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.51 ' CB ' ' O ' ' A' ' 98' ' ' LEU . 3.1 t 76.8 112.34 0.07 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.264 -0.897 . . . . 1.0 110.279 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.432 ' CG ' ' O ' ' A' ' 99' ' ' SER . 3.5 p-10 43.64 31.96 0.51 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.689 -0.632 . . . . 1.0 111.032 179.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.56 ' O ' HD12 ' A' ' 97' ' ' ILE . 2.5 m -160.2 96.29 1.19 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.737 -1.227 . . . . 1.0 110.226 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.479 ' HB2' ' HG3' ' A' ' 80' ' ' GLN . 0.0 OUTLIER -88.87 153.71 20.84 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.229 -0.919 . . . . 1.0 108.943 179.438 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.502 ' CG1' ' HB2' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -144.18 173.57 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.071 -1.018 . . . . 1.0 109.211 -179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.561 HD22 HD23 ' A' ' 63' ' ' LEU . 0.2 OUTLIER -123.92 130.81 53.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.222 -0.924 . . . . 1.0 109.954 -179.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -133.1 122.64 24.39 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.358 -0.839 . . . . 1.0 108.864 179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 1.062 HG22 HD21 ' A' ' 108' ' ' LEU . 26.8 mt -133.94 112.73 12.48 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.035 -1.04 . . . . 1.0 110.119 -179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.946 ' C ' HD23 ' A' ' 108' ' ' LEU . 34.0 Cg_endo -76.56 121.24 5.89 Favored 'Trans proline' 0 C--N 1.316 -1.181 0 C-N-CA 122.091 1.861 . . . . 1.0 109.712 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.062 HD21 HG22 ' A' ' 106' ' ' ILE . 2.5 mt -126.36 165.55 18.82 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -0.934 . . . . 1.0 110.667 -178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.773 ' N ' HD23 ' A' ' 109' ' ' LEU . 0.6 OUTLIER -72.26 -170.82 0.17 Allowed Pre-proline 0 N--CA 1.493 1.676 0 N-CA-C 108.081 -1.081 . . . . 1.0 108.081 179.259 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.59 ' CD ' ' CB ' ' A' ' 109' ' ' LEU . 33.4 Cg_endo -77.64 -76.51 0.01 OUTLIER 'Trans proline' 0 C--N 1.318 -1.058 0 C-N-CA 121.532 1.488 . . . . 1.0 110.848 -179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.455 ' HG3' ' HA ' ' A' ' 51' ' ' HIS . 1.8 tt0 -170.46 52.2 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.897 -1.127 . . . . 1.0 110.131 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.474 ' O ' ' CB ' ' A' ' 113' ' ' SER . 13.2 p30 -79.73 -40.65 28.37 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.086 -1.009 . . . . 1.0 109.166 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 0.5 OUTLIER 164.68 87.89 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.361 -0.837 . . . . 1.0 109.157 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.584 ' HE1' ' N ' ' A' ' 109' ' ' LEU . 0.0 OUTLIER -162.51 139.71 8.06 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.155 -0.966 . . . . 1.0 110.19 -179.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.8 ttp180 -119.6 137.75 53.66 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.386 -0.821 . . . . 1.0 108.937 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -112.49 97.91 6.91 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.158 -0.964 . . . . 1.0 109.749 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 1.016 HG12 HG23 ' A' ' 47' ' ' ILE . 5.4 m -96.42 127.22 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 1.0 109.349 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.486 ' O ' ' HB3' ' A' ' 45' ' ' HIS . 65.9 mt -102.56 111.26 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.282 -0.886 . . . . 1.0 109.358 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.516 ' OD2' ' N ' ' A' ' 44' ' ' GLY . 3.9 t0 -147.12 41.83 1.09 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.943 . . . . 1.0 109.619 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.513 ' HB2' ' CG1' ' A' ' 84' ' ' ILE . 63.8 m -145.22 57.77 1.26 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -0.956 . . . . 1.0 109.824 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.659 ' O ' HG11 ' A' ' 38' ' ' VAL . . . -128.33 152.94 47.56 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 1.0 108.881 179.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . -114.21 -174.35 18.53 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.838 -1.305 . . . . 1.0 109.838 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 1.2 mt -125.23 171.79 13.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.323 -1.104 . . . . 1.0 109.055 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.31 161.36 37.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.214 -0.929 . . . . 1.0 109.569 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.1 mppt? -136.51 124.68 23.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.303 -0.873 . . . . 1.0 109.377 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.506 HD22 ' HD1' ' A' ' 78' ' ' PHE . 1.4 mp -89.77 166.15 13.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 1.0 109.487 -179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -160.7 28.53 0.15 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.253 -0.905 . . . . 1.0 109.413 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -133.46 12.53 4.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.283 -0.886 . . . . 1.0 109.496 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 0.0 OUTLIER -137.11 -85.43 0.32 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.181 -0.949 . . . . 1.0 109.53 -179.999 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 129' ' ' SER . 9.1 t0 83.45 59.32 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.313 0.578 . . . . 1.0 109.468 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.571 ' O ' HG23 ' A' ' 131' ' ' ILE . 12.1 tt -99.34 121.96 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.232 -0.918 . . . . 1.0 109.489 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -169.57 111.18 0.46 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 1.0 109.509 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.665 ' O ' HD12 ' A' ' 133' ' ' LEU . 3.9 pp -127.9 133.81 49.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.921 . . . . 1.0 109.415 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 33.5 ptt85 -178.55 -168.4 0.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 1.0 109.524 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.6 ttmt -94.56 147.77 22.94 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 1.0 109.492 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . 110.7 174.66 20.34 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.544 -1.422 . . . . 1.0 109.544 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -146.47 147.49 31.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -1.135 . . . . 1.0 109.428 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.444 HG21 ' HA ' ' A' ' 143' ' ' LYS . 72.2 p -125.31 -166.32 1.53 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 1.0 109.527 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -76.74 -85.97 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.242 -0.912 . . . . 1.0 109.386 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 20.2 pt -135.18 16.19 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.257 -0.902 . . . . 1.0 109.445 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.526 ' O ' ' CG ' ' A' ' 142' ' ' ARG . . . 169.22 -149.05 12.82 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.548 -1.421 . . . . 1.0 109.548 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.526 ' CG ' ' O ' ' A' ' 141' ' ' GLY . 9.1 ptt180 40.53 57.39 2.57 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.693 -0.887 . . . . 1.0 110.097 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.444 ' HA ' HG21 ' A' ' 138' ' ' THR . 0.0 OUTLIER -97.61 78.13 2.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.314 -0.866 . . . . 1.0 109.304 179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.474 ' HA ' ' HB3' ' A' ' 175' ' ' SER . 0.1 OUTLIER 66.2 137.91 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 1.0 109.272 -179.836 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.756 HG22 ' OH ' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -159.38 53.02 0.38 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.188 -0.945 . . . . 1.0 109.654 -179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.545 ' NH2' ' ND2' ' A' ' 170' ' ' ASN . 6.4 ptm180 -86.73 176.59 7.66 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.233 -0.917 . . . . 1.0 109.288 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.583 HG12 ' NE2' ' A' ' 76' ' ' HIS . 27.7 m -134.7 -174.68 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.403 -0.811 . . . . 1.0 109.877 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.572 ' HG3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -149.29 95.97 2.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.33 -0.856 . . . . 1.0 109.319 -179.922 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.526 ' CD2' HG12 ' A' ' 65' ' ' ILE . 0.9 OUTLIER -78.0 124.51 28.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.986 -1.071 . . . . 1.0 109.035 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 17.6 t -110.04 114.41 46.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 O-C-N 121.233 -0.917 . . . . 1.0 109.776 -179.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 1.096 ' CE1' HD13 ' A' ' 63' ' ' LEU . 21.6 m-85 -110.43 113.29 25.83 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.769 -0.826 . . . . 1.0 108.769 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.486 ' HB3' ' HA ' ' A' ' 166' ' ' GLN . 10.0 ptt180 -149.46 138.73 21.41 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.171 -0.955 . . . . 1.0 109.781 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.537 ' HB ' HD22 ' A' ' 15' ' ' LEU . 8.7 p -112.66 128.52 69.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.471 -0.937 . . . . 1.0 108.471 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.567 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 41.7 m-70 -128.89 118.45 22.71 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.16 -0.962 . . . . 1.0 110.002 -179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.546 HG11 ' HB3' ' A' ' 163' ' ' LEU . 14.7 p -98.52 141.2 22.53 Favored Pre-proline 0 N--CA 1.487 1.406 0 O-C-N 121.279 -0.888 . . . . 1.0 108.788 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.541 ' HD2' HG23 ' A' ' 155' ' ' VAL . 33.0 Cg_endo -74.73 114.05 3.94 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.197 1.931 . . . . 1.0 110.615 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.633 ' HG3' HG21 ' A' ' 162' ' ' THR . 0.6 OUTLIER -135.71 166.05 31.42 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.506 -0.746 . . . . 1.0 109.006 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.463 ' HD2' ' OE1' ' A' ' 157' ' ' GLN . 34.4 Cg_endo -76.34 -64.84 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.261 1.974 . . . . 1.0 110.373 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 6.0 m -53.77 -78.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.195 -0.94 . . . . 1.0 109.349 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 144.44 -42.07 1.06 Allowed Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.458 -1.457 . . . . 1.0 109.458 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -79.01 79.96 5.37 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 108.022 -1.103 . . . . 1.0 108.022 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.786 HG22 ' N ' ' A' ' 163' ' ' LEU . 1.3 m -135.05 -88.38 0.36 Allowed 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.533 -0.73 . . . . 1.0 109.367 -178.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.786 ' N ' HG22 ' A' ' 162' ' ' THR . 7.6 tp -131.15 102.89 6.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.021 -1.049 . . . . 1.0 109.08 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.567 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -162.11 114.31 1.71 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.08 -1.012 . . . . 1.0 109.593 179.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.665 HD12 ' HB3' ' A' ' 15' ' ' LEU . 1.0 OUTLIER -122.81 175.36 6.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.335 -0.853 . . . . 1.0 109.753 -179.449 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.486 ' HA ' ' HB3' ' A' ' 152' ' ' ARG . 0.7 OUTLIER -147.87 105.66 3.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.425 -0.797 . . . . 1.0 109.426 179.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 151' ' ' PHE . 43.8 t -118.28 154.01 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.161 -0.962 . . . . 1.0 109.332 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 149' ' ' LEU . . . -151.41 102.83 2.93 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.302 -0.874 . . . . 1.0 109.214 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 170' ' ' ASN . 0.4 OUTLIER -130.71 161.78 30.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.17 -0.957 . . . . 1.0 109.693 -179.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.545 ' ND2' ' NH2' ' A' ' 146' ' ' ARG . 1.6 p-10 164.93 97.77 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.343 -0.848 . . . . 1.0 109.567 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.47 ' HG2' ' HB3' ' A' ' 23' ' ' SER . 36.1 Cg_endo -79.45 67.81 8.48 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.419 2.08 . . . . 1.0 110.48 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.461 HG12 ' O ' ' A' ' 23' ' ' SER . 16.1 mt -136.6 124.45 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.104 -0.997 . . . . 1.0 109.443 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -147.17 108.0 4.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 1.0 109.363 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.527 ' O ' ' CB ' ' A' ' 175' ' ' SER . 63.9 m -85.17 175.95 8.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.206 -0.933 . . . . 1.0 109.462 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.527 ' CB ' ' O ' ' A' ' 174' ' ' CYS . 1.0 OUTLIER 82.57 -42.78 0.12 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.783 -0.573 . . . . 1.0 110.053 -179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.42 ' CB ' ' O ' ' A' ' 175' ' ' SER . 27.0 tt0 70.32 78.68 0.19 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.981 -1.074 . . . . 1.0 109.597 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.93 -44.91 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.187 -0.946 . . . . 1.0 109.474 179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . 0.426 ' OXT' ' OG ' ' A' ' 178' ' ' SER . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 117.988 -1.006 . . . . 1.0 109.471 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.417 ' O ' ' OD2' ' A' ' 3' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.426 -0.583 . . . . 1.0 109.426 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 3' ' ' ASP . 9.0 tttt -69.91 -32.58 70.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.328 -0.858 . . . . 1.0 109.408 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.559 ' CB ' HD23 ' A' ' 6' ' ' LEU . 11.5 m-20 62.02 169.44 0.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 1.0 109.493 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.569 ' CG ' ' N ' ' A' ' 5' ' ' GLN . 21.9 p-90 -77.41 -46.73 21.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.192 -0.943 . . . . 1.0 109.874 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.569 ' N ' ' CG ' ' A' ' 4' ' ' TRP . 1.1 tt0 176.56 83.4 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 1.0 109.625 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.559 HD23 ' CB ' ' A' ' 3' ' ' ASP . 0.4 OUTLIER -96.38 161.17 27.81 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.305 -0.872 . . . . 1.0 109.253 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 6' ' ' LEU . 34.5 Cg_endo -76.41 160.51 35.43 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.312 2.008 . . . . 1.0 110.274 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 62.7 p -130.62 46.95 2.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 1.0 109.663 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.559 ' CG ' ' N ' ' A' ' 10' ' ' SER . 73.9 t60 -99.77 165.73 11.44 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.178 -0.951 . . . . 1.0 109.343 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.559 ' N ' ' CG ' ' A' ' 9' ' ' HIS . 1.5 p 73.35 146.69 0.08 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.126 -0.984 . . . . 1.0 109.417 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 179.7 -145.26 6.43 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.604 -1.399 . . . . 1.0 109.604 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.5 -158.79 0.09 OUTLIER 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.425 2.083 . . . . 1.0 110.486 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.565 ' CD1' ' O ' ' A' ' 162' ' ' THR . 1.8 m-85 -95.65 162.9 13.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 1.0 109.459 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -152.42 142.69 22.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.138 -0.976 . . . . 1.0 109.918 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.939 HD13 HD12 ' A' ' 50' ' ' LEU . 22.8 tp -136.31 98.05 3.74 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.784 -0.821 . . . . 1.0 108.784 179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.47 164.23 29.92 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 1.0 110.227 -179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.636 HG23 ' O ' ' A' ' 47' ' ' ILE . 0.8 OUTLIER -92.36 145.29 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 N-CA-C 108.547 -0.909 . . . . 1.0 108.547 179.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.421 ' C ' HG23 ' A' ' 19' ' ' VAL . 1.3 tp10 -75.4 -35.83 60.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -0.936 . . . . 1.0 110.3 -179.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.499 ' HB ' HG13 ' A' ' 47' ' ' ILE . 80.0 t -154.48 98.87 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 O-C-N 120.814 -1.179 . . . . 1.0 110.157 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.589 ' NE2' HG21 ' A' ' 17' ' ' ILE . 0.6 OUTLIER -51.63 160.34 1.06 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.442 -0.786 . . . . 1.0 109.037 179.422 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.496 ' HB3' ' O ' ' A' ' 44' ' ' GLY . 36.2 Cg_endo -78.38 154.92 28.36 Favored 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.458 2.106 . . . . 1.0 110.415 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.6 mmtm -46.09 165.12 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.266 -0.896 . . . . 1.0 109.453 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.457 ' O ' ' OG ' ' A' ' 23' ' ' SER . 5.2 t -94.19 24.39 4.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 1.0 110.142 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -136.04 166.38 23.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.94 -1.1 . . . . 1.0 110.003 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.85 ' CD2' HD11 ' A' ' 123' ' ' ILE . 0.8 OUTLIER -162.48 106.76 1.15 Allowed 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 109.303 -0.629 . . . . 1.0 109.303 179.428 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.569 ' HG3' ' CE1' ' A' ' 29' ' ' TYR . 24.1 ttp85 -75.17 91.74 2.64 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.255 -0.903 . . . . 1.0 109.36 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.554 ' O ' ' CD2' ' A' ' 28' ' ' HIS . . . -143.22 88.94 2.06 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.315 -0.866 . . . . 1.0 109.523 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.554 ' CD2' ' O ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER 169.97 38.26 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.229 -0.92 . . . . 1.0 109.503 179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.569 ' CE1' ' HG3' ' A' ' 26' ' ' ARG . 32.2 m-85 -129.54 -70.32 0.65 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.239 -0.913 . . . . 1.0 109.542 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 30' ' ' GLU . 6.8 pt-20 -86.16 118.8 25.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.272 -0.893 . . . . 1.0 109.548 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.9 t -145.1 36.32 1.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.274 -0.891 . . . . 1.0 109.435 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.05 52.32 1.68 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.179 -0.951 . . . . 1.0 109.475 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 132.2 149.45 6.3 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.774 -1.331 . . . . 1.0 109.774 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 36' ' ' GLY . 8.2 t 65.88 9.75 6.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.328 -1.101 . . . . 1.0 109.516 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 52.01 -90.13 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.88 . . . . 1.0 109.434 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.509 ' N ' ' O ' ' A' ' 34' ' ' SER . . . 117.12 112.33 2.65 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.643 -1.383 . . . . 1.0 109.643 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -119.77 174.19 6.58 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -1.112 . . . . 1.0 109.517 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.592 ' HB ' ' CE1' ' A' ' 25' ' ' HIS . 2.4 p -68.33 142.06 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.403 -0.81 . . . . 1.0 109.445 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -143.8 105.41 4.3 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.278 -0.889 . . . . 1.0 109.766 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.601 ' HB3' ' O ' ' A' ' 43' ' ' GLY . . . -161.16 105.8 1.34 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.411 -0.806 . . . . 1.0 108.905 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.471 ' HG ' ' C ' ' A' ' 40' ' ' ALA . 19.2 p 44.17 -105.56 0.09 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 1.0 108.903 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.503 ' O ' ' CB ' ' A' ' 119' ' ' ASP . . . -88.57 48.0 1.58 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.582 -1.324 . . . . 1.0 108.232 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.601 ' O ' ' HB3' ' A' ' 40' ' ' ALA . . . 67.82 -111.11 3.82 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 108.039 -2.024 . . . . 1.0 108.039 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 45' ' ' HIS . . . -89.61 -22.15 37.87 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.219 -1.952 . . . . 1.0 108.219 178.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.606 ' N ' ' CD ' ' A' ' 46' ' ' PRO . 2.3 t-80 79.43 27.96 0.01 OUTLIER Pre-proline 0 N--CA 1.486 1.355 0 N-CA-C 113.315 0.857 . . . . 1.0 113.315 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 45' ' ' HIS . 37.3 Cg_endo -79.34 114.25 3.27 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 N-CA-C 108.935 -1.217 . . . . 1.0 108.935 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.636 ' O ' HG23 ' A' ' 17' ' ' ILE . 0.0 OUTLIER -102.32 144.95 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.967 -1.083 . . . . 1.0 108.802 -179.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.602 HG21 ' CZ ' ' A' ' 151' ' ' PHE . 5.2 t -137.27 124.49 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.033 -1.042 . . . . 1.0 110.369 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.565 ' NE2' ' NH1' ' A' ' 115' ' ' ARG . 4.8 tt0 -140.06 142.51 36.16 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.524 -0.917 . . . . 1.0 108.524 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.939 HD12 HD13 ' A' ' 15' ' ' LEU . 0.5 OUTLIER -118.04 141.05 48.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.939 -1.1 . . . . 1.0 109.897 -179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -140.66 84.98 1.97 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.349 -0.844 . . . . 1.0 109.449 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.494 ' HA3' ' HA ' ' A' ' 13' ' ' TYR . . . 170.01 105.22 0.18 Allowed Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.304 -1.427 . . . . 1.0 110.648 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.595 ' CD2' ' HB2' ' A' ' 111' ' ' GLU . 3.5 t80 175.9 156.95 0.22 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.426 -1.044 . . . . 1.0 109.965 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.748 ' C ' HD12 ' A' ' 54' ' ' LEU . 3.3 pp -140.71 11.02 2.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.421 -0.799 . . . . 1.0 109.255 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.449 ' O ' ' CE2' ' A' ' 53' ' ' TYR . 1.6 tm-20 -120.77 145.67 47.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.303 -0.873 . . . . 1.0 109.658 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.402 ' C ' ' ND2' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -90.25 35.81 0.87 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.21 -0.931 . . . . 1.0 109.96 -179.881 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.677 ' HG3' HD21 ' A' ' 59' ' ' LEU . 15.1 pt-20 -100.62 137.84 19.97 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.146 -0.971 . . . . 1.0 109.424 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 1.05 ' O ' HD23 ' A' ' 59' ' ' LEU . 36.7 Cg_endo -79.92 154.23 22.78 Favored 'Trans proline' 0 C--N 1.314 -1.273 0 C-N-CA 122.511 2.141 . . . . 1.0 110.501 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.05 HD23 ' O ' ' A' ' 58' ' ' PRO . 2.3 mt -141.27 156.29 45.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 1.0 109.172 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . . . . . . . . . 2.4 ptt? -87.26 135.55 33.27 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.223 -0.923 . . . . 1.0 109.104 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.577 HD21 ' HB2' ' A' ' 63' ' ' LEU . 0.9 OUTLIER -87.94 131.15 34.71 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.275 -0.89 . . . . 1.0 109.499 -179.688 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.484 ' HB2' ' O ' ' A' ' 152' ' ' ARG . 0.0 OUTLIER -98.52 82.66 2.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -0.911 . . . . 1.0 109.572 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.93 HD13 ' CZ ' ' A' ' 151' ' ' PHE . 58.9 tp -99.64 135.98 40.25 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.247 -0.908 . . . . 1.0 108.81 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.692 ' HB2' HG12 ' A' ' 103' ' ' VAL . 1.7 t80 -148.4 164.05 35.28 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.226 -0.921 . . . . 1.0 109.042 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.757 ' O ' HG23 ' A' ' 65' ' ' ILE . 8.1 tp -129.38 102.85 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 N-CA-C 108.548 -0.908 . . . . 1.0 108.548 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.581 ' HA3' ' CZ ' ' A' ' 64' ' ' PHE . . . -124.65 153.69 17.83 Favored Glycine 0 N--CA 1.487 2.058 0 N-CA-C 110.067 -1.213 . . . . 1.0 110.067 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.901 HG22 ' CD2' ' A' ' 76' ' ' HIS . 1.1 p -77.22 149.56 35.47 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.464 -1.021 . . . . 1.0 109.23 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.459 ' HB3' ' HD2' ' A' ' 148' ' ' ARG . . . -153.72 115.74 4.3 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 1.0 109.752 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -85.25 -7.95 58.77 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.327 -0.858 . . . . 1.0 109.522 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -159.91 -44.34 0.05 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.214 -0.929 . . . . 1.0 109.452 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.503 ' O ' ' N ' ' A' ' 73' ' ' LEU . 0.0 OUTLIER -175.08 -34.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.262 -0.899 . . . . 1.0 109.625 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -52.08 89.14 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.9 . . . . 1.0 109.739 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 71' ' ' ARG . 2.2 pp -65.35 129.72 40.76 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.283 -0.885 . . . . 1.0 109.666 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.635 ' NH2' HG21 ' A' ' 138' ' ' THR . 13.5 mmt180 -145.13 160.31 46.49 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.238 -0.914 . . . . 1.0 109.247 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -75.99 142.67 25.21 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.342 2.028 . . . . 1.0 110.202 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.901 ' CD2' HG22 ' A' ' 67' ' ' THR . 0.3 OUTLIER -67.44 160.97 26.36 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.221 -0.924 . . . . 1.0 109.569 -179.642 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.87 -65.21 0.86 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.307 -0.871 . . . . 1.0 110.308 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.683 ' CE2' ' CE1' ' A' ' 79' ' ' TYR . 0.1 OUTLIER -111.91 -4.34 14.59 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.033 -1.042 . . . . 1.0 110.219 -179.344 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.683 ' CE1' ' CE2' ' A' ' 78' ' ' PHE . 52.3 m-85 -83.89 105.94 15.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.98 -1.075 . . . . 1.0 108.963 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.53 ' HB2' ' CG ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -143.66 10.11 1.6 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.073 -1.017 . . . . 1.0 110.081 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.848 HG23 ' O ' ' A' ' 122' ' ' GLY . 11.9 m -75.68 146.91 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.983 -1.073 . . . . 1.0 109.497 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.734 ' CE1' HD12 ' A' ' 104' ' ' LEU . 5.7 t-80 -175.49 67.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.476 -0.765 . . . . 1.0 109.237 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.456 ' O ' ' O ' ' A' ' 120' ' ' CYS . 0.6 OUTLIER -122.66 139.9 53.44 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.235 -0.916 . . . . 1.0 109.746 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . 1.104 HG23 ' CB ' ' A' ' 120' ' ' CYS . 4.5 mp -100.11 133.52 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.343 -0.848 . . . . 1.0 109.675 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 86' ' ' GLY . 2.0 p -126.41 -163.88 1.27 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.275 -0.891 . . . . 1.0 109.302 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.405 ' C ' ' O ' ' A' ' 85' ' ' THR . . . 41.66 -124.21 3.2 Favored Glycine 0 N--CA 1.483 1.829 0 N-CA-C 110.039 -1.224 . . . . 1.0 110.039 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.93 108.5 7.7 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.234 -1.156 . . . . 1.0 109.513 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.4 HG22 ' CG2' ' A' ' 84' ' ' ILE . 0.2 OUTLIER -94.64 -177.17 4.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.363 -0.836 . . . . 1.0 109.409 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.569 HG22 ' H ' ' A' ' 91' ' ' THR . 8.7 p -88.49 132.61 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.321 -0.862 . . . . 1.0 109.306 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 6.3 m -74.65 -0.43 17.93 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 1.0 109.806 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.569 ' H ' HG22 ' A' ' 89' ' ' VAL . 16.4 m -80.75 -83.01 0.11 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.069 -1.019 . . . . 1.0 109.387 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.569 ' O ' HG21 ' A' ' 106' ' ' ILE . 0.0 OUTLIER 179.33 162.46 0.85 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.302 -0.874 . . . . 1.0 109.459 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.533 ' HA ' ' CG1' ' A' ' 106' ' ' ILE . 0.0 OUTLIER -165.19 156.98 15.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.263 -0.898 . . . . 1.0 110.014 179.686 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.488 ' HB2' ' O ' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -155.61 150.08 26.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.467 -0.77 . . . . 1.0 109.064 179.78 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -120.45 148.48 43.75 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.136 -0.978 . . . . 1.0 109.837 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -147.29 121.22 9.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.303 -0.873 . . . . 1.0 109.557 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.887 HD13 ' HG2' ' A' ' 102' ' ' LYS . 2.1 tp -110.75 106.12 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.342 -0.849 . . . . 1.0 109.606 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.722 HD23 ' H ' ' A' ' 98' ' ' LEU . 2.1 pt? -110.15 130.28 55.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.205 -0.934 . . . . 1.0 109.48 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.535 ' O ' ' ND2' ' A' ' 100' ' ' ASN . 16.6 m 35.07 83.98 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 122.077 -0.39 . . . . 1.0 111.379 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.535 ' ND2' ' O ' ' A' ' 99' ' ' SER . 0.7 OUTLIER 42.72 29.42 0.17 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.684 -0.635 . . . . 1.0 112.482 178.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.612 ' O ' HD12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -132.34 109.4 9.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.247 -1.533 . . . . 1.0 109.969 179.141 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.887 ' HG2' HD13 ' A' ' 97' ' ' ILE . 9.9 mmtp -85.96 137.93 32.36 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.1 -1.0 . . . . 1.0 109.358 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.692 HG12 ' HB2' ' A' ' 64' ' ' PHE . 0.1 OUTLIER -143.98 172.68 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.331 -0.855 . . . . 1.0 109.089 179.879 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.003 HD22 HD11 ' A' ' 106' ' ' ILE . 0.5 OUTLIER -124.31 135.55 53.44 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.27 -0.894 . . . . 1.0 110.147 -179.511 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 94' ' ' HIS . 0.4 OUTLIER -139.99 125.03 18.58 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.601 -0.889 . . . . 1.0 108.601 179.405 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 1.003 HD11 HD22 ' A' ' 104' ' ' LEU . 4.1 mp -128.94 115.81 19.03 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 120.976 -1.077 . . . . 1.0 110.115 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.41 97.3 1.12 Allowed 'Trans proline' 0 C--N 1.315 -1.216 0 C-N-CA 121.946 1.764 . . . . 1.0 109.64 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.559 HD11 ' HG3' ' A' ' 110' ' ' PRO . 0.7 OUTLIER -145.75 167.59 22.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.343 -0.848 . . . . 1.0 109.485 -179.205 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.772 HD23 ' OD1' ' A' ' 112' ' ' ASN . 3.9 tt -115.03 78.56 5.6 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.227 -0.921 . . . . 1.0 110.346 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.559 ' HG3' HD11 ' A' ' 108' ' ' LEU . 38.1 Cg_endo -83.25 40.13 0.9 Allowed 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 122.589 2.192 . . . . 1.0 110.082 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.595 ' HB2' ' CD2' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -120.81 22.39 11.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.047 -1.033 . . . . 1.0 110.056 -178.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.772 ' OD1' HD23 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -122.32 -52.9 1.93 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.114 -0.991 . . . . 1.0 109.119 179.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.504 ' CB ' ' O ' ' A' ' 112' ' ' ASN . 1.4 p 164.59 86.01 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.371 -0.831 . . . . 1.0 108.989 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' MET . . . . . 0.451 ' CE ' ' HB3' ' A' ' 110' ' ' PRO . 0.5 OUTLIER -154.7 144.55 21.66 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.14 -0.975 . . . . 1.0 109.829 -179.809 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.616 ' NH2' HG22 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -101.44 142.73 32.39 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.541 -0.911 . . . . 1.0 108.541 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.508 ' N ' ' HD3' ' A' ' 115' ' ' ARG . . . -134.78 96.55 3.56 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.994 -1.066 . . . . 1.0 109.87 -179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.451 ' O ' HG23 ' A' ' 117' ' ' VAL . 3.9 m -86.45 131.37 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.346 -0.846 . . . . 1.0 109.145 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.464 ' O ' ' HG2' ' A' ' 46' ' ' PRO . 2.2 mt -117.27 130.1 72.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.217 -0.927 . . . . 1.0 109.153 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 42' ' ' ALA . 0.7 OUTLIER -171.66 57.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -0.863 . . . . 1.0 109.695 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 1.104 ' CB ' HG23 ' A' ' 84' ' ' ILE . 60.7 m -145.19 43.73 1.32 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.137 -0.977 . . . . 1.0 109.845 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . 0.501 ' O ' HG12 ' A' ' 38' ' ' VAL . . . -126.64 165.95 18.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.215 -0.928 . . . . 1.0 108.833 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.848 ' O ' HG23 ' A' ' 81' ' ' VAL . . . -139.76 -179.48 17.76 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.697 -1.361 . . . . 1.0 109.697 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.85 HD11 ' CD2' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -119.43 158.54 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.357 -1.084 . . . . 1.0 109.072 179.848 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.571 ' O ' ' CE2' ' A' ' 79' ' ' TYR . 0.9 OUTLIER -99.9 126.24 46.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.239 -0.913 . . . . 1.0 109.459 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -99.76 88.76 3.89 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.191 -0.943 . . . . 1.0 109.495 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.846 ' O ' HD23 ' A' ' 126' ' ' LEU . 1.7 tt -113.25 -3.6 13.84 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.343 -0.848 . . . . 1.0 109.648 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.6 ttm180 63.69 160.18 0.09 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.141 -0.974 . . . . 1.0 109.505 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 40.8 p30 -115.83 47.81 1.31 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.244 -0.91 . . . . 1.0 109.477 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.467 ' O ' ' CB ' ' A' ' 130' ' ' ASP . 4.4 t -66.43 -28.48 68.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.913 . . . . 1.0 109.482 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.467 ' CB ' ' O ' ' A' ' 129' ' ' SER . 0.3 OUTLIER 167.32 63.82 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.196 -0.94 . . . . 1.0 109.508 -179.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.748 ' O ' HG23 ' A' ' 131' ' ' ILE . 0.6 OUTLIER -72.64 106.04 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.253 -0.904 . . . . 1.0 109.448 -179.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.3 88.43 6.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.305 -0.872 . . . . 1.0 109.578 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.734 ' H ' HD13 ' A' ' 133' ' ' LEU . 0.0 OUTLIER -74.31 159.88 31.83 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.293 -0.88 . . . . 1.0 109.96 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.462 ' O ' HD23 ' A' ' 133' ' ' LEU . 4.2 ptp85 -65.99 -168.29 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.282 -0.886 . . . . 1.0 109.526 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 134' ' ' ARG . 5.6 mmtm -44.03 106.78 0.07 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.216 -0.928 . . . . 1.0 109.466 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLY . . . . . . . . . . . . . . . -106.37 -146.9 14.1 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.604 -1.398 . . . . 1.0 109.604 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -177.3 -34.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.361 -1.082 . . . . 1.0 109.367 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.635 HG21 ' NH2' ' A' ' 74' ' ' ARG . 12.7 t -144.89 177.03 9.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.273 -0.892 . . . . 1.0 109.332 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 138' ' ' THR . 1.8 m-20 66.54 99.79 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -0.932 . . . . 1.0 109.458 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.576 HG23 ' O ' ' A' ' 140' ' ' ILE . 1.1 tp -177.84 42.24 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 1.0 109.422 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.469 ' O ' ' HD3' ' A' ' 142' ' ' ARG . . . -98.78 -8.66 54.06 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.747 -1.341 . . . . 1.0 109.747 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . 0.469 ' HD3' ' O ' ' A' ' 141' ' ' GLY . 0.0 OUTLIER 38.52 37.19 0.16 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.788 -0.831 . . . . 1.0 110.305 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 144' ' ' ASN . 1.5 mtpt -127.13 138.96 53.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.271 -0.893 . . . . 1.0 109.458 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.455 ' HB2' ' O ' ' A' ' 143' ' ' LYS . 1.2 m-20 67.38 163.28 0.19 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.204 -0.935 . . . . 1.0 109.516 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.501 ' HB ' ' CB ' ' A' ' 174' ' ' CYS . 0.0 OUTLIER -156.73 52.45 0.51 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.348 -0.845 . . . . 1.0 109.386 -179.886 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.476 ' O ' ' HB ' ' A' ' 67' ' ' THR . 11.2 mtt180 -85.1 166.62 16.49 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.267 -0.896 . . . . 1.0 109.417 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.761 ' CG2' HG21 ' A' ' 172' ' ' ILE . 2.9 m -140.57 151.7 20.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -0.841 . . . . 1.0 109.422 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.507 ' HA ' ' CB ' ' A' ' 170' ' ' ASN . 42.6 mtt180 -154.52 125.72 7.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.132 -0.98 . . . . 1.0 109.448 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.486 HD23 ' ND2' ' A' ' 170' ' ' ASN . 0.4 OUTLIER -81.26 109.48 15.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.161 -0.962 . . . . 1.0 109.717 -179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.561 HG13 ' OE1' ' A' ' 166' ' ' GLN . 44.0 t -81.47 123.85 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.377 -0.827 . . . . 1.0 109.846 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.93 ' CZ ' HD13 ' A' ' 63' ' ' LEU . 1.9 m-85 -110.4 121.51 45.46 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.656 -0.868 . . . . 1.0 108.656 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . 0.526 ' CG ' ' HA ' ' A' ' 166' ' ' GLN . 1.8 mtt180 -145.03 123.12 12.1 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.92 -1.112 . . . . 1.0 110.184 -179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.56 HG13 ' CD1' ' A' ' 163' ' ' LEU . 7.1 p -114.85 129.71 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.476 -0.935 . . . . 1.0 108.476 178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' HIS . . . . . 0.555 ' CE1' ' OG ' ' A' ' 164' ' ' SER . 49.8 m-70 -130.35 113.43 14.35 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.116 -0.99 . . . . 1.0 109.718 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.808 HG23 HD22 ' A' ' 59' ' ' LEU . 5.2 p -98.74 140.94 22.12 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.306 -0.871 . . . . 1.0 109.019 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PRO . . . . . 0.543 ' HD2' ' CG2' ' A' ' 155' ' ' VAL . 33.6 Cg_endo -75.04 116.17 4.5 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.319 2.012 . . . . 1.0 110.791 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLN . . . . . 0.483 ' HB2' ' HD2' ' A' ' 158' ' ' PRO . 0.8 OUTLIER -132.71 165.24 37.95 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.506 -0.746 . . . . 1.0 109.247 -179.556 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.483 ' HD2' ' HB2' ' A' ' 157' ' ' GLN . 33.8 Cg_endo -76.4 -63.19 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.194 1.93 . . . . 1.0 109.985 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.6 t -64.91 -90.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.32 -0.862 . . . . 1.0 109.184 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . 0.433 ' HA2' ' CD ' ' A' ' 157' ' ' GLN . . . 164.06 -28.21 0.22 Allowed Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.641 -1.383 . . . . 1.0 109.641 179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 11.4 mtt180 -79.28 79.62 5.7 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.363 -1.081 . . . . 1.0 108.556 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.668 HG22 ' N ' ' A' ' 163' ' ' LEU . 1.3 m -134.97 -82.21 0.43 Allowed 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.839 -0.8 . . . . 1.0 108.839 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LEU . . . . . 0.696 ' HG ' HG12 ' A' ' 155' ' ' VAL . 2.1 pp -159.69 106.96 1.69 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.957 -1.09 . . . . 1.0 109.728 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.555 ' OG ' ' CE1' ' A' ' 154' ' ' HIS . 0.1 OUTLIER -164.95 85.02 0.4 Allowed 'General case' 0 C--N 1.294 -1.833 0 O-C-N 120.803 -1.186 . . . . 1.0 109.141 -179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.75 ' N ' HD23 ' A' ' 165' ' ' LEU . 1.5 pt? -131.38 168.82 16.93 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.034 -1.042 . . . . 1.0 110.026 -179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.561 ' OE1' HG13 ' A' ' 150' ' ' VAL . 7.0 tp-100 -101.97 149.74 23.92 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.452 -0.78 . . . . 1.0 109.548 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 167' ' ' VAL . 39.0 t -144.18 71.51 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 1.0 109.521 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -102.44 136.19 42.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.089 -1.007 . . . . 1.0 109.5 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 170' ' ' ASN . 7.3 t -175.3 133.96 0.31 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.238 -0.914 . . . . 1.0 109.613 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.507 ' CB ' ' HA ' ' A' ' 148' ' ' ARG . 1.9 t30 170.03 97.72 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.356 -0.84 . . . . 1.0 109.436 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 23' ' ' SER . 35.3 Cg_endo -77.57 72.18 6.15 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 122.404 2.069 . . . . 1.0 110.615 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ILE . . . . . 0.761 HG21 ' CG2' ' A' ' 147' ' ' VAL . 13.9 mm -107.79 126.92 64.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.202 -0.937 . . . . 1.0 109.251 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.468 ' HA ' ' HG2' ' A' ' 146' ' ' ARG . 9.9 pt-20 -116.0 145.94 42.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.186 -0.946 . . . . 1.0 109.575 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' CYS . . . . . 0.501 ' CB ' ' HB ' ' A' ' 145' ' ' THR . 4.4 m -114.31 -170.35 1.71 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.191 -0.943 . . . . 1.0 109.414 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.415 ' C ' ' HG2' ' A' ' 176' ' ' GLN . 1.2 p 65.64 113.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 1.0 109.479 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLN . . . . . 0.415 ' HG2' ' C ' ' A' ' 175' ' ' SER . 0.0 OUTLIER -131.53 -153.29 0.55 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.301 -0.875 . . . . 1.0 109.404 -179.919 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 2.4 mpt_? -67.55 160.65 27.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 1.0 109.501 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 25.2 p . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.968 -1.015 . . . . 1.0 109.45 179.99 . . . . . . . . 0 0 . 1 stop_ save_